|
|
| G
|
1700001K19Rikl
|
RIKEN cDNA 1700001K19 gene like
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of 1700001K19RIKL mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 6:135,502,831...135,523,451
Ensembl chr 6:135,502,832...135,514,813
|
|
| G
|
9530082P21Rikl
|
RIKEN cDNA 9530082P21 gene like
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of 9530082P21RIKL mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr10:13,275,611...13,276,535
Ensembl chr10:13,275,611...13,276,535
|
|
| G
|
A2m
|
alpha-2-macroglobulin
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of A2M mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 4:156,570,163...156,619,870
Ensembl chr 4:156,569,860...156,619,868
|
|
| G
|
A4galt
|
alpha 1,4-galactosyltransferase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of A4GALT mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:116,248,571...116,272,917
Ensembl chr 7:116,247,880...116,273,171
|
|
| G
|
Aaas
|
aladin WD repeat nucleoporin
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AAAS mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:135,342,901...135,362,545
Ensembl chr 7:135,342,901...135,362,545
|
|
| G
|
Aacs
|
acetoacetyl-CoA synthetase
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of AACS mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr12:36,774,471...36,817,835
Ensembl chr12:36,774,471...36,822,543
|
|
| G
|
Aamdc
|
adipogenesis associated, Mth938 domain containing
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AAMDC mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:161,273,205...161,303,253
Ensembl chr 1:161,262,347...161,299,340
|
|
| G
|
Aars1
|
alanyl-tRNA synthetase 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of AARS1 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr19:55,906,694...55,930,499
Ensembl chr19:55,906,702...55,930,497
|
|
| G
|
Aass
|
aminoadipate-semialdehyde synthase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AASS mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:52,572,146...52,628,811
Ensembl chr 4:52,572,147...52,657,600
|
|
| G
|
Abca1
|
ATP binding cassette subfamily A member 1
|
decreases expression increases expression affects expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of ABCA1 mRNA Oxygen deficiency results in increased expression of ABCA1 mRNA; Oxygen results in increased expression of ABCA1 mRNA Oxygen deficiency affects the expression of ABCA1 protein MIR20A mRNA affects the reaction [Oxygen deficiency affects the expression of ABCA1 protein] Oxygen deficiency results in decreased expression of ABCA1 mRNA; Oxygen deficiency results in decreased expression of ABCA1 protein MIR20A mRNA promotes the reaction [Oxygen deficiency results in decreased expression of ABCA1 mRNA]; MIR20A mRNA promotes the reaction [Oxygen deficiency results in decreased expression of ABCA1 protein] [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of ABCA1 mRNA
|
CTD |
PMID:24236059 PMID:26516004 PMID:27103661 PMID:32720422 PMID:33729688 |
|
NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:72,473,676...72,596,473
|
|
| G
|
Abca3
|
ATP binding cassette subfamily A member 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ABCA3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:13,886,948...13,944,286
Ensembl chr10:13,887,083...13,944,285
|
|
| G
|
Abca4
|
ATP binding cassette subfamily A member 4
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ABCA4 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 2:212,849,470...212,986,730
Ensembl chr 2:212,755,803...212,986,729
|
|
| G
|
Abca8a
|
ATP-binding cassette, subfamily A (ABC1), member 8a
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ABCA10 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:95,501,798...95,571,770
Ensembl chr10:95,501,798...95,571,873
|
|
| G
|
Abcb11
|
ATP binding cassette subfamily B member 11
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ABCB11 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:74,424,979...74,520,581
|
|
| G
|
Abcb1a
|
ATP binding cassette subfamily B member 1A
|
multiple interactions decreases expression increases expression
|
ISO
|
pyrazolanthrone inhibits the reaction [Oxygen deficiency results in increased expression of ABCB1 mRNA] Oxygen deficiency results in decreased expression of ABCB1 mRNA
|
CTD |
PMID:15604272 PMID:19695866 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
|
|
| G
|
Abcb1b
|
ATP-binding cassette, sub-family B member 1B
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ABCB1B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:26,197,706...26,280,156
Ensembl chr 4:26,106,903...26,279,567
|
|
| G
|
Abcb6
|
ATP binding cassette subfamily B member 6
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ABCB6 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 9:84,117,222...84,125,939
Ensembl chr 9:84,117,220...84,125,526
|
|
| G
|
Abcb9
|
ATP binding cassette subfamily B member 9
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ABCB9 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr12:38,146,659...38,192,862
Ensembl chr12:38,159,904...38,192,860
|
|
| G
|
Abcc2
|
ATP binding cassette subfamily C member 2
|
multiple interactions increases expression
|
ISO
|
CA9 mutant form inhibits the reaction [[Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of ABCC2 mRNA]
|
CTD |
PMID:26305601 |
|
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471
|
|
| G
|
Abcc4
|
ATP binding cassette subfamily C member 4
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ABCC4 mRNA
|
CTD |
PMID:25536518 |
|
NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375
|
|
| G
|
Abcc5
|
ATP binding cassette subfamily C member 5
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ABCC5 mRNA
|
CTD |
PMID:25536518 |
|
NCBI chr11:93,975,579...94,071,659
Ensembl chr11:93,978,274...94,071,655
|
|
| G
|
Abcc8
|
ATP binding cassette subfamily C member 8
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of ABCC8 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:105,734,992...105,816,272
Ensembl chr 1:105,734,992...105,815,982
|
|
| G
|
Abcc9
|
ATP binding cassette subfamily C member 9
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ABCC9 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:177,262,848...177,386,837
Ensembl chr 4:177,262,848...177,386,348
|
|
| G
|
Abcg1
|
ATP binding cassette subfamily G member 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ABCG1 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr20:9,128,056...9,184,312
Ensembl chr20:9,127,803...9,186,563
|
|
| G
|
Abcg2
|
ATP binding cassette subfamily G member 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ABCG2 protein
|
CTD |
PMID:23725749 |
|
NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493
|
|
| G
|
Abhd2
|
abhydrolase domain containing 2, acylglycerol lipase
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ABHD2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:142,626,748...142,707,892
Ensembl chr 1:142,626,732...142,712,674
|
|
| G
|
Abhd4
|
abhydrolase domain containing 4, N-acyl phospholipase B
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ABHD4 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr15:31,674,090...31,686,051
Ensembl chr15:31,674,143...31,687,007
|
|
| G
|
Abhd5
|
abhydrolase domain containing 5, lysophosphatidic acid acyltransferase
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of ABHD5 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of ABHD5 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 8:130,877,834...130,903,947
Ensembl chr 8:130,877,703...130,903,947
|
|
| G
|
Abi2
|
abl-interactor 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ABI2 mRNA
|
CTD |
PMID:17175027 |
|
NCBI chr 9:69,321,072...69,490,630
Ensembl chr 9:69,321,150...69,490,597
|
|
| G
|
Abi3bp
|
ABI family member 3 binding protein
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ABI3BP mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of ABI3BP mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr11:57,381,282...57,597,989
Ensembl chr11:57,381,422...57,598,120
|
|
| G
|
Abl1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
increases metabolic processing
|
ISO
|
ABL1 protein mutant form results in increased metabolism of Oxygen
|
CTD |
PMID:33070465 |
|
NCBI chr 3:35,377,587...35,480,843
Ensembl chr 3:35,377,391...35,480,846
|
|
| G
|
Abtb2
|
ankyrin repeat and BTB domain containing 2
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of ABTB2 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ABTB2 mRNA
|
CTD |
PMID:24205000 PMID:30529165 |
|
NCBI chr 3:110,409,672...110,563,488
Ensembl chr 3:110,409,627...110,563,487
|
|
| G
|
Acaa2
|
acetyl-CoA acyltransferase 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ACAA2 mRNA
|
CTD |
PMID:19695866 |
|
NCBI chr18:70,620,310...70,648,417
Ensembl chr18:70,620,110...70,648,420
|
|
| G
|
Acaca
|
acetyl-CoA carboxylase alpha
|
increases phosphorylation
|
ISO
|
Oxygen deficiency results in increased phosphorylation of ACACA protein
|
CTD |
PMID:26087400 |
|
NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,511,857...69,773,888
|
|
| G
|
Acad11
|
acyl-CoA dehydrogenase family, member 11
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACAD11 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:113,560,142...113,625,346
Ensembl chr 8:113,560,196...113,625,352
|
|
| G
|
Acadm
|
acyl-CoA dehydrogenase medium chain
|
decreases expression multiple interactions
|
EXP ISO
|
Oxygen deficiency results in decreased expression of ACADM mRNA Trimetazidine promotes the reaction [Oxygen deficiency results in decreased expression of ACADM mRNA] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACADM mRNA
|
CTD |
PMID:25937560 PMID:30529165 |
|
NCBI chr 2:245,518,693...245,542,864
Ensembl chr 2:245,518,693...245,542,864
|
|
| G
|
Acadsb
|
acyl-CoA dehydrogenase, short/branched chain
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ACADSB mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 1:195,619,088...195,660,564
Ensembl chr 1:195,619,038...195,660,561
|
|
| G
|
Ace
|
angiotensin I converting enzyme
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of ACE mRNA; Oxygen deficiency results in increased expression of ACE protein Losartan inhibits the reaction [Oxygen deficiency results in increased expression of ACE protein]
|
CTD |
PMID:25511041 |
|
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942
|
|
| G
|
Ace2
|
angiotensin converting enzyme 2
|
multiple interactions decreases expression
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACE2 mRNA; Losartan inhibits the reaction [Oxygen deficiency results in decreased expression of ACE2 protein] Oxygen deficiency results in decreased expression of ACE2 mRNA; Oxygen deficiency results in decreased expression of ACE2 protein
|
CTD |
PMID:25511041 PMID:30529165 |
|
NCBI chr X:33,925,458...33,972,851
Ensembl chr X:33,925,458...33,971,596
|
|
| G
|
Acer2
|
alkaline ceramidase 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ACER2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 5:106,437,773...106,488,572
Ensembl chr 5:106,437,796...106,488,583
|
|
| G
|
Ache
|
acetylcholinesterase
|
multiple interactions increases expression decreases expression
|
EXP ISO
|
EPO protein inhibits the reaction [Oxygen results in increased expression of ACHE mRNA alternative form]; Trimetazidine promotes the reaction [Oxygen deficiency results in decreased expression of ACHE mRNA] Oxygen deficiency results in increased expression of ACHE mRNA
|
CTD |
PMID:19729061 PMID:25937560 PMID:26516004 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Ackr1
|
atypical chemokine receptor 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of ACKR1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DARC mRNA; Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of ACKR1 mRNA]
|
CTD |
PMID:22629407 PMID:30529165 |
|
NCBI chr13:88,314,735...88,316,354
Ensembl chr13:88,293,188...88,317,807
|
|
| G
|
Ackr3
|
atypical chemokine receptor 3
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of ACKR3 mRNA; Oxygen deficiency results in increased expression of CXCR7 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CXCR7 mRNA (+)-JQ1 compound inhibits the reaction [Oxygen deficiency results in increased expression of CXCR7 mRNA]; GSK1210151A inhibits the reaction [Oxygen deficiency results in increased expression of CXCR7 mRNA]; molibresib inhibits the reaction [Oxygen deficiency results in increased expression of CXCR7 mRNA]
|
CTD |
PMID:20042640 PMID:27292261 PMID:30529165 |
|
NCBI chr 9:98,247,300...98,258,877
Ensembl chr 9:98,246,605...98,260,214
|
|
| G
|
Acly
|
ATP citrate lyase
|
multiple interactions increases phosphorylation
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACLY mRNA Oxygen deficiency results in increased phosphorylation of ACLY protein
|
CTD |
PMID:26087400 PMID:30529165 |
|
NCBI chr10:85,912,402...85,964,605
Ensembl chr10:85,912,402...85,963,631
|
|
| G
|
Aco1
|
aconitase 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Glucose deficiency] affects the activity of ACO1 protein; Oxygen inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the activity of ACO1 protein]
|
CTD |
PMID:16135072 |
|
NCBI chr 5:60,055,895...60,111,920
Ensembl chr 5:60,055,866...60,112,600
|
|
| G
|
Aco2
|
aconitase 2
|
multiple interactions decreases expression
|
EXP ISO
|
[Glucose co-treated with Oxygen] affects the activity of ACO2 protein; manganese tetrakis-(N-ethyl-2 pyridyl) porphyrin inhibits the reaction [[Glucose co-treated with Oxygen] affects the activity of ACO2 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[Glucose co-treated with Oxygen] affects the activity of ACO2 protein] Oxygen deficiency results in decreased expression of ACO2 protein
|
CTD |
PMID:11520895 PMID:25937538 |
|
NCBI chr 7:115,265,816...115,308,931
Ensembl chr 7:115,265,791...115,308,892
|
|
| G
|
Acoxl
|
acyl-CoA oxidase-like
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACOXL mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:135,514,340...135,820,291
Ensembl chr 3:135,514,275...135,820,291
|
|
| G
|
Acp5
|
acid phosphatase 5, tartrate resistant
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ACP5 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 8:28,939,984...28,946,639
Ensembl chr 8:28,939,985...28,943,929
|
|
| G
|
Acp7
|
acid phosphatase 7, tartrate resistant
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ACP7 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:93,022,801...93,048,484
Ensembl chr 1:93,024,991...93,048,873
|
|
| G
|
Acsl1
|
acyl-CoA synthetase long-chain family member 1
|
increases expression multiple interactions decreases expression
|
ISO
|
Oxygen deficiency results in increased expression of ACSL1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACSL1 mRNA; Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of ACSL1 mRNA] Oxygen deficiency results in decreased expression of ACSL1 mRNA Oxygen deficiency results in increased expression of ACSL1 mRNA; Oxygen deficiency results in increased expression of ACSL1 protein Metformin inhibits the reaction [Oxygen deficiency results in increased expression of ACSL1 mRNA]
|
CTD |
PMID:22629407 PMID:25596134 PMID:26087400 PMID:30529165 PMID:33476677 |
|
NCBI chr16:52,487,870...52,554,110
Ensembl chr16:52,487,870...52,554,023
|
|
| G
|
Acsl4
|
acyl-CoA synthetase long-chain family member 4
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of ACSL4 protein; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of ACSL4 protein]
|
CTD |
PMID:36806343 |
|
NCBI chr X:110,739,633...110,803,416
Ensembl chr X:110,739,648...110,803,261
|
|
| G
|
Acss1
|
acyl-CoA synthetase short-chain family member 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACSS1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:159,910,809...159,960,748
Ensembl chr 3:159,910,809...159,960,748
|
|
| G
|
Acss2
|
acyl-CoA synthetase short-chain family member 2
|
increases expression multiple interactions affects expression
|
ISO
|
Oxygen deficiency results in increased expression of ACSS2 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACSS2 mRNA Oxygen deficiency affects the expression of ACSS2 protein
|
CTD |
PMID:24236059 PMID:26087400 PMID:30529165 |
|
NCBI chr 3:164,464,124...164,507,607
Ensembl chr 3:164,464,055...164,519,830
|
|
| G
|
Acta1
|
actin, alpha 1, skeletal muscle
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACTA1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ACTA1 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr19:68,781,168...68,784,194
Ensembl chr19:68,781,168...68,786,178
|
|
| G
|
Acta2
|
actin alpha 2, smooth muscle
|
affects expression multiple interactions increases expression
|
ISO EXP
|
Oxygen deficiency affects the expression of ACTA2 protein 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [Oxygen results in decreased expression of ACTA2 mRNA]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [Oxygen results in decreased expression of ACTA2 protein]]; rosiglitazone inhibits the reaction [Oxygen results in increased expression of ACTA2 mRNA]; rosiglitazone inhibits the reaction [Oxygen results in increased expression of ACTA2 protein] 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Oxygen results in increased expression of ACTA2 protein]; [POSTN gene mutant form results in decreased susceptibility to Oxygen] which results in decreased expression of ACTA2 mRNA; Y 27632 inhibits the reaction [Oxygen results in increased expression of ACTA2 protein] Oxygen results in increased expression of ACTA2 mRNA; Oxygen results in increased expression of ACTA2 protein [Oxygen deficiency co-treated with Oxygen] results in decreased expression of ACTA2 protein; Cytochalasin D inhibits the reaction [Oxygen results in increased expression of ACTA2 mRNA]; Cytochalasin D inhibits the reaction [Oxygen results in increased expression of ACTA2 protein]; diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of ACTA2 protein]; exoenzyme C3, Clostridium botulinum inhibits the reaction [Oxygen results in increased expression of ACTA2 mRNA]; exoenzyme C3, Clostridium botulinum inhibits the reaction [Oxygen results in increased expression of ACTA2 protein]; KL protein affects the reaction [Oxygen deficiency results in increased expression of ACTA2 protein]; MRTFA protein affects the reaction [Oxygen results in increased expression of ACTA2 mRNA]; MRTFA protein affects the reaction [Oxygen results in increased expression of ACTA2 protein]; Oxygen promotes the reaction [MRTFA protein binds to ACTA2 promoter]; pregna-4,17-diene-3,16-dione inhibits the reaction [Oxygen deficiency results in increased expression of ACTA2 protein]; RHOA protein affects the reaction [Oxygen results in increased expression of ACTA2 mRNA]; RHOA protein affects the reaction [Oxygen results in increased expression of ACTA2 protein]; Y 27632 inhibits the reaction [Oxygen results in increased expression of ACTA2 mRNA]; Y 27632 inhibits the reaction [Oxygen results in increased expression of ACTA2 protein] Oxygen deficiency results in increased expression of ACTA2 protein; Oxygen results in increased expression of ACTA2 mRNA; Oxygen results in increased expression of ACTA2 protein
|
CTD |
PMID:16617452 PMID:20164382 PMID:22363622 PMID:23517783 PMID:28157488 PMID:35123992 More...
|
|
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503
|
|
| G
|
Actb
|
actin, beta
|
multiple interactions
|
ISO
|
Oxygen deficiency promotes the reaction [KDM1A protein binds to ACTB promoter]
|
CTD |
PMID:25043185 |
|
NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242
|
|
| G
|
Actc1
|
actin, alpha, cardiac muscle 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACTC1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:121,266,291...121,271,827
Ensembl chr 3:121,266,291...121,271,827
|
|
| G
|
Actg1
|
actin, gamma 1
|
multiple interactions
|
EXP
|
ACTG1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
|
CTD |
PMID:21124846 |
|
NCBI chr10:106,118,106...106,120,951
Ensembl chr10:106,118,108...106,120,951
|
|
| G
|
Actg2
|
actin gamma 2, smooth muscle
|
increases expression
|
EXP
|
Oxygen results in increased expression of ACTG2 mRNA
|
CTD |
PMID:22911455 |
|
NCBI chr 4:117,579,513...117,604,379
Ensembl chr 4:117,579,514...117,604,295
|
|
| G
|
Actn1
|
actinin, alpha 1
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACTN1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ACTN1 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 6:104,731,485...104,826,312
Ensembl chr 6:104,731,485...104,826,172
|
|
| G
|
Actn2
|
actinin alpha 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACTN2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr17:62,835,055...62,902,331
Ensembl chr17:62,812,988...62,903,552
|
|
| G
|
Actr1a
|
actin related protein 1A
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of ACTR1A mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:255,179,241...255,199,009
Ensembl chr 1:255,179,242...255,199,459
|
|
| G
|
Acvrl1
|
activin A receptor like type 1
|
multiple interactions
|
ISO
|
Oxygen affects the reaction [AHR protein results in decreased expression of ACVRL1 mRNA]
|
CTD |
PMID:27103661 |
|
NCBI chr 7:134,117,917...134,135,306
Ensembl chr 7:134,118,024...134,135,305
|
|
| G
|
Acyp1
|
acylphosphatase 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACYP1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:110,650,213...110,663,404
Ensembl chr 6:110,650,213...110,663,612
|
|
| G
|
Ada
|
adenosine deaminase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADA mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:172,818,174...172,842,283
Ensembl chr 3:172,818,176...172,842,293
|
|
| G
|
Adam12
|
ADAM metallopeptidase domain 12
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of ADAM12 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ADAM12 mRNA
|
CTD |
PMID:26516004 PMID:33729688 |
|
NCBI chr 1:198,116,968...198,443,680
Ensembl chr 1:198,116,975...198,447,552
|
|
| G
|
Adam1a
|
ADAM metallopeptidase domain 1a
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of ADAM1A mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr12:40,674,460...40,680,988
Ensembl chr12:40,676,918...40,684,619
|
|
| G
|
Adam22
|
ADAM metallopeptidase domain 22
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADAM22 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:26,670,984...26,925,843
Ensembl chr 4:26,671,112...26,925,843
|
|
| G
|
Adam28
|
ADAM metallopeptidase domain 28
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ADAM28 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr15:50,184,286...50,250,605
Ensembl chr15:50,127,516...50,250,526
|
|
| G
|
Adam8
|
ADAM metallopeptidase domain 8
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADAM8 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:204,206,206...204,218,988
Ensembl chr 1:204,206,199...204,218,485
|
|
| G
|
Adamts1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of ADAMTS1 mRNA [N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride co-treated with [Oxygen deficiency co-treated with Blood Glucose deficiency]] results in increased expression of ADAMTS1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ADAMTS1 mRNA
|
CTD |
PMID:19640911 PMID:26516004 PMID:33729688 |
|
NCBI chr11:38,418,565...38,427,384
Ensembl chr11:38,418,101...38,427,390
|
|
| G
|
Adamts15
|
ADAM metallopeptidase with thrombospondin type 1 motif, 15
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ADAMTS15 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 8:37,566,064...37,589,446
Ensembl chr 8:37,566,065...37,589,446
|
|
| G
|
Adamts2
|
ADAM metallopeptidase with thrombospondin type 1 motif, 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADAMTS2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:35,422,030...35,627,483
Ensembl chr10:35,422,030...35,627,483
|
|
| G
|
Adamts20
|
ADAM metallopeptidase with thrombospondin type 1 motif, 20
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of ADAMTS20 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADAMTS20 mRNA
|
CTD |
PMID:24236059 PMID:30529165 |
|
NCBI chr 7:127,275,538...127,407,325
Ensembl chr 7:127,275,538...127,407,296
|
|
| G
|
Adamts4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADAMTS4 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ADAMTS4 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr13:86,203,011...86,212,500
Ensembl chr13:86,202,642...86,212,514
|
|
| G
|
Adamts9
|
ADAM metallopeptidase with thrombospondin type 1 motif, 9
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of ADAMTS9 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADAMTS9 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ADAMTS9 mRNA
|
CTD |
PMID:26516004 PMID:30529165 PMID:33729688 |
|
NCBI chr 4:126,847,726...127,019,924
Ensembl chr 4:126,847,729...127,019,876
|
|
| G
|
Adar
|
adenosine deaminase, RNA-specific
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of ADAR mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 2:177,436,076...177,475,969
Ensembl chr 2:177,436,094...177,475,971
|
|
| G
|
Adarb2
|
adenosine deaminase RNA specific B2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ADARB2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr17:66,660,586...67,211,104
Ensembl chr17:66,665,506...67,210,749
|
|
| G
|
Adat2
|
adenosine deaminase, tRNA-specific 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADAT2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:9,774,680...9,795,376
Ensembl chr 1:9,774,680...9,795,376
|
|
| G
|
Adcy1
|
adenylate cyclase 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of ADCY1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr14:86,125,119...86,234,459
Ensembl chr14:86,124,850...86,261,075
|
|
| G
|
Adcy7
|
adenylate cyclase 7
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADCY7 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:34,913,154...34,972,366
Ensembl chr19:34,914,322...34,936,743
|
|
| G
|
Adcy8
|
adenylate cyclase 8
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of ADCY8 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADCY8 mRNA
|
CTD |
PMID:24236059 PMID:30529165 |
|
NCBI chr 7:98,306,434...98,555,687
Ensembl chr 7:98,306,464...98,555,038
|
|
| G
|
Adcyap1r1
|
ADCYAP receptor type I
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ADCYAP1R1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 4:85,924,171...85,972,973
Ensembl chr 4:85,924,100...85,972,973
|
|
| G
|
Adgb
|
androglobin
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ADGB mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:6,573,863...6,717,632
Ensembl chr 1:6,573,225...6,739,715
|
|
| G
|
Adgra1
|
adhesion G protein-coupled receptor A1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ADGRA1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:204,059,218...204,102,869
Ensembl chr 1:204,059,367...204,102,869
|
|
| G
|
Adgrb2
|
adhesion G protein-coupled receptor B2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ADGRB2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 5:147,581,573...147,646,726
Ensembl chr 5:147,611,580...147,646,726
|
|
| G
|
Adgre1
|
adhesion G protein-coupled receptor E1
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of ADGRE1 mRNA [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of ADGRE1 mRNA
|
CTD |
PMID:23539316 PMID:27693381 |
|
NCBI chr 9:2,329,398...2,484,959
Ensembl chr 9:2,329,438...2,484,959
|
|
| G
|
Adgrg2
|
adhesion G protein-coupled receptor G2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADGRG2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr X:38,106,067...38,231,286
Ensembl chr X:38,106,067...38,231,331
|
|
| G
|
Adgrg3
|
adhesion G protein-coupled receptor G3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADGRG3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:9,978,450...10,007,145
Ensembl chr19:9,978,514...10,007,238
|
|
| G
|
Adgrg6
|
adhesion G protein-coupled receptor G6
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of ADGRG6 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADGRG6 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 1:10,633,004...10,774,685
Ensembl chr 1:10,631,829...10,774,023
|
|
| G
|
Adh1c
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ADH1C mRNA
|
CTD |
PMID:19695866 |
|
NCBI chr 2:229,470,703...229,482,291
Ensembl chr 2:229,470,703...229,482,291
|
|
| G
|
Adhfe1
|
alcohol dehydrogenase, iron containing, 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ADHFE1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 5:14,488,784...14,515,405
Ensembl chr 5:14,488,788...14,515,835
|
|
| G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
decreases expression increases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ADIPOQ mRNA Oxygen deficiency results in increased expression of ADIPOQ mRNA
|
CTD |
PMID:20594416 PMID:23539316 |
|
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
|
|
| G
|
Adm
|
adrenomedullin
|
multiple interactions increases expression affects expression
|
ISO EXP
|
1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of ADM mRNA]; Cycloheximide promotes the reaction [Oxygen deficiency results in increased expression of ADM mRNA]; deguelin inhibits the reaction [Oxygen deficiency results in increased expression of ADM mRNA]; Oxygen deficiency inhibits the reaction [darinaparsin results in increased expression of ADM mRNA]; Polyphenols inhibits the reaction [Oxygen deficiency results in increased expression of ADM mRNA]; Propolis inhibits the reaction [Oxygen deficiency results in increased expression of ADM mRNA] Oxygen deficiency results in increased expression of ADM mRNA; Oxygen deficiency results in increased expression of ADM protein Oxygen deficiency affects the expression of ADM mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADM mRNA
|
CTD |
PMID:10666155 PMID:11032871 PMID:11754965 PMID:17175027 PMID:17193925 PMID:17968679 PMID:20042640 PMID:22279137 PMID:22535156 PMID:22745725 PMID:24403227 PMID:26516004 PMID:30529165 More...
|
|
NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371
|
|
| G
|
Adm2
|
adrenomedullin 2
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of ADM2 mRNA VULM 1457 inhibits the reaction [Oxygen deficiency results in increased expression of ADM2 mRNA]
|
CTD |
PMID:16474185 |
|
NCBI chr 7:122,272,808...122,274,594
Ensembl chr 7:122,272,808...122,274,594
|
|
| G
|
Adnp
|
activity-dependent neuroprotector homeobox
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of ADNP mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:177,310,258...177,340,379
Ensembl chr 3:177,310,258...177,336,188
|
|
| G
|
Adora1
|
adenosine A1 receptor
|
multiple interactions
|
ISO
|
[1,3-dipropyl-8-cyclopentylxanthine binds to and results in decreased activity of ADORA1 protein] which results in decreased susceptibility to Oxygen deficiency
|
CTD |
PMID:23437309 |
|
NCBI chr13:48,210,922...48,247,826
Ensembl chr13:48,213,273...48,247,190
|
|
| G
|
Adora2a
|
adenosine A2a receptor
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of ADORA2A mRNA Oxygen deficiency results in increased expression of ADORA2A mRNA; Oxygen deficiency results in increased expression of ADORA2A protein 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine promotes the reaction [Oxygen deficiency results in increased expression of ADORA2A mRNA]; 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine promotes the reaction [Oxygen deficiency results in increased expression of ADORA2A protein]
|
CTD |
PMID:26516004 PMID:27289578 |
|
NCBI chr20:13,315,270...13,332,802
Ensembl chr20:13,315,270...13,332,802
|
|
| G
|
Adora2b
|
adenosine A2B receptor
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADORA2B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:47,439,712...47,456,092
Ensembl chr10:47,439,701...47,456,091
|
|
| G
|
Adra1a
|
adrenoceptor alpha 1A
|
increases expression
|
EXP
|
Oxygen deficiency results in increased expression of ADRA1A mRNA
|
CTD |
PMID:18084315 |
|
NCBI chr15:45,005,648...45,111,416
Ensembl chr15:45,005,799...45,102,534
|
|
| G
|
Adra2b
|
adrenoceptor alpha 2B
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ADRA2B mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr 3:135,038,481...135,042,527
Ensembl chr 3:135,038,474...135,042,525
|
|
| G
|
Adrb1
|
adrenoceptor beta 1
|
increases expression multiple interactions
|
EXP ISO
|
Oxygen deficiency results in increased expression of ADRB1 protein Oxygen deficiency results in increased susceptibility to [Dobutamine binds to and results in increased activity of ADRB1 protein] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADRB1 mRNA
|
CTD |
PMID:10192281 PMID:30529165 |
|
NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:265,766,079...265,849,237
|
|
| G
|
Adrb2
|
adrenoceptor beta 2
|
decreases expression multiple interactions
|
EXP ISO
|
Oxygen results in decreased expression of ADRB2 protein Oxygen affects the reaction [AHR protein results in increased expression of ADRB2 mRNA]
|
CTD |
PMID:19098126 PMID:27103661 |
|
NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803
|
|
| G
|
Adrb3
|
adrenoceptor beta 3
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of ADRB3 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADRB3 mRNA
|
CTD |
PMID:23539316 PMID:30529165 |
|
NCBI chr16:71,544,603...71,547,410
Ensembl chr16:71,542,567...71,547,420
|
|
| G
|
Adss1
|
adenylosuccinate synthase 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ADSS1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 6:137,500,549...137,523,087
Ensembl chr 6:137,501,001...137,523,086
|
|
| G
|
Aebp2
|
AE binding protein 2
|
affects methylation increases expression
|
ISO
|
Oxygen deficiency affects the methylation of AEBP2 promoter Oxygen deficiency results in increased expression of AEBP2 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 4:175,258,286...175,297,149
Ensembl chr 4:175,258,887...175,326,422
|
|
| G
|
Aen
|
apoptosis enhancing nuclease
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AEN mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:142,224,499...142,233,902
Ensembl chr 1:142,224,493...142,233,898
|
|
| G
|
Afap1
|
actin filament associated protein 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of AFAP1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr14:78,967,961...79,081,032
Ensembl chr14:78,967,961...79,080,939
|
|
| G
|
Aff3
|
ALF transcription elongation factor 3
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of AFF3 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 9:47,894,903...48,352,380
Ensembl chr 9:47,894,903...48,353,000
|
|
| G
|
Afg2a
|
AFG2 AAA ATPase homolog A
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AFG2A mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:122,234,619...122,425,808
Ensembl chr 2:122,234,738...122,425,808
|
|
| G
|
Agbl1
|
AGBL carboxypeptidase 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of AGBL1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 1:139,453,667...140,360,473
Ensembl chr 1:139,453,867...140,360,629
|
|
| G
|
Ager
|
advanced glycosylation end product-specific receptor
|
decreases expression multiple interactions
|
EXP
|
Oxygen results in decreased expression of AGER protein modified form [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] affects the expression of AGER protein; [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of AGER protein alternative form; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of AGER protein; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of AGER protein alternative form]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of AGER protein]
|
CTD |
PMID:17343756 PMID:25446913 |
|
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685
|
|
| G
|
Agmat
|
agmatinase
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of AGMAT mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 5:159,326,680...159,357,300
Ensembl chr 5:159,343,160...159,357,299
|
|
| G
|
Agmo
|
alkylglycerol monooxygenase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AGMO mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:59,713,495...60,044,851
Ensembl chr 6:59,713,467...60,044,854
|
|
| G
|
Ago1
|
argonaute RISC component 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AGO1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:144,006,618...144,064,740
Ensembl chr 5:144,006,618...144,041,624
|
|
| G
|
Ago2
|
argonaute RISC catalytic component 2
|
multiple interactions increases expression
|
ISO
|
Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of AGO2 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 7:106,907,209...106,994,124
Ensembl chr 7:106,918,125...106,993,980
|
|
| G
|
Agpat5
|
1-acylglycerol-3-phosphate O-acyltransferase 5
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AGPAT5 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr16:77,641,887...77,688,148
Ensembl chr16:77,641,887...77,688,148
|
|
| G
|
Agrn
|
agrin
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of AGRN mRNA
|
CTD |
PMID:24205000 PMID:25596134 |
|
NCBI chr 5:172,031,528...172,064,429
Ensembl chr 5:172,031,528...172,064,539
|
|
| G
|
Agt
|
angiotensinogen
|
multiple interactions increases abundance decreases expression
|
EXP ISO
|
[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of and results in increased secretion of AGT protein modified form; acetovanillone inhibits the reaction [AGT protein results in increased abundance of Oxygen]; bisphenol A inhibits the reaction [Estradiol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of and results in increased secretion of AGT protein modified form]]; Estradiol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of and results in increased secretion of AGT protein modified form]; Oxygen deficiency promotes the reaction [AGT protein results in increased expression of NOS3 protein]; Oxygen deficiency promotes the reaction [AGT protein results in increased expression of VEGFA protein]; tempol inhibits the reaction [AGT protein results in increased abundance of Oxygen]; Valsartan inhibits the reaction [AGT protein results in increased abundance of Oxygen]; Valsartan inhibits the reaction [Oxygen deficiency promotes the reaction [AGT protein results in increased expression of NOS3 protein]]; Valsartan inhibits the reaction [Oxygen deficiency promotes the reaction [AGT protein results in increased expression of VEGFA protein]] Oxygen deficiency results in decreased expression of AGT protein Oxygen deficiency results in increased expression of and results in increased secretion of AGT protein
|
CTD |
PMID:11897773 PMID:14597645 PMID:19118600 PMID:25511041 PMID:32319667 |
|
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
|
|
| G
|
Agtr1a
|
angiotensin II receptor, type 1a
|
affects expression decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency affects the expression of AGTR1 protein Oxygen deficiency results in decreased expression of AGTR1A mRNA; Oxygen deficiency results in decreased expression of AGTR1A protein Losartan inhibits the reaction [Oxygen deficiency results in increased expression of AGTR1 protein] Oxygen deficiency results in decreased expression of AGTR1 protein
|
CTD |
PMID:19118600 PMID:21825224 PMID:25511041 |
|
NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,381,467...34,435,660
|
|
| G
|
Agtr1b
|
angiotensin II receptor, type 1b
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of AGTR1B protein; bisphenol A inhibits the reaction [Estradiol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of AGTR1B protein]]; Estradiol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of AGTR1B protein]
|
CTD |
PMID:32319667 |
|
NCBI chr 2:104,774,005...104,849,262
Ensembl chr 2:104,773,930...104,849,310
|
|
| G
|
Agtr2
|
angiotensin II receptor, type 2
|
increases expression affects expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of AGTR2 mRNA Oxygen deficiency results in increased expression of AGTR2 mRNA; Oxygen deficiency results in increased expression of AGTR2 protein Oxygen deficiency affects the expression of AGTR2 protein Losartan inhibits the reaction [Oxygen deficiency results in decreased expression of AGTR2 protein]
|
CTD |
PMID:16769992 PMID:19118600 PMID:25511041 |
|
NCBI chr X:116,914,320...116,918,504
Ensembl chr X:116,913,656...116,918,745
|
|
| G
|
Agtrap
|
angiotensin II receptor-associated protein
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of AGTRAP mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:163,790,565...163,802,174
Ensembl chr 5:163,791,887...163,802,174
|
|
| G
|
Ahi1
|
Abelson helper integration site 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AHI1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:17,580,859...17,711,775
Ensembl chr 1:17,582,006...17,711,774
|
|
| G
|
Ahr
|
aryl hydrocarbon receptor
|
multiple interactions affects localization decreases expression increases response to substance affects activity affects response to substance affects expression
|
ISO EXP
|
[Methylcholanthrene co-treated with Oxygen deficiency] results in increased expression of AHR mRNA; [Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] affects the localization of AHR protein; AHR mutant form inhibits the reaction [Oxygen results in increased expression of CYP1A1 mRNA]; AHR mutant form inhibits the reaction [Oxygen results in increased expression of NQO1 mRNA]; AHR mutant form inhibits the reaction [Oxygen results in increased expression of NQO1 protein]; AHR mutant form inhibits the reaction [Oxygen results in increased expression of RELB protein]; AHR mutant form inhibits the reaction [Oxygen results in increased expression of SOD1 protein]; AHR mutant form promotes the reaction [Oxygen results in increased cleavage of PARP1 protein]; AHR mutant form promotes the reaction [Oxygen results in increased expression of CCL3 protein]; AHR mutant form promotes the reaction [Oxygen results in increased expression of CCL4 protein]; alpha-naphthoflavone inhibits the reaction [[Oxygen deficiency co-treated with Tetrachlorodibenzodioxin] results in decreased stability of AHR protein]; ARNT protein inhibits the reaction [Oxygen deficiency results in decreased activity of AHR protein]; Oxygen affects the reaction [AHR protein results in decreased expression of ACVRL1 mRNA]; Oxygen affects the reaction [AHR protein results in decreased expression of BAD mRNA]; Oxygen affects the reaction [AHR protein results in decreased expression of CALM1 mRNA]; Oxygen affects the reaction [AHR protein results in decreased expression of CCL2 mRNA]; Oxygen affects the reaction [AHR protein results in decreased expression of CCND2 mRNA]; Oxygen affects the reaction [AHR protein results in decreased expression of CDKN1A mRNA]; Oxygen affects the reaction [AHR protein results in decreased expression of KLF11 mRNA]; Oxygen affects the reaction [AHR protein results in decreased expression of MXD4 mRNA]; Oxygen affects the reaction [AHR protein results in decreased expression of SMAD3 mRNA]; Oxygen affects the reaction [AHR protein results in decreased expression of TNF mRNA]; Oxygen affects the reaction [AHR protein results in increased expression of ADRB2 mRNA]; Oxygen affects the reaction [AHR protein results in increased expression of ANXA1 mRNA]; Oxygen affects the reaction [AHR protein results in increased expression of CCL3 mRNA]; Oxygen affects the reaction [AHR protein results in increased expression of CCL5 mRNA]; Oxygen affects the reaction [AHR protein results in increased expression of CXCL10 mRNA]; Oxygen affects the reaction [AHR protein results in increased expression of FST mRNA]; Oxygen affects the reaction [AHR protein results in increased expression of KLF4 mRNA]; Oxygen affects the reaction [AHR protein results in increased expression of KPNA2 mRNA]; Oxygen affects the reaction [AHR protein results in increased expression of PRIM1 mRNA]; Oxygen affects the reaction [AHR protein results in increased expression of ZBTB16 mRNA]; Oxygen deficiency affects the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased activity of AHR protein]; Oxygen deficiency inhibits the reaction [AHR protein binds to CYP1A1 promoter]; Oxygen deficiency inhibits the reaction [AHR protein binds to CYP1B1 promoter]; Oxygen deficiency inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of AHR mRNA]; Oxygen deficiency promotes the reaction [Acetaminophen results in increased expression of AHR mRNA] Oxygen affects the localization of AHR protein; Oxygen deficiency affects the localization of AHR protein Oxygen deficiency results in decreased expression of AHR protein AHR gene mutant form results in increased susceptibility to Oxygen AHR protein affects the reaction [Oxygen results in increased expression of CYP1A1 protein]; AHR protein affects the reaction [Oxygen results in increased expression of MGST1 protein]; AHR protein affects the reaction [Oxygen results in increased expression of NQO1 protein] Oxygen deficiency affects the activity of AHR protein Oxygen results in decreased expression of AHR mRNA; Oxygen results in decreased expression of AHR protein AHR affects the susceptibility to Oxygen Oxygen deficiency affects the expression of AHR mRNA
|
CTD |
PMID:10570039 PMID:17599377 PMID:18072750 PMID:23337360 PMID:24355420 PMID:25596134 PMID:25831079 PMID:26272953 PMID:27103661 PMID:33811995 More...
|
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
|
|
| G
|
Ahrr
|
aryl-hydrocarbon receptor repressor
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of AHRR mRNA
|
CTD |
PMID:17599377 |
|
NCBI chr 1:30,822,219...30,917,251
Ensembl chr 1:30,810,866...30,952,866
|
|
| G
|
Ahsp
|
alpha hemoglobin stabilizing protein
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AHSP mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:192,310,306...192,315,943
Ensembl chr 1:192,310,244...192,315,942
|
|
| G
|
Aif1l
|
allograft inflammatory factor 1-like
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AIF1L mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:35,627,239...35,651,793
Ensembl chr 3:35,627,239...35,651,793
|
|
| G
|
Aifm1
|
apoptosis inducing factor, mitochondria associated 1
|
multiple interactions
|
EXP
|
[Oxygen co-treated with Glucose] results in decreased expression of AIFM1 protein; protosappanin A inhibits the reaction [[Oxygen co-treated with Glucose] results in decreased expression of AIFM1 protein]
|
CTD |
PMID:33225685 |
|
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:132,528,107...132,567,237
|
|
| G
|
Aifm2
|
AIF family member 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of AIFM2 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr20:30,195,781...30,222,014
Ensembl chr20:30,193,829...30,220,957
|
|
| G
|
Aimp2
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AIMP2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr12:15,814,854...15,824,432
Ensembl chr12:15,814,878...15,824,431
|
|
| G
|
Ak1
|
adenylate kinase 1
|
multiple interactions
|
EXP
|
[Nitrites co-treated with Oxygen deficiency] results in increased activity of AK1 protein
|
CTD |
PMID:22892143 |
|
NCBI chr 3:36,310,113...36,320,760
Ensembl chr 3:36,310,197...36,320,757
|
|
| G
|
Ak3
|
adenylate kinase 3
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of AK3 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AK3 mRNA
|
CTD |
PMID:25596134 PMID:30529165 |
|
NCBI chr 1:236,151,012...236,178,689
Ensembl chr 1:236,151,012...236,178,183
|
|
| G
|
Ak4
|
adenylate kinase 4
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of AK4 mRNA (+)-JQ1 compound inhibits the reaction [Oxygen deficiency results in increased expression of AK4 mRNA]
|
CTD |
PMID:20880076 PMID:25596134 PMID:26516004 PMID:27292261 |
|
NCBI chr 5:121,154,565...121,214,403
Ensembl chr 5:121,154,572...121,214,401
|
|
| G
|
Akap12
|
A-kinase anchoring protein 12
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of AKAP12 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AKAP12 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of AKAP12 mRNA
|
CTD |
PMID:24205000 PMID:26516004 PMID:30529165 PMID:33729688 |
|
NCBI chr 1:43,135,515...43,225,245
Ensembl chr 1:43,199,008...43,225,557
|
|
| G
|
Akr1b1
|
aldo-keto reductase family 1 member B1
|
multiple interactions
|
EXP ISO
|
AKR1B1 protein inhibits the reaction [Oxygen deficiency results in increased phosphorylation of EIF2A protein]; AKR1B1 protein inhibits the reaction [Oxygen deficiency results in increased phosphorylation of EIF2AK3 protein] AKR1B1 protein promotes the reaction [Oxygen deficiency results in increased expression of TNF protein]; AKR1B1 protein promotes the reaction [Oxygen deficiency results in increased expression of VEGFA protein]
|
CTD |
PMID:19041636 PMID:30682331 |
|
NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:63,899,222...63,913,315
|
|
| G
|
Akr1c14
|
aldo-keto reductase family 1, member C14
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of AKR1C14 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr17:71,066,197...71,083,184
Ensembl chr17:71,066,200...71,083,157
|
|
| G
|
Akr1c2
|
aldo-keto reductase family 1, member C2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of AKR1C2 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr17:70,669,684...70,717,935
Ensembl chr17:70,669,710...70,685,686
|
|
| G
|
Akr1c3
|
aldo-keto reductase family 1, member C3
|
multiple interactions
|
ISO
|
[AKR1C3 protein results in increased reduction of and affects the activity of benzo(a)pyrene-3,6-quinone] which results in decreased abundance of Oxygen
|
CTD |
PMID:21910479 |
|
NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438
|
|
| G
|
Akr7a2
|
aldo-keto reductase family 7, member A2
|
multiple interactions
|
ISO
|
[[AKR7A2 protein co-treated with NADP] results in increased reduction of and affects the activity of 4-hydroxyequilenin-o-quinone] which results in decreased abundance of Oxygen; [[AKR7A2 protein co-treated with NADP] results in increased reduction of and affects the activity of benzo(a)pyrene-7,8-dione] which results in decreased abundance of Oxygen
|
CTD |
PMID:21910479 |
|
NCBI chr 5:156,835,589...156,844,127
Ensembl chr 5:156,835,551...156,844,109
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
increases phosphorylation multiple interactions increases expression affects phosphorylation
|
ISO EXP
|
Oxygen deficiency results in increased phosphorylation of AKT1 protein; Oxygen results in increased phosphorylation of AKT1 protein 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine affects the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [euscaphic acid inhibits the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [tormentic acid promotes the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [euscaphic acid inhibits the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [tormentic acid inhibits the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]]; 3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of AKT1 mRNA]; [AKT1 protein affects the reaction [Sulindac analog results in decreased expression of HIF1A protein]] which affects the susceptibility to Oxygen; [Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT1 protein; [Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of AKT1 mRNA; [Oxygen co-treated with Ozone] results in decreased expression of AKT1 mRNA; [Oxygen deficiency results in increased phosphorylation of AKT1 protein] which affects the susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine; AKT1 protein modified form inhibits the reaction [trichostatin A inhibits the reaction [Oxygen deficiency results in increased expression of MMP2 mRNA]]; AKT1 protein modified form inhibits the reaction [trichostatin A inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA]]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of AKT1 mRNA]; euscaphic acid inhibits the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]; fisetin inhibits the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]; Folic Acid inhibits the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]; genipin inhibits the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of AKT1 mRNA]; Luteolin inhibits the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]; nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT1 protein]; Oxygen deficiency affects the reaction [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [Sorafenib results in decreased phosphorylation of AKT1 protein]]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of AKT1 mRNA]; Quercetin inhibits the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of AKT1 mRNA]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]; shikonin promotes the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]; tormentic acid promotes the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]; trichostatin A inhibits the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]; Wortmannin inhibits the reaction [nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT1 protein]]; Wortmannin inhibits the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein] Oxygen deficiency affects the phosphorylation of AKT1 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Capsaicin co-treated with Oxygen deficiency co-treated with Oxygen] results in increased phosphorylation of AKT1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]; [Capsaicin co-treated with Oxygen deficiency co-treated with Oxygen] results in increased phosphorylation of AKT1 protein; [kaempferol co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] inhibits the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]; cobaltiprotoporphyrin promotes the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]; GW 441756 inhibits the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]; kaempferol inhibits the reaction [Oxygen deficiency results in increased expression of AKT1 mRNA]; kaempferol inhibits the reaction [Oxygen deficiency results in increased expression of AKT1 protein]; kaempferol inhibits the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]; NGF protein inhibits the reaction [Quercetin inhibits the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]]; Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of AKT1 mRNA]; Quercetin inhibits the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]; Sildenafil Citrate inhibits the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]; tin protoporphyrin IX inhibits the reaction [cobaltiprotoporphyrin promotes the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]] Oxygen deficiency results in increased expression of AKT1 mRNA; Oxygen deficiency results in increased expression of AKT1 protein
|
CTD |
PMID:18924134 PMID:19011674 PMID:19587783 PMID:20153296 PMID:23036488 PMID:23144690 PMID:23452621 PMID:23728938 PMID:24658657 PMID:25448280 PMID:26087400 PMID:26476374 PMID:26509796 PMID:26974319 PMID:28684144 PMID:29630948 PMID:32298737 PMID:32992648 PMID:36940862 PMID:37923178 PMID:38528077 More...
|
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Akt2
|
AKT serine/threonine kinase 2
|
multiple interactions increases expression
|
ISO
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of AKT2 protein modified form]; 3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of AKT2 protein]; [Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT2 protein; [Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of AKT2 mRNA; [Oxygen co-treated with Ozone] results in decreased expression of AKT2 mRNA; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of AKT2 protein modified form]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of AKT2 protein]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of AKT2 protein modified form]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of AKT2 protein]; nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT2 protein]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of AKT2 protein modified form]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of AKT2 protein]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of AKT2 protein modified form]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of AKT2 protein]; Wortmannin inhibits the reaction [nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT2 protein]] Oxygen deficiency results in increased expression of AKT2 protein; Oxygen deficiency results in increased expression of AKT2 protein modified form
|
CTD |
PMID:23452621 PMID:32992648 PMID:38528077 |
|
NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:92,014,859...92,061,420
|
|
| G
|
Akt3
|
AKT serine/threonine kinase 3
|
multiple interactions
|
ISO
|
[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT3 protein; nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT3 protein]; Wortmannin inhibits the reaction [nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of AKT3 protein]]
|
CTD |
PMID:38528077 |
|
NCBI chr13:91,475,839...91,758,060
Ensembl chr13:91,475,839...91,748,020
|
|
| G
|
Alas1
|
5'-aminolevulinate synthase 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ALAS1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:115,755,238...115,768,642
Ensembl chr 8:115,755,238...115,768,642
|
|
| G
|
Alas2
|
5'-aminolevulinate synthase 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ALAS2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr X:22,890,650...22,914,046
Ensembl chr X:22,890,689...22,914,043
|
|
| G
|
Alb
|
albumin
|
increases expression multiple interactions increases secretion
|
ISO EXP
|
Oxygen deficiency results in increased expression of ALB protein cobaltous chloride inhibits the reaction [Oxygen deficiency results in increased secretion of ALB protein]
|
CTD |
PMID:21296072 PMID:25937538 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
| G
|
Alcam
|
activated leukocyte cell adhesion molecule
|
multiple interactions
|
EXP ISO
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ALCAM mRNA [Oxygen deficiency co-treated with Oxygen] results in decreased expression of ALCAM mRNA; ALCAM protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of VIM protein]; ALCAM protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of CDH1 protein]; ALCAM protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of ENG protein]; PPARG protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of ALCAM protein]
|
CTD |
PMID:33729688 PMID:34995009 |
|
NCBI chr11:61,804,932...62,005,250
Ensembl chr11:61,805,049...62,006,876
|
|
| G
|
Aldh18a1
|
aldehyde dehydrogenase 18 family, member A1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ALDH18A1 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 1:249,325,082...249,357,383
Ensembl chr 1:249,325,082...249,357,383
|
|
| G
|
Aldh1a1
|
aldehyde dehydrogenase 1 family, member A1
|
multiple interactions increases expression
|
ISO EXP
|
CA9 mutant form inhibits the reaction [[Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of ALDH1A1 mRNA] [Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of ALDH1A1 mRNA; [Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of ALDH1A1 protein [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of ALDH1A1 mRNA
|
CTD |
PMID:26305601 PMID:33729688 |
|
NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500
|
|
| G
|
Aldh1a2
|
aldehyde dehydrogenase 1 family, member A2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ALDH1A2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 8:80,758,641...80,837,891
Ensembl chr 8:80,758,142...80,837,883
|
|
| G
|
Aldh1a3
|
aldehyde dehydrogenase 1 family, member A3
|
affects expression multiple interactions
|
ISO
|
Oxygen deficiency affects the expression of ALDH1A3 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ALDH1A3 mRNA
|
CTD |
PMID:25596134 PMID:30529165 |
|
NCBI chr 1:129,392,516...129,436,552
Ensembl chr 1:129,392,516...129,427,777
|
|
| G
|
Aldh1l2
|
aldehyde dehydrogenase 1 family, member L2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ALDH1L2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:22,141,872...22,193,403
Ensembl chr 7:22,141,842...22,193,398
|
|
| G
|
Aldh3a1
|
aldehyde dehydrogenase 3 family, member A1
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of ALDH3A1 mRNA Oxygen deficiency inhibits the reaction [Benzo(a)pyrene results in increased expression of ALDH3A1 mRNA] [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of ALDH3A1 mRNA
|
CTD |
PMID:14645679 PMID:33729688 |
|
NCBI chr10:46,392,464...46,402,151
Ensembl chr10:46,392,411...46,402,151
|
|
| G
|
Aldh6a1
|
aldehyde dehydrogenase 6 family, member A1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ALDH6A1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:109,809,092...109,829,725
Ensembl chr 6:109,809,122...109,829,743
|
|
| G
|
Aldoa
|
aldolase, fructose-bisphosphate A
|
multiple interactions increases expression
|
ISO
|
Cadmium inhibits the reaction [Oxygen deficiency results in increased expression of ALDOA mRNA]; HIF1A protein alternative form inhibits the reaction [Oxygen deficiency results in increased expression of ALDOA mRNA]
|
CTD |
PMID:10866824 PMID:11739637 PMID:19502547 PMID:20042640 PMID:25596134 |
|
NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:190,832,820...190,838,211
|
|
| G
|
Aldoc
|
aldolase, fructose-bisphosphate C
|
affects expression increases expression
|
ISO
|
Oxygen deficiency affects the expression of ALDOC mRNA Oxygen deficiency results in increased expression of ALDOC mRNA
|
CTD |
PMID:17193925 PMID:19502547 PMID:20042640 PMID:20880076 PMID:24236059 PMID:26516004 More...
|
|
NCBI chr10:63,715,544...63,719,133
Ensembl chr10:63,715,489...63,719,133
|
|
| G
|
Alg10
|
ALG10, alpha-1,2-glucosyltransferase
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of ALG10B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:123,214,636...123,225,104
Ensembl chr 7:123,214,636...123,225,104
|
|
| G
|
Alg13
|
ALG13, UDP-N-acetylglucosaminyltransferase subunit
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ALG13 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr X:112,703,015...112,764,924
Ensembl chr X:112,702,796...112,739,356
|
|
| G
|
Alg3
|
ALG3, alpha-1,3- mannosyltransferase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ALG3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr11:93,804,859...93,810,403
Ensembl chr11:93,804,891...93,812,060
|
|
| G
|
Alkbh2
|
alkB homolog 2, alpha-ketoglutarate-dependent dioxygenase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ALKBH2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr12:48,156,825...48,161,489
Ensembl chr12:48,156,827...48,161,483
|
|
| G
|
Alkbh5
|
alkB homolog 5, RNA demethylase
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of ALKBH5 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of ALKBH5 mRNA] [Oxygen deficiency co-treated with Oxygen] results in increased expression of ALKBH5 mRNA; [Oxygen deficiency co-treated with Oxygen] results in increased expression of ALKBH5 protein; ALKBH5 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of PPARG protein]; ALKBH5 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of VIM protein]; ALKBH5 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of CDH1 protein]; ALKBH5 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of ENG protein]; PKF115-584 promotes the reaction [ALKBH5 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of VIM protein]]; PKF115-584 promotes the reaction [ALKBH5 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of CDH1 protein]]; PKF115-584 promotes the reaction [ALKBH5 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of ENG protein]]
|
CTD |
PMID:22629407 PMID:34995009 |
|
NCBI chr10:45,844,411...45,865,853
Ensembl chr10:45,843,656...45,869,658
|
|
| G
|
Alox12
|
arachidonate 12-lipoxygenase, 12S type
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ALOX12 mRNA
|
CTD |
PMID:35883890 |
|
NCBI chr10:55,456,923...55,469,239
Ensembl chr10:55,456,928...55,469,199
|
|
| G
|
Alox15
|
arachidonate 15-lipoxygenase
|
multiple interactions increases activity
|
EXP
|
[[Oxygen deficiency results in increased activity of ALOX15 protein] which results in increased chemical synthesis of 15-hydroxy-5,8,11,13-eicosatetraenoic acid] which results in decreased expression of KCNA5 mRNA; [[Oxygen deficiency results in increased activity of ALOX15 protein] which results in increased chemical synthesis of 15-hydroxy-5,8,11,13-eicosatetraenoic acid] which results in decreased expression of KCNA5 protein; [Oxygen deficiency results in increased activity of ALOX15 protein] which results in increased chemical synthesis of 15-hydroxy-5,8,11,13-eicosatetraenoic acid; ALOX15 protein promotes the reaction [Oxygen deficiency results in decreased activity of KCNA5 protein]; cinnamyl-3,4-dihydroxycyanocinnamate inhibits the reaction [[[Oxygen deficiency results in increased activity of ALOX15 protein] which results in increased chemical synthesis of 15-hydroxy-5,8,11,13-eicosatetraenoic acid] which results in decreased expression of KCNA5 mRNA]; Masoprocol inhibits the reaction [[[Oxygen deficiency results in increased activity of ALOX15 protein] which results in increased chemical synthesis of 15-hydroxy-5,8,11,13-eicosatetraenoic acid] which results in decreased expression of KCNA5 mRNA]
|
CTD |
PMID:18984061 |
|
NCBI chr10:55,559,060...55,567,535
Ensembl chr10:55,559,061...55,567,723
|
|
| G
|
Alox5
|
arachidonate 5-lipoxygenase
|
multiple interactions increases expression
|
EXP ISO
|
[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein; caffeic acid inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein]; Edaravone inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein]; SB 203580 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein] Oxygen deficiency results in increased expression of ALOX5 mRNA
|
CTD |
PMID:18951527 PMID:26516004 |
|
NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:151,203,949...151,251,126
|
|
| G
|
Alox5ap
|
arachidonate 5-lipoxygenase activating protein
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ALOX5AP mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr12:10,785,254...10,809,295
Ensembl chr12:10,785,257...10,817,038
|
|
| G
|
Alpl
|
alkaline phosphatase, biomineralization associated
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of ALPL mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ALPL mRNA; Oxygen deficiency inhibits the reaction [LIF protein affects the reaction ALPL mRNA]
|
CTD |
PMID:26516004 PMID:26723917 PMID:30529165 |
|
NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167
|
|
| G
|
Als2cl
|
ALS2 C-terminal like
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ALS2CL mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 8:119,746,498...119,762,824
Ensembl chr 8:119,743,248...119,762,843
|
|
| G
|
Alyref
|
Aly/REF export factor
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ALYREF mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:106,369,750...106,373,395
Ensembl chr10:106,369,750...106,373,395
|
|
| G
|
Ampd3
|
adenosine monophosphate deaminase 3
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of AMPD3 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AMPD3 mRNA
|
CTD |
PMID:20880076 PMID:30529165 |
|
NCBI chr 1:174,319,526...174,364,605
Ensembl chr 1:174,294,867...174,364,608
|
|
| G
|
Anapc13
|
anaphase promoting complex subunit 13
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANAPC13 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:112,084,405...112,092,821
Ensembl chr 8:112,084,405...112,092,821
|
|
| G
|
Anapc15
|
anaphase promoting complex subunit 15
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANAPC15 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:165,650,478...165,678,004
Ensembl chr 1:165,675,754...165,679,501
|
|
| G
|
Anapc16
|
anaphase promoting complex subunit 16
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ANAPC16 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr20:28,470,282...28,484,601
Ensembl chr20:28,470,282...28,484,987
|
|
| G
|
Anapc4
|
anaphase promoting complex subunit 4
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of ANAPC4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:62,338,798...62,370,572
Ensembl chr14:62,338,798...62,370,572
|
|
| G
|
Ang
|
angiogenin
|
increases expression increases secretion
|
ISO
|
Oxygen deficiency results in increased expression of ANG mRNA Oxygen deficiency results in increased secretion of ANG protein
|
CTD |
PMID:16490744 |
|
NCBI chr15:26,786,233...26,796,883
Ensembl chr15:26,786,065...26,801,106
|
|
| G
|
Angpt1
|
angiopoietin 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of ANGPT1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANGPT1 mRNA; ARNT gene mutant form inhibits the reaction [Oxygen deficiency results in increased expression of ANGPT1 mRNA]
|
CTD |
PMID:20412331 PMID:30529165 |
|
NCBI chr 7:75,415,959...75,668,696
Ensembl chr 7:75,418,218...75,668,696
|
|
| G
|
Angpt2
|
angiopoietin 2
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of ANGPT2 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANGPT2 mRNA; cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [Oxygen results in increased expression of ANGPT2 mRNA] [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ANGPT2 mRNA
|
CTD |
PMID:10854229 PMID:25203536 PMID:30529165 PMID:33729688 |
|
NCBI chr16:77,790,760...77,841,241
Ensembl chr16:77,790,563...77,841,239
|
|
| G
|
Angpt4
|
angiopoietin 4
|
decreases expression
|
ISO
|
Oxygen results in decreased expression of ANGPT4 mRNA
|
CTD |
PMID:23034257 |
|
NCBI chr 3:160,880,539...160,913,923
Ensembl chr 3:160,880,728...160,913,921
|
|
| G
|
Angptl1
|
angiopoietin-like 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of ANGPTL1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr13:71,463,913...71,531,810
Ensembl chr13:71,511,727...71,531,818
|
|
| G
|
Angptl2
|
angiopoietin-like 2
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANGPTL2 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of ANGPTL2 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 3:36,914,876...36,944,715
Ensembl chr 3:36,914,745...36,945,876
|
|
| G
|
Angptl4
|
angiopoietin-like 4
|
increases expression multiple interactions decreases expression
|
ISO EXP
|
Oxygen deficiency results in increased expression of ANGPTL4 mRNA 1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of ANGPTL4 mRNA]; deguelin inhibits the reaction [Oxygen deficiency results in increased expression of ANGPTL4 mRNA]; diallyl trisulfide inhibits the reaction [Oxygen deficiency results in increased expression of ANGPTL4 mRNA] Oxygen results in decreased expression of ANGPTL4 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANGPTL4 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ANGPTL4 mRNA
|
CTD |
PMID:17175027 PMID:19924283 PMID:20880076 PMID:22535284 PMID:22745725 PMID:24403227 PMID:25596134 PMID:26516004 PMID:28574600 PMID:30529165 PMID:33729688 More...
|
|
NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:15,252,473...15,258,681
|
|
| G
|
Angptl6
|
angiopoietin-like 6
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANGPTL6 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:27,689,804...27,696,172
Ensembl chr 8:27,689,806...27,696,111
|
|
| G
|
Angptl7
|
angiopoietin like 7
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of ANGPTL7 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of ANGPTL7 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 5:164,215,223...164,220,408
Ensembl chr 5:164,215,223...164,220,584
|
|
| G
|
Angptl8
|
angiopoietin-like 8
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANGPTL8 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:28,652,555...28,654,581
Ensembl chr 8:28,652,555...28,654,581
|
|
| G
|
Ank1
|
ankyrin 1
|
multiple interactions increases expression
|
ISO
|
Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of ANK1 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr16:75,578,824...75,757,464
Ensembl chr16:75,578,824...75,757,464
|
|
| G
|
Ank2
|
ankyrin 2
|
increases expression decreases expression
|
ISO
|
Oxygen deficiency results in increased expression of ANK2 mRNA Oxygen deficiency results in decreased expression of ANK2 mRNA
|
CTD |
PMID:24205000 PMID:24236059 |
|
NCBI chr 2:218,052,555...218,628,414
Ensembl chr 2:218,052,555...218,537,259
|
|
| G
|
Ank3
|
ankyrin 3
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ANK3 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr20:18,601,307...19,224,790
Ensembl chr20:18,601,826...19,084,879
|
|
| G
|
Ankra2
|
ankyrin repeat family A member 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ANKRA2 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 2:31,347,158...31,358,002
Ensembl chr 2:31,347,090...31,364,394
|
|
| G
|
Ankrd1
|
ankyrin repeat domain 1
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of ANKRD1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANKRD1 mRNA
|
CTD |
PMID:24236059 PMID:30529165 |
|
NCBI chr 1:243,228,460...243,237,014
Ensembl chr 1:243,228,448...243,263,751
|
|
| G
|
Ankrd10
|
ankyrin repeat domain 10
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of ANKRD10 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr16:84,566,021...84,591,849
Ensembl chr16:84,568,506...84,591,846
|
|
| G
|
Ankrd17
|
ankyrin repeat domain 17
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ANKRD17 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr14:18,007,342...18,145,980
Ensembl chr14:18,008,859...18,145,980
|
|
| G
|
Ankrd2
|
ankyrin repeat domain 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ANKRD2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:250,796,419...250,805,867
Ensembl chr 1:250,796,409...250,805,870
|
|
| G
|
Ankrd28
|
ankyrin repeat domain 28
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANKRD28 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr16:6,924,868...7,056,593
Ensembl chr16:6,924,882...7,056,593
|
|
| G
|
Ankrd37
|
ankyrin repeat domain 37
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of ANKRD37 mRNA 1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of ANKRD37 mRNA] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANKRD37 mRNA
|
CTD |
PMID:19502547 PMID:20042640 PMID:20880076 PMID:24236059 PMID:24403227 PMID:26516004 PMID:30529165 More...
|
|
NCBI chr16:53,001,487...53,004,545
Ensembl chr16:52,994,740...53,004,545
|
|
| G
|
Ankrd44
|
ankyrin repeat domain 44
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANKRD44 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:63,621,193...63,921,999
Ensembl chr 9:63,555,869...63,921,940
|
|
| G
|
Ankrd45
|
ankyrin repeat domain 45
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ANKRD45 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr13:75,957,047...75,984,868
Ensembl chr13:75,957,926...75,984,910
|
|
| G
|
Ankrd49
|
ankyrin repeat domain 49
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANKRD49 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:19,908,968...19,913,656
Ensembl chr 8:19,908,973...19,913,656
|
|
| G
|
Ankrd50
|
ankyrin repeat domain containing 50
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANKRD50 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:123,394,311...123,428,788
Ensembl chr 2:123,396,606...123,427,340
|
|
| G
|
Ankrd9
|
ankyrin repeat domain 9
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ANKRD9 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 6:135,827,355...135,830,002
Ensembl chr 6:135,775,869...135,837,893
|
|
| G
|
Anln
|
anillin, actin binding protein
|
increases expression decreases expression
|
ISO
|
Oxygen deficiency results in increased expression of ANLN mRNA Oxygen deficiency results in decreased expression of ANLN mRNA
|
CTD |
PMID:24205000 PMID:26516004 |
|
NCBI chr 8:29,134,222...29,197,513
Ensembl chr 8:29,134,222...29,197,513
|
|
| G
|
Antxr1
|
ANTXR cell adhesion molecule 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of ANTXR1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANTXR1 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 4:121,148,102...121,335,549
Ensembl chr 4:121,148,103...121,336,892
|
|
| G
|
Antxr2
|
ANTXR cell adhesion molecule 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANTXR2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:11,845,774...11,986,166
Ensembl chr14:11,845,700...11,986,168
|
|
| G
|
Anxa1
|
annexin A1
|
multiple interactions
|
ISO
|
Oxygen affects the reaction [AHR protein results in increased expression of ANXA1 mRNA]
|
CTD |
PMID:27103661 |
|
NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831
|
|
| G
|
Anxa2
|
annexin A2
|
affects expression
|
ISO
|
Oxygen deficiency affects the expression of ANXA2 mRNA
|
CTD |
PMID:17193925 |
|
NCBI chr 8:78,986,252...79,022,638
Ensembl chr 8:78,986,242...79,022,631
|
|
| G
|
Anxa3
|
annexin A3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANXA3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:13,031,675...13,085,678
Ensembl chr14:13,023,762...13,085,849
|
|
| G
|
Anxa8
|
annexin A8
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANXA8 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr16:9,403,267...9,418,317
Ensembl chr16:9,403,353...9,418,310
|
|
| G
|
Aoc1
|
amine oxidase, copper containing 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of AOC1 mRNA Simvastatin inhibits the reaction [Oxygen deficiency results in increased expression of AOC1 mRNA]
|
CTD |
PMID:16373842 |
|
NCBI chr 4:79,143,126...79,162,705
Ensembl chr 4:79,143,126...79,162,704
|
|
| G
|
Aoc3
|
amine oxidase, copper containing 3
|
decreases expression
|
EXP
|
Oxygen results in decreased expression of AOC3 mRNA
|
CTD |
PMID:22911455 |
|
NCBI chr10:86,773,018...86,780,961
|
|
| G
|
Aox1
|
aldehyde oxidase 1
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AOX1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of AOX1 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 9:67,073,831...67,152,980
Ensembl chr 9:67,073,821...67,152,980
|
|
| G
|
Ap1m1
|
adaptor related protein complex 1 subunit mu 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of AP1M1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr16:17,620,910...17,636,431
Ensembl chr16:17,616,187...17,636,462
|
|
| G
|
Ap2a1
|
adaptor related protein complex 2 subunit alpha 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of AP2A1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 1:104,520,789...104,550,655
Ensembl chr 1:104,520,792...104,550,655
|
|
| G
|
Ap3b2
|
adaptor related protein complex 3 subunit beta 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of AP3B2 mRNA
|
CTD |
PMID:17175027 |
|
NCBI chr 1:144,821,819...144,854,533
Ensembl chr 1:144,821,819...144,854,432
|
|
| G
|
Ap3m1
|
adaptor related protein complex 3 subunit mu 1
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of AP3M1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr15:3,285,591...3,314,139
Ensembl chr15:3,295,444...3,313,104
|
|
| G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
increases expression
|
EXP
|
Oxygen deficiency results in increased expression of APAF1 protein
|
CTD |
PMID:21468576 |
|
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772
|
|
| G
|
Apbb1
|
amyloid beta precursor protein binding family B member 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of APBB1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:169,308,719...169,332,372
Ensembl chr 1:169,308,720...169,332,552
|
|
| G
|
Apc
|
APC regulator of WNT signaling pathway
|
increases expression affects methylation
|
ISO
|
Oxygen deficiency results in increased expression of APC mRNA Oxygen deficiency affects the methylation of APC promoter
|
CTD |
PMID:24205000 |
|
NCBI chr18:26,138,382...26,196,021
Ensembl chr18:26,102,679...26,197,022
|
|
| G
|
Apex1
|
apurinic/apyrimidinic endodeoxyribonuclease 1
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of APEX1 mRNA; Oxygen deficiency results in decreased expression of APEX1 protein APEX1 protein inhibits the reaction [RAC1 protein inhibits the reaction [Oxygen deficiency results in increased expression of SERPINE1 mRNA]]; APEX1 protein promotes the reaction [Oxygen deficiency results in increased expression of SERPINE1 mRNA] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of APEX1 mRNA
|
CTD |
PMID:12719791 PMID:25030372 PMID:30529165 PMID:38909692 |
|
NCBI chr15:26,618,146...26,620,330
Ensembl chr15:26,618,224...26,620,329
|
|
| G
|
Apln
|
apelin
|
increases secretion increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased secretion of APLN protein Oxygen deficiency results in increased expression of APLN mRNA cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [Oxygen results in increased expression of APLN mRNA]; HIF1A gene mutant form inhibits the reaction [Oxygen deficiency results in increased secretion of APLN protein]; Rotenone inhibits the reaction [Oxygen deficiency results in increased expression of APLN mRNA]; Rotenone inhibits the reaction [Oxygen deficiency results in increased expression of APLN protein] Oxygen deficiency results in increased expression of APLN mRNA; Oxygen deficiency results in increased expression of APLN protein; Oxygen results in increased expression of APLN mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of APLN mRNA
|
CTD |
PMID:17878221 PMID:24236059 PMID:25203536 PMID:33729688 |
|
NCBI chr X:132,058,739...132,091,518
Ensembl chr X:132,081,759...132,091,246
|
|
| G
|
Aplnr
|
apelin receptor
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of APLNR mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:90,624,055...90,627,700
Ensembl chr 3:90,624,012...90,627,908
|
|
| G
|
Apob
|
apolipoprotein B
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of APOB mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:36,563,704...36,611,814
|
|
| G
|
Apoc1
|
apolipoprotein C1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of APOC1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:88,475,018...88,479,052
Ensembl chr 1:88,474,663...88,478,155
|
|
| G
|
Apod
|
apolipoprotein D
|
decreases response to substance
|
ISO
|
APOD protein results in decreased susceptibility to Oxygen deficiency
|
CTD |
PMID:18458334 |
|
NCBI chr11:82,936,216...82,957,264
Ensembl chr11:82,936,038...82,957,263
|
|
| G
|
Apol9a
|
apolipoprotein L9a
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of APOL9A mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 7:111,021,452...111,030,380
Ensembl chr 7:111,021,453...111,028,213
|
|
| G
|
Apold1
|
apolipoprotein L domain containing 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of APOLD1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of APOLD1 mRNA
|
CTD |
PMID:20880076 PMID:30529165 |
|
NCBI chr 4:169,499,728...169,557,075
Ensembl chr 4:169,549,679...169,559,176
|
|
| G
|
Appl2
|
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of APPL2 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of APPL2 mRNA
|
CTD |
PMID:20880076 PMID:30529165 |
|
NCBI chr 7:22,019,480...22,072,386
Ensembl chr 7:22,022,963...22,072,385
|
|
| G
|
Aprt
|
adenine phosphoribosyl transferase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of APRT mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:67,534,737...67,537,027
|
|
| G
|
Aptx
|
aprataxin
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of APTX mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:60,593,338...60,618,946
Ensembl chr 5:60,597,648...60,618,790
|
|
| G
|
Aqp1
|
aquaporin 1
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of AQP1 mRNA Oxygen deficiency results in increased expression of AQP1 protein Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of AQP1 protein] [AQP1 protein results in increased stability of EPAS1 protein] promotes the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]; Oxygen deficiency inhibits the reaction [AQP1 protein results in decreased expression of EGLN3 mRNA]
|
CTD |
PMID:22415096 PMID:23545307 PMID:24205000 |
|
NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:85,812,784...85,830,504
|
|
| G
|
Aqp3
|
aquaporin 3 (Gill blood group)
|
multiple interactions
|
EXP
|
[AQP3 protein results in increased stability of EPAS1 protein] promotes the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]; [Oxygen deficiency co-treated with AQP3 protein] results in increased expression of EGLN1 mRNA; [Oxygen deficiency co-treated with AQP3 protein] results in increased expression of PGK1 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of AQP3 mRNA; AQP3 protein promotes the reaction [Oxygen deficiency results in increased expression of EGLN3 mRNA]; AQP3 protein promotes the reaction [Oxygen deficiency results in increased expression of VEGFA mRNA]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Oxygen inhibits the reaction [AQP3 protein results in increased stability of EPAS1 protein]]; Oxygen deficiency inhibits the reaction [AQP3 protein results in decreased expression of EGLN3 mRNA]; Oxygen inhibits the reaction [AQP3 protein results in increased stability of EPAS1 protein]
|
CTD |
PMID:23545307 PMID:33729688 |
|
NCBI chr 5:61,035,165...61,040,683
Ensembl chr 5:61,035,166...61,040,685
|
|
| G
|
Aqp5
|
aquaporin 5
|
multiple interactions
|
EXP
|
[AQP5 protein results in increased stability of EPAS1 protein] promotes the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Oxygen inhibits the reaction [AQP5 protein results in increased stability of EPAS1 protein]]; Oxygen inhibits the reaction [AQP5 protein results in increased stability of EPAS1 protein]
|
CTD |
PMID:23545307 |
|
NCBI chr 7:132,601,528...132,605,060
Ensembl chr 7:132,601,059...132,605,062
|
|
| G
|
Aqp9
|
aquaporin 9
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of AQP9 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 8:80,678,027...80,718,273
Ensembl chr 8:80,678,030...80,717,240
|
|
| G
|
Ar
|
androgen receptor
|
multiple interactions
|
ISO EXP
|
Oxygen deficiency promotes the reaction [Dihydrotestosterone results in increased activity of AR protein]; resveratrol inhibits the reaction [Oxygen deficiency promotes the reaction [Dihydrotestosterone results in increased activity of AR protein]]; resveratrol inhibits the reaction [Oxygen deficiency results in increased activity of AR protein] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AR mRNA [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of AR mRNA; tetrahydropalmatine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of AR mRNA]
|
CTD |
PMID:25297617 PMID:30529165 PMID:37606869 |
|
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
|
|
| G
|
Arap2
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARAP2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:50,921,323...51,120,972
Ensembl chr14:50,921,713...51,120,962
|
|
| G
|
Areg
|
amphiregulin
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AREG mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of AREG mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr14:17,256,384...17,265,641
Ensembl chr14:17,256,384...17,265,641
|
|
| G
|
Arf4
|
ARF GTPase 4
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ARF4 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr16:1,903,238...1,920,012
Ensembl chr16:1,903,371...1,920,011
|
|
| G
|
Arfgef2
|
ARF guanine nucleotide exchange factor 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ARFGEF2 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 3:175,966,575...176,052,715
Ensembl chr 3:175,966,579...176,052,713
|
|
| G
|
Arg1
|
arginase 1
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of ARG1 mRNA [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of ARG1 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ARG1 mRNA; HU 308 promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of ARG1 mRNA]; iodopravadoline inhibits the reaction [peoniflorin promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of ARG1 mRNA]]; peoniflorin promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of ARG1 mRNA]
|
CTD |
PMID:20880076 PMID:27313889 PMID:29560022 PMID:33729688 |
|
NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:22,295,322...22,307,713
|
|
| G
|
Arg2
|
arginase 2
|
multiple interactions increases expression
|
ISO
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of ARG2 protein]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of ARG2 mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of ARG2 protein] Oxygen deficiency results in increased expression of ARG2 mRNA; Oxygen deficiency results in increased expression of ARG2 protein [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARG2 mRNA
|
CTD |
PMID:20042640 PMID:23424623 PMID:24951775 PMID:30529165 |
|
NCBI chr 6:103,669,001...103,694,375
Ensembl chr 6:103,668,988...103,694,375
|
|
| G
|
Arhgap11a
|
Rho GTPase activating protein 11A
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ARHGAP11A mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 3:121,045,187...121,071,985
Ensembl chr 3:121,045,187...121,061,468
|
|
| G
|
Arhgap19
|
Rho GTPase activating protein 19
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ARHGAP19 mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr 1:250,519,703...250,566,705
Ensembl chr 1:250,530,214...250,580,190
|
|
| G
|
Arhgap31
|
Rho GTPase activating protein 31
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ARHGAP31 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr11:75,544,176...75,657,087
Ensembl chr11:75,544,040...75,661,076
|
|
| G
|
Arhgap32
|
Rho GTPase activating protein 32
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ARHGAP32 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 8:38,679,368...38,939,960
Ensembl chr 8:38,684,484...38,939,960
|
|
| G
|
Arhgap42
|
Rho GTPase activating protein 42
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARHGAP42 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:14,436,478...14,666,588
Ensembl chr 8:14,419,256...14,666,385
|
|
| G
|
Arhgap45
|
Rho GTPase activating protein 45
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of ARHGAP45 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ARHGAP45 mRNA
|
CTD |
PMID:26095815 PMID:33729688 |
|
NCBI chr 7:10,325,515...10,340,955
Ensembl chr 7:10,325,539...10,341,890
|
|
| G
|
Arhgap8
|
Rho GTPase activating protein 8
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARHGAP8 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:117,723,512...117,782,031
Ensembl chr 7:117,730,578...117,782,030
|
|
| G
|
Arhgdia
|
Rho GDP dissociation inhibitor alpha
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ARHGDIA mRNA
|
CTD |
PMID:17175027 |
|
NCBI chr10:106,352,858...106,356,347
Ensembl chr10:106,353,491...106,356,347
|
|
| G
|
Arhgef10
|
Rho guanine nucleotide exchange factor 10
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ARHGEF10 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr16:81,349,429...81,440,439
Ensembl chr16:81,349,429...81,440,054
|
|
| G
|
Arhgef15
|
Rho guanine nucleotide exchange factor 15
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARHGEF15 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:54,149,372...54,162,128
Ensembl chr10:54,149,372...54,162,128
|
|
| G
|
Arhgef39
|
Rho guanine nucleotide exchange factor 39
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ARHGEF39 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 5:62,548,300...62,551,870
Ensembl chr 5:62,548,303...62,551,870
|
|
| G
|
Arhgef4
|
Rho guanine nucleotide exchange factor 4
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ARHGEF4 mRNA
|
CTD |
PMID:17175027 |
|
NCBI chr 9:44,357,716...44,500,959
Ensembl chr 9:44,357,736...44,501,550
|
|
| G
|
Arid1a
|
AT-rich interaction domain 1A
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARID1A mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:151,192,014...151,269,291
Ensembl chr 5:151,192,014...151,265,386
|
|
| G
|
Arid2
|
AT-rich interaction domain 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARID2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:129,326,371...129,443,813
Ensembl chr 7:129,324,137...129,443,187
|
|
| G
|
Arid3a
|
AT-rich interaction domain 3A
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ARID3A mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 7:10,403,161...10,431,551
Ensembl chr 7:10,405,631...10,427,926
|
|
| G
|
Arid5a
|
AT-rich interaction domain 5A
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARID5A mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:46,030,513...46,058,729
Ensembl chr 9:46,030,548...46,045,363
|
|
| G
|
Arl1
|
ARF like GTPase 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ARL1 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 7:25,007,401...25,018,572
Ensembl chr 7:25,006,981...25,019,319
|
|
| G
|
Arl10
|
ARF like GTPase 10
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ARL10 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr17:10,035,320...10,043,732
Ensembl chr17:10,035,320...10,043,981
|
|
| G
|
Arl2bp
|
ARF like GTPase 2 binding protein
|
multiple interactions increases expression
|
ISO EXP
|
Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of ARL2BP mRNA] [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of ARL2BP mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of ARL2BP mRNA
|
CTD |
PMID:22629407 PMID:33729688 |
|
NCBI chr19:10,342,895...10,352,529
Ensembl chr19:10,342,895...10,352,514
|
|
| G
|
Arl4a
|
ARF like GTPase 4A
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARL4A mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:62,809,287...62,811,297
Ensembl chr 6:62,804,548...62,820,760
|
|
| G
|
Arl4d
|
ARF like GTPase 4D
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of ARL4D mRNA; ARL4D protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
|
CTD |
PMID:21124846 |
|
NCBI chr10:87,092,276...87,103,079
Ensembl chr10:87,077,523...87,106,199
|
|
| G
|
Arl6ip1
|
ARL6 interacting reticulophagy regulator 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARL6IP1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:181,864,717...181,874,232
Ensembl chr 1:181,864,746...181,874,232
|
|
| G
|
Arln
|
allregulin
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ARLN mRNA
|
CTD |
PMID:20042640 PMID:24236059 PMID:25596134 |
|
NCBI chr 2:213,740,519...213,742,279
Ensembl chr 2:213,740,525...213,742,952
|
|
| G
|
Armcx6
|
armadillo repeat containing, X-linked 6
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ARMCX6 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr X:102,222,288...102,229,871
Ensembl chr X:102,222,220...102,240,052
|
|
| G
|
Arnt
|
aryl hydrocarbon receptor nuclear translocator
|
multiple interactions affects localization decreases response to substance
|
ISO
|
(+)-JQ1 compound inhibits the reaction [Oxygen deficiency promotes the reaction [ARNT protein binds to CA9 promoter]]; [HIF1A protein alternative form inhibits the reaction [Oxygen deficiency affects the localization of ARNT protein]] promotes the reaction [HIF1A protein alternative form binds to ARNT protein]; ARNT protein affects the reaction [Oxygen deficiency results in increased activity of CP promoter]; ARNT protein inhibits the reaction [Oxygen deficiency results in decreased activity of AHR protein]; Genistein affects the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to ARNT protein binds to EDN1 promoter]]; HIF1A protein alternative form inhibits the reaction [Oxygen deficiency affects the localization of ARNT protein]; Oxygen deficiency promotes the reaction [[HIF1A protein binds to ARNT protein] which binds to EPO enhancer]; Oxygen deficiency promotes the reaction [ARNT protein binds to CA9 promoter]; Oxygen deficiency promotes the reaction [HIF1A protein binds to ARNT protein binds to EDN1 promoter]; Oxygen deficiency promotes the reaction [HIF1A protein binds to ARNT protein]; vosaroxin inhibits the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to ARNT protein]] [Glucose co-treated with Oxygen deficiency] inhibits the reaction [ARNT protein binds to HIF1A protein]; ARNT gene mutant form inhibits the reaction [Oxygen deficiency results in increased expression of ANGPT1 mRNA]; ARNT gene mutant form inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 mRNA]; ARNT gene mutant form inhibits the reaction [Oxygen deficiency results in increased expression of PDGFB mRNA]; ARNT gene mutant form inhibits the reaction [Oxygen deficiency results in increased expression of SLC2A1 mRNA]; ARNT gene mutant form inhibits the reaction [Oxygen deficiency results in increased expression of VEGFA mRNA]; ARNT protein affects the reaction [Oxygen deficiency results in increased expression of CA9 mRNA] ARNT gene mutant form results in decreased susceptibility to Oxygen deficiency ARNT protein results in decreased susceptibility to Oxygen deficiency
|
CTD |
PMID:10777486 PMID:10939628 PMID:11739637 PMID:16189267 PMID:18227068 PMID:19154183 PMID:20412331 PMID:24355420 PMID:27292261 PMID:29800573 More...
|
|
NCBI chr 2:185,686,703...185,745,546
Ensembl chr 2:185,680,683...185,745,546
|
|
| G
|
Arrb1
|
arrestin, beta 1
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARRB1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ARRB1 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 1:163,249,654...163,321,711
Ensembl chr 1:163,250,157...163,340,859
|
|
| G
|
Arrdc3
|
arrestin domain containing 3
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ARRDC3 mRNA
|
CTD |
PMID:24236059 PMID:26516004 |
|
NCBI chr 2:12,873,202...12,885,716
Ensembl chr 2:12,873,202...12,885,875
|
|
| G
|
Arrdc4
|
arrestin domain containing 4
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ARRDC4 mRNA
|
CTD |
PMID:20042640 |
|
NCBI chr 1:131,779,436...131,793,438
Ensembl chr 1:131,779,437...131,793,565
|
|
| G
|
Arsb
|
arylsulfatase B
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARSB mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:26,736,395...26,895,682
Ensembl chr 2:26,736,957...26,897,611
|
|
| G
|
Art3
|
ADP-ribosyltransferase 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ART3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:15,921,540...16,003,764
Ensembl chr14:15,921,395...15,949,806
|
|
| G
|
Art5
|
ADP-ribosyltransferase 5
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of ART5 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:165,885,344...165,895,306
Ensembl chr 1:165,885,280...165,895,306
|
|
| G
|
Artn
|
artemin
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARTN mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:136,750,188...136,755,645
Ensembl chr 5:136,750,188...136,753,457
|
|
| G
|
Arv1
|
ARV1 homolog, fatty acid homeostasis modulator
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARV1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:69,589,728...69,601,547
Ensembl chr19:69,589,328...69,601,537
|
|
| G
|
As3mt
|
arsenite methyltransferase
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of AS3MT mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr 1:255,536,879...255,569,245
Ensembl chr 1:255,537,109...255,569,249
|
|
| G
|
Asb3
|
ankyrin repeat and SOCS box-containing 3
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ASB3 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr14:108,860,318...108,988,939
Ensembl chr14:108,811,930...108,988,942
|
|
| G
|
Asb4
|
ankyrin repeat and SOCS box-containing 4
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ASB4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:34,473,527...34,511,163
Ensembl chr 4:34,473,408...34,512,888
|
|
| G
|
Asf1b
|
anti-silencing function 1B histone chaperone
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ASF1B mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr19:41,085,786...41,100,352
Ensembl chr19:41,086,114...41,100,352
|
|
| G
|
Asns
|
asparagine synthetase (glutamine-hydrolyzing)
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of ASNS mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ASNS mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ASNS mRNA
|
CTD |
PMID:25596134 PMID:30529165 PMID:33729688 |
|
NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050
|
|
| G
|
Aspn
|
asporin
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ASPN mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of ASPN mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr17:15,286,338...15,310,567
Ensembl chr17:15,287,065...15,310,632
|
|
| G
|
Ass1
|
argininosuccinate synthase 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ASS1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 3:35,144,765...35,194,632
Ensembl chr 3:35,144,999...35,194,627
|
|
| G
|
Astn2
|
astrotactin 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ASTN2 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 5:83,772,988...84,759,439
Ensembl chr 5:83,773,633...84,759,485
|
|
| G
|
Asxl3
|
ASXL transcriptional regulator 3
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ASXL3 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr18:13,868,223...14,040,867
Ensembl chr18:13,868,674...14,037,373
|
|
| G
|
Atad1
|
ATPase family, AAA domain containing 1
|
multiple interactions
|
EXP
|
ATAD1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
|
CTD |
PMID:21124846 |
|
NCBI chr 1:239,957,329...240,023,792
Ensembl chr 1:239,957,882...240,009,822
|
|
| G
|
Atad2
|
ATPase family, AAA domain containing 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ATAD2 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 7:91,523,626...91,566,238
Ensembl chr 7:91,523,626...91,566,238
|
|
| G
|
Atad3a
|
ATPase family, AAA domain containing 3A
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of ATAD3A mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ATAD3A mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 5:171,632,545...171,652,725
Ensembl chr 5:171,632,547...171,652,725
|
|
| G
|
Atad5
|
ATPase family, AAA domain containing 5
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ATAD5 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:65,568,569...65,616,379
Ensembl chr10:65,568,591...65,616,376
|
|
| G
|
Atf1
|
activating transcription factor 1
|
multiple interactions increases expression increases phosphorylation
|
ISO
|
ATF1 protein promotes the reaction [Oxygen deficiency results in increased expression of UCP3 protein]; Oxygen deficiency promotes the reaction [[ATF1 protein binds to UCP3 promoter] which results in increased expression of UCP3 mRNA]; SB 203580 inhibits the reaction [Oxygen deficiency results in increased phosphorylation of ATF1 protein] Oxygen deficiency results in increased expression of ATF1 mRNA; Oxygen deficiency results in increased expression of ATF1 protein 3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of ATF1 mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of ATF1 mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of ATF1 mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of ATF1 mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of ATF1 mRNA]
|
CTD |
PMID:18579531 PMID:23452621 |
|
NCBI chr 7:133,240,774...133,283,488
Ensembl chr 7:133,241,197...133,283,485
|
|
| G
|
Atf3
|
activating transcription factor 3
|
affects expression increases expression multiple interactions
|
ISO
|
Oxygen deficiency affects the expression of ATF3 mRNA Oxygen deficiency results in increased expression of ATF3 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ATF3 mRNA
|
CTD |
PMID:17193925 PMID:20042640 PMID:25596134 PMID:30529165 |
|
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750
|
|
| G
|
Atf4
|
activating transcription factor 4
|
increases expression affects stability decreases expression affects activity multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of ATF4 protein; Oxygen results in increased expression of ATF4 mRNA Oxygen deficiency affects the stability of ATF4 protein Oxygen results in decreased expression of ATF4 protein Oxygen deficiency affects the activity of ATF4 protein [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ATF4 mRNA
|
CTD |
PMID:14604972 PMID:25596134 PMID:27103661 PMID:30529165 |
|
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739
|
|
| G
|
Atf6
|
activating transcription factor 6
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of ATF6 protein; Oxygen results in increased expression of ATF6 protein 1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone inhibits the reaction [Oxygen results in increased expression of ATF6 protein]; 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline inhibits the reaction [1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone inhibits the reaction [Oxygen results in increased expression of ATF6 protein]]
|
CTD |
PMID:24680926 PMID:32996202 |
|
NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033
|
|
| G
|
Atf7ip2
|
activating transcription factor 7 interacting protein 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ATF7IP2 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr10:5,909,898...5,952,844
Ensembl chr10:5,909,658...5,952,995
|
|
| G
|
Atg12
|
autophagy related 12
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of ATG12 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr18:41,638,841...41,649,311
Ensembl chr18:41,635,835...41,649,261
|
|
| G
|
Atg5
|
autophagy related 5
|
decreases expression multiple interactions
|
EXP
|
Oxygen deficiency results in decreased expression of ATG5 mRNA sanggenone C inhibits the reaction [Oxygen deficiency results in decreased expression of ATG5 mRNA]
|
CTD |
PMID:28983604 |
|
NCBI chr20:49,380,835...49,471,826
Ensembl chr20:49,380,813...49,471,821
|
|
| G
|
Atg9a
|
autophagy related 9A
|
multiple interactions
|
ISO
|
Oxygen deficiency promotes the reaction [HIF1A protein binds to ATG9A promoter]
|
CTD |
PMID:23880069 |
|
NCBI chr 9:84,126,071...84,136,723
Ensembl chr 9:84,126,071...84,136,666
|
|
| G
|
Atic
|
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ATIC mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:80,614,311...80,634,360
Ensembl chr 9:80,614,283...80,635,756
|
|
| G
|
Atl1
|
atlastin GTPase 1
|
multiple interactions
|
EXP
|
ATL1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
|
CTD |
PMID:21124846 |
|
NCBI chr 6:94,113,149...94,210,955
Ensembl chr 6:94,112,877...94,211,219
|
|
| G
|
Atosa
|
atos homolog A
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of ATOSA mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ATOSA mRNA
|
CTD |
PMID:25596134 PMID:30529165 |
|
NCBI chr 8:84,575,360...84,653,103
Ensembl chr 8:84,575,370...84,653,091
|
|
| G
|
Atp13a4
|
ATPase 13A4
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ATP13A4 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr11:84,727,014...84,864,747
Ensembl chr11:84,731,041...84,864,747
|
|
| G
|
Atp1a1
|
ATPase Na+/K+ transporting subunit alpha 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of and affects the localization of ATP1A1 protein; Antigen-Antibody Complex inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of and affects the localization of ATP1A1 protein]
|
CTD |
PMID:29702141 |
|
NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:191,709,311...191,737,425
|
|
| G
|
Atp1a2
|
ATPase Na+/K+ transporting subunit alpha 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ATP1A2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr13:87,261,964...87,286,911
Ensembl chr13:87,261,968...87,286,911
|
|
| G
|
Atp1a3
|
ATPase Na+/K+ transporting subunit alpha 3
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ATP1A3 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:89,700,645...89,729,782
Ensembl chr 1:89,700,649...89,729,825
|
|
| G
|
Atp1b1
|
ATPase Na+/K+ transporting subunit beta 1
|
increases expression
|
EXP
|
Oxygen deficiency results in increased expression of ATP1B1 mRNA; Oxygen results in increased expression of ATP1B1 mRNA
|
CTD |
PMID:11713096 PMID:22911455 |
|
NCBI chr13:79,319,708...79,340,226
Ensembl chr13:79,319,706...79,340,549
|
|
| G
|
Atp2a2
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
|
decreases expression multiple interactions
|
EXP
|
Oxygen deficiency results in decreased expression of ATP2A2 mRNA Trimetazidine inhibits the reaction [Oxygen deficiency results in decreased expression of ATP2A2 mRNA]
|
CTD |
PMID:25937560 |
|
NCBI chr12:39,733,519...39,782,942
Ensembl chr12:39,733,458...39,782,934
|
|
| G
|
Atp2a3
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ATP2A3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:58,079,710...58,111,279
Ensembl chr10:58,079,852...58,111,278
|
|
| G
|
Atp2b4
|
ATPase plasma membrane Ca2+ transporting 4
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of ATP2B4 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ATP2B4 mRNA
|
CTD |
PMID:24205000 PMID:33729688 |
|
NCBI chr13:47,708,157...47,807,389
Ensembl chr13:47,711,121...47,758,876
|
|
| G
|
Atp5f1a
|
ATP synthase F1 subunit alpha
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ATP5F1A protein
|
CTD |
PMID:25937538 |
|
NCBI chr18:73,567,537...73,575,473
Ensembl chr18:73,567,526...73,575,922
|
|
| G
|
Atp5f1b
|
ATP synthase F1 subunit beta
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ATP5F1B protein
|
CTD |
PMID:25937538 |
|
NCBI chr 7:1,100,058...1,106,461
Ensembl chr 7:1,099,860...1,106,462
|
|
| G
|
Atp5f1d
|
ATP synthase F1 subunit delta
|
multiple interactions decreases expression
|
EXP ISO
|
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid inhibits the reaction [notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of ATP5F1D protein]]; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of ATP5F1D protein; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of ATP5F1D protein]; Y 27632 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of ATP5F1D protein] Oxygen deficiency results in decreased expression of ATP5F1D protein
|
CTD |
PMID:25305180 PMID:25937538 |
|
NCBI chr 7:10,211,260...10,218,989
Ensembl chr 7:10,211,262...10,216,583
|
|
| G
|
Atp5mk
|
ATP synthase membrane subunit K
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ATP5MK mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 1:255,915,255...255,922,185
Ensembl chr 1:255,915,259...255,922,106 Ensembl chr10:255,915,259...255,922,106
|
|
| G
|
Atp6v0d2
|
ATPase H+ transporting V0 subunit D2
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of ATP6V0D2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:38,133,151...38,182,245
Ensembl chr 5:38,133,158...38,182,245
|
|
| G
|
Atp6v1c2
|
ATPase H+ transporting V1 subunit C2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ATP6V1C2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:45,809,269...45,872,914
Ensembl chr 6:45,809,271...45,848,747
|
|
| G
|
Atp7a
|
ATPase copper transporting alpha
|
multiple interactions increases expression affects localization
|
ISO
|
tetrathiomolybdate inhibits the reaction [Oxygen deficiency affects the localization of ATP7A protein] Oxygen deficiency results in increased expression of ATP7A mRNA; Oxygen deficiency results in increased expression of ATP7A protein
|
CTD |
PMID:19351718 PMID:24614111 |
|
NCBI chr X:75,159,635...75,267,094
Ensembl chr X:75,159,782...75,267,093
|
|
| G
|
Atp7b
|
ATPase copper transporting beta
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ATP7B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr16:76,654,725...76,726,092
Ensembl chr16:76,653,660...76,728,801
|
|
| G
|
Atp8a1
|
ATPase phospholipid transporting 8A1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ATP8A1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:40,668,932...40,911,465
Ensembl chr14:40,731,846...40,911,463
|
|
| G
|
Atp8b4
|
ATPase phospholipid transporting 8B4 (putative)
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ATP8B4 mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr 3:134,008,367...134,212,394
Ensembl chr 3:134,009,580...134,210,260
|
|
| G
|
Atxn1
|
ataxin 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ATXN1 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr17:18,943,397...19,354,751
Ensembl chr17:19,208,200...19,356,790
|
|
| G
|
Atxn2
|
ataxin 2
|
increases expression affects methylation
|
ISO
|
Oxygen deficiency results in increased expression of ATXN2 mRNA Oxygen deficiency affects the methylation of ATXN2 promoter
|
CTD |
PMID:24205000 |
|
NCBI chr12:40,413,657...40,509,895
Ensembl chr12:40,414,904...40,510,473
|
|
| G
|
Aunip
|
aurora kinase A and ninein interacting protein
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of AUNIP mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 5:152,006,021...152,018,614
Ensembl chr 5:152,006,042...152,020,190
|
|
| G
|
Aurka
|
aurora kinase A
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of AURKA mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:181,546,742...181,562,771
|
|
| G
|
Aurkb
|
aurora kinase B
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of AURKB mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of AURKB mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr10:54,243,116...54,249,675
Ensembl chr10:54,242,850...54,252,285
|
|
| G
|
Avpi1
|
arginine vasopressin-induced 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AVPI1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:250,879,530...250,885,448
Ensembl chr 1:250,879,530...250,885,704
|
|
| G
|
Avpr1a
|
arginine vasopressin receptor 1A
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AVPR1A mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:59,999,743...60,003,667
Ensembl chr 7:59,999,738...60,003,837
|
|
| G
|
Axin1
|
axin 1
|
multiple interactions
|
ISO
|
[Paclitaxel co-treated with FV-429 compound] promotes the reaction [Oxygen deficiency results in increased expression of AXIN1 protein]
|
CTD |
PMID:34648812 |
|
NCBI chr10:15,667,894...15,720,092
Ensembl chr10:15,667,958...15,720,092
|
|
| G
|
Axin2
|
axin 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of AXIN2 protein
|
CTD |
PMID:34648812 |
|
NCBI chr10:94,393,379...94,426,579
Ensembl chr10:94,395,909...94,426,575
|
|
| G
|
Axl
|
Axl receptor tyrosine kinase
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of AXL mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 1:90,392,864...90,424,123
Ensembl chr 1:90,392,864...90,424,009
|
|
| G
|
Azgp1
|
alpha-2-glycoprotein 1, zinc-binding
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AZGP1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr12:22,044,685...22,051,248
Ensembl chr12:22,044,751...22,053,020
|
|
| G
|
Azin1
|
antizyme inhibitor 1
|
multiple interactions increases expression
|
ISO
|
Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of AZIN1 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 7:71,539,711...71,566,515
Ensembl chr 7:71,539,711...71,566,515
|
|
| G
|
B3galt2
|
Beta-1,3-galactosyltransferase 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of B3GALT2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr13:57,939,724...57,948,735
Ensembl chr13:57,930,539...57,956,539
|
|
| G
|
B3gat3
|
beta-1,3-glucuronyltransferase 3
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of B3GAT3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:215,246,453...215,253,033
Ensembl chr 1:215,246,482...215,266,876
|
|
| G
|
B3glct
|
beta 3-glucosyltransferase
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of B3GLCT mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr12:10,291,910...10,383,190
Ensembl chr12:10,291,910...10,426,357
|
|
| G
|
B3gnt4
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4
|
multiple interactions increases expression
|
ISO
|
1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of B3GNT4 mRNA]
|
CTD |
PMID:24403227 |
|
NCBI chr12:38,729,653...38,734,911
Ensembl chr12:38,728,889...38,734,744
|
|
| G
|
B430306N03Rikl
|
RIKEN cDNA B430306N03 gene
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of B430306N03RIKL mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 9:20,179,219...20,188,163
Ensembl chr 9:20,180,117...20,192,148
|
|
| G
|
Bace1
|
beta-secretase 1
|
multiple interactions increases expression
|
ISO
|
alpha-Tocopherol inhibits the reaction [Oxygen deficiency results in increased expression of BACE1 mRNA]; CAT protein inhibits the reaction [Oxygen deficiency results in increased expression of BACE1 mRNA]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of BACE1 mRNA]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of BACE1 protein]; MAPK8 protein affects the reaction [Oxygen deficiency results in increased expression of BACE1 protein]; MAPK9 protein affects the reaction [Oxygen deficiency results in increased expression of BACE1 protein]; Rotenone inhibits the reaction [Oxygen deficiency results in increased expression of BACE1 mRNA] Oxygen deficiency results in increased expression of BACE1 mRNA; Oxygen deficiency results in increased expression of BACE1 protein
|
CTD |
PMID:19196431 |
|
NCBI chr 8:55,038,842...55,061,138
Ensembl chr 8:55,038,823...55,064,918
|
|
| G
|
Bace2
|
beta-secretase 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of BACE2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr11:50,176,852...50,258,948
Ensembl chr11:50,176,621...50,259,008
|
|
| G
|
Bach1
|
BTB domain and CNC homolog 1
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of BACH1 mRNA [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of BACH1 mRNA; [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of BACH1 protein; [Antagomirs results in decreased expression of MIR30C1 mRNA] inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of BACH1 mRNA]; [Antagomirs results in decreased expression of MIR30C1 mRNA] inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of BACH1 protein]; [Antagomirs results in decreased expression of MIR30C1 mRNA] inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of BACH1 mRNA]; [Antagomirs results in decreased expression of MIR30C1 mRNA] inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of BACH1 protein]; [Oxygen deficiency co-treated with Oxygen] results in decreased expression of BACH1 mRNA; [Oxygen deficiency co-treated with Oxygen] results in decreased expression of BACH1 protein; BACH1 protein inhibits the reaction [MIR30C1 mRNA promotes the reaction [[Oxygen deficiency co-treated with Oxygen] affects the localization of and results in increased activity of NFE2L2 protein]]; MIR30C1 mRNA promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of BACH1 mRNA]; MIR30C1 mRNA promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of BACH1 protein]; MIR30C1 mRNA promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of BACH1 mRNA]; MIR30C1 mRNA promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of BACH1 protein]
|
CTD |
PMID:26516004 PMID:34217758 |
|
NCBI chr11:40,425,721...40,461,118
Ensembl chr11:40,425,664...40,461,277
|
|
| G
|
Bach2
|
BTB domain and CNC homolog 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BACH2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:51,428,802...51,779,030
Ensembl chr 5:51,434,870...51,774,234
|
|
| G
|
Bad
|
BCL2-associated agonist of cell death
|
multiple interactions increases expression decreases expression
|
ISO EXP
|
Oxygen affects the reaction [AHR protein results in decreased expression of BAD mRNA] [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAD protein; Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of BAD mRNA]; Tea inhibits the reaction [Oxygen deficiency results in decreased expression of BAD protein modified form]; Tea inhibits the reaction [Oxygen deficiency results in increased expression of BAD protein modified form] Oxygen deficiency results in increased expression of BAD mRNA; Oxygen deficiency results in increased expression of BAD protein modified form
|
CTD |
PMID:17293559 PMID:26476374 PMID:27103661 PMID:29139225 |
|
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034
|
|
| G
|
Bag2
|
BAG cochaperone 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of BAG2 mRNA
|
CTD |
PMID:35883890 |
|
NCBI chr 9:43,465,993...43,476,637
Ensembl chr 9:43,465,995...43,476,752
|
|
| G
|
Bag3
|
BAG cochaperone 3
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of BAG3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:192,533,460...192,557,281
Ensembl chr 1:192,475,828...192,557,280
|
|
| G
|
Bak1
|
BCL2-antagonist/killer 1
|
multiple interactions
|
EXP ISO
|
[[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Carvedilol] which results in decreased expression of BAK1 mRNA [Betulinic Acid co-treated with Oxygen deficiency] results in increased expression of BAK1 protein
|
CTD |
PMID:29122578 PMID:33181113 |
|
NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,102,335...5,110,974
|
|
| G
|
Bank1
|
B-cell scaffold protein with ankyrin repeats 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BANK1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:227,203,998...227,474,008
Ensembl chr 2:227,203,998...227,474,037
|
|
| G
|
Bap1
|
BRCA1 associated deubiquitinase 1
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of BAP1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr16:6,453,126...6,461,952
Ensembl chr16:6,452,974...6,461,952
|
|
| G
|
Basp1
|
brain abundant, membrane attached signal protein 1
|
increases expression
|
EXP
|
Oxygen results in increased expression of BASP1 mRNA
|
CTD |
PMID:22911455 |
|
NCBI chr 2:77,546,628...77,594,297
Ensembl chr 2:77,546,092...77,597,178
|
|
| G
|
Batf
|
basic leucine zipper ATF-like transcription factor
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BATF mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:111,084,717...111,107,052
Ensembl chr 6:111,084,717...111,107,052
|
|
| G
|
Batf2
|
basic leucine zipper ATF-like transcription factor 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of BATF2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:212,897,076...212,905,740
Ensembl chr 1:212,875,148...212,905,831
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions affects expression decreases expression increases expression
|
ISO EXP
|
[Oxygen deficiency results in increased expression of HIF1A protein] which affects the expression of BAX protein; NDRG2 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; Oxygen deficiency promotes the reaction [HIF1A mutant form results in increased expression of BAX] 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX mRNA]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [wedelolactone inhibits the reaction [Oxygen results in increased expression of BAX protein]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX mRNA]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX mRNA; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BAX mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein modified form; atractylenolide III inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; Edaravone inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX mRNA]]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX mRNA]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; wedelolactone inhibits the reaction [Oxygen results in increased expression of BAX protein] Oxygen deficiency affects the expression of BAX protein (2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide inhibits the reaction [Apigenin inhibits the reaction [Oxygen deficiency results in decreased expression of BAX protein]]; 4-phenylbutyric acid inhibits the reaction [Oxygen deficiency results in increased expression of BAX protein]; [Apigenin co-treated with Oxygen deficiency] results in increased expression of BAX protein; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased expression of BAX protein; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of BAX protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein; Apigenin inhibits the reaction [Oxygen deficiency results in decreased expression of BAX protein]; HIF1A protein inhibits the reaction [Apigenin inhibits the reaction [Oxygen deficiency results in decreased expression of BAX protein]]; kaempferol inhibits the reaction [Oxygen deficiency results in decreased expression of BAX protein]; norwogonin inhibits the reaction [Oxygen deficiency results in increased expression of BAX mRNA]; norwogonin inhibits the reaction [Oxygen deficiency results in increased expression of BAX protein]; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased expression of BAX protein]; protosappanin A inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; Quercetin inhibits the reaction [Oxygen deficiency results in decreased expression of BAX protein]; Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of BAX mRNA]; Rutin inhibits the reaction [Oxygen deficiency results in increased expression of BAX mRNA]; Rutin inhibits the reaction [Oxygen deficiency results in increased expression of BAX protein]; sanggenone C inhibits the reaction [Oxygen deficiency results in increased expression of BAX protein]; Streptozocin promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of BAX protein]; trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; Trimetazidine inhibits the reaction [Oxygen deficiency results in increased expression of BAX mRNA] Oxygen deficiency results in increased expression of BAX mRNA; Oxygen deficiency results in increased expression of BAX protein
|
CTD |
PMID:20206160 PMID:23451161 PMID:24680926 PMID:24682241 PMID:24860939 PMID:25238743 PMID:25305180 PMID:25450231 PMID:25937560 PMID:26476374 PMID:28675767 PMID:28983604 PMID:29690507 PMID:30529165 PMID:30611788 PMID:31930969 PMID:31935362 PMID:33225685 PMID:33413359 PMID:33508982 PMID:33759271 PMID:36940862 PMID:39110510 PMID:39326406 More...
|
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bbc3
|
Bcl-2 binding component 3
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of BBC3 mRNA [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BBC3 protein modified form; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BBC3 protein]
|
CTD |
PMID:25596134 PMID:28675767 PMID:29690507 |
|
NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:86,141,603...86,150,666
|
|
| G
|
Bcar3
|
BCAR3 adaptor protein, NSP family member
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of BCAR3 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 2:213,209,907...213,323,305
Ensembl chr 2:213,209,893...213,323,302
|
|
| G
|
Bcat1
|
branched chain amino acid transaminase 1
|
affects expression multiple interactions
|
ISO EXP
|
Oxygen deficiency affects the expression of BCAT1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of BCAT1 mRNA
|
CTD |
PMID:25596134 PMID:33729688 |
|
NCBI chr 4:179,695,662...179,777,973
Ensembl chr 4:179,695,662...179,777,288
|
|
| G
|
Bckdha
|
branched chain keto acid dehydrogenase E1 subunit alpha
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of BCKDHA mRNA [sulforaphane affects the susceptibility to Oxygen] which affects the expression of BCKDHA mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 1:90,266,731...90,295,521
Ensembl chr 1:90,261,629...90,295,749
|
|
| G
|
Bcl10
|
BCL10, immune signaling adaptor
|
multiple interactions increases expression
|
ISO
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of BCL10 mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of BCL10 mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of BCL10 mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of BCL10 mRNA]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of BCL10 mRNA] [sulforaphane affects the susceptibility to Oxygen] which affects the expression of BCL10 mRNA
|
CTD |
PMID:23452621 PMID:30529165 |
|
NCBI chr 2:237,501,181...237,510,821
Ensembl chr 2:237,501,134...237,511,829
|
|
| G
|
Bcl11a
|
BCL11 transcription factor A
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BCL11A mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:102,230,147...102,325,289
Ensembl chr14:102,231,113...102,325,623
|
|
| G
|
Bcl11b
|
BCL11 transcription factor B
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BCL11B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:132,598,968...132,692,123
Ensembl chr 6:132,598,968...132,691,301
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
increases expression affects expression multiple interactions decreases expression
|
ISO EXP
|
Oxygen deficiency results in increased expression of BCL2 mRNA Oxygen deficiency affects the expression of BCL2 protein [betulin co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein; [Betulinic Acid co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein; [Oxygen co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 mRNA]; icariin inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; Niacinamide promotes the reaction [[Oxygen co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; Oxygen deficiency promotes the reaction [HIF1A mutant form results in decreased expression of BCL2]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 mRNA]; Resveratrol inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 mRNA]; SIRT1 mutant form promotes the reaction [[Oxygen co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein] Oxygen deficiency results in decreased expression of BCL2 mRNA; Oxygen deficiency results in decreased expression of BCL2 protein 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 mRNA]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [wedelolactone inhibits the reaction [Oxygen results in decreased expression of BCL2 protein]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 mRNA]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; [Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 mRNA; [Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA; atractylenolide III inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]; cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]]; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 mRNA]]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 mRNA]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; MIR210 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 mRNA]; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]; U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]; wedelolactone inhibits the reaction [Oxygen results in decreased expression of BCL2 protein] Oxygen deficiency results in increased expression of BCL2 protein; Oxygen results in increased expression of BCL2 protein (2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide inhibits the reaction [Apigenin inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 protein]]; 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid inhibits the reaction [notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of BCL2 protein]]; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of BCL2 protein; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of BCL2 protein; [Oxygen deficiency co-treated with Glucose deficiency] affects the expression of BCL2 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein; Apigenin inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 protein]; cardamonin inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of BCL2 protein]; ginsenoside Rg1 inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 protein]; HIF1A protein inhibits the reaction [Apigenin inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 protein]]; Isoflurane promotes the reaction [Oxygen deficiency results in increased expression of BCL2 protein]; kaempferol inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 protein]; norwogonin inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 mRNA]; norwogonin inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 protein]; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of BCL2 protein]; Phenylephrine inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 mRNA]; Phenylephrine inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 protein]; Quercetin inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 mRNA]; Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 protein]; Resveratrol inhibits the reaction [Oxygen results in increased expression of BCL2 protein]; Rutin inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 mRNA]; Rutin inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 protein]; sanggenone C inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 protein]; sodium bisulfide inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of BCL2 protein]; Streptozocin promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of BCL2 protein]; Tea inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 protein]; trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]; Trimetazidine inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 mRNA]; Valproic Acid inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 protein]; Vorinostat inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 protein]
|
CTD |
PMID:10657591 PMID:11042672 PMID:16249675 PMID:22148982 PMID:22711276 PMID:23108914 PMID:23452621 PMID:23637816 PMID:24058562 PMID:24680926 PMID:24682241 PMID:24860939 PMID:25305180 PMID:25472572 PMID:25937560 PMID:26476374 PMID:26516004 PMID:26593335 PMID:27481074 PMID:28966130 PMID:28983604 PMID:29139225 PMID:30611788 PMID:31930969 PMID:31935362 PMID:33181113 PMID:33413359 PMID:33508982 PMID:33759271 PMID:36940862 PMID:38909692 PMID:39110510 PMID:39326406 More...
|
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bcl2a1
|
BCL2-related protein A1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of BCL2A1B mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 8:98,596,806...98,604,890
Ensembl chr 8:98,596,650...98,604,890
|
|
| G
|
Bcl2l1
|
Bcl2-like 1
|
decreases expression multiple interactions increases expression
|
EXP ISO
|
Oxygen deficiency results in decreased expression of BCL2L1 mRNA; Oxygen deficiency results in decreased expression of BCL2L1 protein BCL2L1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]; Phenylephrine inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2L1 mRNA]; Phenylephrine inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2L1 protein] Oxygen deficiency results in increased expression of BCL2L1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BCL2L1 mRNA; Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of BCL2L1 mRNA] 3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of BCL2L1 mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of BCL2L1 mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of BCL2L1 mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of BCL2L1 mRNA]
|
CTD |
PMID:11042672 PMID:21124846 PMID:22629407 PMID:23452621 PMID:30529165 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
|
|
| G
|
Bcl2l11
|
Bcl2-like 11
|
multiple interactions
|
ISO EXP
|
[Oxygen co-treated with Oxygen deficiency] results in increased expression of BCL2L11 protein; icariin inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in increased expression of BCL2L11 protein]; Niacinamide promotes the reaction [[Oxygen co-treated with Oxygen deficiency] results in increased expression of BCL2L11 protein]; resveratrol inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in increased expression of BCL2L11 protein]; SIRT1 mutant form promotes the reaction [[Oxygen co-treated with Oxygen deficiency] results in increased expression of BCL2L11 protein] [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of BCL2L11 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of BCL2L11 mRNA
|
CTD |
PMID:25472572 PMID:33729688 |
|
NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:135,817,562...135,960,695
|
|
| G
|
Bcl2l2
|
Bcl2-like 2
|
multiple interactions
|
ISO
|
[Oxygen deficiency co-treated with Oxygen] results in decreased expression of BCL2L2 protein; resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of BCL2L2 protein]; salvin inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of BCL2L2 protein]; SIRT1 mutant form promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of BCL2L2 protein]
|
CTD |
PMID:24557422 |
|
NCBI chr15:32,326,686...32,337,834
Ensembl chr15:32,326,020...32,335,379
|
|
| G
|
Bcl3
|
BCL3, transcription coactivator
|
multiple interactions increases expression decreases expression
|
ISO
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of BCL3 mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of BCL3 mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of BCL3 mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of BCL3 mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of BCL3 mRNA] Oxygen deficiency results in decreased expression of BCL3 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BCL3 mRNA
|
CTD |
PMID:23452621 PMID:25596134 PMID:30529165 |
|
NCBI chr 1:88,599,321...88,613,555
Ensembl chr 1:88,599,321...88,614,368
|
|
| G
|
Bcor
|
BCL6 co-repressor
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of BCOR mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr X:13,282,431...13,402,254
Ensembl chr X:13,360,376...13,402,254
|
|
| G
|
Bdkrb1
|
bradykinin receptor B1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BDKRB1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:130,275,631...130,284,968
Ensembl chr 6:130,275,478...130,280,973
|
|
| G
|
Bdkrb2
|
bradykinin receptor B2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BDKRB2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:130,237,055...130,267,205
Ensembl chr 6:130,237,255...130,267,209
|
|
| G
|
Bdnf
|
brain-derived neurotrophic factor
|
multiple interactions decreases secretion decreases expression
|
ISO EXP
|
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [Oxygen deficiency results in increased secretion of BDNF protein]; [Cadmium results in decreased transport of Calcium] inhibits the reaction [Oxygen deficiency results in increased secretion of BDNF protein]; Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased secretion of BDNF protein]; Calcium affects the reaction [Oxygen deficiency results in increased secretion of BDNF protein]; Dantrolene inhibits the reaction [Oxygen deficiency results in increased secretion of BDNF protein]; Oxygen deficiency results in increased secretion of and results in increased expression of BDNF protein; tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex inhibits the reaction [Oxygen deficiency results in increased secretion of BDNF protein] Oxygen deficiency results in decreased secretion of BDNF protein Oxygen deficiency results in decreased expression of BDNF mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of BDNF protein; [Oxygen deficiency co-treated with Carbon Dioxide] results in decreased expression of BDNF protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased expression of BDNF protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased expression of BDNF protein]; panaxydol inhibits the reaction [Oxygen deficiency results in decreased expression of BDNF mRNA]; panaxydol inhibits the reaction [Oxygen deficiency results in decreased secretion of BDNF protein]; Prasugrel Hydrochloride inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of BDNF protein] 3,5-dichloro-N-(1-(2,2-dimethyltetrahydropyran-4-ylmethyl)-4-fluoropiperidin-4-ylmethyl)benzamide inhibits the reaction [Oxygen deficiency promotes the reaction [BDNF protein results in increased transport of Calcium]]; 3,5-dichloro-N-(1-(2,2-dimethyltetrahydropyran-4-ylmethyl)-4-fluoropiperidin-4-ylmethyl)benzamide promotes the reaction [Tetrodotoxin inhibits the reaction [Oxygen deficiency promotes the reaction [BDNF protein results in increased transport of Calcium]]]; Oxygen deficiency promotes the reaction [BDNF protein results in increased transport of Calcium]; Tetrodotoxin inhibits the reaction [Oxygen deficiency promotes the reaction [BDNF protein results in increased transport of Calcium]]
|
CTD |
PMID:16553631 PMID:18541227 PMID:24718106 PMID:26095976 PMID:34174262 |
|
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657
|
|
| G
|
Bean1
|
brain expressed, associated with NEDD4, 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BEAN1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:745,993...792,853
Ensembl chr19:745,993...793,039
|
|
| G
|
Becn1
|
beclin 1
|
multiple interactions decreases expression
|
ISO EXP
|
[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of BECN1 protein; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of BECN1 protein; [Oxygen deficiency co-treated with Oxygen] results in decreased expression of BECN1 protein; epigallocatechin gallate inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of BECN1 protein]; Octreotide inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of BECN1 protein]; SIRT1 promotes the reaction [SNHG12 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of BECN1 protein]]; SNHG12 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of BECN1 protein]; SNHG12 mRNA promotes the reaction [Octreotide inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of BECN1 mRNA]]; YAP1 promotes the reaction [SNHG12 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of BECN1 protein]] Oxygen deficiency results in decreased expression of BECN1 mRNA sanggenone C inhibits the reaction [Oxygen deficiency results in decreased expression of BECN1 mRNA]
|
CTD |
PMID:28983604 PMID:34740634 PMID:35307376 |
|
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
| G
|
Bend5
|
BEN domain containing 5
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of BEND5 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 5:131,519,214...131,565,228
Ensembl chr 5:131,519,214...131,762,906
|
|
| G
|
Bend6
|
BEN domain containing 6
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of BEND6 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 9:43,576,982...43,631,437
Ensembl chr 9:43,576,982...43,631,194
|
|
| G
|
Best4
|
bestrophin 4
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of BEST4 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 5:135,858,774...135,865,624
Ensembl chr 5:135,860,018...135,863,707
|
|
| G
|
Bex1
|
brain expressed X-linked 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BEX2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr X:104,010,639...104,012,143
Ensembl chr X:104,010,371...104,011,236
|
|
| G
|
Bex4
|
brain expressed, X-linked 4
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BEX4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr X:103,923,609...103,925,041
Ensembl chr X:103,923,338...103,925,496
|
|
| G
|
Bgn
|
biglycan
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of BGN mRNA
|
CTD |
PMID:24205000 PMID:26516004 |
|
NCBI chr X:156,348,633...156,360,797
Ensembl chr X:156,348,615...156,360,799
|
|
| G
|
Bhlhe22
|
basic helix-loop-helix family, member e22
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BHLHE22 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:102,402,622...102,405,732
Ensembl chr 2:102,400,164...102,420,508
|
|
| G
|
Bhlhe40
|
basic helix-loop-helix family, member e40
|
affects expression increases expression multiple interactions
|
ISO
|
Oxygen deficiency affects the expression of BHLHE40 mRNA Oxygen deficiency results in increased expression of BHLHE40 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BHLHE40 mRNA
|
CTD |
PMID:17193925 PMID:20042640 PMID:20880076 PMID:24236059 PMID:25596134 PMID:26516004 PMID:30529165 More...
|
|
NCBI chr 4:143,174,450...143,180,150
Ensembl chr 4:143,174,048...143,180,783
|
|
| G
|
Bhlhe41
|
basic helix-loop-helix family, member e41
|
multiple interactions increases expression
|
ISO
|
1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of BHLHE41 mRNA]
|
CTD |
PMID:24236059 PMID:24403227 PMID:30381462 |
|
NCBI chr 4:180,565,003...180,569,415
Ensembl chr 4:180,565,003...180,569,355
|
|
| G
|
Bid
|
BH3 interacting domain death agonist
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BID mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275
|
|
| G
|
Birc2
|
baculoviral IAP repeat-containing 2
|
multiple interactions increases expression
|
ISO
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of BIRC2 protein]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of BIRC2 protein]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of BIRC2 protein]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of BIRC2 protein]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of BIRC2 protein] Oxygen deficiency results in increased expression of BIRC2 mRNA; Oxygen deficiency results in increased expression of BIRC2 protein
|
CTD |
PMID:23452621 |
|
NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:13,253,706...13,271,911
|
|
| G
|
Birc3
|
baculoviral IAP repeat-containing 3
|
multiple interactions increases expression
|
ISO
|
[Rotenone co-treated with Thenoyltrifluoroacetone] inhibits the reaction [Oxygen deficiency results in increased expression of BIRC3 mRNA]; AG 1879 inhibits the reaction [Oxygen deficiency results in increased expression of BIRC3 mRNA]
|
CTD |
PMID:17671207 |
|
NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:13,285,703...13,298,590
|
|
| G
|
Birc5
|
baculoviral IAP repeat-containing 5
|
multiple interactions increases expression decreases expression
|
ISO
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of BIRC5 protein]; [Arsenic Trioxide co-treated with Oxygen deficiency] results in decreased expression of BIRC5 mRNA; [Arsenic Trioxide co-treated with Oxygen deficiency] results in decreased expression of BIRC5 protein; betulin analog promotes the reaction [Oxygen deficiency results in decreased expression of BIRC5 protein]; Betulinic Acid promotes the reaction [Oxygen deficiency results in decreased expression of BIRC5 protein]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of BIRC5 protein]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of BIRC5 protein]; HIF1A affects the reaction [Oxygen deficiency affects the expression of BIRC5 mRNA]; HIF1A affects the reaction [Oxygen deficiency affects the expression of BIRC5 protein]; ITGB1 affects the reaction [Oxygen deficiency affects the expression of BIRC5 mRNA]; ITGB1 affects the reaction [Oxygen deficiency affects the expression of BIRC5 protein]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of BIRC5 protein]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of BIRC5 protein] Oxygen deficiency results in increased expression of BIRC5 mRNA; Oxygen deficiency results in increased expression of BIRC5 protein Oxygen deficiency results in decreased expression of BIRC5 protein; Oxygen results in decreased expression of BIRC5 mRNA
|
CTD |
PMID:16628086 PMID:19825857 PMID:23452621 PMID:26540049 PMID:27103661 |
|
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155
|
|
| G
|
Blk
|
BLK proto-oncogene, Src family tyrosine kinase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BLK mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr15:41,802,701...41,841,004
Ensembl chr15:41,802,994...41,840,982
|
|
| G
|
Blm
|
BLM RecQ like helicase
|
decreases expression increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of BLM mRNA Oxygen deficiency results in increased expression of BLM mRNA Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of BLM mRNA]
|
CTD |
PMID:26476374 PMID:26516004 |
|
NCBI chr 1:143,819,072...143,905,300
Ensembl chr 1:143,819,090...143,905,210
|
|
| G
|
Bloc1s2
|
biogenesis of lysosomal organelles complex-1, subunit 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BLOC1S2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:252,973,818...252,980,873
Ensembl chr 1:252,973,202...252,980,873
|
|
| G
|
Bltp3b
|
bridge-like lipid transfer protein family member 3B
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of BLTP3B mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 7:26,068,948...26,149,033
Ensembl chr 7:26,068,955...26,149,083
|
|
| G
|
Bmal1
|
basic helix-loop-helix ARNT like 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of BMAL1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:176,829,305...176,864,739
|
|
| G
|
Bmf
|
Bcl2 modifying factor
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of BMF mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BMF mRNA
|
CTD |
PMID:25596134 PMID:30529165 |
|
NCBI chr 3:125,953,466...125,974,087
Ensembl chr 3:125,953,466...125,974,258
|
|
| G
|
Bmp2
|
bone morphogenetic protein 2
|
increases expression multiple interactions
|
EXP ISO
|
Oxygen deficiency results in increased expression of BMP2 mRNA Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of BMP2 mRNA] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BMP2 mRNA
|
CTD |
PMID:26476374 PMID:30529165 |
|
NCBI chr 3:141,264,648...141,275,416
Ensembl chr 3:141,264,646...141,274,760
|
|
| G
|
Bmp4
|
bone morphogenetic protein 4
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BMP4 mRNA; [sulforaphane affects the susceptibility to Oxygen] which affects the expression of BMP4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr15:22,098,191...22,113,145
Ensembl chr15:22,098,470...22,105,172
|
|
| G
|
Bmp6
|
bone morphogenetic protein 6
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BMP6 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr17:26,523,704...26,785,558
Ensembl chr17:26,523,704...26,675,261
|
|
| G
|
Bnip3
|
BCL2 interacting protein 3
|
affects expression increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency affects the expression of BNIP3 mRNA Oxygen deficiency results in increased expression of BNIP3 mRNA [eprenetapopt co-treated with Oxygen deficiency] results in increased expression of BNIP3 mRNA; [Quinolones co-treated with Oxygen deficiency] results in increased expression of BNIP3 mRNA; Mustard Gas inhibits the reaction [Oxygen deficiency results in increased expression of BNIP3 mRNA]; Mustard Gas inhibits the reaction [Oxygen deficiency results in increased expression of BNIP3 protein]; Oxygen deficiency inhibits the reaction [[eprenetapopt co-treated with Cisplatin] results in decreased expression of BNIP3 mRNA]; Oxygen deficiency inhibits the reaction [Cisplatin results in decreased expression of BNIP3 mRNA]; Quinolones inhibits the reaction [Mustard Gas inhibits the reaction [Oxygen deficiency results in increased expression of BNIP3 protein]] Oxygen deficiency results in increased expression of BNIP3 mRNA; Oxygen deficiency results in increased expression of BNIP3 protein Tea inhibits the reaction [Oxygen deficiency results in increased expression of BNIP3 protein]
|
CTD |
PMID:17193925 PMID:17914565 PMID:20042640 PMID:20880076 PMID:23624791 PMID:24236059 PMID:25596134 PMID:26082309 PMID:27292261 PMID:29139225 PMID:29690507 PMID:30381462 PMID:35883890 More...
|
|
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962
|
|
| G
|
Bnip3l
|
BCL2 interacting protein 3 like
|
affects expression increases expression multiple interactions
|
ISO
|
Oxygen deficiency affects the expression of BNIP3L mRNA Oxygen deficiency results in increased expression of BNIP3L mRNA Oxygen deficiency promotes the reaction [HIF1A protein binds to BNIP3L promoter]
|
CTD |
PMID:17193925 PMID:20042640 PMID:20880076 PMID:23880069 PMID:24236059 PMID:26516004 More...
|
|
NCBI chr15:45,350,081...45,373,213
Ensembl chr15:45,334,537...45,373,282
|
|
| G
|
Bod1l1
|
biorientation of chromosomes in cell division 1-like 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of BOD1L mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr14:73,320,880...73,375,662
Ensembl chr14:73,320,832...73,375,658
|
|
| G
|
Bop1
|
BOP1 ribosomal biogenesis factor
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of BOP1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 7:110,052,716...110,076,529
Ensembl chr 7:110,052,720...110,076,529
|
|
| G
|
Bpgm
|
bisphosphoglycerate mutase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BPGM mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:64,106,809...64,135,749
Ensembl chr 4:64,106,804...64,135,627
|
|
| G
|
Bphl
|
biphenyl hydrolase like
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BPHL mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr17:31,006,283...31,042,631
Ensembl chr17:31,004,972...31,042,632
|
|
| G
|
Bpi
|
bactericidal/permeability-increasing protein
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of BPI mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 3:167,329,513...167,356,217
Ensembl chr 3:167,329,530...167,356,396
|
|
| G
|
Bptf
|
bromodomain PHD finger transcription factor
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of BPTF mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr10:92,480,007...92,582,485
Ensembl chr10:92,480,007...92,582,413
|
|
| G
|
Braf
|
B-Raf proto-oncogene, serine/threonine kinase
|
multiple interactions
|
ISO
|
[Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of BRAF mRNA
|
CTD |
PMID:32992648 |
|
NCBI chr 4:69,329,772...69,476,931
Ensembl chr 4:69,342,813...69,476,931
|
|
| G
|
Brca1
|
BRCA1, DNA repair associated
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of BRCA1 mRNA; Oxygen deficiency results in decreased expression of BRCA1 protein
|
CTD |
PMID:17599377 PMID:26516004 PMID:28472268 |
|
NCBI chr10:86,917,693...86,978,012
Ensembl chr10:86,917,693...86,977,763
|
|
| G
|
Brca2
|
BRCA2, DNA repair associated
|
decreases expression increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of BRCA2 mRNA Oxygen deficiency results in increased expression of BRCA2 mRNA Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of BRCA2 mRNA] [Oxygen co-treated with Ozone] inhibits the reaction [Cannabidiol results in decreased expression of BRCA2 mRNA]; [Oxygen co-treated with Ozone] results in increased expression of BRCA2 mRNA; Cannabidiol inhibits the reaction [[Oxygen co-treated with Ozone] results in increased expression of BRCA2 mRNA]
|
CTD |
PMID:26476374 PMID:26516004 PMID:32992648 PMID:38909692 |
|
NCBI chr12:4,895,092...4,939,340
Ensembl chr12:4,895,447...4,936,194
|
|
| G
|
Brd2
|
bromodomain containing 2
|
decreases expression increases expression
|
ISO
|
Oxygen deficiency results in decreased expression of BRD2 mRNA Oxygen deficiency results in increased expression of BRD2
|
CTD |
PMID:25596134 PMID:27292261 |
|
NCBI chr20:4,728,282...4,737,286
Ensembl chr20:4,728,951...4,737,290
|
|
| G
|
Brd3
|
bromodomain containing 3
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of BRD3
|
CTD |
PMID:27292261 |
|
NCBI chr 3:31,173,332...31,227,749
Ensembl chr 3:31,173,332...31,227,629
|
|
| G
|
Brd4
|
bromodomain containing 4
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of BRD4 mRNA Oxygen deficiency promotes the reaction [BRD4 protein binds to CA9 promoter]; Oxygen deficiency promotes the reaction [BRD4 protein binds to VEGFA promoter]
|
CTD |
PMID:24205000 PMID:27292261 |
|
NCBI chr 7:11,866,997...11,946,575
Ensembl chr 7:11,866,997...11,946,923
|
|
| G
|
Bri3bp
|
Bri3 binding protein
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of BRI3BP mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr12:36,838,098...36,849,919
Ensembl chr12:36,838,098...36,849,919
|
|
| G
|
Brinp1
|
BMP/retinoic acid inducible neural specific 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BRINP1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:87,363,621...87,565,580
Ensembl chr 5:87,364,050...87,508,256
|
|
| G
|
Brip1
|
BRCA1 interacting DNA helicase 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of BRIP1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:71,402,035...71,528,083
Ensembl chr10:71,401,151...71,575,206
|
|
| G
|
Brix1
|
biogenesis of ribosomes BRX1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BRIX1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:61,177,769...61,188,647
Ensembl chr 2:61,177,771...61,188,647
|
|
| G
|
Brox
|
BRO1 domain and CAAX motif containing
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of BROX mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr13:97,451,736...97,471,598
Ensembl chr13:97,451,737...97,471,519
|
|
| G
|
Bsdc1
|
BSD domain containing 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of BSDC1 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of BSDC1 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 5:147,083,044...147,113,997
Ensembl chr 5:147,079,838...147,114,241
|
|
| G
|
Bst2
|
bone marrow stromal cell antigen 2
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of BST2 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of BST2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr16:18,250,593...18,254,967
Ensembl chr16:18,251,847...18,254,967
|
|
| G
|
Btaf1
|
B-TFIID TATA-box binding protein associated factor 1
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of BTAF1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:244,065,728...244,156,457
Ensembl chr 1:244,065,743...244,156,457
|
|
| G
|
Btbd19
|
BTB domain containing 19
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BTBD19 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:135,834,251...135,843,679
Ensembl chr 5:135,834,508...135,840,903
|
|
| G
|
Btg2
|
BTG anti-proliferation factor 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of BTG2 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690
|
|
| G
|
Btla
|
B and T lymphocyte associated
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BTLA mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr11:69,069,734...69,099,331
Ensembl chr11:69,052,644...69,093,224
|
|
| G
|
Btnl9
|
butyrophilin-like 9
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of BTNL9 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:33,967,098...33,990,304
Ensembl chr10:33,970,675...33,990,354
|
|
| G
|
Bub1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of BUB1 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of BUB1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 3:135,473,525...135,504,921
Ensembl chr 3:135,472,582...135,504,921
|
|
| G
|
Bub1b
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of BUB1B mRNA [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of BUB1B mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of BUB1B mRNA
|
CTD |
PMID:26516004 PMID:33729688 |
|
NCBI chr 3:126,017,019...126,069,470
Ensembl chr 3:126,017,045...126,069,796
|
|
| G
|
Bysl
|
bystin-like
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BYSL mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:20,880,341...20,890,092
Ensembl chr 9:20,880,026...20,890,900
|
|
| G
|
Bzw1
|
basic leucine zipper and W2 domains 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BZW1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:67,424,860...67,438,656
Ensembl chr 9:67,424,866...67,439,684
|
|
| G
|
C11h21orf91
|
similar to human chromosome 21 open reading frame 91
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of C11H21ORF91 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr11:30,716,034...30,749,292
Ensembl chr11:30,716,034...30,749,415
|
|
| G
|
C13h1orf21
|
similar to human chromosome 1 open reading frame 21
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of C1ORF21 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr13:66,540,245...66,749,631
Ensembl chr13:66,540,245...66,659,684
|
|
| G
|
C15h8orf58
|
similar to human chromosome 8 open reading frame 58
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of C8ORF58 mRNA
|
CTD |
PMID:25596134 PMID:26516004 |
|
NCBI chr15:51,638,336...51,645,141
Ensembl chr15:51,638,350...51,642,974
|
|
| G
|
C16h10orf71
|
similar to human chromosome 10 open reading frame 71
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of C16H10ORF71 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr16:7,916,901...7,968,280
Ensembl chr16:7,915,011...7,967,682
|
|
| G
|
C18h18orf32
|
similar to human chromosome 18 open reading frame 32
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of C18ORF32 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr18:70,861,434...70,869,983
Ensembl chr18:70,861,435...70,869,983
|
|
| G
|
C18h5orf46
|
similar to human chromosome 5 open reading frame 46
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of C5ORF46 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr18:36,199,309...36,220,409
Ensembl chr18:36,199,309...36,220,409
|
|
| G
|
C1qa
|
complement C1q A chain
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of C1QA mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 5:154,417,086...154,419,933
Ensembl chr 5:154,417,087...154,427,732
|
|
| G
|
C1qb
|
complement C1q B chain
|
increases expression multiple interactions
|
EXP ISO
|
Oxygen results in increased expression of C1QB mRNA [N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride co-treated with [Oxygen deficiency co-treated with Blood Glucose deficiency]] results in increased expression of C1QB mRNA
|
CTD |
PMID:19640911 PMID:22911455 |
|
NCBI chr 5:154,402,276...154,407,827
Ensembl chr 5:154,402,279...154,407,840
|
|
| G
|
C1qbp
|
complement C1q binding protein
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of C1QBP mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:56,198,534...56,203,185
Ensembl chr10:56,198,540...56,203,235
|
|
| G
|
C1qtnf2
|
C1q and TNF related 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of C1QTNF2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:28,443,326...28,460,400
Ensembl chr10:28,443,425...28,460,395
|
|
| G
|
C1qtnf3
|
C1q and TNF related 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of C1QTNF3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:61,644,225...61,666,640
Ensembl chr 2:61,644,276...61,666,559
|
|
| G
|
C1qtnf7
|
C1q and TNF related 7
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of C1QTNF7 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of C1QTNF7 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr14:71,680,415...71,792,931
Ensembl chr14:71,680,479...71,792,865
|
|
| G
|
C1r
|
complement C1r
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of C1R mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 4:159,099,013...159,109,770
Ensembl chr 4:159,098,918...159,109,714
|
|
| G
|
C1s
|
complement C1s
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of C1S mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 4:159,116,549...159,128,736
Ensembl chr 4:159,116,549...159,128,736
|
|
| G
|
C2h4orf46
|
similar to human chromosome 4 open reading frame 46
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of C4ORF46 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 2:167,061,141...167,064,273
Ensembl chr 2:167,060,941...167,064,271
|
|
| G
|
C2h5orf34
|
similar to human chromosome 5 open reading frame 34
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of C5ORF34 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 2:53,287,353...53,309,804
Ensembl chr 2:53,287,957...53,309,806
|
|
| G
|
C3
|
complement C3
|
multiple interactions
|
ISO
|
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of C3 mRNA
|
CTD |
PMID:23199288 |
|
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339
|
|
| G
|
C3ar1
|
complement C3a receptor 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of C3AR1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:157,747,419...157,756,609
Ensembl chr 4:157,746,089...157,776,323
|
|
| G
|
C3h11orf96
|
similar to human chromosome 11 open reading frame 96
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of C3H11ORF96 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 3:100,375,474...100,376,717
Ensembl chr 3:100,351,199...100,378,346
|
|
| G
|
C4a
|
complement C4A (Rodgers blood group)
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of C4A mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr20:4,010,306...4,024,707
|
|
| G
|
C5
|
complement C5
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HC mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:38,668,174...38,759,468
|
|
| G
|
C5ar1
|
complement C5a receptor 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of C5AR1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:86,077,309...86,088,001
|
|
| G
|
C5h1orf94
|
similar to human chromosome 1 open reading frame 94
|
affects methylation increases expression
|
ISO
|
Oxygen deficiency affects the methylation of CK137956 promoter Oxygen deficiency results in increased expression of CK137956 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 5:145,566,517...145,610,294
Ensembl chr 5:145,552,750...145,610,294
|
|
| G
|
C6
|
complement C6
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of C6 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:55,573,596...55,648,857
Ensembl chr 2:55,573,653...55,649,120
|
|
| G
|
Ca11
|
carbonic anhydrase 11
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CA11 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:105,306,347...105,311,651
Ensembl chr 1:105,302,289...105,311,832
|
|
| G
|
Ca12
|
carbonic anhydrase 12
|
multiple interactions increases expression
|
ISO EXP
|
[4-(4-((2',3',4',6'-tetra-O-acetylglucopyranosyl)thiomethyl)-5-iodo-1-H-1,2,3-triazol-1-yl)benzenesulfonamide inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]] which results in increased expression of CA12 protein Oxygen deficiency results in increased expression of CA12 mRNA; Oxygen deficiency results in increased expression of CA12 protein [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CAR12 mRNA
|
CTD |
PMID:19695866 PMID:20042640 PMID:21851094 PMID:33729688 |
|
NCBI chr 8:76,169,723...76,225,465
Ensembl chr 8:76,169,815...76,225,465
|
|
| G
|
Ca13
|
carbonic anhydrase 13
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CAR13 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:88,649,643...88,680,763
Ensembl chr 2:88,649,625...88,680,763
|
|
| G
|
Ca14
|
carbonic anhydrase 14
|
affects methylation decreases expression
|
ISO
|
Oxygen deficiency affects the methylation of CAR14 promoter Oxygen deficiency results in decreased expression of CAR14 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 2:186,131,196...186,138,164
Ensembl chr 2:186,129,341...186,138,863
|
|
| G
|
Ca8
|
carbonic anhydrase 8
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of CAR8 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CAR8 mRNA
|
CTD |
PMID:24205000 PMID:30529165 |
|
NCBI chr 5:26,102,767...26,199,819
Ensembl chr 5:26,102,813...26,199,796
|
|
| G
|
Ca9
|
carbonic anhydrase 9
|
multiple interactions increases expression
|
ISO EXP
|
ARNT protein affects the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA] Oxygen deficiency results in increased expression of CA9; Oxygen deficiency results in increased expression of CA9 mRNA [Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of ABCC2 mRNA; [Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of ALDH1A1 mRNA; [Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of ALDH1A1 protein; [Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of IGF1 mRNA; [Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of LIN28A mRNA; [Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of SOX2 mRNA; [Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of TWIST1 mRNA; [Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of WNT2 mRNA; Oxygen deficiency results in increased expression of CA9; Oxygen deficiency results in increased expression of CA9 mRNA; Oxygen deficiency results in increased expression of CA9 protein (+)-JQ1 compound inhibits the reaction [Oxygen deficiency promotes the reaction [ARNT protein binds to CA9 promoter]]; (+)-JQ1 compound inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; (+)-JQ1 compound inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]; 1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; 1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]; 4-(4-((2',3',4',6'-tetra-O-acetylglucopyranosyl)thiomethyl)-5-iodo-1-H-1,2,3-triazol-1-yl)benzenesulfonamide inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; 4-(4-((2',3',4',6'-tetra-O-acetylglucopyranosyl)thiomethyl)-5-iodo-1-H-1,2,3-triazol-1-yl)benzenesulfonamide inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]; [4-(4-((2',3',4',6'-tetra-O-acetylglucopyranosyl)thiomethyl)-5-iodo-1-H-1,2,3-triazol-1-yl)benzenesulfonamide inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]] which results in increased expression of CA12 protein; [Oxygen deficiency co-treated with Lipopolysaccharides] results in increased expression of CA9 mRNA; betulin analog inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]; Betulinic Acid inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]; Bezafibrate inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; Butyric Acid inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]; CA9 mutant form inhibits the reaction [[Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of ABCC2 mRNA]; CA9 mutant form inhibits the reaction [[Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of ALDH1A1 mRNA]; CA9 mutant form inhibits the reaction [[Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of LIN28A mRNA]; CA9 mutant form inhibits the reaction [[Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of TWIST1 mRNA]; CA9 mutant form inhibits the reaction [[Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of WNT2 mRNA]; CAY10591 inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]; Clofibrate inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; cobaltiprotoporphyrin inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; cobaltiprotoporphyrin inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]; deguelin inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; Fenofibrate inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; Fenofibrate inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]; Gemfibrozil inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; genipin inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; GSK1210151A inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; HIF1A mRNA promotes the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; molibresib inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; Oxygen deficiency promotes the reaction [ARNT protein binds to CA9 promoter]; Oxygen deficiency promotes the reaction [BRD4 protein binds to CA9 promoter]; PTEN protein promotes the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]]; PTEN protein promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]]; Tetrachlorodibenzodioxin inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]; Vorinostat inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein] Oxygen deficiency results in increased expression of CAR9 protein
|
CTD |
PMID:18924134 PMID:19154183 PMID:19502547 PMID:19695866 PMID:19808899 PMID:20042640 PMID:20526721 PMID:21361354 PMID:21851094 PMID:22745725 PMID:23424623 PMID:24403227 PMID:25030372 PMID:25043185 PMID:25351418 PMID:26305601 PMID:26540049 PMID:27292261 PMID:29630948 PMID:29690507 PMID:33245928 PMID:34520103 PMID:36527649 PMID:40024754 More...
|
|
NCBI chr 5:62,559,024...62,565,626
Ensembl chr 5:62,558,823...62,565,626
|
|
| G
|
Cab39
|
calcium binding protein 39
|
affects methylation increases expression
|
ISO
|
Oxygen deficiency affects the methylation of CAB39 promoter Oxygen deficiency results in increased expression of CAB39 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 9:93,911,099...93,972,542
Ensembl chr 9:93,911,054...93,972,542
|
|
| G
|
Cabp1
|
calcium binding protein 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CABP1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr12:47,045,914...47,109,614
Ensembl chr12:47,085,292...47,109,611
|
|
| G
|
Cacna1c
|
calcium voltage-gated channel subunit alpha1 C
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CACNA1C mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 4:153,431,169...154,051,932
Ensembl chr 4:153,436,427...154,051,762
|
|
| G
|
Cacna1h
|
calcium voltage-gated channel subunit alpha1 H
|
multiple interactions increases expression
|
EXP
|
EPAS1 protein affects the reaction [Oxygen deficiency results in increased expression of CACNA1H mRNA]
|
CTD |
PMID:12679337 |
|
NCBI chr10:14,894,630...14,952,317
Ensembl chr10:14,894,641...14,952,771
|
|
| G
|
Cacna1i
|
calcium voltage-gated channel subunit alpha1 I
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CACNA1I mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 7:113,716,266...113,827,670
Ensembl chr 7:113,716,266...113,827,670
|
|
| G
|
Cad
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CAD mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 6:31,012,091...31,035,098
Ensembl chr 6:31,012,091...31,035,297
|
|
| G
|
Cadm1
|
cell adhesion molecule 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CADM1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:56,744,374...57,075,264
Ensembl chr 8:56,744,372...57,080,192
|
|
| G
|
Cadm2
|
cell adhesion molecule 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CADM2 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr11:17,994,856...18,971,895
Ensembl chr11:17,994,856...18,971,448
|
|
| G
|
Cadps2
|
calcium dependent secretion activator 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CADPS2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:52,746,054...53,275,252
Ensembl chr 4:52,746,065...53,275,004
|
|
| G
|
Calb1
|
calbindin 1
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of CALB1 mRNA Simvastatin inhibits the reaction [Oxygen deficiency results in decreased expression of CALB1 mRNA]
|
CTD |
PMID:16373842 |
|
NCBI chr 5:34,172,612...34,199,555
Ensembl chr 5:34,172,664...34,200,160
|
|
| G
|
Calcoco1
|
calcium binding and coiled coil domain 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CALCOCO1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:135,713,208...135,728,044
Ensembl chr 7:135,713,208...135,727,928
|
|
| G
|
Calcoco2
|
calcium binding and coiled-coil domain 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CALCOCO2 mRNA
|
CTD |
PMID:17175027 |
|
NCBI chr10:81,552,084...81,568,266
|
|
| G
|
Calcrl
|
calcitonin receptor like receptor
|
multiple interactions increases expression
|
ISO
|
Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of CALCRL mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 3:89,835,071...89,932,616
Ensembl chr 3:89,835,077...89,887,350
|
|
| G
|
Cald1
|
caldesmon 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of CALD1 mRNA Oxygen deficiency inhibits the reaction [darinaparsin results in increased expression of CALD1 mRNA] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CALD1 mRNA
|
CTD |
PMID:22535156 PMID:24205000 PMID:30529165 |
|
NCBI chr 4:64,232,906...64,414,085
Ensembl chr 4:64,233,171...64,414,085
|
|
| G
|
Calhm2
|
calcium homeostasis modulator family member 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CALHM2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:255,963,661...255,969,387
Ensembl chr 1:255,963,663...255,969,387
|
|
| G
|
Calhm6
|
calcium homeostasis modulator family member 6
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CALHM6 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr20:26,638,721...26,640,466
Ensembl chr20:26,638,722...26,640,408
|
|
| G
|
Calm1
|
calmodulin 1
|
multiple interactions
|
ISO
|
Oxygen affects the reaction [AHR protein results in decreased expression of CALM1 mRNA]
|
CTD |
PMID:27103661 |
|
NCBI chr 6:125,217,191...125,227,855
Ensembl chr 6:125,217,246...125,225,381
|
|
| G
|
Calm2
|
calmodulin 2
|
multiple interactions
|
EXP
|
CALM2 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
|
CTD |
PMID:21124846 |
|
NCBI chr 6:12,845,170...12,857,830
Ensembl chr15:64,519,554...64,520,657 Ensembl chr 6:64,519,554...64,520,657
|
|
| G
|
Caly
|
calcyon neuron-specific vesicular protein
|
multiple interactions
|
EXP
|
CALY protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
|
CTD |
PMID:21124846 |
|
NCBI chr 1:204,292,317...204,303,506
Ensembl chr 1:204,292,318...204,303,196
|
|
| G
|
Camk2b
|
calcium/calmodulin-dependent protein kinase II beta
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of CAMK2B mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CAMK2B mRNA; [Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of CAMK2B protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of CAMK2B protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of CAMK2B protein]
|
CTD |
PMID:24718106 PMID:26516004 PMID:33729688 |
|
NCBI chr14:85,059,166...85,148,121
Ensembl chr14:85,059,191...85,148,485
|
|
| G
|
Camk2g
|
calcium/calmodulin-dependent protein kinase II gamma
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CAMK2G mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr15:3,553,238...3,612,310
Ensembl chr15:3,553,294...3,612,310
|
|
| G
|
Camk2n2
|
calcium/calmodulin-dependent protein kinase II inhibitor 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CAMK2N2 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr11:93,792,112...93,796,153
Ensembl chr11:93,794,095...93,795,222
|
|
| G
|
Camkk2
|
calcium/calmodulin-dependent protein kinase kinase 2
|
affects expression
|
ISO
|
Oxygen deficiency affects the expression of CAMKK2 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr12:39,451,828...39,505,719
Ensembl chr12:39,451,834...39,514,964
|
|
| G
|
Camp
|
cathelicidin antimicrobial peptide
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CAMP mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CAMP mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 8:118,720,184...118,721,998
Ensembl chr 8:118,720,184...118,721,998
|
|
| G
|
Canx
|
calnexin
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CANX mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr10:35,124,941...35,157,954
Ensembl chr10:35,124,941...35,157,857
|
|
| G
|
Capg
|
capping actin protein, gelsolin like
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CAPG mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:106,152,912...106,170,010
Ensembl chr 4:106,152,890...106,170,672
|
|
| G
|
Capn1
|
calpain 1
|
multiple interactions
|
EXP
|
2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside inhibits the reaction [[Oxygen co-treated with Glucose deficiency] results in increased expression of CAPN1 protein]; [Oxygen co-treated with Glucose deficiency] results in increased expression of CAPN1 protein
|
CTD |
PMID:24726522 |
|
NCBI chr 1:212,705,219...212,736,134
Ensembl chr 1:212,705,222...212,729,445
|
|
| G
|
Capn6
|
calpain 6
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CAPN6 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr X:112,177,467...112,202,178
Ensembl chr X:112,177,467...112,202,178
|
|
| G
|
Carmil2
|
capping protein regulator and myosin 1 linker 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CARMIL2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr19:50,481,911...50,496,672
Ensembl chr19:50,484,324...50,496,669
|
|
| G
|
Cars1
|
cysteinyl-tRNA synthetase 1
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of CARS1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CARS1 mRNA
|
CTD |
PMID:25596134 PMID:30529165 |
|
NCBI chr 1:208,183,092...208,225,425
Ensembl chr 1:208,182,788...208,225,407
|
|
| G
|
Casp1
|
caspase 1
|
multiple interactions increases expression
|
ISO EXP
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of CASP1 mRNA]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP1 protein; bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP1 protein]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of CASP1 mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of CASP1 mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of CASP1 mRNA]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of CASP1 mRNA] [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CASP1 mRNA]; [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CASP1 protein]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CASP1 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CASP1 protein; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CASP1 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CASP1 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP1 protein modified form; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP1 protein modified form]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CASP1 mRNA]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CASP1 protein] Oxygen deficiency results in increased expression of CASP1 protein Oxygen deficiency affects the reaction [NFE2L2 protein affects the expression of CASP1 mRNA]
|
CTD |
PMID:23452621 PMID:26464617 PMID:33729688 PMID:35191607 PMID:37127800 PMID:39038764 More...
|
|
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:10,746,333...10,882,275
|
|
| G
|
Casp12
|
caspase 12
|
increases cleavage
|
ISO
|
Oxygen deficiency results in increased cleavage of CASP12 protein
|
CTD |
PMID:24680926 |
|
NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:10,926,994...10,954,442
|
|
| G
|
Casp3
|
caspase 3
|
multiple interactions increases cleavage increases activity increases expression
|
ISO EXP
|
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [euscaphic acid inhibits the reaction [Oxygen deficiency results in increased cleavage of CASP3 protein]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased cleavage of CASP3 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [tormentic acid inhibits the reaction [Oxygen deficiency results in increased cleavage of CASP3 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [euscaphic acid inhibits the reaction [Oxygen deficiency results in increased cleavage of CASP3 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased cleavage of CASP3 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [tormentic acid inhibits the reaction [Oxygen deficiency results in increased cleavage of CASP3 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [voacangine inhibits the reaction [Oxygen deficiency results in increased activity of CASP3 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Oxygen deficiency results in increased activity of CASP3 protein]; [Oxygen deficiency co-treated with Oxygen] results in increased cleavage of CASP3 protein; cyanidin-3-O-beta-glucopyranoside inhibits the reaction [Oxygen deficiency results in increased activity of CASP3 protein]; euscaphic acid inhibits the reaction [Oxygen deficiency results in increased cleavage of CASP3 protein]; iroxanadine inhibits the reaction [Oxygen deficiency results in increased activity of CASP3 protein]; N-ethoxymethyl-3-amino-1,2,4-benzotriazine-1,4-dioxide promotes the reaction [Oxygen deficiency results in increased cleavage of CASP3 protein]; Oxygen deficiency affects the reaction [Acetylcysteine results in increased activity of CASP3 protein]; Oxygen deficiency inhibits the reaction [Etoposide results in increased expression of CASP3 protein]; Oxygen deficiency promotes the reaction [Cisplatin promotes the reaction [eprenetapopt results in increased cleavage of CASP3 protein]]; Oxygen deficiency promotes the reaction [eprenetapopt results in increased cleavage of CASP3 protein]; Oxygen deficiency promotes the reaction [HBEGF protein mutant form results in increased activity of CASP3 protein]; Oxygen deficiency promotes the reaction [HIF1A mutant form results in increased activity of CASP3 protein]; Oxygen deficiency results in decreased expression of and results in decreased cleavage of CASP3 protein; pyrazolanthrone inhibits the reaction [Oxygen deficiency promotes the reaction [HBEGF protein mutant form results in increased activity of CASP3 protein]]; Quercetin inhibits the reaction [iroxanadine inhibits the reaction [Oxygen deficiency results in increased activity of CASP3 protein]]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased cleavage of CASP3 protein]; salvin inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased cleavage of CASP3 protein]; SIRT1 mutant form promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased cleavage of CASP3 protein]; tormentic acid inhibits the reaction [Oxygen deficiency results in increased cleavage of CASP3 protein]; voacangine inhibits the reaction [Oxygen deficiency results in increased activity of CASP3 protein] 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CASP3 mRNA]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [wedelolactone inhibits the reaction [Oxygen results in increased cleavage of CASP3 protein]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CASP3 mRNA]; [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased cleavage of CASP3 protein; [Butylated Hydroxytoluene co-treated with Oxygen] results in increased cleavage of CASP3 protein; [Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CASP3 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein; [Oxygen deficiency co-treated with Oxygen] results in increased cleavage of CASP3 protein; atractylenolide III inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein]; bazedoxifene promotes the reaction [Oxygen deficiency results in increased activity of CASP3 protein]; CDX2 protein inhibits the reaction [Oxygen deficiency results in increased activity of CASP3 protein]; CTNNB1 protein promotes the reaction [Oxygen deficiency results in increased activity of CASP3 protein]; Edaravone inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein]; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CASP3 mRNA]]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CASP3 mRNA]; MIR144 mRNA promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; NFE2L2 protein affects the reaction [PHLPP2 protein affects the reaction [Oxygen deficiency results in increased activity of CASP3 protein]]; Octreotide inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased cleavage of CASP3 protein]; PHLPP2 protein affects the reaction [Oxygen deficiency results in increased activity of CASP3 protein]; PHLPP2 protein promotes the reaction [Oxygen deficiency results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein]; SGMS2 protein promotes the reaction [Oxygen deficiency results in increased activity of CASP3 protein]; SIRT1 promotes the reaction [SNHG12 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased cleavage of CASP3 protein]]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; SNHG12 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased cleavage of CASP3 protein]; SNHG12 mRNA promotes the reaction [Octreotide inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased cleavage of CASP3 protein]]; TWS 119 inhibits the reaction [PHLPP2 protein promotes the reaction [Oxygen deficiency results in increased activity of CASP3 protein]]; U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein]; VDAC1 protein inhibits the reaction [Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; VDAC1 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; wedelolactone inhibits the reaction [Oxygen results in increased cleavage of CASP3 protein]; YAP1 promotes the reaction [SNHG12 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased cleavage of CASP3 protein]]; zAsp(Ome)-Arg-His-Asp(Ome)-fluoromethyl ketone inhibits the reaction [[Butylated Hydroxytoluene co-treated with Oxygen] results in increased cleavage of CASP3 protein] Oxygen deficiency results in increased cleavage of CASP3 protein; Oxygen results in increased cleavage of CASP3 protein Oxygen deficiency results in increased expression of CASP3 mRNA; Oxygen deficiency results in increased expression of CASP3 protein (2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide inhibits the reaction [[Apigenin co-treated with Oxygen deficiency] results in increased expression of CASP3 protein modified form]; 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid inhibits the reaction [notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased cleavage of CASP3 protein]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [naringin inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased cleavage of and results in increased activity of CASP3 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [2-chloro-N(6)cyclopentyladenosine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [LY 379268 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [naringin inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased cleavage of and results in increased activity of CASP3 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; 2-chloro-N(6)cyclopentyladenosine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [Oxygen deficiency results in increased expression of CASP3 protein]; [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with Hemin] results in increased cleavage of CASP3 protein; [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in increased cleavage of CASP3 protein; [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased cleavage of CASP3 protein; [Antagomirs results in decreased expression of MIR205 mRNA] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CASP3 protein modified form]; [Antagomirs results in decreased expression of MIR205 mRNA] promotes the reaction [Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in increased expression of CASP3 protein modified form]]; [Antagomirs results in decreased expression of MIR205 mRNA] promotes the reaction [Remifentanil inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CASP3 protein modified form]]; [Antagomirs results in decreased expression of MIR30C1 mRNA] promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased activity of CASP3 protein]; [Apigenin co-treated with Oxygen deficiency] results in increased expression of CASP3 protein modified form; [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein; [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CASP3 mRNA; [N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride affects the susceptibility to Oxygen deficiency] which results in increased expression of CASP3 protein; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased activity of CASP3 protein; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased cleavage of CASP3 protein; [Oxygen co-treated with Dithionite] results in increased expression of CASP3 protein modified form; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CASP3 protein modified form; [Oxygen deficiency co-treated with Glucose deficiency] affects the expression of and affects the activity of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of and results in increased cleavage of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form; [Oxygen deficiency co-treated with Oxygen] results in increased activity of CASP3 protein; [Oxygen deficiency co-treated with Oxygen] results in increased cleavage of and results in increased activity of CASP3 protein; Antigen-Antibody Complex inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; Capsaicin inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased activity of CASP3 protein]; diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]; Ethanol promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased cleavage of CASP3 protein]; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; Hemin inhibits the reaction [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in increased cleavage of CASP3 protein]; Hemin inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased cleavage of CASP3 protein]; HIF1A protein inhibits the reaction [[Apigenin co-treated with Oxygen deficiency] results in increased expression of CASP3 protein modified form]; HMOX1 protein promotes the reaction [diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; kaempferol inhibits the reaction [Oxygen deficiency results in increased cleavage of CASP3 protein]; KEAP1 protein inhibits the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; LY 379268 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; MIR205 mRNA inhibits the reaction [Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in increased expression of CASP3 protein modified form]]; MIR30C1 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased activity of CASP3 protein]; naringin inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased cleavage of and results in increased activity of CASP3 protein]; NFE2L2 mutant form promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased cleavage of and results in increased activity of CASP3 protein]; NFE2L2 protein mutant form affects the reaction [plumbagin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; NFE2L2 protein promotes the reaction [diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; NFE2L2 protein promotes the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; norwogonin inhibits the reaction [Oxygen deficiency results in increased cleavage of CASP3 protein]; norwogonin inhibits the reaction [Oxygen deficiency results in increased expression of CASP3 mRNA]; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased activity of CASP3 protein]; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased cleavage of CASP3 protein]; Oxygen deficiency results in increased expression of and results in increased cleavage of CASP3 protein; panaxydol inhibits the reaction [Oxygen deficiency results in increased activity of CASP3 protein]; Phenylephrine inhibits the reaction [Oxygen deficiency results in increased activity of CASP3 protein]; plumbagin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; protosappanin A inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of and results in increased cleavage of CASP3 protein]; Quercetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein]; Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in increased expression of CASP3 protein modified form]; Remifentanil inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CASP3 protein modified form]; rottlerin inhibits the reaction [naringin inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased cleavage of and results in increased activity of CASP3 protein]]; Rutin inhibits the reaction [Oxygen deficiency results in increased cleavage of CASP3 protein]; Rutin inhibits the reaction [Oxygen deficiency results in increased expression of CASP3 mRNA]; sanggenone C inhibits the reaction [Oxygen deficiency results in increased cleavage of CASP3 protein]; sodium bisulfide inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CASP3 protein modified form]; Tacrolimus inhibits the reaction [Oxygen deficiency results in increased activity of CASP3 protein]; Tea inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased cleavage of CASP3 protein]; trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; Trimetazidine inhibits the reaction [Oxygen deficiency results in increased expression of CASP3 mRNA]; U 0126 inhibits the reaction [2-chloro-N(6)cyclopentyladenosine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; U 0126 inhibits the reaction [LY 379268 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; Y 27632 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased cleavage of CASP3 protein]; zinc protoporphyrin promotes the reaction [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in increased cleavage of CASP3 protein]; zinc protoporphyrin promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased cleavage of CASP3 protein]
|
CTD |
PMID:11042672 PMID:11526447 PMID:12892836 PMID:15322300 PMID:15583868 PMID:16135072 PMID:16272459 PMID:17131054 PMID:17293559 PMID:17468103 PMID:18541227 PMID:19011674 PMID:19193634 PMID:20028456 PMID:20530905 PMID:23144690 PMID:23637816 PMID:23758074 PMID:24058562 PMID:24518827 PMID:24557422 PMID:24680926 PMID:24682241 PMID:24720662 PMID:24846829 PMID:24860939 PMID:25238743 PMID:25305180 PMID:25322861 PMID:25450231 PMID:25488258 PMID:25773745 PMID:25896937 PMID:25937560 PMID:26747958 PMID:27693381 PMID:28675767 PMID:28859903 PMID:28983604 PMID:29139225 PMID:29457851 PMID:29605020 PMID:29690507 PMID:29702141 PMID:29719095 PMID:31610156 PMID:31930969 PMID:31935362 PMID:32298737 PMID:33111559 PMID:33225685 PMID:33413359 PMID:33508982 PMID:33759271 PMID:34078833 PMID:34217758 PMID:34355838 PMID:35191607 PMID:35307376 PMID:36940862 PMID:38295844 PMID:38666302 PMID:38909692 PMID:39110510 PMID:39326406 More...
|
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp4
|
caspase 4
|
multiple interactions
|
ISO
|
Oxygen deficiency inhibits the reaction [darinaparsin results in increased expression of CASP4 mRNA] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CASP4 mRNA
|
CTD |
PMID:22535156 PMID:30529165 |
|
NCBI chr 8:10,883,817...10,919,978
Ensembl chr 8:10,883,769...10,920,727
|
|
| G
|
Casp8
|
caspase 8
|
multiple interactions increases expression
|
ISO
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of CASP8 mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of CASP8 mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of CASP8 mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of CASP8 mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of CASP8 mRNA]
|
CTD |
PMID:23452621 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
|
|
| G
|
Casp8ap2
|
caspase 8 associated protein 2
|
increases expression multiple interactions
|
EXP
|
Oxygen deficiency results in increased expression of CASP8AP2 mRNA Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of CASP8AP2 mRNA]
|
CTD |
PMID:26476374 |
|
NCBI chr 5:51,809,366...51,848,633
Ensembl chr 5:51,810,972...51,848,632
|
|
| G
|
Casp9
|
caspase 9
|
multiple interactions increases activity affects response to substance increases cleavage
|
ISO EXP
|
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [euscaphic acid inhibits the reaction [Oxygen deficiency results in increased cleavage of CASP9 protein]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased cleavage of CASP9 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [tormentic acid inhibits the reaction [Oxygen deficiency results in increased cleavage of CASP9 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [euscaphic acid inhibits the reaction [Oxygen deficiency results in increased cleavage of CASP9 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [tormentic acid inhibits the reaction [Oxygen deficiency results in increased cleavage of CASP9 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Oxygen deficiency results in increased cleavage of CASP9 protein]; euscaphic acid inhibits the reaction [Oxygen deficiency results in increased cleavage of CASP9 protein]; iroxanadine inhibits the reaction [Oxygen deficiency results in increased activity of CASP9 protein]; Oxygen deficiency promotes the reaction [HIF1A mutant form results in increased activity of CASP9 protein]; Quercetin inhibits the reaction [iroxanadine inhibits the reaction [Oxygen deficiency results in increased activity of CASP9 protein]]; tormentic acid inhibits the reaction [Oxygen deficiency results in increased cleavage of CASP9 protein] CASP9 protein affects the susceptibility to Oxygen deficiency (2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide inhibits the reaction [[Apigenin co-treated with Oxygen deficiency] results in increased expression of CASP9 protein modified form]; [Apigenin co-treated with Oxygen deficiency] results in increased expression of CASP9 protein modified form; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CASP9 protein modified form; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of and results in increased cleavage of CASP9 protein; [Oxygen deficiency co-treated with Oxygen] results in increased cleavage of and results in increased activity of CASP9 protein; HIF1A protein inhibits the reaction [[Apigenin co-treated with Oxygen deficiency] results in increased expression of CASP9 protein modified form]; naringin inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased cleavage of and results in increased activity of CASP9 protein]; protosappanin A inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of and results in increased cleavage of CASP9 protein]; sodium bisulfide inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CASP9 protein modified form]; Tea inhibits the reaction [Oxygen deficiency results in increased cleavage of CASP9 protein]
|
CTD |
PMID:11042672 PMID:15583868 PMID:15786717 PMID:21468576 PMID:24058562 PMID:24860939 PMID:25773745 PMID:29139225 PMID:31930969 PMID:32298737 PMID:33225685 More...
|
|
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Casq2
|
calsequestrin 2
|
affects methylation decreases expression
|
ISO
|
Oxygen deficiency affects the methylation of CASQ2 promoter Oxygen deficiency results in decreased expression of CASQ2 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 2:192,214,556...192,270,821
Ensembl chr 2:192,214,537...192,270,820
|
|
| G
|
Casr
|
calcium-sensing receptor
|
increases expression multiple interactions
|
EXP
|
Oxygen deficiency results in increased expression of CASR mRNA; Oxygen deficiency results in increased expression of CASR protein Chloroquine inhibits the reaction [Oxygen deficiency results in increased expression of CASR mRNA]; Chloroquine inhibits the reaction [Oxygen deficiency results in increased expression of CASR protein]
|
CTD |
PMID:32956540 |
|
NCBI chr11:77,738,398...77,813,639
Ensembl chr11:77,740,614...77,810,167
|
|
| G
|
Castor2
|
cytosolic arginine sensor for mTORC1 subunit 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CASTOR2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr12:28,213,927...28,256,593
Ensembl chr12:28,213,935...28,256,593
|
|
| G
|
Cat
|
catalase
|
multiple interactions decreases activity affects expression increases expression decreases expression
|
ISO EXP
|
CAT protein inhibits the reaction [Oxygen deficiency results in increased expression of BACE1 mRNA]; CAT protein promotes the reaction [SOD2 protein results in decreased susceptibility to Oxygen]; cyclopamine inhibits the reaction [SHH protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]]; SHH protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein] Oxygen deficiency results in decreased activity of CAT protein Oxygen deficiency affects the expression of CAT mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased activity of CAT protein; [Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in decreased activity of CAT protein; [Oxygen deficiency co-treated with Oxygen] results in decreased activity of CAT protein; [Oxygen deficiency co-treated with Oxygen] results in increased expression of CAT protein; cardamonin inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased activity of CAT protein]; Curcumin inhibits the reaction [Oxygen deficiency results in decreased activity of CAT protein]; ginsenoside Rg1 inhibits the reaction [Oxygen deficiency results in decreased expression of CAT protein]; kaempferol inhibits the reaction [Oxygen deficiency results in decreased expression of CAT protein]; naringin inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased activity of CAT protein]; norwogonin inhibits the reaction [Oxygen deficiency results in decreased activity of CAT protein]; Oxygen deficiency affects the reaction [CAT protein affects the abundance of Reactive Oxygen Species]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in decreased activity of CAT protein]; Rutin inhibits the reaction [Oxygen deficiency results in decreased activity of CAT protein] Oxygen results in increased expression of CAT [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CAT mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein; cyclopamine inhibits the reaction [polydatin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]]; cyclopamine promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]; polydatin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]
|
CTD |
PMID:2518282 PMID:11306437 PMID:16770732 PMID:17963755 PMID:19031291 PMID:19196431 PMID:21159781 PMID:23421680 PMID:25773745 PMID:27481074 PMID:28966130 PMID:30529165 PMID:33413359 PMID:37923178 More...
|
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Cav1
|
caveolin 1
|
multiple interactions increases expression increases response to substance
|
ISO EXP
|
[Oxygen deficiency co-treated with 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene] results in increased expression of CAV1 protein; N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [Oxygen deficiency results in increased expression of CAV1 protein] Oxygen deficiency results in increased expression of CAV1 mRNA; Oxygen deficiency results in increased expression of CAV1 protein CAV1 gene mutant form results in increased susceptibility to Oxygen deficiency [CAV1 gene mutant form results in increased susceptibility to Oxygen deficiency] which results in increased expression of CYBB mRNA; [CAV1 gene mutant form results in increased susceptibility to Oxygen deficiency] which results in increased expression of CYBB protein; [CAV1 gene mutant form results in increased susceptibility to Oxygen deficiency] which results in increased expression of NOX4 mRNA; [CAV1 gene mutant form results in increased susceptibility to Oxygen deficiency] which results in increased expression of NOX4 protein [Semaxinib co-treated with Oxygen deficiency] results in decreased expression of CAV1 mRNA; [Semaxinib co-treated with Oxygen deficiency] results in decreased expression of CAV1 protein; Simvastatin inhibits the reaction [[Semaxinib co-treated with Oxygen deficiency] results in decreased expression of CAV1 protein]
|
CTD |
PMID:16698853 PMID:18717816 PMID:24835767 |
|
NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:46,600,738...46,639,740
|
|
| G
|
Cav2
|
caveolin 2
|
multiple interactions
|
EXP
|
[Semaxinib co-treated with Oxygen deficiency] results in decreased expression of CAV2 protein; Simvastatin inhibits the reaction [[Semaxinib co-treated with Oxygen deficiency] results in decreased expression of CAV2 protein]
|
CTD |
PMID:16698853 |
|
NCBI chr 4:46,582,681...46,590,058
Ensembl chr 4:46,582,096...46,591,425
|
|
| G
|
Cav3
|
caveolin 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CAV3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:147,137,993...147,153,967
Ensembl chr 4:147,137,797...147,153,967
|
|
| G
|
Cavin2
|
caveolae associated protein 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CAVIN2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:57,794,007...57,806,024
Ensembl chr 9:57,794,019...57,806,024
|
|
| G
|
Cavin3
|
caveolae associated protein 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CAVIN3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:169,238,384...169,239,973
Ensembl chr 1:169,238,384...169,239,981
|
|
| G
|
Cbarp
|
CACN subunit beta associated regulatory protein
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CBARP mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 7:10,217,314...10,225,855
Ensembl chr 7:10,217,328...10,225,854
|
|
| G
|
Cblc
|
Cbl proto-oncogene C
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CBLC mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:88,567,930...88,584,709
Ensembl chr 1:88,567,932...88,584,709
|
|
| G
|
Cbr1
|
carbonyl reductase 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of CBR1 mRNA; Oxygen deficiency results in increased expression of CBR1 protein 3,5-dihydroxy-4'-methoxystilbene inhibits the reaction [Oxygen deficiency results in increased expression of CBR1 protein]; HIF1A mutant form inhibits the reaction [Oxygen deficiency results in increased expression of CBR1 protein]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of CBR1 mRNA]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of CBR1 protein] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CBR1 mRNA
|
CTD |
PMID:24975222 PMID:30529165 |
|
NCBI chr11:46,346,405...46,348,815
Ensembl chr11:46,378,411...46,381,104 Ensembl chr11:46,378,411...46,381,104
|
|
| G
|
Cbr2
|
carbonyl reductase 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CBR2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:106,508,964...106,511,614
Ensembl chr10:106,509,136...106,511,180
|
|
| G
|
Cbs
|
cystathionine beta synthase
|
increases expression multiple interactions
|
ISO
|
Oxygen results in increased expression of CBS protein [CBS gene mutant form results in increased susceptibility to [Blood Glucose deficiency co-treated with Oxygen deficiency]] which results in increased acetylation of RELA protein; [CBS gene mutant form results in increased susceptibility to [Blood Glucose deficiency co-treated with Oxygen deficiency]] which results in increased expression of IL1B protein; [CBS gene mutant form results in increased susceptibility to [Blood Glucose deficiency co-treated with Oxygen deficiency]] which results in increased expression of IL6 protein; [CBS gene mutant form results in increased susceptibility to [Blood Glucose deficiency co-treated with Oxygen deficiency]] which results in increased expression of TNF protein; CBS gene mutant form results in increased susceptibility to [Blood Glucose deficiency co-treated with Oxygen deficiency]
|
CTD |
PMID:27273718 PMID:31283913 |
|
NCBI chr20:9,709,394...9,733,925
Ensembl chr20:9,709,395...9,734,066
|
|
| G
|
Cbx6
|
chromobox 6
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CBX6 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:113,253,364...113,263,413
Ensembl chr 7:113,253,364...113,263,413
|
|
| G
|
Ccdc110
|
coiled-coil domain containing 110
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CCDC110 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr16:53,048,305...53,069,606
Ensembl chr16:53,047,965...53,069,777
|
|
| G
|
Ccdc124
|
coiled-coil domain containing 124
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CCDC124 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr16:18,600,737...18,606,556
Ensembl chr16:18,600,737...18,606,556
|
|
| G
|
Ccdc126
|
coiled-coil domain containing 126
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CCDC126 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 4:79,628,483...79,649,513
Ensembl chr 4:79,628,412...79,649,508
|
|
| G
|
Ccdc141
|
coiled-coil domain containing 141
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCDC141 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:82,357,046...82,517,199
Ensembl chr 3:82,357,681...82,517,710
|
|
| G
|
Ccdc180
|
coiled-coil domain containing 180
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CCDC180 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 5:64,950,522...65,019,127
Ensembl chr 5:64,950,515...65,019,127
|
|
| G
|
Ccdc38
|
coiled-coil domain containing 38
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CCDC38 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 7:29,943,046...30,017,512
Ensembl chr 7:29,946,783...30,017,504
|
|
| G
|
Ccdc68
|
coiled-coil domain containing 68
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCDC68 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CCDC68 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr18:65,817,232...65,859,529
Ensembl chr18:65,786,926...65,859,526
|
|
| G
|
Ccdc80
|
coiled-coil domain containing 80
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CCDC80 mRNA
|
CTD |
PMID:20042640 |
|
NCBI chr11:69,191,188...69,224,844
Ensembl chr11:69,191,189...69,224,844
|
|
| G
|
Ccdc86
|
coiled-coil domain containing 86
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCDC86 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:217,015,059...217,021,439
Ensembl chr 1:217,014,848...217,021,468
|
|
| G
|
Ccdc88a
|
coiled coil domain containing 88A
|
increases expression affects methylation
|
ISO
|
Oxygen deficiency results in increased expression of CCDC88A mRNA Oxygen deficiency affects the methylation of CCDC88A promoter
|
CTD |
PMID:24205000 |
|
NCBI chr14:107,304,654...107,456,104
Ensembl chr14:107,305,199...107,453,285
|
|
| G
|
Ccdc89
|
coiled-coil domain containing 89
|
decreases expression increases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CCDC89 mRNA Oxygen deficiency results in increased expression of CCDC89 mRNA
|
CTD |
PMID:24205000 PMID:26516004 |
|
NCBI chr 1:153,798,786...153,800,048
Ensembl chr 1:153,797,440...153,803,002
|
|
| G
|
Ccdc90b
|
coiled-coil domain containing 90B
|
affects expression
|
ISO
|
Oxygen deficiency affects the expression of CCDC90B mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 1:156,045,192...156,058,750
Ensembl chr 1:156,045,138...156,061,403
|
|
| G
|
Cckar
|
cholecystokinin A receptor
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCKAR mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:61,505,270...61,513,618
Ensembl chr14:61,505,270...61,513,618
|
|
| G
|
Cckbr
|
cholecystokinin B receptor
|
multiple interactions
|
ISO
|
CCKBR protein promotes the reaction [Oxygen deficiency results in increased expression of GAST mRNA]
|
CTD |
PMID:22593272 |
|
NCBI chr 1:169,183,578...169,193,583
Ensembl chr 1:169,183,194...169,193,745
|
|
| G
|
Ccl11
|
C-C motif chemokine ligand 11
|
decreases expression increases expression multiple interactions
|
ISO
|
Oxygen results in decreased expression of CCL11 mRNA Oxygen results in increased expression of CCL11 mRNA SCGB1A1 protein affects the reaction [Oxygen results in increased expression of CCL11 mRNA]
|
CTD |
PMID:9555576 PMID:10027076 |
|
NCBI chr10:67,525,975...67,530,576
Ensembl chr10:67,525,862...67,530,575
|
|
| G
|
Ccl17
|
C-C motif chemokine ligand 17
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCL17 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:10,208,120...10,218,340
Ensembl chr19:10,208,120...10,209,895
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
multiple interactions decreases secretion decreases expression increases expression increases response to substance
|
ISO EXP
|
Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 mRNA]; Oxygen affects the reaction [AHR protein results in decreased expression of CCL2 mRNA]; Oxygen deficiency inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]; Oxygen deficiency inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein] Oxygen deficiency results in decreased secretion of CCL2 protein Oxygen deficiency results in decreased expression of CCL2 mRNA Oxygen deficiency results in increased expression of CCL2 mRNA; Oxygen results in increased expression of CCL2 mRNA CCL2 results in increased susceptibility to Oxygen deficiency [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of and results in increased secretion of CCL2 protein]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of and results in increased secretion of CCL2 protein; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CCL2 mRNA; cobaltous chloride inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 protein]; deguelin promotes the reaction [Oxygen deficiency results in increased expression of CCL2 mRNA]; Edaravone inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased secretion of CCL2 protein]; Oxygen deficiency results in increased expression of and results in increased secretion of CCL2 protein; Rolipram inhibits the reaction [Oxygen results in increased expression of CCL2 protein]; SDC2 protein promotes the reaction [Oxygen deficiency results in increased expression of and results in increased secretion of CCL2 protein] Oxygen deficiency results in increased expression of CCL2 mRNA; Oxygen deficiency results in increased expression of CCL2 protein; Oxygen results in increased expression of CCL2 mRNA; Oxygen results in increased expression of CCL2 protein [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCL2 mRNA; ARNT gene mutant form inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 mRNA]; cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [Oxygen results in increased expression of CCL2 mRNA]; R 59949 inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 protein]; Valsartan inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 mRNA]
|
CTD |
PMID:10781441 PMID:11498801 PMID:14652683 PMID:18436887 PMID:18635243 PMID:18803305 PMID:18941502 PMID:19278353 PMID:20412331 PMID:21296072 PMID:22535284 PMID:22745725 PMID:23034257 PMID:23043544 PMID:23452621 PMID:23539316 PMID:25203536 PMID:27103661 PMID:30529165 PMID:33729688 More...
|
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Ccl20
|
C-C motif chemokine ligand 20
|
multiple interactions
|
ISO EXP
|
Oxygen deficiency inhibits the reaction [darinaparsin results in decreased expression of CCL20 mRNA] [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CCL20 mRNA
|
CTD |
PMID:22535156 PMID:33729688 |
|
NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:91,836,946...91,839,736
|
|
| G
|
Ccl21
|
C-C motif chemokine ligand 21
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CCL21 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 5:61,776,411...61,777,515
Ensembl chr 5:61,776,413...61,777,540
|
|
| G
|
Ccl24
|
C-C motif chemokine ligand 24
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CCL24 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr12:26,737,423...26,741,420
Ensembl chr12:26,737,439...26,750,924
|
|
| G
|
Ccl26
|
C-C motif chemokine ligand 26
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CCL26 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr12:26,745,972...26,750,924
|
|
| G
|
Ccl3
|
C-C motif chemokine ligand 3
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen results in increased expression of CCL3 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCL3 mRNA; SCGB1A1 protein affects the reaction [Oxygen results in increased expression of CCL3 mRNA] AHR mutant form promotes the reaction [Oxygen results in increased expression of CCL3 protein]; Oxygen affects the reaction [AHR protein results in increased expression of CCL3 mRNA] [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CCL3 mRNA
|
CTD |
PMID:10027076 PMID:10781441 PMID:25831079 PMID:27103661 PMID:30529165 PMID:33729688 More...
|
|
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439
|
|
| G
|
Ccl4
|
C-C motif chemokine ligand 4
|
multiple interactions increases expression
|
ISO
|
[POSTN gene mutant form results in decreased susceptibility to Oxygen] which results in decreased expression of CCL4 mRNA; POSTN gene mutant form inhibits the reaction [Oxygen results in increased expression of CCL4 mRNA]; SCGB1A1 protein affects the reaction [Oxygen results in increased expression of CCL4 mRNA] AHR mutant form promotes the reaction [Oxygen results in increased expression of CCL4 protein]
|
CTD |
PMID:10027076 PMID:22363622 PMID:25831079 |
|
NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722
|
|
| G
|
Ccl5
|
C-C motif chemokine ligand 5
|
increases expression multiple interactions
|
ISO
|
Oxygen results in increased expression of CCL5 mRNA [Oxygen deficiency co-treated with Catechin] results in increased expression of CCL5 mRNA; Oxygen affects the reaction [AHR protein results in increased expression of CCL5 mRNA] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCL5 mRNA
|
CTD |
PMID:27103661 PMID:30529165 PMID:35883890 |
|
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884
|
|
| G
|
Ccl7
|
C-C motif chemokine ligand 7
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCL7 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:67,514,095...67,515,945
Ensembl chr10:67,514,091...67,515,947
|
|
| G
|
Ccl9
|
C-C motif chemokine ligand 9
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CCL6 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr10:68,863,994...68,868,928
Ensembl chr10:68,863,995...68,868,877
|
|
| G
|
Ccn1
|
cellular communication network factor 1
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of CCN1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCN1 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CCN1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CCN1 mRNA
|
CTD |
PMID:19640911 PMID:24236059 PMID:30529165 PMID:33729688 |
|
NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883
|
|
| G
|
Ccn2
|
cellular communication network factor 2
|
affects expression multiple interactions increases expression
|
ISO EXP
|
Oxygen deficiency affects the expression of CCN2 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CCN2 mRNA; CCN2 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] Oxygen results in increased expression of CCN2 mRNA Oxygen deficiency results in increased expression of CCN2 protein [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCN2 mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] affects the reaction [Oxygen deficiency results in increased expression of CCN2 protein]; NFE2L2 protein affects the reaction [Oxygen deficiency results in increased expression of CCN2 protein]; sulforaphane inhibits the reaction [Oxygen deficiency results in increased expression of CCN2 protein]
|
CTD |
PMID:17193925 PMID:21124846 PMID:22911455 PMID:24657099 PMID:30096613 PMID:30529165 PMID:33729688 More...
|
|
NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976
|
|
| G
|
Ccn4
|
cellular communication network factor 4
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCN4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:100,534,578...100,566,287
Ensembl chr 7:100,534,505...100,563,094
|
|
| G
|
Ccn5
|
cellular communication network factor 5
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CCN5 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 3:172,910,670...172,922,064
Ensembl chr 3:172,910,681...172,922,062
|
|
| G
|
Ccna1
|
cyclin A1
|
decreases expression
|
ISO
|
Oxygen results in decreased expression of CCNA1 mRNA
|
CTD |
PMID:27103661 |
|
NCBI chr 2:141,383,352...141,428,205
Ensembl chr 2:141,382,468...141,393,300
|
|
| G
|
Ccna2
|
cyclin A2
|
decreases expression increases expression multiple interactions
|
ISO EXP
|
Oxygen results in decreased expression of CCNA2 mRNA Oxygen deficiency results in increased expression of CCNA2 mRNA; Oxygen deficiency results in increased expression of CCNA2 protein [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CCNA2 mRNA]; [Oxygen deficiency co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] results in decreased expression of CCNA2 protein; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CCNA2 mRNA; [Oxygen deficiency co-treated with kaempferol co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] results in increased expression of CCNA2 protein; [Oxygen deficiency co-treated with kaempferol] results in increased expression of CCNA2 protein; kaempferol inhibits the reaction [Oxygen deficiency results in increased expression of CCNA2 protein]; Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of CCNA2 mRNA]; Sildenafil Citrate inhibits the reaction [Oxygen deficiency results in increased expression of CCNA2 protein] [Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of CCNA2 mRNA; [Oxygen co-treated with Ozone] results in decreased expression of CCNA2 mRNA
|
CTD |
PMID:26476374 PMID:27103661 PMID:32992648 PMID:33729688 PMID:36940862 PMID:38909692 More...
|
|
NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701
|
|
| G
|
Ccnb1
|
cyclin B1
|
multiple interactions increases expression decreases expression
|
ISO EXP
|
[Arsenic Trioxide co-treated with Oxygen deficiency] results in decreased expression of CCNB1 mRNA; [Arsenic Trioxide co-treated with Oxygen deficiency] results in decreased expression of CCNB1 protein; [FV-429 compound co-treated with Oxygen deficiency co-treated with Paclitaxel] affects the expression of CCNB1 protein; [Oxygen co-treated with Ozone] results in decreased expression of CCNB1 mRNA; Cannabidiol promotes the reaction [[Oxygen co-treated with Ozone] results in decreased expression of CCNB1 mRNA]; HIF1A protein affects the reaction [Paclitaxel inhibits the reaction [Oxygen deficiency results in decreased expression of CCNB1 protein]]; Paclitaxel inhibits the reaction [Oxygen deficiency results in decreased expression of CCNB1 protein] Oxygen deficiency results in increased expression of CCNB1 protein [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CCNB1 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CCNB1 mRNA; Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of CCNB1 protein]
|
CTD |
PMID:19825857 PMID:26476374 PMID:32992648 PMID:33729688 PMID:34648812 |
|
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225
|
|
| G
|
Ccnd1
|
cyclin D1
|
increases expression multiple interactions decreases expression
|
ISO EXP
|
Oxygen deficiency results in increased expression of CCND1 mRNA [Butylated Hydroxytoluene co-treated with Oxygen] results in increased expression of CCND1 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND1 mRNA; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND1 mRNA]; cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND1 mRNA]]; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND1 mRNA] Oxygen deficiency results in decreased expression of CCND1 mRNA; Oxygen deficiency results in decreased expression of CCND1 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of CCND1 protein]; [kaempferol co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] inhibits the reaction [Oxygen deficiency results in increased expression of CCND1 protein]; kaempferol inhibits the reaction [Oxygen deficiency results in increased expression of CCND1 mRNA]; kaempferol inhibits the reaction [Oxygen deficiency results in increased expression of CCND1 protein]; Quercetin inhibits the reaction [Oxygen deficiency results in decreased expression of CCND1 protein]; Sildenafil Citrate inhibits the reaction [Oxygen deficiency results in increased expression of CCND1 protein] [Betulinic Acid co-treated with Oxygen deficiency] results in decreased expression of CCND1 protein; [Oxygen co-treated with Ozone] results in decreased expression of CCND1 mRNA; Cannabidiol promotes the reaction [[Oxygen co-treated with Ozone] results in decreased expression of CCND1 mRNA] Oxygen deficiency results in increased expression of CCND1 mRNA; Oxygen deficiency results in increased expression of CCND1 protein
|
CTD |
PMID:16272459 PMID:17914565 PMID:26476374 PMID:26516004 PMID:27481074 PMID:32992648 PMID:33181113 PMID:36940862 PMID:38909692 More...
|
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Ccnd2
|
cyclin D2
|
increases expression affects methylation multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of CCND2 mRNA Oxygen deficiency affects the methylation of CCND2 promoter Oxygen affects the reaction [AHR protein results in decreased expression of CCND2 mRNA] [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND2 mRNA; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND2 mRNA]; cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND2 mRNA]]; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND2 mRNA]
|
CTD |
PMID:24205000 PMID:27103661 PMID:27481074 |
|
NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:161,653,048...161,680,301 Ensembl chr 4:161,653,048...161,680,301
|
|
| G
|
Ccne1
|
cyclin E1
|
multiple interactions decreases expression
|
ISO
|
[Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of CCNE1 mRNA; [Oxygen co-treated with Ozone] results in decreased expression of CCNE1 mRNA Oxygen deficiency results in decreased expression of CCNE1 protein
|
CTD |
PMID:32992648 PMID:38909692 |
|
NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822
|
|
| G
|
Ccne2
|
cyclin E2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CCNE2 mRNA
|
CTD |
PMID:25596134 PMID:26516004 |
|
NCBI chr 5:29,082,169...29,094,879
Ensembl chr 5:29,082,703...29,094,882
|
|
| G
|
Ccnf
|
cyclin F
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CCNF mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:13,757,884...13,783,669
Ensembl chr10:13,758,421...13,783,837
|
|
| G
|
Ccng1
|
cyclin G1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCNG1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:25,678,503...25,684,876
Ensembl chr10:25,677,885...25,683,766
|
|
| G
|
Ccng2
|
cyclin G2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CCNG2 mRNA
|
CTD |
PMID:20042640 PMID:20880076 PMID:24236059 PMID:25596134 |
|
NCBI chr14:15,088,694...15,097,190
Ensembl chr14:15,088,695...15,096,206
|
|
| G
|
Ccni
|
cyclin I
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of CCNI mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCNI mRNA; Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of CCNI mRNA]
|
CTD |
PMID:22629407 PMID:30529165 |
|
NCBI chr14:15,164,047...15,186,885
Ensembl chr14:15,164,095...15,186,885
|
|
| G
|
Ccnj
|
cyclin J
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CCNJ mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:249,608,991...249,626,798
Ensembl chr 1:249,608,969...249,626,794
|
|
| G
|
Ccnjl
|
cyclin J-like
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CCNJL mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr10:28,497,144...28,554,877
Ensembl chr10:28,496,990...28,554,877
|
|
| G
|
Ccny
|
cyclin Y
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CCNY mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr17:62,079,925...62,207,780
Ensembl chr17:62,079,925...62,207,979
|
|
| G
|
Ccnyl1
|
cyclin Y-like 1
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CCNYL1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:73,565,484...73,601,926
Ensembl chr 9:73,565,402...73,601,922
|
|
| G
|
Ccp110
|
centriolar coiled-coil protein 110
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCP110 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:182,475,571...182,504,235
Ensembl chr 1:182,476,422...182,504,232
|
|
| G
|
Ccpg1
|
cell cycle progression 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCPG1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:82,600,677...82,633,082
Ensembl chr 8:82,600,536...82,660,246
|
|
| G
|
Ccr1
|
C-C motif chemokine receptor 1
|
multiple interactions increases expression
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCR1 mRNA; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of CCR1 mRNA] [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CCR1 mRNA
|
CTD |
PMID:20880076 PMID:30529165 PMID:33729688 |
|
NCBI chr 8:132,433,711...132,439,266
Ensembl chr 8:132,431,592...132,439,374
|
|
| G
|
Ccr5
|
C-C motif chemokine receptor 5
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of CCR5 mRNA; Oxygen deficiency results in increased expression of CCR5 protein [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCR5 mRNA; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of CCR5 mRNA]
|
CTD |
PMID:20880076 PMID:30529165 |
|
NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:132,629,683...132,637,594
|
|
| G
|
Ccr6
|
C-C motif chemokine receptor 6
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCR6 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:55,022,037...55,055,857
Ensembl chr 1:55,021,833...55,046,059
|
|
| G
|
Ccr7
|
C-C motif chemokine receptor 7
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCR7 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:84,594,399...84,604,514
Ensembl chr10:84,593,594...84,604,501
|
|
| G
|
Ccs
|
copper chaperone for superoxide dismutase
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CCS protein
|
CTD |
PMID:19351718 |
|
NCBI chr 1:211,543,192...211,564,354
Ensembl chr 1:211,542,701...211,564,260
|
|
| G
|
Cct2
|
chaperonin containing TCP1 subunit 2
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CCT2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:54,578,654...54,591,428
Ensembl chr 7:54,578,663...54,592,977
|
|
| G
|
Cct3
|
chaperonin containing TCP1 subunit 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCT3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:176,063,529...176,088,180
Ensembl chr 2:176,063,526...176,089,925
|
|
| G
|
Cct8
|
chaperonin containing TCP1 subunit 8
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CCT8 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr11:40,196,619...40,208,328
Ensembl chr11:40,196,619...40,208,328
|
|
| G
|
Cd101
|
CD101 molecule
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CD101 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 2:191,109,782...191,148,184
Ensembl chr 2:191,110,637...191,148,149
|
|
| G
|
Cd109
|
CD109 molecule
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CD109 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 8:88,334,736...88,449,463
Ensembl chr 8:88,334,736...88,449,462
|
|
| G
|
Cd14
|
CD14 molecule
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD14 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CD14 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292
|
|
| G
|
Cd151
|
CD151 molecule (Raph blood group)
|
multiple interactions
|
EXP
|
CD151 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
|
CTD |
PMID:21124846 |
|
NCBI chr 1:205,994,300...205,998,307
Ensembl chr 1:205,994,738...205,998,784
|
|
| G
|
Cd163
|
CD163 molecule
|
multiple interactions
|
EXP
|
[deguelin co-treated with Oxygen deficiency] results in increased expression of CD163 mRNA
|
CTD |
PMID:22745725 |
|
NCBI chr 4:158,770,751...158,804,146
Ensembl chr 4:158,770,749...158,804,146
|
|
| G
|
Cd177
|
CD177 molecule
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD177 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:89,467,926...89,488,490
Ensembl chr 1:89,467,926...89,488,443
|
|
| G
|
Cd19
|
CD19 molecule
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD19 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:190,417,853...190,424,494
Ensembl chr 1:190,417,853...190,424,355
|
|
| G
|
Cd1d1
|
CD1d1 molecule
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD1D1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:174,721,522...174,725,029
Ensembl chr 2:174,721,522...174,725,029
|
|
| G
|
Cd2
|
Cd2 molecule
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:191,399,510...191,412,659
Ensembl chr 2:191,399,510...191,413,665
|
|
| G
|
Cd200r1
|
CD200 receptor 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CD200R1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr11:69,392,943...69,427,213
Ensembl chr11:69,392,975...69,427,128
|
|
| G
|
Cd22
|
CD22 molecule
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD22 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:95,243,785...95,270,430
Ensembl chr 1:95,244,868...95,259,730
|
|
| G
|
Cd247
|
Cd247 molecule
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CD247 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr13:80,576,264...80,651,422
Ensembl chr13:80,576,202...80,655,248
|
|
| G
|
Cd274
|
CD274 molecule
|
multiple interactions
|
ISO
|
Oxygen deficiency inhibits the reaction [darinaparsin results in increased expression of CD274 mRNA]
|
CTD |
PMID:22535156 |
|
NCBI chr 1:236,526,215...236,549,956
Ensembl chr 1:236,496,463...236,549,951
|
|
| G
|
Cd28
|
Cd28 molecule
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD28 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:69,660,316...69,689,192
Ensembl chr 9:69,545,326...69,689,192
|
|
| G
|
Cd300a
|
Cd300a molecule
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of CD300A mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD300A mRNA
|
CTD |
PMID:24236059 PMID:30529165 |
|
NCBI chr10:100,428,826...100,441,693
Ensembl chr10:100,428,826...100,442,958
|
|
| G
|
Cd300lb
|
CD300 molecule-like family member b
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CD300LB mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr10:100,463,815...100,473,804
Ensembl chr10:100,463,815...100,473,804
|
|
| G
|
Cd34
|
CD34 molecule
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CD34 protein
|
CTD |
PMID:23725749 |
|
NCBI chr13:109,008,786...109,029,317
Ensembl chr13:109,008,623...109,029,315
|
|
| G
|
Cd36
|
CD36 molecule
|
multiple interactions increases expression decreases expression
|
ISO
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of CD36 mRNA]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of CD36 mRNA]]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of CD36 protein]]; [Oxygen deficiency results in increased abundance of Reactive Oxygen Species] which results in increased expression of CD36 mRNA; acetovanillone inhibits the reaction [[Oxygen deficiency results in increased abundance of Reactive Oxygen Species] which results in increased expression of CD36 mRNA]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of CD36 mRNA]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of CD36 protein]; myxothiazol inhibits the reaction [[Oxygen deficiency results in increased abundance of Reactive Oxygen Species] which results in increased expression of CD36 mRNA]; Oxygen deficiency promotes the reaction [[HIF1A protein binds to CD36 promoter] which results in increased expression of CD36 mRNA]; Oxygen deficiency results in increased expression of and results in increased localization of CD36 protein; PIK3R1 protein promotes the reaction [Oxygen deficiency results in increased expression of CD36 mRNA]; PIK3R1 protein promotes the reaction [Oxygen deficiency results in increased expression of CD36 protein]; Rotenone inhibits the reaction [[Oxygen deficiency results in increased abundance of Reactive Oxygen Species] which results in increased expression of CD36 mRNA]; Sirolimus inhibits the reaction [Oxygen deficiency results in increased expression of CD36 mRNA]; U 74389F inhibits the reaction [[Oxygen deficiency results in increased abundance of Reactive Oxygen Species] which results in increased expression of CD36 mRNA]; Wortmannin inhibits the reaction [Oxygen deficiency results in increased expression of CD36 mRNA] Oxygen deficiency results in decreased expression of CD36 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of CD36 mRNA]
|
CTD |
PMID:19640849 PMID:22629407 PMID:24205000 |
|
NCBI chr 4:18,209,088...18,302,142
|
|
| G
|
Cd3g
|
CD3 gamma subunit of T-cell receptor complex
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD3G mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:54,177,572...54,184,087
Ensembl chr 8:54,177,977...54,183,918
|
|
| G
|
Cd40lg
|
CD40 ligand
|
multiple interactions
|
ISO
|
[CD40LG protein binds to and co-treated with CD40LG protein binds to and co-treated with CD40LG protein binds to and co-treated with diphenyleneiodonium] inhibits the reaction [Oxygen deficiency results in increased abundance of Reactive Oxygen Species]; [CD40LG protein binds to CD40LG protein binds to CD40LG protein] promotes the reaction [[Oxygen co-treated with Oxygen deficiency] results in increased abundance of Reactive Oxygen Species]; diphenyliodonium inhibits the reaction [[CD40LG protein binds to CD40LG protein binds to CD40LG protein] promotes the reaction [[Oxygen co-treated with Oxygen deficiency] results in increased abundance of Reactive Oxygen Species]]
|
CTD |
PMID:22295117 |
|
NCBI chr X:140,164,341...140,176,057
Ensembl chr X:140,164,302...140,176,475
|
|
| G
|
Cd44
|
CD44 molecule
|
multiple interactions decreases expression
|
ISO EXP
|
vorinostat inhibits the reaction [Oxygen deficiency results in increased expression of CD44 protein] Oxygen deficiency results in decreased expression of CD44 protein [N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride co-treated with [Oxygen deficiency co-treated with Blood Glucose deficiency]] results in increased expression of CD44 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CD44 mRNA
|
CTD |
PMID:19640911 PMID:25351418 PMID:26305601 PMID:33729688 |
|
NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424
|
|
| G
|
Cd5
|
Cd5 molecule
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CD5 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:216,790,245...216,811,209
Ensembl chr 1:216,790,245...216,811,209
|
|
| G
|
Cd53
|
Cd53 molecule
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CD53 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 2:197,040,369...197,087,925
Ensembl chr 2:197,040,369...197,218,593
|
|
| G
|
Cd63
|
Cd63 molecule
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CD63 protein
|
CTD |
PMID:35179300 |
|
NCBI chr 7:1,909,538...1,924,937
Ensembl chr 7:1,922,169...1,924,938
|
|
| G
|
Cd68
|
Cd68 molecule
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD68 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CD68 mRNA HU 308 inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CD68 protein]; iodopravadoline inhibits the reaction [peoniflorin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CD68 protein]]; peoniflorin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CD68 protein]
|
CTD |
PMID:19640911 PMID:29560022 PMID:30529165 |
|
NCBI chr10:54,880,562...54,882,441
Ensembl chr10:54,880,563...54,882,540
|
|
| G
|
Cd69
|
Cd69 molecule
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD69 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:164,411,485...164,419,403
Ensembl chr 4:164,411,485...164,419,509
|
|
| G
|
Cd72
|
Cd72 molecule
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CD72 mRNA
|
CTD |
PMID:20880076 PMID:26516004 |
|
NCBI chr 5:62,493,155...62,500,779
Ensembl chr 5:62,493,161...62,500,519
|
|
| G
|
Cd74
|
CD74 molecule
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD74 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr18:56,527,071...56,536,406
Ensembl chr18:56,527,132...56,536,410
|
|
| G
|
Cd79a
|
CD79a molecule
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD79A mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:89,621,460...89,625,813
Ensembl chr 1:89,621,460...89,625,812
|
|
| G
|
Cd79b
|
CD79b molecule
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD79B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:91,739,134...91,742,312
Ensembl chr10:91,739,137...91,742,405
|
|
| G
|
Cd80
|
Cd80 molecule
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD80 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CD80 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr11:75,760,073...75,798,978
Ensembl chr11:75,760,147...75,797,540
|
|
| G
|
Cd81
|
Cd81 molecule
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CD81 protein
|
CTD |
PMID:35179300 |
|
NCBI chr 1:207,665,274...207,681,094
Ensembl chr 1:207,664,885...207,681,092
|
|
| G
|
Cd83
|
CD83 molecule
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD83 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr17:21,093,281...21,113,223
Ensembl chr17:21,093,281...21,113,047
|
|
| G
|
Cd86
|
CD86 molecule
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CD86 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361
|
|
| G
|
Cd8a
|
CD8 subunit alpha
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CD8A mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CD8A mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 4:104,924,116...104,928,353
Ensembl chr 4:104,900,833...104,928,358
|
|
| G
|
Cd93
|
CD93 molecule
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CD93 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 3:156,345,019...156,351,537
Ensembl chr 3:156,345,019...156,351,537
|
|
| G
|
Cda
|
cytidine deaminase
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CDA mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 5:155,839,929...155,866,541
Ensembl chr 5:155,839,929...155,866,541
|
|
| G
|
Cdc16
|
cell division cycle 16
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CDC16 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr16:82,475,234...82,498,797
Ensembl chr16:82,474,523...82,498,765
|
|
| G
|
Cdc20
|
cell division cycle 20
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen results in decreased expression of CDC20 mRNA [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CDC20 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CDC20 mRNA
|
CTD |
PMID:27103661 PMID:33729688 |
|
NCBI chr 5:137,251,596...137,255,799
Ensembl chr 5:137,251,596...137,255,799
|
|
| G
|
Cdc25a
|
cell division cycle 25A
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CDC25A mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 8:118,742,824...118,761,190
Ensembl chr 8:118,742,426...118,761,188
|
|
| G
|
Cdc25c
|
cell division cycle 25C
|
multiple interactions decreases phosphorylation
|
ISO
|
[FV-429 compound co-treated with Oxygen deficiency co-treated with Paclitaxel] affects the phosphorylation of CDC25C protein; HIF1A protein affects the reaction [Paclitaxel affects the reaction [Oxygen deficiency results in decreased phosphorylation of CDC25C protein]]; Paclitaxel affects the reaction [Oxygen deficiency results in decreased phosphorylation of CDC25C protein]
|
CTD |
PMID:34648812 |
|
NCBI chr18:26,608,483...26,630,292
Ensembl chr18:26,609,959...26,630,292
|
|
| G
|
Cdc34
|
cell division cycle 34, ubiquitin conjugating enzyme
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of CDC34 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDC34 mRNA
|
CTD |
PMID:24205000 PMID:30529165 |
|
NCBI chr 7:10,668,209...10,674,206
Ensembl chr 7:10,668,210...10,674,526
|
|
| G
|
Cdc42ep3
|
CDC42 effector protein 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDC42EP3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:21,463,081...21,483,553
Ensembl chr 6:21,461,762...21,508,540
|
|
| G
|
Cdc42ep4
|
CDC42 effector protein 4
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDC42EP4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:99,271,750...99,298,551
Ensembl chr10:99,267,540...99,300,168
|
|
| G
|
Cdc45
|
cell division cycle 45
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of CDC45 mRNA [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CDC45 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CDC45 mRNA
|
CTD |
PMID:26516004 PMID:33729688 |
|
NCBI chr11:95,689,702...95,714,980
Ensembl chr11:95,689,919...95,714,981
|
|
| G
|
Cdc6
|
cell division cycle 6
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CDC6 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:84,360,361...84,374,239
Ensembl chr10:84,360,381...84,374,241
|
|
| G
|
Cdc7
|
cell division cycle 7
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CDC7 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr14:2,949,538...2,969,656
Ensembl chr14:2,949,539...2,969,656
|
|
| G
|
Cdca2
|
cell division cycle associated 2
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of CDCA2 mRNA [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CDCA2 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CDCA2 mRNA
|
CTD |
PMID:26516004 PMID:33729688 |
|
NCBI chr15:46,071,360...46,117,524
Ensembl chr15:46,071,360...46,116,639
|
|
| G
|
Cdca3
|
cell division cycle associated 3
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CDCA3 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 4:159,321,203...159,325,072
Ensembl chr 4:159,321,014...159,325,068
|
|
| G
|
Cdca4
|
cell division cycle associated 4
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CDCA4 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 6:137,713,390...137,722,652
Ensembl chr 6:137,713,051...137,722,580
|
|
| G
|
Cdca5
|
cell division cycle associated 5
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CDCA5 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:212,807,863...212,821,313
Ensembl chr 1:212,804,014...212,821,309
|
|
| G
|
Cdca7
|
cell division cycle associated 7
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CDCA7 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 3:77,730,315...77,740,950
Ensembl chr 3:77,729,970...77,740,947
|
|
| G
|
Cdcp1
|
CUB domain containing protein 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDCP1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:131,706,140...131,742,799
Ensembl chr 8:131,706,140...131,742,877
|
|
| G
|
Cdh1
|
cadherin 1
|
multiple interactions increases expression decreases expression
|
ISO
|
[Butylated Hydroxytoluene co-treated with Oxygen] results in decreased expression of CDH1 protein Oxygen deficiency results in increased expression of CDH1 mRNA [dictamnine co-treated with Oxygen deficiency] results in increased expression of CDH1 protein; [Oxygen deficiency co-treated with Oxygen] results in increased expression of CDH1 protein; ALCAM protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of CDH1 protein]; ALKBH5 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of CDH1 protein]; DICER1 protein inhibits the reaction [Oxygen deficiency results in decreased expression of CDH1 mRNA]; HIF1A protein promotes the reaction [Oxygen deficiency results in decreased expression of CDH1 mRNA]; PKF115-584 promotes the reaction [ALKBH5 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of CDH1 protein]]; PPARG protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of CDH1 protein] Oxygen deficiency results in decreased expression of CDH1 mRNA; Oxygen deficiency results in decreased expression of CDH1 protein
|
CTD |
PMID:16272459 PMID:22340517 PMID:24205000 PMID:25351418 PMID:30266538 PMID:34995009 More...
|
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
|
|
| G
|
Cdh13
|
cadherin 13
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CDH13 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr19:63,258,251...64,296,122
Ensembl chr19:63,258,122...64,296,119
|
|
| G
|
Cdh16
|
cadherin 16
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDH16 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:367,202...377,710
Ensembl chr19:367,274...388,934
|
|
| G
|
Cdh17
|
cadherin 17
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CDH17 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 5:30,024,544...30,112,226
Ensembl chr 5:30,060,090...30,112,226
|
|
| G
|
Cdh2
|
cadherin 2
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of CDH2 mRNA [dictamnine co-treated with Oxygen deficiency] results in decreased expression of CDH2 protein [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDH2 mRNA
|
CTD |
PMID:25351418 PMID:30266538 PMID:30529165 |
|
NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288
|
|
| G
|
Cdh20
|
cadherin 20
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CDH20 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr13:21,252,272...21,583,526
Ensembl chr13:21,515,123...21,584,349
|
|
| G
|
Cdh5
|
cadherin 5
|
multiple interactions increases expression
|
ISO
|
[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased degradation of CDH5 protein [Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of and affects the localization of CDH5 protein; [Glucose deficiency co-treated with Oxygen deficiency] results in increased localization of CDH5 protein; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of CDH5 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [PLAT protein promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased degradation of CDH5 protein]]; nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased localization of CDH5 protein]; PLAT protein promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased degradation of CDH5 protein]; SENP1 protein affects the reaction [Oxygen deficiency results in increased expression of CDH5 protein]; Wortmannin inhibits the reaction [nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased localization of CDH5 protein]]
|
CTD |
PMID:23876515 PMID:31953908 PMID:38528077 |
|
NCBI chr19:821,875...860,931
Ensembl chr19:822,464...860,822
|
|
| G
|
Cdk1
|
cyclin-dependent kinase 1
|
decreases expression increases expression multiple interactions decreases phosphorylation
|
ISO EXP
|
Oxygen deficiency results in decreased expression of CDK1 mRNA Oxygen deficiency results in increased expression of CDK1 protein [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CDK1 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CDK1 mRNA; Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of CDK1 protein] [FV-429 compound co-treated with Oxygen deficiency co-treated with Paclitaxel] affects the phosphorylation of CDK1 protein; HIF1A protein affects the reaction [Paclitaxel promotes the reaction [Oxygen deficiency results in decreased phosphorylation of CDK1 protein]]; Paclitaxel promotes the reaction [Oxygen deficiency results in decreased phosphorylation of CDK1 protein]
|
CTD |
PMID:26476374 PMID:26516004 PMID:33729688 PMID:34648812 |
|
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455
|
|
| G
|
Cdk14
|
cyclin-dependent kinase 14
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDK14 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:29,619,237...30,213,651
Ensembl chr 4:29,621,217...30,213,651
|
|
| G
|
Cdk18
|
cyclin-dependent kinase 18
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CDK18 mRNA
|
CTD |
PMID:17914565 |
|
NCBI chr13:46,107,763...46,140,705
Ensembl chr13:46,108,911...46,140,865
|
|
| G
|
Cdk19
|
cyclin-dependent kinase 19
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDK19 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr20:45,324,911...45,465,121
Ensembl chr20:45,324,862...45,465,121
|
|
| G
|
Cdk2
|
cyclin dependent kinase 2
|
multiple interactions increases expression
|
ISO EXP
|
[Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of CDK2 mRNA; [Oxygen co-treated with Ozone] results in decreased expression of CDK2 mRNA 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of CDK2 protein]; [kaempferol co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] inhibits the reaction [Oxygen deficiency results in increased expression of CDK2 protein]; kaempferol inhibits the reaction [Oxygen deficiency results in increased expression of CDK2 protein]
|
CTD |
PMID:32992648 PMID:36940862 |
|
NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878
|
|
| G
|
Cdk4
|
cyclin-dependent kinase 4
|
multiple interactions increases expression
|
ISO EXP
|
[Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of CDK4 mRNA; [Oxygen co-treated with Ozone] results in decreased expression of CDK4 mRNA Oxygen deficiency results in increased expression of CDK4 mRNA; Oxygen deficiency results in increased expression of CDK4 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of CDK4 protein]; [kaempferol co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] inhibits the reaction [Oxygen deficiency results in increased expression of CDK4 protein]; kaempferol inhibits the reaction [Oxygen deficiency results in increased expression of CDK4 mRNA]; kaempferol inhibits the reaction [Oxygen deficiency results in increased expression of CDK4 protein]
|
CTD |
PMID:32992648 PMID:36940862 |
|
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163
|
|
| G
|
Cdk6
|
cyclin-dependent kinase 6
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CDK6 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 4:31,592,384...31,784,732
Ensembl chr 4:31,601,192...31,781,701
|
|
| G
|
Cdkl1
|
cyclin dependent kinase like 1
|
multiple interactions increases expression
|
ISO
|
Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of CDKL1 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 6:93,960,157...94,005,207
Ensembl chr 6:93,959,911...94,006,115
|
|
| G
|
Cdkl5
|
cyclin-dependent kinase-like 5
|
increases expression affects methylation
|
ISO
|
Oxygen deficiency results in increased expression of CDKL5 mRNA Oxygen deficiency affects the methylation of CDKL5 promoter
|
CTD |
PMID:24205000 |
|
NCBI chr X:37,566,320...37,796,766
Ensembl chr X:37,566,378...37,796,760
|
|
| G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
multiple interactions increases expression affects expression
|
ISO EXP
|
4'-O-methylalpinumisoflavone inhibits the reaction [Oxygen deficiency results in increased expression of CDKN1A mRNA]; [eprenetapopt co-treated with Cisplatin co-treated with Oxygen deficiency] results in increased expression of CDKN1A mRNA; [Oxygen deficiency co-treated with Cisplatin] results in increased expression of CDKN1A mRNA; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of CDKN1A mRNA]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of CDKN1A protein]; Oxygen affects the reaction [AHR protein results in decreased expression of CDKN1A mRNA]; Rotenone inhibits the reaction [Oxygen deficiency results in increased expression of CDKN1A mRNA]; TP53 protein affects the reaction [[Oxygen deficiency co-treated with Cisplatin] results in increased expression of CDKN1A mRNA] Oxygen deficiency results in increased expression of CDKN1A mRNA; Oxygen deficiency results in increased expression of CDKN1A protein Oxygen deficiency affects the expression of CDKN1A mRNA [Valproic Acid co-treated with Oxygen deficiency] results in increased expression of CDKN1A protein; [vorinostat co-treated with Oxygen deficiency] results in increased expression of CDKN1A protein [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDKN1A mRNA
|
CTD |
PMID:10951577 PMID:17193925 PMID:19091749 PMID:19958256 PMID:22711276 PMID:25596134 PMID:27103661 PMID:29690507 PMID:30529165 More...
|
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
| G
|
Cdkn1b
|
cyclin-dependent kinase inhibitor 1B
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CDKN1B mRNA
|
CTD |
PMID:17914565 |
|
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498
|
|
| G
|
Cdkn1c
|
cyclin-dependent kinase inhibitor 1C
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CDKN1C mRNA
|
CTD |
PMID:17914565 PMID:20042640 PMID:26516004 |
|
NCBI chr 1:208,084,801...208,087,680
Ensembl chr 1:208,084,787...208,087,498
|
|
| G
|
Cdkn2a
|
cyclin-dependent kinase inhibitor 2A
|
multiple interactions
|
ISO
|
[Oxygen co-treated with Ozone] results in increased expression of CDKN2A mRNA; Cannabidiol promotes the reaction [[Oxygen co-treated with Ozone] results in increased expression of CDKN2A mRNA]
|
CTD |
PMID:32992648 |
|
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248
|
|
| G
|
Cdkn2c
|
cyclin-dependent kinase inhibitor 2C
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDKN2C mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:129,639,736...129,645,564
Ensembl chr 5:129,639,736...129,644,891
|
|
| G
|
Cdkn2d
|
cyclin dependent kinase inhibitor 2D
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CDKN2D mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 8:28,108,036...28,110,809
Ensembl chr 8:28,108,044...28,110,809
|
|
| G
|
Cds2
|
CDP-diacylglycerol synthase 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CDS2 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 3:139,967,870...140,006,459
Ensembl chr 3:139,967,742...140,009,201
|
|
| G
|
Cdx2
|
caudal type homeo box 2
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of CDX2 mRNA; Oxygen deficiency results in decreased expression of CDX2 protein CDX2 protein inhibits the reaction [Oxygen deficiency results in increased activity of CASP3 protein]; CDX2 protein inhibits the reaction [Oxygen deficiency results in increased expression of CTNNB1 protein]; CDX2 protein inhibits the reaction [Oxygen deficiency results in increased expression of MYC protein]
|
CTD |
PMID:38295844 |
|
NCBI chr12:12,762,769...12,769,246
Ensembl chr12:12,762,904...12,769,246
|
|
| G
|
Cebpa
|
CCAAT/enhancer binding protein alpha
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of CEBPA mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CEBPA mRNA
|
CTD |
PMID:20594416 PMID:30529165 |
|
NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:96,896,171...96,899,309
|
|
| G
|
Cebpb
|
CCAAT/enhancer binding protein beta
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of CEBPB mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CEBPB mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072
|
|
| G
|
Cebpd
|
CCAAT/enhancer binding protein delta
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of CEBPD mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CEBPD mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CEBPD mRNA
|
CTD |
PMID:17175027 PMID:19640911 PMID:26516004 PMID:30529165 |
|
NCBI chr11:98,268,856...98,269,994
Ensembl chr11:98,265,651...98,280,824
|
|
| G
|
Celf1
|
CUGBP, Elav-like family member 1
|
multiple interactions increases expression
|
ISO
|
Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of CELF1 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 3:97,380,407...97,455,253
Ensembl chr 3:97,380,424...97,452,791
|
|
| G
|
Celsr1
|
cadherin, EGF LAG seven-pass G-type receptor 1
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of CELSR1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CELSR1 mRNA
|
CTD |
PMID:26516004 PMID:33729688 |
|
NCBI chr 7:118,867,450...119,004,859
Ensembl chr 7:118,867,450...119,004,856
|
|
| G
|
Cemip2
|
cell migration inducing hyaluronidase 2
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of CEMIP2 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CEMIP2 mRNA
|
CTD |
PMID:24236059 PMID:33729688 |
|
NCBI chr 1:228,756,826...228,834,313
Ensembl chr 1:228,757,466...228,832,906
|
|
| G
|
Cenatac
|
centrosomal AT-AC splicing factor
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CENATAC mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:53,632,777...53,639,661
Ensembl chr 8:53,632,044...53,639,650
|
|
| G
|
Cenpe
|
centromere protein E
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CENPE mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CENPE mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 2:226,310,970...226,369,636
Ensembl chr 2:226,300,798...226,369,636
|
|
| G
|
Cenpf
|
centromere protein F
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of CENPF mRNA [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CENPF mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CENPF mRNA
|
CTD |
PMID:24205000 PMID:33729688 |
|
NCBI chr13:103,715,344...103,760,931
Ensembl chr13:103,715,344...103,760,886
|
|
| G
|
Cenpi
|
centromere protein I
|
increases expression decreases expression
|
ISO
|
Oxygen deficiency results in increased expression of CENPI mRNA Oxygen deficiency results in decreased expression of CENPI mRNA
|
CTD |
PMID:24205000 PMID:26516004 |
|
NCBI chr X:101,809,192...101,860,935
Ensembl chr X:101,809,659...101,860,934
|
|
| G
|
Cenpk
|
centromere protein K
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CENPK mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 2:37,094,163...37,155,158
Ensembl chr 2:37,094,248...37,119,488
|
|
| G
|
Cenpl
|
centromere protein L
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CENPL mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr13:75,870,479...75,885,466
Ensembl chr13:75,870,489...75,905,250
|
|
| G
|
Cenpm
|
centromere protein M
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CENPM mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 7:115,628,117...115,639,401
Ensembl chr 7:115,628,129...115,643,866
|
|
| G
|
Cenpp
|
centromere protein P
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CENPP mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr17:15,220,521...15,395,741
Ensembl chr17:15,220,291...15,395,739
|
|
| G
|
Cenpv
|
centromere protein V
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CENPV mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:47,713,778...47,746,800
Ensembl chr10:47,713,778...47,727,679
|
|
| G
|
Cenpx
|
centromere protein X
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CENPX mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:106,489,796...106,492,637
Ensembl chr10:106,489,796...106,492,637
|
|
| G
|
Cep128
|
centrosomal protein 128
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CEP128 mRNA
|
CTD |
PMID:17175027 |
|
NCBI chr 6:115,681,753...116,059,758
Ensembl chr 6:115,681,712...116,057,167
|
|
| G
|
Cep55
|
centrosomal protein 55
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CEP55 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CEP55 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:245,245,272...245,260,835
Ensembl chr 1:245,245,306...245,260,890
|
|
| G
|
Cep70
|
centrosomal protein 70
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CEP70 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:108,689,562...108,742,620
Ensembl chr 8:108,689,671...108,742,617
|
|
| G
|
Cep72
|
centrosomal protein 72
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CEP72 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:31,053,884...31,083,863
Ensembl chr 1:31,053,914...31,083,863
|
|
| G
|
Cep76
|
centrosomal protein 76
|
multiple interactions increases expression
|
ISO
|
Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of CEP76 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr18:63,444,389...63,478,358
Ensembl chr18:63,443,746...63,478,358
|
|
| G
|
Cep78
|
centrosomal protein 78
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CEP78 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:222,674,193...222,702,124
Ensembl chr 1:222,674,194...222,702,120
|
|
| G
|
Cep85
|
centrosomal protein 85
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CEP85 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 5:151,640,316...151,687,891
Ensembl chr 5:151,639,282...151,687,860
|
|
| G
|
Cept1
|
choline/ethanolamine phosphotransferase 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CEPT1 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 2:196,682,455...196,724,430
Ensembl chr 2:196,681,681...196,723,812
|
|
| G
|
Cers3
|
ceramide synthase 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CERS3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:129,728,136...129,833,182
Ensembl chr 1:129,677,781...129,833,181
|
|
| G
|
Cers5
|
ceramide synthase 5
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CERS5 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 7:132,738,834...132,776,920
Ensembl chr 7:132,738,834...132,776,786
|
|
| G
|
Ces1d
|
carboxylesterase 1D
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CES1D mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:30,046,494...30,085,039
Ensembl chr19:30,046,449...30,085,449
|
|
| G
|
Ces2a
|
carboxylesterase 2A
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CES2A mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CES2A mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr19:135,885...142,935
Ensembl chr19:135,885...142,935
|
|
| G
|
Cfap157
|
cilia and flagella associated protein 157
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CFAP157 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 3:36,464,219...36,471,193
Ensembl chr 3:36,464,219...36,471,193
|
|
| G
|
Cfap251
|
cilia and flagella associated protein 251
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CFAP251 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr12:38,923,154...38,997,881
Ensembl chr12:38,922,330...38,954,783
|
|
| G
|
Cfap263
|
cilia and flagella associated protein 263
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CFAP263 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr19:9,503,062...9,522,957
Ensembl chr19:9,503,066...9,522,957
|
|
| G
|
Cfap58
|
cilia and flagella associated protein 58
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CFAP58 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:256,743,971...256,852,633
Ensembl chr 1:256,743,971...256,852,623
|
|
| G
|
Cfap96
|
cilia and flagella associated protein 96
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CFAP96 mRNA
|
CTD |
PMID:24236059 PMID:26516004 |
|
NCBI chr16:53,023,623...53,048,176
Ensembl chr16:53,023,878...53,048,965
|
|
| G
|
Cfi
|
complement factor I
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CFI mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:221,062,206...221,104,790
Ensembl chr 2:221,062,212...221,104,786
|
|
| G
|
Cfl1
|
cofilin 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CFL1 protein
|
CTD |
PMID:25937538 |
|
NCBI chr 1:212,227,124...212,230,656
Ensembl chr 1:212,226,121...212,231,353
|
|
| G
|
Cflar
|
CASP8 and FADD-like apoptosis regulator
|
multiple interactions increases expression
|
ISO
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of CFLAR mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of CFLAR mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of CFLAR mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of CFLAR mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of CFLAR mRNA]
|
CTD |
PMID:23452621 |
|
NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:67,679,559...67,726,434
|
|
| G
|
Cgref1
|
cell growth regulator with EF hand domain 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CGREF1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:31,151,795...31,163,801
Ensembl chr 6:31,151,795...31,163,800
|
|
| G
|
Ch25h
|
cholesterol 25-hydroxylase
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of CH25H mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CH25H mRNA
|
CTD |
PMID:20880076 PMID:30529165 |
|
NCBI chr 1:241,428,048...241,429,366
Ensembl chr 1:241,331,619...241,431,190
|
|
| G
|
Chac1
|
ChaC glutathione-specific gamma-glutamylcyclotransferase 1
|
multiple interactions
|
EXP ISO
|
CHAC1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHAC1 mRNA
|
CTD |
PMID:21124846 PMID:30529165 |
|
NCBI chr 3:126,796,131...126,799,352
Ensembl chr 3:126,796,024...126,799,361
|
|
| G
|
Chac2
|
ChaC glutathione specific gamma-glutamylcyclotransferase 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CHAC2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr14:108,921,669...108,929,215
Ensembl chr14:108,921,341...108,929,469
|
|
| G
|
Chaf1a
|
chromatin assembly factor 1 subunit A
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CHAF1A mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 9:961,225...987,825
Ensembl chr 9:961,084...987,868
|
|
| G
|
Chaf1b
|
chromatin assembly factor 1 subunit B
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CHAF1B mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr11:46,670,560...46,690,739
Ensembl chr11:46,670,630...46,690,733
|
|
| G
|
Chd6
|
chromodomain helicase DNA binding protein 6
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHD6 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:170,016,204...170,177,480
Ensembl chr 3:170,016,204...170,177,558
|
|
| G
|
Cherp
|
calcium homeostasis endoplasmic reticulum protein
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CHERP mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr16:17,401,497...17,414,549
Ensembl chr16:17,401,497...17,414,549
|
|
| G
|
Chi3l1
|
chitinase 3 like 1
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHI3L1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CHI3L1 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr13:48,193,839...48,201,822
Ensembl chr13:48,193,800...48,201,825
|
|
| G
|
Chi3l3
|
chitinase 3-like 3
|
multiple interactions
|
EXP
|
[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CHI3L3 mRNA; HU 308 promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CHI3L3 mRNA]; iodopravadoline inhibits the reaction [peoniflorin promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CHI3L3 mRNA]]; peoniflorin promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CHI3L3 mRNA]
|
CTD |
PMID:29560022 |
|
NCBI chr 2:196,496,456...196,513,834
Ensembl chr 2:196,496,454...196,513,836
|
|
| G
|
Chia
|
chitinase, acidic
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHIA mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:196,302,687...196,344,849
Ensembl chr 2:196,302,545...196,344,850
|
|
| G
|
Chkb
|
choline kinase beta
|
multiple interactions
|
EXP
|
CHKB protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
|
CTD |
PMID:21124846 |
|
NCBI chr 7:122,380,592...122,385,102
Ensembl chr 7:122,380,594...122,383,949
|
|
| G
|
Chl1
|
cell adhesion molecule L1-like
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHL1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:137,847,648...138,062,077
Ensembl chr 4:137,847,895...138,062,077
|
|
| G
|
Chmp6
|
charged multivesicular body protein 6
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of CHMP6 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in decreased expression of CHMP6 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr10:105,690,400...105,696,070
Ensembl chr10:105,690,398...105,696,333
|
|
| G
|
Chordc1
|
cysteine and histidine rich domain containing 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CHORDC1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 8:23,650,721...23,674,786
Ensembl chr 8:23,650,865...23,677,696
|
|
| G
|
Chpt1
|
choline phosphotransferase 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHPT1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:24,753,880...24,802,529
Ensembl chr 7:24,750,343...24,802,521
|
|
| G
|
Chrdl1
|
chordin-like 1
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHRDL1 mRNA [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CHRDL1 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CHRDL1 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr X:111,685,864...111,789,684
Ensembl chr X:111,685,866...111,789,661
|
|
| G
|
Chrdl2
|
chordin-like 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CHRDL2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:163,755,316...163,782,758
Ensembl chr 1:163,755,316...163,782,757
|
|
| G
|
Chrm2
|
cholinergic receptor, muscarinic 2
|
decreases response to substance
|
ISO
|
CHRM2 gene mutant form results in decreased susceptibility to Oxygen; CHRM2 gene SNP results in decreased susceptibility to Oxygen
|
CTD |
PMID:24571919 |
|
NCBI chr 4:65,981,136...66,116,128
Ensembl chr 4:65,981,006...66,126,464
|
|
| G
|
Chrna1
|
cholinergic receptor nicotinic alpha 1 subunit
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CHRNA1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 3:78,862,286...78,877,353
Ensembl chr 3:78,862,286...78,877,353
|
|
| G
|
Chrna4
|
cholinergic receptor nicotinic alpha 4 subunit
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CHRNA4 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:188,501,209...188,535,105
|
|
| G
|
Chrna7
|
cholinergic receptor nicotinic alpha 7 subunit
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHRNA7 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:126,123,425...126,249,181
Ensembl chr 1:126,123,425...126,446,858
|
|
| G
|
Chrnb1
|
cholinergic receptor nicotinic beta 1 subunit
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CHRNB1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:54,999,943...55,015,137
Ensembl chr10:55,002,788...55,015,107
|
|
| G
|
Chrnb3
|
cholinergic receptor nicotinic beta 3 subunit
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CHRNB3 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr16:71,411,847...71,454,225
Ensembl chr16:71,417,039...71,454,225
|
|
| G
|
Chst1
|
carbohydrate sulfotransferase 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CHST1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 3:99,003,987...99,030,214
Ensembl chr 3:99,009,958...99,031,262
|
|
| G
|
Chst11
|
carbohydrate sulfotransferase 11
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CHST11 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 7:22,412,121...22,630,577
Ensembl chr 7:22,415,686...22,630,441
|
|
| G
|
Chst15
|
carbohydrate sulfotransferase 15
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CHST15 mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr 1:196,458,978...196,540,088
Ensembl chr 1:196,460,425...196,491,444
|
|
| G
|
Chst6
|
carbohydrate sulfotransferase 6
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CHST6 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr19:56,769,991...56,790,276
Ensembl chr19:56,769,967...56,790,306
|
|
| G
|
Chst7
|
carbohydrate sulfotransferase 7
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHST7 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr X:4,949,810...4,986,372
Ensembl chr X:4,938,757...4,986,907
|
|
| G
|
Chsy1
|
chondroitin sulfate synthase 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CHSY1 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 1:129,100,088...129,161,167
Ensembl chr 1:129,100,041...129,161,081
|
|
| G
|
Chsy3
|
chondroitin sulfate synthase 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHSY3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr18:54,842,260...55,096,008
Ensembl chr18:54,842,180...55,095,981
|
|
| G
|
Chtf18
|
chromosome transmission fidelity factor 18
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CHTF18 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:15,247,525...15,255,573
Ensembl chr10:15,246,362...15,255,685
|
|
| G
|
Chtf8
|
chromosome transmission fidelity factor 8
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHTF8 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:51,691,776...51,702,076
Ensembl chr19:51,678,543...51,707,144
|
|
| G
|
Ciart
|
circadian associated repressor of transcription
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CIART mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 2:186,108,744...186,113,778
Ensembl chr 2:186,108,752...186,112,246
|
|
| G
|
Cidea
|
cell death-inducing DFFA-like effector a
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CIDEA mRNA
|
CTD |
PMID:23539316 |
|
NCBI chr18:63,164,817...63,190,384
Ensembl chr18:63,164,099...63,190,382
|
|
| G
|
Cimap1b
|
ciliary microtubule associated protein 1B
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CIMAP1B mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 7:122,323,860...122,326,921
Ensembl chr 7:122,323,860...122,326,876
|
|
| G
|
Cited2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
increases expression
|
ISO
|
Oxygen results in increased expression of CITED2 mRNA
|
CTD |
PMID:27103661 |
|
NCBI chr 1:14,132,303...14,134,746
Ensembl chr 1:14,103,457...14,134,782
|
|
| G
|
Ckap2
|
cytoskeleton associated protein 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CKAP2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr16:76,542,114...76,567,297
Ensembl chr16:76,542,104...76,567,352
|
|
| G
|
Ckap2l
|
cytoskeleton associated protein 2-like
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of CKAP2L mRNA [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CKAP2L mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CKAP2L mRNA
|
CTD |
PMID:26516004 PMID:33729688 |
|
NCBI chr 3:136,950,390...136,977,503
Ensembl chr 3:136,950,381...136,977,565
|
|
| G
|
Ckb
|
creatine kinase B
|
multiple interactions
|
EXP
|
[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased secretion of [CKM protein binds to CKB protein]; PHLDA3 protein promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased secretion of [CKM protein binds to CKB protein]]
|
CTD |
PMID:34351043 |
|
NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:136,549,844...136,553,478
|
|
| G
|
Ckm
|
creatine kinase, M-type
|
multiple interactions increases expression
|
ISO EXP
|
Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of CKM protein] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CKM mRNA [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased secretion of [CKM protein binds to CKB protein]; PHLDA3 protein promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased secretion of [CKM protein binds to CKB protein]]
|
CTD |
PMID:22363556 PMID:30529165 PMID:34351043 |
|
NCBI chr 1:88,189,382...88,199,717
Ensembl chr 1:88,189,485...88,199,719
|
|
| G
|
Ckmt1
|
creatine kinase, mitochondrial 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CKMT1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:128,783,408...128,789,485
Ensembl chr 3:128,783,597...128,789,483
|
|
| G
|
Ckmt2
|
creatine kinase, mitochondrial 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CKMT2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:24,815,008...24,845,511
Ensembl chr 2:24,815,008...24,845,511
|
|
| G
|
Cks2
|
CDC28 protein kinase regulatory subunit 2
|
increases expression decreases expression
|
ISO
|
Oxygen deficiency results in increased expression of CKS2 mRNA Oxygen deficiency results in decreased expression of CKS2 mRNA
|
CTD |
PMID:24205000 PMID:26516004 |
|
NCBI chr17:13,722,360...13,727,519
Ensembl chr17:13,722,361...13,727,519
|
|
| G
|
Clca2
|
chloride channel accessory 2
|
increases expression
|
EXP
|
Oxygen results in increased expression of CLCA2 mRNA
|
CTD |
PMID:22911455 |
|
NCBI chr 2:236,655,419...236,682,669
Ensembl chr 2:236,639,545...236,685,129
|
|
| G
|
Clcf1
|
cardiotrophin-like cytokine factor 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CLCF1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:210,937,763...210,947,064
Ensembl chr 1:210,937,255...210,947,064
|
|
| G
|
Cldn10
|
claudin 10
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CLDN10 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr15:102,269,858...102,361,589
Ensembl chr15:102,269,858...102,361,589
|
|
| G
|
Cldn3
|
claudin 3
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CLDN3 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr12:27,345,075...27,346,547
Ensembl chr12:27,345,076...27,348,841
|
|
| G
|
Cldn4
|
claudin 4
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CLDN4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr12:27,388,160...27,389,958
Ensembl chr12:27,387,981...27,389,958
|
|
| G
|
Cldn5
|
claudin 5
|
multiple interactions
|
ISO
|
[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased degradation of CLDN5 protein
|
CTD |
PMID:23876515 |
|
NCBI chr11:95,717,172...95,718,598
Ensembl chr11:95,717,176...95,719,322
|
|
| G
|
Cldn8
|
claudin 8
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CLDN8 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr11:41,362,081...41,364,330
|
|
| G
|
Clec11a
|
C-type lectin domain containing 11A
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CLEC11A mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:103,938,029...103,941,170
Ensembl chr 1:103,935,185...103,946,784
|
|
| G
|
Clec12b
|
C-type lectin domain family 12, member B
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CLEC12B mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 4:164,512,893...164,529,846
Ensembl chr 4:164,513,497...164,524,976
|
|
| G
|
Clec1a
|
C-type lectin domain family 1, member A
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CLEC1A mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:164,561,385...164,588,593
Ensembl chr 4:164,563,374...164,587,269
|
|
| G
|
Clec3b
|
C-type lectin domain family 3, member B
|
decreases expression increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of CLEC3B mRNA Oxygen deficiency results in increased expression of CLEC3B mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CLEC3B mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CLEC3B mRNA
|
CTD |
PMID:24205000 PMID:26516004 PMID:30529165 PMID:33729688 |
|
NCBI chr 8:131,687,575...131,693,292
|
|
| G
|
Clec4b2
|
C-type lectin domain family 4, member B2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CLEC4B2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 4:158,148,434...158,171,933
Ensembl chr 4:158,148,314...158,172,249
|
|
| G
|
Clec4d
|
C-type lectin domain family 4, member D
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CLEC4D mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 4:158,275,287...158,286,978
Ensembl chr 4:158,275,341...158,287,055
|
|
| G
|
Clec4e
|
C-type lectin domain family 4, member E
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of CLEC4E mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CLEC4E mRNA
|
CTD |
PMID:20880076 PMID:33729688 |
|
NCBI chr 4:158,292,624...158,298,607
Ensembl chr 4:158,293,311...158,298,467
|
|
| G
|
Clec5a
|
C-type lectin domain containing 5A
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CLEC5A mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CLEC5A mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 4:70,373,855...70,383,560
Ensembl chr 4:70,374,529...70,398,230
|
|
| G
|
Clec7a
|
C-type lectin domain containing 7A
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CLEC7A mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 4:164,588,737...164,599,953
Ensembl chr 4:164,588,754...164,599,919
|
|
| G
|
Cln6
|
CLN6, transmembrane ER protein
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CLN6 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 8:72,198,773...72,213,777
Ensembl chr 8:72,198,712...72,213,776
|
|
| G
|
Clpb
|
ClpB family mitochondrial disaggregase
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CLPB mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:165,440,705...165,563,514
Ensembl chr 1:165,440,861...165,583,815
|
|
| G
|
Clptm1
|
CLPTM1 regulator of GABA type A receptor forward trafficking
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CLPTM1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:88,417,447...88,449,047
Ensembl chr 1:88,417,447...88,449,446
|
|
| G
|
Clspn
|
claspin
|
decreases expression increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of CLSPN mRNA Oxygen deficiency results in increased expression of CLSPN mRNA Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of CLSPN mRNA]
|
CTD |
PMID:26476374 PMID:26516004 |
|
NCBI chr 5:144,134,619...144,169,531
Ensembl chr 5:144,134,632...144,169,530
|
|
| G
|
Clstn1
|
calsyntenin 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CLSTN1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:165,314,128...165,377,627
Ensembl chr 5:165,314,309...165,377,625
|
|
| G
|
Cltb
|
clathrin, light chain B
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CLTB mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr17:10,006,416...10,024,278
Ensembl chr17:10,006,656...10,024,915
|
|
| G
|
Cltc
|
clathrin heavy chain
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CLTC mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr10:72,014,984...72,073,308
Ensembl chr10:72,014,986...72,070,691
|
|
| G
|
Clu
|
clusterin
|
multiple interactions
|
ISO
|
Oxygen deficiency inhibits the reaction [darinaparsin results in increased expression of CLU mRNA]
|
CTD |
PMID:22535156 |
|
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860
|
|
| G
|
Cluh
|
clustered mitochondria homolog
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CLUH mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:60,008,052...60,029,742
Ensembl chr10:60,008,119...60,029,742
|
|
| G
|
Clybl
|
citramalyl-CoA lyase
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CLYBL mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr15:105,690,283...105,912,347
Ensembl chr15:105,690,295...105,912,345
|
|
| G
|
Cmah
|
cytidine monophospho-N-acetylneuraminic acid hydroxylase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CMAH mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr17:40,985,129...41,070,317
Ensembl chr17:41,011,641...41,070,252
|
|
| G
|
Cmbl
|
carboxymethylenebutenolidase homolog
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CMBL mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 2:84,280,128...84,301,878
Ensembl chr 2:84,242,512...84,301,880
|
|
| G
|
Cmpk2
|
cytidine/uridine monophosphate kinase 2
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CMPK2 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CMPK2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 6:48,802,150...48,813,652
Ensembl chr 6:48,802,321...48,813,652
|
|
| G
|
Cmtm8
|
CKLF-like MARVEL transmembrane domain containing 8
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CMTM8 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:123,360,168...123,425,291
Ensembl chr 8:123,360,170...123,425,276
|
|
| G
|
Cmtr2
|
cap methyltransferase 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CMTR2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:55,100,135...55,106,966
Ensembl chr19:55,099,843...55,124,234
|
|
| G
|
Cmya5
|
cardiomyopathy associated 5
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CMYA5 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:26,014,545...26,113,273
Ensembl chr 2:26,014,177...26,113,376
|
|
| G
|
Cnksr1
|
connector enhancer of kinase suppressor of Ras 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CNKSR1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:151,731,222...151,742,049
Ensembl chr 5:151,731,224...151,742,203
|
|
| G
|
Cnksr3
|
Cnksr family member 3
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CNKSR3 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:45,904,581...45,996,921
Ensembl chr 1:45,904,581...45,996,921
|
|
| G
|
Cnn2
|
calponin 2
|
affects expression
|
ISO
|
Oxygen deficiency affects the expression of CNN2 mRNA
|
CTD |
PMID:17193925 |
|
NCBI chr 7:10,363,141...10,370,312
Ensembl chr 7:10,363,102...10,370,312
|
|
| G
|
Cnot6
|
CCR4-NOT transcription complex, subunit 6
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CNOT6 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:34,479,892...34,532,166
Ensembl chr10:34,481,938...34,524,416
|
|
| G
|
Cnot9
|
CCR4-NOT transcription complex subunit 9
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CNOT9 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:83,533,369...83,558,207
Ensembl chr 9:83,533,369...83,558,197
|
|
| G
|
Cnpy2
|
canopy FGF signaling regulator 2
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of CNPY2 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in decreased expression of CNPY2 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 7:1,332,293...1,338,081
Ensembl chr 7:1,334,335...1,340,333
|
|
| G
|
Cnr1
|
cannabinoid receptor 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CNR1 mRNA
|
CTD |
PMID:21863215 |
|
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:53,204,260...53,239,252
|
|
| G
|
Cnr2
|
cannabinoid receptor 2
|
multiple interactions
|
EXP
|
[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CNR2 mRNA; [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CNR2 protein; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CNR2 mRNA; HU 308 promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CNR2 mRNA]; HU 308 promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CNR2 protein]; iodopravadoline inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CNR2 protein]; iodopravadoline inhibits the reaction [peoniflorin promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CNR2 mRNA]]; iodopravadoline inhibits the reaction [peoniflorin promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CNR2 protein]]; peoniflorin promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CNR2 mRNA]; peoniflorin promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CNR2 protein]
|
CTD |
PMID:29560022 PMID:33729688 |
|
NCBI chr 5:153,408,968...153,435,092
Ensembl chr 5:153,409,147...153,435,961
|
|
| G
|
Coa7
|
cytochrome c oxidase assembly factor 7
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of COA7 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of COA7 mRNA
|
CTD |
PMID:24236059 PMID:26516004 PMID:30529165 |
|
NCBI chr 5:128,298,084...128,308,935
Ensembl chr 5:128,298,093...128,309,664
|
|
| G
|
Cobll1
|
cordon-bleu WH2 repeat protein-like 1
|
multiple interactions increases expression
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of COBLL1 mRNA Oxygen deficiency results in increased expression of COBLL1 protein
|
CTD |
PMID:34355838 |
|
NCBI chr 3:70,161,369...70,324,844
Ensembl chr 3:70,161,372...70,323,460
|
|
| G
|
Coch
|
cochlin
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of COCH mRNA
|
CTD |
PMID:24236059 PMID:25596134 |
|
NCBI chr 6:74,766,485...74,780,504
Ensembl chr 6:74,766,419...74,780,502
|
|
| G
|
Col12a1
|
collagen type XII alpha 1 chain
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of COL12A1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 8:89,427,834...89,545,886
Ensembl chr 8:89,427,834...89,545,711
|
|
| G
|
Col13a1
|
collagen type XIII alpha 1 chain
|
decreases expression increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of COL13A1 mRNA Oxygen deficiency results in increased expression of COL13A1 mRNA TP53 protein mutant form promotes the reaction [Oxygen deficiency results in increased expression of COL13A1 mRNA]
|
CTD |
PMID:26516004 PMID:30381462 |
|
NCBI chr20:30,326,744...30,466,800
Ensembl chr20:30,326,744...30,466,800
|
|
| G
|
Col14a1
|
collagen type XIV alpha 1 chain
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of COL14A1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of COL14A1 mRNA
|
CTD |
PMID:20880076 PMID:33729688 |
|
NCBI chr 7:88,611,827...88,826,939
Ensembl chr 7:88,611,828...88,826,938
|
|
| G
|
Col18a1
|
collagen type XVIII alpha 1 chain
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of COL18A1 mRNA SB 203580 inhibits the reaction [Oxygen deficiency results in increased expression of COL18A1 mRNA] [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of COL18A1 mRNA
|
CTD |
PMID:13679210 PMID:24205000 PMID:33729688 |
|
NCBI chr20:11,473,645...11,582,111
Ensembl chr20:11,473,645...11,582,112
|
|
| G
|
Col1a1
|
collagen type I alpha 1 chain
|
increases expression multiple interactions
|
EXP ISO
|
Oxygen deficiency results in increased expression of COL1A1 mRNA; Oxygen deficiency results in increased expression of COL1A1 protein [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of COL1A1 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of COL1A1 mRNA; [Paraquat co-treated with Oxygen] results in increased expression of COL1A1 mRNA Oxygen deficiency results in increased expression of COL1A1 mRNA; Oxygen results in increased expression of COL1A1 mRNA Y 27632 inhibits the reaction [Oxygen results in increased expression of COL1A1 mRNA] Cytochalasin D inhibits the reaction [Oxygen results in increased expression of COL1A1 mRNA]; exoenzyme C3, Clostridium botulinum inhibits the reaction [Oxygen results in increased expression of COL1A1 mRNA]; RHOA protein affects the reaction [Oxygen results in increased expression of COL1A1 mRNA]; Y 27632 inhibits the reaction [Oxygen results in increased expression of COL1A1 mRNA]
|
CTD |
PMID:11981751 PMID:12882763 PMID:21439370 PMID:22363622 PMID:23517783 PMID:24205000 PMID:24236059 PMID:33729688 More...
|
|
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
|
|
| G
|
Col1a2
|
collagen type I alpha 2 chain
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of COL1A2 mRNA; Oxygen results in increased expression of COL1A2 mRNA Y 27632 inhibits the reaction [Oxygen results in increased expression of COL1A2 mRNA] Cytochalasin D inhibits the reaction [Oxygen results in increased expression of COL1A2 mRNA]; exoenzyme C3, Clostridium botulinum inhibits the reaction [Oxygen results in increased expression of COL1A2 mRNA]; Oxygen deficiency promotes the reaction [darinaparsin results in increased expression of COL1A2 mRNA]; RHOA protein affects the reaction [Oxygen results in increased expression of COL1A2 mRNA]; Y 27632 inhibits the reaction [Oxygen results in increased expression of COL1A2 mRNA] [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of COL1A2 mRNA
|
CTD |
PMID:21439370 PMID:22535156 PMID:23517783 PMID:24205000 PMID:33729688 |
|
NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995
|
|
| G
|
Col2a1
|
collagen type II alpha 1 chain
|
multiple interactions increases expression
|
ISO
|
cobaltiprotoporphyrin promotes the reaction [IL1B protein inhibits the reaction [Oxygen deficiency results in increased expression of COL2A1 protein]]; HMOX1 mutant form inhibits the reaction [cobaltiprotoporphyrin promotes the reaction [IL1B protein inhibits the reaction [Oxygen deficiency results in increased expression of COL2A1 protein]]]; IL1B protein inhibits the reaction [Oxygen deficiency results in increased expression of COL2A1 protein]
|
CTD |
PMID:23406266 |
|
NCBI chr 7:130,977,561...131,006,627
Ensembl chr 7:130,977,561...131,006,627
|
|
| G
|
Col3a1
|
collagen type III alpha 1 chain
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of COL3A1 mRNA [Oxygen deficiency results in increased susceptibility to epigallocatechin gallate] which results in decreased expression of COL3A1 mRNA; epigallocatechin gallate inhibits the reaction [Oxygen deficiency results in increased expression of COL3A1 mRNA]
|
CTD |
PMID:24205000 PMID:24236059 PMID:28478070 |
|
NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232
|
|
| G
|
Col4a1
|
collagen type IV alpha 1 chain
|
decreases expression increases expression
|
ISO EXP
|
Oxygen deficiency results in decreased expression of COL4A1 mRNA Oxygen deficiency results in increased expression of COL4A1 protein
|
CTD |
PMID:25596134 PMID:36414118 |
|
NCBI chr16:84,885,597...84,996,482
Ensembl chr16:84,885,597...84,996,482
|
|
| G
|
Col4a2
|
collagen type IV alpha 2 chain
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of COL4A2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr16:84,749,672...84,885,520
Ensembl chr16:84,749,672...84,885,520
|
|
| G
|
Col4a3
|
collagen type IV alpha 3 chain
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of COL4A3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:91,323,990...91,453,088
Ensembl chr 9:91,323,990...91,453,077
|
|
| G
|
Col4a4
|
collagen type IV alpha 4 chain
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of COL4A4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:91,281,324...91,323,577
Ensembl chr 9:91,203,670...91,323,577
|
|
| G
|
Col4a5
|
collagen type IV alpha 5 chain
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of COL4A5 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr X:109,907,251...110,111,214
Ensembl chr X:109,907,346...110,111,214
|
|
| G
|
Col4a6
|
collagen type IV alpha 6 chain
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of COL4A6 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr X:109,554,945...109,905,987
Ensembl chr X:109,552,651...109,905,944
|
|
| G
|
Col5a2
|
collagen type V alpha 2 chain
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of COL5A2 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of COL5A2 mRNA
|
CTD |
PMID:24205000 PMID:30529165 |
|
NCBI chr 9:54,940,768...55,090,151
Ensembl chr 9:54,940,764...55,090,150
|
|
| G
|
Col7a1
|
collagen type VII alpha 1 chain
|
multiple interactions increases expression
|
ISO
|
HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of COL7A1 mRNA]; SMARCA2 protein promotes the reaction [Oxygen deficiency results in increased expression of COL7A1 mRNA]; SMARCA4 protein promotes the reaction [Oxygen deficiency results in increased expression of COL7A1 mRNA]; TP53 protein mutant form promotes the reaction [Oxygen deficiency results in increased expression of COL7A1 mRNA]; TP53 protein mutant form promotes the reaction [Oxygen deficiency results in increased expression of COL7A1 protein] Oxygen deficiency results in increased expression of COL7A1 mRNA; Oxygen deficiency results in increased expression of COL7A1 protein
|
CTD |
PMID:30381462 |
|
NCBI chr 8:118,483,364...118,515,736
Ensembl chr 8:118,483,364...118,517,439
|
|
| G
|
Col8a1
|
collagen type VIII alpha 1 chain
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of COL8A1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr11:56,245,998...56,378,586
Ensembl chr11:56,369,868...56,376,229
|
|
| G
|
Colgalt2
|
collagen beta(1-O)galactosyltransferase 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of COLGALT2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr13:67,073,551...67,178,194
Ensembl chr13:67,073,551...67,178,194
|
|
| G
|
Commd7
|
COMM domain containing 7
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of COMMD7 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in decreased expression of COMMD7 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 3:162,559,762...162,574,543
Ensembl chr 3:162,554,374...162,574,692
|
|
| G
|
Commd9
|
COMM domain containing 9
|
multiple interactions
|
EXP
|
COMMD9 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
|
CTD |
PMID:21124846 |
|
NCBI chr 3:108,630,903...108,645,427
Ensembl chr 3:108,630,980...108,666,091
|
|
| G
|
Cops2
|
COP9 signalosome subunit 2
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of COPS2 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of COPS2 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 3:133,537,729...133,563,493
Ensembl chr 3:133,537,732...133,563,369
|
|
| G
|
Coq10b
|
coenzyme Q10B
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of COQ10B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:64,048,168...64,068,082
Ensembl chr 9:64,048,103...64,068,322
|
|
| G
|
Coq3
|
coenzyme Q3 methyltransferase
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of COQ3 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 5:40,226,313...40,257,383
Ensembl chr 5:40,226,368...40,257,617
|
|
| G
|
Coq8a
|
coenzyme Q8A
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADCK3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr13:94,436,680...94,465,535
Ensembl chr13:94,436,546...94,463,378
|
|
| G
|
Corin
|
corin, serine peptidase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CORIN mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:36,034,613...36,264,671
Ensembl chr14:36,034,993...36,264,649
|
|
| G
|
Coro1a
|
coronin 1A
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CORO1A mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:190,726,129...190,731,133
Ensembl chr 1:190,726,130...190,731,102
|
|
| G
|
Coro2a
|
coronin 2A
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CORO2A mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 5:65,623,820...65,677,483
Ensembl chr 5:65,623,823...65,654,602
|
|
| G
|
Cox10
|
cytochrome c oxidase assembly factor heme A:farnesyltransferase COX10
|
multiple interactions
|
EXP
|
COX10 protein affects the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]
|
CTD |
PMID:18353899 |
|
NCBI chr10:49,130,209...49,242,009
Ensembl chr10:49,130,209...49,242,009
|
|
| G
|
Cox4i1
|
cytochrome c oxidase subunit 4i1
|
decreases expression
|
EXP
|
Oxygen deficiency results in decreased expression of COX4I1 protein
|
CTD |
PMID:28751209 |
|
NCBI chr19:65,630,383...65,636,623
Ensembl chr19:65,630,432...65,636,624
|
|
| G
|
Cox5a
|
cytochrome c oxidase subunit 5A
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of COX5A mRNA Oxygen inhibits the reaction [Oxygen deficiency results in decreased expression of COX5A mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 8:66,818,284...66,829,691
Ensembl chr 8:66,818,196...66,830,279
|
|
| G
|
Cox5b
|
cytochrome c oxidase subunit 5B
|
multiple interactions
|
EXP
|
COX5B protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
|
CTD |
PMID:21124846 |
|
NCBI chr 9:46,417,735...46,419,664
Ensembl chr 9:46,417,838...46,420,403
|
|
| G
|
Cox7a1
|
cytochrome c oxidase subunit 7A1
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of COX7A1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of COX7A1 mRNA
|
CTD |
PMID:24205000 PMID:30529165 |
|
NCBI chr 1:94,549,663...94,572,330
Ensembl chr 1:94,569,216...94,570,889
|
|
| G
|
Cp
|
ceruloplasmin
|
multiple interactions increases activity increases expression
|
ISO
|
ARNT protein affects the reaction [Oxygen deficiency results in increased activity of CP promoter] Oxygen deficiency results in increased expression of CP protein Oxygen deficiency results in increased expression of CP mRNA
|
CTD |
PMID:10777486 PMID:15741220 PMID:18679377 PMID:19351718 PMID:25596134 |
|
NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:104,368,456...104,427,087
|
|
| G
|
Cpap
|
centrosome assembly and centriole elongation protein
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CPAP mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr15:34,742,838...34,806,020
Ensembl chr15:34,742,838...34,802,421
|
|
| G
|
Cpe
|
carboxypeptidase E
|
multiple interactions
|
ISO
|
Oxygen deficiency inhibits the reaction [darinaparsin results in increased expression of CPE mRNA]
|
CTD |
PMID:22535156 |
|
NCBI chr16:29,796,707...29,908,647
Ensembl chr16:29,796,689...29,909,524
|
|
| G
|
Cpm
|
carboxypeptidase M
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CPM mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:55,111,599...55,172,114
Ensembl chr 7:55,111,599...55,172,114
|
|
| G
|
Cpn2
|
carboxypeptidase N subunit 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CPN2 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr11:83,990,943...84,000,821
Ensembl chr11:83,990,940...84,001,059
|
|
| G
|
Cpne2
|
copine 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CPNE2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:10,440,245...10,477,783
Ensembl chr19:10,434,647...10,477,783
|
|
| G
|
Cpne6
|
copine 6
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CPNE6 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr15:32,968,047...32,975,008
Ensembl chr15:32,968,046...32,975,007
|
|
| G
|
Cps1
|
carbamoyl-phosphate synthase 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CPS1 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 9:76,063,863...76,186,739
Ensembl chr 9:76,000,754...76,186,734
|
|
| G
|
Cpt1a
|
carnitine palmitoyltransferase 1A
|
multiple interactions decreases expression increases metabolic processing
|
ISO
|
[Paclitaxel co-treated with FV-429 compound co-treated with Oxygen deficiency] results in increased expression of CPT1A mRNA; EPAS1 gene mutant form inhibits the reaction [Oxygen deficiency results in decreased expression of CPT1A mRNA]; HIF1A gene mutant form inhibits the reaction [Oxygen deficiency results in decreased expression of CPT1A mRNA] CPT1A protein results in increased metabolism of Oxygen
|
CTD |
PMID:24503013 PMID:31040181 PMID:34648812 |
|
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326
|
|
| G
|
Cpt1b
|
carnitine palmitoyltransferase 1B
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of CPT1B mRNA rosiglitazone inhibits the reaction [Oxygen deficiency results in decreased expression of CPT1B mRNA]
|
CTD |
PMID:21113404 |
|
NCBI chr 7:122,370,974...122,380,473
Ensembl chr 7:122,370,444...122,380,036
|
|
| G
|
Cpt1c
|
carnitine palmitoyltransferase 1c
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CPT1C mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:104,579,297...104,593,824
Ensembl chr 1:104,579,298...104,593,763
|
|
| G
|
Cpxm1
|
carboxypeptidase X (M14 family), member 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CPXM1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:138,041,645...138,048,443
Ensembl chr 3:138,041,645...138,048,857
|
|
| G
|
Cpxm2
|
carboxypeptidase X (M14 family), member 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CPXM2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:196,266,930...196,377,350
Ensembl chr 1:196,266,930...196,377,347
|
|
| G
|
Cr2
|
complement C3d receptor 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CR2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr13:109,207,034...109,244,980
Ensembl chr13:109,213,867...109,244,552
|
|
| G
|
Crct1
|
cysteine-rich C-terminal 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CRCT1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:181,329,392...181,330,877
Ensembl chr 2:181,329,392...181,330,877
|
|
| G
|
Creb1
|
cAMP responsive element binding protein 1
|
multiple interactions decreases expression
|
EXP ISO
|
[Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased phosphorylation of CREB1 protein; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased phosphorylation of CREB1 protein; [Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of CREB1 protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of CREB1 protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of CREB1 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased phosphorylation of CREB1 protein]; Prasugrel Hydrochloride inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased phosphorylation of CREB1 protein] Oxygen deficiency results in decreased expression of CREB1 mRNA
|
CTD |
PMID:24718106 PMID:24726522 PMID:34174262 PMID:34998824 |
|
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339
|
|
| G
|
Crebbp
|
CREB binding protein
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of CREBBP mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of CREBBP mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,822,620...11,968,266
|
|
| G
|
Crebl2
|
cAMP responsive element binding protein-like 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CREBL2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:169,404,630...169,430,618
Ensembl chr 4:169,376,495...169,430,611
|
|
| G
|
Crebrf
|
CREB3 regulatory factor
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of CREBRF mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CREBRF mRNA
|
CTD |
PMID:24236059 PMID:30529165 |
|
NCBI chr10:16,903,607...16,967,450
Ensembl chr10:16,903,547...16,966,430
|
|
| G
|
Creld1
|
cysteine-rich with EGF-like domains 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CRELD1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 4:148,187,510...148,197,120
Ensembl chr 4:148,187,265...148,197,116
|
|
| G
|
Creld2
|
cysteine-rich with EGF-like domains 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CRELD2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 7:121,788,754...121,796,230
Ensembl chr 7:121,788,745...121,796,228
|
|
| G
|
Crip1
|
cysteine rich protein 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CRIP1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:138,047,801...138,055,672
Ensembl chr 6:138,047,801...138,055,672
|
|
| G
|
Crlf2
|
cytokine receptor-like factor 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CRLF2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:118,932...123,632
Ensembl chr14:115,497...123,631
|
|
| G
|
Crlf3
|
cytokine receptor-like factor 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CRLF3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:65,521,296...65,559,162
Ensembl chr10:65,521,492...65,558,804
|
|
| G
|
Crmp1
|
collapsin response mediator protein 1
|
multiple interactions increases expression
|
EXP ISO
|
CRMP1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] Oxygen deficiency results in increased expression of CRMP1 protein
|
CTD |
PMID:21124846 PMID:25937538 |
|
NCBI chr14:77,734,675...77,780,916
Ensembl chr14:77,734,675...77,780,916
|
|
| G
|
Cry1
|
cryptochrome circadian regulator 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CRY1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:20,417,526...20,481,791
Ensembl chr 7:20,417,107...20,481,822
|
|
| G
|
Cryl1
|
crystallin, lambda 1
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CRYL1 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CRYL1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr15:35,542,628...35,661,563
Ensembl chr15:35,542,628...35,661,563
|
|
| G
|
Cs
|
citrate synthase
|
affects methylation increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency affects the methylation of CS promoter Oxygen deficiency results in increased expression of CS mRNA [Nitrites co-treated with Oxygen deficiency] results in increased activity of CS protein [sulforaphane affects the susceptibility to Oxygen] which affects the expression of CS mRNA
|
CTD |
PMID:22892143 PMID:24205000 PMID:30529165 |
|
NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:1,342,942...1,375,938
|
|
| G
|
Csad
|
cysteine sulfinic acid decarboxylase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CSAD mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:135,187,175...135,216,495
Ensembl chr 7:135,187,175...135,215,581
|
|
| G
|
Csde1
|
cold shock domain containing E1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of CSDE1 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of CSDE1 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 2:193,234,546...193,271,301
Ensembl chr 2:193,243,526...193,271,301
|
|
| G
|
Cse1l
|
chromosome segregation 1 like
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CSE1L mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 3:176,060,183...176,097,909
Ensembl chr 3:176,060,215...176,108,734
|
|
| G
|
Csf1
|
colony stimulating factor 1
|
multiple interactions increases expression
|
EXP ISO
|
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of CSF1 mRNA] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CSF1 mRNA
|
CTD |
PMID:24223152 PMID:30529165 |
|
NCBI chr 2:198,065,400...198,084,774
Ensembl chr 2:198,065,405...198,084,468
|
|
| G
|
Csf2ra
|
colony stimulating factor 2 receptor subunit alpha
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CSF2RA mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr14:113,219...118,808
Ensembl chr14:113,225...118,117
|
|
| G
|
Csf2rb
|
colony stimulating factor 2 receptor subunit beta
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CSF2RB mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 7:111,756,950...111,782,089
Ensembl chr 7:111,757,405...111,784,654
|
|
| G
|
Csf3
|
colony stimulating factor 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CSF3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:84,157,485...84,159,860
Ensembl chr10:84,157,211...84,159,860
|
|
| G
|
Csf3r
|
colony stimulating factor 3 receptor
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CSF3R mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 5:143,583,126...143,604,382
Ensembl chr 5:143,583,213...143,602,411
|
|
| G
|
Csgalnact1
|
chondroitin sulfate N-acetylgalactosaminyltransferase 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CSGALNACT1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr16:25,761,946...26,097,306
Ensembl chr16:26,002,530...26,096,065
|
|
| G
|
Csnk1d
|
casein kinase 1, delta
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CSNK1D mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr10:106,713,497...106,754,953
Ensembl chr10:106,694,279...106,754,953
|
|
| G
|
Cspg4
|
chondroitin sulfate proteoglycan 4
|
increases expression affects methylation
|
ISO
|
Oxygen deficiency results in increased expression of CSPG4 mRNA Oxygen deficiency affects the methylation of CSPG4 promoter
|
CTD |
PMID:24205000 |
|
NCBI chr 8:66,160,942...66,195,987
Ensembl chr 8:66,160,942...66,200,806
|
|
| G
|
Cspg4b
|
chondroitin sulfate proteoglycan 4B
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CSPG4B mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 2:46,673,142...46,743,288
Ensembl chr 2:46,673,259...46,741,461
|
|
| G
|
Csrnp1
|
cysteine and serine rich nuclear protein 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CSRNP1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:128,582,364...128,594,163
Ensembl chr 8:128,582,365...128,588,469
|
|
| G
|
Csrp2
|
cysteine and glycine-rich protein 2
|
increases expression
|
EXP
|
Oxygen deficiency results in increased expression of CSRP2 protein
|
CTD |
PMID:36414118 |
|
NCBI chr 7:48,235,415...48,254,049
Ensembl chr 7:48,235,383...48,266,238
|
|
| G
|
Csrp3
|
cysteine and glycine rich protein 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CSRP3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:107,664,338...107,682,916
Ensembl chr 1:107,664,338...107,682,916
|
|
| G
|
Cst3
|
cystatin C
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CST3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:156,790,061...156,794,116
Ensembl chr 3:156,790,079...156,793,937
|
|
| G
|
Cstb
|
cystatin B
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CSTB mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr20:10,245,157...10,247,199
Ensembl chr20:10,245,158...10,247,199
|
|
| G
|
Cstf1
|
cleavage stimulation factor subunit 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CSTF1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:181,562,953...181,574,727
Ensembl chr 3:181,562,955...181,574,727
|
|
| G
|
Ctdnep1
|
CTD nuclear envelope phosphatase 1
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CTDNEP1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:55,203,047...55,212,469
Ensembl chr10:55,203,543...55,212,852
|
|
| G
|
Ctdp1
|
CTD phosphatase subunit 1
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of CTDP1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CTDP1 mRNA
|
CTD |
PMID:25596134 PMID:30529165 |
|
NCBI chr18:76,129,243...76,193,404
Ensembl chr18:76,129,243...76,190,578
|
|
| G
|
Ctdsp1
|
CTD small phosphatase 1
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CTDSP1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:83,422,755...83,428,411
Ensembl chr 9:83,423,051...83,428,412
|
|
| G
|
Ctdspl2
|
CTD small phosphatase like 2
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CTDSPL2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:129,365,709...129,424,232
Ensembl chr 3:129,368,938...129,424,232
|
|
| G
|
Ctf1
|
cardiotrophin 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CTF1 protein
|
CTD |
PMID:16507596 |
|
NCBI chr 1:191,758,512...191,771,259
Ensembl chr 1:191,757,477...191,776,395
|
|
| G
|
Cth
|
cystathionine gamma-lyase
|
decreases expression multiple interactions increases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CTH mRNA [Oxygen deficiency co-treated with Oxygen] results in decreased expression of CTH protein Oxygen results in increased expression of CTH protein
|
CTD |
PMID:20880076 PMID:25596134 PMID:27273718 PMID:28157488 |
|
NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:249,634,731...249,661,066
|
|
| G
|
Ctnnb1
|
catenin beta 1
|
multiple interactions decreases expression decreases acetylation affects localization increases expression affects expression
|
ISO
|
[Butylated Hydroxytoluene co-treated with Oxygen] affects the localization of CTNNB1 protein; [Butylated Hydroxytoluene co-treated with Oxygen] results in increased expression of CTNNB1 protein; Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased expression of CTNNB1 protein]; CDX2 protein inhibits the reaction [Oxygen deficiency results in increased expression of CTNNB1 protein]; CTNNB1 protein promotes the reaction [Oxygen deficiency results in increased activity of CASP3 protein]; CTNNB1 protein promotes the reaction [Oxygen deficiency results in increased expression of MYC protein] Oxygen deficiency results in decreased expression of CTNNB1 mRNA [amurensin G results in decreased activity of SIRT1 protein] inhibits the reaction [Oxygen deficiency results in decreased expression of CTNNB1]; [betulin co-treated with Oxygen deficiency] results in decreased expression of CTNNB1 protein; [Betulinic Acid co-treated with Oxygen deficiency] results in decreased expression of CTNNB1 protein; [Oxygen deficiency co-treated with Paclitaxel co-treated with FV-429 compound co-treated with Deferoxamine] affects the localization of CTNNB1 protein; [Paclitaxel co-treated with FV-429 compound] inhibits the reaction [Oxygen deficiency results in increased expression of CTNNB1 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde affects the reaction [bruceine D affects the reaction [Oxygen deficiency affects the expression of CTNNB1 protein]]; bruceine D affects the reaction [Oxygen deficiency affects the expression of CTNNB1 protein]; CTNNB1 protein affects the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; FV-429 compound inhibits the reaction [Oxygen deficiency results in increased expression of CTNNB1 protein]; Resveratrol inhibits the reaction [Oxygen deficiency affects the localization of CTNNB1 protein]; SIRT1 protein affects the reaction [Oxygen deficiency results in decreased expression of CTNNB1 protein] Oxygen deficiency results in decreased acetylation of CTNNB1 protein
|
CTD |
PMID:16272459 PMID:17175027 PMID:22245592 PMID:25297617 PMID:33181113 PMID:34648812 PMID:34900531 PMID:38295844 More...
|
|
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662
|
|
| G
|
Ctnnbip1
|
catenin, beta-interacting protein 1
|
increases expression affects methylation multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of CTNNBIP1 mRNA Oxygen deficiency affects the methylation of CTNNBIP1 promoter CTNNBIP1 protein affects the reaction [bruceine D affects the reaction [Oxygen deficiency affects the expression of HK2 protein]]; CTNNBIP1 protein affects the reaction [bruceine D affects the reaction [Oxygen deficiency affects the expression of LDHA protein]]; CTNNBIP1 protein affects the reaction [bruceine D affects the reaction [Oxygen deficiency affects the expression of PKM protein]]; CTNNBIP1 protein affects the reaction [bruceine D affects the reaction [Oxygen deficiency affects the expression of SLC16A3 protein]]; CTNNBIP1 protein affects the reaction [bruceine D affects the reaction [Oxygen deficiency affects the expression of SLC2A1 protein]]; CTNNBIP1 protein affects the reaction [bruceine D affects the reaction [Oxygen deficiency affects the expression of SLC2A3 protein]]; CTNNBIP1 protein affects the reaction [bruceine D inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]]
|
CTD |
PMID:24205000 PMID:34900531 |
|
NCBI chr 5:165,245,019...165,293,994
Ensembl chr 5:165,245,098...165,293,991
|
|
| G
|
Ctnnd2
|
catenin delta 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CTNND2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:82,879,469...83,727,409
Ensembl chr 2:82,879,469...83,727,409
|
|
| G
|
Ctps1
|
CTP synthase 1
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of CTPS1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CTPS1 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 5:139,372,349...139,440,441
Ensembl chr 5:139,410,249...139,440,465
|
|
| G
|
Ctsb
|
cathepsin B
|
multiple interactions
|
ISO
|
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CTSB protein; Melatonin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CTSB protein]
|
CTD |
PMID:21392095 |
|
NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478
|
|
| G
|
Ctsc
|
cathepsin C
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CTSC mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 1:151,440,860...151,472,430
Ensembl chr 1:151,441,032...151,474,082
|
|
| G
|
Ctse
|
cathepsin E
|
multiple interactions increases expression
|
ISO
|
Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of CTSE mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr13:45,644,168...45,666,722
Ensembl chr13:45,644,147...45,666,722
|
|
| G
|
Ctsf
|
cathepsin F
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of CTSF mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of CTSF mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 1:211,582,169...211,587,917
Ensembl chr 1:211,582,098...211,587,916
|
|
| G
|
Cttn
|
cortactin
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CTTN mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 1:209,029,048...209,064,577
Ensembl chr 1:209,029,048...209,058,211
|
|
| G
|
Cttnbp2
|
cortactin binding protein 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CTTNBP2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:47,766,867...47,930,598
Ensembl chr 4:47,766,870...47,930,540
|
|
| G
|
Cwc27
|
CWC27 spliceosome associated cyclophilin
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CWC27 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:37,498,462...37,709,691
Ensembl chr 2:37,498,468...37,709,355
|
|
| G
|
Cwf19l2
|
CWF19 like cell cycle control factor 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CWF19L2 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 6:6,036,158...6,102,686
Ensembl chr 6:6,026,861...6,102,635
|
|
| G
|
Cx3cl1
|
C-X3-C motif chemokine ligand 1
|
increases response to substance
|
ISO
|
Oxygen deficiency results in increased susceptibility to CX3CL1 protein
|
CTD |
PMID:17476338 |
|
NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,233,329...10,242,999
|
|
| G
|
Cx3cr1
|
C-X3-C motif chemokine receptor 1
|
increases expression decreases expression
|
ISO
|
Oxygen deficiency results in increased expression of CX3CR1 mRNA; Oxygen deficiency results in increased expression of CX3CR1 protein Oxygen deficiency results in decreased expression of CX3CR1 mRNA
|
CTD |
PMID:17476338 PMID:24205000 |
|
NCBI chr 8:128,661,294...128,679,048
Ensembl chr 8:128,654,833...128,685,983
|
|
| G
|
Cxcl10
|
C-X-C motif chemokine ligand 10
|
multiple interactions
|
ISO EXP
|
Oxygen affects the reaction [AHR protein results in increased expression of CXCL10 mRNA] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CXCL10 mRNA [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CXCL10 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CXCL10 mRNA
|
CTD |
PMID:27103661 PMID:30529165 PMID:33729688 |
|
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
|
|
| G
|
Cxcl12
|
C-X-C motif chemokine ligand 12
|
multiple interactions increases response to substance increases expression
|
ISO EXP
|
[Streptozocin co-treated with Oxygen deficiency] results in decreased expression of CXCL12 mRNA; HMOX1 protein promotes the reaction [Oxygen deficiency results in increased expression of CXCL12 mRNA]; HMOX1 protein promotes the reaction [Oxygen deficiency results in increased expression of CXCL12 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[Streptozocin co-treated with Oxygen deficiency] results in decreased expression of CXCL12 mRNA] Edaravone inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased secretion of CXCL12 protein]; Oxygen deficiency results in increased expression of and results in increased secretion of CXCL12 protein; SDC2 protein promotes the reaction [Oxygen deficiency results in increased expression of and results in increased secretion of CXCL12 protein] Oxygen deficiency results in increased susceptibility to CXCL12 protein Oxygen deficiency results in increased expression of CXCL12 mRNA; Oxygen deficiency results in increased expression of CXCL12 protein
|
CTD |
PMID:17476338 PMID:18227068 PMID:18803305 PMID:21048024 PMID:22652775 PMID:26516004 More...
|
|
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627
|
|
| G
|
Cxcl14
|
C-X-C motif chemokine ligand 14
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CXCL14 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr17:8,323,150...8,331,176
Ensembl chr17:8,323,143...8,331,172
|
|
| G
|
Cxcl16
|
C-X-C motif chemokine ligand 16
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CXCL16 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:55,665,355...55,669,950
Ensembl chr10:55,664,742...55,670,226
|
|
| G
|
Cxcl17
|
C-X-C motif chemokine ligand 17
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CXCL17 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:90,112,561...90,124,648
Ensembl chr 1:90,112,771...90,124,535
|
|
| G
|
Cxcl2
|
C-X-C motif chemokine ligand 2
|
multiple interactions increases expression
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CXCL2 mRNA; [POSTN gene mutant form results in decreased susceptibility to Oxygen] which results in decreased expression of CXCL2 mRNA; POSTN gene mutant form inhibits the reaction [Oxygen results in increased expression of CXCL2 mRNA]; SCGB1A1 protein affects the reaction [Oxygen results in increased expression of CXCL2 mRNA] Oxygen results in increased expression of CXCL2 mRNA; Oxygen results in increased expression of CXCL2 protein [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CXCL2 mRNA; Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of CXCL2 mRNA]
|
CTD |
PMID:10027076 PMID:10781441 PMID:11498801 PMID:22363622 PMID:26476374 PMID:30529165 PMID:33729688 More...
|
|
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
|
|
| G
|
Cxcl3
|
C-X-C motif chemokine ligand 3
|
multiple interactions increases expression
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CXCL1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CXCL3 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CXCL1 protein; [POSTN gene mutant form results in decreased susceptibility to Oxygen] which results in decreased expression of CXCL1 mRNA; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CXCL1 protein]; PARP1 gene mutant form inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CXCL1 protein]; POSTN gene mutant form inhibits the reaction [Oxygen results in increased expression of CXCL1 mRNA] [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CXCL3 mRNA
|
CTD |
PMID:15696051 PMID:22363622 PMID:30529165 PMID:33729688 |
|
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624
|
|
| G
|
Cxcl9
|
C-X-C motif chemokine ligand 9
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CXCL9 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr14:16,007,166...16,012,077
Ensembl chr14:16,007,204...16,014,299
|
|
| G
|
Cxcr2
|
C-X-C motif chemokine receptor 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CXCR2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 9:83,178,645...83,185,017
Ensembl chr 9:83,183,808...83,188,602
|
|
| G
|
Cxcr4
|
C-X-C motif chemokine receptor 4
|
multiple interactions increases expression
|
ISO EXP
|
[Glucose co-treated with Oxygen deficiency] results in decreased expression of CXCR4 mRNA; [Glucose co-treated with Oxygen deficiency] results in decreased expression of CXCR4 protein; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CXCR4 mRNA arsenic trioxide inhibits the reaction [Oxygen deficiency results in increased expression of CXCR4 mRNA]; arsenic trioxide inhibits the reaction [Oxygen deficiency results in increased expression of CXCR4 protein]; deguelin inhibits the reaction [Oxygen deficiency results in increased expression of CXCR4 mRNA] Oxygen deficiency results in increased expression of CXCR4 mRNA; Oxygen deficiency results in increased expression of CXCR4 protein Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of CXCR4 mRNA]; Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of CXCR4 protein]
|
CTD |
PMID:17476338 PMID:17517823 PMID:18227068 PMID:22745725 PMID:25047463 PMID:26476374 PMID:26516004 PMID:30529165 More...
|
|
NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459
|
|
| G
|
Cxcr5
|
C-X-C motif chemokine receptor 5
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CXCR5 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:53,738,878...53,756,813
Ensembl chr 8:53,740,197...53,754,816
|
|
| G
|
Cyba
|
cytochrome b-245 alpha chain
|
increases expression multiple interactions
|
ISO
|
Oxygen results in increased expression of CYBA mRNA; Oxygen results in increased expression of CYBA protein MIR34C promotes the reaction [Oxygen results in increased expression of CYBA mRNA]; SRT1720 inhibits the reaction [Oxygen results in decreased expression of CYBA mRNA]; SRT1720 inhibits the reaction [Oxygen results in decreased expression of CYBA protein]
|
CTD |
PMID:35848756 |
|
NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214
|
|
| G
|
Cybb
|
cytochrome b-245 beta chain
|
increases expression multiple interactions
|
EXP ISO
|
Oxygen deficiency results in increased expression of CYBB mRNA; Oxygen deficiency results in increased expression of CYBB protein Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of CYBB mRNA]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of CYBB protein] [CAV1 gene mutant form results in increased susceptibility to Oxygen deficiency] which results in increased expression of CYBB mRNA; [CAV1 gene mutant form results in increased susceptibility to Oxygen deficiency] which results in increased expression of CYBB protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CYBB protein; MIR34C promotes the reaction [Oxygen results in increased expression of CYBB mRNA]; MIR34C promotes the reaction [Oxygen results in increased expression of CYBB protein]; Prodigiosin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CYBB protein]; prolinedithiocarbamate inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CYBB protein] [Oxygen deficiency co-treated with Catechin] results in decreased expression of CYBB mRNA Oxygen results in increased expression of CYBB mRNA; Oxygen results in increased expression of CYBB protein
|
CTD |
PMID:21925195 PMID:24492474 PMID:24835767 PMID:35848756 PMID:35883890 |
|
NCBI chr X:16,030,596...16,065,065
Ensembl chr X:16,030,596...16,065,065
|
|
| G
|
Cybrd1
|
cytochrome b reductase 1
|
affects methylation increases expression multiple interactions
|
ISO
|
Oxygen deficiency affects the methylation of CYBRD1 promoter Oxygen deficiency results in increased expression of CYBRD1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CYBRD1 mRNA
|
CTD |
PMID:24205000 PMID:30529165 |
|
NCBI chr 3:76,342,231...76,369,846
Ensembl chr 3:76,342,404...76,370,061
|
|
| G
|
Cyc1
|
cytochrome c-1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CYC1 mRNA
|
CTD |
PMID:23539316 |
|
NCBI chr 7:109,947,750...109,950,142
Ensembl chr 7:109,947,766...109,950,657
|
|
| G
|
Cycs
|
cytochrome c, somatic
|
decreases expression multiple interactions affects expression increases expression
|
ISO EXP
|
Oxygen deficiency results in decreased expression of CYCS mRNA (2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide inhibits the reaction [[Apigenin co-treated with Oxygen deficiency] results in increased expression of CYCS protein]; [Apigenin co-treated with Oxygen deficiency] results in increased expression of CYCS protein; HIF1A protein inhibits the reaction [[Apigenin co-treated with Oxygen deficiency] results in increased expression of CYCS protein]; norwogonin inhibits the reaction [Oxygen deficiency results in increased expression of CYCS mRNA]; norwogonin inhibits the reaction [Oxygen deficiency results in increased expression of CYCS protein]; Rutin inhibits the reaction [Oxygen deficiency results in increased expression of CYCS mRNA]; Rutin inhibits the reaction [Oxygen deficiency results in increased expression of CYCS protein] Oxygen deficiency affects the expression of CYCS protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [euscaphic acid inhibits the reaction [Oxygen deficiency results in increased expression of CYCS protein]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of CYCS protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [tormentic acid inhibits the reaction [Oxygen deficiency results in increased expression of CYCS protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [euscaphic acid inhibits the reaction [Oxygen deficiency results in increased expression of CYCS protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of CYCS protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [tormentic acid inhibits the reaction [Oxygen deficiency results in increased expression of CYCS protein]]; bruceine D affects the reaction [Oxygen deficiency affects the expression of CYCS protein]; euscaphic acid inhibits the reaction [Oxygen deficiency results in increased expression of CYCS protein]; tormentic acid inhibits the reaction [Oxygen deficiency results in increased expression of CYCS protein] Oxygen deficiency results in increased expression of CYCS mRNA; Oxygen deficiency results in increased expression of CYCS protein
|
CTD |
PMID:26516004 PMID:31930969 PMID:32298737 PMID:33413359 PMID:34900531 |
|
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816 Ensembl chr18:80,982,668...80,984,816
|
|
| G
|
Cygb
|
cytoglobin
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CYGB mRNA
|
CTD |
PMID:35883890 |
|
NCBI chr10:102,376,506...102,386,272
Ensembl chr10:102,376,507...102,386,272
|
|
| G
|
Cyp19a1
|
cytochrome P450, family 19, subfamily a, polypeptide 1
|
multiple interactions affects expression
|
ISO
|
bazedoxifene affects the reaction [Oxygen deficiency affects the expression of CYP19A1 mRNA]
|
CTD |
PMID:28859903 |
|
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917
|
|
| G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
decreases expression increases activity multiple interactions increases response to substance increases expression affects expression decreases activity
|
ISO EXP
|
Oxygen deficiency results in decreased expression of CYP1A1 mRNA; Oxygen deficiency results in decreased expression of CYP1A1 protein Oxygen results in increased activity of CYP1A1 protein [Methylcholanthrene co-treated with Oxygen deficiency] results in increased expression of CYP1A1 mRNA; [Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in increased expression of CYP1A1 mRNA; [Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in increased expression of CYP1A1 protein; AHR mutant form inhibits the reaction [Oxygen results in increased expression of CYP1A1 mRNA]; CYP1A2 gene mutant form inhibits the reaction [beta-Naphthoflavone promotes the reaction [Oxygen results in increased expression of CYP1A1 mRNA]]; CYP1A2 gene mutant form inhibits the reaction [Oxygen promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 protein]]; Oxygen deficiency affects the reaction [CYP1A1 protein results in increased metabolism of aristolochic acid I]; Oxygen deficiency affects the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; Oxygen deficiency inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A1 mRNA]; Oxygen deficiency inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A1 protein]; Oxygen deficiency inhibits the reaction [Acetaminophen results in increased expression of CYP1A1 mRNA]; Oxygen deficiency inhibits the reaction [AHR protein binds to CYP1A1 promoter]; Oxygen deficiency inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; Oxygen deficiency inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; Oxygen deficiency inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein]; Oxygen deficiency promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] [beta-Naphthoflavone results in increased expression of CYP1A2 protein] inhibits the reaction [CYP1A1 gene mutant form results in increased susceptibility to Oxygen]; [beta-Naphthoflavone results in increased expression of NQO1 protein] inhibits the reaction [CYP1A1 gene mutant form results in increased susceptibility to Oxygen]; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CYP1A1 mRNA; [Quercetin co-treated with Oxygen] results in increased expression of CYP1A1 mRNA; [Quercetin co-treated with Oxygen] results in increased expression of CYP1A1 protein; AHR protein affects the reaction [Oxygen results in increased expression of CYP1A1 protein]; beta-Naphthoflavone inhibits the reaction [CYP1A1 gene mutant form results in increased susceptibility to Oxygen]; beta-Naphthoflavone promotes the reaction [Oxygen results in increased activity of CYP1A1 protein]; beta-Naphthoflavone promotes the reaction [Oxygen results in increased expression of CYP1A1 mRNA]; beta-Naphthoflavone promotes the reaction [Oxygen results in increased expression of CYP1A1 protein]; CYP1A1 gene mutant form promotes the reaction [Oxygen results in increased abundance of F2-Isoprostanes]; CYP1A1 gene mutant form promotes the reaction [Oxygen results in increased expression of IL6 mRNA]; Omeprazole inhibits the reaction [Oxygen results in increased expression of CYP1A1 protein]; Omeprazole promotes the reaction [Oxygen results in decreased expression of CYP1A1 mRNA]; Oxygen deficiency inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein]; Oxygen inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Oxygen inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 protein]; Oxygen promotes the reaction [beta-Naphthoflavone results in increased activity of CYP1A1 protein]; Oxygen promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; Oxygen promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 protein]; Oxygen results in increased expression of and results in increased activity of CYP1A1 protein Oxygen results in increased expression of CYP1A1 mRNA; Oxygen results in increased expression of CYP1A1 protein Oxygen deficiency results in increased expression of CYP1A1 mRNA; Oxygen results in increased expression of CYP1A1 mRNA Oxygen deficiency affects the expression of CYP1A1 mRNA 1-aminobenzotriazole inhibits the reaction [Oxygen results in increased activity of CYP1A1 protein]; [1-aminobenzotriazole co-treated with Oxygen] results in increased activity of CYP1A1 protein; [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with zinc protoporphyrin] results in increased expression of CYP1A1 protein; [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in decreased expression of CYP1A1 protein; [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of CYP1A1 protein; [Benzo(a)pyrene co-treated with Oxygen] affects the expression of CYP1A1 protein; Hemin inhibits the reaction [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in decreased expression of CYP1A1 protein]; Hemin inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of CYP1A1 protein]; Oxygen deficiency affects the reaction [CYP1A1 protein results in increased metabolism of aristolochic acid I]; Oxygen deficiency inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; Oxygen deficiency inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein]; Oxygen inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; Oxygen results in increased expression of and results in increased activity of CYP1A1 protein Oxygen deficiency results in decreased activity of CYP1A1 protein
|
CTD |
PMID:10570039 PMID:10640292 PMID:17599377 PMID:18072750 PMID:19154183 PMID:20610613 PMID:21745492 PMID:23337360 PMID:24355420 PMID:24657529 PMID:24893714 PMID:25596134 PMID:25703676 PMID:25831079 PMID:26272953 PMID:26516004 PMID:26747958 PMID:26845733 PMID:28201809 PMID:29180065 PMID:29432836 PMID:30529165 PMID:32416225 PMID:33811995 More...
|
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
| G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
decreases expression multiple interactions increases activity increases expression increases response to substance
|
ISO EXP
|
Oxygen deficiency results in decreased expression of CYP1A2 mRNA [beta-Naphthoflavone results in increased expression of CYP1A2 protein] inhibits the reaction [CYP1A1 gene mutant form results in increased susceptibility to Oxygen]; [beta-Naphthoflavone results in increased expression of CYP1A2 protein] which results in decreased susceptibility to Oxygen; [Quercetin co-treated with Oxygen] results in increased expression of CYP1A2 mRNA; beta-Naphthoflavone promotes the reaction [Oxygen results in increased activity of CYP1A2 protein]; beta-Naphthoflavone promotes the reaction [Oxygen results in increased expression of CYP1A2 mRNA]; Oxygen inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 protein]; Oxygen promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 mRNA] [CYP1A2 gene mutant form results in increased susceptibility to Oxygen] which results in increased expression of NQO1 mRNA; CYP1A2 gene mutant form inhibits the reaction [beta-Naphthoflavone promotes the reaction [Oxygen results in increased expression of CYP1A1 mRNA]]; CYP1A2 gene mutant form inhibits the reaction [Oxygen promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 protein]]; CYP1A2 gene mutant form inhibits the reaction [Oxygen promotes the reaction [beta-Naphthoflavone results in increased expression of NQO1 protein]]; Oxygen deficiency affects the reaction [CYP1A2 protein results in increased metabolism of aristolochic acid I]; Oxygen deficiency affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]; Oxygen deficiency inhibits the reaction [Acetaminophen results in increased expression of CYP1A2 mRNA]; Oxygen deficiency inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA] [1-aminobenzotriazole co-treated with Oxygen] results in increased activity of CYP1A2 protein; [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with Hemin] results in decreased expression of CYP1A2 protein; [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with zinc protoporphyrin] results in increased expression of CYP1A2 protein; [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in decreased expression of CYP1A2 protein; [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of CYP1A2 protein; [Oxygen co-treated with 1-aminobenzotriazole] results in increased expression of CYP1A2 protein; Hemin inhibits the reaction [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in decreased expression of CYP1A2 protein]; Hemin inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of CYP1A2 protein]; Oxygen deficiency affects the reaction [CYP1A2 protein results in increased metabolism of aristolochic acid I]; Oxygen inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] Oxygen deficiency results in increased expression of CYP1A2 mRNA
|
CTD |
PMID:10640292 PMID:19695866 PMID:21745492 PMID:24657529 PMID:25703676 PMID:26747958 PMID:26845733 PMID:28201809 PMID:29180065 PMID:29432836 PMID:33811995 More...
|
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
|
|
| G
|
Cyp1b1
|
cytochrome P450, family 1, subfamily b, polypeptide 1
|
multiple interactions decreases expression increases expression decreases response to substance
|
ISO EXP
|
[Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of CYP1B1 protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of CYP1B1 protein; Oxygen deficiency inhibits the reaction [AHR protein binds to CYP1B1 promoter] [Benzo(a)pyrene co-treated with Oxygen] affects the expression of CYP1B1 protein Oxygen deficiency results in decreased expression of CYP1B1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CYP1B1 mRNA; [Quercetin co-treated with Oxygen] results in increased expression of CYP1B1 mRNA; CYP1B1 gene mutant form promotes the reaction [Oxygen results in increased secretion of VEGFA protein] Oxygen results in increased expression of CYP1B1 mRNA CYP1B1 gene mutant form results in decreased susceptibility to Oxygen
|
CTD |
PMID:24355420 PMID:24657529 PMID:25596134 PMID:28400208 PMID:29432836 PMID:29939353 PMID:30529165 More...
|
|
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
|
|
| G
|
Cyp26b1
|
cytochrome P450, family 26, subfamily b, polypeptide 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CYP26B1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 4:118,599,356...118,616,176
Ensembl chr 4:118,599,356...118,616,176
|
|
| G
|
Cyp27a1
|
cytochrome P450, family 27, subfamily a, polypeptide 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CYP27A1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:83,713,293...83,743,215
|
|
| G
|
Cyp27b1
|
cytochrome P450, family 27, subfamily b, polypeptide 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CYP27B1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 7:64,756,626...64,761,570
Ensembl chr 7:64,756,626...64,761,570
|
|
| G
|
Cyp2b1
|
cytochrome P450, family 2, subfamily b, polypeptide 1
|
multiple interactions decreases activity
|
EXP
|
[[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with Hemin] results in decreased expression of CYP2B1 protein; [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with zinc protoporphyrin] results in increased expression of CYP2B1 protein; [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in decreased expression of CYP2B1 protein; [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of CYP2B1 protein; [Oxygen co-treated with N-benzyl-1-aminobenzotriazole] results in decreased activity of CYP2B1 protein; Ethanol promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of CYP2B1 protein]; Hemin inhibits the reaction [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in decreased expression of CYP2B1 protein]; Hemin inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of CYP2B1 protein] Oxygen deficiency results in decreased activity of CYP2B1 protein
|
CTD |
PMID:10640292 PMID:26747958 PMID:32416225 |
|
NCBI chr 1:90,646,098...90,669,762
|
|
| G
|
Cyp2c24
|
cytochrome P450, family 2, subfamily c, polypeptide 24
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CYP2C55 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 1:246,286,341...246,348,607
Ensembl chr 1:246,286,341...246,348,607
|
|
| G
|
Cyp2d4
|
cytochrome P450, family 2, subfamily d, polypeptide 4
|
multiple interactions
|
ISO
|
CYP2D6 protein inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA]; CYP2D6 protein inhibits the reaction [Oxygen deficiency results in increased expression of VEGFA mRNA]
|
CTD |
PMID:21566342 |
|
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837
|
|
| G
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1
|
decreases expression multiple interactions increases expression
|
ISO EXP
|
Oxygen deficiency results in decreased expression of CYP2E1 mRNA [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with zinc protoporphyrin] results in increased expression of CYP2E1 mRNA; [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with zinc protoporphyrin] results in increased expression of CYP2E1 protein; [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in increased expression of CYP2E1 mRNA; [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in increased expression of CYP2E1 protein; [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of CYP2E1 mRNA; [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of CYP2E1 protein; Ethanol promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of CYP2E1 mRNA]; Ethanol promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of CYP2E1 protein]; Hemin inhibits the reaction [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in increased expression of CYP2E1 mRNA]; Hemin inhibits the reaction [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in increased expression of CYP2E1 protein]; Hemin inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of CYP2E1 mRNA]; Hemin inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of CYP2E1 protein]; zinc protoporphyrin promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of CYP2E1 mRNA]; zinc protoporphyrin promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of CYP2E1 protein] Oxygen deficiency inhibits the reaction [Acetaminophen results in increased expression of CYP2E1 mRNA] Oxygen deficiency results in increased expression of CYP2E1 mRNA
|
CTD |
PMID:19695866 PMID:26747958 PMID:33811995 |
|
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
|
|
| G
|
Cyp2s1
|
cytochrome P450, family 2, subfamily s, polypeptide 1
|
multiple interactions
|
ISO
|
Oxygen affects the reaction [CYP2S1 protein results in increased reduction of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole metabolite]
|
CTD |
PMID:23682735 |
|
NCBI chr 1:90,437,741...90,453,073
Ensembl chr 1:90,438,224...90,453,073
|
|
| G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of CYP3A4 mRNA [[CYP3A4 protein co-treated with Oxygen co-treated with NADP] results in increased reduction of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 1,4-dihydroxy-2-nonene; [CYP3A4 protein co-treated with Oxygen co-treated with NADP] results in increased reduction of and results in increased oxidation of 4-hydroxy-2-nonenal; CYP3A4 protein promotes the reaction [Oxygen deficiency results in increased expression of EPO mRNA]; CYP3A4 protein promotes the reaction [Oxygen deficiency results in increased expression of VEGFA mRNA]; Ketoconazole inhibits the reaction [CYP3A4 protein promotes the reaction [Oxygen deficiency results in increased expression of EPO mRNA]]; Ketoconazole inhibits the reaction [CYP3A4 protein promotes the reaction [Oxygen deficiency results in increased expression of VEGFA mRNA]]; Oxygen deficiency inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Paclitaxel]; Oxygen deficiency inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Testosterone]; Oxygen deficiency results in decreased expression of and results in decreased activity of CYP3A4 protein
|
CTD |
PMID:19695866 PMID:21566342 PMID:21766881 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|
| G
|
Cyp4f18
|
cytochrome P450, family 4, subfamily f, polypeptide 18
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CYP4F18 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr16:17,797,558...17,838,958
Ensembl chr16:17,740,001...17,838,958
|
|
| G
|
Cyp4v3
|
cytochrome P450, family 4, subfamily v, polypeptide 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CYP4V3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr16:53,650,978...53,675,916
Ensembl chr16:53,650,569...53,676,746
|
|
| G
|
Cyp51
|
cytochrome P450, family 51
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CYP51 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:30,991,693...31,010,147
Ensembl chr 4:30,991,613...31,010,450
|
|
| G
|
Cyp7a1
|
cytochrome P450 family 7 subfamily A member 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of CYP7A1 mRNA
|
CTD |
PMID:19695866 |
|
NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:24,174,505...24,184,202
|
|
| G
|
Cyp7b1
|
cytochrome P450 family 7 subfamily B member 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CYP7B1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:102,419,011...102,586,047
Ensembl chr 2:102,419,011...102,451,804
|
|
| G
|
Cyria
|
CYFIP related Rac1 interactor A
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CYRIA mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:40,774,165...40,883,005
Ensembl chr 6:40,774,171...40,881,860
|
|
| G
|
Cys1
|
cystin 1
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of CYS1 mRNA [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CYS1 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CYS1 mRNA
|
CTD |
PMID:20880076 PMID:33729688 |
|
NCBI chr 6:47,029,440...47,046,671
Ensembl chr 6:47,028,461...47,046,671
|
|
| G
|
Cysltr1
|
cysteinyl leukotriene receptor 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CYSLTR1 mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr X:75,734,281...75,762,873
Ensembl chr X:75,734,270...75,763,050
|
|
| G
|
Cytip
|
cytohesin 1 interacting protein
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of CYTIP mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CYTIP mRNA
|
CTD |
PMID:20880076 PMID:33729688 |
|
NCBI chr 3:63,106,895...63,183,769
Ensembl chr 3:63,107,607...63,134,832
|
|
| G
|
Dag1
|
dystroglycan 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DAG1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:117,769,517...117,834,347
Ensembl chr 8:117,769,517...117,782,199
|
|
| G
|
Dapk2
|
death-associated protein kinase 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DAPK2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:75,601,621...75,720,619
Ensembl chr 8:75,601,634...75,720,617
|
|
| G
|
Dapk3
|
death-associated protein kinase 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DAPK3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:9,174,903...9,183,272
Ensembl chr 7:9,174,904...9,183,272
|
|
| G
|
Daw1
|
dynein assembly factor with WD repeats 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of DAW1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 9:91,883,656...91,920,733
Ensembl chr 9:91,881,067...91,921,349
|
|
| G
|
Dbf4
|
DBF4-CDC7 kinase regulatory subunit
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of DBF4 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DBF4 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 4:26,631,491...26,656,080
Ensembl chr 4:26,631,514...26,656,562
|
|
| G
|
Dbn1
|
drebrin 1
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of DBN1 protein [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DBN1 mRNA
|
CTD |
PMID:25937538 PMID:30529165 |
|
NCBI chr17:9,155,729...9,170,121
Ensembl chr17:9,155,787...9,170,122
|
|
| G
|
Dbp
|
D-box binding PAR bZIP transcription factor
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of DBP mRNA Simvastatin inhibits the reaction [Oxygen deficiency results in increased expression of DBP mRNA] [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of DBP mRNA
|
CTD |
PMID:16373842 PMID:33729688 |
|
NCBI chr 1:105,312,256...105,317,205
Ensembl chr 1:105,312,108...105,317,205
|
|
| G
|
Dcaf7
|
DDB1 and CUL4 associated factor 7
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of DCAF7 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:91,473,900...91,496,080
Ensembl chr10:91,473,900...91,496,080
|
|
| G
|
Dcc
|
DCC netrin 1 receptor
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of DCC mRNA
|
CTD |
PMID:17914565 |
|
NCBI chr18:67,144,272...68,248,159
Ensembl chr18:67,149,179...68,247,541
|
|
| G
|
Dclk1
|
doublecortin-like kinase 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DCLK1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:141,567,215...141,861,088
Ensembl chr 2:141,571,983...141,861,090
|
|
| G
|
Dclre1b
|
DNA cross-link repair 1B
|
increases expression multiple interactions decreases expression
|
ISO
|
Oxygen deficiency results in increased expression of DCLRE1B mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of DCLRE1B mRNA] Oxygen deficiency results in decreased expression of DCLRE1B mRNA
|
CTD |
PMID:22629407 PMID:26516004 |
|
NCBI chr 2:193,998,350...194,006,873
Ensembl chr 2:193,998,354...194,006,864
|
|
| G
|
Dcp2
|
decapping mRNA 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of DCP2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr18:37,001,615...37,037,949
Ensembl chr18:37,001,615...37,049,939
|
|
| G
|
Dcstamp
|
dendrocyte expressed seven transmembrane protein
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of DCSTAMP mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 7:72,692,364...72,706,983
Ensembl chr 7:72,671,477...72,707,009
|
|
| G
|
Dctd
|
dCMP deaminase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DCTD mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr16:50,799,699...50,831,398
Ensembl chr16:50,787,875...50,831,186
|
|
| G
|
Dctpp1
|
dCTP pyrophosphatase 1
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of DCTPP1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DCTPP1 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 1:191,307,933...191,311,326
Ensembl chr 1:191,307,935...191,313,405
|
|
| G
|
Dcun1d1
|
defective in cullin neddylation 1 domain containing 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of DCUN1D1 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of DCUN1D1 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 2:120,649,445...120,700,879
Ensembl chr 2:120,649,445...120,700,870
|
|
| G
|
Dcun1d2
|
defective in cullin neddylation 1 domain containing 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of DCUN1D2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr16:82,956,493...82,983,308
Ensembl chr16:82,956,339...82,983,307
|
|
| G
|
Ddah1
|
dimethylarginine dimethylaminohydrolase 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DDAH1 mRNA; [sulforaphane affects the susceptibility to Oxygen] which affects the expression of DDAH1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:237,327,812...237,460,624
Ensembl chr 2:237,327,766...237,460,626
|
|
| G
|
Ddah2
|
DDAH family member 2, ADMA-independent
|
decreases expression increases expression
|
EXP
|
Oxygen deficiency results in decreased expression of DDAH2 protein Oxygen deficiency results in increased expression of DDAH2 mRNA
|
CTD |
PMID:27313889 |
|
NCBI chr20:3,766,115...3,769,161
Ensembl chr20:3,766,120...3,769,183
|
|
| G
|
Ddb2
|
damage specific DNA binding protein 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of DDB2 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 3:97,640,923...97,667,617
Ensembl chr 3:97,640,579...97,664,066
|
|
| G
|
Ddc
|
dopa decarboxylase
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of DDC mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of DDC mRNA
|
CTD |
PMID:19695866 PMID:33729688 |
|
NCBI chr14:90,592,304...90,682,830
Ensembl chr14:90,592,304...90,682,806
|
|
| G
|
Ddit3
|
DNA-damage inducible transcript 3
|
multiple interactions increases expression
|
EXP ISO
|
4-chlorobenzyltetrahydroberberine inhibits the reaction [Oxygen deficiency results in increased expression of DDIT3 mRNA]; 4-chlorobenzyltetrahydroberberine inhibits the reaction [Oxygen deficiency results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Oxygen deficiency results in increased expression of DDIT3 protein]; [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in increased expression of DDIT3 protein; [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of DDIT3 protein; Ethanol promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of DDIT3 protein]; Hemin inhibits the reaction [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in increased expression of DDIT3 protein]; Hemin inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of DDIT3 protein]; Nifedipine inhibits the reaction [Oxygen deficiency results in increased expression of DDIT3 mRNA]; Nifedipine inhibits the reaction [Oxygen deficiency results in increased expression of DDIT3 protein]; zinc protoporphyrin promotes the reaction [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in increased expression of DDIT3 protein]; zinc protoporphyrin promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of DDIT3 protein] Oxygen deficiency results in increased expression of DDIT3 mRNA; Oxygen deficiency results in increased expression of DDIT3 protein
|
CTD |
PMID:14604972 PMID:21337367 PMID:22226148 PMID:24680926 PMID:25351418 PMID:25450231 PMID:25596134 PMID:26747958 More...
|
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
| G
|
Ddit4
|
DNA-damage-inducible transcript 4
|
multiple interactions decreases expression increases expression
|
ISO
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of DDIT4 mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of DDIT4 protein]; Oxygen deficiency promotes the reaction [HIF1A protein binds to DDIT4 promoter]; SP1 protein affects the reaction [Oxygen deficiency results in increased expression of DDIT4 mRNA] Oxygen results in decreased expression of DDIT4 protein Oxygen deficiency results in increased expression of DDIT4 mRNA; Oxygen deficiency results in increased expression of DDIT4 protein [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DDIT4 mRNA
|
CTD |
PMID:17307335 PMID:19587783 PMID:23880069 PMID:24236059 PMID:25596134 PMID:26516004 PMID:30529165 More...
|
|
NCBI chr20:28,434,938...28,437,037
Ensembl chr20:28,434,944...28,437,037
|
|
| G
|
Ddn
|
dendrin
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of DDN mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 7:131,832,270...131,836,252
Ensembl chr 7:131,832,271...131,836,294
|
|
| G
|
Ddx11
|
DEAD/H-box helicase 11
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of DDX11 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 9:113,204,886...113,309,692
Ensembl chr 9:113,276,985...113,316,152
|
|
| G
|
Ddx17
|
DEAD-box helicase 17
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of DDX17 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 7:112,971,522...112,989,747
Ensembl chr 7:112,971,523...112,989,747
|
|
| G
|
Ddx21
|
DExD-box helicase 21
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DDX21 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr20:31,077,044...31,097,238
Ensembl chr20:31,077,045...31,097,238
|
|
| G
|
Ddx27
|
DEAD-box helicase 27
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DDX27 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:176,163,220...176,182,418
Ensembl chr 3:176,163,203...176,182,410
|
|
| G
|
Ddx28
|
DEAD-box helicase 28
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of DDX28 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr19:50,819,643...50,821,573
Ensembl chr19:50,819,313...50,822,803
|
|
| G
|
Ddx39a
|
DExD-box helicase 39A
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DDX39A mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:41,323,465...41,331,413
Ensembl chr19:41,322,836...41,332,306
|
|
| G
|
Ddx52
|
DExD-box helicase 52
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of DDX52 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr10:69,322,062...69,344,856
Ensembl chr10:69,322,114...69,428,714
|
|
| G
|
Ddx56
|
DEAD-box helicase 56
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DDX56 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:85,325,942...85,336,262
Ensembl chr14:85,325,942...85,336,262
|
|
| G
|
Ddx59
|
DEAD-box helicase 59
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DDX59 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr13:50,427,940...50,452,893
Ensembl chr13:50,427,936...50,453,208
|
|
| G
|
Ddx6
|
DEAD-box helicase 6
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DDX6 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:53,827,661...53,864,538
Ensembl chr 8:53,827,835...53,860,977
|
|
| G
|
Dennd10
|
DENN domain containing 10
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of DENND10 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 1:269,937,023...269,960,506
Ensembl chr 1:269,936,895...269,962,853
|
|
| G
|
Dennd2a
|
DENN domain containing 2A
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of DENND2A mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 4:69,199,814...69,299,128
Ensembl chr 4:69,199,814...69,298,984
|
|
| G
|
Dennd4c
|
DENN domain containing 4C
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DENND4C mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:106,316,942...106,421,484
Ensembl chr 5:106,318,281...106,415,489
|
|
| G
|
Denr
|
density regulated reinitiation and release factor
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DENR mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr12:38,323,433...38,346,207
Ensembl chr12:38,323,445...38,344,797
|
|
| G
|
Derl3
|
derlin 3
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of DERL3 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr20:12,753,926...12,766,478
Ensembl chr20:12,762,981...12,766,477
|
|
| G
|
Des
|
desmin
|
increases expression multiple interactions
|
EXP ISO
|
Oxygen results in increased expression of DES mRNA [Oxygen deficiency co-treated with Oxygen] results in decreased expression of DES protein; diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of DES protein]
|
CTD |
PMID:22911455 PMID:28157488 |
|
NCBI chr 9:84,299,626...84,307,344
Ensembl chr 9:84,298,447...84,307,347
|
|
| G
|
Dgka
|
diacylglycerol kinase, alpha
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of DGKA mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 7:1,733,247...1,761,181
Ensembl chr 7:1,733,248...1,759,569
|
|
| G
|
Dgkb
|
diacylglycerol kinase, beta
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of DGKB mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 6:60,368,101...61,124,420
Ensembl chr 6:60,368,519...61,124,420
|
|
| G
|
Dgkz
|
diacylglycerol kinase zeta
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DGKZ mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:98,359,804...98,401,847
Ensembl chr 3:98,359,804...98,401,951
|
|
| G
|
Dhcr24
|
24-dehydrocholesterol reductase
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of DHCR24 mRNA; Oxygen results in decreased expression of DHCR24 mRNA [sulforaphane affects the susceptibility to Oxygen] which affects the expression of DHCR24 mRNA
|
CTD |
PMID:26516004 PMID:27103661 PMID:30529165 |
|
NCBI chr 5:126,573,366...126,599,940
Ensembl chr 5:126,573,338...126,599,936
|
|
| G
|
Dhh
|
desert hedgehog signaling molecule
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of DHH mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 7:131,929,857...131,935,352
Ensembl chr 7:131,929,857...131,935,352
|
|
| G
|
Dhodh
|
dihydroorotate dehydrogenase
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of DHODH mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr19:54,460,636...54,483,049
Ensembl chr19:54,468,690...54,514,496
|
|
| G
|
Dhps
|
deoxyhypusine synthase
|
multiple interactions
|
EXP
|
DHPS protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
|
CTD |
PMID:21124846 |
|
NCBI chr19:39,987,328...39,991,418
Ensembl chr19:39,987,324...39,991,432
|
|
| G
|
Dhrs3
|
dehydrogenase/reductase 3
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of DHRS3 mRNA 1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of DHRS3 mRNA] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DHRS3 mRNA
|
CTD |
PMID:24403227 PMID:30529165 |
|
NCBI chr 5:162,031,853...162,065,655
Ensembl chr 5:162,031,386...162,065,653
|
|
| G
|
Dhrs7c
|
dehydrogenase/reductase 7C
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DHRS7C mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:52,994,205...53,012,281
Ensembl chr10:52,994,205...53,012,281
|
|
| G
|
Dhrs9
|
dehydrogenase/reductase 9
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of DHRS9 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of DHRS9 mRNA
|
CTD |
PMID:26516004 PMID:33729688 |
|
NCBI chr 3:74,553,357...74,579,535
Ensembl chr 3:74,555,606...74,581,376
|
|
| G
|
Dhx35
|
DEAH-box helicase 35
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DHX35 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:167,869,971...167,927,300
Ensembl chr 3:167,870,055...167,927,300
|
|
| G
|
Dhx37
|
DEAH-box helicase 37
|
affects expression multiple interactions
|
ISO
|
Oxygen deficiency affects the expression of DHX37 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DHX37 mRNA
|
CTD |
PMID:25596134 PMID:30529165 |
|
NCBI chr12:36,856,119...36,876,245
Ensembl chr12:36,849,701...36,876,240
|
|
| G
|
Dhx58
|
DEXH-box helicase 58
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of DHX58 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of DHX58 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr10:86,120,677...86,132,095
Ensembl chr10:86,120,677...86,131,844
|
|
| G
|
Diablo
|
diablo, IAP-binding mitochondrial protein
|
multiple interactions
|
ISO
|
3-hydroxy-4-pentenoic acid promotes the reaction [Oxygen deficiency results in increased secretion of DIABLO protein]
|
CTD |
PMID:17671207 |
|
NCBI chr12:38,716,668...38,731,285
Ensembl chr12:38,716,668...38,731,265
|
|
| G
|
Diaph3
|
diaphanous-related formin 3
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DIAPH3 mRNA [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of DIAPH3 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of DIAPH3 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr15:68,951,992...69,421,623
Ensembl chr15:68,951,989...69,421,552
|
|
| G
|
Dicer1
|
dicer 1 ribonuclease III
|
multiple interactions decreases expression
|
ISO
|
DICER1 protein inhibits the reaction [Oxygen deficiency results in decreased cleavage of MIR200A mRNA]; DICER1 protein inhibits the reaction [Oxygen deficiency results in decreased cleavage of MIR200B mRNA]; DICER1 protein inhibits the reaction [Oxygen deficiency results in decreased cleavage of MIR429 mRNA]; DICER1 protein inhibits the reaction [Oxygen deficiency results in decreased expression of CDH1 mRNA]; DICER1 protein inhibits the reaction [Oxygen deficiency results in increased expression of ZEB1 mRNA]; Oxygen deficiency promotes the reaction [EZH2 protein binds to DICER1 promoter]; Oxygen deficiency promotes the reaction [KDM6A protein binds to DICER1 promoter]; Oxygen deficiency promotes the reaction [KDM6B protein binds to DICER1 promoter] Oxygen deficiency results in decreased expression of DICER1 mRNA; Oxygen deficiency results in decreased expression of DICER1 protein
|
CTD |
PMID:25351418 |
|
NCBI chr 6:129,392,298...129,457,252
Ensembl chr 6:129,396,014...129,457,252
|
|
| G
|
Dimt1
|
DIM1 rRNA methyltransferase and ribosome maturation factor
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of DIMT1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:40,076,622...40,101,792
Ensembl chr 2:40,076,570...40,101,787
|
|
| G
|
Dio2
|
iodothyronine deiodinase 2
|
multiple interactions
|
EXP ISO
|
diphenyleneiodonium inhibits the reaction [Oxygen deficiency results in increased activity of DIO2 protein]; Oxygen deficiency results in decreased degradation of and results in increased activity of DIO2 protein [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DIO2 mRNA
|
CTD |
PMID:17615150 PMID:30529165 |
|
NCBI chr 6:115,396,308...115,410,594
Ensembl chr 6:115,396,308...115,410,594
|
|
| G
|
Dip2c
|
disco-interacting protein 2 homolog C
|
affects methylation increases expression
|
ISO
|
Oxygen deficiency affects the methylation of DIP2C promoter Oxygen deficiency results in increased expression of DIP2C mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr17:65,338,711...65,724,111
Ensembl chr17:65,338,711...65,723,344
|
|
| G
|
Dis3
|
DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DIS3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr15:82,231,922...82,258,299
Ensembl chr15:82,231,283...82,258,333
|
|
| G
|
Disp2
|
dispatched RND transporter family member 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DISP2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:126,216,194...126,231,724
Ensembl chr 3:126,216,218...126,231,711
|
|
| G
|
Dixdc1
|
DIX domain containing 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DIXDC1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:59,904,218...59,977,595
Ensembl chr 8:59,904,218...59,978,447
|
|
| G
|
Dkk3
|
dickkopf WNT signaling pathway inhibitor 3
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of DKK3 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:175,672,834...175,715,867
Ensembl chr 1:175,672,834...175,715,186
|
|
| G
|
Dld
|
dihydrolipoamide dehydrogenase
|
increases abundance multiple interactions
|
EXP
|
DLD protein results in increased abundance of Oxygen Hydrogen Peroxide promotes the reaction [DLD protein results in increased abundance of Oxygen]
|
CTD |
PMID:1454754 |
|
NCBI chr 6:53,631,686...53,655,059
Ensembl chr 6:53,619,631...53,652,354
|
|
| G
|
Dlg1
|
discs large MAGUK scaffold protein 1
|
increases expression affects methylation
|
ISO
|
Oxygen deficiency results in increased expression of DLG1 mRNA Oxygen deficiency affects the methylation of DLG1 promoter
|
CTD |
PMID:24205000 |
|
NCBI chr11:82,416,853...82,607,797
Ensembl chr11:82,416,853...82,607,797
|
|
| G
|
Dlg2
|
discs large MAGUK scaffold protein 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of DLG2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:153,864,545...155,916,238
Ensembl chr 1:153,865,299...155,916,215
|
|
| G
|
Dlg3
|
discs large MAGUK scaffold protein 3
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of DLG3 protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of DLG3 protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of DLG3 protein]
|
CTD |
PMID:24718106 |
|
NCBI chr X:69,899,694...69,951,928
Ensembl chr X:69,900,003...69,950,696
|
|
| G
|
Dlgap5
|
DLG associated protein 5
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of DLGAP5 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of DLGAP5 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr15:23,113,678...23,144,281
Ensembl chr15:23,113,678...23,144,176
|
|
| G
|
Dll1
|
delta like canonical Notch ligand 1
|
increases expression
|
EXP ISO
|
Oxygen deficiency results in increased expression of DLL1 mRNA; Oxygen deficiency results in increased expression of DLL1 protein
|
CTD |
PMID:24223152 PMID:25596134 |
|
NCBI chr 1:64,985,161...64,993,274
Ensembl chr 1:64,985,161...64,993,276
|
|
| G
|
Dll4
|
delta like canonical Notch ligand 4
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of DLL4 mRNA cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [Oxygen results in increased expression of DLL4 mRNA]
|
CTD |
PMID:25203536 PMID:26516004 |
|
NCBI chr 3:126,770,945...126,780,769
Ensembl chr 3:126,770,794...126,780,763
|
|
| G
|
Dlx1
|
distal-less homeobox 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of DLX1 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 3:76,763,864...76,768,454
Ensembl chr 3:76,763,500...76,768,447
|
|
| G
|
Dmac2
|
distal membrane arm assembly component 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of DMAC2 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 1:90,250,262...90,262,592
Ensembl chr 1:90,243,532...90,262,594
|
|
| G
|
Dmd
|
dystrophin
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DMD mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr X:51,070,098...53,437,845
Ensembl chr X:51,070,273...53,437,835
|
|
| G
|
Dmp1
|
dentin matrix acidic phosphoprotein 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of DMP1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr14:5,833,111...5,867,154
Ensembl chr14:5,833,111...5,843,993
|
|
| G
|
Dmtn
|
dematin actin binding protein
|
multiple interactions increases expression
|
ISO
|
Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of DMTN mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr15:52,087,667...52,111,956
Ensembl chr15:52,087,667...52,112,128
|
|
| G
|
Dnah11
|
dynein, axonemal, heavy chain 11
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of DNAH11 mRNA
|
CTD |
PMID:24236059 PMID:26516004 |
|
NCBI chr 6:144,982,130...145,298,523
Ensembl chr 6:144,973,797...145,298,692
|
|
| G
|
Dnah14
|
dynein axonemal heavy chain 14
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of DNAH14 mRNA
|
CTD |
PMID:17175027 |
|
NCBI chr13:95,853,735...96,070,327
Ensembl chr13:95,854,534...96,070,330
|
|
| G
|
Dnah5
|
dynein, axonemal, heavy chain 5
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of DNAH5 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 2:80,668,182...80,985,918
Ensembl chr 2:80,668,208...80,985,914
|
|
| G
|
Dnah8
|
dynein, axonemal, heavy chain 8
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of DNAH8 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DNAH8 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr20:8,694,371...8,948,849
Ensembl chr20:8,694,398...8,948,849
|
|
| G
|
Dnai3
|
dynein axonemal intermediate chain 3
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of DNAI3 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 2:237,608,202...237,666,465
Ensembl chr 2:237,604,068...237,666,465
|
|
| G
|
Dnaja1
|
DnaJ heat shock protein family (Hsp40) member A1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of DNAJA1 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 5:60,638,404...60,649,315
Ensembl chr 5:60,638,410...60,650,160
|
|
| G
|
Dnaja4
|
DnaJ heat shock protein family (Hsp40) member A4
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DNAJA4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:63,975,177...63,998,836
Ensembl chr 8:63,981,559...63,998,836
|
|
| G
|
Dnajb2
|
DnaJ heat shock protein family (Hsp40) member B2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of DNAJB2 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 9:84,179,702...84,187,942
Ensembl chr 9:84,179,695...84,187,942
|
|
| G
|
Dnajb6
|
DnaJ heat shock protein family (Hsp40) member B6
|
multiple interactions increases expression
|
ISO
|
Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of DNAJB6 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 4:6,010,081...6,232,052
Ensembl chr 4:6,128,070...6,232,005
|
|
| G
|
Dnajb9
|
DnaJ heat shock protein family (Hsp40) member B9
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of DNAJB9 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 6:66,997,842...67,007,371
Ensembl chr 6:66,997,842...67,009,344
|
|
| G
|
Dnajc11
|
DnaJ heat shock protein family (Hsp40) member C11
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DNAJC11 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:167,724,776...167,770,032
Ensembl chr 5:167,724,717...167,770,694
|
|
| G
|
Dnajc17
|
DnaJ heat shock protein family (Hsp40) member C17
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of DNAJC17 mRNA [sulforaphane affects the susceptibility to Oxygen] which affects the expression of DNAJC17 mRNA; Oxygen inhibits the reaction [Oxygen deficiency results in decreased expression of DNAJC17 mRNA]
|
CTD |
PMID:22629407 PMID:30529165 |
|
NCBI chr 3:126,616,043...126,649,599
Ensembl chr 3:126,616,051...126,649,656
|
|
| G
|
Dnajc28
|
DnaJ heat shock protein family (Hsp40) member C28
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DNAJC28 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr11:44,341,528...44,344,348
Ensembl chr11:44,338,646...44,344,482
|
|
| G
|
Dnajc9
|
DnaJ heat shock protein family (Hsp40) member C9
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of DNAJC9 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr15:3,970,843...4,003,009
Ensembl chr15:3,970,114...3,977,304
|
|
| G
|
Dnal4
|
dynein, axonemal, light chain 4
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of DNAL4 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 7:113,192,807...113,205,665
Ensembl chr20:21,722,009...21,723,262 Ensembl chr 7:21,722,009...21,723,262
|
|
| G
|
Dnase1l1
|
deoxyribonuclease 1-like 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DNASE1L1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr X:157,208,230...157,216,812
Ensembl chr X:157,208,230...157,216,711
|
|
| G
|
Dnase1l3
|
deoxyribonuclease 1L3
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of DNASE1L3 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr15:19,351,683...19,378,536
Ensembl chr15:19,352,493...19,378,531
|
|
| G
|
Dnase2
|
deoxyribonuclease 2, lysosomal
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DNASE2A mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:40,149,505...40,152,225
Ensembl chr19:40,149,505...40,152,225
|
|
| G
|
Dner
|
delta/notch-like EGF repeat containing
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of DNER mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 9:93,035,108...93,350,568
Ensembl chr 9:93,035,108...93,350,568
|
|
| G
|
Dnm1
|
dynamin 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of DNM1 protein
|
CTD |
PMID:38909692 |
|
NCBI chr 3:36,002,535...36,055,220
Ensembl chr 3:36,002,064...36,046,289
|
|
| G
|
Dnm1l
|
dynamin 1-like
|
multiple interactions increases expression
|
ISO EXP
|
[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of DNM1L protein; genipin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of DNM1L protein] [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased susceptibility to 6-(5-((cyclopropylamino)carbonyl)-3-fluoro-2-methylphenyl)-N-(2,2-dimethylprpyl)-3-pyridinecarboxamide] which results in decreased expression of DNM1L protein; [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased susceptibility to SB 239063] which results in decreased expression of DNM1L protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of DNM1L protein; [Oxygen deficiency co-treated with Oxygen] results in increased expression of DNM1L protein; dorsomorphin inhibits the reaction [sappanone A inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of DNM1L protein]]; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of DNM1L protein]; Ru 360 inhibits the reaction [Oxygen deficiency results in increased expression of DNM1L protein]; sappanone A inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of DNM1L protein]; Sevoflurane inhibits the reaction [Oxygen deficiency results in increased expression of DNM1L protein]
|
CTD |
PMID:25911325 PMID:26116440 PMID:27684054 PMID:28477916 PMID:34358556 PMID:36806343 More...
|
|
NCBI chr11:98,084,049...98,135,663
Ensembl chr11:98,085,397...98,137,420
|
|
| G
|
Dnmbp
|
dynamin binding protein
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of DNMBP mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 1:252,685,406...252,778,642
Ensembl chr 1:252,685,406...252,778,688
|
|
| G
|
Dnmt1
|
DNA methyltransferase 1
|
increases expression decreases expression
|
ISO
|
Oxygen deficiency results in increased expression of DNMT1 protein Oxygen deficiency results in decreased expression of DNMT1 mRNA
|
CTD |
PMID:18314485 PMID:26516004 |
|
NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119
|
|
| G
|
Doc2b
|
double C2 domain beta
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of DOC2B mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:61,126,295...61,151,533
Ensembl chr10:61,126,295...61,151,533
|
|
| G
|
Dock10
|
dedicator of cytokinesis 10
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DOCK10 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:89,291,936...89,549,871
Ensembl chr 9:89,291,800...89,549,973
|
|
| G
|
Dop1b
|
DOP1 leucine zipper like protein B
|
affects methylation increases expression multiple interactions
|
ISO
|
Oxygen deficiency affects the methylation of DOP1B promoter Oxygen deficiency results in increased expression of DOP1B mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DOP1B mRNA
|
CTD |
PMID:24205000 PMID:30529165 |
|
NCBI chr11:46,494,058...46,595,601
Ensembl chr11:46,494,058...46,595,601
|
|
| G
|
Dorip1
|
dopamine receptor interacting protein 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of DORIP1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 6:88,701,651...88,710,204
Ensembl chr 6:88,701,818...88,708,820
|
|
| G
|
Dpf1
|
double PHD fingers 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of DPF1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:93,729,683...93,743,425
Ensembl chr 1:93,726,970...93,743,425
|
|
| G
|
Dph2
|
diphthamide biosynthesis 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DPH2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:136,713,868...136,716,828
|
|
| G
|
Dph5
|
diphthamide biosynthesis 5
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DPH5 mRNA; [sulforaphane affects the susceptibility to Oxygen] which affects the expression of DPH5 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:206,489,556...206,540,590
Ensembl chr 2:206,489,556...206,523,556
|
|
| G
|
Dpm3
|
dolichyl-phosphate mannosyltransferase subunit 3, regulatory
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of DPM3 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 2:176,974,290...176,974,805
Ensembl chr15:52,612,418...52,612,696
|
|
| G
|
Dpp4
|
dipeptidylpeptidase 4
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DPP4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:67,370,794...67,452,422
Ensembl chr 3:67,370,804...67,452,422
|
|
| G
|
Dpp9
|
dipeptidyl peptidase 9
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of DPP9 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 9:1,098,505...1,133,500
Ensembl chr 9:1,095,929...1,177,715
|
|
| G
|
Dppa4
|
developmental pluripotency associated 4
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of DPPA4 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr11:66,033,256...66,041,754
Ensembl chr11:66,033,256...66,041,754
|
|
| G
|
Dpt
|
dermatopontin
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DPT mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr13:79,656,341...79,684,759
Ensembl chr13:79,655,985...79,684,758
|
|
| G
|
Dpyd
|
dihydropyrimidine dehydrogenase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DPYD mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:209,293,902...210,159,777
Ensembl chr 2:209,293,929...210,159,778
|
|
| G
|
Dpysl2
|
dihydropyrimidinase-like 2
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of DPYSL2 protein [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DPYSL2 mRNA
|
CTD |
PMID:25937538 PMID:30529165 |
|
NCBI chr15:45,181,041...45,287,065
Ensembl chr15:45,181,041...45,287,065
|
|
| G
|
Dpysl3
|
dihydropyrimidinase-like 3
|
increases expression decreases expression
|
ISO
|
Oxygen deficiency results in increased expression of DPYSL3 mRNA Oxygen deficiency results in decreased expression of DPYSL3 protein
|
CTD |
PMID:25596134 PMID:25937538 |
|
NCBI chr18:35,625,357...35,731,152
Ensembl chr18:35,625,357...35,731,152
|
|
| G
|
Dram1
|
DNA-damage regulated autophagy modulator 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DRAM1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:24,630,233...24,665,270
Ensembl chr 7:24,630,238...24,664,354
|
|
| G
|
Drap1
|
Dr1 associated protein 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of DRAP1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 1:212,161,107...212,163,833
Ensembl chr 1:212,161,125...212,163,762
|
|
| G
|
Drd1
|
dopamine receptor D1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of DRD1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr17:10,545,488...10,550,029
Ensembl chr17:10,545,111...10,567,166
|
|
| G
|
Dscc1
|
DNA replication and sister chromatid cohesion 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of DSCC1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 7:88,372,349...88,390,815
Ensembl chr 7:88,372,146...88,387,973
|
|
| G
|
Dsn1
|
DSN1 component of MIS12 kinetochore complex
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of DSN1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 3:166,072,775...166,089,029
Ensembl chr 3:166,074,033...166,085,890
|
|
| G
|
Dsp
|
desmoplakin
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of DSP mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr17:26,829,153...26,877,419
Ensembl chr17:26,829,153...26,877,121
|
|
| G
|
Dst
|
dystonin
|
increases expression affects methylation
|
ISO
|
Oxygen deficiency results in increased expression of DST mRNA Oxygen deficiency affects the methylation of DST promoter
|
CTD |
PMID:24205000 PMID:24236059 |
|
NCBI chr 9:43,631,716...44,025,535
Ensembl chr 9:43,631,517...44,025,533
|
|
| G
|
Dtl
|
denticleless E3 ubiquitin protein ligase homolog
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of DTL mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr13:105,646,908...105,685,921
Ensembl chr13:105,646,908...105,686,174
|
|
| G
|
Dtnbp1
|
dystrobrevin binding protein 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DTNBP1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr17:19,891,313...19,982,770
Ensembl chr17:19,891,337...19,984,418
|
|
| G
|
Dtwd1
|
DTW domain containing 1
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of DTWD1 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in decreased expression of DTWD1 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 3:133,845,768...133,859,965
Ensembl chr 3:133,841,935...133,860,316
|
|
| G
|
Dtx3l
|
deltex E3 ubiquitin ligase 3L
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of DTX3L mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of DTX3L mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr11:78,320,225...78,329,837
Ensembl chr11:78,317,650...78,329,837
|
|
| G
|
Duox2
|
dual oxidase 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of DUOX2 mRNA
|
CTD |
PMID:35883890 |
|
NCBI chr 3:129,680,543...129,698,886
Ensembl chr 3:129,680,546...129,699,203
|
|
| G
|
Dusp1
|
dual specificity phosphatase 1
|
increases expression multiple interactions
|
EXP ISO
|
Oxygen deficiency results in increased expression of DUSP1 mRNA; Oxygen deficiency results in increased expression of DUSP1 protein SB 203580 inhibits the reaction [Oxygen deficiency results in increased expression of DUSP1 mRNA] [Oxygen deficiency co-treated with Catechin] results in decreased expression of DUSP1 mRNA; DUSP1 mutant form inhibits the reaction [Oxygen deficiency results in increased expression of SOD2 protein]
|
CTD |
PMID:11577072 PMID:24236059 PMID:24267255 PMID:26516004 PMID:35883890 |
|
NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644
|
|
| G
|
Dusp22
|
dual specificity phosphatase 22
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of DUSP22 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr17:33,989,637...34,040,021
Ensembl chr17:33,989,637...34,039,895
|
|
| G
|
Dusp4
|
dual specificity phosphatase 4
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of DUSP4 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DUSP4 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr16:64,079,893...64,101,396
Ensembl chr16:64,079,893...64,093,700
|
|
| G
|
Dusp5
|
dual specificity phosphatase 5
|
multiple interactions increases expression
|
ISO
|
[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in decreased expression of DUSP5 mRNA; [Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in decreased expression of DUSP5 protein; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in decreased expression of DUSP5 mRNA]; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in decreased expression of DUSP5 protein] Oxygen deficiency results in increased expression of DUSP5 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of DUSP5 protein; epigallocatechin gallate inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of DUSP5 protein]
|
CTD |
PMID:19578757 PMID:25596134 PMID:34740634 |
|
NCBI chr 1:262,543,774...262,557,201
Ensembl chr 1:262,543,738...262,562,417
|
|
| G
|
Dusp6
|
dual specificity phosphatase 6
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of DUSP6 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DUSP6 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of DUSP6 mRNA
|
CTD |
PMID:26516004 PMID:30529165 PMID:33729688 |
|
NCBI chr 7:35,979,502...35,983,834
Ensembl chr 7:35,977,921...35,983,833
|
|
| G
|
Dvl2
|
dishevelled segment polarity protein 2
|
multiple interactions
|
ISO
|
[Paclitaxel co-treated with FV-429 compound co-treated with Oxygen deficiency] results in decreased expression of DVL2 protein
|
CTD |
PMID:34648812 |
|
NCBI chr10:55,222,245...55,231,506
Ensembl chr10:55,222,056...55,231,506
|
|
| G
|
Dync1h1
|
dynein cytoplasmic 1 heavy chain 1
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of DYNC1H1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:135,436,375...135,502,117
Ensembl chr 6:135,430,750...135,502,116
|
|
| G
|
Dync2i1
|
dynein 2 intermediate chain 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of DYNC2I1 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 6:143,276,441...143,333,006
Ensembl chr 6:143,276,441...143,331,773
|
|
| G
|
Dynlt3
|
dynein light chain Tctex-type 3
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of DYNLT3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr X:16,000,425...16,009,632
Ensembl chr X:16,000,395...16,009,627
|
|
| G
|
Dyrk3
|
dual specificity tyrosine phosphorylation regulated kinase 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DYRK3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr13:45,146,383...45,157,082
Ensembl chr13:45,146,384...45,157,249
|
|
| G
|
E2f1
|
E2F transcription factor 1
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of E2F1 mRNA [Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of E2F1 mRNA; [Oxygen co-treated with Ozone] results in decreased expression of E2F1 mRNA
|
CTD |
PMID:26516004 PMID:32992648 |
|
NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:163,524,739...163,535,563
|
|
| G
|
E2f2
|
E2F transcription factor 2
|
increases expression multiple interactions decreases expression
|
ISO
|
Oxygen deficiency results in increased expression of E2F2 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of E2F2 mRNA; Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of E2F2 mRNA] Oxygen deficiency results in decreased expression of E2F2 mRNA
|
CTD |
PMID:22629407 PMID:26516004 PMID:30529165 |
|
NCBI chr 5:153,682,789...153,706,087
Ensembl chr 5:153,682,789...153,706,087
|
|
| G
|
E2f3
|
E2F transcription factor 3
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of E2F3 mRNA
|
CTD |
PMID:17914565 |
|
NCBI chr17:34,810,355...34,887,725
Ensembl chr17:34,809,998...34,887,725
|
|
| G
|
E2f7
|
E2F transcription factor 7
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of E2F7 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 7:48,036,881...48,079,055
Ensembl chr 7:48,037,749...48,079,055
|
|
| G
|
E2f8
|
E2F transcription factor 8
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of E2F8 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:107,701,985...107,720,538
Ensembl chr 1:107,701,985...107,720,009
|
|
| G
|
Ebf1
|
EBF transcription factor 1
|
increases expression
|
EXP
|
Oxygen results in increased expression of EBF1 mRNA
|
CTD |
PMID:22911455 |
|
NCBI chr10:29,597,221...29,990,571
Ensembl chr10:29,601,351...29,988,702
|
|
| G
|
Ebna1bp2
|
EBNA1 binding protein 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EBNA1BP2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:137,433,534...137,438,100
Ensembl chr 5:137,433,226...137,438,637
|
|
| G
|
Ece1
|
endothelin converting enzyme 1
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of ECE1 mRNA; Oxygen deficiency results in increased expression of ECE1 protein Rosiglitazone inhibits the reaction [Oxygen deficiency results in increased expression of ECE1 mRNA]; Rosiglitazone inhibits the reaction [Oxygen deficiency results in increased expression of ECE1 protein] Oxygen deficiency promotes the reaction [HIF1A protein binds to ECE1 intron]; Oxygen deficiency promotes the reaction [HIF1A protein binds to ECE1 promoter]
|
CTD |
PMID:21926265 PMID:25469848 |
|
NCBI chr 5:155,361,031...155,462,723
Ensembl chr 5:155,360,639...155,462,719
|
|
| G
|
Ece2
|
endothelin-converting enzyme 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ECE2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr11:93,767,559...93,782,896
Ensembl chr11:93,767,559...93,793,292
|
|
| G
|
Ecel1
|
endothelin converting enzyme-like 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ECEL1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 9:95,267,417...95,276,508
Ensembl chr 9:95,264,618...95,274,575
|
|
| G
|
Echdc1
|
ethylmalonyl-CoA decarboxylase 1
|
decreases expression multiple interactions
|
EXP
|
Oxygen deficiency results in decreased expression of ECHDC1 mRNA Quercetin inhibits the reaction [Oxygen deficiency results in decreased expression of ECHDC1 mRNA]
|
CTD |
PMID:26476374 |
|
NCBI chr 1:30,304,968...30,355,957
Ensembl chr 1:30,304,971...30,337,208
|
|
| G
|
Ecm2
|
extracellular matrix protein 2
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ECM2 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of ECM2 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr17:15,326,359...15,358,938
Ensembl chr17:15,326,359...15,358,855
|
|
| G
|
Eda2r
|
ectodysplasin A2 receptor
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EDA2R mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr X:66,225,557...66,280,674
Ensembl chr X:66,236,111...66,280,663
|
|
| G
|
Edaradd
|
EDAR associated via death domain
|
multiple interactions increases expression
|
ISO
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of EDARADD mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of EDARADD mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of EDARADD mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of EDARADD mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of EDARADD mRNA]
|
CTD |
PMID:23452621 |
|
NCBI chr17:92,850,791...92,894,808
Ensembl chr17:92,831,613...92,894,361
|
|
| G
|
Edc3
|
enhancer of mRNA decapping 3
|
affects expression
|
ISO
|
Oxygen deficiency affects the expression of EDC3 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 8:67,002,032...67,047,563
Ensembl chr 8:67,002,014...67,047,559
|
|
| G
|
Edem3
|
ER degradation enhancing alpha-mannosidase like protein 3
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of EDEM3 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr13:66,403,022...66,470,496
Ensembl chr13:66,408,590...66,472,270
|
|
| G
|
Edil3
|
EGF like repeats and discoidin domains 3
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of EDIL3 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 2:21,625,604...22,140,380
Ensembl chr 2:21,625,596...22,140,379
|
|
| G
|
Edn1
|
endothelin 1
|
multiple interactions increases expression increases secretion
|
EXP ISO
|
[Ozone co-treated with Oxygen] inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of EDN1 mRNA]; [Ozone co-treated with Oxygen] inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of EDN1 protein]; MMP2 protein affects the susceptibility to [EDN1 protein co-treated with Oxygen deficiency]; natakalim inhibits the reaction [Oxygen deficiency results in increased expression of EDN1 mRNA]; Oxygen deficiency promotes the reaction [chromium mesoporphyrin results in increased expression of EDN1 protein]; tanshinone inhibits the reaction [Oxygen deficiency results in increased expression of EDN1 protein] caffeic acid phenethyl ester inhibits the reaction [Oxygen deficiency results in increased expression of EDN1 mRNA]; caffeic acid phenethyl ester inhibits the reaction [Oxygen deficiency results in increased expression of EDN1 protein]; chetomin inhibits the reaction [Oxygen deficiency results in increased expression of EDN1 mRNA]; chetomin inhibits the reaction [Oxygen deficiency results in increased expression of EDN1 protein]; cyclo(Trp-Asp-Pro-Val-Leu) promotes the reaction [Oxygen deficiency results in increased secretion of EDN1 protein]; EPO protein inhibits the reaction [Oxygen deficiency results in increased secretion of EDN1 protein]; Genistein affects the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to ARNT protein binds to EDN1 promoter]]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of EDN1 mRNA]; Oxygen deficiency promotes the reaction [HIF1A protein binds to ARNT protein binds to EDN1 promoter]; Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of EDN1 protein] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EDN1 mRNA; MMP2 protein affects the susceptibility to [EDN1 protein co-treated with Oxygen deficiency]; Rosiglitazone inhibits the reaction [Oxygen deficiency results in increased expression of EDN1 mRNA]; Rosiglitazone inhibits the reaction [Oxygen deficiency results in increased expression of EDN1 protein] Oxygen deficiency results in increased expression of EDN1 mRNA; Oxygen deficiency results in increased expression of EDN1 protein Oxygen deficiency results in increased expression of EDN1 mRNA; Oxygen deficiency results in increased expression of EDN1 protein; Oxygen results in increased expression of EDN1 mRNA
|
CTD |
PMID:10939628 PMID:12969895 PMID:14508066 PMID:16980344 PMID:17968679 PMID:18001528 PMID:20042640 PMID:21926265 PMID:22363556 PMID:22860425 PMID:24557580 PMID:25203536 PMID:25469848 PMID:26550192 PMID:28985491 PMID:30529165 More...
|
|
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687
|
|
| G
|
Edn2
|
endothelin 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of EDN2 mRNA; Oxygen results in increased expression of EDN2 mRNA; Oxygen results in increased expression of EDN2 protein
|
CTD |
PMID:25203536 |
|
NCBI chr 5:139,036,576...139,042,074
Ensembl chr 5:139,036,492...139,043,070
|
|
| G
|
Ednra
|
endothelin receptor type A
|
multiple interactions increases expression
|
ISO EXP
|
rosiglitazone inhibits the reaction [Oxygen deficiency results in increased expression of EDNRA mRNA]; rosiglitazone inhibits the reaction [Oxygen deficiency results in increased expression of EDNRA protein] 4-chlorobenzyltetrahydroberberine inhibits the reaction [Oxygen deficiency results in increased expression of EDNRA mRNA]; 4-chlorobenzyltetrahydroberberine inhibits the reaction [Oxygen deficiency results in increased expression of EDNRA protein]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of EDNRA mRNA; [Ozone co-treated with Oxygen] inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of EDNRA mRNA]; acetovanillone inhibits the reaction [Oxygen deficiency results in increased expression of EDNRA mRNA]; acetovanillone inhibits the reaction [Oxygen deficiency results in increased expression of EDNRA protein]; tanshinone inhibits the reaction [Oxygen deficiency results in increased expression of EDNRA protein] Oxygen deficiency results in increased expression of EDNRA mRNA; Oxygen deficiency results in increased expression of EDNRA protein Oxygen deficiency results in increased expression of EDNRA mRNA; Oxygen deficiency results in increased expression of EDNRA protein; Oxygen results in increased expression of EDNRA mRNA
|
CTD |
PMID:21926265 PMID:23270704 PMID:25203536 PMID:26550192 PMID:28985491 PMID:33729688 PMID:34478853 More...
|
|
NCBI chr19:47,137,360...47,207,961
Ensembl chr19:47,137,771...47,201,284
|
|
| G
|
Ednrb
|
endothelin receptor type B
|
multiple interactions increases expression decreases expression decreases methylation
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EDNRB mRNA; Rosiglitazone inhibits the reaction [Oxygen deficiency results in increased expression of EDNRB mRNA]; Rosiglitazone inhibits the reaction [Oxygen deficiency results in increased expression of EDNRB protein] Oxygen deficiency results in increased expression of EDNRB mRNA; Oxygen deficiency results in increased expression of EDNRB protein; Oxygen results in increased expression of EDNRB mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of EDNRB mRNA; [Ozone co-treated with Oxygen] inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in decreased expression of EDNRB mRNA]; tanshinone inhibits the reaction [Oxygen deficiency results in decreased expression of EDNRB protein] Oxygen deficiency results in decreased methylation of EDNRB promoter
|
CTD |
PMID:21926265 PMID:24236059 PMID:25203536 PMID:26550192 PMID:28985491 PMID:30529165 PMID:33729688 PMID:34478853 More...
|
|
NCBI chr15:87,055,490...87,086,765
Ensembl chr15:87,057,691...87,086,765
|
|
| G
|
Eef1a1
|
eukaryotic translation elongation factor 1 alpha 1
|
multiple interactions
|
EXP
|
EEF1A1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
|
CTD |
PMID:21124846 |
|
NCBI chr 8:88,221,839...88,225,688
Ensembl chr 8:88,221,843...88,225,072
|
|
| G
|
Eef1akmt1
|
EEF1A lysine methyltransferase 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of EEF1AKMT1 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr15:35,809,842...35,826,921
Ensembl chr15:35,809,842...35,827,129
|
|
| G
|
Eef1e1
|
eukaryotic translation elongation factor 1 epsilon 1
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of EEF1E1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EEF1E1 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr17:26,354,247...26,364,953
Ensembl chr17:26,354,228...26,370,687
|
|
| G
|
Eepd1
|
endonuclease/exonuclease/phosphatase family domain containing 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of EEPD1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 8:32,233,834...32,340,148
Ensembl chr 8:32,233,070...32,340,147
|
|
| G
|
Efemp1
|
EGF containing fibulin extracellular matrix protein 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EFEMP1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:106,811,769...106,890,961
Ensembl chr14:106,802,304...106,892,808
|
|
| G
|
Efhb
|
EF hand domain family, member B
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of EFHB mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 9:6,608,791...6,680,104
Ensembl chr 9:6,608,794...6,678,827
|
|
| G
|
Efhd1
|
EF-hand domain family, member D1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EFHD1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:95,386,155...95,432,800
Ensembl chr 9:95,386,169...95,432,798
|
|
| G
|
Efhd2
|
EF-hand domain family, member D2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of EFHD2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 5:159,443,959...159,459,993
Ensembl chr 5:159,443,960...159,460,369
|
|
| G
|
Efna1
|
ephrin A1
|
multiple interactions increases expression
|
ISO
|
1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of EFNA1 mRNA]
|
CTD |
PMID:20042640 PMID:24403227 PMID:25596134 PMID:26516004 |
|
NCBI chr 2:176,979,434...176,988,675
Ensembl chr 2:176,979,434...176,988,726
|
|
| G
|
Efna3
|
ephrin A3
|
multiple interactions increases expression
|
ISO
|
1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of EFNA3 mRNA]
|
CTD |
PMID:24403227 |
|
NCBI chr 2:177,026,928...177,035,838
Ensembl chr 2:177,026,933...177,044,843
|
|
| G
|
Efnb3
|
ephrin B3
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of EFNB3 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of EFNB3 mRNA
|
CTD |
PMID:26516004 PMID:33729688 |
|
NCBI chr10:54,773,282...54,780,727
Ensembl chr10:54,773,282...54,797,651
|
|
| G
|
Efr3b
|
EFR3 homolog B
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EFR3B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:32,664,593...32,740,417
Ensembl chr 6:32,666,945...32,740,417
|
|
| G
|
Egfl6
|
EGF-like-domain, multiple 6
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of EGFL6 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of EGFL6 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr X:31,515,752...31,573,699
Ensembl chr X:31,515,767...31,574,632
|
|
| G
|
Egflam
|
EGF-like, fibronectin type III and laminin G domains
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EGFLAM mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:58,029,934...58,204,010
Ensembl chr 2:58,029,935...58,203,643
|
|
| G
|
Egfr
|
epidermal growth factor receptor
|
multiple interactions
|
ISO
|
[Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of EGFR mRNA; [Oxygen co-treated with Ozone] results in decreased expression of EGFR mRNA; [RTKI cpd results in decreased activity of EGFR protein] inhibits the reaction [Equol results in increased chemical synthesis of Oxygen]
|
CTD |
PMID:21300668 PMID:32992648 |
|
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358
|
|
| G
|
Egln1
|
egl-9 family hypoxia-inducible factor 1
|
multiple interactions increases expression decreases expression
|
ISO EXP
|
[[Minocycline promotes the reaction [HIF1A protein binds to VHL protein]] co-treated with [Minocycline results in increased expression of EGLN1 protein]] inhibits the reaction [Oxygen deficiency results in increased stability of HIF1A protein]; [amurensin G results in decreased activity of SIRT1 protein] inhibits the reaction [Oxygen deficiency results in decreased expression of EGLN1 protein]; [IL15 protein co-treated with Oxygen deficiency] results in increased expression of EGLN1 mRNA; [Oxygen deficiency co-treated with Tetrachlorodibenzodioxin] results in decreased expression of EGLN1 protein; [Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in decreased expression of EGLN1 mRNA; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in decreased expression of EGLN1 mRNA]; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in decreased expression of EGLN1 protein] Oxygen deficiency results in increased expression of EGLN1 mRNA; Oxygen deficiency results in increased expression of EGLN1 protein [Oxygen deficiency co-treated with AQP3 protein] results in increased expression of EGLN1 mRNA
|
CTD |
PMID:14686790 PMID:18072750 PMID:19502547 PMID:20042640 PMID:20880076 PMID:22245592 PMID:23545307 PMID:24292262 PMID:26516004 PMID:27129235 More...
|
|
NCBI chr19:69,765,276...69,804,681
|
|
| G
|
Egln3
|
egl-9 family hypoxia-inducible factor 3
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of EGLN3 mRNA deguelin inhibits the reaction [Oxygen deficiency results in increased expression of EGLN3 mRNA] AQP3 protein promotes the reaction [Oxygen deficiency results in increased expression of EGLN3 mRNA]; Oxygen deficiency inhibits the reaction [AQP1 protein results in decreased expression of EGLN3 mRNA]; Oxygen deficiency inhibits the reaction [AQP3 protein results in decreased expression of EGLN3 mRNA]
|
CTD |
PMID:20042640 PMID:20880076 PMID:22745725 PMID:23545307 PMID:24236059 PMID:26516004 More...
|
|
NCBI chr 6:77,385,549...77,411,015
Ensembl chr 6:77,385,549...77,411,015
|
|
| G
|
Egr1
|
early growth response 1
|
multiple interactions increases expression
|
EXP ISO
|
15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased activity of EGR1 protein]; 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [Oxygen deficiency results in increased expression of EGR1 mRNA]; Oxygen deficiency results in increased expression of and results in increased activity of EGR1 protein; troglitazone inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased activity of EGR1 protein]; troglitazone inhibits the reaction [Oxygen deficiency results in increased expression of EGR1 mRNA] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EGR1 mRNA
|
CTD |
PMID:12468449 PMID:17914565 PMID:19502547 PMID:24236059 PMID:30529165 |
|
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843
|
|
| G
|
Egr2
|
early growth response 2
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EGR2 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of EGR2 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr20:21,050,149...21,055,201
Ensembl chr20:21,050,149...21,057,748
|
|
| G
|
Egr3
|
early growth response 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EGR3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr15:51,560,482...51,565,778
Ensembl chr15:51,560,344...51,565,712
|
|
| G
|
Ehd3
|
EH-domain containing 3
|
multiple interactions
|
EXP
|
EHD3 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
|
CTD |
PMID:21124846 |
|
NCBI chr 6:27,392,709...27,417,445
Ensembl chr 6:27,392,709...27,417,445
|
|
| G
|
Ehd4
|
EH-domain containing 4
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EHD4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:127,511,973...127,575,856
Ensembl chr 3:127,511,954...127,576,072
|
|
| G
|
Ehf
|
ets homologous factor
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EHF mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:110,094,770...110,134,991
Ensembl chr 3:110,096,756...110,134,928
|
|
| G
|
Eif1a
|
eukaryotic translation initiation factor 1A
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of EIF1A mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr18:41,512,298...41,524,645
Ensembl chr18:41,503,180...41,549,696
|
|
| G
|
Eif2a
|
eukaryotic translation initiation factor 2A
|
increases phosphorylation multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased phosphorylation of EIF2A protein AKR1B1 protein inhibits the reaction [Oxygen deficiency results in increased phosphorylation of EIF2A protein]
|
CTD |
PMID:19041636 |
|
NCBI chr 2:144,911,247...144,944,705
Ensembl chr 2:144,911,153...144,945,201
|
|
| G
|
Eif2ak2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of EIF2AK2 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of EIF2AK2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 6:21,941,147...21,977,115
Ensembl chr 6:21,952,631...21,977,116
|
|
| G
|
Eif2ak3
|
eukaryotic translation initiation factor 2 alpha kinase 3
|
increases phosphorylation multiple interactions increases expression
|
ISO EXP
|
Oxygen deficiency results in increased phosphorylation of EIF2AK3 protein 4-chlorobenzyltetrahydroberberine inhibits the reaction [Oxygen deficiency results in increased expression of EIF2AK3 mRNA]; 4-chlorobenzyltetrahydroberberine inhibits the reaction [Oxygen deficiency results in increased expression of EIF2AK3 protein]; [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in increased phosphorylation of EIF2AK3 protein; [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased phosphorylation of EIF2AK3 protein; acetovanillone inhibits the reaction [Oxygen deficiency results in increased expression of EIF2AK3 mRNA]; acetovanillone inhibits the reaction [Oxygen deficiency results in increased expression of EIF2AK3 protein]; AKR1B1 protein inhibits the reaction [Oxygen deficiency results in increased phosphorylation of EIF2AK3 protein]; Ethanol promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased phosphorylation of EIF2AK3 protein]; Hemin inhibits the reaction [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in increased phosphorylation of EIF2AK3 protein]; Hemin inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased phosphorylation of EIF2AK3 protein]; Nifedipine inhibits the reaction [Oxygen deficiency results in increased expression of EIF2AK3 mRNA]; Nifedipine inhibits the reaction [Oxygen deficiency results in increased expression of EIF2AK3 protein]; zinc protoporphyrin promotes the reaction [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in increased phosphorylation of EIF2AK3 protein]; zinc protoporphyrin promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased phosphorylation of EIF2AK3 protein] Oxygen deficiency results in increased expression of EIF2AK3 mRNA; Oxygen deficiency results in increased expression of EIF2AK3 protein Oxygen results in increased expression of EIF2AK3 protein 1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone inhibits the reaction [Oxygen results in increased expression of EIF2AK3 protein]; 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline inhibits the reaction [1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone inhibits the reaction [Oxygen results in increased expression of EIF2AK3 protein]]
|
CTD |
PMID:19041636 PMID:22226148 PMID:23270704 PMID:26747958 PMID:32996202 |
|
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268
|
|
| G
|
Eif2b3
|
eukaryotic translation initiation factor 2B subunit gamma
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of EIF2B3 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EIF2B3 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 5:135,728,764...135,795,276
Ensembl chr 5:135,728,959...135,799,914
|
|
| G
|
Eif2s1
|
eukaryotic translation initiation factor 2 subunit alpha
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EIF2S1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649
|
|
| G
|
Eif2s2
|
eukaryotic translation initiation factor 2 subunit beta
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of EIF2S2 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 3:163,834,846...163,855,733
Ensembl chr 3:163,834,851...163,855,570
|
|
| G
|
Eif3a
|
eukaryotic translation initiation factor 3, subunit A
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of EIF3A mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 1:269,888,730...269,925,785
Ensembl chr 1:269,888,615...269,919,025
|
|
| G
|
Eif3c
|
eukaryotic translation initiation factor 3, subunit C
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of EIF3C mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 1:190,565,183...190,583,067
Ensembl chr 1:190,565,184...190,583,067
|
|
| G
|
Eif4a1
|
eukaryotic translation initiation factor 4A1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EIF4A1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:54,883,093...54,888,602
Ensembl chr10:54,883,093...54,888,602
|
|
| G
|
Eif4e
|
eukaryotic translation initiation factor 4E
|
multiple interactions
|
ISO
|
[dictamnine co-treated with Oxygen deficiency] results in decreased phosphorylation of EIF4E protein
|
CTD |
PMID:30266538 |
|
NCBI chr 2:229,736,309...229,772,628
Ensembl chr 2:229,739,897...229,774,105
|
|
| G
|
Eif4ebp1
|
eukaryotic translation initiation factor 4E binding protein 1
|
multiple interactions affects phosphorylation increases phosphorylation
|
ISO
|
[dictamnine co-treated with Oxygen deficiency] results in decreased phosphorylation of EIF4EBP1 protein; [Sirolimus co-treated with Oxygen deficiency] results in increased phosphorylation of EIF4EBP1 protein; Digitoxin inhibits the reaction [Oxygen deficiency results in increased phosphorylation of EIF4EBP1 protein]; shikonin affects the reaction [Oxygen deficiency affects the phosphorylation of EIF4EBP1 protein] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EIF4EBP1 mRNA
|
CTD |
PMID:28684144 PMID:30266538 PMID:30529165 PMID:34717917 |
|
NCBI chr16:71,495,457...71,508,845
Ensembl chr16:71,487,930...71,508,874
|
|
| G
|
Eif4g1
|
eukaryotic translation initiation factor 4 gamma 1
|
increases expression affects methylation
|
ISO
|
Oxygen deficiency results in increased expression of EIF4G1 mRNA Oxygen deficiency affects the methylation of EIF4G1 promoter
|
CTD |
PMID:24205000 |
|
NCBI chr11:93,726,322...93,746,387
Ensembl chr11:93,726,322...93,746,367
|
|
| G
|
Eif5
|
eukaryotic translation initiation factor 5
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of EIF5 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of EIF5 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 6:136,410,333...136,418,827
Ensembl chr 6:136,407,440...136,418,821
|
|
| G
|
Eif6
|
eukaryotic translation initiation factor 6
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EIF6 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:164,785,162...164,791,410
Ensembl chr 3:164,785,163...164,791,525
|
|
| G
|
Elane
|
elastase, neutrophil expressed
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ELANE mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 7:10,467,877...10,469,725
Ensembl chr 7:10,467,877...10,469,725
|
|
| G
|
Elavl2
|
ELAV like RNA binding protein 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ELAVL2 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 5:111,076,705...111,202,341
Ensembl chr 5:111,076,705...111,224,918
|
|
| G
|
Elavl4
|
ELAV like RNA binding protein 4
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ELAVL4 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 5:130,285,418...130,429,106
Ensembl chr 5:130,285,418...130,429,096
|
|
| G
|
Elf4
|
E74 like ETS transcription factor 4
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ELF4 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr X:132,465,290...132,508,175
Ensembl chr X:132,468,539...132,478,689
|
|
| G
|
Elf5
|
E74 like ETS transcription factor 5
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ELF5 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:110,264,460...110,291,926
Ensembl chr 3:110,252,797...110,291,926
|
|
| G
|
Elfn1
|
extracellular leucine-rich repeat and fibronectin type III domain containing 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ELFN1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr12:19,773,911...19,839,375
Ensembl chr12:19,772,908...19,841,961
|
|
| G
|
Elk1
|
ETS transcription factor ELK1
|
multiple interactions increases expression
|
ISO
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of ELK1 mRNA]; [Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of ELK1 mRNA; [Oxygen co-treated with Ozone] results in decreased expression of ELK1 mRNA; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of ELK1 mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of ELK1 mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of ELK1 mRNA]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of ELK1 mRNA]
|
CTD |
PMID:23452621 PMID:32992648 |
|
NCBI chr X:3,692,367...3,709,252
Ensembl chr X:3,693,293...3,709,249
|
|
| G
|
Elk4
|
ETS transcription factor ELK4
|
affects expression
|
ISO
|
Oxygen deficiency affects the expression of ELK4 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr13:46,004,145...46,027,206
Ensembl chr13:46,004,182...46,027,199
|
|
| G
|
Ell2
|
elongation factor for RNA polymerase II 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ELL2 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 2:6,910,446...6,990,654
Ensembl chr 2:6,921,771...7,016,199
|
|
| G
|
Elmod1
|
ELMO domain containing 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ELMOD1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 8:63,194,539...63,251,526
Ensembl chr 8:63,137,295...63,251,322
|
|
| G
|
Eln
|
elastin
|
multiple interactions increases expression
|
ISO
|
[Oxygen co-treated with Butylated Hydroxytoluene] results in increased expression of ELN mRNA; [POSTN gene mutant form results in decreased susceptibility to Oxygen] which results in decreased expression of ELN mRNA; POSTN gene mutant form inhibits the reaction [Oxygen results in increased expression of ELN mRNA]
|
CTD |
PMID:10761639 PMID:22363622 |
|
NCBI chr12:27,604,983...27,648,413
Ensembl chr12:27,604,680...27,648,413
|
|
| G
|
Elovl6
|
ELOVL fatty acid elongase 6
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ELOVL6 mRNA
|
CTD |
PMID:20880076 PMID:26516004 |
|
NCBI chr 2:220,738,095...220,845,528
Ensembl chr 2:220,738,064...220,845,549
|
|
| G
|
Elp4
|
elongator acetyltransferase complex subunit 4
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ELP4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:112,617,020...112,839,963
Ensembl chr 3:112,617,035...112,839,963
|
|
| G
|
Emb
|
embigin
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of EMB mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 2:50,803,468...50,858,001
Ensembl chr 2:50,801,973...50,862,920
|
|
| G
|
Emc4
|
ER membrane protein complex subunit 4
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of EMC4 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in decreased expression of EMC4 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 3:119,624,100...119,633,170
Ensembl chr 3:119,624,100...119,629,118
|
|
| G
|
Emcn
|
endomucin
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EMCN mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:228,564,445...228,644,370
Ensembl chr 2:228,564,430...228,645,155
|
|
| G
|
Eme1
|
essential meiotic structure-specific endonuclease 1
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of EME1 mRNA [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of EME1 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of EME1 mRNA
|
CTD |
PMID:26516004 PMID:33729688 |
|
NCBI chr10:80,083,585...80,092,450
Ensembl chr10:80,083,585...80,092,301
|
|
| G
|
Emid1
|
EMI domain containing 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EMID1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:84,214,530...84,257,628
Ensembl chr14:84,214,530...84,257,579
|
|
| G
|
Eml2
|
EMAP like 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of EML2 mRNA
|
CTD |
PMID:17175027 |
|
NCBI chr 1:87,955,924...87,987,366
Ensembl chr 1:87,955,606...87,987,366
|
|
| G
|
Emp1
|
epithelial membrane protein 1
|
multiple interactions
|
ISO EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of EMP1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of EMP1 mRNA
|
CTD |
PMID:19640911 PMID:33729688 |
|
NCBI chr 4:169,931,537...169,964,366
Ensembl chr 4:169,931,440...169,964,365
|
|
| G
|
Enc1
|
ectodermal-neural cortex 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ENC1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:30,285,274...30,297,194
Ensembl chr 2:30,283,736...30,315,721
|
|
| G
|
Endod1
|
endonuclease domain containing 1
|
multiple interactions increases expression
|
ISO
|
Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of ENDOD1 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 8:19,490,615...19,520,007
Ensembl chr 8:19,490,615...19,520,007
|
|
| G
|
Endog
|
endonuclease G
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ENDOG mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr 3:33,846,935...33,849,531
Ensembl chr 3:33,846,885...33,849,573
|
|
| G
|
Eng
|
endoglin
|
multiple interactions
|
ISO
|
[Oxygen deficiency co-treated with Oxygen] results in increased expression of ENG protein; ALCAM protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of ENG protein]; ALKBH5 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of ENG protein]; PKF115-584 promotes the reaction [ALKBH5 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of ENG protein]]; PPARG protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of ENG protein]
|
CTD |
PMID:34995009 |
|
NCBI chr 3:36,332,190...36,370,324
Ensembl chr 3:36,326,202...36,370,933
|
|
| G
|
Enkur
|
enkurin, TRPC channel interacting protein
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ENKUR mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr17:88,599,057...88,622,668
Ensembl chr17:88,599,057...88,622,668
|
|
| G
|
Eno1
|
enolase 1
|
multiple interactions increases expression
|
ISO
|
Amphotericin B inhibits the reaction [Oxygen deficiency results in increased expression of ENO1 mRNA]; Cadmium inhibits the reaction [Oxygen deficiency results in increased expression of ENO1 mRNA]
|
CTD |
PMID:10866824 PMID:16189267 PMID:19502547 PMID:20042640 |
|
NCBI chr 5:166,002,867...166,014,252
Ensembl chr 3:77,946,261...77,986,003 Ensembl chr 5:77,946,261...77,986,003
|
|
| G
|
Eno2
|
enolase 2
|
affects expression multiple interactions increases expression
|
ISO EXP
|
Oxygen deficiency affects the expression of ENO2 mRNA 1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of ENO2 mRNA] [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ENO2 mRNA
|
CTD |
PMID:17193925 PMID:19502547 PMID:20042640 PMID:24403227 PMID:25596134 PMID:26516004 PMID:33729688 More...
|
|
NCBI chr 4:159,258,371...159,267,220
Ensembl chr 4:159,258,371...159,267,220
|
|
| G
|
Eno3
|
enolase 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ENO3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:55,868,880...55,876,099
Ensembl chr10:55,866,101...55,874,540
|
|
| G
|
Enosf1
|
enolase superfamily member 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ENOSF1 mRNA
|
CTD |
PMID:25596134 |
|
|
|
| G
|
Enpep
|
glutamyl aminopeptidase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ENPEP mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:220,456,258...220,526,218
Ensembl chr 2:220,456,278...220,526,218
|
|
| G
|
Enpp2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
multiple interactions increases activity increases expression
|
ISO
|
alpha-naphthoflavone inhibits the reaction [Oxygen deficiency inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of ENPP2 mRNA]]; Oxygen deficiency inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of ENPP2 mRNA] Oxygen deficiency results in increased activity of ENPP2 mRNA Oxygen deficiency results in increased expression of ENPP2 mRNA
|
CTD |
PMID:19028555 |
|
NCBI chr 7:88,092,140...88,214,758
Ensembl chr 7:88,092,140...88,214,957
|
|
| G
|
Enpp3
|
ectonucleotide pyrophosphatase/phosphodiesterase 3
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ENPP3 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:22,382,717...22,454,324
Ensembl chr 1:22,382,964...22,454,314
|
|
| G
|
Enpp5
|
ectonucleotide pyrophosphatase/phosphodiesterase family member 5
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ENPP5 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:24,407,574...24,415,029
Ensembl chr 9:24,408,218...24,414,867
|
|
| G
|
Entpd1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of ENTPD1 mRNA; Oxygen deficiency results in increased expression of ENTPD1 protein 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin inhibits the reaction [Oxygen deficiency results in increased expression of ENTPD1 protein]; deguelin inhibits the reaction [Oxygen deficiency results in increased expression of ENTPD1 protein]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of ENTPD1 protein] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ENTPD1 mRNA
|
CTD |
PMID:23437309 PMID:27899277 PMID:30529165 |
|
NCBI chr 1:249,374,810...249,502,310
Ensembl chr 1:249,374,836...249,502,317
|
|
| G
|
Entpd4
|
ectonucleoside triphosphate diphosphohydrolase 4
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ENTPD4 mRNA
|
CTD |
PMID:20042640 |
|
NCBI chr15:51,040,665...51,068,450
Ensembl chr15:51,040,673...51,068,441
|
|
| G
|
Entpd7
|
ectonucleoside triphosphate diphosphohydrolase 7
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of ENTPD7 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ENTPD7 mRNA
|
CTD |
PMID:25596134 PMID:33729688 |
|
NCBI chr 1:252,508,594...252,550,269
Ensembl chr 1:252,508,594...252,550,269
|
|
| G
|
Entrep1
|
endosomal transmembrane epsin interactor 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of ENTREP1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ENTREP1 mRNA
|
CTD |
PMID:24236059 PMID:26516004 PMID:30529165 |
|
NCBI chr 1:231,018,987...231,073,474
Ensembl chr 1:231,018,987...231,102,708
|
|
| G
|
Entrep3
|
endosomal transmembrane epsin interactor 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ENTREP3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:176,886,903...176,893,047
Ensembl chr 2:176,887,135...176,893,047
|
|
| G
|
Ep300
|
E1A binding protein p300
|
multiple interactions
|
ISO
|
Amphotericin B inhibits the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]]; Apigenin inhibits the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]]; fisetin promotes the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]]; flavone inhibits the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]]; galangin promotes the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]]; kaempferol promotes the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]]; myricetin promotes the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]]; Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]; Quercetin promotes the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]]
|
CTD |
PMID:16189267 PMID:20153296 |
|
NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:114,946,982...115,058,574
|
|
| G
|
Ep400
|
E1A binding protein p400
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of EP400 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr12:51,551,665...51,658,635
Ensembl chr12:51,551,695...51,658,634
|
|
| G
|
Epas1
|
endothelial PAS domain protein 1
|
multiple interactions affects response to substance increases expression affects localization
|
EXP ISO
|
[AQP1 protein results in increased stability of EPAS1 protein] promotes the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]; [AQP3 protein results in increased stability of EPAS1 protein] promotes the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]; [AQP5 protein results in increased stability of EPAS1 protein] promotes the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]; Antimycin A inhibits the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Oxygen inhibits the reaction [AQP3 protein results in increased stability of EPAS1 protein]]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Oxygen inhibits the reaction [AQP5 protein results in increased stability of EPAS1 protein]]; COX10 protein affects the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]; EPAS1 mutant form inhibits the reaction [Oxygen deficiency results in increased expression of NTRK2 mRNA]; EPAS1 protein affects the reaction [Oxygen deficiency results in increased expression of CACNA1H mRNA]; myxothiazol inhibits the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]; Oxygen inhibits the reaction [AQP3 protein results in increased stability of EPAS1 protein]; Oxygen inhibits the reaction [AQP5 protein results in increased stability of EPAS1 protein]; Rotenone inhibits the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]; Sodium Cyanide inhibits the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]; UQCRFS1 protein affects the reaction [Oxygen deficiency results in increased expression of EPAS1 protein] EPAS1 protein affects the susceptibility to Oxygen deficiency Oxygen deficiency affects the localization of and results in increased activity of EPAS1 protein Oxygen deficiency results in increased expression of EPAS1 mRNA; Oxygen deficiency results in increased expression of EPAS1 protein 1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]; 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine inhibits the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]; 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]; [HIF1A mRNA co-treated with EPAS1 mRNA] affects the reaction [Oxygen deficiency results in decreased expression of USP28 protein]; [HIF1A mRNA co-treated with EPAS1 mRNA] affects the reaction [Oxygen deficiency results in increased degradation of MYC protein]; [Oxygen deficiency co-treated with molibresib] results in increased expression of EPAS1 mRNA; [Oxygen deficiency results in increased expression of EPAS1 protein] promotes the reaction [EPAS1 protein binds to USF2 protein]; Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]; cobaltiprotoporphyrin inhibits the reaction [IL1B protein inhibits the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]]; Curcumin analog inhibits the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]; Cycloheximide inhibits the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]; EPAS1 affects the reaction [Oxygen deficiency results in increased expression of MYC protein]; EPAS1 gene mutant form inhibits the reaction [Oxygen deficiency results in decreased expression of CPT1A mRNA]; EPAS1 gene mutant form inhibits the reaction [Oxygen deficiency results in decreased expression of FASN mRNA]; EPAS1 gene mutant form inhibits the reaction [Oxygen deficiency results in decreased expression of PPARGC1A protein]; EPAS1 gene mutant form inhibits the reaction [Oxygen deficiency results in decreased expression of SCD mRNA]; EPAS1 gene mutant form inhibits the reaction [Oxygen deficiency results in decreased expression of SREBF1 protein]; EPAS1 mutant form inhibits the reaction [Oxygen deficiency results in increased expression of NEK8 protein]; EPAS1 protein affects the reaction [Oxygen deficiency results in increased expression of EPO mRNA]; EPAS1 protein affects the reaction [Oxygen deficiency results in increased expression of SOD2 mRNA]; Glutathione inhibits the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]; HMOX1 mutant form inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [IL1B protein inhibits the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]]]; IL1B protein inhibits the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]; linderalactone inhibits the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]; Niclosamide inhibits the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]; Oxygen deficiency results in increased expression of and affects the localization of EPAS1 protein Oxygen deficiency affects the localization of EPAS1 protein
|
CTD |
PMID:12679337 PMID:18353899 PMID:20046830 PMID:20554536 PMID:20862257 PMID:20880076 PMID:21994956 PMID:23406266 PMID:23545307 PMID:23725749 PMID:23958427 PMID:24236059 PMID:24403227 PMID:24503013 PMID:24755467 PMID:25451921 PMID:26095976 PMID:26723917 PMID:27292261 PMID:32173479 PMID:36318118 More...
|
|
NCBI chr 6:13,543,252...13,626,147
Ensembl chr 6:13,544,389...13,624,729
|
|
| G
|
Epb41l4b
|
erythrocyte membrane protein band 4.1 like 4B
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EPB41L4B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:76,486,886...76,647,752
Ensembl chr 5:76,486,902...76,647,752
|
|
| G
|
Epb42
|
erythrocyte membrane protein band 4.2
|
multiple interactions increases expression
|
ISO
|
Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of EPB42 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 3:128,433,460...128,451,683
Ensembl chr 3:128,433,464...128,451,683
|
|
| G
|
Epcam
|
epithelial cell adhesion molecule
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of EPCAM mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 6:12,633,715...12,649,678
Ensembl chr 6:12,631,611...12,649,702
|
|
| G
|
Epha1
|
Eph receptor A1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EPHA1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:72,213,022...72,227,543
Ensembl chr 4:72,213,037...72,227,474
|
|
| G
|
Epha2
|
Eph receptor A2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EPHA2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:158,888,629...158,917,100
Ensembl chr 5:158,888,629...158,917,234
|
|
| G
|
Epha3
|
Eph receptor A3
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of EPHA3 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr11:14,585,041...14,920,721
Ensembl chr11:14,586,727...14,920,425
|
|
| G
|
Ephx1
|
epoxide hydrolase 1
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of EPHX1 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of EPHX1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981
|
|
| G
|
Ephx2
|
epoxide hydrolase 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of EPHX2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr15:44,465,447...44,503,157
Ensembl chr15:44,465,448...44,503,160
|
|
| G
|
Epm2aip1
|
EPM2A interacting protein 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of EPM2AIP1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 8:120,112,265...120,119,613
Ensembl chr 8:120,112,084...120,121,458
|
|
| G
|
Epo
|
erythropoietin
|
multiple interactions increases secretion increases expression increases abundance
|
ISO EXP
|
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA]; Amphotericin B inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA]; Cadmium Chloride inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA]; Cadmium Chloride inhibits the reaction [Oxygen deficiency results in increased expression of EPO protein]; Cadmium inhibits the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EPO promoter]]; Cadmium inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA]; Cisplatin inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA]; Cisplatin inhibits the reaction [Oxygen deficiency results in increased expression of EPO protein]; cobaltous chloride inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA]; CYP2D6 protein inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA]; CYP3A4 protein promotes the reaction [Oxygen deficiency results in increased expression of EPO mRNA]; dihydrotanshinone I inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA]; EPAS1 protein affects the reaction [Oxygen deficiency results in increased expression of EPO mRNA]; EPO protein inhibits the reaction [Oxygen deficiency results in increased secretion of EDN1 protein]; Indican inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA]; Ketoconazole inhibits the reaction [CYP3A4 protein promotes the reaction [Oxygen deficiency results in increased expression of EPO mRNA]]; Ketoconazole inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA]; Mercuric Chloride inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA]; Mercuric Chloride inhibits the reaction [Oxygen deficiency results in increased expression of EPO protein]; Nitroprusside inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA]; Oxygen deficiency inhibits the reaction [sodium arsenate results in decreased expression of EPO mRNA]; Oxygen deficiency promotes the reaction [[HIF1A protein binds to ARNT protein] which binds to EPO enhancer]; Oxygen deficiency promotes the reaction [HIF1A protein binds to EPO promoter]; SIRT1 protein inhibits the reaction [Oxygen deficiency results in increased abundance of EPO protein]; sodium arsenate inhibits the reaction [Oxygen deficiency results in increased abundance of EPO protein]; zinc chloride inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA] [Oxygen deficiency co-treated with cobaltous chloride] results in increased expression of EPO mRNA; [Oxygen deficiency co-treated with cobaltous chloride] results in increased expression of EPO protein; Amphotericin B inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA]; cyclo(Trp-Asp-Pro-Val-Leu) promotes the reaction [Oxygen deficiency results in increased expression of EPO mRNA]; Diethylstilbestrol inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA]; Diethylstilbestrol inhibits the reaction [Oxygen deficiency results in increased expression of EPO protein]; EPO protein inhibits the reaction [Oxygen results in increased expression of ACHE mRNA alternative form] Cycloheximide inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA]; Hydrogen Peroxide inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA] Oxygen deficiency results in increased secretion of EPO protein Oxygen deficiency results in increased expression of EPO; Oxygen deficiency results in increased expression of EPO mRNA; Oxygen deficiency results in increased expression of EPO protein
|
CTD |
PMID:10756076 PMID:10866824 PMID:11090055 PMID:11286986 PMID:16189267 PMID:18331222 PMID:19278353 PMID:19497871 PMID:19729061 PMID:21120517 PMID:21566342 PMID:21863063 PMID:23437309 PMID:23877121 PMID:23958427 PMID:24557580 PMID:24614111 PMID:26282490 PMID:34541741 PMID:38876227 More...
|
|
NCBI chr12:24,841,285...24,844,725
Ensembl chr12:24,841,285...24,844,725
|
|
| G
|
Epor
|
erythropoietin receptor
|
increases expression
|
EXP
|
Oxygen deficiency results in increased expression of EPOR mRNA; Oxygen deficiency results in increased expression of EPOR protein
|
CTD |
PMID:19497871 |
|
NCBI chr 8:28,765,738...28,770,371
Ensembl chr 8:28,765,746...28,770,322
|
|
| G
|
Eprs1
|
glutamyl-prolyl-tRNA synthetase 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of EPRS1 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr13:99,431,955...99,503,510
Ensembl chr13:99,433,130...99,503,509
|
|
| G
|
Eps8l1
|
EPS8 signaling adaptor L1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EPS8L1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:78,386,916...78,409,972
Ensembl chr 1:78,386,916...78,406,187
|
|
| G
|
Epsti1
|
epithelial stromal interaction 1
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of EPSTI1 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of EPSTI1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr15:59,692,712...59,791,376
Ensembl chr15:59,693,142...59,791,380
|
|
| G
|
Erbb2
|
erb-b2 receptor tyrosine kinase 2
|
multiple interactions
|
ISO
|
[Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of ERBB2 mRNA; [Oxygen co-treated with Ozone] inhibits the reaction [Cannabidiol results in decreased expression of ERBB2 mRNA]; [Oxygen co-treated with Ozone] results in decreased expression of ERBB2 mRNA; Cannabidiol inhibits the reaction [[Oxygen co-treated with Ozone] results in decreased expression of ERBB2 mRNA]
|
CTD |
PMID:32992648 |
|
NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,907,460...83,931,481
|
|
| G
|
Erbb3
|
erb-b2 receptor tyrosine kinase 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ERBB3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:1,579,079...1,600,379
Ensembl chr 7:1,579,816...1,601,120
|
|
| G
|
Ercc1
|
ERCC excision repair 1, endonuclease non-catalytic subunit
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ERCC1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:88,099,308...88,135,966
Ensembl chr 1:88,118,891...88,139,120
|
|
| G
|
Ercc6l
|
ERCC excision repair 6 like, spindle assembly checkpoint helicase
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ERCC6L mRNA
|
CTD |
PMID:17175027 PMID:26516004 |
|
NCBI chr X:71,285,380...71,301,186
Ensembl chr X:71,285,380...71,301,186
|
|
| G
|
Ercc8
|
ERCC excision repair 8, CSA ubiquitin ligase complex subunit
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ERCC8 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:41,380,901...41,418,294
Ensembl chr 2:41,380,901...41,418,294
|
|
| G
|
Ereg
|
epiregulin
|
multiple interactions
|
ISO EXP
|
Oxygen inhibits the reaction [darinaparsin results in decreased expression of EREG mRNA] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EREG mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of EREG mRNA
|
CTD |
PMID:22535156 PMID:30529165 PMID:33729688 |
|
NCBI chr14:17,311,485...17,325,260
Ensembl chr14:17,311,485...17,325,260
|
|
| G
|
Erich1
|
glutamate-rich 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ERICH1 mRNA
|
CTD |
PMID:17175027 |
|
NCBI chr16:82,203,536...82,271,361
Ensembl chr16:82,203,610...82,272,989
|
|
| G
|
Erln
|
endoregulin
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of ERLN mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:101,643,129...101,652,465
|
|
| G
|
Ermap
|
erythroblast membrane associated protein (Scianna blood group)
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of ERMAP mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of ERMAP mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 5:138,074,155...138,088,340
Ensembl chr 5:138,065,824...138,087,015 Ensembl chr 5:138,065,824...138,087,015
|
|
| G
|
Ern1
|
endoplasmic reticulum to nucleus signaling 1
|
multiple interactions increases expression
|
ISO
|
1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone inhibits the reaction [Oxygen results in increased expression of ERN1 protein]; 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline inhibits the reaction [1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone inhibits the reaction [Oxygen results in increased expression of ERN1 protein]]
|
CTD |
PMID:32996202 |
|
NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,830,428...91,920,791
|
|
| G
|
Ero1a
|
endoplasmic reticulum oxidoreductase 1 alpha
|
increases expression multiple interactions
|
EXP ISO
|
Oxygen deficiency results in increased expression of ERO1A mRNA; Oxygen deficiency results in increased expression of ERO1A protein Oxygen deficiency results in increased expression of ERO1A; Oxygen deficiency results in increased expression of ERO1A mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ERO1A mRNA
|
CTD |
PMID:12752442 PMID:20880076 PMID:25596134 PMID:26516004 PMID:33729688 |
|
NCBI chr15:20,974,771...21,010,170
Ensembl chr15:20,972,679...21,018,039
|
|
| G
|
Ero1b
|
endoplasmic reticulum oxidoreductase 1 beta
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ERO1B
|
CTD |
PMID:12752442 |
|
NCBI chr17:92,913,696...92,987,401
Ensembl chr17:92,814,368...92,987,555
|
|
| G
|
Erp27
|
endoplasmic reticulum protein 27
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ERP27 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 4:171,535,845...171,552,848
Ensembl chr 4:171,535,847...171,553,072
|
|
| G
|
Errfi1
|
ERBB receptor feedback inhibitor 1
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of ERRFI1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ERRFI1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ERRFI1 mRNA
|
CTD |
PMID:26516004 PMID:30529165 PMID:33729688 |
|
NCBI chr 5:166,606,841...166,620,124
Ensembl chr 5:166,606,834...166,620,432
|
|
| G
|
Esco2
|
establishment of sister chromatid cohesion N-acetyltransferase 2
|
increases expression multiple interactions decreases expression
|
ISO
|
Oxygen deficiency results in increased expression of ESCO2 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of ESCO2 mRNA] Oxygen deficiency results in decreased expression of ESCO2 mRNA
|
CTD |
PMID:22629407 PMID:26516004 |
|
NCBI chr15:44,210,124...44,230,785
Ensembl chr15:44,210,641...44,231,304 Ensembl chr15:44,210,641...44,231,304
|
|
| G
|
Espl1
|
extra spindle pole bodies like 1, separase
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ESPL1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 7:135,302,460...135,329,570
Ensembl chr 7:135,302,716...135,329,570
|
|
| G
|
Esr1
|
estrogen receptor 1
|
decreases expression multiple interactions increases expression affects expression
|
ISO EXP
|
Oxygen deficiency results in decreased expression of ESR1 mRNA; Oxygen deficiency results in decreased expression of ESR1 protein [Oxygen deficiency co-treated with Diethylhexyl Phthalate] results in decreased expression of ESR1 protein; [Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in increased activity of ESR1 protein; Oxygen deficiency promotes the reaction [bisphenol A results in decreased expression of ESR1 mRNA]; Oxygen deficiency promotes the reaction [bisphenol A results in decreased expression of ESR1 protein]; Oxygen deficiency promotes the reaction [butylbenzyl phthalate results in decreased expression of ESR1 mRNA]; Oxygen deficiency promotes the reaction [butylbenzyl phthalate results in decreased expression of ESR1 protein]; Oxygen deficiency promotes the reaction [Diethylhexyl Phthalate results in decreased expression of ESR1 mRNA]; Oxygen deficiency promotes the reaction [Estradiol results in decreased expression of ESR1 mRNA]; Oxygen deficiency promotes the reaction [Estradiol results in decreased expression of ESR1 protein] Oxygen deficiency results in increased expression of ESR1 mRNA; Oxygen deficiency results in increased expression of ESR1 protein [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of ESR1 mRNA; Estradiol affects the reaction [Oxygen deficiency affects the expression of ESR1 mRNA]; Estradiol affects the reaction [Oxygen deficiency affects the expression of ESR1 protein]; Estradiol inhibits the reaction [Oxygen deficiency results in decreased expression of ESR1 mRNA]; Genistein affects the reaction [Oxygen deficiency affects the expression of ESR1 mRNA]; Genistein affects the reaction [Oxygen deficiency affects the expression of ESR1 protein]; Genistein inhibits the reaction [Oxygen deficiency results in decreased expression of ESR1 mRNA]; parthenocissin A analog affects the reaction [Oxygen deficiency affects the expression of ESR1 mRNA]; parthenocissin A analog affects the reaction [Oxygen deficiency affects the expression of ESR1 protein]; parthenocissin A analog affects the reaction [Oxygen deficiency results in decreased expression of ESR1 protein]; parthenocissin A analog inhibits the reaction [Oxygen deficiency results in decreased expression of ESR1 mRNA]; Resveratrol affects the reaction [Oxygen deficiency affects the expression of ESR1 mRNA]; Resveratrol affects the reaction [Oxygen deficiency affects the expression of ESR1 protein]; Resveratrol inhibits the reaction [Oxygen deficiency results in decreased expression of ESR1 mRNA]; tetrahydropalmatine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of ESR1 mRNA] Oxygen deficiency affects the expression of ESR1 mRNA; Oxygen deficiency affects the expression of ESR1 protein Oxygen deficiency affects the expression of ESR1 protein; Oxygen deficiency affects the expression of ESR1 protein alternative form [Raloxifene Hydrochloride co-treated with Oxygen deficiency] results in increased expression of ESR1 protein; bazedoxifene affects the reaction [Oxygen deficiency affects the expression of ESR1 protein alternative form]; bazedoxifene affects the reaction [Oxygen deficiency affects the expression of ESR1 protein]; Raloxifene Hydrochloride affects the reaction [Oxygen deficiency affects the expression of ESR1 protein alternative form]; Raloxifene Hydrochloride inhibits the reaction [Oxygen deficiency results in decreased expression of ESR1 mRNA]
|
CTD |
PMID:15927375 PMID:18457817 PMID:19578757 PMID:24333797 PMID:24846829 PMID:28859903 PMID:30851587 PMID:37606869 More...
|
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
Esr2
|
estrogen receptor 2
|
multiple interactions decreases expression affects expression increases expression
|
EXP ISO
|
Estradiol affects the reaction [Oxygen deficiency affects the expression of ESR2 mRNA]; Estradiol affects the reaction [Oxygen deficiency affects the expression of ESR2 protein]; Estradiol inhibits the reaction [Oxygen deficiency results in decreased expression of ESR2 mRNA]; Estradiol inhibits the reaction [Oxygen deficiency results in decreased expression of ESR2 protein]; Genistein affects the reaction [Oxygen deficiency affects the expression of ESR2 mRNA]; Genistein affects the reaction [Oxygen deficiency affects the expression of ESR2 protein]; Genistein inhibits the reaction [Oxygen deficiency results in decreased expression of ESR2 mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in decreased expression of ESR2 protein]; parthenocissin A analog affects the reaction [Oxygen deficiency affects the expression of ESR2 mRNA]; parthenocissin A analog affects the reaction [Oxygen deficiency affects the expression of ESR2 protein]; parthenocissin A analog inhibits the reaction [Oxygen deficiency results in decreased expression of ESR2 mRNA]; parthenocissin A analog inhibits the reaction [Oxygen deficiency results in decreased expression of ESR2 protein]; resveratrol affects the reaction [Oxygen deficiency affects the expression of ESR2 mRNA]; resveratrol affects the reaction [Oxygen deficiency affects the expression of ESR2 protein]; resveratrol inhibits the reaction [Oxygen deficiency results in decreased expression of ESR2 mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in decreased expression of ESR2 protein] Oxygen deficiency results in decreased expression of ESR2 mRNA; Oxygen deficiency results in decreased expression of ESR2 protein Oxygen deficiency affects the expression of ESR2 mRNA; Oxygen deficiency affects the expression of ESR2 protein Raloxifene Hydrochloride inhibits the reaction [Oxygen deficiency results in increased expression of ESR2 mRNA]; Raloxifene Hydrochloride inhibits the reaction [Oxygen deficiency results in increased expression of ESR2 protein] Oxygen deficiency results in increased expression of ESR2 mRNA; Oxygen deficiency results in increased expression of ESR2 protein
|
CTD |
PMID:18457817 PMID:24333797 PMID:24846829 |
|
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
| G
|
Esyt2
|
extended synaptotagmin 2
|
multiple interactions
|
ISO EXP
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of ESYT2 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ESYT2 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 6:143,359,870...143,455,600
Ensembl chr 6:143,362,694...143,455,593
|
|
| G
|
Esyt3
|
extended synaptotagmin 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ESYT3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:108,749,761...108,796,630
Ensembl chr 8:108,750,489...108,796,572
|
|
| G
|
Etf1
|
eukaryotic translation termination factor 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ETF1 mRNA; [sulforaphane affects the susceptibility to Oxygen] which affects the expression of ETF1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr18:26,776,518...26,804,857
Ensembl chr18:26,777,858...26,804,613
|
|
| G
|
Etfbkmt
|
electron transfer flavoprotein subunit beta lysine methyltransferase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ETFBKMT mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:183,871,819...183,936,843
Ensembl chr 4:183,871,827...183,881,621
|
|
| G
|
Etl4
|
enhancer trap locus 4
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ETL4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr17:87,749,486...88,213,158
Ensembl chr17:87,403,819...88,213,158
|
|
| G
|
Ets1
|
ETS proto-oncogene 1, transcription factor
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ETS1 mRNA
|
CTD |
PMID:20042640 |
|
NCBI chr 8:39,303,936...39,426,022
Ensembl chr 8:39,303,925...39,426,021
|
|
| G
|
Etv4
|
ETS variant transcription factor 4
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ETV4 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:87,206,977...87,222,202
Ensembl chr10:87,206,977...87,222,318
|
|
| G
|
Etv5
|
ETS variant transcription factor 5
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of ETV5 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ETV5 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr11:92,113,171...92,170,758
Ensembl chr11:92,113,224...92,170,767
|
|
| G
|
Etv6
|
ETS variant transcription factor 6
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ETV6 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:168,580,405...168,819,817
Ensembl chr 4:168,580,138...168,819,802
|
|
| G
|
Eva1b
|
eva-1 homolog B
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EVA1B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:143,711,627...143,716,963
Ensembl chr 5:143,711,395...143,717,551
|
|
| G
|
Evi2b
|
ecotropic viral integration site 2B
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of EVI2B mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:64,970,659...64,972,277
Ensembl chr10:64,964,719...64,979,417
|
|
| G
|
Evl
|
Enah/Vasp-like
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EVL mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:133,238,547...133,358,730
Ensembl chr 6:133,238,547...133,358,729
|
|
| G
|
Exo1
|
exonuclease 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of EXO1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr13:90,341,947...90,366,861
Ensembl chr13:90,342,018...90,366,861
|
|
| G
|
Exoc1
|
exocyst complex component 1
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of EXOC1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:31,965,782...32,014,156
Ensembl chr14:31,965,782...32,014,127
|
|
| G
|
Exoc7
|
exocyst complex component 7
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of EXOC7 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr10:102,019,805...102,039,333
Ensembl chr10:102,019,806...102,039,447
|
|
| G
|
Exosc1
|
exosome component 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EXOSC1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:250,684,746...250,694,748
Ensembl chr 1:250,684,750...250,694,748
|
|
| G
|
Exosc2
|
exosome component 2
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of EXOSC2 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EXOSC2 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 3:35,360,652...35,370,948
Ensembl chr 3:35,360,666...35,371,373
|
|
| G
|
Exph5
|
exophilin 5
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EXPH5 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:62,595,116...62,671,575
Ensembl chr 8:62,595,116...62,671,575
|
|
| G
|
Ext2
|
exostosin glycosyltransferase 2
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of EXT2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:100,120,776...100,253,424
Ensembl chr 3:100,120,776...100,253,596
|
|
| G
|
Eya4
|
EYA transcriptional coactivator and phosphatase 4
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of EYA4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:23,991,431...24,235,132
Ensembl chr 1:23,991,431...24,235,131
|
|
| G
|
Ezh2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
multiple interactions
|
ISO
|
Oxygen deficiency promotes the reaction [EZH2 protein binds to DICER1 promoter]
|
CTD |
PMID:25351418 |
|
NCBI chr 4:77,624,223...77,698,598
Ensembl chr 4:77,624,223...77,687,183
|
|
| G
|
F10
|
coagulation factor X
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of F10 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr16:83,170,973...83,190,280
Ensembl chr16:83,170,977...83,190,280
|
|
| G
|
F13a1
|
coagulation factor XIII A1 chain
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of F13A1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of F13A1 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr17:28,021,197...28,197,960
Ensembl chr17:28,020,845...28,197,948
|
|
| G
|
F2r
|
coagulation factor II (thrombin) receptor
|
multiple interactions increases expression
|
ISO
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of F2R mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of F2R mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of F2R mRNA]; Oxygen deficiency inhibits the reaction [darinaparsin results in increased expression of F2R mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of F2R mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of F2R mRNA]
|
CTD |
PMID:22535156 PMID:23452621 |
|
NCBI chr 2:28,604,066...28,620,579
Ensembl chr 2:28,604,066...28,620,579
|
|
| G
|
F2rl2
|
coagulation factor II (thrombin) receptor-like 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of F2RL2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 2:28,706,766...28,711,808
Ensembl chr 2:28,706,501...28,712,473
|
|
| G
|
F3
|
coagulation factor III, tissue factor
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of F3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369
|
|
| G
|
F8
|
coagulation factor VIII
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of F8 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr18:155,237...187,186
Ensembl chr18:155,309...186,683
|
|
| G
|
Fabp1
|
fatty acid binding protein 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of FABP1 protein sarpogrelate inhibits the reaction [Oxygen deficiency results in increased expression of FABP1 protein]
|
CTD |
PMID:24107419 |
|
NCBI chr 4:104,744,302...104,753,119
Ensembl chr 4:104,744,309...104,753,113
|
|
| G
|
Fabp3
|
fatty acid binding protein 3
|
increases expression decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of FABP3 mRNA; Oxygen deficiency results in increased expression of FABP3 protein Oxygen deficiency results in decreased expression of FABP3 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FABP3 mRNA [FV-429 compound co-treated with Paclitaxel] inhibits the reaction [Oxygen deficiency results in increased expression of FABP3 protein]
|
CTD |
PMID:24236059 PMID:25596134 PMID:30529165 PMID:34648812 |
|
NCBI chr 5:147,936,027...147,942,870
Ensembl chr 5:147,936,119...147,942,881
|
|
| G
|
Fabp4
|
fatty acid binding protein 4
|
decreases expression increases expression
|
ISO
|
Oxygen deficiency results in decreased expression of FABP4 mRNA Oxygen deficiency results in increased expression of FABP4 mRNA
|
CTD |
PMID:12032628 PMID:20880076 |
|
NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972
|
|
| G
|
Fabp5
|
fatty acid binding protein 5
|
increases expression
|
EXP
|
Oxygen results in increased expression of FABP5 mRNA
|
CTD |
PMID:22911455 |
|
NCBI chr 2:93,672,451...93,676,186
Ensembl chr 2:93,672,458...93,676,127
|
|
| G
|
Fabp7
|
fatty acid binding protein 7
|
multiple interactions increases expression
|
ISO
|
[FV-429 compound co-treated with Paclitaxel] inhibits the reaction [Oxygen deficiency results in increased expression of FABP7 protein]; Paclitaxel inhibits the reaction [Oxygen deficiency results in increased expression of FABP7 protein]
|
CTD |
PMID:34648812 |
|
NCBI chr20:37,667,125...37,673,299
Ensembl chr20:37,669,601...37,675,907
|
|
| G
|
Fadd
|
Fas associated via death domain
|
multiple interactions increases expression
|
ISO
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of FADD mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of FADD mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of FADD mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of FADD mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of FADD mRNA]
|
CTD |
PMID:23452621 |
|
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:209,169,318...209,174,976
|
|
| G
|
Fam110b
|
family with sequence similarity 110, member B
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FAM110B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:23,587,093...23,727,188
Ensembl chr 5:23,586,867...23,799,583
|
|
| G
|
Fam111a
|
FAM111 trypsin like peptidase A
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FAM111A mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FAM111A mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:219,065,542...219,081,213
Ensembl chr 1:219,065,601...219,081,211
|
|
| G
|
Fam117a
|
family with sequence similarity 117, member A
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of FAM117A mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FAM117A mRNA; Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of FAM117A mRNA]
|
CTD |
PMID:22629407 PMID:30529165 |
|
NCBI chr10:80,778,229...80,822,119
Ensembl chr10:80,755,883...80,822,119
|
|
| G
|
Fam117b
|
family with sequence similarity 117, member B
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of FAM117B mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 9:68,834,334...68,902,543
Ensembl chr 9:68,834,354...68,902,543
|
|
| G
|
Fam13a
|
family with sequence similarity 13, member A
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of FAM13A mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FAM13A mRNA
|
CTD |
PMID:24236059 PMID:26516004 PMID:30529165 |
|
NCBI chr 4:89,386,685...89,485,940
Ensembl chr 4:89,388,569...89,485,988
|
|
| G
|
Fam162a
|
family with sequence similarity 162, member A
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of FAM162A mRNA
|
CTD |
PMID:20880076 PMID:24236059 PMID:25596134 |
|
NCBI chr11:78,186,260...78,215,186
Ensembl chr11:78,185,852...78,216,560
|
|
| G
|
Fam167a
|
family with sequence similarity 167, member A
|
affects expression multiple interactions
|
ISO EXP
|
Oxygen deficiency affects the expression of FAM167A mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FAM167A mRNA
|
CTD |
PMID:25596134 PMID:33729688 |
|
NCBI chr15:41,861,271...41,891,427
Ensembl chr15:41,861,227...41,891,418
|
|
| G
|
Fam174b
|
family with sequence similarity 174, member B
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FAM174B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:136,925,162...137,006,082
Ensembl chr 1:136,925,151...137,035,589
|
|
| G
|
Fam184b
|
family with sequence similarity 184, member B
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FAM184B mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr14:69,688,031...69,803,922
Ensembl chr14:69,688,031...69,803,922
|
|
| G
|
Fam193b
|
family with sequence similarity 193, member B
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FAM193B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr17:9,071,974...9,104,659
Ensembl chr17:9,071,795...9,104,656
|
|
| G
|
Fam210a
|
family with sequence similarity 210, member A
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of FAM210A mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr18:64,116,274...64,155,971
Ensembl chr18:64,116,274...64,155,949
|
|
| G
|
Fam210b
|
family with sequence similarity 210, member B
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of FAM210B mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 3:181,536,665...181,546,830
Ensembl chr 3:181,536,673...181,546,834
|
|
| G
|
Fam221a
|
family with sequence similarity 221, member A
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FAM221A mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:79,668,130...79,689,768
Ensembl chr 4:79,667,284...79,689,761
|
|
| G
|
Fam222a
|
family with sequence similarity 222, member A
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of FAM222A mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr12:47,647,221...47,693,703
Ensembl chr12:47,647,405...47,693,703
|
|
| G
|
Fam81a
|
family with sequence similarity 81, member A
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FAM81A mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 8:79,643,754...79,702,792
Ensembl chr 8:79,644,516...79,702,767
|
|
| G
|
Fam83d
|
family with sequence similarity 83, member D
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of FAM83D mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 3:167,841,748...167,861,062
Ensembl chr 3:167,841,791...167,861,061
|
|
| G
|
Fam83h
|
family with sequence similarity 83, member H
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FAM83H mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:109,597,129...109,605,317
Ensembl chr 7:109,597,129...109,609,188
|
|
| G
|
Fanca
|
FA complementation group A
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of FANCA mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr19:68,210,562...68,271,080
Ensembl chr19:68,212,643...68,271,019
|
|
| G
|
Fancb
|
FA complementation group B
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of FANCB mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr X:33,035,387...33,051,993
Ensembl chr X:33,035,387...33,051,808
|
|
| G
|
Fancd2
|
FA complementation group D2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of FANCD2 mRNA; Oxygen deficiency results in decreased expression of FANCD2 protein
|
CTD |
PMID:26516004 PMID:28472268 |
|
NCBI chr 4:148,234,633...148,299,035
Ensembl chr 4:148,234,708...148,299,035
|
|
| G
|
Fanci
|
FA complementation group I
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of FANCI mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:142,736,636...142,792,999
Ensembl chr 1:142,736,653...142,792,999
|
|
| G
|
Farsb
|
phenylalanyl-tRNA synthetase subunit beta
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of FARSB mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 9:87,336,321...87,395,546
Ensembl chr 9:87,336,326...87,395,505
|
|
| G
|
Fas
|
Fas cell surface death receptor
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of FAS mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FAS mRNA
|
CTD |
PMID:25596134 PMID:30529165 |
|
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104
|
|
| G
|
Faslg
|
Fas ligand
|
multiple interactions increases expression
|
ISO
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of FASLG mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of FASLG mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of FASLG mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of FASLG mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of FASLG mRNA]
|
CTD |
PMID:23452621 |
|
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503
|
|
| G
|
Fasn
|
fatty acid synthase
|
increases expression multiple interactions decreases expression
|
ISO
|
Oxygen deficiency results in increased expression of FASN mRNA [FV-429 compound co-treated with Oxygen deficiency] affects the expression of FASN protein; [FV-429 compound co-treated with Paclitaxel] inhibits the reaction [Oxygen deficiency results in increased expression of FASN protein]; [Paclitaxel co-treated with FV-429 compound co-treated with Deferoxamine] promotes the reaction [Oxygen deficiency results in increased expression of FASN protein]; [Paclitaxel co-treated with FV-429 compound] inhibits the reaction [Oxygen deficiency results in increased expression of FASN mRNA]; [Paclitaxel co-treated with FV-429 compound] inhibits the reaction [Oxygen deficiency results in increased expression of FASN protein]; Deferoxamine promotes the reaction [Oxygen deficiency results in increased expression of FASN protein]; EPAS1 gene mutant form inhibits the reaction [Oxygen deficiency results in decreased expression of FASN mRNA]; HIF1A gene mutant form inhibits the reaction [Oxygen deficiency results in decreased expression of FASN mRNA]; Paclitaxel inhibits the reaction [Oxygen deficiency results in increased expression of FASN protein] Oxygen deficiency results in decreased expression of FASN mRNA; Oxygen deficiency results in decreased expression of FASN protein [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FASN mRNA Oxygen deficiency results in increased expression of FASN mRNA; Oxygen deficiency results in increased expression of FASN protein
|
CTD |
PMID:24205000 PMID:24503013 PMID:26087400 PMID:26516004 PMID:30529165 PMID:34648812 More...
|
|
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
|
|
| G
|
Fat3
|
FAT atypical cadherin 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FAT3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:20,972,840...21,555,679
Ensembl chr 8:20,972,840...21,555,240
|
|
| G
|
Fbln1
|
fibulin 1
|
multiple interactions
|
ISO EXP
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of FBLN1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FBLN1 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 7:118,190,347...118,269,965
Ensembl chr 7:118,190,478...118,269,965
|
|
| G
|
Fbln2
|
fibulin 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of FBLN2 mRNA
|
CTD |
PMID:24205000 PMID:26516004 |
|
NCBI chr 4:125,261,464...125,321,030
Ensembl chr 4:125,261,607...125,321,029
|
|
| G
|
Fbln5
|
fibulin 5
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of FBLN5 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 6:126,664,100...126,742,847
Ensembl chr 6:126,664,100...126,746,296
|
|
| G
|
Fbn2
|
fibrillin 2
|
multiple interactions
|
ISO
|
Oxygen inhibits the reaction [darinaparsin results in increased expression of FBN2 mRNA]
|
CTD |
PMID:22535156 |
|
NCBI chr18:53,696,197...53,901,992
Ensembl chr18:53,697,708...53,902,191
|
|
| G
|
Fbp2
|
fructose-bisphosphatase 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FBP2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr17:2,241,767...2,259,371
Ensembl chr17:2,241,975...2,259,366
|
|
| G
|
Fbrsl1
|
fibrosin-like 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of FBRSL1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr12:51,891,211...51,979,715
Ensembl chr12:51,960,790...51,979,361
|
|
| G
|
Fbxl7
|
F-box and leucine-rich repeat protein 7
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of FBXL7 mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr 2:78,870,236...79,239,697
Ensembl chr 2:78,871,287...79,239,697
|
|
| G
|
Fbxo15
|
F-box protein 15
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FBXO15 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr18:80,594,444...80,909,549
Ensembl chr 6:51,576,566...51,577,639 Ensembl chr18:51,576,566...51,577,639
|
|
| G
|
Fbxo17
|
F-box protein 17
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FBXO17 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:93,129,776...93,151,983
Ensembl chr 1:93,129,849...93,151,981
|
|
| G
|
Fbxo22
|
F-box protein 22
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of FBXO22 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 8:64,476,034...64,492,063
Ensembl chr 8:64,475,957...64,492,062
|
|
| G
|
Fbxo30
|
F-box protein 30
|
increases expression multiple interactions decreases expression
|
ISO
|
Oxygen deficiency results in increased expression of FBXO30 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of FBXO30 mRNA] Oxygen deficiency results in decreased expression of FBXO30 mRNA
|
CTD |
PMID:22629407 PMID:25596134 |
|
NCBI chr 1:7,475,636...7,491,719
Ensembl chr 1:7,475,575...7,493,199
|
|
| G
|
Fbxo32
|
F-box protein 32
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of FBXO32 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FBXO32 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FBXO32 mRNA
|
CTD |
PMID:23624791 PMID:26516004 PMID:30529165 PMID:33729688 |
|
NCBI chr 7:91,620,925...91,654,491
Ensembl chr 7:91,620,925...91,654,491
|
|
| G
|
Fbxo39
|
F-box protein 39
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FBXO39 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FBXO39 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr10:57,428,259...57,433,468
Ensembl chr10:57,430,848...57,433,467
|
|
| G
|
Fbxo7
|
F-box protein 7
|
multiple interactions increases expression
|
ISO
|
Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of FBXO7 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 7:19,696,951...19,725,180
Ensembl chr 7:19,696,961...19,725,180
|
|
| G
|
Fbxo9
|
f-box protein 9
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FBXO9 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:87,838,787...87,864,362
Ensembl chr 8:87,838,789...87,864,504
|
|
| G
|
Fbxw10
|
F-box and WD repeat domain containing 10
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FBXW10 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FBXW10 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr10:48,012,555...48,051,136
Ensembl chr10:47,958,677...48,051,136
|
|
| G
|
Fbxw7
|
F-box and WD repeat domain containing 7
|
multiple interactions
|
ISO
|
FBXW7 mRNA affects the reaction [Oxygen deficiency results in increased degradation of MYC protein]; FBXW7 protein affects the reaction [Oxygen deficiency results in increased degradation of MYC protein]
|
CTD |
PMID:20046830 |
|
NCBI chr 2:172,447,738...172,609,591
Ensembl chr 2:172,447,738...172,609,591
|
|
| G
|
Fcar
|
Fc alpha receptor
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FCAR mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:78,669,119...78,703,223
|
|
| G
|
Fcer2
|
Fc epsilon receptor II
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FCER2A mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr12:6,540,697...6,552,364
Ensembl chr12:6,540,703...6,549,374
|
|
| G
|
Fcgr1a
|
Fc gamma receptor 1A
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FCGR1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:186,539,941...186,548,941
Ensembl chr 2:186,539,942...186,548,858
|
|
| G
|
Fcgr2a
|
Fc gamma receptor 2A
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FCGR3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr13:85,813,516...85,830,269
Ensembl chr13:85,855,437...85,864,394 Ensembl chr13:85,855,437...85,864,394
|
|
| G
|
Fcgr2b
|
Fc gamma receptor 2B
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FCGR2B mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FCGR2B mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr13:85,725,897...85,740,517
Ensembl chr13:85,725,897...85,740,517
|
|
| G
|
Fcgr3a
|
Fc gamma receptor 3A
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FCGR3A mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FCGR3A mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr13:85,782,636...85,792,656
Ensembl chr13:85,782,490...85,792,651
|
|
| G
|
Fcmr
|
Fc mu receptor
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FCMR mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr13:44,889,628...44,903,926
Ensembl chr13:44,889,697...44,906,314
|
|
| G
|
Fcrl2
|
Fc receptor-like 2
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FCRL2 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FCRL2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 2:174,992,226...175,005,177
Ensembl chr 2:174,992,226...175,004,967
|
|
| G
|
Fcrla
|
Fc receptor-like A
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FCRLA mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr13:85,693,177...85,702,875
Ensembl chr13:85,693,122...85,703,176
|
|
| G
|
Fdft1
|
farnesyl diphosphate farnesyl transferase 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FDFT1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr15:41,588,114...41,616,168
Ensembl chr15:41,588,117...41,616,168
|
|
| G
|
Fdxacb1
|
ferredoxin-fold anticodon binding domain containing 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of FDXACB1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 8:60,009,818...60,014,625
|
|
| G
|
Fech
|
ferrochelatase
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of FECH mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FECH mRNA
|
CTD |
PMID:25596134 PMID:30529165 |
|
NCBI chr18:60,215,325...60,248,525
Ensembl chr18:60,215,325...60,249,546
|
|
| G
|
Fen1
|
flap structure-specific endonuclease 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of FEN1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:216,270,016...216,274,873
Ensembl chr 1:216,269,163...216,275,016
|
|
| G
|
Fermt1
|
FERM domain containing kindlin 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of FERMT1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 3:140,624,434...140,666,419
Ensembl chr 3:140,624,434...140,666,419
|
|
| G
|
Fermt3
|
FERM domain containing kindlin 3
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FERMT3 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:213,618,691...213,636,889
Ensembl chr 1:213,618,208...213,636,273
|
|
| G
|
Ferry3
|
FERRY endosomal RAB5 effector complex subunit 3
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of FERRY3 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 4:161,458,942...161,494,213
Ensembl chr 4:161,458,931...161,493,075
|
|
| G
|
Fetub
|
fetuin B
|
increases expression multiple interactions
|
EXP
|
Oxygen results in increased expression of FETUB mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FETUB mRNA
|
CTD |
PMID:22911455 PMID:33729688 |
|
NCBI chr11:91,586,750...91,599,789
Ensembl chr11:91,586,748...91,599,310
|
|
| G
|
Ffar2
|
free fatty acid receptor 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FFAR2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:95,199,277...95,202,599
Ensembl chr 1:95,199,271...95,202,623
|
|
| G
|
Fgb
|
fibrinogen beta chain
|
multiple interactions
|
ISO
|
[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased abundance of [[FGB protein binds to FGG protein] binds to [FGB protein binds to FGG protein]]
|
CTD |
PMID:16153449 |
|
NCBI chr 2:170,693,966...170,700,875
Ensembl chr 2:170,692,965...170,705,434
|
|
| G
|
Fgd2
|
FYVE, RhoGEF and PH domain containing 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FGD2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr20:7,426,407...7,443,207
Ensembl chr20:7,426,414...7,443,207
|
|
| G
|
Fgd3
|
FYVE, RhoGEF and PH domain containing 3
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FGD3 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr17:15,531,237...15,593,678
Ensembl chr17:15,543,236...15,593,676
|
|
| G
|
Fgf1
|
fibroblast growth factor 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FGF1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,939,870...30,961,393
|
|
| G
|
Fgf11
|
fibroblast growth factor 11
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of FGF11 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FGF11 mRNA
|
CTD |
PMID:20042640 PMID:24236059 PMID:26516004 PMID:33729688 |
|
NCBI chr10:55,015,232...55,020,773
Ensembl chr10:55,016,411...55,020,454
|
|
| G
|
Fgf12
|
fibroblast growth factor 12
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FGF12 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr11:85,501,947...86,069,543
Ensembl chr11:85,501,936...86,069,543
|
|
| G
|
Fgf2
|
fibroblast growth factor 2
|
multiple interactions
|
EXP ISO
|
Oxygen inhibits the reaction [Paraquat results in increased expression of FGF2 mRNA] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FGF2 mRNA
|
CTD |
PMID:26722498 PMID:30529165 |
|
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493
|
|
| G
|
Fgf21
|
fibroblast growth factor 21
|
decreases expression decreases secretion
|
ISO
|
Oxygen deficiency results in decreased expression of FGF21 mRNA Oxygen deficiency results in decreased secretion of FGF21 protein
|
CTD |
PMID:22917661 |
|
NCBI chr 1:105,219,825...105,221,376
Ensembl chr 1:105,219,825...105,232,056
|
|
| G
|
Fgf23
|
fibroblast growth factor 23
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FGF23 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 4:161,600,439...161,609,991
Ensembl chr 4:161,600,383...161,609,991
|
|
| G
|
Fgf5
|
fibroblast growth factor 5
|
multiple interactions
|
ISO
|
Oxygen deficiency promotes the reaction [LIF protein affects the reaction FGF5 mRNA]
|
CTD |
PMID:26723917 |
|
NCBI chr14:11,627,906...11,650,243
Ensembl chr14:11,627,906...11,650,243
|
|
| G
|
Fgfr2
|
fibroblast growth factor receptor 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FGFR2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:194,175,705...194,280,914
|
|
| G
|
Fgfr4
|
fibroblast growth factor receptor 4
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FGFR4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr17:9,466,686...9,481,423
Ensembl chr17:9,466,692...9,481,389
|
|
| G
|
Fgg
|
fibrinogen gamma chain
|
multiple interactions
|
ISO
|
[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased abundance of [[FGB protein binds to FGG protein] binds to [FGB protein binds to FGG protein]]
|
CTD |
PMID:16153449 |
|
NCBI chr 2:170,652,929...170,660,372
Ensembl chr 2:170,652,234...170,661,170
|
|
| G
|
Fgl2
|
fibrinogen-like 2
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FGL2 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FGL2 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 4:14,602,762...14,608,405
Ensembl chr 4:14,602,771...14,608,405
|
|
| G
|
Fgr
|
FGR proto-oncogene, Src family tyrosine kinase
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FGR mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 5:150,473,767...150,503,524
Ensembl chr 5:150,473,792...150,503,169
|
|
| G
|
Fhad1
|
forkhead associated phosphopeptide binding domain 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FHAD1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 5:159,474,111...159,593,455
Ensembl chr 5:159,474,158...159,593,367
|
|
| G
|
Fhdc1
|
FH2 domain containing 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FHDC1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:172,088,987...172,127,838
Ensembl chr 2:172,089,010...172,125,956
|
|
| G
|
Fhip1a
|
FHF complex subunit HOOK interacting protein 1A
|
multiple interactions increases expression
|
ISO
|
1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of FHIP1A mRNA]
|
CTD |
PMID:24403227 PMID:26516004 |
|
NCBI chr 2:173,319,252...173,489,514
Ensembl chr 2:173,319,257...173,453,902
|
|
| G
|
Fhl1
|
four and a half LIM domains 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FHL1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr X:139,592,794...139,652,290
Ensembl chr X:139,592,604...139,652,282
|
|
| G
|
Fhl2
|
four and a half LIM domains 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FHL2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:52,881,091...52,954,540
Ensembl chr 9:52,880,998...52,923,326
|
|
| G
|
Fhod1
|
formin homology 2 domain containing 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FHOD1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:50,116,415...50,135,868
Ensembl chr19:50,116,415...50,135,330
|
|
| G
|
Fhod3
|
formin homology 2 domain containing 3
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of FHOD3 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FHOD3 mRNA
|
CTD |
PMID:20880076 PMID:33729688 |
|
NCBI chr18:16,267,830...16,700,508
Ensembl chr18:16,267,977...16,700,508
|
|
| G
|
Fign
|
fidgetin, microtubule severing factor
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FIGN mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:69,045,918...69,169,148
Ensembl chr 3:69,045,050...69,169,988
|
|
| G
|
Fis1
|
fission, mitochondrial 1
|
increases expression multiple interactions
|
EXP
|
Oxygen deficiency results in increased expression of FIS1 protein Ru 360 inhibits the reaction [Oxygen deficiency results in increased expression of FIS1 protein]; Spermine inhibits the reaction [Oxygen deficiency results in increased expression of FIS1 protein]
|
CTD |
PMID:25911325 PMID:27684054 |
|
NCBI chr12:25,345,239...25,360,135
Ensembl chr12:25,345,239...25,349,335
|
|
| G
|
Fjx1
|
four-jointed box kinase 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FJX1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 3:109,229,223...109,231,324
Ensembl chr 3:109,227,170...109,232,479
|
|
| G
|
Fkbp10
|
FKBP prolyl isomerase 10
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FKBP10 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:85,845,801...85,858,361
Ensembl chr10:85,844,703...85,858,355
|
|
| G
|
Fkbp5
|
FKBP prolyl isomerase 5
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FKBP5 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,458,940...6,543,118
|
|
| G
|
Flcn
|
folliculin
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of FLCN mRNA
|
CTD |
PMID:17175027 |
|
NCBI chr10:45,088,164...45,107,581
Ensembl chr10:45,088,167...45,107,309
|
|
| G
|
Flnc
|
filamin C
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FLNC mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 4:58,999,445...59,027,240
Ensembl chr 4:58,999,547...59,027,240
|
|
| G
|
Flrt1
|
fibronectin leucine rich transmembrane protein 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FLRT1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:213,704,983...213,782,958
Ensembl chr 1:213,704,038...213,782,981
|
|
| G
|
Flrt3
|
fibronectin leucine rich transmembrane protein 3
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of FLRT3 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 3:148,448,115...148,461,458
Ensembl chr 3:148,439,354...148,461,650
|
|
| G
|
Flt1
|
Fms related receptor tyrosine kinase 1
|
multiple interactions increases expression
|
ISO EXP
|
5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Oxygen deficiency results in increased expression of FLT1 protein]]; Bilirubin inhibits the reaction [Oxygen deficiency results in increased expression of FLT1 protein]; cobaltiprotoporphyrin inhibits the reaction [Oxygen deficiency results in increased expression of FLT1 protein]; Diazoxide inhibits the reaction [Oxygen deficiency results in increased expression of FLT1 protein]; HMOX1 protein affects the reaction [Diazoxide inhibits the reaction [Oxygen deficiency results in increased expression of FLT1 protein]]; NS 1619 inhibits the reaction [Oxygen deficiency results in increased expression of FLT1 protein]; paxilline inhibits the reaction [NS 1619 inhibits the reaction [Oxygen deficiency results in increased expression of FLT1 protein]]; zinc protoporphyrin inhibits the reaction [Diazoxide inhibits the reaction [Oxygen deficiency results in increased expression of FLT1 protein]] Oxygen deficiency results in increased expression of FLT1 mRNA Oxygen deficiency results in increased expression of FLT1 mRNA; Oxygen deficiency results in increased expression of FLT1 protein
|
CTD |
PMID:10613739 PMID:11981751 PMID:18679377 PMID:25371888 PMID:26516004 |
|
NCBI chr12:12,333,050...12,504,750
Ensembl chr12:12,333,430...12,504,750
|
|
| G
|
Flvcr2
|
FLVCR choline and putative heme transporter 2
|
affects expression
|
ISO
|
Oxygen deficiency affects the expression of FLVCR2 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 6:111,139,352...111,203,345
Ensembl chr 6:111,139,295...111,203,345
|
|
| G
|
Fmo1
|
flavin containing dimethylaniline monoxygenase 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FMO1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr13:77,715,405...77,747,666
Ensembl chr13:77,715,402...77,747,874
|
|
| G
|
Fmo2
|
flavin containing dimethylaniline monoxygenase 2
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of FMO2 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FMO2 mRNA
|
CTD |
PMID:24205000 PMID:30529165 |
|
NCBI chr13:77,755,131...77,777,597
Ensembl chr13:77,757,629...77,777,534
|
|
| G
|
Fmo5
|
flavin containing dimethylaniline monoxygenase 5
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FMO5 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:187,885,741...187,938,468
Ensembl chr 2:187,910,964...187,938,464
|
|
| G
|
Fmod
|
fibromodulin
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FMOD mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr13:48,045,567...48,056,184
Ensembl chr13:47,990,774...48,056,183
|
|
| G
|
Fn1
|
fibronectin 1
|
multiple interactions increases expression
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FN1 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of FN1 protein Oxygen deficiency results in increased expression of FN1 protein
|
CTD |
PMID:33729688 PMID:34355838 PMID:36414118 |
|
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137
|
|
| G
|
Fndc1
|
fibronectin type III domain containing 1
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FNDC1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FNDC1 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 1:49,686,856...49,769,263
Ensembl chr 1:49,686,856...49,769,263
|
|
| G
|
Fndc5
|
fibronectin type III domain containing 5
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of FNDC5 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:146,765,951...146,775,611
Ensembl chr 5:146,751,416...146,778,540
|
|
| G
|
Folh1
|
folate hydrolase 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of FOLH1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:149,828,286...149,914,313
Ensembl chr 1:149,840,760...149,914,035
|
|
| G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
increases expression multiple interactions
|
EXP ISO
|
Oxygen deficiency results in increased expression of FOS protein 3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of FOS mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of FOS mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of FOS mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of FOS mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of FOS mRNA] [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of FOS mRNA
|
CTD |
PMID:8809800 PMID:17914565 PMID:19640911 PMID:23452621 PMID:24236059 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
| G
|
Fosb
|
FosB proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FOSB mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:88,082,127...88,089,477
|
|
| G
|
Fosl1
|
FOS like 1, AP-1 transcription factor subunit
|
increases expression decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of FOSL1 mRNA Oxygen deficiency results in decreased expression of FOSL1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FOSL1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FOSL1 mRNA
|
CTD |
PMID:25596134 PMID:26516004 PMID:30529165 PMID:33729688 |
|
NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:212,183,833...212,192,391
|
|
| G
|
Fosl2
|
FOS like 2, AP-1 transcription factor subunit
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of FOSL2 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FOSL2 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FOSL2 mRNA
|
CTD |
PMID:25596134 PMID:30529165 PMID:33729688 |
|
NCBI chr 6:30,017,952...30,039,269
Ensembl chr 6:30,021,916...30,039,406
|
|
| G
|
Foxa1
|
forkhead box A1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FOXA1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:80,838,380...80,871,195
Ensembl chr 6:80,800,960...80,871,191
|
|
| G
|
Foxc2
|
forkhead box C2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of FOXC2 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr19:66,094,718...66,097,420
Ensembl chr19:66,094,700...66,153,977
|
|
| G
|
Foxf2
|
forkhead box F2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FOXF2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr17:33,044,446...33,051,259
Ensembl chr17:32,846,603...33,051,259
|
|
| G
|
Foxm1
|
forkhead box M1
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FOXM1 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FOXM1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 4:163,325,628...163,338,100
Ensembl chr 4:163,325,614...163,337,172
|
|
| G
|
Foxn3
|
forkhead box N3
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of FOXN3 mRNA 1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of FOXN3 mRNA]
|
CTD |
PMID:24403227 |
|
NCBI chr 6:124,191,695...124,572,070
Ensembl chr 6:124,195,701...124,572,040
|
|
| G
|
Foxo1
|
forkhead box O1
|
increases expression multiple interactions increases phosphorylation
|
ISO EXP
|
Oxygen deficiency results in increased expression of FOXO1 mRNA [Oxygen deficiency co-treated with Oxygen] affects the localization of and results in decreased phosphorylation of FOXO1 protein voacangine inhibits the reaction [Oxygen deficiency results in increased phosphorylation of FOXO1 protein]
|
CTD |
PMID:21159781 PMID:23624791 PMID:38666302 |
|
NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:138,462,697...138,541,419
|
|
| G
|
Foxo3
|
forkhead box O3
|
increases expression multiple interactions increases phosphorylation
|
ISO EXP
|
Oxygen deficiency results in increased expression of FOXO3 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of FOXO3 mRNA] [Oxygen co-treated with Oxygen deficiency] results in increased acetylation of and results in increased expression of FOXO3 protein; icariin inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in increased acetylation of and results in increased expression of FOXO3 protein]; Niacinamide inhibits the reaction [icariin inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in increased acetylation of and results in increased expression of FOXO3 protein]]; Niacinamide promotes the reaction [[Oxygen co-treated with Oxygen deficiency] results in increased acetylation of FOXO3 protein]; resveratrol inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in increased acetylation of FOXO3 protein]; SIRT1 mutant form promotes the reaction [[Oxygen co-treated with Oxygen deficiency] results in increased acetylation of FOXO3 protein] [Oxygen deficiency co-treated with Oxygen] affects the localization of and results in decreased phosphorylation of FOXO3 protein; sanggenone C inhibits the reaction [Oxygen deficiency results in increased phosphorylation of FOXO3 protein]
|
CTD |
PMID:21159781 PMID:22629407 PMID:25472572 PMID:28983604 |
|
NCBI chr20:47,251,968...47,348,254
Ensembl chr20:47,255,878...47,346,845
|
|
| G
|
Foxo4
|
forkhead box O4
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of FOXO4 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of FOXO4 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr X:70,425,218...70,432,120
Ensembl chr X:70,425,563...70,432,120
|
|
| G
|
Foxs1
|
forkhead box S1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of FOXS1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 3:161,857,264...161,858,548
Ensembl chr 3:161,850,782...161,858,662
|
|
| G
|
Fras1
|
Fraser extracellular matrix complex subunit 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of FRAS1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr14:13,095,370...13,506,895
Ensembl chr14:13,095,370...13,504,664
|
|
| G
|
Frat2
|
FRAT regulator of WNT signaling pathway 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FRAT2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:250,603,450...250,605,779
Ensembl chr 1:250,603,088...250,606,921
|
|
| G
|
Frem2
|
FRAS1 related extracellular matrix 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of FREM2 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 2:139,753,055...139,891,046
Ensembl chr 2:139,753,055...139,891,046
|
|
| G
|
Frmd3
|
FERM domain containing 3
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of FRMD3 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FRMD3 mRNA
|
CTD |
PMID:20880076 PMID:33729688 |
|
NCBI chr 5:92,810,989...93,077,326
Ensembl chr 5:92,810,736...93,077,325
|
|
| G
|
Frrs1
|
ferric-chelate reductase 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FRRS1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:207,505,786...207,566,376
Ensembl chr 2:207,507,910...207,566,376
|
|
| G
|
Fryl
|
FRY like transcription coactivator
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FRYL mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:35,307,225...35,545,199
Ensembl chr14:35,310,656...35,545,147
|
|
| G
|
Frzb
|
frizzled-related protein
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of FRZB mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 3:85,739,162...85,772,168
Ensembl chr 3:85,739,165...85,772,096
|
|
| G
|
Fscn1
|
fascin actin-bundling protein 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FSCN1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr12:16,710,601...16,723,734
Ensembl chr12:16,710,601...16,723,734
|
|
| G
|
Fscn2
|
fascin actin-bundling protein 2, retinal
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of FSCN2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:106,121,038...106,139,683
Ensembl chr10:106,133,144...106,139,683
|
|
| G
|
Fshb
|
follicle stimulating hormone subunit beta
|
multiple interactions increases expression
|
EXP
|
4-chlorobenzyltetrahydroberberine inhibits the reaction [Oxygen deficiency results in increased expression of FSHB protein]; acetovanillone inhibits the reaction [Oxygen deficiency results in increased expression of FSHB protein]
|
CTD |
PMID:23270704 |
|
NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:114,003,262...114,007,072
|
|
| G
|
Fst
|
follistatin
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of FST mRNA Oxygen affects the reaction [AHR protein results in increased expression of FST mRNA] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FST mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FST mRNA
|
CTD |
PMID:24236059 PMID:26516004 PMID:27103661 PMID:30529165 PMID:33729688 |
|
NCBI chr 2:47,856,345...47,863,670
Ensembl chr 2:47,856,345...47,863,491
|
|
| G
|
Fstl3
|
follistatin like 3
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FSTL3 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FSTL3 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 7:10,574,195...10,579,844
Ensembl chr 7:10,574,186...10,590,509
|
|
| G
|
Fstl5
|
follistatin-like 5
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of FSTL5 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 2:163,156,576...163,825,140
Ensembl chr 2:163,156,576...163,825,140
|
|
| G
|
Fth1
|
ferritin heavy chain 1
|
affects expression multiple interactions decreases expression
|
ISO EXP
|
Oxygen deficiency affects the expression of FTH1 mRNA [[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Oxygen] results in increased expression of [FTH1 protein binds to FTL protein] Oxygen results in decreased expression of FTH1 protein 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [wedelolactone inhibits the reaction [Oxygen results in increased expression of FTH1 protein]]; wedelolactone inhibits the reaction [Oxygen results in decreased expression of FTH1 protein]
|
CTD |
PMID:16135072 PMID:25596134 PMID:39110510 |
|
NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:216,051,998...216,055,214
|
|
| G
|
Ftl1
|
ferritin light chain 1
|
multiple interactions increases expression
|
EXP ISO
|
[[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Oxygen] results in increased expression of [FTH1 protein binds to FTL protein] Oxygen deficiency results in increased expression of FTL mRNA; Oxygen deficiency results in increased expression of FTL protein
|
CTD |
PMID:16135072 PMID:33969609 |
|
NCBI chr 1:105,072,858...105,074,705
Ensembl chr X:45,399,355...45,399,915 Ensembl chr 2:45,399,355...45,399,915 Ensembl chr 1:45,399,355...45,399,915
|
|
| G
|
Ftsj3
|
FtsJ RNA 2'-O-methyltransferase 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FTSJ3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:91,680,735...91,687,475
Ensembl chr10:91,680,753...91,687,179
|
|
| G
|
Fus
|
Fus RNA binding protein
|
increases metabolic processing
|
ISO
|
FUS protein mutant form results in increased metabolism of Oxygen
|
CTD |
PMID:29419416 |
|
NCBI chr 1:192,007,011...192,020,887
Ensembl chr 1:192,007,006...192,020,884
|
|
| G
|
Fxn
|
frataxin
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FXN mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:231,300,457...231,323,989
Ensembl chr 1:231,300,150...231,323,989
|
|
| G
|
Fxr1
|
FMR1 autosomal homolog 1
|
affects methylation increases expression
|
ISO
|
Oxygen deficiency affects the methylation of FXR1 promoter Oxygen deficiency results in increased expression of FXR1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 2:118,812,287...118,865,813
Ensembl chr 2:118,811,980...118,867,027
|
|
| G
|
Fxr2
|
FMR1 autosomal homolog 2
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of FXR2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:54,849,345...54,869,713
Ensembl chr10:54,849,267...54,869,713
|
|
| G
|
Fxyd1
|
FXYD domain-containing ion transport regulator 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FXYD1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:95,414,556...95,418,645
Ensembl chr 1:95,414,557...95,418,591
|
|
| G
|
Fyco1
|
FYVE and coiled-coil domain autophagy adaptor 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FYCO1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:132,289,538...132,356,810
Ensembl chr 8:132,289,539...132,356,451
|
|
| G
|
Fzd4
|
frizzled class receptor 4
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of FZD4 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 1:152,692,507...152,701,372
Ensembl chr 1:152,692,507...152,701,372
|
|
| G
|
Fzd7
|
frizzled class receptor 7
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FZD7 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:68,425,538...68,428,357
Ensembl chr 9:68,411,259...68,432,585
|
|
| G
|
G0s2
|
G0/G1switch 2
|
increases expression multiple interactions decreases expression
|
ISO
|
Oxygen deficiency results in increased expression of G0S2 mRNA Oxygen deficiency inhibits the reaction [darinaparsin results in decreased expression of G0S2 mRNA] Oxygen deficiency results in decreased expression of G0S2 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of G0S2 mRNA
|
CTD |
PMID:20880076 PMID:22535156 PMID:26516004 PMID:30529165 |
|
NCBI chr13:107,335,036...107,335,948
Ensembl chr13:107,335,036...107,336,293
|
|
| G
|
G6pd
|
glucose-6-phosphate dehydrogenase
|
multiple interactions increases expression increases activity
|
EXP
|
Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased expression of G6PD mRNA]; Glutathione inhibits the reaction [Oxygen deficiency results in increased expression of G6PD mRNA]; S-ethyl glutathione inhibits the reaction [Oxygen deficiency results in increased expression of G6PD mRNA] Oxygen deficiency results in increased activity of G6PD protein
|
CTD |
PMID:15225644 |
|
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:157,352,373...157,372,144
|
|
| G
|
Gab1
|
GRB2-associated binding protein 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GAB1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:44,035,693...44,143,617
Ensembl chr19:44,035,063...44,143,617
|
|
| G
|
Gabarapl1
|
GABA type A receptor associated protein like 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of GABARAPL1 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 4:164,666,332...164,675,474
Ensembl chr 4:164,666,246...164,674,578
|
|
| G
|
Gabarapl2
|
GABA type A receptor associated protein like 2
|
multiple interactions increases expression
|
ISO
|
Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of GABARAPL2 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr19:56,819,826...56,830,662
Ensembl chr19:56,819,791...56,830,660
|
|
| G
|
Gabbr2
|
gamma-aminobutyric acid type B receptor subunit 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of GABBR2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 5:65,743,073...66,083,695
Ensembl chr 5:65,743,073...66,083,695
|
|
| G
|
Gabra2
|
gamma-aminobutyric acid type A receptor subunit alpha 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of GABRA2 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr14:37,451,218...37,587,458
Ensembl chr14:37,450,683...37,587,457
|
|
| G
|
Gabrb2
|
gamma-aminobutyric acid type A receptor subunit beta 2
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of GABRB2 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of GABRB2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr10:27,438,127...27,657,680
Ensembl chr10:27,438,238...27,655,171
|
|
| G
|
Gabrp
|
gamma-aminobutyric acid type A receptor subunit pi
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GABRP mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:18,647,243...18,673,806
Ensembl chr10:18,647,243...18,673,727
|
|
| G
|
Gad1
|
glutamate decarboxylase 1
|
increases expression multiple interactions decreases expression
|
ISO EXP
|
Oxygen deficiency results in increased expression of GAD1 mRNA GAD1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] Oxygen deficiency results in decreased expression of GAD1 mRNA benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Oxygen deficiency results in decreased expression of GAD1 protein]; Dizocilpine Maleate inhibits the reaction [Oxygen deficiency results in decreased expression of GAD1 protein]; Oxygen deficiency results in decreased expression of and results in increased degradation of GAD1 protein
|
CTD |
PMID:25966616 PMID:26516004 PMID:29107683 |
|
NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:75,777,534...75,818,759
|
|
| G
|
Gad2
|
glutamate decarboxylase 2
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of GAD2 mRNA benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Oxygen deficiency results in decreased expression of GAD2 protein]; Oxygen deficiency results in decreased expression of and results in increased degradation of GAD2 protein
|
CTD |
PMID:29107683 |
|
NCBI chr17:89,671,718...89,734,246
Ensembl chr17:89,671,716...89,941,089
|
|
| G
|
Gadd45a
|
growth arrest and DNA-damage-inducible, alpha
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of GADD45A mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GADD45A mRNA
|
CTD |
PMID:25596134 PMID:30529165 |
|
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807
|
|
| G
|
Gadd45b
|
growth arrest and DNA-damage-inducible, beta
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of GADD45B mRNA [N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride co-treated with [Oxygen deficiency co-treated with Blood Glucose deficiency]] results in increased expression of GADD45B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GADD45B mRNA
|
CTD |
PMID:19640911 PMID:26516004 PMID:30529165 |
|
NCBI chr 7:9,428,689...9,430,991
Ensembl chr 7:9,428,689...9,430,718
|
|
| G
|
Gadd45g
|
growth arrest and DNA-damage-inducible, gamma
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GADD45G mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of GADD45G mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr17:13,528,606...13,530,351
Ensembl chr17:13,528,610...13,530,369
|
|
| G
|
Gadd45gip1
|
GADD45G interacting protein 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GADD45GIP1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:40,225,503...40,228,052
Ensembl chr19:40,225,984...40,228,055
|
|
| G
|
Gal3st1
|
galactose-3-O-sulfotransferase 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of GAL3ST1 mRNA
|
CTD |
PMID:23880069 |
|
NCBI chr14:83,094,265...83,109,992
Ensembl chr14:83,094,385...83,109,978
|
|
| G
|
Galk1
|
galactokinase 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of GALK1 mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr10:101,742,067...101,746,244
Ensembl chr10:101,735,061...101,746,258
|
|
| G
|
Galnt1
|
polypeptide N-acetylgalactosaminyltransferase 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of GALNT1 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of GALNT1 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr18:15,763,697...15,843,598
Ensembl chr18:15,764,277...15,843,588
|
|
| G
|
Galnt12
|
polypeptide N-acetylgalactosaminyltransferase 12
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of GALNT12 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 5:66,180,171...66,208,931
Ensembl chr 5:66,180,164...66,208,938
|
|
| G
|
Galnt14
|
polypeptide N-acetylgalactosaminyltransferase 14
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of GALNT14 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 6:27,507,878...27,724,033
Ensembl chr 6:27,507,627...27,724,031
|
|
| G
|
Galnt15
|
polypeptide N-acetylgalactosaminyltransferase 15
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of GALNT15 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr16:7,233,524...7,273,290
Ensembl chr16:7,233,606...7,273,285
|
|
| G
|
Galnt16
|
polypeptide N-acetylgalactosaminyltransferase 16
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of GALNT16 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 6:105,900,987...105,982,039
Ensembl chr 6:105,901,153...105,991,350
|
|
| G
|
Galnt18
|
polypeptide N-acetylgalactosaminyltransferase 18
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of GALNT18 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:175,027,832...175,338,883
Ensembl chr 1:175,027,839...175,338,883
|
|
| G
|
Galnt3
|
polypeptide N-acetylgalactosaminyltransferase 3
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of GALNT3 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of GALNT3 mRNA
|
CTD |
PMID:24236059 PMID:33729688 |
|
NCBI chr 3:71,150,559...71,187,321
Ensembl chr 3:71,150,571...71,174,323
|
|
| G
|
Gap43
|
growth associated protein 43
|
multiple interactions
|
EXP
|
[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of GAP43 protein
|
CTD |
PMID:27693381 |
|
NCBI chr11:71,882,131...71,975,799
Ensembl chr11:71,882,131...71,975,797
|
|
| G
|
Gapdh
|
glyceraldehyde-3-phosphate dehydrogenase
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of GAPDH mRNA Oxygen results in increased expression of GAPDH mRNA HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of GAPDH mRNA] [eprenetapopt co-treated with Cisplatin] inhibits the reaction [Oxygen deficiency results in increased expression of GAPDH mRNA]; Cisplatin inhibits the reaction [Oxygen deficiency results in increased expression of GAPDH mRNA]; Oxygen deficiency promotes the reaction [HIF1A protein binds to GAPDH promoter]
|
CTD |
PMID:10646848 PMID:19502547 PMID:22911455 PMID:23880069 PMID:29690507 |
|
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:159,648,592...159,653,377
|
|
| G
|
Gapdhs
|
glyceraldehyde-3-phosphate dehydrogenase, spermatogenic
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of GAPDHS protein
|
CTD |
PMID:25937538 |
|
NCBI chr 1:95,106,516...95,125,918
Ensembl chr 1:95,106,518...95,121,055
|
|
| G
|
Gar1
|
GAR1 ribonucleoprotein
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GAR1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of GAR1 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 2:221,049,471...221,056,749
Ensembl chr 2:221,049,473...221,056,749
|
|
| G
|
Garin4
|
golgi associated RAB2 interactor family member 4
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of GARIN4 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr13:105,274,107...105,276,287
Ensembl chr13:105,274,106...105,276,286
|
|
| G
|
Gars1
|
glycyl-tRNA synthetase 1
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of GARS1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GARS1 mRNA
|
CTD |
PMID:25596134 PMID:30529165 |
|
NCBI chr 4:85,484,939...85,542,876
Ensembl chr 4:85,493,753...85,542,876
|
|
| G
|
Gas1
|
growth arrest-specific 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GAS1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr17:4,487,716...4,490,701
Ensembl chr17:4,484,283...4,497,657
|
|
| G
|
Gas7
|
growth arrest specific 7
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GAS7 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:52,651,690...52,882,244
Ensembl chr10:52,651,690...52,882,244
|
|
| G
|
Gast
|
gastrin
|
multiple interactions increases expression
|
ISO
|
CCKBR protein promotes the reaction [Oxygen deficiency results in increased expression of GAST mRNA]
|
CTD |
PMID:22593272 |
|
NCBI chr10:85,765,216...85,767,881
Ensembl chr10:85,765,216...85,767,880
|
|
| G
|
Gata3
|
GATA binding protein 3
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of GATA3 protein
|
CTD |
PMID:38909692 |
|
NCBI chr17:73,544,234...73,575,670
Ensembl chr17:73,553,548...73,575,670
|
|
| G
|
Gatc
|
glutamyl-tRNA amidotransferase subunit C
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of GATC mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr12:46,930,820...46,938,790
Ensembl chr12:46,930,630...46,938,776
|
|
| G
|
Gbe1
|
1,4-alpha-glucan branching enzyme 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of GBE1 mRNA
|
CTD |
PMID:15094311 PMID:20880076 PMID:24236059 PMID:25596134 |
|
NCBI chr11:22,181,194...22,446,640
Ensembl chr11:22,181,103...22,446,638
|
|
| G
|
Gbp2
|
guanylate binding protein 2
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GBP2 mRNA [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of GBP2 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of GBP2 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 2:234,005,727...234,021,812
Ensembl chr 2:234,008,590...234,021,810
|
|
| G
|
Gbp3
|
guanylate binding protein 3
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of GBP3 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 2:234,144,042...234,173,527
Ensembl chr 2:234,146,519...234,180,055
|
|
| G
|
Gbp4
|
guanylate binding protein 4
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GBP3 mRNA [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of GBP4 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of GBP4 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 2:233,978,163...233,992,124
Ensembl chr 2:233,978,486...233,992,120
|
|
| G
|
Gbp5
|
guanylate binding protein 5
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of GBP5 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of GBP5 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 2:233,910,999...233,930,320
Ensembl chr 2:233,902,113...233,930,826
|
|
| G
|
Gbp6
|
guanylate binding protein family member 6
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GBP6 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of GBP6 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr14:5,034,999...5,062,023
Ensembl chr14:4,968,325...4,983,692 Ensembl chr14:4,968,325...4,983,692
|
|
| G
|
Gbp7
|
guanylate binding protein 7
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GBP7 mRNA [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of GBP7 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of GBP7 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 2:233,948,774...233,970,532
Ensembl chr 2:233,948,677...233,970,526
|
|
| G
|
Gch1
|
GTP cyclohydrolase 1
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of GCH1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GCH1 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr15:22,884,006...22,917,412
Ensembl chr15:22,884,006...22,917,412
|
|
| G
|
Gchfr
|
GTP cyclohydrolase I feedback regulator
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GCHFR mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:126,611,892...126,615,926
Ensembl chr 3:126,613,240...126,615,926
|
|
| G
|
Gck
|
glucokinase
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of GCK mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr14:84,999,019...85,041,098
Ensembl chr14:84,999,020...85,040,949
|
|
| G
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit
|
multiple interactions increases expression decreases expression
|
EXP ISO
|
[Oxygen deficiency co-treated with Oxygen] results in increased expression of GCLC protein; naringin promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of GCLC protein]; NFE2L2 mutant form inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of GCLC protein] [Oxygen deficiency co-treated with Oxygen] results in increased expression of GCLC mRNA Oxygen deficiency results in increased expression of GCLC mRNA Oxygen deficiency results in decreased expression of GCLC mRNA [Oxygen deficiency co-treated with Catechin] results in increased expression of GCLC mRNA
|
CTD |
PMID:25596134 PMID:25773745 PMID:25922074 PMID:29966676 PMID:35883890 |
|
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
|
|
| G
|
Gclm
|
glutamate cysteine ligase, modifier subunit
|
decreases expression increases expression
|
ISO
|
Oxygen deficiency results in decreased expression of GCLM mRNA Oxygen deficiency results in increased expression of GCLM mRNA
|
CTD |
PMID:25596134 PMID:26516004 PMID:29966676 PMID:35883890 |
|
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003
|
|
| G
|
Gcnt3
|
glucosaminyl (N-acetyl) transferase 3, mucin type
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of GCNT3 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 8:79,570,081...79,577,389
Ensembl chr 8:79,566,753...79,581,595
|
|
| G
|
Gdap2
|
ganglioside-induced differentiation-associated-protein 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of GDAP2 mRNA
|
CTD |
PMID:17175027 |
|
NCBI chr 2:190,217,158...190,276,128
Ensembl chr 2:190,217,164...190,276,126
|
|
| G
|
Gdf15
|
growth differentiation factor 15
|
multiple interactions increases expression decreases expression
|
ISO EXP
|
Oxygen deficiency inhibits the reaction [darinaparsin results in decreased expression of GDF15 mRNA] Oxygen deficiency results in increased expression of GDF15 mRNA; Oxygen results in increased expression of GDF15 mRNA; Oxygen results in increased expression of GDF15 protein Oxygen deficiency results in decreased expression of GDF15 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GDF15 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of GDF15 mRNA
|
CTD |
PMID:22535156 PMID:25596134 PMID:26516004 PMID:28734801 PMID:30529165 PMID:33729688 More...
|
|
NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022
|
|
| G
|
Gdf6
|
growth differentiation factor 6
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of GDF6 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of GDF6 mRNA
|
CTD |
PMID:26516004 PMID:33729688 |
|
NCBI chr 5:27,793,561...27,809,884
Ensembl chr 5:27,793,552...27,811,825
|
|
| G
|
Gdf7
|
growth differentiation factor 7
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of GDF7 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 6:36,890,799...36,901,783
Ensembl chr 6:36,890,799...36,901,783
|
|
| G
|
Gdnf
|
glial cell derived neurotrophic factor
|
decreases response to substance
|
ISO
|
GDNF protein results in decreased susceptibility to Oxygen
|
CTD |
PMID:17935603 |
|
NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:58,621,327...58,647,240
|
|
| G
|
Gem
|
GTP binding protein overexpressed in skeletal muscle
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GEM mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:30,011,641...30,022,554
Ensembl chr 5:30,011,592...30,022,542
|
|
| G
|
Gfap
|
glial fibrillary acidic protein
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen results in increased expression of GFAP protein [Oxygen co-treated with coenzyme Q10] results in decreased expression of GFAP protein; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of GFAP protein; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of GFAP protein]
|
CTD |
PMID:25203536 PMID:25727173 PMID:35212449 |
|
NCBI chr10:88,352,987...88,361,661
Ensembl chr10:88,352,986...88,361,685
|
|
| G
|
Gfer
|
growth factor, augmenter of liver regeneration
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GFER mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:14,223,023...14,225,736
Ensembl chr10:14,223,023...14,225,935
|
|
| G
|
Gfpt2
|
glutamine-fructose-6-phosphate transaminase 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GFPT2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:34,616,146...34,662,420
Ensembl chr10:34,615,370...34,662,419
|
|
| G
|
Gfra1
|
GDNF family receptor alpha 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GFRA1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:267,325,297...267,557,037
Ensembl chr 1:267,326,817...267,556,501
|
|
| G
|
Gfra4
|
GDNF family receptor alpha 4
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of GFRA4 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 3:138,707,970...138,715,279
Ensembl chr 3:138,703,114...138,711,561
|
|
| G
|
Ggct
|
gamma-glutamyl cyclotransferase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GGCT mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:85,453,387...85,459,597
Ensembl chr 4:85,453,387...85,470,224
|
|
| G
|
Ggps1
|
geranylgeranyl diphosphate synthase 1
|
multiple interactions increases expression
|
ISO
|
Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of GGPS1 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr17:55,958,750...55,982,762
Ensembl chr17:55,958,755...55,971,709
|
|
| G
|
Ghitm
|
growth hormone inducible transmembrane protein
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of GHITM mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of GHITM mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr16:12,907,062...12,918,149
Ensembl chr16:12,905,806...12,918,123
|
|
| G
|
Gimap4
|
GTPase, IMAP family member 4
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GIMAP4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:78,967,297...78,974,211
Ensembl chr 4:78,967,297...78,974,202
|
|
| G
|
Gimap8
|
GTPase, IMAP family member 8
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GIMAP8 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:78,931,003...78,942,491
Ensembl chr 4:78,931,029...78,942,488
|
|
| G
|
Gins1
|
GINS complex subunit 1
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of GINS1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GINS1 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 3:160,184,920...160,206,334
Ensembl chr 3:160,180,151...160,206,332
|
|
| G
|
Gins2
|
GINS complex subunit 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of GINS2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr19:65,535,492...65,548,270
Ensembl chr19:65,535,492...65,548,052
|
|
| G
|
Gins3
|
GINS complex subunit 3
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of GINS3 mRNA
|
CTD |
PMID:24236059 PMID:26516004 |
|
NCBI chr19:9,426,140...9,435,192
Ensembl chr19:9,399,759...9,434,679
|
|
| G
|
Gins4
|
GINS complex subunit 4
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of GINS4 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr16:75,489,990...75,502,455
Ensembl chr16:75,490,126...75,505,000
|
|
| G
|
Gja1
|
gap junction protein, alpha 1
|
multiple interactions increases expression decreases expression increases phosphorylation
|
EXP ISO
|
4-chlorobenzyltetrahydroberberine inhibits the reaction [Oxygen deficiency results in decreased expression of GJA1 mRNA]; 4-chlorobenzyltetrahydroberberine inhibits the reaction [Oxygen deficiency results in decreased expression of GJA1 protein]; acetovanillone inhibits the reaction [Oxygen deficiency results in decreased expression of GJA1 mRNA]; acetovanillone inhibits the reaction [Oxygen deficiency results in decreased expression of GJA1 protein]; ebselen inhibits the reaction [Oxygen deficiency results in increased expression of GJA1 mRNA]; ebselen inhibits the reaction [Oxygen deficiency results in increased expression of GJA1 protein]; Rotenone inhibits the reaction [Oxygen deficiency results in increased expression of GJA1 mRNA]; Rotenone inhibits the reaction [Oxygen deficiency results in increased expression of GJA1 protein] Oxygen deficiency results in increased expression of GJA1 mRNA; Oxygen deficiency results in increased expression of GJA1 protein Oxygen deficiency results in decreased expression of GJA1 mRNA; Oxygen deficiency results in decreased expression of GJA1 protein Oxygen deficiency results in increased phosphorylation of GJA1 protein 3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of GJA1 mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of GJA1 mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of GJA1 mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of GJA1 mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of GJA1 mRNA] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GJA1 mRNA
|
CTD |
PMID:12958040 PMID:18665255 PMID:23270704 PMID:23452621 PMID:30529165 |
|
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689
|
|
| G
|
Gja4
|
gap junction protein, alpha 4
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of GJA4 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 5:144,917,791...144,920,324
Ensembl chr 5:144,914,147...144,921,216
|
|
| G
|
Gja5
|
gap junction protein, alpha 5
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of GJA5 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 2:187,291,227...187,310,770
Ensembl chr 2:187,234,674...187,318,512
|
|
| G
|
Gjb2
|
gap junction protein, beta 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of GJB2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr15:35,375,977...35,393,817
Ensembl chr15:35,375,692...35,393,877
|
|
| G
|
Gjb3
|
gap junction protein, beta 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GJB3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:144,933,692...144,939,435
Ensembl chr 5:144,933,696...144,940,280
|
|
| G
|
Gla
|
galactosidase, alpha
|
multiple interactions decreases expression
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GLA mRNA Oxygen deficiency results in decreased expression of GLA mRNA
|
CTD |
PMID:30529165 PMID:35883890 |
|
NCBI chr X:102,062,497...102,073,915
Ensembl chr X:102,056,718...102,073,915
|
|
| G
|
Glb1l2
|
galactosidase, beta 1-like 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GLB1L2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:33,391,201...33,442,587
Ensembl chr 8:33,390,678...33,442,695
|
|
| G
|
Glb1l3
|
galactosidase, beta 1-like 3
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of GLB1L3 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GLB1L3 mRNA
|
CTD |
PMID:24236059 PMID:30529165 |
|
NCBI chr 8:33,454,914...33,496,641
Ensembl chr 8:33,454,914...33,496,641
|
|
| G
|
Glcci1
|
glucocorticoid induced 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GLCCI1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:37,274,271...37,601,898
Ensembl chr 4:37,529,364...37,599,802 Ensembl chr 4:37,529,364...37,599,802
|
|
| G
|
Gli1
|
GLI family zinc finger 1
|
multiple interactions
|
ISO
|
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GLI1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased localization of GLI1 protein; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GLI1 mRNA]; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased localization of GLI1 protein]; cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GLI1 mRNA]]; cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased localization of GLI1 protein]]; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GLI1 mRNA]; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased localization of GLI1 protein]
|
CTD |
PMID:27481074 |
|
NCBI chr 7:65,042,237...65,054,888
Ensembl chr 7:65,042,237...65,054,540
|
|
| G
|
Glipr1
|
GLI pathogenesis-related 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of GLIPR1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 7:49,373,579...49,399,190
Ensembl chr 7:49,373,581...49,384,640
|
|
| G
|
Glipr2
|
GLI pathogenesis-related 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GLIPR2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:62,966,163...62,998,016
Ensembl chr 5:62,966,195...62,998,716
|
|
| G
|
Glo1
|
glyoxalase 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of GLO1 protein
|
CTD |
PMID:25937538 |
|
NCBI chr20:8,665,061...8,683,095
Ensembl chr20:8,665,061...8,683,191
|
|
| G
|
Glrx
|
glutaredoxin
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GLRX mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of GLRX mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 2:7,073,737...7,083,548
Ensembl chr 2:7,073,759...7,083,543
|
|
| G
|
Glrx5
|
glutaredoxin 5
|
affects methylation increases expression
|
ISO
|
Oxygen deficiency affects the methylation of GLRX5 promoter Oxygen deficiency results in increased expression of GLRX5 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 6:129,752,902...129,763,278
Ensembl chr 6:129,752,840...129,763,278
|
|
| G
|
Glud1
|
glutamate dehydrogenase 1
|
decreases expression multiple interactions increases expression
|
ISO EXP
|
Oxygen deficiency results in decreased expression of GLUD1 protein ginsenoside Rg1 inhibits the reaction [Oxygen deficiency results in increased expression of GLUD1 protein] Oxygen deficiency results in increased expression of GLUD1 mRNA; Oxygen deficiency results in increased expression of GLUD1 protein
|
CTD |
PMID:25937538 PMID:26593335 |
|
NCBI chr16:9,646,569...9,680,215
Ensembl chr16:9,646,509...9,680,210
|
|
| G
|
Glul
|
glutamate-ammonia ligase
|
multiple interactions
|
EXP
|
[SCH 442416 co-treated with Oxygen deficiency] results in increased expression of GLUL mRNA
|
CTD |
PMID:22969972 |
|
NCBI chr13:68,519,500...68,585,554
Ensembl chr13:68,576,067...68,585,520
|
|
| G
|
Gmds
|
GDP-mannose 4, 6-dehydratase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GMDS mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr17:32,304,029...32,830,708
Ensembl chr17:32,304,056...32,830,706
|
|
| G
|
Gmfg
|
glia maturation factor, gamma
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of GMFG mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:92,856,154...92,866,722
Ensembl chr 1:92,854,995...92,866,723
|
|
| G
|
Gmnn
|
geminin, DNA replication inhibitor
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of GMNN mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GMNN mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr17:40,729,760...40,738,077
Ensembl chr17:40,729,824...40,738,068
|
|
| G
|
Gmpr2
|
guanosine monophosphate reductase 2
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of GMPR2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr15:33,135,455...33,144,923
Ensembl chr15:33,135,682...33,144,899
|
|
| G
|
Gna14
|
G protein subunit alpha 14
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of GNA14 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:223,141,802...223,324,210
Ensembl chr 1:223,141,802...223,324,210
|
|
| G
|
Gnai2
|
G protein subunit alpha i2
|
decreases expression
|
EXP
|
Oxygen deficiency results in decreased expression of GNAI2 protein
|
CTD |
PMID:10192281 |
|
NCBI chr 8:117,167,045...117,187,652
Ensembl chr 8:117,167,045...117,187,622
|
|
| G
|
Gnas
|
GNAS complex locus
|
decreases expression increases expression
|
EXP ISO
|
Oxygen deficiency results in decreased expression of GNAS protein Oxygen deficiency results in increased expression of GNAS mRNA
|
CTD |
PMID:10192281 PMID:20862257 |
|
NCBI chr 3:183,489,648...183,554,570
Ensembl chr 3:183,503,243...183,554,536
|
|
| G
|
Gnb1
|
G protein subunit beta 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of GNB1 protein
|
CTD |
PMID:25937538 |
|
NCBI chr 5:171,357,778...171,424,489
Ensembl chr 5:171,357,797...171,424,488
|
|
| G
|
Gnb1l
|
G protein subunit beta 1 like
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GNB1L mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr11:95,933,994...96,011,933
Ensembl chr11:95,936,961...96,011,931
|
|
| G
|
Gnb2
|
G protein subunit beta 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of GNB2 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr12:24,795,505...24,800,796
Ensembl chr12:24,795,827...24,800,796
|
|
| G
|
Gng11
|
G protein subunit gamma 11
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GNG11 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:32,977,681...32,983,121
Ensembl chr 4:32,977,664...32,984,438
|
|
| G
|
Gng12
|
G protein subunit gamma 12
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of GNG12 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 4:97,340,830...97,464,422
Ensembl chr 4:97,340,472...97,464,476
|
|
| G
|
Gnl3
|
G protein nucleolar 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GNL3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr16:6,213,844...6,220,029
Ensembl chr16:6,213,871...6,219,845
|
|
| G
|
Gnpnat1
|
glucosamine-phosphate N-acetyltransferase 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GNPNAT1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr15:21,076,129...21,088,526
Ensembl chr15:21,076,130...21,088,423
|
|
| G
|
Golim4
|
golgi integral membrane protein 4
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of GOLIM4 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 2:162,939,429...163,031,901
Ensembl chr 2:162,939,429...163,031,901
|
|
| G
|
Gorasp1
|
golgi reassembly stacking protein 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of GORASP1 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 8:128,532,933...128,544,686
Ensembl chr 8:128,532,934...128,544,636
|
|
| G
|
Got1
|
glutamic-oxaloacetic transaminase 1
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of GOT1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GOT1 mRNA
|
CTD |
PMID:25596134 PMID:30529165 |
|
NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871
|
|
| G
|
Gpam
|
glycerol-3-phosphate acyltransferase, mitochondrial
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPAM mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:264,111,599...264,176,112
Ensembl chr 1:264,113,813...264,175,911
|
|
| G
|
Gpat2
|
glycerol-3-phosphate acyltransferase 2, mitochondrial
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of GPAT2 mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr 3:135,099,751...135,110,355
Ensembl chr 3:135,096,752...135,110,353
|
|
| G
|
Gpat3
|
glycerol-3-phosphate acyltransferase 3
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of GPAT3 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr14:9,018,762...9,072,552
|
|
| G
|
Gpatch4
|
G patch domain containing 4
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of GPATCH4 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPATCH4 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 2:175,797,503...175,816,547
Ensembl chr 2:175,807,682...175,817,358
|
|
| G
|
Gpbp1
|
GC-rich promoter binding protein 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of GPBP1 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of GPBP1 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 2:44,756,861...44,824,281
Ensembl chr 2:44,756,861...44,824,315
|
|
| G
|
Gpc1
|
glypican 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of GPC1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 9:100,843,645...100,871,458
Ensembl chr 9:100,843,645...100,879,933
|
|
| G
|
Gpcpd1
|
glycerophosphocholine phosphodiesterase 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of GPCPD1 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of GPCPD1 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 3:140,240,574...140,285,469
Ensembl chr 3:140,240,575...140,285,372
|
|
| G
|
Gpd1l
|
glycerol-3-phosphate dehydrogenase 1 like
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of GPD1L protein
|
CTD |
PMID:25937538 |
|
NCBI chr 8:123,469,282...123,498,948
Ensembl chr 8:123,466,667...123,498,908
|
|
| G
|
Gper1
|
G protein-coupled estrogen receptor 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of GPER1 mRNA Raloxifene Hydrochloride inhibits the reaction [Oxygen deficiency results in increased expression of GPER1 mRNA]
|
CTD |
PMID:24846829 |
|
NCBI chr12:20,331,073...20,336,527
Ensembl chr12:20,327,679...20,337,144
|
|
| G
|
Gphn
|
gephyrin
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of GPHN mRNA Oxygen deficiency results in decreased expression of and affects the localization of GPHN protein
|
CTD |
PMID:25596134 PMID:29107683 |
|
NCBI chr 6:102,687,405...103,216,679
Ensembl chr 6:102,687,423...103,216,674
|
|
| G
|
Gpi
|
glucose-6-phosphate isomerase
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of GPI mRNA
|
CTD |
PMID:20042640 PMID:24236059 |
|
NCBI chr 1:95,965,389...95,996,932
Ensembl chr 1:95,965,396...95,993,261
|
|
| G
|
Gpihbp1
|
glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of GPIHBP1 mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr 7:109,166,334...109,169,448
Ensembl chr 7:109,163,160...109,169,448
|
|
| G
|
Gpnmb
|
glycoprotein nmb
|
increases expression multiple interactions
|
EXP ISO
|
Oxygen results in increased expression of GPNMB mRNA; Oxygen results in increased expression of GPNMB protein Oxygen deficiency results in increased expression of GPNMB mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPNMB mRNA
|
CTD |
PMID:22911455 PMID:25596134 PMID:30529165 |
|
NCBI chr 4:79,341,128...79,362,366
Ensembl chr 4:79,341,021...79,380,240
|
|
| G
|
Gpr141
|
G protein-coupled receptor 141
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of GPR141 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr17:49,813,489...49,875,721
Ensembl chr17:49,733,713...49,875,719
|
|
| G
|
Gpr146
|
G protein-coupled receptor 146
|
multiple interactions increases expression
|
ISO
|
1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of GPR146 mRNA]
|
CTD |
PMID:24403227 |
|
NCBI chr12:20,365,790...20,381,122
Ensembl chr12:20,364,269...20,381,345
|
|
| G
|
Gpr155
|
G protein-coupled receptor 155
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPR155 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of GPR155 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 3:78,623,931...78,677,803
Ensembl chr 3:78,607,976...78,677,803
|
|
| G
|
Gpr157
|
G protein-coupled receptor 157
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of GPR157 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 5:165,833,651...165,849,376
Ensembl chr 5:165,833,673...165,851,280
|
|
| G
|
Gpr160
|
G protein-coupled receptor 160
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of GPR160 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPR160 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 2:114,414,084...114,491,590
Ensembl chr 2:114,410,261...114,474,790
|
|
| G
|
Gpr174
|
G protein-coupled receptor 174
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPR174 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr X:76,428,274...76,469,020
Ensembl chr X:76,377,973...76,468,985
|
|
| G
|
Gpr176
|
G protein-coupled receptor 176
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPR176 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:125,690,750...125,791,172
Ensembl chr 3:125,690,751...125,791,172
|
|
| G
|
Gpr182
|
G protein-coupled receptor 182
|
increases expression multiple interactions decreases expression
|
ISO EXP
|
Oxygen deficiency results in increased expression of ACKR5 protein VULM 1457 inhibits the reaction [Oxygen deficiency results in increased expression of ACKR5 protein] Oxygen deficiency results in increased expression of GPR182 mRNA Oxygen results in decreased expression of GPR182 mRNA
|
CTD |
PMID:10666155 PMID:16474185 PMID:22911455 |
|
NCBI chr 7:65,471,254...65,474,110
Ensembl chr 7:65,452,965...65,474,998
|
|
| G
|
Gpr26
|
G protein-coupled receptor 26
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of GPR26 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 1:196,196,138...196,235,574
Ensembl chr 1:196,196,767...196,235,559
|
|
| G
|
Gpr35
|
G protein-coupled receptor 35
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPR35 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:100,974,580...100,995,330
Ensembl chr 9:100,962,538...100,986,985
|
|
| G
|
Gpr4
|
G protein-coupled receptor 4
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of GPR4 protein
|
CTD |
PMID:33161135 |
|
NCBI chr 1:87,993,398...88,004,568
Ensembl chr 1:87,993,430...88,006,254
|
|
| G
|
Gpr65
|
G-protein coupled receptor 65
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of GPR65 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPR65 mRNA
|
CTD |
PMID:28174749 PMID:30529165 |
|
NCBI chr 6:123,245,534...123,262,758
Ensembl chr 6:123,219,633...123,266,285
|
|
| G
|
Gpr68
|
G protein-coupled receptor 68
|
multiple interactions increases expression
|
ISO
|
GPR68 protein affects the reaction [Oxygen deficiency results in increased expression of SPARC mRNA]; GPR68 protein affects the reaction [Oxygen deficiency results in increased expression of TNF mRNA] AICA ribonucleotide inhibits the reaction [TNF protein promotes the reaction [Oxygen deficiency results in increased expression of GPR68 mRNA]]; Oxygen deficiency promotes the reaction [HIF1A protein binds to GPR68 promoter]; Oxygen deficiency promotes the reaction [TNF protein results in increased expression of GPR68 mRNA]; SC 514 inhibits the reaction [Oxygen deficiency promotes the reaction [TNF protein results in increased expression of GPR68 mRNA]]; SC 514 inhibits the reaction [TNF protein promotes the reaction [Oxygen deficiency results in increased expression of GPR68 mRNA]]; TNF protein promotes the reaction [Oxygen deficiency results in increased expression of GPR68 mRNA]
|
CTD |
PMID:28174749 |
|
NCBI chr 6:125,865,205...125,895,674
Ensembl chr 6:125,864,942...125,895,674
|
|
| G
|
Gpr84
|
G protein-coupled receptor 84
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPR84 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:136,322,374...136,324,648
Ensembl chr 7:136,322,191...136,324,703
|
|
| G
|
Gpr87
|
G protein-coupled receptor 87
|
affects expression
|
ISO
|
Oxygen deficiency affects the expression of GPR87 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 2:145,589,630...145,608,094
Ensembl chr 2:145,589,569...145,604,442
|
|
| G
|
Gprasp1
|
G protein-coupled receptor associated sorting protein 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPRASP1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr X:103,556,493...103,564,275
Ensembl chr X:103,501,377...103,565,649
|
|
| G
|
Gprc5a
|
G protein-coupled receptor, class C, group 5, member A
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of GPRC5A mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 4:169,634,896...169,653,627
Ensembl chr 4:169,634,748...169,653,625
|
|
| G
|
Gprin3
|
GPRIN family member 3
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPRIN3 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of GPRIN3 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 4:89,902,198...89,987,496
Ensembl chr 4:89,892,867...89,987,565
|
|
| G
|
Gpsm2
|
G-protein signaling modulator 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPSM2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:199,015,250...199,063,788
Ensembl chr 2:199,015,250...199,063,056
|
|
| G
|
Gpsm3
|
G-protein signaling modulator 3
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of GPSM3 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr20:4,161,730...4,163,591
Ensembl chr20:4,161,730...4,189,072
|
|
| G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPT mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
| G
|
Gpx1
|
glutathione peroxidase 1
|
multiple interactions decreases response to substance decreases activity increases expression decreases expression
|
ISO EXP
|
GPX1 protein inhibits the reaction [Oxygen deficiency results in increased activity of PRKCE protein]; MIR34C promotes the reaction [Oxygen results in decreased expression of GPX1 protein]; SRT1720 inhibits the reaction [Oxygen results in decreased expression of GPX1 protein] GPX1 protein results in decreased susceptibility to Oxygen Oxygen results in decreased activity of GPX1 protein Oxygen results in increased expression of GPX1 mRNA
|
CTD |
PMID:15680347 PMID:17087917 PMID:18638544 PMID:35848756 |
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
| G
|
Gpx2
|
glutathione peroxidase 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of GPX2 mRNA
|
CTD |
PMID:35883890 |
|
NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:101,226,745...101,230,862
|
|
| G
|
Gpx3
|
glutathione peroxidase 3
|
multiple interactions
|
ISO
|
Oxygen results in increased expression of and results in increased activity of GPX3 protein
|
CTD |
PMID:10590029 |
|
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,529,448...39,537,405
|
|
| G
|
Gpx4
|
glutathione peroxidase 4
|
multiple interactions decreases expression
|
EXP ISO
|
[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of GPX4 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of GPX4 protein; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of GPX4 mRNA]; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of GPX4 protein] 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [wedelolactone inhibits the reaction [Oxygen results in increased expression of GPX4 protein]]; wedelolactone inhibits the reaction [Oxygen results in decreased expression of GPX4 protein] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [voacangine inhibits the reaction [Oxygen deficiency results in decreased expression of GPX4 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Oxygen deficiency results in decreased expression of GPX4 protein]; [cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of GPX4 protein; KDM4A protein affects the reaction [[cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of GPX4 protein]; voacangine inhibits the reaction [Oxygen deficiency results in decreased expression of GPX4 protein]
|
CTD |
PMID:36806343 PMID:38666302 PMID:38727079 PMID:39110510 |
|
NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629
|
|
| G
|
Grap2
|
GRB2-related adaptor protein 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of GRAP2 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 7:113,997,356...114,071,073
Ensembl chr 7:113,997,307...114,075,367
|
|
| G
|
Grb2
|
growth factor receptor bound protein 2
|
multiple interactions
|
ISO
|
[Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of GRB2 mRNA; [Oxygen co-treated with Ozone] results in decreased expression of GRB2 mRNA
|
CTD |
PMID:32992648 |
|
NCBI chr10:101,380,354...101,448,138
Ensembl chr10:101,380,356...101,448,138
|
|
| G
|
Grem1
|
gremlin 1, DAN family BMP antagonist
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of GREM1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 3:120,966,639...120,978,319
Ensembl chr 3:120,966,623...120,979,089
|
|
| G
|
Grem2
|
gremlin 2, DAN family BMP antagonist
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GREM2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr13:89,310,897...89,403,856
Ensembl chr13:89,310,662...89,404,312
|
|
| G
|
Grhl1
|
grainyhead-like transcription factor 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of GRHL1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 6:46,935,947...46,986,126
Ensembl chr 6:46,935,967...46,980,264
|
|
| G
|
Grhpr
|
glyoxylate and hydroxypyruvate reductase
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of GRHPR mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr 5:64,029,856...64,039,287
Ensembl chr 5:64,022,368...64,039,276
|
|
| G
|
Grin2b
|
glutamate ionotropic receptor NMDA type subunit 2B
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of GRIN2B protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of GRIN2B protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of GRIN2B protein]
|
CTD |
PMID:24718106 |
|
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:170,322,617...170,773,570
|
|
| G
|
Grin3b
|
glutamate ionotropic receptor NMDA type subunit 3B
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of GRIN3B mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 7:10,381,495...10,387,817
Ensembl chr 7:10,381,496...10,387,817
|
|
| G
|
Grk1
|
G protein-coupled receptor kinase 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of GRK1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr16:82,821,184...82,837,971
Ensembl chr16:82,826,022...82,837,971
|
|
| G
|
Grk4
|
G protein-coupled receptor kinase 4
|
multiple interactions
|
ISO
|
Oxygen deficiency inhibits the reaction [darinaparsin results in increased expression of GRK4 mRNA]
|
CTD |
PMID:22535156 |
|
NCBI chr14:80,230,699...80,305,292
Ensembl chr14:80,230,816...80,305,292
|
|
| G
|
Grwd1
|
glutamate-rich WD repeat containing 1
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of GRWD1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GRWD1 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 1:105,437,708...105,443,410
Ensembl chr 1:105,437,709...105,443,825
|
|
| G
|
Gsap
|
gamma-secretase activating protein
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GSAP mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:14,705,237...14,800,057
Ensembl chr 4:14,705,237...14,800,005
|
|
| G
|
Gsdmd
|
gasdermin D
|
multiple interactions increases cleavage increases expression
|
ISO
|
[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of GSDMD protein alternative form; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSDMD protein; bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of GSDMD protein alternative form]; bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSDMD protein] Oxygen deficiency results in increased cleavage of GSDMD protein Oxygen deficiency results in increased expression of GSDMD mRNA
|
CTD |
PMID:37127800 PMID:39038764 |
|
NCBI chr 7:109,423,209...109,427,771
Ensembl chr 7:109,422,910...109,430,722
|
|
| G
|
Gse1
|
Gse1 coiled-coil protein
|
increases expression affects methylation
|
ISO
|
Oxygen deficiency results in increased expression of GSE1 mRNA Oxygen deficiency affects the methylation of GSE1 promoter
|
CTD |
PMID:24205000 |
|
NCBI chr19:65,182,678...65,538,183
Ensembl chr19:65,446,263...65,538,176
|
|
| G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
increases phosphorylation multiple interactions decreases phosphorylation increases expression
|
EXP ISO
|
Oxygen deficiency results in increased phosphorylation of GSK3B protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased phosphorylation of GSK3B protein]; [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased susceptibility to SB 239063] which results in increased phosphorylation of GSK3B protein; [kaempferol co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] inhibits the reaction [Oxygen deficiency results in increased phosphorylation of GSK3B protein]; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased phosphorylation of GSK3B protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSK3B mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSK3B protein; [Oxygen deficiency co-treated with Oxygen] results in decreased phosphorylation of GSK3B protein; cobaltiprotoporphyrin promotes the reaction [Oxygen deficiency results in increased phosphorylation of GSK3B protein]; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of HMOX1 mRNA]]; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]]; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NQO1 mRNA]]; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; kaempferol inhibits the reaction [Oxygen deficiency results in increased expression of GSK3B mRNA]; kaempferol inhibits the reaction [Oxygen deficiency results in increased phosphorylation of GSK3B protein]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSK3B mRNA]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSK3B protein]; MK 2206 promotes the reaction [PHLDA3 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased phosphorylation of GSK3B protein]]; PHLDA3 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased phosphorylation of GSK3B protein]; sodium bisulfide inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased phosphorylation of GSK3B protein]; tin protoporphyrin IX inhibits the reaction [cobaltiprotoporphyrin promotes the reaction [Oxygen deficiency results in increased phosphorylation of GSK3B protein]] [betulin co-treated with Oxygen deficiency] affects the phosphorylation of GSK3B protein; [Betulinic Acid co-treated with Oxygen deficiency] results in increased phosphorylation of GSK3B protein; [Paclitaxel co-treated with FV-429 compound] inhibits the reaction [Oxygen deficiency results in increased phosphorylation of GSK3B protein]; [Paclitaxel co-treated with FV-429 compound] promotes the reaction [Oxygen deficiency results in increased expression of GSK3B protein]; dictamnine inhibits the reaction [Oxygen deficiency results in increased phosphorylation of GSK3B protein]; FV-429 compound affects the reaction [Oxygen deficiency results in increased expression of GSK3B protein]; FV-429 compound inhibits the reaction [Oxygen deficiency results in increased phosphorylation of GSK3B protein]; FV-429 compound promotes the reaction [Oxygen deficiency results in increased expression of GSK3B protein]; FV-429 compound promotes the reaction [Oxygen deficiency results in increased phosphorylation of GSK3B protein]; Oxygen deficiency results in increased expression of and results in increased phosphorylation of GSK3B protein Oxygen deficiency results in decreased phosphorylation of GSK3B protein PHLPP2 protein inhibits the reaction [Oxygen deficiency results in decreased phosphorylation of GSK3B protein]; SGMS2 protein promotes the reaction [Oxygen deficiency results in decreased phosphorylation of GSK3B protein]
|
CTD |
PMID:24058562 PMID:24658657 PMID:26116440 PMID:29719095 PMID:30266538 PMID:31610156 PMID:33111559 PMID:33181113 PMID:34351043 PMID:34648812 PMID:36940862 More...
|
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
|
|
| G
|
Gsr
|
glutathione-disulfide reductase
|
affects response to substance increases expression decreases expression
|
EXP ISO
|
Oxygen affects the susceptibility to GSR protein Oxygen results in increased expression of GSR Oxygen deficiency results in decreased expression of GSR mRNA
|
CTD |
PMID:2343184 PMID:2518282 PMID:25596134 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
| G
|
Gsta1
|
glutathione S-transferase alpha 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of GSTA1 mRNA
|
CTD |
PMID:19695866 |
|
NCBI chr 9:31,199,887...31,216,606
Ensembl chr 9:31,199,888...31,211,528
|
|
| G
|
Gstk1
|
glutathione S-transferase kappa 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GSTK1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:72,085,532...72,089,934
Ensembl chr 4:72,085,531...72,089,927
|
|
| G
|
Gstm1
|
glutathione S-transferase mu 1
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of GSTM1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GSTM1 mRNA
|
CTD |
PMID:19695866 PMID:30529165 |
|
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569
|
|
| G
|
Gstp1
|
glutathione S-transferase pi 1
|
increases expression
|
EXP
|
Oxygen results in increased expression of GSTP1 mRNA
|
CTD |
PMID:22911455 |
|
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705
|
|
| G
|
Gstz1
|
glutathione S-transferase zeta 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GSTZ1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:112,525,576...112,536,228
Ensembl chr 6:112,525,377...112,536,233
|
|
| G
|
Gtdc1
|
glycosyltransferase-like domain containing 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of GTDC1 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of GTDC1 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 3:49,176,110...49,571,594
Ensembl chr 3:49,176,110...49,571,843
|
|
| G
|
Gtf2f2
|
general transcription factor IIF subunit 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GTF2F2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr15:57,615,361...57,736,477
Ensembl chr15:57,614,841...57,736,516
|
|
| G
|
Gtf2h1
|
general transcription factor IIH subunit 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GTF2H1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:106,457,692...106,485,729
Ensembl chr 1:106,457,394...106,485,727
|
|
| G
|
Gtf3c3
|
general transcription factor IIIC subunit 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GTF3C3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:63,375,860...63,437,475
Ensembl chr 9:63,375,874...63,437,413
|
|
| G
|
Gtpbp4
|
GTP binding protein 4
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GTPBP4 mRNA; [sulforaphane affects the susceptibility to Oxygen] which affects the expression of GTPBP4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr17:65,997,472...66,019,530
Ensembl chr17:66,276,566...66,289,637
|
|
| G
|
Gucy1a1
|
guanylate cyclase 1 soluble subunit alpha 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GUCY1A1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:169,716,684...169,780,360
Ensembl chr 2:169,716,709...169,779,737
|
|
| G
|
Gucy1a2
|
guanylate cyclase 1 soluble subunit alpha 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GUCY1A2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:8,785,212...9,174,322
Ensembl chr 8:8,785,121...9,174,272
|
|
| G
|
Gulp1
|
GULP PTB domain containing engulfment adaptor 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GULP1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:54,114,823...54,391,058
Ensembl chr 9:54,114,731...54,397,452
|
|
| G
|
Gvin1
|
GTPase, very large interferon inducible 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of GVIN1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:169,689,178...169,718,522
Ensembl chr 1:169,691,586...169,718,522
|
|
| G
|
Gys1
|
glycogen synthase 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of GYS1 mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr 1:105,051,916...105,071,763
Ensembl chr 1:105,051,961...105,072,419
|
|
| G
|
Gzma
|
granzyme A
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GZMA mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:46,473,763...46,485,696
Ensembl chr 2:46,473,763...46,485,696
|
|
| G
|
H1f1
|
H1.1 linker histone, cluster member
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of H1-1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr17:41,762,278...41,794,876
|
|
| G
|
H1f2
|
H1.2 linker histone, cluster member
|
affects expression
|
ISO
|
Oxygen deficiency affects the expression of H1-2 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr17:41,818,962...41,820,453
Ensembl chr17:41,779,051...41,822,317
|
|
| G
|
H1f5
|
H1.5 linker histone, cluster member
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of H1-5 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr17:47,421,875...47,422,905
Ensembl chr17:47,421,843...47,477,387
|
|
| G
|
H2ac12
|
H2A clustered histone 12
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of H2AC12 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr17:47,182,193...47,182,658
|
|
| G
|
H2ac13
|
H2A clustered histone 13
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of H2AC8 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr17:41,807,261...41,807,653
|
|
| G
|
H2ac21
|
H2A clustered histone 21
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of H2AC21 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 2:186,468,224...186,468,657
|
|
| G
|
H2ac22
|
H2A clustered histone 22
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of H2AC11 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr17:41,812,378...41,812,875
Ensembl chr17:41,797,862...41,812,946
|
|
| G
|
H2ax
|
H2A.X variant histone
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of H2AX mRNA; Oxygen deficiency results in decreased expression of H2AX protein Oxygen deficiency inhibits the reaction [ferric oxide analog results in increased expression of H2AX protein]; Oxygen deficiency inhibits the reaction [nickel monoxide analog results in increased expression of H2AX protein]
|
CTD |
PMID:26516004 PMID:27270449 PMID:38909692 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
| G
|
H2az2
|
H2A.Z variant histone 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of H2AZ2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:85,507,228...85,526,166
Ensembl chr14:85,507,228...85,526,207 Ensembl chr16:85,507,228...85,526,207
|
|
| G
|
H2bc12
|
H2B clustered histone 12
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of H2BC12 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr17:47,181,477...47,181,940
Ensembl chr17:47,121,467...47,182,816
|
|
| G
|
H2bc14
|
H2B clustered histone 14
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of H2BC21 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr17:47,488,627...47,489,008
|
|
| G
|
H2bc18
|
H2B clustered histone 18
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of H2BC18 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 2:186,527,197...186,531,634
|
|
| G
|
H2bc21
|
H2B clustered histone 21
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of H2BC11 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 2:186,469,452...186,471,899
|
|
| G
|
H2bc27
|
H2B clustered histone 27
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of H2BC26 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:44,232,318...44,233,065
Ensembl chr10:44,232,318...44,233,065
|
|
| G
|
H2bc3
|
H2B clustered histone 3
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of H2BC3 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr17:41,807,913...41,808,543
|
|
| G
|
H2bc8
|
H2B clustered histone 8
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of H2BC8 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr17:47,404,405...47,405,155
|
|
| G
|
H3-7l
|
H3.7 histone like
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of H3-7 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 7:102,145,916...102,146,683
|
|
| G
|
H3c1
|
H3 clustered histone 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of H3C1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr17:41,796,236...41,796,759
Ensembl chr17:41,795,396...41,797,281 Ensembl chr17:41,795,396...41,797,281
|
|
| G
|
H3c13
|
H3 clustered histone 13
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of H3C13 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr17:41,959,540...41,960,009
Ensembl chr17:41,958,965...41,960,099
|
|
| G
|
H3c15
|
H3 clustered histone 15
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of H3C14 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 2:186,526,162...186,526,587
Ensembl chr 2:186,521,116...186,550,846
|
|
| G
|
H4c1
|
H4 clustered histone 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of H4C1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr17:47,393,764...47,394,168
Ensembl chr17:47,393,603...47,453,972 Ensembl chr17:47,393,603...47,453,972 Ensembl chr 4:47,393,603...47,453,972 Ensembl chr17:47,393,603...47,453,972 Ensembl chr17:47,393,603...47,453,972
|
|
| G
|
H4c8
|
H4 clustered histone 8
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of H4C9 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr17:47,176,246...47,180,690
Ensembl chr17:41,797,152...41,806,539 Ensembl chr17:41,797,152...41,806,539 Ensembl chr17:41,797,152...41,806,539 Ensembl chr 4:41,797,152...41,806,539
|
|
| G
|
Hacd1
|
3-hydroxyacyl-CoA dehydratase 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HACD1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr17:81,992,284...82,014,676
Ensembl chr17:81,992,292...82,014,592
|
|
| G
|
Hacd3
|
3-hydroxyacyl-CoA dehydratase 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HACD3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:74,396,441...74,433,700
Ensembl chr 8:74,396,442...74,433,700
|
|
| G
|
Hacd4
|
3-hydroxyacyl-CoA dehydratase 4
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HACD4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:107,935,514...107,961,271
Ensembl chr 5:107,934,937...107,962,836
|
|
| G
|
Hacl1
|
2-hydroxyacyl-CoA lyase 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HACL1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr16:6,831,293...6,869,410
Ensembl chr16:6,833,268...6,869,410
|
|
| G
|
Hadh
|
hydroxyacyl-CoA dehydrogenase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HADH mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:222,462,049...222,504,446
Ensembl chr 2:222,462,049...222,504,446
|
|
| G
|
Hal
|
histidine ammonia lyase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HAL mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:29,894,495...29,924,744
Ensembl chr 7:29,893,855...29,924,744
|
|
| G
|
Hamp
|
hepcidin antimicrobial peptide
|
affects expression multiple interactions
|
ISO EXP
|
Oxygen deficiency affects the expression of HAMP mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HAMP mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of HAMP mRNA
|
CTD |
PMID:19924283 PMID:30529165 PMID:33729688 |
|
NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:95,298,307...95,300,297
|
|
| G
|
Hao1
|
hydroxyacid oxidase 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of HAO1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 3:142,102,873...142,281,527
Ensembl chr 3:142,224,612...142,281,494
|
|
| G
|
Hapln1
|
hyaluronan and proteoglycan link protein 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of HAPLN1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 2:22,366,967...22,431,709
Ensembl chr 2:22,366,967...22,429,098
|
|
| G
|
Has1
|
hyaluronan synthase 1
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of HAS1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of HAS1 mRNA
|
CTD |
PMID:24205000 PMID:33729688 |
|
NCBI chr 1:67,366,460...67,378,686
Ensembl chr 1:67,366,460...67,378,444
|
|
| G
|
Has2
|
hyaluronan synthase 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of HAS2 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 7:90,002,929...90,028,933
Ensembl chr 7:90,002,929...90,018,535
|
|
| G
|
Haspin
|
histone H3 associated protein kinase
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of HASPIN mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:58,246,244...58,249,031
Ensembl chr10:58,240,447...58,249,249
|
|
| G
|
Haus2
|
HAUS augmin like complex subunit 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HAUS2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:128,006,894...128,019,730
Ensembl chr 3:128,006,932...128,019,729
|
|
| G
|
Haus6
|
HAUS augmin like complex subunit 6
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HAUS6 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:106,162,526...106,201,503
Ensembl chr 5:106,162,526...106,199,072
|
|
| G
|
Haus8
|
HAUS augmin-like complex, subunit 8
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of HAUS8 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr16:17,964,813...17,979,313
Ensembl chr16:17,964,814...17,979,192
|
|
| G
|
Havcr2
|
hepatitis A virus cellular receptor 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of HAVCR2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr10:31,383,801...31,415,334
Ensembl chr10:31,383,925...31,413,872
|
|
| G
|
Hba-a2
|
hemoglobin alpha, adult chain 2
|
affects binding
|
ISO
|
HBA1 protein binds to Oxygen; HBA1 protein polymorphism binds to Oxygen
|
CTD |
PMID:1634355 |
|
NCBI chr10:15,828,291...15,829,138
Ensembl chr10:15,828,377...15,829,141
|
|
| G
|
Hbb
|
hemoglobin subunit beta
|
affects binding multiple interactions
|
ISO
|
HBB protein binds to Oxygen; HBB protein polymorphism binds to Oxygen [voxelotor binds to and affects the folding of and results in increased stability of HBB protein] promotes the reaction [HBB protein binds to Oxygen]; [voxelotor binds to and affects the folding of HBB protein mutant form] promotes the reaction [HBB protein mutant form binds to Oxygen]
|
CTD |
PMID:5773089 PMID:30655275 PMID:33489427 |
|
NCBI chr 1:167,662,310...167,663,721
Ensembl chr 1:167,630,245...167,663,873
|
|
| G
|
Hbegf
|
heparin-binding EGF-like growth factor
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HBEGF mRNA Oxygen deficiency promotes the reaction [HBEGF protein mutant form results in increased activity of CASP3 protein]; Oxygen deficiency promotes the reaction [HBEGF protein mutant form results in increased phosphorylation of MAPK8 protein]; pyrazolanthrone inhibits the reaction [Oxygen deficiency promotes the reaction [HBEGF protein mutant form results in increased activity of CASP3 protein]] [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of HBEGF mRNA
|
CTD |
PMID:19193634 PMID:30529165 PMID:33729688 |
|
NCBI chr18:28,380,337...28,390,220
Ensembl chr18:28,380,337...28,390,220
|
|
| G
|
Hcar2
|
hydroxycarboxylic acid receptor 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of HCAR2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr12:38,387,163...38,389,149
Ensembl chr12:38,387,230...38,389,391
|
|
| G
|
Hccs
|
holocytochrome c synthase
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of HCCS mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr X:28,505,370...28,514,812
Ensembl chr X:28,505,417...28,514,812
|
|
| G
|
Hcfc1r1
|
host cell factor C1 regulator 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of HCFC1R1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:13,209,757...13,211,445
Ensembl chr10:13,209,558...13,211,443
|
|
| G
|
Hcn1
|
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of HCN1 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 2:51,228,710...51,632,806
Ensembl chr 2:51,228,710...51,632,806
|
|
| G
|
Hcn2
|
hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of HCN2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 7:10,620,422...10,639,457
Ensembl chr 7:10,620,422...10,639,457
|
|
| G
|
Hcrtr1
|
hypocretin receptor 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of HCRTR1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 5:147,761,392...147,771,846
Ensembl chr 5:147,760,145...147,770,850
|
|
| G
|
Hdac1
|
histone deacetylase 1
|
increases expression multiple interactions
|
EXP
|
Oxygen deficiency results in increased expression of HDAC1 protein Valproic Acid inhibits the reaction [Oxygen deficiency results in increased expression of HDAC1 protein]; vorinostat inhibits the reaction [Oxygen deficiency results in increased expression of HDAC1 protein]
|
CTD |
PMID:22711276 |
|
NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:147,138,156...147,165,387
|
|
| G
|
Hdac5
|
histone deacetylase 5
|
increases expression multiple interactions
|
EXP ISO
|
Oxygen deficiency results in increased expression of HDAC5 protein [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HDAC5 mRNA
|
CTD |
PMID:22711276 PMID:30529165 |
|
NCBI chr10:87,653,139...87,688,078
Ensembl chr10:87,652,656...87,694,244
|
|
| G
|
Heatr1
|
HEAT repeat containing 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of HEATR1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HEATR1 mRNA
|
CTD |
PMID:24205000 PMID:30529165 |
|
NCBI chr17:62,745,008...62,785,609
Ensembl chr17:62,745,008...62,785,186
|
|
| G
|
Hectd1
|
HECT domain E3 ubiquitin protein ligase 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of HECTD1 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of HECTD1 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 6:74,916,803...75,003,408
Ensembl chr 6:74,916,803...75,003,408
|
|
| G
|
Hells
|
helicase, lymphoid specific
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of HELLS mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of HELLS mRNA
|
CTD |
PMID:26516004 PMID:33729688 |
|
NCBI chr 1:246,113,580...246,159,230
Ensembl chr 1:246,114,096...246,159,228
|
|
| G
|
Helz2
|
helicase with zinc finger 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of HELZ2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 3:188,716,370...188,730,776
Ensembl chr 3:188,716,370...188,730,716
|
|
| G
|
Hepacam2
|
HEPACAM family member 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HEPACAM2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:32,400,523...32,435,936
Ensembl chr 4:32,400,558...32,435,512
|
|
| G
|
Herc3
|
HECT and RLD domain containing E3 ubiquitin protein ligase 3
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of HERC3 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 4:89,282,374...89,372,656
Ensembl chr 4:89,282,445...89,372,652
|
|
| G
|
Herc6
|
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of HERC6 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of HERC6 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 4:88,854,612...88,897,043
Ensembl chr 4:88,854,640...88,896,993
|
|
| G
|
Herpud1
|
homocysteine inducible ER protein with ubiquitin like domain 1
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of HERPUD1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:10,604,360...10,624,168
Ensembl chr19:10,604,362...10,624,081
|
|
| G
|
Hes1
|
hes family bHLH transcription factor 1
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of HES1 mRNA; Oxygen deficiency results in increased expression of HES1 protein N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of HES1 protein] N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of HES1 mRNA]
|
CTD |
PMID:24223152 PMID:26516004 |
|
NCBI chr11:84,210,632...84,213,045
Ensembl chr11:84,210,633...84,213,061
|
|
| G
|
Hes2
|
hes family bHLH transcription factor 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of HES2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 5:167,947,948...167,964,660
Ensembl chr 5:167,949,918...167,955,601
|
|
| G
|
Hes6
|
hes family bHLH transcription factor 6
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of HES6 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 9:99,449,375...99,451,343
Ensembl chr 9:99,449,371...99,451,096
|
|
| G
|
Hey2
|
hes-related family bHLH transcription factor with YRPW motif 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of HEY2 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 1:28,641,100...28,651,187
Ensembl chr 1:28,641,057...28,651,187
|
|
| G
|
Hgf
|
hepatocyte growth factor
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of HGF mRNA
|
CTD |
PMID:20880076 PMID:26516004 |
|
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851
|
|
| G
|
Hhip
|
Hedgehog-interacting protein
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HHIP mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:44,768,038...44,856,878
Ensembl chr19:44,767,536...44,862,795
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
multiple interactions affects localization affects response to substance decreases expression affects degradation decreases degradation increases activity increases expression increases stability increases degradation affects activity
|
ISO EXP
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; 1-Methyl-4-phenylpyridinium inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased activity of HIF1A protein]; [3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole results in decreased activity of HIF1A protein] results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]; [baysilon results in increased abundance of Oxygen] which results in decreased expression of HIF1A mRNA; [baysilon results in increased abundance of Oxygen] which results in decreased expression of HIF1A protein; [Glucose co-treated with Oxygen deficiency] inhibits the reaction [ARNT protein binds to HIF1A protein]; [Glucose co-treated with Oxygen deficiency] promotes the reaction [Pyruvaldehyde binds to and results in decreased activity of HIF1A protein]; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HIF1A protein; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HIF1A mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HIF1A mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HIF1A protein; Emodin inhibits the reaction [Oxygen deficiency results in decreased expression of HIF1A mRNA]; fasudil inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; gingerol inhibits the reaction [Oxygen deficiency results in decreased expression of HIF1A mRNA]; HIF1A gene mutant form inhibits the reaction [Oxygen deficiency results in increased secretion of APLN protein]; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of GAPDH mRNA]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of NDRG1 mRNA]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of SLC2A1 mRNA]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of VEGFA mRNA]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of CCR1 mRNA]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of CCR5 mRNA]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of IL13RA1 mRNA]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of MIF mRNA]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of P4HA2 mRNA]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of PGF mRNA]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of SLC37A4 mRNA]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of VEGFA mRNA]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Oxygen deficiency results in decreased expression of HIF1A mRNA]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HIF1A protein]; Oxygen deficiency affects the localization of and results in increased activity of HIF1A protein; Oxygen deficiency promotes the reaction [[HIF1A protein binds to SLC37A4 promoter] which results in increased expression of SLC37A4 mRNA]; Oxygen deficiency promotes the reaction [HIF1A protein binds to MTF1 promoter]; Oxygen deficiency results in increased activity of and affects the localization of HIF1A protein; Oxygen deficiency results in increased expression of and results in increased activity of HIF1A protein; Rosiglitazone inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; Rotenone inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased activity of HIF1A protein]; Y 27632 inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein] Oxygen deficiency affects the localization of HIF1A protein HIF1A affects the susceptibility to Oxygen deficiency Oxygen deficiency results in decreased expression of HIF1A mRNA; Oxygen results in decreased expression of HIF1A Oxygen affects the degradation of HIF1A protein Oxygen deficiency results in decreased degradation of HIF1A protein Oxygen deficiency results in increased activity of HIF1A protein Oxygen deficiency results in increased expression of HIF1A mRNA; Oxygen deficiency results in increased expression of HIF1A protein Oxygen deficiency results in increased stability of HIF1A protein Oxygen results in increased degradation of HIF1A protein 1-Methyl-4-phenylpyridinium inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased activity of HIF1A protein]; [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HIF1A protein] which results in increased expression of SLC8A1 mRNA; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HIF1A protein; [Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HIF1A mRNA; [Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HIF1A protein; [Xanthine co-treated with XDH protein] inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Apigenin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; HIF1A protein inhibits the reaction [[Apigenin co-treated with Oxygen deficiency] results in increased expression of CASP3 protein modified form]; HIF1A protein inhibits the reaction [[Apigenin co-treated with Oxygen deficiency] results in increased expression of CASP9 protein modified form]; HIF1A protein inhibits the reaction [[Apigenin co-treated with Oxygen deficiency] results in increased expression of CYCS protein]; HIF1A protein inhibits the reaction [Apigenin inhibits the reaction [Oxygen deficiency results in decreased expression of BAX protein]]; HIF1A protein inhibits the reaction [Apigenin inhibits the reaction [Oxygen deficiency results in decreased expression of KCNA5 protein]]; HIF1A protein inhibits the reaction [Apigenin inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 protein]]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of SLC8A1 protein]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of TUFT1 mRNA]; norwogonin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; norwogonin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Oxygen deficiency results in increased expression of and results in increased activity of HIF1A protein; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HIF1A mRNA]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HIF1A protein]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; Rotenone inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased activity of HIF1A protein]; Rutin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; Rutin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Tea inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Vitamin K 3 inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein] Oxygen deficiency affects the activity of HIF1A protein 1-(2-chloroethyl)-1-nitrosourea inhibits the reaction [Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]]; 1-(2-chloroethyl)-1-nitrosourea inhibits the reaction [glutathione glycylethyl ester inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]]; 1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; 1-Methyl-4-phenylpyridinium inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; 3,5-dihydroxy-4'-methoxystilbene inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; 3-(4-bromophenyl)-2-(ethylsulfonyl)-6-methylquinoxaline-1,4-dioxide inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Oxygen deficiency results in increased expression of HIF1A protein]]; 3-(4-bromophenyl)-2-(ethylsulfonyl)-6-methylquinoxaline-1,4-dioxide inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of CD36 mRNA]]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of CD36 protein]]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; 4'-O-methylalpinumisoflavone inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]; 4'-O-methylalpinumisoflavone inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; 4-(4-cyanophenyl)-2-(2-cyclopentylidenehydrazinyl)thiazole inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Cadmium inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]]; [[Minocycline promotes the reaction [HIF1A protein binds to VHL protein]] co-treated with [Minocycline results in increased expression of EGLN1 protein]] inhibits the reaction [Oxygen deficiency results in increased stability of HIF1A protein]; [AKT1 protein affects the reaction [Sulindac analog results in decreased expression of HIF1A protein]] which affects the susceptibility to Oxygen; [amurensin G results in decreased activity of SIRT1 protein] inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; [Apigenin co-treated with Oxygen deficiency] affects the expression of HIF1A mRNA; [Apigenin co-treated with Oxygen deficiency] affects the expression of HIF1A protein; [benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with Oxygen deficiency] affects the expression of HIF1A protein; [Betulinic Acid co-treated with Oxygen deficiency] affects the expression of HIF1A protein; [cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of HIF1A mRNA; [cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of HIF1A protein; [Curcumin analog co-treated with Sirolimus] inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; [Curcumin analog co-treated with terpestacin] inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; [Curcumin analog co-treated with Vorinostat] inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; [Cycloheximide co-treated with Oxygen deficiency] affects the expression of HIF1A protein; [FV-429 compound co-treated with Oxygen deficiency] affects the expression of HIF1A protein; [FV-429 compound co-treated with Paclitaxel] inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; [HIF1A mRNA co-treated with EPAS1 mRNA] affects the reaction [Oxygen deficiency results in decreased expression of USP28 protein]; [HIF1A mRNA co-treated with EPAS1 mRNA] affects the reaction [Oxygen deficiency results in increased degradation of MYC protein]; [HIF1A protein alternative form inhibits the reaction [Oxygen deficiency affects the localization of ARNT protein]] promotes the reaction [HIF1A protein alternative form binds to ARNT protein]; [Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HIF1A protein]; [Oxygen deficiency co-treated with Arsenic Trioxide] results in increased expression of HIF1A protein; [Oxygen deficiency co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] affects the expression of HIF1A protein; [Oxygen deficiency co-treated with Cycloheximide] affects the expression of HIF1A protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HIF1A protein; [Oxygen deficiency co-treated with sodium arsenite] results in decreased expression of HIF1A mRNA; [Oxygen deficiency co-treated with sodium arsenite] results in increased stability of HIF1A protein; [Oxygen deficiency co-treated with Tetrachlorodibenzodioxin] results in decreased stability of HIF1A protein; [Oxygen deficiency results in increased expression of HIF1A protein] which affects the expression of BAX protein; [Paclitaxel co-treated with FV-429 compound co-treated with Deferoxamine] promotes the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; [Paclitaxel co-treated with FV-429 compound] inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; [Paclitaxel co-treated with FV-429 compound] inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; [Polyphenols co-treated with Oxygen deficiency] promotes the reaction [VHL protein results in increased degradation of HIF1A protein]; [Polyphenols co-treated with Oxygen deficiency] results in decreased stability of HIF1A protein; [Polyphenols inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]] which results in decreased expression of VEGFA; [Propolis co-treated with Oxygen deficiency] promotes the reaction [VHL protein results in increased degradation of HIF1A protein]; [Propolis co-treated with Oxygen deficiency] results in decreased stability of HIF1A protein; [Propolis inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]] which results in decreased expression of VEGFA; [Thymidine co-treated with TYMP co-treated with Oxygen deficiency] results in increased expression of HIF1A protein; acetovanillone inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Acetylcysteine inhibits the reaction [Cadmium inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]]; Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]; Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; alpinumisoflavone inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]; Amphotericin B inhibits the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]]; annonacin inhibits the reaction [Oxygen deficiency results in increased expression of and affects the localization of HIF1A protein]; Apigenin inhibits the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]]; Apigenin inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde affects the reaction [[Apigenin co-treated with Oxygen deficiency] affects the expression of HIF1A protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; betulin analog inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; bruceine D inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Oxygen deficiency results in increased expression of HIF1A protein]]; bruceine D inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Cadmium Chloride inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]; Cadmium inhibits the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EPO promoter]]; Cadmium inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Catechin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; CGB3 protein promotes the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; chetomin inhibits the reaction [HIF1A protein promotes the reaction [TNF protein results in decreased metabolism of Oxygen]]; Cisplatin inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]; Cisplatin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; cobaltiprotoporphyrin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; CTNNB1 protein affects the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; CTNNBIP1 protein affects the reaction [bruceine D inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]]; Curcumin analog inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Oxygen deficiency results in increased expression of HIF1A protein]]; Curcumin analog inhibits the reaction [Ionomycin promotes the reaction [Oxygen deficiency results in increased activity of HIF1A protein]]; Curcumin analog inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased activity of HIF1A protein]; cyanidin-3-O-beta-glucopyranoside inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Cycloheximide affects the reaction [[Apigenin co-treated with Oxygen deficiency] affects the expression of HIF1A protein]; Cycloheximide inhibits the reaction [bruceine D inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]]; Cycloheximide inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Cycloheximide promotes the reaction [sodium arsenite inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]]; Dactinomycin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Deferoxamine promotes the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; deguelin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; deguelin metabolite inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; diallyl trisulfide inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; dictamnine inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Oxygen deficiency results in increased expression of HIF1A protein]]; dictamnine inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Digitoxin inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Oxygen deficiency results in increased expression of HIF1A protein]]; Digitoxin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; dihydrotanshinone I inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Oxygen deficiency results in increased expression of HIF1A protein]]; dodecaborate analog inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; ebselen inhibits the reaction [Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]]; ebselen inhibits the reaction [Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]]; ebselen inhibits the reaction [glutathione glycylethyl ester inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]]; ebselen inhibits the reaction [glutathione glycylethyl ester inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]]; Edaravone inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; Edaravone inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Fenofibrate inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; fisetin promotes the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]]; fisetin promotes the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; flavone inhibits the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]]; Folic Acid inhibits the reaction [Oxygen deficiency results in increased expression of and affects the localization of HIF1A protein]; Folic Acid inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; galangin promotes the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]]; galangin promotes the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; genipin affects the reaction [[Oxygen deficiency co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] affects the expression of HIF1A protein]; genipin affects the reaction [[Oxygen deficiency co-treated with Cycloheximide] affects the expression of HIF1A protein]; genipin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Genistein affects the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to ARNT protein binds to EDN1 promoter]]; Glucosamine inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Glutathione Disulfide analog promotes the reaction [Oxygen deficiency results in increased activity of HIF1A protein]; glutathione glycylethyl ester inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]; glutathione glycylethyl ester inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; HIF1A affects the reaction [Oxygen deficiency affects the expression of BIRC5 mRNA]; HIF1A affects the reaction [Oxygen deficiency affects the expression of BIRC5 protein]; HIF1A gene mutant form inhibits the reaction [Oxygen deficiency results in decreased expression of CPT1A mRNA]; HIF1A gene mutant form inhibits the reaction [Oxygen deficiency results in decreased expression of FASN mRNA]; HIF1A gene mutant form inhibits the reaction [Oxygen deficiency results in decreased expression of PPARGC1A protein]; HIF1A gene mutant form inhibits the reaction [Oxygen deficiency results in decreased expression of SCD mRNA]; HIF1A gene mutant form inhibits the reaction [Oxygen deficiency results in decreased expression of SREBF1 protein]; HIF1A mRNA promotes the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; HIF1A mRNA promotes the reaction [Oxygen deficiency results in increased expression of HMMR-AS1]; HIF1A mRNA promotes the reaction [Oxygen deficiency results in increased expression of SLC31A1 mRNA]; HIF1A mutant form inhibits the reaction [Oxygen deficiency results in decreased susceptibility to Etoposide]; HIF1A mutant form inhibits the reaction [Oxygen deficiency results in increased expression of CBR1 protein]; HIF1A mutant form inhibits the reaction [Oxygen deficiency results in increased expression of NEK8 protein]; HIF1A mutant form inhibits the reaction [Oxygen deficiency results in increased expression of SLC51A mRNA]; HIF1A protein affects the reaction [Oxygen deficiency results in decreased expression of SLC19A2 protein]; HIF1A protein affects the reaction [Oxygen deficiency results in decreased expression of SLC19A3 protein]; HIF1A protein affects the reaction [Oxygen deficiency results in decreased expression of SLC44A4 protein]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of BACE1 mRNA]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of BACE1 protein]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of CDH5 protein]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of CDKN1A mRNA]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of CDKN1A protein]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of ENTPD1 protein]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of FASN1 protein]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of KDR protein]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of NOD2 mRNA]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of NT5E protein]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of PECAM1 protein]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of PGK1 mRNA]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of PLIN2 protein]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of SENP1 protein]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of SLC2A1 protein]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of SLC2A3 protein]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of SREBF1 protein]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of TRPC1 protein]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of TRPC6 protein]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of VWF protein]; HIF1A protein affects the reaction [Paclitaxel affects the reaction [Oxygen deficiency results in decreased phosphorylation of CDC25C protein]]; HIF1A protein affects the reaction [Paclitaxel inhibits the reaction [Oxygen deficiency results in decreased expression of CCNB1 protein]]; HIF1A protein affects the reaction [Paclitaxel promotes the reaction [Oxygen deficiency results in decreased phosphorylation of CDK1 protein]]; HIF1A protein alternative form inhibits the reaction [Oxygen deficiency affects the localization of ARNT protein]; HIF1A protein alternative form inhibits the reaction [Oxygen deficiency results in increased expression of ALDOA mRNA]; HIF1A protein alternative form inhibits the reaction [Oxygen deficiency results in increased expression of LDHA mRNA]; HIF1A protein alternative form inhibits the reaction [Oxygen deficiency results in increased expression of SERPINH1 mRNA]; HIF1A protein alternative form inhibits the reaction [Oxygen deficiency results in increased expression of VEGFA mRNA]; HIF1A protein promotes the reaction [[Oxygen deficiency results in increased expression of PTGES protein] which results in increased chemical synthesis of Dinoprostone]; HIF1A protein promotes the reaction [Oxygen deficiency results in decreased expression of CDH1 mRNA]; HIF1A protein promotes the reaction [Oxygen deficiency results in decreased expression of MMP2 mRNA]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of CD36 mRNA]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of CD36 protein]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of COL7A1 mRNA]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of IGFBP3 mRNA]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of LAMC2 mRNA]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of NDRG1 mRNA]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of NDRG1 protein]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of PTGS2 mRNA]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of SNAI1 protein]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of STC2 mRNA]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of VEGFA mRNA]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of VEGFA protein]; HIF1A protein promotes the reaction [TNF protein results in decreased metabolism of Oxygen]; Ionomycin promotes the reaction [Oxygen deficiency results in increased activity of HIF1A protein]; kaempferol promotes the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]]; KC7F2 compound inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; KDR protein affects the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; L-4F peptide inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; linderalactone inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Luteolin inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]; Luteolin promotes the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Mercuric Chloride inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]; Minocycline inhibits the reaction [Oxygen deficiency results in increased stability of HIF1A protein]; Mustard Gas inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased stability of HIF1A protein]; mycothiazole inhibits the reaction [Oxygen deficiency results in increased expression of and affects the localization of HIF1A protein]; myricetin promotes the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]]; N-ethoxymethyl-3-amino-1,2,4-benzotriazine-1,4-dioxide inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; NFE2L2 protein inhibits the reaction [sodium arsenite inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]]; NFE2L2 protein promotes the reaction [sodium arsenite inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]]; nickel sulfate promotes the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Niclosamide inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Nitroprusside inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; NOX4 protein promotes the reaction [Oxygen deficiency results in increased expression of and results in increased activity of HIF1A protein]; NOX4 protein promotes the reaction [sodium arsenite inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased activity of HIF1A protein]]; Oxygen deficiency inhibits the reaction [Cisplatin results in decreased expression of HIF1A protein]; Oxygen deficiency inhibits the reaction [Sirolimus inhibits the reaction [sodium arsenite results in increased expression of HIF1A protein]]; Oxygen deficiency inhibits the reaction [sodium arsenite results in increased expression of HIF1A mRNA]; Oxygen deficiency promotes the reaction [[HIF1A protein binds to ARNT protein] which binds to EPO enhancer]; Oxygen deficiency promotes the reaction [[HIF1A protein binds to CD36 promoter] which results in increased expression of CD36 mRNA]; Oxygen deficiency promotes the reaction [[HIF1A protein binds to NMBR promoter] which results in increased expression of NMBR mRNA]; Oxygen deficiency promotes the reaction [HIF1A mutant form results in decreased expression of BCL2]; Oxygen deficiency promotes the reaction [HIF1A mutant form results in increased activity of CASP3 protein]; Oxygen deficiency promotes the reaction [HIF1A mutant form results in increased activity of CASP9 protein]; Oxygen deficiency promotes the reaction [HIF1A mutant form results in increased expression of BAX]; Oxygen deficiency promotes the reaction [HIF1A protein binds to ARNT protein binds to EDN1 promoter]; Oxygen deficiency promotes the reaction [HIF1A protein binds to ARNT protein]; Oxygen deficiency promotes the reaction [HIF1A protein binds to ATG9A promoter]; Oxygen deficiency promotes the reaction [HIF1A protein binds to BNIP3L promoter]; Oxygen deficiency promotes the reaction [HIF1A protein binds to DDIT4 promoter]; Oxygen deficiency promotes the reaction [HIF1A protein binds to ECE1 intron]; Oxygen deficiency promotes the reaction [HIF1A protein binds to ECE1 promoter]; Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]; Oxygen deficiency promotes the reaction [HIF1A protein binds to EPO promoter]; Oxygen deficiency promotes the reaction [HIF1A protein binds to GAPDH promoter]; Oxygen deficiency promotes the reaction [HIF1A protein binds to GPR68 promoter]; Oxygen deficiency promotes the reaction [HIF1A protein binds to HMMR-AS1 promoter]; Oxygen deficiency promotes the reaction [HIF1A protein binds to LDHA promoter]; Oxygen deficiency promotes the reaction [HIF1A protein binds to NMBR promoter]; Oxygen deficiency promotes the reaction [HIF1A protein binds to NOD2 promoter]; Oxygen deficiency promotes the reaction [HIF1A protein binds to P4HA1 promoter]; Oxygen deficiency promotes the reaction [HIF1A protein binds to SORL1 promoter]; Oxygen deficiency promotes the reaction [HIF1A protein binds to TP53 protein mutant form]; Oxygen deficiency promotes the reaction [HIF1A protein binds to VEGFA promoter]; Oxygen deficiency promotes the reaction [HIF1A protein results in increased expression of PFKFB4 mRNA]; Oxygen deficiency promotes the reaction [Ketoglutaric Acids results in increased expression of HIF1A protein]; Oxygen deficiency promotes the reaction [Lipopolysaccharides results in increased expression of HIF1A protein]; Oxygen deficiency promotes the reaction [SIRT1 protein binds to HIF1A protein]; Oxygen deficiency promotes the reaction [sodium arsenite results in increased expression of and results in increased stability of HIF1A protein]; Oxygen deficiency results in increased expression of and affects the localization of HIF1A protein; Oxygen deficiency results in increased expression of and results in increased activity of HIF1A protein; Oxygen deficiency results in increased expression of and results in increased localization of and results in increased activity of HIF1A protein; Oxygen deficiency results in increased expression of and results in increased secretion of HIF1A protein; Oxygen deficiency results in increased expression of and results in increased stability of HIF1A protein; Oxygen deficiency results in increased stability of and results in increased expression of HIF1A protein; Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Oxygen inhibits the reaction [Oxygen deficiency results in increased stability of HIF1A protein]; Particulate Matter inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HIF1A protein]; peoniflorin inhibits the reaction [[cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of HIF1A mRNA]; peoniflorin inhibits the reaction [[cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of HIF1A protein]; peptide 5F inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Phytochemicals inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; PIK3R1 protein promotes the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; PIK3R1 protein promotes the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Polyphenols inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; PRKCD protein promotes the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; Propolis inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; PTEN protein inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]; PTEN protein inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; PTGES protein promotes the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; PTGES protein promotes the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; Quercetin promotes the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]]; Quercetin promotes the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Quinolones inhibits the reaction [Mustard Gas inhibits the reaction [Oxygen deficiency results in increased stability of HIF1A protein]]; Quinolones promotes the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Resveratrol inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Oxygen deficiency results in increased expression of HIF1A protein]]; Resveratrol inhibits the reaction [Oxygen deficiency affects the localization of HIF1A protein]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; ROCK1 protein affects the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; ROCK2 protein affects the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Rosiglitazone inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; Rotenone inhibits the reaction [Oxygen deficiency results in decreased degradation of HIF1A protein]; Rotenone inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]; Rotenone inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; SB 203580 inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; SENP1 protein affects the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; shikonin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Sirolimus inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; Sirolimus inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; SIRT1 protein affects the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; sodium arsenite inhibits the reaction [Cycloheximide inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]]; sodium arsenite inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased activity of HIF1A protein]; ST6GAL1 protein inhibits the reaction [Oxygen deficiency results in decreased expression of HIF1A mRNA]; ST6GAL1 protein promotes the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Tetradecanoylphorbol Acetate inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; TP53 protein affects the reaction [Cisplatin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]]; VEGFA protein affects the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Vehicle Emissions inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HIF1A protein]; vosaroxin inhibits the reaction [Oxygen deficiency affects the localization of HIF1A protein]; vosaroxin inhibits the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to ARNT protein]]; Wortmannin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; Wortmannin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; zinc chloride inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]; zinc chloride inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein] [Oxygen deficiency results in increased expression of HIF1A protein] which results in increased expression of SORL1 protein; Oxygen deficiency results in increased expression of HIF1A mRNA; Oxygen deficiency results in increased expression of HIF1A protein
|
CTD |
PMID:10646848 PMID:10866824 PMID:10939628 PMID:10961998 PMID:11090055 PMID:11286986 PMID:11424089 PMID:11641398 PMID:11739637 PMID:11886167 PMID:12054621 PMID:12062197 PMID:12376345 PMID:12595275 PMID:13679210 PMID:14604972 PMID:15341671 PMID:15525582 PMID:15604272 PMID:15741220 PMID:15841086 PMID:16025159 PMID:16189267 PMID:16357179 PMID:16490744 PMID:16507596 PMID:16628086 PMID:16814746 PMID:17015263 PMID:17307335 PMID:17442736 PMID:17599377 PMID:17671207 PMID:17764071 PMID:17878221 PMID:17889387 PMID:17968710 PMID:18072750 PMID:18227068 PMID:18394600 PMID:18575727 PMID:18591213 PMID:18674879 PMID:18924134 PMID:19074414 PMID:19091749 PMID:19139008 PMID:19196431 PMID:19228841 PMID:19254699 PMID:19278353 PMID:19324842 PMID:19374849 PMID:19384570 PMID:19542490 PMID:19587783 PMID:19640849 PMID:19695866 PMID:19714248 PMID:19744167 PMID:19808899 PMID:19825857 PMID:19958256 PMID:20042640 PMID:20046830 PMID:20153296 PMID:20206160 PMID:20412331 PMID:20423107 PMID:20524035 PMID:20530905 PMID:20554536 PMID:20616211 PMID:20637638 PMID:20658530 PMID:20862257 PMID:20880076 PMID:20881000 PMID:20881940 PMID:21036805 PMID:21293012 PMID:21382473 PMID:21914476 PMID:21926265 PMID:22087807 PMID:22087877 PMID:22245592 PMID:22269387 PMID:22279137 PMID:22340517 PMID:22363556 PMID:22537771 PMID:22652775 PMID:22745725 PMID:23036488 PMID:23108914 PMID:23144690 PMID:23326410 PMID:23421680 PMID:23424623 PMID:23486467 PMID:23568779 PMID:23624237 PMID:23728938 PMID:23880069 PMID:23958427 PMID:24066183 PMID:24236059 PMID:24270971 PMID:24292262 PMID:24349381 PMID:24403227 PMID:24503013 PMID:24518827 PMID:24614111 PMID:24639359 PMID:24703425 PMID:24846829 PMID:24860939 PMID:24975222 PMID:25030372 PMID:25297617 PMID:25351418 PMID:25451921 PMID:25469848 PMID:25511041 PMID:25596134 PMID:26054451 PMID:26082309 PMID:26087400 PMID:26282490 PMID:26516004 PMID:26540049 PMID:26723917 PMID:26974319 PMID:27286880 PMID:27292261 PMID:27899277 PMID:28174749 PMID:28400208 PMID:28574600 PMID:28684144 PMID:28734801 PMID:29107683 PMID:29139225 PMID:29156398 PMID:29475939 PMID:29630948 PMID:29685624 PMID:29690507 PMID:29800573 PMID:29966676 PMID:29984229 PMID:30266538 PMID:30381462 PMID:30529165 PMID:30831131 PMID:31930969 PMID:31953908 PMID:32173479 PMID:32638257 PMID:33181113 PMID:33413359 PMID:33759271 PMID:34520103 PMID:34541741 PMID:34648812 PMID:34717917 PMID:34900531 PMID:34998824 PMID:35179300 PMID:35513012 PMID:35883890 PMID:36318118 More...
|
|
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Hif3a
|
hypoxia inducible factor 3 subunit alpha
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of HIF3A mRNA Oxygen deficiency promotes the reaction [HIF3A protein binds to KDM3A promoter]
|
CTD |
PMID:26516004 PMID:34826399 |
|
NCBI chr 1:86,846,196...86,878,527
Ensembl chr 1:86,850,554...86,877,838
|
|
| G
|
Higd1a
|
HIG1 hypoxia inducible domain family, member 1A
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of HIGD1A mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr 8:130,391,658...130,400,888
Ensembl chr 8:130,391,661...130,400,888
|
|
| G
|
Higd1b
|
HIG1 hypoxia inducible domain family, member 1B
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HIGD1B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:88,302,284...88,304,558
Ensembl chr10:88,302,790...88,304,558
|
|
| G
|
Hilpda
|
hypoxia inducible lipid droplet-associated
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of HILPDA mRNA 1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of HILPDA mRNA] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HILPDA mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of HILPDA mRNA
|
CTD |
PMID:19502547 PMID:20880076 PMID:24236059 PMID:24403227 PMID:30529165 PMID:33729688 More...
|
|
NCBI chr 4:58,836,463...58,839,423
Ensembl chr 4:58,836,463...58,839,423
|
|
| G
|
Hipk2
|
homeodomain interacting protein kinase 2
|
decreases expression multiple interactions increases expression
|
ISO
|
Oxygen deficiency results in decreased expression of HIPK2 protein zinc chloride inhibits the reaction [Oxygen deficiency results in decreased expression of HIPK2 protein] [Oxygen deficiency co-treated with Oxygen] results in increased expression of HIPK2 mRNA; [Oxygen deficiency co-treated with Oxygen] results in increased expression of HIPK2 protein; HIPK2 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased activity of NFE2L2 protein]; HIPK2 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of HMOX1 mRNA]; HIPK2 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of NQO1 mRNA]; Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of HIPK2 mRNA]
|
CTD |
PMID:19714248 PMID:22629407 PMID:31837296 |
|
NCBI chr 4:68,399,358...68,586,404
Ensembl chr 4:68,369,099...68,586,108
|
|
| G
|
Hjv
|
hemojuvelin BMP co-receptor
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of HJV mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 2:186,754,801...186,758,708
Ensembl chr 2:186,754,811...186,758,867
|
|
| G
|
Hk1
|
hexokinase 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of HK1 mRNA
|
CTD |
PMID:19502547 PMID:20880076 |
|
NCBI chr20:30,773,222...30,874,814
Ensembl chr20:30,773,220...30,874,814
|
|
| G
|
Hk2
|
hexokinase 2
|
affects expression increases expression multiple interactions
|
ISO
|
Oxygen deficiency affects the expression of HK2 mRNA Oxygen deficiency results in increased expression of HK2 mRNA; Oxygen deficiency results in increased expression of HK2 protein bruceine D affects the reaction [Oxygen deficiency affects the expression of HK2 protein]; CTNNBIP1 protein affects the reaction [bruceine D affects the reaction [Oxygen deficiency affects the expression of HK2 protein]]
|
CTD |
PMID:17193925 PMID:19502547 PMID:20042640 PMID:24236059 PMID:26087400 PMID:30381462 PMID:34900531 More...
|
|
NCBI chr 4:116,792,258...116,841,275
Ensembl chr 4:116,792,258...116,841,275
|
|
| G
|
Hkdc1
|
hexokinase domain containing 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HKDC1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr20:30,878,037...30,917,044
Ensembl chr20:30,878,319...30,916,704
|
|
| G
|
Hltf
|
helicase-like transcription factor
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HLTF mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:104,478,725...104,538,531
Ensembl chr 2:104,478,772...104,538,818
|
|
| G
|
Hmcn1
|
hemicentin 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HMCN1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr13:65,165,532...65,634,681
Ensembl chr13:65,165,532...65,634,519
|
|
| G
|
Hmcn2
|
hemicentin 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of HMCN2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 3:34,986,246...35,136,047
Ensembl chr 3:34,986,263...35,136,106
|
|
| G
|
Hmga2
|
high mobility group AT-hook 2
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of HMGA2 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HMGA2 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 7:57,762,710...57,884,555
Ensembl chr 7:57,765,675...57,880,341
|
|
| G
|
Hmgb1
|
high mobility group box 1
|
multiple interactions increases expression
|
EXP ISO
|
5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinato iron(III) chloride inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of HMGB1 protein]; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of HMGB1 protein; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of HMGB1 protein]; saxagliptin inhibits the reaction [Oxygen deficiency results in increased expression of HMGB1 mRNA]; saxagliptin inhibits the reaction [Oxygen deficiency results in increased expression of HMGB1 protein] [Oxygen deficiency results in increased secretion of HMGB1 protein] which results in increased expression of ICAM1 protein; [Oxygen deficiency results in increased secretion of HMGB1 protein] which results in increased expression of VCAM1 protein; Oxygen deficiency results in increased expression of and results in increased secretion of HMGB1 protein; tanshinone II A sodium sulfonate inhibits the reaction [[Oxygen deficiency results in increased secretion of HMGB1 protein] which results in increased expression of ICAM1 protein]; tanshinone II A sodium sulfonate inhibits the reaction [[Oxygen deficiency results in increased secretion of HMGB1 protein] which results in increased expression of VCAM1 protein]; tanshinone II A sodium sulfonate inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased secretion of HMGB1 protein]; tanshinone II A sodium sulfonate inhibits the reaction [Oxygen deficiency results in increased expression of HMGB1 mRNA] Oxygen deficiency results in increased expression of HMGB1 mRNA; Oxygen deficiency results in increased expression of HMGB1 protein
|
CTD |
PMID:21113057 PMID:28294475 PMID:31629700 |
|
NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327 Ensembl chr12:39,039,050...39,041,327
|
|
| G
|
Hmgcl
|
3-hydroxy-3-methylglutaryl-CoA lyase
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of HMGCL mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 5:153,461,738...153,475,552
Ensembl chr 5:153,461,769...153,475,604
|
|
| G
|
Hmgcr
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HMGCR mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533
|
|
| G
|
Hmmr
|
hyaluronan-mediated motility receptor
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of HMMR mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of HMMR mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr10:25,635,249...25,665,389
Ensembl chr10:25,635,915...25,665,390
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
multiple interactions increases expression affects localization decreases expression affects expression
|
ISO EXP
|
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 mRNA; [Oxygen deficiency co-treated with Oxygen] results in increased expression of HMOX1 mRNA; HIPK2 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of HMOX1 mRNA]; HMOX1 protein promotes the reaction [Oxygen deficiency results in increased expression of CXCL12 mRNA]; HMOX1 protein promotes the reaction [Oxygen deficiency results in increased expression of CXCL12 protein]; HMOX1 protein promotes the reaction [Oxygen deficiency results in increased expression of VEGFA mRNA]; HMOX1 protein promotes the reaction [Oxygen deficiency results in increased expression of VEGFA protein]; MIR144 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 mRNA]; PHLPP2 protein inhibits the reaction [Oxygen deficiency results in increased expression of HMOX1 mRNA]; wedelolactone inhibits the reaction [Oxygen results in decreased expression of HMOX1 protein] Oxygen deficiency results in increased expression of HMOX1 mRNA; Oxygen deficiency results in increased expression of HMOX1 protein Oxygen deficiency affects the localization of HMOX1 protein 1,10-phenanthroline inhibits the reaction [Oxygen results in increased expression of HMOX1 mRNA]; 3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of HMOX1 mRNA]; [Oxygen co-treated with Glucose] promotes the reaction [Vehicle Emissions promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 protein]]; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 protein; Acetylcysteine promotes the reaction [Oxygen results in increased expression of HMOX1 mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of HMOX1 mRNA]; Cycloheximide inhibits the reaction [Oxygen results in increased expression of HMOX1 mRNA]; Dactinomycin inhibits the reaction [Oxygen results in increased expression of HMOX1 mRNA]; Deferoxamine inhibits the reaction [Oxygen results in increased expression of HMOX1 mRNA]; Diazoxide inhibits the reaction [Oxygen deficiency results in decreased expression of HMOX1 mRNA]; Diazoxide inhibits the reaction [Oxygen deficiency results in decreased expression of HMOX1 protein]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of HMOX1 mRNA]; GSK3235025 inhibits the reaction [Oxygen deficiency results in decreased expression of HMOX1 protein]; HMOX1 mutant form inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [[Oxygen deficiency co-treated with IL1B protein] results in increased expression of TNF protein]]; HMOX1 mutant form inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [IL1B protein inhibits the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]]]; HMOX1 mutant form inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [IL1B protein inhibits the reaction [Oxygen deficiency results in increased expression of SOX9 protein]]]; HMOX1 mutant form inhibits the reaction [cobaltiprotoporphyrin promotes the reaction [IL1B protein inhibits the reaction [Oxygen deficiency results in increased expression of COL2A1 protein]]]; HMOX1 protein affects the reaction [Diazoxide inhibits the reaction [Oxygen deficiency results in increased expression of FLT1 protein]]; Oxygen deficiency inhibits the reaction [sodium arsenite results in increased expression of HMOX1 protein]; Particulate Matter promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 protein]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of HMOX1 mRNA]; POR protein inhibits the reaction [Oxygen deficiency affects the localization of HMOX1 protein]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of HMOX1 mRNA]; Vehicle Emissions promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 protein] Oxygen deficiency results in decreased expression of HMOX1 mRNA; Oxygen deficiency results in decreased expression of HMOX1 protein Oxygen deficiency results in increased expression of HMOX1 mRNA; Oxygen deficiency results in increased expression of HMOX1 protein; Oxygen results in increased expression of HMOX1 mRNA; Oxygen results in increased expression of HMOX1 protein Oxygen deficiency affects the expression of HMOX1 mRNA [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with zinc protoporphyrin] results in increased expression of HMOX1 mRNA; [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with zinc protoporphyrin] results in increased expression of HMOX1 mRNA; [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of HMOX1 mRNA; [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of HMOX1 protein; [Antagomirs results in decreased expression of MIR30C1 mRNA] inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of HMOX1 protein]; [Antagomirs results in decreased expression of MIR30C1 mRNA] inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of HMOX1 protein]; [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HMOX1 mRNA; [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HMOX1 protein; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of HMOX1 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of HMOX1 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of HMOX1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 protein; [Oxygen deficiency co-treated with Oxygen] results in increased expression of HMOX1 protein; cobaltiprotoporphyrin promotes the reaction [Oxygen deficiency results in increased expression of HMOX1 protein]; cobaltous chloride inhibits the reaction [Oxygen deficiency results in increased expression of HMOX1 mRNA]; cobaltous chloride promotes the reaction [Oxygen deficiency results in increased expression of HMOX1 protein]; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of HMOX1 protein]; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 mRNA]; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 protein]; Ethanol inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of HMOX1 mRNA]; Ethanol inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of HMOX1 protein]; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of HMOX1 mRNA]]; Hemin promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of HMOX1 mRNA]; Hemin promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of HMOX1 protein]; HMOX1 protein promotes the reaction [diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of HMOX1 mRNA]; MIR30C1 mRNA promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of HMOX1 protein]; MIR30C1 mRNA promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of HMOX1 protein]; naringin promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of HMOX1 protein]; NFE2L2 mutant form inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of HMOX1 protein]; Oxygen deficiency results in increased expression of and results in increased activity of HMOX1 protein; PHLDA3 protein inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of HMOX1 protein]; PHLDA3 protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of HMOX1 protein]; saxagliptin promotes the reaction [Oxygen deficiency results in increased expression of HMOX1 mRNA]; saxagliptin promotes the reaction [Oxygen deficiency results in increased expression of HMOX1 protein]; Tea inhibits the reaction [Oxygen deficiency results in decreased expression of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of HMOX1 protein]
|
CTD |
PMID:9747510 PMID:10814519 PMID:11406497 PMID:15708121 PMID:16373842 PMID:17706837 PMID:18331222 PMID:18635243 PMID:19278353 PMID:21048024 PMID:21296072 PMID:21468576 PMID:22545110 PMID:23406266 PMID:23452621 PMID:24518827 PMID:24658657 PMID:25322861 PMID:25371888 PMID:25448280 PMID:25596134 PMID:25773745 PMID:25831079 PMID:25896937 PMID:25922074 PMID:26516004 PMID:26747958 PMID:27286880 PMID:28400208 PMID:29139225 PMID:29457851 PMID:29719095 PMID:29966676 PMID:31610156 PMID:31629700 PMID:31837296 PMID:31885778 PMID:33729688 PMID:34217758 PMID:34351043 PMID:35191607 PMID:38909692 PMID:39110510 More...
|
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hnf1a
|
HNF1 homeobox A
|
multiple interactions decreases response to substance
|
ISO
|
[Butylated Hydroxytoluene co-treated with Oxygen] results in increased expression of HNF1A mRNA HNF1A gene mutant form results in decreased susceptibility to Oxygen deficiency
|
CTD |
PMID:16272459 PMID:21994956 |
|
NCBI chr12:47,299,171...47,333,457
Ensembl chr12:47,306,245...47,332,755
|
|
| G
|
Hnmt
|
histamine N-methyltransferase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HNMT mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:26,978,274...27,010,291
Ensembl chr 3:26,977,933...27,010,482
|
|
| G
|
Hnrnpa3
|
heterogeneous nuclear ribonucleoprotein A3
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of HNRNPA3 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 3:80,984,470...80,999,413
Ensembl chr 3:80,985,969...80,996,043
|
|
| G
|
Hnrnpab
|
heterogeneous nuclear ribonucleoprotein A/B
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of HNRNPAB mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of HNRNPAB mRNA
|
CTD |
PMID:26516004 PMID:33729688 |
|
NCBI chr10:36,358,004...36,363,898
Ensembl chr10:36,358,006...36,364,307
|
|
| G
|
Hnrnpk
|
heterogeneous nuclear ribonucleoprotein K
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of HNRNPK protein
|
CTD |
PMID:25937538 |
|
NCBI chr17:6,269,302...6,280,429
Ensembl chr17:6,268,385...6,280,565
|
|
| G
|
Hnrnpl
|
heterogeneous nuclear ribonucleoprotein L
|
multiple interactions decreases expression
|
ISO
|
[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of HNRNPL protein; [sulforaphane affects the susceptibility to Oxygen] which affects the expression of HNRNPL mRNA; LINC01588 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of HNRNPL protein] heclin inhibits the reaction [LINC01588 mRNA inhibits the reaction [Oxygen deficiency results in decreased expression of HNRNPL protein]]; HNRNPL promotes the reaction [LINC01588 mRNA inhibits the reaction [Oxygen deficiency results in decreased expression of WWP2 protein]]; HNRNPL promotes the reaction [LINC01588 mRNA inhibits the reaction [Oxygen deficiency results in increased expression of SEPTIN4 protein]]; HNRNPL promotes the reaction [LINC01588 mRNA inhibits the reaction [Oxygen deficiency results in increased secretion of IL6 protein]]; HNRNPL promotes the reaction [LINC01588 mRNA inhibits the reaction [Oxygen deficiency results in increased secretion of TNF protein]]; LINC01588 mRNA inhibits the reaction [Oxygen deficiency results in decreased expression of HNRNPL protein]
|
CTD |
PMID:30529165 PMID:35258167 |
|
NCBI chr 1:93,226,373...93,239,084
Ensembl chr 1:93,235,729...93,239,061
|
|
| G
|
Hnrnpll
|
heterogeneous nuclear ribonucleoprotein L-like
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of HNRNPLL mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:20,720,013...20,752,803
Ensembl chr 6:20,722,184...20,752,802
|
|
| G
|
Hoga1
|
4-hydroxy-2-oxoglutarate aldolase 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HOGA1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:250,806,430...250,833,544
Ensembl chr 1:250,806,255...250,833,869
|
|
| G
|
Homer1
|
homer scaffold protein 1
|
increases expression
|
EXP
|
Oxygen results in increased expression of HOMER1 mRNA
|
CTD |
PMID:22911455 |
|
NCBI chr 2:26,279,012...26,388,279
Ensembl chr 2:26,278,105...26,381,657
|
|
| G
|
Homez
|
homeobox and leucine zipper encoding
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of HOMEZ mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr15:32,292,897...32,309,564
Ensembl chr15:32,291,048...32,321,319
|
|
| G
|
Hoxa1
|
homeobox A1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of HOXA1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 4:82,586,505...82,589,209
Ensembl chr 4:82,586,505...82,589,209
|
|
| G
|
Hoxb9
|
homeo box B9
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of HOXB9 mRNA
|
CTD |
PMID:17175027 |
|
NCBI chr10:81,733,857...81,737,363
Ensembl chr10:81,733,658...81,738,872
|
|
| G
|
Hpdl
|
4-hydroxyphenylpyruvate dioxygenase-like
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of HPDL mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 5:135,523,258...135,524,864
Ensembl chr 5:135,523,262...135,535,704
|
|
| G
|
Hpgd
|
15-hydroxyprostaglandin dehydrogenase
|
increases expression decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of HPGD mRNA Oxygen results in decreased expression of HPGD mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HPGD mRNA
|
CTD |
PMID:20042640 PMID:22911455 PMID:30529165 |
|
NCBI chr16:38,996,876...39,034,831
Ensembl chr16:38,996,876...39,034,831
|
|
| G
|
Hprt1
|
hypoxanthine phosphoribosyltransferase 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of HPRT1 mRNA
|
CTD |
PMID:35883890 |
|
NCBI chr X:137,655,744...137,687,718
Ensembl chr X:137,655,680...137,687,712
|
|
| G
|
Hpse
|
heparanase
|
affects expression multiple interactions
|
ISO
|
Oxygen affects the expression of HPSE mRNA; Oxygen affects the expression of HPSE protein phosphomannopentaose sulfate affects the reaction [Oxygen affects the expression of HPSE mRNA]; phosphomannopentaose sulfate affects the reaction [Oxygen affects the expression of HPSE protein]
|
CTD |
PMID:22956610 |
|
NCBI chr14:9,200,971...9,241,377
Ensembl chr14:9,188,275...9,241,754
|
|
| G
|
Hr
|
HR, lysine demethylase and nuclear receptor corepressor
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of HR mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr15:52,036,540...52,056,019
Ensembl chr15:52,036,540...52,056,015
|
|
| G
|
Hras
|
HRas proto-oncogene, GTPase
|
multiple interactions
|
ISO
|
Oxygen deficiency inhibits the reaction [HRAS protein promotes the reaction [[sodium bichromate results in increased abundance of chromium hexavalent ion] which results in increased abundance of Hydroxyl Radical]]
|
CTD |
PMID:14971653 |
|
NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:205,725,975...205,729,590
|
|
| G
|
Hrc
|
histidine rich calcium binding protein
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HRC mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:104,949,750...104,953,475
Ensembl chr 1:104,949,741...104,954,193
|
|
| G
|
Hrh2
|
histamine receptor H 2
|
multiple interactions
|
ISO
|
[Cimetidine binds to and results in decreased activity of HRH2 protein] results in decreased susceptibility to [Histamine co-treated with [Oxygen deficiency co-treated with Oxygen]]
|
CTD |
PMID:22926047 |
|
NCBI chr17:10,371,083...10,412,979
Ensembl chr17:10,371,083...10,391,041
|
|
| G
|
Hrnr
|
hornerin
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of HRNR mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 2:181,650,772...181,663,633
|
|
| G
|
Hs2st1
|
heparan sulfate 2-O-sulfotransferase 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HS2ST1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:236,168,391...236,302,186
Ensembl chr 2:236,168,392...236,302,133
|
|
| G
|
Hs3st1
|
heparan sulfate-glucosamine 3-sulfotransferase 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of HS3ST1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr14:75,398,101...75,429,628
Ensembl chr14:75,398,026...75,436,848
|
|
| G
|
Hs6st1
|
heparan sulfate 6-O-sulfotransferase 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of HS6ST1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 9:45,779,402...45,818,583
Ensembl chr 9:45,779,019...45,818,582
|
|
| G
|
Hs6st3
|
heparan sulfate 6-O-sulfotransferase 3
|
affects methylation increases expression
|
ISO
|
Oxygen deficiency affects the methylation of HS6ST3 promoter Oxygen deficiency results in increased expression of HS6ST3 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr15:102,688,420...103,407,725
Ensembl chr15:102,688,365...103,408,384
|
|
| G
|
Hsd11b2
|
hydroxysteroid 11-beta dehydrogenase 2
|
decreases expression increases methylation
|
EXP
|
Oxygen deficiency results in decreased expression of HSD11B2 mRNA; Oxygen deficiency results in decreased expression of HSD11B2 protein Oxygen deficiency results in increased methylation of HSD11B2 promoter
|
CTD |
PMID:35378222 |
|
NCBI chr19:50,307,569...50,312,812
Ensembl chr19:50,307,569...50,312,812
|
|
| G
|
Hsd17b11
|
hydroxysteroid (17-beta) dehydrogenase 11
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HSD17B11 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:5,997,893...6,047,816
Ensembl chr14:5,997,906...6,047,811
|
|
| G
|
Hsd17b2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of HSD17B2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr19:62,662,320...62,733,944
Ensembl chr19:62,662,098...62,733,943
|
|
| G
|
Hsf1
|
heat shock transcription factor 1
|
multiple interactions increases expression
|
ISO
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of HSF1 mRNA]; bisindolylmaleimide II inhibits the reaction [Oxygen deficiency results in increased expression of HSF1 mRNA]; PRKCD protein promotes the reaction [Oxygen deficiency results in increased expression of HSF1 mRNA]; Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of HSF1 mRNA]; wortmannin inhibits the reaction [Oxygen deficiency results in increased expression of HSF1 mRNA]
|
CTD |
PMID:11424089 |
|
NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:110,076,710...110,103,665
|
|
| G
|
Hsf4
|
heat shock transcription factor 4
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of HSF4 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr19:50,057,331...50,068,134
Ensembl chr19:50,057,672...50,063,404
|
|
| G
|
Hsh2d
|
hematopoietic SH2 domain containing
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of HSH2D mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr16:17,664,548...17,686,976
Ensembl chr16:17,669,345...17,682,013
|
|
| G
|
Hsp90aa1
|
heat shock protein 90 alpha family class A member 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of HSP90AA1 mRNA; Oxygen results in decreased expression of HSP90AA1 mRNA
|
CTD |
PMID:27103661 PMID:35883890 |
|
NCBI chr 6:135,523,604...135,529,687
Ensembl chr 6:135,523,616...135,528,499
|
|
| G
|
Hsp90b1
|
heat shock protein 90 beta family member 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of HSP90B1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 7:22,997,962...23,012,293
Ensembl chr 7:22,997,962...23,012,293
|
|
| G
|
Hspa12b
|
heat shock protein family A (Hsp70) member 12B
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HSPA12B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:138,799,396...138,817,396
Ensembl chr 3:138,799,398...138,818,935
|
|
| G
|
Hspa1a
|
heat shock protein family A (Hsp70) member 1A
|
multiple interactions increases expression decreases expression
|
EXP ISO
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of HSPA1A mRNA; cobaltous chloride inhibits the reaction [Oxygen deficiency results in increased expression of HSPA1A protein] Oxygen deficiency results in increased expression of HSPA1A mRNA; Oxygen deficiency results in increased expression of HSPA1A protein [Oxygen deficiency co-treated with Catechin] results in increased expression of HSPA1A mRNA; Oxygen deficiency inhibits the reaction [darinaparsin results in increased expression of HSPA1A mRNA] Oxygen deficiency results in decreased expression of HSPA1A mRNA
|
CTD |
PMID:19278353 PMID:22535156 PMID:26516004 PMID:33729688 PMID:35883890 |
|
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979
|
|
| G
|
Hspa1b
|
heat shock protein family A (Hsp70) member 1B
|
increases expression decreases expression multiple interactions
|
EXP ISO
|
Oxygen deficiency results in increased expression of HSPA1B mRNA; Oxygen deficiency results in increased expression of HSPA1B protein Oxygen deficiency results in decreased expression of HSPA1B mRNA [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HSPA1B mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of HSPA1B mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of HSPA1B mRNA
|
CTD |
PMID:17706837 PMID:19640911 PMID:25322861 PMID:25596134 PMID:26516004 PMID:33729688 More...
|
|
NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,855,780...3,877,979
|
|
| G
|
Hspa4l
|
heat shock protein family A (Hsp70) member 4 like
|
decreases expression multiple interactions
|
EXP
|
Oxygen deficiency results in decreased expression of HSPA4L mRNA Quercetin inhibits the reaction [Oxygen deficiency results in decreased expression of HSPA4L mRNA]
|
CTD |
PMID:26476374 |
|
NCBI chr 2:125,668,346...125,726,404
Ensembl chr 2:125,668,236...125,720,986
|
|
| G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
multiple interactions increases expression affects expression decreases expression
|
ISO EXP
|
Oxygen deficiency inhibits the reaction [Deoxyglucose results in increased expression of HSPA5 protein] 4-chlorobenzyltetrahydroberberine inhibits the reaction [Oxygen deficiency results in increased expression of HSPA5 mRNA]; 4-chlorobenzyltetrahydroberberine inhibits the reaction [Oxygen deficiency results in increased expression of HSPA5 protein]; Nifedipine inhibits the reaction [Oxygen deficiency results in increased expression of HSPA5 mRNA]; Nifedipine inhibits the reaction [Oxygen deficiency results in increased expression of HSPA5 protein] Oxygen deficiency results in increased expression of HSPA5 mRNA; Oxygen deficiency results in increased expression of HSPA5 protein Oxygen deficiency affects the expression of HSPA5 mRNA Oxygen deficiency results in decreased expression of HSPA5 protein
|
CTD |
PMID:20593179 PMID:21337367 PMID:22226148 PMID:24680926 PMID:25596134 PMID:25937538 More...
|
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
| G
|
Hspa8
|
heat shock protein family A (Hsp70) member 8
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of HSPA8 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372
|
|
| G
|
Hspa9
|
heat shock protein family A (Hsp70) member 9
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HSPA9 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,804,774...26,828,398
|
|
| G
|
Hspb1
|
heat shock protein family B (small) member 1
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of HSPB1 mRNA iroxanadine promotes the reaction [Oxygen affects the expression of HSPB1 protein]; Quercetin inhibits the reaction [iroxanadine promotes the reaction [Oxygen affects the expression of HSPB1 protein]] [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HSPB1 mRNA; [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HSPB1 protein; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of HSPB1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HSPB1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HSPB1 protein; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HSPB1 mRNA]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of HSPB1 protein]
|
CTD |
PMID:15583868 PMID:17914565 PMID:23421680 PMID:25322861 PMID:33729688 |
|
NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301
|
|
| G
|
Hspb7
|
heat shock protein family B (small) member 7
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HSPB7 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:159,010,759...159,014,245
Ensembl chr 5:159,010,629...159,014,243
|
|
| G
|
Hspb8
|
heat shock protein family B (small) member 8
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HSPB8 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr12:45,835,899...45,866,449
Ensembl chr12:45,837,066...45,851,937
|
|
| G
|
Hspd1
|
heat shock protein family D (Hsp60) member 1
|
multiple interactions
|
ISO
|
iroxanadine promotes the reaction [Oxygen affects the expression of HSPD1 protein]; Quercetin inhibits the reaction [iroxanadine promotes the reaction [Oxygen affects the expression of HSPD1 protein]]
|
CTD |
PMID:15583868 |
|
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037
|
|
| G
|
Hspg2
|
heparan sulfate proteoglycan 2
|
affects methylation increases expression
|
ISO
|
Oxygen deficiency affects the methylation of HSPG2 promoter Oxygen deficiency results in increased expression of HSPG2 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 5:154,960,818...155,061,971
Ensembl chr 5:154,960,846...155,061,971
|
|
| G
|
Hsph1
|
heat shock protein family H (Hsp110) member 1
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of HSPH1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of HSPH1 mRNA
|
CTD |
PMID:26516004 PMID:33729688 |
|
NCBI chr12:10,427,368...10,446,602
Ensembl chr12:10,427,297...10,446,891
|
|
| G
|
Htatip2
|
HIV-1 Tat interactive protein 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of HTATIP2 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 1:108,609,424...108,624,810
Ensembl chr 1:108,605,811...108,624,815
|
|
| G
|
Htr2b
|
5-hydroxytryptamine receptor 2B
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HTR2B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:94,184,442...94,206,851
Ensembl chr 9:94,190,109...94,204,087
|
|
| G
|
Htr2c
|
5-hydroxytryptamine receptor 2C
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of HTR2C mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr X:115,453,190...115,682,325
Ensembl chr X:115,452,842...115,682,324
|
|
| G
|
Htr7
|
5-hydroxytryptamine receptor 7
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of HTR7 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of HTR7 mRNA
|
CTD |
PMID:24236059 PMID:33729688 |
|
NCBI chr 1:243,049,064...243,173,636
Ensembl chr 1:243,049,081...243,173,230
|
|
| G
|
Htra3
|
HtrA serine peptidase 3
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of HTRA3 mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr14:79,293,535...79,321,936
Ensembl chr14:79,293,541...79,321,936
|
|
| G
|
Hvcn1
|
hydrogen voltage-gated channel 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HVCN1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr12:40,001,205...40,030,671
Ensembl chr12:40,001,498...40,042,020
|
|
| G
|
Hycc1
|
hyccin PI4KA lipid kinase complex subunit 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HYCC1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:12,024,692...12,131,504
Ensembl chr 4:12,024,739...12,131,501
|
|
| G
|
Hykk
|
hydroxylysine kinase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HYKK mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:64,212,043...64,235,809
Ensembl chr 8:64,212,071...64,235,818
|
|
| G
|
Iah1
|
isoamyl acetate hydrolyzing esterase 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IAH1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:46,594,177...46,601,394
Ensembl chr 6:46,594,080...46,601,392
|
|
| G
|
Iars1
|
isoleucyl-tRNA synthetase 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of IARS1 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr17:15,147,357...15,193,716
Ensembl chr17:15,147,357...15,193,652
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of ICAM1 mRNA; Oxygen deficiency results in increased expression of ICAM1 protein Oxygen results in increased expression of ICAM1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of ICAM1 mRNA; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of ICAM1 mRNA]; TNFRSF1A protein affects the reaction [Oxygen results in increased expression of ICAM1 mRNA] [Oxygen deficiency results in increased secretion of HMGB1 protein] which results in increased expression of ICAM1 protein; deguelin inhibits the reaction [Oxygen deficiency results in increased expression of ICAM1 mRNA]; deguelin inhibits the reaction [Oxygen deficiency results in increased expression of ICAM1 protein]; tanshinone II A sodium sulfonate inhibits the reaction [[Oxygen deficiency results in increased secretion of HMGB1 protein] which results in increased expression of ICAM1 protein] carnosol inhibits the reaction [Oxygen deficiency results in increased expression of ICAM1 protein]; cobaltous chloride inhibits the reaction [Oxygen deficiency results in increased expression of ICAM1 protein]; natakalim inhibits the reaction [Oxygen deficiency results in increased expression of ICAM1 mRNA]
|
CTD |
PMID:10781441 PMID:16865091 PMID:19324842 PMID:20740350 PMID:21296072 PMID:22745725 PMID:22860425 PMID:26516004 PMID:28294475 More...
|
|
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Icam5
|
intercellular adhesion molecule 5
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ICAM5 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 8:27,843,563...27,851,767
Ensembl chr 8:27,844,780...27,857,104
|
|
| G
|
Icmt
|
isoprenylcysteine carboxyl methyltransferase
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ICMT mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 5:168,084,487...168,097,519
Ensembl chr 5:168,086,057...168,093,094
|
|
| G
|
Icoslg
|
inducible T-cell co-stimulator ligand
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ICOSLG mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr20:10,600,078...10,610,385
Ensembl chr20:10,600,078...10,610,365
|
|
| G
|
Id1
|
inhibitor of DNA binding 1
|
decreases expression increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of ID1 mRNA Oxygen deficiency results in increased expression of ID1 mRNA Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of ID1 mRNA]
|
CTD |
PMID:26476374 PMID:26516004 |
|
NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:161,671,538...161,672,685
|
|
| G
|
Id2
|
inhibitor of DNA binding 2
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of ID2 mRNA Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of ID2 mRNA]
|
CTD |
PMID:17175027 PMID:26476374 |
|
NCBI chr 6:47,469,162...47,470,995
Ensembl chr 6:47,457,554...47,472,961
|
|
| G
|
Ide
|
insulin degrading enzyme
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of IDE mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 1:244,415,495...244,516,925
Ensembl chr 1:244,416,343...244,514,526
|
|
| G
|
Idh1
|
isocitrate dehydrogenase (NADP(+)) 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IDH1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:74,027,887...74,057,442
Ensembl chr 9:74,027,892...74,049,555
|
|
| G
|
Ids
|
iduronate 2-sulfatase
|
affects expression
|
ISO
|
Oxygen deficiency affects the expression of IDS mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr X:154,070,781...154,093,681
Ensembl chr X:154,070,781...154,091,444
|
|
| G
|
Ier2
|
immediate early response 2
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IER2 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IER2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr19:40,399,373...40,400,897
Ensembl chr19:40,398,160...40,402,708
|
|
| G
|
Ier3
|
immediate early response 3
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of IER3 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IER3 mRNA
|
CTD |
PMID:20880076 PMID:26516004 PMID:30529165 |
|
NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,933,174...2,934,377
|
|
| G
|
Ier5
|
immediate early response 5
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of IER5 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr13:69,820,450...69,822,542
Ensembl chr13:69,820,451...69,822,543
|
|
| G
|
Ier5l
|
immediate early response 5-like
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IER5L mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:34,141,866...34,143,457
Ensembl chr 3:34,139,672...34,144,452
|
|
| G
|
Iffo2
|
intermediate filament family orphan 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IFFO2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:157,114,089...157,160,135
Ensembl chr 5:157,114,089...157,160,135
|
|
| G
|
Ifgga4l
|
interferon-gamma-inducible GTPase 4 like
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFGGA4L mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFGGA4L mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr18:56,108,872...56,125,302
Ensembl chr18:56,108,872...56,125,302
|
|
| G
|
Ifi27l2a
|
interferon, alpha-inducible protein 27 like 2A
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFI27L2B mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFI27L2B mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 6:128,363,658...128,365,144
Ensembl chr 6:128,363,658...128,365,146
|
|
| G
|
Ifi35
|
interferon-induced protein 35
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFI35 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFI35 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr10:86,881,270...86,889,523
Ensembl chr10:86,887,122...86,889,750
|
|
| G
|
Ifi44
|
interferon-induced protein 44
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFI44 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFI44 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 2:243,286,050...243,303,869
Ensembl chr 2:243,286,052...243,306,877
|
|
| G
|
Ifi44l
|
interferon-induced protein 44-like
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFI44L mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFI44L mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 2:243,328,629...243,366,404
Ensembl chr 2:243,328,723...243,366,404
|
|
| G
|
Ifi47
|
interferon gamma inducible protein 47
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFI47 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFI47 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr10:33,798,744...33,806,374
Ensembl chr10:33,776,399...33,806,372
|
|
| G
|
Ifih1
|
interferon induced with helicase C domain 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFIH1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 3:67,635,924...67,683,968
Ensembl chr 3:67,637,545...67,683,968
|
|
| G
|
Ifit2
|
interferon-induced protein with tetratricopeptide repeats 2
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFIT2 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFIT2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:241,515,735...241,521,799
Ensembl chr 1:241,515,709...241,521,798
|
|
| G
|
Ifit3
|
interferon-induced protein with tetratricopeptide repeats 3
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFIT3 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFIT3 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:241,527,326...241,532,469
Ensembl chr 1:241,526,880...241,532,521
|
|
| G
|
Ifitm10
|
interferon induced transmembrane protein 10
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of IFITM10 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:206,936,979...206,954,594
Ensembl chr 1:206,936,444...206,954,629
|
|
| G
|
Ifna1
|
interferon, alpha 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of IFNA1 mRNA 3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of IFNA1 mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of IFNA1 mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of IFNA1 mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of IFNA1 mRNA]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of IFNA1 mRNA]
|
CTD |
PMID:23452621 |
|
NCBI chr 5:108,143,240...108,143,809
Ensembl chr 5:108,143,240...108,143,809
|
|
| G
|
Ifng
|
interferon gamma
|
multiple interactions increases expression
|
EXP ISO
|
cobaltous chloride inhibits the reaction [Oxygen deficiency results in increased expression of IFNG protein] 3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of IFNG mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of IFNG mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of IFNG mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of IFNG mRNA]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of IFNG mRNA]
|
CTD |
PMID:18635243 PMID:19278353 PMID:21296072 PMID:23452621 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
| G
|
Ifrd1
|
interferon-related developmental regulator 1
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IFRD1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of IFRD1 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 6:62,996,560...63,044,996
Ensembl chr 6:62,996,562...63,016,131
|
|
| G
|
Ifrd2
|
interferon-related developmental regulator 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of IFRD2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 8:117,139,612...117,144,834
Ensembl chr 8:117,139,550...117,144,836
|
|
| G
|
Ift20
|
intraflagellar transport 20
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IFT20 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:63,930,629...63,936,174
Ensembl chr10:63,930,681...63,936,172
|
|
| G
|
Ift70a2
|
intraflagellar transport 70A2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of IFT70A mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 3:81,306,455...81,308,896
Ensembl chr 3:81,307,245...81,320,093
|
|
| G
|
Ift70b
|
intraflagellar transport 70B
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IFT70B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:81,263,074...81,265,645
|
|
| G
|
Igdcc4
|
immunoglobulin superfamily, DCC subclass, member 4
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IGDCC4 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 8:74,517,082...74,552,834
Ensembl chr 8:74,517,086...74,552,834
|
|
| G
|
Igf1
|
insulin-like growth factor 1
|
affects methylation decreases expression increases expression
|
ISO EXP
|
Oxygen deficiency affects the methylation of IGF1 promoter Oxygen deficiency results in decreased expression of IGF1 mRNA Oxygen results in increased expression of IGF1 mRNA [Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of IGF1 mRNA
|
CTD |
PMID:22911455 PMID:24205000 PMID:26305601 |
|
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
|
|
| G
|
Igf1r
|
insulin-like growth factor 1 receptor
|
multiple interactions decreases expression
|
EXP
|
Tea inhibits the reaction [Oxygen deficiency results in decreased expression of IGF1R protein modified form]
|
CTD |
PMID:29139225 |
|
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:130,959,997...131,248,664
|
|
| G
|
Igf2
|
insulin-like growth factor 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of IGF2 mRNA
|
CTD |
PMID:20862257 |
|
NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:207,243,873...207,260,667
|
|
| G
|
Igf2bp2
|
insulin-like growth factor 2 mRNA binding protein 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IGF2BP2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr11:92,378,908...92,478,893
Ensembl chr11:92,378,908...92,478,867
|
|
| G
|
Igfbp1
|
insulin-like growth factor binding protein 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of IGFBP1 mRNA
|
CTD |
PMID:19924283 |
|
NCBI chr14:86,261,277...86,266,344
Ensembl chr14:86,261,277...86,266,344
|
|
| G
|
Igfbp2
|
insulin-like growth factor binding protein 2
|
multiple interactions increases expression
|
EXP ISO
|
Tretinoin affects the reaction [Oxygen affects the secretion of IGFBP2 protein] Oxygen deficiency results in increased expression of IGFBP2 mRNA
|
CTD |
PMID:16055936 PMID:24236059 |
|
NCBI chr 9:81,864,811...81,892,179
Ensembl chr 9:81,864,783...81,892,171
|
|
| G
|
Igfbp3
|
insulin-like growth factor binding protein 3
|
multiple interactions increases expression
|
EXP ISO
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of IGFBP3 mRNA; Tretinoin affects the reaction [Oxygen affects the secretion of IGFBP3 protein] HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of IGFBP3 mRNA] [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IGFBP3 mRNA
|
CTD |
PMID:16055936 PMID:19640911 PMID:20042640 PMID:26516004 PMID:33729688 |
|
NCBI chr14:86,270,208...86,277,944
Ensembl chr14:86,270,208...86,277,944
|
|
| G
|
Igfbp4
|
insulin-like growth factor binding protein 4
|
multiple interactions
|
ISO
|
[Oxygen deficiency co-treated with Oxygen] results in decreased expression of IGFBP4 mRNA; [sulforaphane affects the susceptibility to Oxygen] which affects the expression of IGFBP4 mRNA; SULT1E1 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of IGFBP4 mRNA]
|
CTD |
PMID:25922074 PMID:30529165 |
|
NCBI chr10:84,491,471...84,503,487
Ensembl chr10:84,485,775...84,503,473
|
|
| G
|
Igfbp5
|
insulin-like growth factor binding protein 5
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IGFBP5 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:81,897,616...81,914,390
|
|
| G
|
Igfbp6
|
insulin-like growth factor binding protein 6
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IGFBP6 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IGFBP6 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 7:135,154,919...135,159,550
Ensembl chr 7:135,154,685...135,159,795
|
|
| G
|
Igfn1
|
immunoglobulin-like and fibronectin type III domain containing 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of IGFN1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr13:49,947,330...49,979,203
Ensembl chr13:49,947,330...49,989,601
|
|
| G
|
Igsf3
|
immunoglobulin superfamily, member 3
|
increases expression affects methylation
|
ISO
|
Oxygen deficiency results in increased expression of IGSF3 mRNA Oxygen deficiency affects the methylation of IGSF3 promoter
|
CTD |
PMID:24205000 |
|
NCBI chr 2:191,499,972...191,588,249
Ensembl chr 2:191,500,045...191,588,249
|
|
| G
|
Igsf6
|
immunoglobulin superfamily, member 6
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of IGSF6 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of IGSF6 mRNA
|
CTD |
PMID:20880076 PMID:33729688 |
|
NCBI chr 1:185,041,462...185,051,956
Ensembl chr 1:185,041,462...185,052,245
|
|
| G
|
Igtp
|
interferon gamma induced GTPase
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IGTP mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IGTP mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr10:42,875,047...42,882,866
Ensembl chr10:42,876,790...42,882,858
|
|
| G
|
Ikbkb
|
inhibitor of nuclear factor kappa B kinase subunit beta
|
multiple interactions increases expression
|
ISO
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of IKBKB mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of IKBKB mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of IKBKB mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of IKBKB mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of IKBKB mRNA]
|
CTD |
PMID:23452621 |
|
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:76,022,008...76,081,911
|
|
| G
|
Ikbke
|
inhibitor of nuclear factor kappa B kinase subunit epsilon
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of IKBKE mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr13:45,264,404...45,290,737
Ensembl chr13:45,264,412...45,289,396
|
|
| G
|
Ikbkg
|
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
|
multiple interactions increases expression
|
ISO
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of IKBKG mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of IKBKG mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of IKBKG mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of IKBKG mRNA]
|
CTD |
PMID:23452621 |
|
NCBI chr X:157,358,279...157,397,563
Ensembl chr X:157,367,639...157,392,757
|
|
| G
|
Ikzf2
|
IKAROS family zinc finger 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IKZF2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:78,495,670...78,640,896
Ensembl chr 9:78,492,275...78,640,463
|
|
| G
|
Ikzf5
|
IKAROS family zinc finger 5
|
multiple interactions increases expression
|
ISO
|
Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of IKZF5 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 1:195,599,287...195,619,024
Ensembl chr 1:195,600,967...195,619,013
|
|
| G
|
Il10
|
interleukin 10
|
multiple interactions increases expression decreases expression decreases secretion
|
ISO EXP
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of IL10 mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of IL10 mRNA]; deguelin inhibits the reaction [Oxygen deficiency results in increased expression of IL10 mRNA]; Folic Acid inhibits the reaction [Oxygen deficiency results in decreased expression of IL10 mRNA]; Folic Acid inhibits the reaction [Oxygen deficiency results in decreased secretion of IL10 protein]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of IL10 mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of IL10 mRNA]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of IL10 mRNA] [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL10 mRNA; HU 308 promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL10 mRNA]; iodopravadoline inhibits the reaction [peoniflorin promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL10 mRNA]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of IL10 mRNA]; peoniflorin promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL10 mRNA] Oxygen results in decreased secretion of IL10 protein [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL10 protein; HU 308 promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL10 protein]; iodopravadoline inhibits the reaction [peoniflorin promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL10 protein]]; peoniflorin promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL10 protein]
|
CTD |
PMID:22745725 PMID:23452621 PMID:23539316 PMID:24223152 PMID:26974319 PMID:29560022 PMID:29939353 More...
|
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il11
|
interleukin 11
|
multiple interactions
|
ISO EXP
|
Oxygen deficiency promotes the reaction [darinaparsin results in increased expression of IL11 mRNA] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IL11 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of IL11 mRNA
|
CTD |
PMID:22535156 PMID:30529165 PMID:33729688 |
|
NCBI chr 1:78,098,622...78,104,915
Ensembl chr 1:78,096,930...78,104,915
|
|
| G
|
Il12a
|
interleukin 12A
|
multiple interactions increases expression
|
ISO
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of IL12A mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of IL12A mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of IL12A mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of IL12A mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of IL12A mRNA]
|
CTD |
PMID:17175027 PMID:23452621 |
|
NCBI chr 2:155,275,734...155,282,997
Ensembl chr 2:155,275,625...155,282,997
|
|
| G
|
Il12b
|
interleukin 12B
|
decreases expression multiple interactions increases expression
|
ISO
|
Oxygen deficiency results in decreased expression of IL12B mRNA 3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of IL12B mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of IL12B mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of IL12B mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of IL12B mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of IL12B mRNA]
|
CTD |
PMID:23452621 PMID:24205000 |
|
NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194
|
|
| G
|
Il13ra1
|
interleukin 13 receptor subunit alpha 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of IL13RA1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IL13RA1 mRNA; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of IL13RA1 mRNA]
|
CTD |
PMID:20880076 PMID:30529165 |
|
NCBI chr X:120,213,670...120,294,777
Ensembl chr X:120,214,075...120,274,461
|
|
| G
|
Il13ra2
|
interleukin 13 receptor subunit alpha 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of IL13RA2 mRNA
|
CTD |
PMID:20660070 |
|
NCBI chr X:115,814,620...115,886,080
Ensembl chr X:115,814,622...115,841,455
|
|
| G
|
Il15
|
interleukin 15
|
multiple interactions
|
ISO
|
[IL15 protein co-treated with Oxygen deficiency] results in increased expression of EGLN1 mRNA; [IL15 protein co-treated with Oxygen deficiency] results in increased expression of PGK1 mRNA; [IL15 protein co-treated with Oxygen deficiency] results in increased expression of PKM mRNA; [IL15 protein co-treated with Oxygen deficiency] results in increased expression of TPI1 mRNA; IL15 protein affects the reaction [Oxygen deficiency results in increased expression of TKTL1 mRNA]; IL15 protein promotes the reaction [Oxygen deficiency results in increased expression of PDK1 mRNA]; IL15 protein promotes the reaction [Oxygen deficiency results in increased expression of PFKFB3 mRNA]
|
CTD |
PMID:27129235 |
|
NCBI chr19:42,536,160...42,611,349
Ensembl chr19:42,545,346...42,611,348
|
|
| G
|
Il17d
|
interleukin 17D
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of IL17D mRNA; Oxygen deficiency results in increased expression of IL17D protein 2-tert-butylhydroquinone promotes the reaction [Oxygen deficiency results in increased expression of IL17D protein]
|
CTD |
PMID:34023435 |
|
NCBI chr15:35,786,898...35,804,391
Ensembl chr15:35,786,898...35,804,391
|
|
| G
|
Il17ra
|
interleukin 17 receptor A
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IL17RA mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of IL17RA mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 4:155,339,742...155,362,382
Ensembl chr 4:155,339,400...155,362,382
|
|
| G
|
Il17rb
|
interleukin 17 receptor B
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of IL17RB mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr16:5,186,961...5,200,657
Ensembl chr16:5,186,961...5,200,694
|
|
| G
|
Il17rd
|
interleukin 17 receptor D
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IL17RD mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr16:2,235,172...2,489,827
Ensembl chr16:2,235,169...2,301,850
|
|
| G
|
Il18
|
interleukin 18
|
multiple interactions increases secretion
|
EXP ISO
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of and results in increased secretion of IL18 protein]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of and results in increased secretion of IL18 protein; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL18 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL18 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL18 protein; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL18 protein]; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL18 protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL18 mRNA]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL18 protein] [Oxygen deficiency co-treated with Glucose deficiency] results in increased secretion of IL18 protein; bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased secretion of IL18 protein] 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [wedelolactone inhibits the reaction [Oxygen results in increased secretion of IL18 protein]]; Oxygen deficiency affects the reaction [NFE2L2 protein affects the expression of IL18 mRNA]; wedelolactone inhibits the reaction [Oxygen results in increased secretion of IL18 protein]
|
CTD |
PMID:26464617 PMID:33729688 PMID:35191607 PMID:37127800 PMID:39038764 PMID:39110510 More...
|
|
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
|
|
| G
|
Il18r1
|
interleukin 18 receptor 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IL18R1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:50,223,274...50,257,370
Ensembl chr 9:50,223,200...50,257,367
|
|
| G
|
Il18rap
|
interleukin 18 receptor accessory protein
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of IL18RAP mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 9:50,263,723...50,296,583
Ensembl chr 9:50,263,733...50,296,583
|
|
| G
|
Il1a
|
interleukin 1 alpha
|
decreases expression multiple interactions increases expression
|
ISO EXP
|
Oxygen deficiency results in decreased expression of IL1A protein Oxygen deficiency inhibits the reaction [TNF protein results in increased expression of IL1A protein]; Oxygen deficiency results in decreased stability of and results in decreased expression of IL1A mRNA; Oxygen promotes the reaction [TNF protein results in increased expression of IL1A protein]; SOD2 protein promotes the reaction [Oxygen deficiency inhibits the reaction [TNF protein results in increased expression of IL1A protein]]; SOD2 protein promotes the reaction [Oxygen deficiency results in decreased expression of IL1A protein] Oxygen results in increased expression of IL1A mRNA; Oxygen results in increased expression of IL1A protein [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of and results in increased secretion of IL1A protein]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of and results in increased secretion of IL1A protein
|
CTD |
PMID:8702551 PMID:24024155 PMID:33729688 |
|
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013
|
|
| G
|
Il1b
|
interleukin 1 beta
|
affects expression multiple interactions increases expression increases secretion
|
ISO EXP
|
Oxygen affects the expression of IL1B mRNA [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of IL1B protein; [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased secretion of IL1B protein; [Antagomirs results in decreased expression of MIR30C1 mRNA] promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of IL1B protein]; [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL1B mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL1B mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL1B protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL1B protein; [Oxygen deficiency co-treated with Oxygen] results in increased expression of IL1B protein; [Oxygen deficiency co-treated with Oxygen] results in increased secretion of IL1B protein; [Thiazoles analog binds to indoline analog] promotes the reaction [PHLDA3 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of IL1B protein]]; cobaltous chloride inhibits the reaction [Oxygen deficiency results in increased expression of IL1B protein]; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL1B protein]; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL1B protein]; Edaravone inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased secretion of IL1B protein]; HU 308 inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL1B mRNA]; iodopravadoline inhibits the reaction [peoniflorin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL1B mRNA]]; Mifepristone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL1B protein]; MIR30C1 mRNA inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of IL1B protein]; MK 2206 promotes the reaction [PHLDA3 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of IL1B protein]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of IL1B mRNA]; NUCB2 protein inhibits the reaction [Oxygen results in increased expression of IL1B mRNA]; NUCB2 protein inhibits the reaction [Oxygen results in increased expression of IL1B protein]; Oxygen deficiency results in increased expression of and results in increased secretion of IL1B protein; peoniflorin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL1B mRNA]; PHLDA3 protein promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of IL1B protein]; PHLDA3 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased secretion of IL1B protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased secretion of IL1B protein]; RSVA314 inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL1B mRNA]; RSVA405 inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL1B mRNA]; sanggenone C inhibits the reaction [Oxygen deficiency results in increased expression of IL1B mRNA]; SDC2 protein promotes the reaction [Oxygen deficiency results in increased expression of and results in increased secretion of IL1B protein]; Simvastatin inhibits the reaction [Oxygen deficiency results in increased expression of IL1B mRNA]; Streptozocin promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL1B mRNA]; Streptozocin promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL1B protein]; Tadalafil inhibits the reaction [Oxygen deficiency results in increased expression of IL1B mRNA]; trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL1B protein] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of IL1B mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased secretion of IL1B protein]; [IL1B protein co-treated with Oxygen deficiency] results in increased degradation of NFKBIA protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased secretion of IL1B protein; [Oxygen deficiency co-treated with IL1B protein] results in increased expression of TNF protein; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide promotes the reaction [Folic Acid inhibits the reaction [Oxygen deficiency results in increased expression of IL1B mRNA]]; bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased secretion of IL1B protein]; cobaltiprotoporphyrin inhibits the reaction [[Oxygen deficiency co-treated with IL1B protein] results in increased expression of TNF protein]; cobaltiprotoporphyrin inhibits the reaction [IL1B protein inhibits the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]]; cobaltiprotoporphyrin inhibits the reaction [IL1B protein inhibits the reaction [Oxygen deficiency results in increased expression of SOX9 protein]]; cobaltiprotoporphyrin promotes the reaction [IL1B protein inhibits the reaction [Oxygen deficiency results in increased expression of COL2A1 protein]]; Folic Acid inhibits the reaction [Oxygen deficiency results in increased expression of IL1B mRNA]; Folic Acid inhibits the reaction [Oxygen deficiency results in increased secretion of IL1B protein]; HMOX1 mutant form inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [[Oxygen deficiency co-treated with IL1B protein] results in increased expression of TNF protein]]; HMOX1 mutant form inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [IL1B protein inhibits the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]]]; HMOX1 mutant form inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [IL1B protein inhibits the reaction [Oxygen deficiency results in increased expression of SOX9 protein]]]; HMOX1 mutant form inhibits the reaction [cobaltiprotoporphyrin promotes the reaction [IL1B protein inhibits the reaction [Oxygen deficiency results in increased expression of COL2A1 protein]]]; IL1B protein inhibits the reaction [Oxygen deficiency results in increased expression of COL2A1 protein]; IL1B protein inhibits the reaction [Oxygen deficiency results in increased expression of EPAS1 protein]; IL1B protein inhibits the reaction [Oxygen deficiency results in increased expression of SOX9 protein]; KC7F2 compound inhibits the reaction [Oxygen deficiency results in increased expression of IL1B mRNA]; KC7F2 compound inhibits the reaction [Oxygen deficiency results in increased secretion of IL1B protein]; Oxygen deficiency inhibits the reaction [darinaparsin results in decreased expression of IL1B mRNA]; Oxygen deficiency inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]; Oxygen deficiency inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein]; Oxygen deficiency promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] Oxygen deficiency results in increased expression of IL1B mRNA; Oxygen deficiency results in increased expression of IL1B protein; Oxygen results in increased expression of IL1B mRNA 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [wedelolactone inhibits the reaction [Oxygen results in increased secretion of IL1B protein]]; [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL1B protein; [CBS gene mutant form results in increased susceptibility to [Blood Glucose deficiency co-treated with Oxygen deficiency]] which results in increased expression of IL1B protein; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL1B protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL1B protein; atractylenolide III inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL1B protein]; Edaravone inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL1B protein]; genipin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL1B protein]; HU 308 inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL1B protein]; iodopravadoline inhibits the reaction [peoniflorin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL1B protein]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of IL1B protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL1B protein]; peoniflorin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL1B protein]; sodium bisulfide inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL1B protein]; wedelolactone inhibits the reaction [Oxygen results in increased secretion of IL1B protein] Oxygen deficiency results in increased expression of IL1B mRNA; Oxygen deficiency results in increased expression of IL1B protein; Oxygen results in increased expression of IL1B mRNA; Oxygen results in increased expression of IL1B protein
|
CTD |
PMID:9555576 PMID:10781441 PMID:12829860 PMID:14652683 PMID:16368379 PMID:16872633 PMID:18635243 PMID:18803305 PMID:21296072 PMID:22535156 PMID:23406266 PMID:24223152 PMID:24236059 PMID:25214260 PMID:26464617 PMID:26974319 PMID:27064547 PMID:28477916 PMID:28983604 PMID:29560022 PMID:29685624 PMID:30229846 PMID:30611788 PMID:31283913 PMID:31935362 PMID:34217758 PMID:34351043 PMID:35191607 PMID:37127800 PMID:38511245 PMID:39038764 PMID:39110510 PMID:39326406 PMID:40024754 More...
|
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il1r2
|
interleukin 1 receptor type 2
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IL1R2 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of IL1R2 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 9:49,879,928...49,920,374
Ensembl chr 9:49,877,266...49,920,374
|
|
| G
|
Il1rl1
|
interleukin 1 receptor-like 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of IL1RL1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 9:50,157,326...50,222,888
Ensembl chr 9:50,204,551...50,222,891
|
|
| G
|
Il1rl2
|
interleukin 1 receptor-like 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of IL1RL2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 9:50,087,271...50,134,225
Ensembl chr 9:50,083,903...50,204,607
|
|
| G
|
Il1rn
|
interleukin 1 receptor antagonist
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of IL1RN mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of IL1RN mRNA
|
CTD |
PMID:24236059 PMID:33729688 |
|
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732
|
|
| G
|
Il22ra2
|
interleukin 22 receptor subunit alpha 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of IL22RA2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:16,172,238...16,228,009
Ensembl chr 1:16,184,113...16,197,950
|
|
| G
|
Il3
|
interleukin 3
|
affects expression
|
ISO
|
Oxygen affects the expression of IL3 mRNA
|
CTD |
PMID:9555576 |
|
NCBI chr10:38,906,460...38,908,810
Ensembl chr10:38,906,460...38,908,810
|
|
| G
|
Il31ra
|
interleukin 31 receptor A
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of IL31RA mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 2:45,851,073...45,922,300
Ensembl chr 2:45,855,868...45,917,009
|
|
| G
|
Il33
|
interleukin 33
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of and results in increased secretion of IL33 protein]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of and results in increased secretion of IL33 protein
|
CTD |
PMID:33729688 |
|
NCBI chr 1:237,115,478...237,149,897
Ensembl chr 1:237,115,572...237,150,901
|
|
| G
|
Il3ra
|
interleukin 3 receptor subunit alpha
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of IL3RA mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr12:21,431,848...21,437,336
Ensembl chr12:21,431,848...21,437,250
|
|
| G
|
Il4
|
interleukin 4
|
multiple interactions decreases expression increases expression
|
EXP ISO
|
deguelin inhibits the reaction [Oxygen deficiency results in decreased expression of IL4 mRNA] Oxygen deficiency results in increased expression of IL4 protein 2-tert-butylhydroquinone promotes the reaction [Oxygen deficiency results in increased expression of IL4 protein]
|
CTD |
PMID:22745725 PMID:34023435 |
|
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
|
|
| G
|
Il4r
|
interleukin 4 receptor
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IL4RA mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:189,545,739...189,570,639
Ensembl chr 1:189,544,988...189,570,636
|
|
| G
|
Il6
|
interleukin 6
|
multiple interactions increases expression affects expression increases secretion
|
ISO EXP
|
1-Methyl-4-phenylpyridinium inhibits the reaction [Oxygen deficiency results in increased expression of IL6 protein]; 2-tert-butylhydroquinone promotes the reaction [Oxygen deficiency results in increased expression of IL6 protein]; [Oxygen deficiency co-treated with Nitrogen Dioxide] results in increased expression of IL6 mRNA; diphenyleneiodonium inhibits the reaction [Oxygen deficiency results in increased expression of IL6 mRNA]; heclin inhibits the reaction [LINC01588 mRNA inhibits the reaction [Oxygen deficiency results in increased secretion of IL6 protein]]; HNRNPL promotes the reaction [LINC01588 mRNA inhibits the reaction [Oxygen deficiency results in increased secretion of IL6 protein]]; LINC01588 mRNA inhibits the reaction [Oxygen deficiency results in increased secretion of IL6 protein]; Rotenone inhibits the reaction [Oxygen deficiency results in increased expression of IL6 mRNA]; Rotenone inhibits the reaction [Oxygen deficiency results in increased expression of IL6 protein] Oxygen deficiency results in increased expression of IL6 mRNA; Oxygen deficiency results in increased expression of IL6 protein; Oxygen results in increased expression of IL6 mRNA Oxygen affects the expression of IL6 mRNA [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of IL6 protein; [Antagomirs results in decreased expression of MIR30C1 mRNA] promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of IL6 protein]; [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL6 mRNA; [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of and results in increased secretion of IL6 protein]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of and results in increased secretion of IL6 protein; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of IL6 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL6 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL6 protein; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased secretion of IL6 protein; [Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of and results in increased secretion of IL6 protein; [Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of IL6 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL6 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL6 protein; [Oxygen deficiency co-treated with Oxygen] results in increased expression of IL6 protein; [Thiazoles analog binds to indoline analog] promotes the reaction [PHLDA3 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of IL6 protein]]; carnosol inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased secretion of IL6 protein]; cobaltous chloride affects the reaction [Oxygen deficiency results in increased expression of IL6 protein]; ginsenoside Rg1 inhibits the reaction [Oxygen deficiency results in increased expression of IL6 protein]; HU 308 inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL6 mRNA]; kaempferol inhibits the reaction [Oxygen deficiency results in increased expression of IL6 protein]; Lipopolysaccharides promotes the reaction [Oxygen deficiency results in increased expression of IL6 mRNA]; Mifepristone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL6 protein]; MIR30C1 mRNA inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of IL6 protein]; MK 2206 promotes the reaction [PHLDA3 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of IL6 protein]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of IL6 mRNA]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL6 mRNA]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased secretion of IL6 protein]; Oxygen deficiency results in increased expression of and results in increased secretion of IL6 protein; Oxygen promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL6 mRNA]; peoniflorin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL6 mRNA]; PHLDA3 protein promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of IL6 protein]; PHLDA3 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of IL6 protein]; prolinedithiocarbamate inhibits the reaction [Oxygen deficiency results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in increased secretion of IL6 protein]; RSVA314 inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL6 mRNA]; RSVA405 inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL6 mRNA]; sanggenone C inhibits the reaction [Oxygen deficiency results in increased expression of IL6 mRNA]; Streptozocin promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL6 mRNA]; Streptozocin promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL6 protein]; trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL6 protein] Oxygen deficiency results in increased expression of IL6 mRNA; Oxygen deficiency results in increased expression of IL6 protein; Oxygen results in increased expression of IL6 mRNA; Oxygen results in increased expression of IL6 protein [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL6 protein; [CBS gene mutant form results in increased susceptibility to [Blood Glucose deficiency co-treated with Oxygen deficiency]] which results in increased expression of IL6 protein; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IL6 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL6 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL6 protein; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased secretion of IL6 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL6 protein; atractylenolide III inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL6 protein]; CYP1A1 gene mutant form promotes the reaction [Oxygen results in increased expression of IL6 mRNA]; Edaravone inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of IL6 protein]; genipin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL6 protein]; HU 308 inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL6 protein]; IL6 protein inhibits the reaction [[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] inhibits the reaction [IL6RA protein binds to IL6ST protein]]; IL6 protein inhibits the reaction [[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] results in decreased expression of SOD2 protein]; IL6 protein inhibits the reaction [[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] results in decreased phosphorylation of STAT3 protein]; iodopravadoline inhibits the reaction [peoniflorin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL6 protein]]; LINC01588 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased secretion of IL6 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL6 mRNA]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of IL6 protein]; peoniflorin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL6 protein]; sodium bisulfide inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of IL6 protein] Oxygen results in increased secretion of IL6 protein
|
CTD |
PMID:9555576 PMID:10781441 PMID:11108930 PMID:11950692 PMID:16865091 PMID:16872633 PMID:18635243 PMID:18941502 PMID:20740350 PMID:21296072 PMID:21940958 PMID:22535284 PMID:23034257 PMID:23082119 PMID:23466666 PMID:23539316 PMID:24223152 PMID:24236059 PMID:24893714 PMID:25214260 PMID:25221900 PMID:27103661 PMID:27693381 PMID:28174749 PMID:28477916 PMID:28983604 PMID:29560022 PMID:29939353 PMID:30229846 PMID:30529165 PMID:30611788 PMID:31283913 PMID:31935362 PMID:33729688 PMID:34023435 PMID:34217758 PMID:34351043 PMID:35258167 PMID:37923178 PMID:39038764 PMID:39326406 PMID:39529574 More...
|
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Il6r
|
interleukin 6 receptor
|
multiple interactions
|
ISO
|
[[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] inhibits the reaction [IL6RA protein binds to IL6ST protein]] promotes the reaction [IL6ST protein binds to and results in increased phosphorylation of STAT3 protein]; [[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] inhibits the reaction [IL6RA protein binds to IL6ST protein]; [[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] results in increased oxidation of IL6RA protein; IL6 protein inhibits the reaction [[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] inhibits the reaction [IL6RA protein binds to IL6ST protein]]
|
CTD |
PMID:21940958 |
|
NCBI chr 2:177,582,020...177,646,705
Ensembl chr 2:177,582,164...177,645,221
|
|
| G
|
Il6st
|
interleukin 6 cytokine family signal transducer
|
multiple interactions
|
ISO
|
[[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] inhibits the reaction [IL6RA protein binds to IL6ST protein]] promotes the reaction [IL6ST protein binds to and results in increased phosphorylation of STAT3 protein]; [[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] inhibits the reaction [IL6RA protein binds to IL6ST protein]; [[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] results in increased oxidation of IL6ST protein; IL6 protein inhibits the reaction [[[Oxygen deficiency co-treated with Glucose deficiency] co-treated with Oxygen] inhibits the reaction [IL6RA protein binds to IL6ST protein]]
|
CTD |
PMID:21940958 |
|
NCBI chr 2:45,798,872...45,839,501
Ensembl chr 2:45,799,380...45,843,182
|
|
| G
|
Il7
|
interleukin 7
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of IL7 mRNA
|
CTD |
PMID:17175027 |
|
NCBI chr 2:96,142,523...96,186,282
Ensembl chr 2:96,142,092...96,187,389
|
|
| G
|
Ilk
|
integrin-linked kinase
|
multiple interactions
|
ISO
|
[Butylated Hydroxytoluene co-treated with Oxygen] results in increased expression of ILK protein
|
CTD |
PMID:16272459 |
|
NCBI chr 1:169,500,716...169,506,972
Ensembl chr 1:169,498,681...169,506,964
|
|
| G
|
Impa2
|
inositol monophosphatase 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of IMPA2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr18:63,104,113...63,135,232
Ensembl chr18:63,104,083...63,137,543
|
|
| G
|
Impg2
|
interphotoreceptor matrix proteoglycan 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of IMPG2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr11:57,787,914...57,887,450
Ensembl chr11:57,787,914...58,033,766
|
|
| G
|
Inhba
|
inhibin subunit beta A
|
decreases expression increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of INHBA mRNA Oxygen deficiency results in increased expression of INHBA mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of INHBA mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of INHBA mRNA
|
CTD |
PMID:20042640 PMID:20660070 PMID:26516004 PMID:30529165 PMID:33729688 |
|
NCBI chr17:53,787,159...53,810,942
Ensembl chr17:53,791,444...53,804,508
|
|
| G
|
Inhbb
|
inhibin subunit beta B
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of INHBB mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of INHBB mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr13:33,083,671...33,089,373
Ensembl chr13:33,083,671...33,089,609
|
|
| G
|
Inmt
|
indolethylamine N-methyltransferase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of INMT mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:85,648,459...85,652,755
Ensembl chr 4:85,648,459...85,652,755
|
|
| G
|
Inpp5b
|
inositol polyphosphate-5-phosphatase B
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of INPP5B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:142,281,454...142,345,993
Ensembl chr 5:142,281,418...142,345,991
|
|
| G
|
Inpp5k
|
inositol polyphosphate-5-phosphatase K
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of INPP5K mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:60,974,183...60,995,047
Ensembl chr10:60,973,950...60,995,046
|
|
| G
|
Insig1
|
insulin induced gene 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of INSIG1 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778
|
|
| G
|
Insig2
|
insulin induced gene 2
|
multiple interactions increases expression
|
ISO
|
1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of INSIG2 mRNA]
|
CTD |
PMID:24236059 PMID:24403227 PMID:25596134 |
|
NCBI chr13:35,025,160...35,052,937
Ensembl chr13:35,025,164...35,047,658
|
|
| G
|
Insr
|
insulin receptor
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of INSR mRNA Oxygen deficiency results in increased expression of INSR protein resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of INSR protein]
|
CTD |
PMID:25352008 PMID:26516004 |
|
NCBI chr12:5,991,135...6,129,275
Ensembl chr12:5,981,835...6,128,803
|
|
| G
|
Ints14
|
integrator complex subunit 14
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of INTS14 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 8:74,370,687...74,398,153
Ensembl chr 8:74,371,015...74,396,209
|
|
| G
|
Ipo5
|
importin 5
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IPO5 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr15:104,397,626...104,447,985
Ensembl chr15:104,397,276...104,447,985
|
|
| G
|
Irak1
|
interleukin-1 receptor-associated kinase 1
|
multiple interactions increases expression
|
ISO
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of IRAK1 mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of IRAK1 mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of IRAK1 mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of IRAK1 mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of IRAK1 mRNA]
|
CTD |
PMID:23452621 |
|
NCBI chr X:156,919,927...156,929,825
Ensembl chr X:156,920,081...156,929,825
|
|
| G
|
Irak2
|
interleukin-1 receptor-associated kinase 2
|
multiple interactions increases expression
|
ISO
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of IRAK2 mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of IRAK2 mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of IRAK2 mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of IRAK2 mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of IRAK2 mRNA] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IRAK2 mRNA
|
CTD |
PMID:23452621 PMID:30529165 |
|
NCBI chr 4:148,341,704...148,398,211
Ensembl chr 4:148,341,719...148,398,210
|
|
| G
|
Irak3
|
interleukin-1 receptor-associated kinase 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IRAK3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:57,538,522...57,600,166
Ensembl chr 7:57,539,557...57,598,706
|
|
| G
|
Ireb2
|
iron responsive element binding protein 2
|
multiple interactions decreases expression
|
EXP ISO
|
[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of IREB2 protein; Deferoxamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of IREB2 protein] Oxygen deficiency results in decreased expression of IREB2 mRNA; Oxygen deficiency results in decreased expression of IREB2 protein
|
CTD |
PMID:16135072 PMID:33969609 |
|
NCBI chr 8:64,124,152...64,207,702
Ensembl chr 8:64,154,945...64,205,520
|
|
| G
|
Irf7
|
interferon regulatory factor 7
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IRF7 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IRF7 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:205,796,956...205,800,543
Ensembl chr 1:205,796,959...205,800,023
|
|
| G
|
Irgm
|
immunity-related GTPase M
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IRGM mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IRGM mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr10:33,734,640...33,742,720
Ensembl chr10:33,732,961...33,743,228
|
|
| G
|
Irs1
|
insulin receptor substrate 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IRS1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:90,993,519...91,054,538
|
|
| G
|
Irs2
|
insulin receptor substrate 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IRS2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr16:85,190,310...85,214,543
Ensembl chr16:85,190,111...85,214,543
|
|
| G
|
Irx3
|
iroquois homeobox 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IRX3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:31,384,803...31,388,241
Ensembl chr19:31,384,833...31,388,238
|
|
| G
|
Irx5
|
iroquois homeobox 5
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IRX5 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:30,812,033...30,816,885
Ensembl chr19:30,797,202...30,815,029
|
|
| G
|
Iscu
|
iron-sulfur cluster assembly enzyme
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ISCU mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr12:48,512,852...48,518,696
Ensembl chr12:48,512,852...48,518,696
|
|
| G
|
Isg15
|
ISG15 ubiquitin-like modifier
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of ISG15 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of ISG15 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 5:172,066,369...172,067,656
Ensembl chr 5:172,066,369...172,067,656
|
|
| G
|
Isg20
|
interferon stimulated exonuclease gene 20
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of ISG20 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ISG20 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of ISG20 mRNA
|
CTD |
PMID:20880076 PMID:30529165 PMID:33729688 |
|
NCBI chr 1:142,234,729...142,246,403
Ensembl chr 1:142,236,137...142,246,401
|
|
| G
|
Islr
|
immunoglobulin superfamily containing leucine-rich repeat
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ISLR mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:67,467,013...67,469,989
Ensembl chr 8:67,444,536...67,487,493
|
|
| G
|
Itfg2
|
integrin alpha FG-GAP repeat containing 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ITFG2 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 4:163,371,125...163,384,676
Ensembl chr 4:163,338,702...163,384,367
|
|
| G
|
Itga1
|
integrin subunit alpha 1
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of ITGA1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ITGA1 mRNA
|
CTD |
PMID:20880076 PMID:30529165 |
|
NCBI chr 2:48,379,181...48,545,336
Ensembl chr 2:48,386,249...48,545,284
|
|
| G
|
Itga11
|
integrin subunit alpha 11
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ITGA11 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 8:72,041,432...72,150,137
Ensembl chr 8:72,016,652...72,150,137
|
|
| G
|
Itga2
|
integrin subunit alpha 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ITGA2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 2:48,253,412...48,354,509
Ensembl chr 2:48,253,412...48,354,509
|
|
| G
|
Itga3
|
integrin subunit alpha 3
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ITGA3 mRNA
|
CTD |
PMID:17175027 |
|
NCBI chr10:80,486,998...80,522,548
Ensembl chr10:80,486,999...80,518,901
|
|
| G
|
Itga4
|
integrin subunit alpha 4
|
affects expression
|
ISO
|
Oxygen deficiency affects the expression of ITGA4 mRNA
|
CTD |
PMID:17193925 |
|
NCBI chr 3:84,569,487...84,646,276
Ensembl chr 3:84,560,369...84,641,039
|
|
| G
|
Itga5
|
integrin subunit alpha 5
|
multiple interactions increases expression
|
EXP
|
Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of ITGA5 protein]
|
CTD |
PMID:26476374 |
|
NCBI chr 7:136,358,097...136,381,305
Ensembl chr 7:136,358,097...136,381,305
|
|
| G
|
Itga8
|
integrin subunit alpha 8
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ITGA8 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr17:80,213,139...80,410,633
Ensembl chr17:80,213,143...80,410,633
|
|
| G
|
Itgad
|
integrin subunit alpha D
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ITGAD mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:192,190,204...192,218,864
Ensembl chr 1:192,190,204...192,218,864
|
|
| G
|
Itgam
|
integrin subunit alpha M
|
multiple interactions
|
EXP ISO
|
[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of ITGAM protein; resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of ITGAM protein] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ITGAM mRNA
|
CTD |
PMID:25727173 PMID:30529165 |
|
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:192,089,542...192,139,943
|
|
| G
|
Itgax
|
integrin subunit alpha X
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ITGAX mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:192,140,089...192,171,151
Ensembl chr 1:192,149,905...192,171,151
|
|
| G
|
Itgb1
|
integrin subunit beta 1
|
multiple interactions increases expression
|
ISO EXP
|
ITGB1 affects the reaction [Oxygen deficiency affects the expression of BIRC5 mRNA]; ITGB1 affects the reaction [Oxygen deficiency affects the expression of BIRC5 protein] Oxygen deficiency results in increased expression of ITGB1 mRNA Oxygen deficiency results in increased expression of ITGB1 protein Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of ITGB1 protein]
|
CTD |
PMID:16628086 PMID:25596134 PMID:26476374 |
|
NCBI chr19:73,602,277...73,650,271
Ensembl chr19:73,602,126...73,650,269
|
|
| G
|
Itgb1bp2
|
integrin subunit beta 1 binding protein 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ITGB1BP2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr X:70,612,118...70,617,158
Ensembl chr X:70,612,521...70,617,158
|
|
| G
|
Itgb2
|
integrin subunit beta 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ITGB2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr20:11,061,009...11,097,242
Ensembl chr20:11,058,492...11,097,182
|
|
| G
|
Itgb7
|
integrin subunit beta 7
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ITGB7 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 7:135,225,962...135,243,522
Ensembl chr 7:135,226,555...135,243,597
|
|
| G
|
Itgbl1
|
integrin subunit beta like 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of ITGBL1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr15:107,186,792...107,448,335
Ensembl chr15:107,186,689...107,451,098
|
|
| G
|
Itih5
|
inter-alpha-trypsin inhibitor heavy chain 5
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of ITIH5 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ITIH5 mRNA
|
CTD |
PMID:24205000 PMID:30529165 |
|
NCBI chr17:73,161,886...73,261,930
Ensembl chr17:73,161,611...73,262,496
|
|
| G
|
Itm2a
|
integral membrane protein 2A
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of ITM2A mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ITM2A mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr X:76,559,183...76,565,144
Ensembl chr X:76,559,181...76,565,437
|
|
| G
|
Itpkc
|
inositol-trisphosphate 3-kinase C
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ITPKC mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:91,628,606...91,650,182
Ensembl chr 1:91,628,608...91,653,350
|
|
| G
|
Itpripl1
|
ITPRIP like 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ITPRIPL1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 3:134,858,316...134,861,241
Ensembl chr 3:134,854,417...134,868,960
|
|
| G
|
Ivd
|
isovaleryl-CoA dehydrogenase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IVD mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:126,305,584...126,326,016
Ensembl chr 3:126,305,364...126,328,160
|
|
| G
|
Iyd
|
iodotyrosine deiodinase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IYD mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:42,410,099...42,425,414
Ensembl chr 1:42,410,130...42,426,386
|
|
| G
|
Jak1
|
Janus kinase 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of JAK1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 5:120,895,606...121,004,207
Ensembl chr 5:120,896,046...120,996,758
|
|
| G
|
Jak2
|
Janus kinase 2
|
multiple interactions increases phosphorylation
|
ISO
|
alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide promotes the reaction [Folic Acid inhibits the reaction [Oxygen deficiency results in increased phosphorylation of JAK2 protein]]; Folic Acid inhibits the reaction [Oxygen deficiency results in increased phosphorylation of JAK2 protein]
|
CTD |
PMID:29685624 |
|
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:236,408,662...236,468,762
|
|
| G
|
Jam2
|
junctional adhesion molecule 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of JAM2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr11:37,316,287...37,366,517
Ensembl chr11:37,317,511...37,367,510
|
|
| G
|
Jaml
|
junction adhesion molecule like
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of JAML mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 8:54,281,596...54,313,655
Ensembl chr 8:54,281,644...54,313,500
|
|
| G
|
Jazf1
|
JAZF zinc finger 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of JAZF1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 4:83,210,054...83,513,790
Ensembl chr 4:83,210,058...83,513,644
|
|
| G
|
Jchain
|
joining chain of multimeric IgA and IgM
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of JCHAIN mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:19,822,976...19,831,072
Ensembl chr14:19,822,976...19,838,307
|
|
| G
|
Jmjd6
|
jumonji domain containing 6, arginine demethylase and lysine hydroxylase
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of JMJD6 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of JMJD6 mRNA
|
CTD |
PMID:20880076 PMID:30529165 |
|
NCBI chr10:102,539,935...102,545,986
Ensembl chr10:102,539,894...102,545,986
|
|
| G
|
Jpt2
|
Jupiter microtubule associated homolog 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of JPT2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:14,467,652...14,487,769
Ensembl chr10:14,467,661...14,535,664
|
|
| G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions increases expression
|
ISO
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of JUN mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of JUN mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of JUN mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of JUN mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of JUN mRNA]
|
CTD |
PMID:17914565 PMID:23452621 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
|
|
| G
|
Junb
|
JunB proto-oncogene, AP-1 transcription factor subunit
|
increases expression multiple interactions
|
EXP ISO
|
Oxygen deficiency results in increased expression of JUNB mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of JUNB mRNA
|
CTD |
PMID:11577072 PMID:26516004 PMID:30529165 |
|
NCBI chr19:40,081,126...40,082,910
Ensembl chr19:40,073,541...40,085,218
|
|
| G
|
Kank3
|
KN motif and ankyrin repeat domains 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KANK3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:15,296,538...15,309,838
Ensembl chr 7:15,296,585...15,311,408
|
|
| G
|
Kank4
|
KN motif and ankyrin repeat domains 4
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KANK4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:118,516,994...118,581,024
Ensembl chr 5:118,517,971...118,581,002
|
|
| G
|
Kat6b
|
lysine acetyltransferase 6B
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of KAT6B mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr15:2,688,535...2,861,443
Ensembl chr15:2,688,811...2,844,343
|
|
| G
|
Kazald1
|
Kazal-type serine peptidase inhibitor domain 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KAZALD1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:253,888,639...253,892,211
Ensembl chr 1:253,888,783...253,892,305
|
|
| G
|
Kbtbd11
|
kelch repeat and BTB domain containing 11
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of KBTBD11 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr16:81,318,596...81,340,334
Ensembl chr16:81,313,093...81,340,390
|
|
| G
|
Kbtbd8
|
kelch repeat and BTB domain containing 8
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of KBTBD8 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 4:129,232,781...129,245,608
Ensembl chr 4:129,232,027...129,245,605
|
|
| G
|
Kcmf1
|
potassium channel modulatory factor 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCMF1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:106,447,974...106,508,359
Ensembl chr 4:106,447,981...106,508,359
|
|
| G
|
Kcna2
|
potassium voltage-gated channel subfamily A member 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCNA2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:197,392,746...197,406,606
Ensembl chr 2:197,392,698...197,407,519
|
|
| G
|
Kcna5
|
potassium voltage-gated channel subfamily A member 5
|
multiple interactions decreases expression decreases activity
|
EXP ISO
|
(2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide inhibits the reaction [Apigenin inhibits the reaction [Oxygen deficiency results in decreased expression of KCNA5 protein]]; [[Oxygen deficiency results in increased activity of ALOX15 protein] which results in increased chemical synthesis of 15-hydroxy-5,8,11,13-eicosatetraenoic acid] which results in decreased expression of KCNA5 mRNA; [[Oxygen deficiency results in increased activity of ALOX15 protein] which results in increased chemical synthesis of 15-hydroxy-5,8,11,13-eicosatetraenoic acid] which results in decreased expression of KCNA5 protein; ALOX15 protein promotes the reaction [Oxygen deficiency results in decreased activity of KCNA5 protein]; Apigenin inhibits the reaction [Oxygen deficiency results in decreased expression of KCNA5 protein]; cinnamyl-3,4-dihydroxycyanocinnamate inhibits the reaction [[[Oxygen deficiency results in increased activity of ALOX15 protein] which results in increased chemical synthesis of 15-hydroxy-5,8,11,13-eicosatetraenoic acid] which results in decreased expression of KCNA5 mRNA]; HIF1A protein inhibits the reaction [Apigenin inhibits the reaction [Oxygen deficiency results in decreased expression of KCNA5 protein]]; Masoprocol inhibits the reaction [[[Oxygen deficiency results in increased activity of ALOX15 protein] which results in increased chemical synthesis of 15-hydroxy-5,8,11,13-eicosatetraenoic acid] which results in decreased expression of KCNA5 mRNA] Oxygen deficiency results in decreased expression of KCNA5 mRNA; Oxygen deficiency results in decreased expression of KCNA5 protein Oxygen results in decreased expression of KCNA5 protein
|
CTD |
PMID:18984061 PMID:25447406 PMID:31930969 |
|
NCBI chr 4:161,040,853...161,044,311
Ensembl chr 4:160,996,950...161,044,408
|
|
| G
|
Kcnab1
|
potassium voltage-gated channel subfamily A regulatory beta subunit 1
|
increases expression decreases expression
|
ISO
|
Oxygen results in increased expression of KCNAB1 mRNA Oxygen deficiency results in decreased expression of KCNAB1 mRNA
|
CTD |
PMID:25447406 PMID:26516004 |
|
NCBI chr 2:151,446,975...151,913,636
Ensembl chr 2:151,446,947...151,913,636
|
|
| G
|
Kcnab2
|
potassium voltage-gated channel subfamily A regulatory beta subunit 2
|
decreases expression
|
ISO
|
Oxygen results in decreased expression of KCNAB2 mRNA
|
CTD |
PMID:25447406 |
|
NCBI chr 5:168,182,228...168,270,760
Ensembl chr 5:168,184,613...168,270,760
|
|
| G
|
Kcnb1
|
potassium voltage-gated channel subfamily B member 1
|
decreases expression
|
EXP
|
Oxygen deficiency results in decreased expression of KCNB1 protein
|
CTD |
PMID:31930969 |
|
NCBI chr 3:176,239,285...176,332,408
Ensembl chr 3:176,242,589...176,332,408
|
|
| G
|
Kcnc4
|
potassium voltage-gated channel subfamily C member 4
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of KCNC4 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 2:197,747,095...197,788,467
Ensembl chr 2:197,759,010...197,788,433
|
|
| G
|
Kcnd2
|
potassium voltage-gated channel subfamily D member 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCND2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:50,741,595...51,243,540
Ensembl chr 4:50,742,839...51,243,522
|
|
| G
|
Kcne2
|
potassium voltage-gated channel subfamily E regulatory subunit 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCNE2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr11:45,003,468...45,015,942
Ensembl chr11:45,014,406...45,016,168
|
|
| G
|
Kcne3
|
potassium voltage-gated channel subfamily E regulatory subunit 3
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of KCNE3 mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr 1:163,936,035...163,942,998
Ensembl chr 1:163,935,991...163,950,162
|
|
| G
|
Kcne4
|
potassium voltage-gated channel subfamily E regulatory subunit 4
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of KCNE4 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCNE4 mRNA
|
CTD |
PMID:20880076 PMID:30529165 |
|
NCBI chr 9:87,674,264...87,699,088
Ensembl chr 9:87,650,462...87,704,131
|
|
| G
|
Kcnh1
|
potassium voltage-gated channel subfamily H member 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCNH1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr13:106,253,101...106,555,712
Ensembl chr13:106,253,213...106,555,710
|
|
| G
|
Kcnh2
|
potassium voltage-gated channel subfamily H member 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of KCNH2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:11,692,980...11,751,421
|
|
| G
|
Kcnip2
|
potassium voltage-gated channel interacting protein 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of KCNIP2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:254,590,172...254,614,437
Ensembl chr 1:254,590,175...254,613,898
|
|
| G
|
Kcnj10
|
potassium inwardly-rectifying channel, subfamily J, member 10
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with SCH 442416] results in increased expression of KCNJ10 mRNA
|
CTD |
PMID:24431311 |
|
NCBI chr13:87,334,510...87,367,747
Ensembl chr13:87,334,216...87,368,678
|
|
| G
|
Kcnj11
|
potassium inwardly-rectifying channel, subfamily J, member 11
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of KCNJ11 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:105,727,473...105,731,167
Ensembl chr 1:105,727,570...105,731,169
|
|
| G
|
Kcnj13
|
potassium inwardly-rectifying channel, subfamily J, member 13
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCNJ13 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:95,509,228...95,528,400
Ensembl chr 9:95,510,877...95,520,817
|
|
| G
|
Kcnj15
|
potassium inwardly-rectifying channel, subfamily J, member 15
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCNJ15 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr11:48,046,953...48,091,285
Ensembl chr11:48,035,655...48,092,457
|
|
| G
|
Kcnj2
|
potassium inwardly-rectifying channel, subfamily J, member 2
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of KCNJ2 mRNA [Oxygen deficiency co-treated with SCH 442416] results in increased expression of KCNJ2 mRNA
|
CTD |
PMID:24236059 PMID:24431311 |
|
NCBI chr10:96,560,225...96,570,788
Ensembl chr10:96,565,600...96,570,901
|
|
| G
|
Kcnj3
|
potassium inwardly-rectifying channel, subfamily J, member 3
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of KCNJ3 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 3:60,353,990...60,518,110
Ensembl chr 3:60,354,146...60,518,104
|
|
| G
|
Kcnk13
|
potassium two pore domain channel subfamily K member 13
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCNK13 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:124,970,363...125,074,919
Ensembl chr 6:124,971,212...125,075,923
|
|
| G
|
Kcnk2
|
potassium two pore domain channel subfamily K member 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCNK2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr13:103,297,387...103,494,686
Ensembl chr13:103,297,393...103,494,686
|
|
| G
|
Kcnk6
|
potassium two pore domain channel subfamily K member 6
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of KCNK6 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:93,652,888...93,661,419
|
|
| G
|
Kcnma1
|
potassium calcium-activated channel subfamily M alpha 1
|
decreases response to substance increases expression
|
EXP
|
KCNMA1 mRNA alternative form results in decreased susceptibility to Oxygen deficiency Oxygen deficiency results in increased expression of KCNMA1 mRNA alternative form; Oxygen deficiency results in increased expression of KCNMA1 protein alternative form
|
CTD |
PMID:28090300 |
|
NCBI chr15:351,065...1,057,117
Ensembl chr15:351,659...1,057,117
|
|
| G
|
Kcnmb4
|
potassium calcium-activated channel subfamily M regulatory beta subunit 4
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCNMB4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:53,952,150...54,005,101
Ensembl chr 7:53,949,881...54,005,281
|
|
| G
|
Kcnt2
|
potassium sodium-activated channel subfamily T member 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of KCNT2 mRNA
|
CTD |
PMID:26100633 |
|
NCBI chr13:54,214,831...54,609,889
Ensembl chr13:54,215,307...54,607,924
|
|
| G
|
Kctd11
|
potassium channel tetramerization domain containing 11
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of KCTD11 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCTD11 mRNA
|
CTD |
PMID:20042640 PMID:30529165 |
|
NCBI chr10:55,101,292...55,103,455
Ensembl chr10:55,100,801...55,103,583
|
|
| G
|
Kctd12b
|
potassium channel tetramerization domain containing 12b
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCTD12B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr X:20,989,053...21,000,208
Ensembl chr X:20,989,164...21,000,207
|
|
| G
|
Kctd16
|
potassium channel tetramerization domain containing 16
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of KCTD16 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr18:32,417,306...32,711,928
Ensembl chr18:32,419,225...32,712,820
|
|
| G
|
Kctd21
|
potassium channel tetramerization domain containing 21
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCTD21 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:161,061,318...161,081,002
Ensembl chr 1:161,054,045...161,088,271
|
|
| G
|
Kdm1a
|
lysine demethylase 1A
|
multiple interactions
|
EXP ISO
|
KDM1A protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] [KDM1A protein binds to RCOR1 protein] promotes the reaction [Oxygen deficiency results in decreased expression of MLH1 mRNA]; [KDM1A protein binds to RCOR1 protein] promotes the reaction [Oxygen deficiency results in decreased expression of MLH1 protein]; [KDM1A protein binds to RCOR1 protein] promotes the reaction [Oxygen deficiency results in increased methylation of MLH1 promoter]; KDM1A protein promotes the reaction [Oxygen deficiency results in decreased expression of MLH1 mRNA]; KDM1A protein promotes the reaction [Oxygen deficiency results in increased methylation of MLH1 promoter]; Oxygen deficiency promotes the reaction [KDM1A protein binds to ACTB promoter]; Oxygen deficiency promotes the reaction [KDM1A protein binds to MLH1 promoter]
|
CTD |
PMID:21124846 PMID:25043185 |
|
NCBI chr 5:154,066,436...154,121,913
Ensembl chr 5:154,065,543...154,121,775
|
|
| G
|
Kdm3a
|
lysine demethylase 3A
|
multiple interactions increases expression
|
ISO
|
Oxygen deficiency promotes the reaction [HIF3A protein binds to KDM3A promoter]; Oxygen deficiency promotes the reaction [KDM3A protein binds to SPRY2 promoter] Oxygen deficiency results in increased expression of KDM3A mRNA; Oxygen deficiency results in increased expression of KDM3A protein
|
CTD |
PMID:20042640 PMID:20880076 PMID:20881000 PMID:23546878 PMID:24236059 PMID:25596134 PMID:26516004 PMID:34826399 More...
|
|
NCBI chr 4:105,189,208...105,233,526
Ensembl chr 4:105,189,208...105,233,370
|
|
| G
|
Kdm4a
|
lysine demethylase 4A
|
multiple interactions
|
ISO
|
[cobaltous chloride results in decreased abundance of Oxygen] promotes the reaction [SUMO1 protein binds to KDM4A protein]; [cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of KDM4A protein; KDM4A protein affects the reaction [[cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of GPX4 protein]; KDM4A protein affects the reaction [[cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of SLC7A11 mRNA]; KDM4A protein affects the reaction [[cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of SLC7A11 protein]
|
CTD |
PMID:38727079 |
|
NCBI chr 5:136,958,178...137,004,942
Ensembl chr 5:136,958,178...137,004,951
|
|
| G
|
Kdm5b
|
lysine demethylase 5B
|
multiple interactions decreases expression
|
ISO
|
KDM5B protein promotes the reaction [Oxygen deficiency results in decreased expression of MLH1 mRNA] Oxygen deficiency results in decreased expression of KDM5B protein
|
CTD |
PMID:25043185 |
|
NCBI chr13:48,554,367...48,625,721
Ensembl chr13:48,554,420...48,626,423
|
|
| G
|
Kdm6a
|
lysine demethylase 6A
|
multiple interactions
|
ISO
|
Oxygen deficiency promotes the reaction [KDM6A protein binds to DICER1 promoter]
|
CTD |
PMID:25351418 |
|
NCBI chr X:6,920,374...7,060,027
Ensembl chr X:6,920,343...7,059,960
|
|
| G
|
Kdm6b
|
lysine demethylase 6B
|
multiple interactions
|
ISO
|
Oxygen deficiency promotes the reaction [KDM6B protein binds to DICER1 promoter]
|
CTD |
PMID:25351418 |
|
NCBI chr10:54,619,520...54,641,014
Ensembl chr10:54,619,544...54,629,610
|
|
| G
|
Kdm7a
|
lysine demethylase 7A
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of KDM7A mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of KDM7A mRNA]
|
CTD |
PMID:22629407 PMID:24236059 |
|
NCBI chr 4:68,866,263...68,992,979
Ensembl chr 4:68,871,677...68,931,506
|
|
| G
|
Kdr
|
kinase insert domain receptor
|
multiple interactions increases phosphorylation decreases expression increases expression
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KDR mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of KDR protein; Omeprazole promotes the reaction [Oxygen results in decreased expression of KDR protein] [Apigenin co-treated with Oxygen deficiency] affects the phosphorylation of KDR protein; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of KDR protein]; KDR protein affects the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; SENP1 protein affects the reaction [Oxygen deficiency results in increased expression of KDR protein] Oxygen deficiency results in increased phosphorylation of KDR protein Oxygen deficiency results in decreased expression of KDR mRNA; Oxygen results in decreased expression of KDR mRNA; Oxygen results in decreased expression of KDR protein [Diethylhexyl Phthalate co-treated with Oxygen] results in decreased expression of KDR mRNA
|
CTD |
PMID:8537383 PMID:19228841 PMID:22363622 PMID:23144690 PMID:26272953 PMID:28576411 PMID:30529165 PMID:31953908 PMID:34541741 PMID:35513012 PMID:39038764 More...
|
|
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,572,049...32,615,192
|
|
| G
|
Keap1
|
Kelch-like ECH-associated protein 1
|
decreases expression increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of KEAP1 mRNA; Oxygen deficiency results in decreased expression of KEAP1 protein Oxygen deficiency results in increased expression of KEAP1 protein [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of KEAP1 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of KEAP1 protein; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of KEAP1 protein]; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of KEAP1 protein]; KEAP1 protein inhibits the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; KEAP1 protein inhibits the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PARP1 protein modified form]]; KEAP1 protein inhibits the reaction [diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of KEAP1 protein]]; KEAP1 protein inhibits the reaction [diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and affects the localization of NFE2L2 protein]]; NFE2L2 protein promotes the reaction [diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of KEAP1 protein]]; Tea inhibits the reaction [Oxygen deficiency results in increased expression of KEAP1 protein] [Ozone co-treated with Oxygen] inhibits the reaction [KEAP1 protein results in increased degradation of NFE2L2 protein]; [Ozone co-treated with Oxygen] results in increased expression of KEAP1 protein
|
CTD |
PMID:25596134 PMID:26270818 PMID:29139225 PMID:29864481 PMID:34023435 PMID:35191607 More...
|
|
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:28,044,555...28,054,042
|
|
| G
|
Khdrbs3
|
KH RNA binding domain containing, signal transduction associated 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KHDRBS3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:102,726,628...102,884,545
Ensembl chr 7:102,726,843...102,884,541
|
|
| G
|
Khk
|
ketohexokinase
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of KHK mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 6:31,165,246...31,175,779
Ensembl chr 6:31,165,248...31,175,481
|
|
| G
|
Kif11
|
kinesin family member 11
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of KIF11 mRNA [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of KIF11 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of KIF11 mRNA
|
CTD |
PMID:26516004 PMID:33729688 |
|
NCBI chr 1:244,494,916...244,589,250
Ensembl chr 1:244,494,875...244,589,250
|
|
| G
|
Kif18b
|
kinesin family member 18B
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of KIF18B mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:88,370,520...88,392,388
Ensembl chr10:88,370,524...88,389,691
|
|
| G
|
Kif19
|
kinesin family member 19
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of KIF19 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:100,298,912...100,325,591
Ensembl chr10:100,299,275...100,325,767
|
|
| G
|
Kif20a
|
kinesin family member 20A
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of KIF20A mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of KIF20A mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr18:26,504,422...26,512,908
Ensembl chr18:26,504,072...26,512,909
|
|
| G
|
Kif20b
|
kinesin family member 20B
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of KIF20B mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:241,840,898...241,896,451
Ensembl chr 1:241,840,987...241,896,451
|
|
| G
|
Kif21b
|
kinesin family member 21B
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of KIF21B mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of KIF21B mRNA
|
CTD |
PMID:20880076 PMID:33729688 |
|
NCBI chr13:50,127,842...50,177,822
Ensembl chr13:50,127,842...50,177,822
|
|
| G
|
Kif22
|
kinesin family member 22
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of KIF22 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:191,065,875...191,080,955
Ensembl chr 1:191,065,875...191,080,878
|
|
| G
|
Kif23
|
kinesin family member 23
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of KIF23 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of KIF23 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 8:71,293,439...71,321,911
Ensembl chr 8:71,293,482...71,320,856
|
|
| G
|
Kif24
|
kinesin family member 24
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of KIF24 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 5:61,357,078...61,423,882
Ensembl chr 5:61,357,940...61,399,379
|
|
| G
|
Kif26a
|
kinesin family member 26A
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KIF26A mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:137,035,986...137,072,027
Ensembl chr 6:137,033,789...137,072,022
|
|
| G
|
Kif26b
|
kinesin family member 26B
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KIF26B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr13:92,815,427...93,221,071
Ensembl chr13:92,815,427...93,215,453
|
|
| G
|
Kif4a
|
kinesin family member 4A
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of KIF4A mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of KIF4A mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr X:69,761,803...69,864,335
Ensembl chr X:69,761,883...69,864,335
|
|
| G
|
Kifbp
|
kinesin family binding protein
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of KIFBP mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr20:31,055,625...31,075,232
Ensembl chr20:31,055,626...31,075,201
|
|
| G
|
Kifc1
|
kinesin family member C1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of KIFC1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr20:5,000,929...5,018,967
Ensembl chr20:5,000,648...5,018,988
|
|
| G
|
Kiss1
|
KiSS-1 metastasis-suppressor
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of KISS1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr13:47,327,159...47,332,759
Ensembl chr13:47,327,004...47,332,906
|
|
| G
|
Kit
|
KIT proto-oncogene receptor tyrosine kinase
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KIT mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of KIT mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,903,033...32,978,812
|
|
| G
|
Kl
|
Klotho
|
multiple interactions decreases expression
|
ISO
|
KL protein affects the reaction [Oxygen deficiency results in increased expression of ACTA2 protein]; KL protein affects the reaction [Oxygen deficiency results in increased expression of TGFB1 protein]; KL protein affects the reaction [pregna-4,17-diene-3,16-dione inhibits the reaction [Oxygen deficiency results in increased expression of TP53 protein]]; pregna-4,17-diene-3,16-dione inhibits the reaction [Oxygen deficiency results in decreased expression of KL protein]
|
CTD |
PMID:35123992 |
|
NCBI chr12:5,326,003...5,367,016
Ensembl chr12:5,325,959...5,367,015
|
|
| G
|
Klf10
|
KLF transcription factor 10
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KLF10 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:71,352,612...71,358,680
Ensembl chr 7:71,350,573...71,358,948
|
|
| G
|
Klf11
|
KLF transcription factor 11
|
multiple interactions
|
ISO
|
Oxygen affects the reaction [AHR protein results in decreased expression of KLF11 mRNA]
|
CTD |
PMID:27103661 |
|
NCBI chr 6:47,014,312...47,026,152
Ensembl chr 6:47,014,326...47,037,044
|
|
| G
|
Klf12
|
KLF transcription factor 12
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KLF12 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr15:83,037,548...83,469,998
Ensembl chr15:83,045,463...83,670,640
|
|
| G
|
Klf13
|
KLF transcription factor 13
|
multiple interactions
|
EXP
|
[[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Carvedilol] which results in decreased expression of KLF13 mRNA
|
CTD |
PMID:29122578 |
|
NCBI chr 1:126,917,671...126,948,436
Ensembl chr 1:126,916,781...126,961,056
|
|
| G
|
Klf15
|
KLF transcription factor 15
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KLF15 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:124,522,652...124,535,613
Ensembl chr 4:124,522,909...124,542,373
|
|
| G
|
Klf4
|
KLF transcription factor 4
|
increases expression multiple interactions decreases expression
|
ISO EXP
|
Oxygen deficiency results in increased expression of KLF4 mRNA; Oxygen results in increased expression of KLF4 mRNA Oxygen affects the reaction [AHR protein results in increased expression of KLF4 mRNA] epigallocatechin gallate inhibits the reaction [Oxygen deficiency results in decreased expression of KLF4 mRNA]; epigallocatechin gallate inhibits the reaction [Oxygen deficiency results in decreased expression of KLF4 protein]; KLF4 protein promotes the reaction [epigallocatechin gallate inhibits the reaction [Oxygen deficiency results in decreased expression of MFN2 mRNA]]; KLF4 protein promotes the reaction [epigallocatechin gallate inhibits the reaction [Oxygen deficiency results in decreased expression of MFN2 protein]] Oxygen deficiency results in decreased expression of KLF4 mRNA; Oxygen deficiency results in decreased expression of KLF4 protein
|
CTD |
PMID:17175027 PMID:27103661 PMID:28478070 PMID:34998824 |
|
NCBI chr 5:75,074,107...75,079,182
Ensembl chr 5:75,074,236...75,078,592
|
|
| G
|
Klf6
|
KLF transcription factor 6
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of KLF6 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr17:69,449,483...69,458,478
Ensembl chr17:69,441,493...69,498,601
|
|
| G
|
Klf7
|
KLF transcription factor 7
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of KLF7 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 9:72,927,485...73,020,167
Ensembl chr 9:72,933,136...73,020,056
|
|
| G
|
Klhdc8a
|
kelch domain containing 8A
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KLHDC8A mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr13:46,287,011...46,296,429
Ensembl chr13:46,288,344...46,296,429
|
|
| G
|
Klhdc8b
|
kelch domain containing 8B
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of KLHDC8B mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 8:118,020,136...118,025,102
Ensembl chr 8:118,020,376...118,025,102
|
|
| G
|
Klhl20
|
kelch-like family member 20
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of KLHL20 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr13:75,896,802...75,941,724
Ensembl chr13:75,898,410...75,945,061
|
|
| G
|
Klhl24
|
kelch-like family member 24
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KLHL24 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr11:94,348,024...94,382,085
Ensembl chr11:94,351,157...94,382,050
|
|
| G
|
Klhl41
|
kelch-like family member 41
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KLHL41 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:74,842,118...74,855,244
|
|
| G
|
Klrd1
|
killer cell lectin like receptor D1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of KLRD1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KLRD1 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 4:164,730,833...164,742,539
Ensembl chr 4:164,730,856...164,742,538
|
|
| G
|
Klrk1
|
killer cell lectin like receptor K1
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of KLRK1 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of KLRK1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 4:164,767,377...164,778,453
Ensembl chr 4:164,767,946...164,778,382
|
|
| G
|
Knstrn
|
kinetochore-localized astrin/SPAG5 binding protein
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of KNSTRN mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of KNSTRN mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 3:126,254,633...126,274,412
Ensembl chr 3:126,254,663...126,274,418
|
|
| G
|
Kpna1
|
karyopherin subunit alpha 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of KPNA1 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of KPNA1 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr11:78,221,165...78,279,778
Ensembl chr11:78,222,884...78,267,067
|
|
| G
|
Kpna2
|
karyopherin subunit alpha 2
|
decreases expression multiple interactions
|
ISO
|
Oxygen results in decreased expression of KPNA2 mRNA Oxygen affects the reaction [AHR protein results in increased expression of KPNA2 mRNA]
|
CTD |
PMID:27103661 |
|
NCBI chr10:92,433,678...92,445,841
Ensembl chr10:92,433,679...92,445,937
|
|
| G
|
Kpna3
|
karyopherin subunit alpha 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KPNA3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr15:39,712,375...39,786,127
Ensembl chr15:39,712,381...39,786,319
|
|
| G
|
Kras
|
KRAS proto-oncogene, GTPase
|
multiple interactions
|
ISO
|
[Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of KRAS mRNA; [Oxygen co-treated with Ozone] results in decreased expression of KRAS mRNA
|
CTD |
PMID:32992648 |
|
NCBI chr 4:179,916,255...179,949,613
Ensembl chr 4:179,919,802...179,949,320
|
|
| G
|
Kri1
|
KRI1 homolog
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of KRI1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:28,093,175...28,107,576
Ensembl chr 8:28,093,175...28,107,557
|
|
| G
|
Krr1
|
KRR1, small subunit processome component homolog
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of KRR1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:49,361,794...49,374,222
Ensembl chr 7:49,361,901...49,374,216
|
|
| G
|
Krt15
|
keratin 15
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of KRT15 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr10:85,567,197...85,571,014
Ensembl chr10:85,567,202...85,571,142
|
|
| G
|
Krt18
|
keratin 18
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KRT18 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:135,036,168...135,039,844
Ensembl chr 7:135,035,982...135,039,848 Ensembl chr10:135,035,982...135,039,848
|
|
| G
|
Krt19
|
keratin 19
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of KRT19 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KRT19 mRNA
|
CTD |
PMID:20880076 PMID:30529165 |
|
NCBI chr10:85,576,235...85,580,952
Ensembl chr10:85,576,235...85,580,952
|
|
| G
|
Krt23
|
keratin 23
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KRT23 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:84,930,603...84,946,929
Ensembl chr10:84,930,603...84,946,929
|
|
| G
|
Krt4
|
keratin 4
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of KRT4 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 7:134,924,753...134,931,050
Ensembl chr 7:134,924,753...134,930,713
|
|
| G
|
Krt7
|
keratin 7
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KRT7 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of KRT7 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 7:134,407,626...134,423,787
Ensembl chr 7:134,407,584...134,423,786
|
|
| G
|
Krt75
|
keratin 75
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of KRT75 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 7:134,565,826...134,576,074
Ensembl chr 7:134,565,826...134,576,074
|
|
| G
|
Krt8
|
keratin 8
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KRT8 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:135,002,886...135,010,339
Ensembl chr 7:135,002,894...135,010,403
|
|
| G
|
Krtap17-1
|
keratin associated protein 17-1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KRTAP17-1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:85,424,325...85,425,039
Ensembl chr10:85,424,325...85,425,039
|
|
| G
|
Krtap27-1
|
keratin associated protein 27-1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of KRTAP27-1 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr11:41,467,160...41,468,354
|
|
| G
|
Ktn1
|
kinectin 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of KTN1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr15:23,392,570...23,485,061
Ensembl chr15:23,394,315...23,482,263
|
|
| G
|
Ky
|
kyphoscoliosis peptidase
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of KY mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 8:111,965,862...112,005,206
Ensembl chr 8:111,965,862...112,005,206
|
|
| G
|
Kyat3
|
kynurenine aminotransferase 3
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of KYAT3 mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr 2:234,362,306...234,407,646
Ensembl chr 2:234,362,322...234,407,878
|
|
| G
|
L1cam
|
L1 cell adhesion molecule
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of L1CAM mRNA; Oxygen deficiency results in increased expression of L1CAM protein 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Oxygen deficiency results in increased expression of L1CAM mRNA]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Oxygen deficiency results in increased expression of L1CAM protein]; diallyl trisulfide inhibits the reaction [Oxygen deficiency results in increased expression of L1CAM mRNA]; diallyl trisulfide inhibits the reaction [Oxygen deficiency results in increased expression of L1CAM protein]
|
CTD |
PMID:28574600 |
|
NCBI chr X:156,748,597...156,775,116
Ensembl chr X:156,748,597...156,775,077
|
|
| G
|
Lama1
|
laminin subunit alpha 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of LAMA1 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 9:115,139,548...115,263,620
Ensembl chr 9:115,139,548...115,264,251
|
|
| G
|
Lama3
|
laminin subunit alpha 3
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of LAMA3 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LAMA3 mRNA
|
CTD |
PMID:25596134 PMID:30529165 |
|
NCBI chr18:3,797,898...4,033,021
Ensembl chr18:3,797,939...4,026,449
|
|
| G
|
Lamc1
|
laminin subunit gamma 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of LAMC1 mRNA TP53 protein mutant form promotes the reaction [Oxygen deficiency results in increased expression of LAMC1 mRNA]
|
CTD |
PMID:30381462 |
|
NCBI chr13:67,924,872...68,051,986
Ensembl chr13:67,924,872...68,051,986
|
|
| G
|
Lamc2
|
laminin subunit gamma 2
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of LAMC2 mRNA; Oxygen deficiency results in increased expression of LAMC2 protein HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of LAMC2 mRNA]; SMARCA2 protein promotes the reaction [Oxygen deficiency results in increased expression of LAMC2 mRNA]; SMARCA4 protein promotes the reaction [Oxygen deficiency results in increased expression of LAMC2 mRNA]; TP53 protein mutant form promotes the reaction [Oxygen deficiency results in increased expression of LAMC2 mRNA]; TP53 protein mutant form promotes the reaction [Oxygen deficiency results in increased expression of LAMC2 protein]
|
CTD |
PMID:30381462 |
|
NCBI chr13:67,835,199...67,894,694
Ensembl chr13:67,835,199...67,895,102
|
|
| G
|
Lamp2
|
lysosomal-associated membrane protein 2
|
multiple interactions
|
ISO
|
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of LAMP2 protein
|
CTD |
PMID:21392095 |
|
NCBI chr X:122,038,734...122,087,745
Ensembl chr X:121,922,187...122,087,675
|
|
| G
|
Laptm5
|
lysosomal protein transmembrane 5
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of LAPTM5 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 5:148,371,880...148,393,927
Ensembl chr 5:148,339,435...148,393,927
|
|
| G
|
Larp1b
|
La ribonucleoprotein 1B
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of LARP1B mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of LARP1B mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 2:125,860,935...125,897,189
Ensembl chr 2:125,863,997...125,897,189
|
|
| G
|
Lasp1
|
LIM and SH3 protein 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of LASP1 protein
|
CTD |
PMID:25937538 |
|
NCBI chr10:83,290,820...83,331,989
Ensembl chr10:83,290,865...83,331,988
|
|
| G
|
Lbh
|
LBH regulator of WNT signaling pathway
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LBH mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:28,321,040...28,344,855
Ensembl chr 6:28,321,040...28,370,238
|
|
| G
|
Lclat1
|
lysocardiolipin acyltransferase 1
|
increases expression affects methylation
|
ISO
|
Oxygen deficiency results in increased expression of LCLAT1 mRNA Oxygen deficiency affects the methylation of LCLAT1 promoter
|
CTD |
PMID:24205000 |
|
NCBI chr 6:27,980,749...28,125,076
Ensembl chr 6:27,982,936...28,112,511
|
|
| G
|
Lcmt2
|
leucine carboxyl methyltransferase 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of LCMT2 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 3:128,553,707...128,555,831
Ensembl chr 3:128,553,052...128,590,969
|
|
| G
|
Lcn2
|
lipocalin 2
|
increases expression multiple interactions
|
EXP ISO
|
Oxygen results in increased expression of LCN2 mRNA [N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride co-treated with [Oxygen deficiency co-treated with Blood Glucose deficiency]] results in increased expression of LCN2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LCN2 mRNA
|
CTD |
PMID:19640911 PMID:22911455 PMID:30529165 |
|
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842
|
|
| G
|
Ldb3
|
LIM domain binding 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LDB3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr16:9,862,161...9,926,338
Ensembl chr16:9,862,161...9,926,985
|
|
| G
|
Ldha
|
lactate dehydrogenase A
|
multiple interactions increases expression affects expression
|
ISO EXP
|
[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with ferulic acid] inhibits the reaction [[Ozone co-treated with Oxygen] results in increased secretion of LDHA protein]; [Ozone co-treated with Oxygen] results in increased secretion of LDHA protein; bruceine D affects the reaction [Oxygen deficiency affects the expression of LDHA protein]; Cadmium inhibits the reaction [Oxygen deficiency results in increased expression of LDHA mRNA]; CTNNBIP1 protein affects the reaction [bruceine D affects the reaction [Oxygen deficiency affects the expression of LDHA protein]]; HIF1A protein alternative form inhibits the reaction [Oxygen deficiency results in increased expression of LDHA mRNA]; Niclosamide inhibits the reaction [Oxygen deficiency results in increased expression of LDHA mRNA]; Oxygen deficiency promotes the reaction [HIF1A protein binds to LDHA promoter]; Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of LDHA protein] LDHA protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] Oxygen deficiency results in increased expression of LDHA mRNA; Oxygen deficiency results in increased expression of LDHA protein Oxygen results in increased expression of LDHA mRNA
|
CTD |
PMID:10866824 PMID:11739637 PMID:19502547 PMID:20880076 PMID:21124846 PMID:22363556 PMID:22911455 PMID:23880069 PMID:24236059 PMID:26270818 PMID:27292261 PMID:34900531 PMID:36318118 More...
|
|
NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:106,502,182...106,517,521
|
|
| G
|
Ldhb
|
lactate dehydrogenase B
|
affects response to substance multiple interactions
|
ISO
|
LDHB protein affects the susceptibility to Oxygen deficiency [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LDHB mRNA
|
CTD |
PMID:23437403 PMID:30529165 |
|
NCBI chr 4:177,159,389...177,177,408
Ensembl chr 4:177,159,392...177,177,408
|
|
| G
|
Ldlr
|
low density lipoprotein receptor
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of LDLR mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675
|
|
| G
|
Ldlrad3
|
low density lipoprotein receptor class A domain containing 3
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of LDLRAD3 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 3:108,694,528...108,936,330
Ensembl chr 3:108,694,528...108,936,368
|
|
| G
|
Lef1
|
lymphoid enhancer binding factor 1
|
multiple interactions
|
ISO
|
[Butylated Hydroxytoluene co-treated with Oxygen] results in increased expression of LEF1 mRNA
|
CTD |
PMID:16272459 |
|
NCBI chr 2:222,340,541...222,453,931
Ensembl chr 2:222,340,704...222,453,929
|
|
| G
|
Lefty2
|
Left-right determination factor 2
|
multiple interactions decreases expression
|
EXP
|
Quercetin inhibits the reaction [Oxygen deficiency results in decreased expression of LEFTY2 mRNA]
|
CTD |
PMID:26476374 |
|
NCBI chr13:95,147,139...95,151,657
Ensembl chr13:95,147,139...95,151,657
|
|
| G
|
Lep
|
leptin
|
increases secretion decreases expression increases expression
|
ISO
|
Oxygen deficiency results in increased secretion of LEP protein Oxygen deficiency results in decreased expression of LEP mRNA; Oxygen deficiency results in decreased expression of LEP protein Oxygen deficiency results in increased expression of LEP mRNA
|
CTD |
PMID:12032628 PMID:21531777 PMID:23466666 PMID:23539316 |
|
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661
|
|
| G
|
Lepr
|
leptin receptor
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of LEPR mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LEPR mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:121,474,099...121,591,215
|
|
| G
|
Lfng
|
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of LFNG mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr12:19,144,474...19,152,951
Ensembl chr12:19,124,662...19,152,918
|
|
| G
|
Lgals12
|
galectin 12
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LGALS12 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:214,261,216...214,272,825
Ensembl chr 1:214,261,216...214,271,910
|
|
| G
|
Lgals3
|
galectin 3
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of LGALS3 mRNA Oxygen deficiency results in increased expression of LGALS3 protein; Oxygen results in increased expression of LGALS3 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LGALS3 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of LGALS3 mRNA
|
CTD |
PMID:17193925 PMID:19640911 PMID:22911455 PMID:30529165 PMID:32003113 |
|
NCBI chr15:23,099,795...23,111,731
Ensembl chr15:23,086,841...23,111,737
|
|
| G
|
Lgals3bp
|
galectin 3 binding protein
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of LGALS3BP mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of LGALS3BP mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr10:104,118,510...104,127,848
Ensembl chr10:104,118,510...104,127,848
|
|
| G
|
Lgals9
|
galectin 9
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of LGALS9 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of LGALS9 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr10:64,405,044...64,428,249
Ensembl chr10:64,405,044...64,428,070
|
|
| G
|
Lgi3
|
leucine-rich repeat LGI family, member 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LGI3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr15:52,015,317...52,022,445
Ensembl chr15:52,015,230...52,022,443
|
|
| G
|
Lgmn
|
legumain
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LGMN mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:127,308,913...127,347,355
Ensembl chr 6:127,308,913...127,347,328
|
|
| G
|
Lgr5
|
leucine rich repeat containing G protein coupled receptor 5
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of LGR5 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 7:52,973,151...53,107,964
Ensembl chr 7:52,974,332...53,108,163
|
|
| G
|
Lhb
|
luteinizing hormone subunit beta
|
multiple interactions increases expression
|
EXP
|
4-chlorobenzyltetrahydroberberine inhibits the reaction [Oxygen deficiency results in increased expression of LHB protein]; acetovanillone inhibits the reaction [Oxygen deficiency results in increased expression of LHB protein]
|
CTD |
PMID:22226148 PMID:23270704 |
|
NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:105,037,457...105,038,445
|
|
| G
|
Lif
|
LIF, interleukin 6 family cytokine
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LIF mRNA; Oxygen deficiency inhibits the reaction [LIF protein affects the reaction ALPL mRNA]; Oxygen deficiency promotes the reaction [LIF protein affects the reaction FGF5 mRNA]; Oxygen deficiency promotes the reaction [LIF protein affects the reaction NANOG mRNA]; Oxygen deficiency promotes the reaction [LIF protein affects the reaction ZFP42 mRNA] [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of LIF mRNA
|
CTD |
PMID:26723917 PMID:30529165 PMID:33729688 |
|
NCBI chr14:83,354,602...83,364,053
Ensembl chr14:83,358,164...83,364,053
|
|
| G
|
Lifr
|
LIF receptor subunit alpha
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LIFR mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:57,951,787...58,020,357
Ensembl chr 2:57,952,975...58,020,364
|
|
| G
|
Lig4
|
DNA ligase 4
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of LIG4 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr16:86,220,345...86,228,930
Ensembl chr16:86,220,279...86,229,926
|
|
| G
|
Lilra5
|
leukocyte immunoglobulin like receptor A5
|
decreases expression affects methylation
|
ISO
|
Oxygen deficiency results in decreased expression of LILRA5 mRNA Oxygen deficiency affects the methylation of LILRA5 promoter
|
CTD |
PMID:24205000 |
|
NCBI chr 1:79,011,865...79,073,860
Ensembl chr 1:79,045,546...79,050,111
|
|
| G
|
Lilrb2
|
leukocyte immunoglobulin like receptor B2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of LILRB2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:74,242,200...74,250,051
Ensembl chr 1:74,242,200...74,250,047
|
|
| G
|
Lilrb4
|
leukocyte immunoglobulin like receptor B4
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of LILRB4 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:78,847,685...78,853,294
Ensembl chr 1:78,847,685...78,853,326
|
|
| G
|
Lilrc2
|
leukocyte immunoglobulin-like receptor, subfamily C, member 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of LILRC2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:74,187,623...74,192,646
Ensembl chr 1:74,188,164...74,192,719
|
|
| G
|
Limch1
|
LIM and calponin homology domains 1
|
affects methylation increases expression multiple interactions
|
ISO
|
Oxygen deficiency affects the methylation of LIMCH1 promoter Oxygen deficiency results in increased expression of LIMCH1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LIMCH1 mRNA
|
CTD |
PMID:24205000 PMID:26516004 PMID:30529165 |
|
NCBI chr14:41,466,433...41,779,477
Ensembl chr14:41,466,433...41,778,837
|
|
| G
|
Lime1
|
Lck interacting transmembrane adaptor 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of LIME1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 3:188,868,338...188,870,661
Ensembl chr 3:188,868,320...188,870,658
|
|
| G
|
Lin28a
|
lin-28 homolog A
|
multiple interactions increases expression
|
ISO
|
CA9 mutant form inhibits the reaction [[Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of LIN28A mRNA]
|
CTD |
PMID:26305601 |
|
NCBI chr 5:151,510,891...151,527,884
Ensembl chr 5:151,510,891...151,527,884
|
|
| G
|
Lin7c
|
lin-7 homolog C, crumbs cell polarity complex component
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of LIN7C mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 3:116,859,425...116,872,363
Ensembl chr 3:116,860,282...116,872,363
|
|
| G
|
Lipe
|
lipase E, hormone sensitive type
|
decreases expression increases expression
|
ISO
|
Oxygen deficiency results in decreased expression of LIPE mRNA Oxygen deficiency results in increased expression of LIPE mRNA
|
CTD |
PMID:12032628 PMID:23539316 |
|
NCBI chr 1:90,093,433...90,112,117
Ensembl chr 1:90,093,433...90,112,117
|
|
| G
|
Lipg
|
lipase G, endothelial type
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of LIPG mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr18:70,790,077...70,811,259
Ensembl chr18:70,790,077...70,812,260
|
|
| G
|
Litaf
|
lipopolysaccharide-induced TNF factor
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LITAF mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of LITAF mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr10:5,163,258...5,199,930
Ensembl chr10:5,163,242...5,199,930
|
|
| G
|
Lmbrd2
|
LMBR1 domain containing 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of LMBRD2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 2:59,916,736...59,978,739
Ensembl chr 2:59,916,749...59,978,738
|
|
| G
|
Lmcd1
|
LIM and cysteine-rich domains 1
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of LMCD1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of LMCD1 mRNA
|
CTD |
PMID:25596134 PMID:33729688 |
|
NCBI chr 4:146,948,993...147,007,878
Ensembl chr 4:146,948,958...147,007,875
|
|
| G
|
Lmf2
|
lipase maturation factor 2
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of LMF2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:122,297,971...122,302,423
Ensembl chr 7:122,297,973...122,302,423
|
|
| G
|
Lmln
|
leishmanolysin like peptidase
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of LMLN mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr11:81,161,330...81,230,972
Ensembl chr11:81,161,330...81,229,447
|
|
| G
|
Lmnb1
|
lamin B1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of LMNB1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr18:52,373,939...52,413,284
Ensembl chr18:52,373,757...52,413,283
|
|
| G
|
Lmnb2
|
lamin B2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of LMNB2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 7:9,443,308...9,459,468
Ensembl chr 7:9,440,128...9,459,342
|
|
| G
|
Lmntd2
|
lamin tail domain containing 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of LMNTD2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:205,744,694...205,750,460
Ensembl chr 1:205,744,697...205,748,738
|
|
| G
|
Lmo2
|
LIM domain only 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LMO2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:110,810,162...110,832,895
Ensembl chr 3:110,809,912...110,833,075
|
|
| G
|
Lonrf2
|
LON peptidase N-terminal domain and ring finger 2
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of LONRF2 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of LONRF2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 9:48,524,962...48,566,353
Ensembl chr 9:48,530,549...48,570,807
|
|
| G
|
Lox
|
lysyl oxidase
|
multiple interactions increases expression increases activity
|
ISO
|
(+)-JQ1 compound inhibits the reaction [Oxygen deficiency results in increased expression of LOX mRNA]; deguelin inhibits the reaction [Oxygen deficiency results in increased expression of LOX mRNA]; diallyl trisulfide inhibits the reaction [Oxygen deficiency results in increased expression of LOX mRNA]; GSK1210151A inhibits the reaction [Oxygen deficiency results in increased expression of LOX mRNA]; molibresib inhibits the reaction [Oxygen deficiency results in increased expression of LOX mRNA] Oxygen deficiency results in increased expression of LOX mRNA; Oxygen deficiency results in increased expression of LOX protein Oxygen deficiency results in increased activity of LOX protein [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LOX mRNA
|
CTD |
PMID:18924134 PMID:22745725 PMID:24614111 PMID:25044713 PMID:26516004 PMID:27292261 PMID:28574600 PMID:30529165 More...
|
|
NCBI chr18:48,162,889...48,175,640
Ensembl chr18:48,165,688...48,239,810
|
|
| G
|
Loxl4
|
lysyl oxidase-like 4
|
multiple interactions increases expression
|
ISO
|
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Oxygen deficiency results in increased expression of LOXL4 mRNA]; diallyl trisulfide inhibits the reaction [Oxygen deficiency results in increased expression of LOXL4 mRNA]
|
CTD |
PMID:28574600 |
|
NCBI chr 1:251,345,445...251,365,640
Ensembl chr 1:251,347,238...251,365,577
|
|
| G
|
Lpar3
|
lysophosphatidic acid receptor 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LPAR3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:237,785,371...237,854,199
Ensembl chr 2:237,787,766...237,854,197
|
|
| G
|
Lpcat1
|
lysophosphatidylcholine acyltransferase 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LPCAT1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:31,594,621...31,644,946
Ensembl chr 1:31,594,622...31,644,946
|
|
| G
|
Lpcat2
|
lysophosphatidylcholine acyltransferase 2
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LPCAT2 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of LPCAT2 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr19:30,261,369...30,325,715
Ensembl chr19:30,262,676...30,325,775
|
|
| G
|
Lpl
|
lipoprotein lipase
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of LPL mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr16:25,596,205...25,621,928
Ensembl chr16:25,596,211...25,622,107
|
|
| G
|
Lrat
|
lecithin retinol acyltransferase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LRAT mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:170,562,148...170,571,212
Ensembl chr 2:170,565,543...170,571,148
|
|
| G
|
Lratd2
|
LRAT domain containing 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of LRATD2 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 7:94,270,753...94,276,445
Ensembl chr 7:94,073,513...94,277,046
|
|
| G
|
Lrch2
|
leucine rich repeats and calponin homology domain containing 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of LRCH2 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr X:115,903,760...115,986,569
Ensembl chr X:115,903,767...115,986,266
|
|
| G
|
Lrfn3
|
leucine rich repeat and fibronectin type III domain containing 3
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of LRFN3 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 1:94,744,315...94,751,001
Ensembl chr 1:94,744,321...94,751,178
|
|
| G
|
Lrg1
|
leucine-rich alpha-2-glycoprotein 1
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LRG1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of LRG1 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 9:1,034,691...1,036,937
Ensembl chr 9:1,034,679...1,037,337
|
|
| G
|
Lrig1
|
leucine-rich repeats and immunoglobulin-like domains 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of LRIG1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 4:128,687,723...128,788,219
Ensembl chr 4:128,687,723...128,788,219
|
|
| G
|
Lrp1
|
LDL receptor related protein 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of LRP1 mRNA [sulforaphane affects the susceptibility to Oxygen] which affects the expression of LRP1 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 7:65,265,639...65,346,196
Ensembl chr 7:65,265,639...65,346,196
|
|
| G
|
Lrp12
|
LDL receptor related protein 12
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LRP12 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:72,825,979...72,897,308
Ensembl chr 7:72,825,979...72,897,171
|
|
| G
|
Lrp4
|
LDL receptor related protein 4
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LRP4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:97,885,373...97,939,366
Ensembl chr 3:97,885,400...97,939,370
|
|
| G
|
Lrp6
|
LDL receptor related protein 6
|
multiple interactions increases expression
|
ISO
|
[Paclitaxel co-treated with FV-429 compound] inhibits the reaction [Oxygen deficiency results in increased expression of LRP6 protein]
|
CTD |
PMID:34648812 |
|
NCBI chr 4:168,997,937...169,131,716
Ensembl chr 4:169,000,968...169,131,716
|
|
| G
|
Lrp8
|
LDL receptor related protein 8
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of LRP8 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of LRP8 mRNA
|
CTD |
PMID:26516004 PMID:33729688 |
|
NCBI chr 5:127,792,236...127,864,207
Ensembl chr 5:127,792,299...127,864,207
|
|
| G
|
Lrpprc
|
leucine-rich pentatricopeptide repeat containing
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of LRPPRC mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 6:15,612,638...15,695,113
Ensembl chr 6:15,612,655...15,695,116
|
|
| G
|
Lrr1
|
leucine rich repeat protein 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of LRR1 mRNA
|
CTD |
PMID:24205000 PMID:26516004 |
|
NCBI chr 6:93,379,159...93,387,950
Ensembl chr 6:93,379,169...93,387,950
|
|
| G
|
Lrrc14b
|
leucine rich repeat containing 14B
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of LRRC14B mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:30,748,103...30,754,236
Ensembl chr 1:30,749,746...30,755,258
|
|
| G
|
Lrrc17
|
leucine rich repeat containing 17
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LRRC17 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:14,393,632...14,424,048
Ensembl chr 4:14,393,640...14,424,048
|
|
| G
|
Lrrc4
|
leucine rich repeat containing 4
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of LRRC4 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of LRRC4 mRNA
|
CTD |
PMID:26516004 PMID:33729688 |
|
NCBI chr 4:58,398,942...58,402,538
Ensembl chr 4:58,397,302...58,402,808
|
|
| G
|
Lrrc45
|
leucine rich repeat containing 45
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of LRRC45 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:106,492,846...106,500,751
Ensembl chr10:106,492,592...106,500,751
|
|
| G
|
Lrrc59
|
leucine rich repeat containing 59
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LRRC59 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:80,069,162...80,083,820
Ensembl chr10:80,069,120...80,084,079
|
|
| G
|
Lrrc8d
|
leucine rich repeat containing 8 VRAC subunit D
|
increases expression affects methylation
|
ISO
|
Oxygen deficiency results in increased expression of LRRC8D mRNA Oxygen deficiency affects the methylation of LRRC8D promoter
|
CTD |
PMID:24205000 |
|
NCBI chr14:4,335,114...4,411,549
Ensembl chr14:4,332,130...4,445,639
|
|
| G
|
Lrrk2
|
leucine-rich repeat kinase 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of LRRK2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 7:124,706,246...124,867,234
Ensembl chr 7:124,706,080...124,867,239
|
|
| G
|
Lrrn3
|
leucine rich repeat neuronal 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LRRN3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:64,216,164...64,247,293
Ensembl chr 6:64,215,878...64,247,614
|
|
| G
|
Lrtm2
|
leucine-rich repeats and transmembrane domains 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of LRTM2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 4:154,158,165...154,180,389
Ensembl chr 4:154,158,168...154,167,641
|
|
| G
|
Lsamp
|
limbic system-associated membrane protein
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of LSAMP mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of LSAMP mRNA
|
CTD |
PMID:24205000 PMID:33729688 |
|
NCBI chr11:72,053,285...74,223,019
Ensembl chr11:72,053,285...72,702,134
|
|
| G
|
Lsg1
|
large 60S subunit nuclear export GTPase 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LSG1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr11:83,648,757...83,673,431
Ensembl chr11:83,648,772...83,673,878
|
|
| G
|
Lsm4
|
LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LSM4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr16:18,789,466...18,795,164
Ensembl chr16:18,789,467...18,794,886
|
|
| G
|
Lsp1
|
lymphocyte-specific protein 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of LSP1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:207,044,157...207,077,891
Ensembl chr 1:207,044,159...207,077,893
|
|
| G
|
Lta4h
|
leukotriene A4 hydrolase
|
multiple interactions
|
ISO
|
Oxygen inhibits the reaction [LTA4H protein results in increased chemical synthesis of Leukotriene B4]; Oxygen inhibits the reaction [LTA4H protein results in increased hydrolysis of Leukotriene A4] [sulforaphane affects the susceptibility to Oxygen] which affects the expression of LTA4H mRNA
|
CTD |
PMID:2827578 PMID:30529165 |
|
NCBI chr 7:29,856,846...29,888,642
Ensembl chr 7:29,856,802...29,888,641
|
|
| G
|
Ltb
|
lymphotoxin beta
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LTB mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr20:3,632,209...3,634,054
Ensembl chr20:3,632,210...3,634,054
|
|
| G
|
Ltb4r
|
leukotriene B4 receptor
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LTB4R1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of LTB4R mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr15:33,233,120...33,235,636
Ensembl chr15:33,232,820...33,235,637
|
|
| G
|
Ltbp2
|
latent transforming growth factor beta binding protein 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of LTBP2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 6:110,161,029...110,261,586
Ensembl chr 6:110,161,029...110,257,298
|
|
| G
|
Ltbp3
|
latent transforming growth factor beta binding protein 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LTBP3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:212,458,362...212,475,302
Ensembl chr 1:212,459,185...212,475,302
|
|
| G
|
Ltbp4
|
latent transforming growth factor beta binding protein 4
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LTBP4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:91,727,769...91,759,822
Ensembl chr 1:91,727,769...91,760,006
|
|
| G
|
Ltbr
|
lymphotoxin beta receptor
|
multiple interactions increases expression
|
ISO
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of LTBR mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of LTBR mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of LTBR mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of LTBR mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of LTBR mRNA]
|
CTD |
PMID:23452621 |
|
NCBI chr 4:159,795,115...159,801,571
Ensembl chr 4:159,795,115...159,807,296
|
|
| G
|
Ltn1
|
listerin E3 ubiquitin protein ligase 1
|
affects expression
|
ISO
|
Oxygen deficiency affects the expression of LTN1 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr11:40,090,169...40,147,159
Ensembl chr11:40,090,169...40,147,303
|
|
| G
|
Ltv1
|
LTV1 ribosome biogenesis factor
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LTV1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:9,385,834...9,398,557
Ensembl chr 1:9,385,830...9,398,677
|
|
| G
|
Luc7l2
|
LUC7 pre-mRNA splicing factor like 2
|
multiple interactions increases expression
|
ISO
|
Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of LUC7L2 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 4:68,251,435...68,314,861
Ensembl chr 4:68,271,414...68,314,837
|
|
| G
|
Lum
|
lumican
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of LUM mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 7:34,245,323...34,252,510
Ensembl chr 7:34,245,360...34,252,508
|
|
| G
|
Lxn
|
latexin
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LXN mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:154,037,604...154,043,473
Ensembl chr 2:154,037,292...154,043,488
|
|
| G
|
Ly6a
|
lymphocyte antigen 6 family member A
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of LY6A mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr 7:109,064,222...109,067,757
|
|
| G
|
Ly6c
|
Ly6-C antigen
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of LY6C mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of LY6C mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 7:108,840,263...108,844,082
Ensembl chr 7:108,840,263...108,878,007
|
|
| G
|
Ly6e
|
lymphocyte antigen 6 family member E
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of LY6E mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of LY6E mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 7:108,815,970...108,820,444
Ensembl chr 7:108,816,887...108,820,443
|
|
| G
|
Ly86
|
lymphocyte antigen 86
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LY86 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr17:27,621,313...27,705,336
Ensembl chr17:27,621,313...27,692,743
|
|
| G
|
Ly96
|
lymphocyte antigen 96
|
multiple interactions
|
ISO
|
LY96 results in increased susceptibility to [Oxygen deficiency co-treated with Blood Glucose deficiency]
|
CTD |
PMID:28063877 |
|
NCBI chr 5:7,365,536...7,397,864
Ensembl chr 5:7,365,557...7,395,816
|
|
| G
|
Lyar
|
Ly1 antibody reactive
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of LYAR mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LYAR mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr14:76,789,193...76,802,973
Ensembl chr14:76,789,200...76,802,765
|
|
| G
|
Lypd2
|
Ly6/Plaur domain containing 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LYPD2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:108,506,545...108,508,582
Ensembl chr 7:108,506,545...108,508,582
|
|
| G
|
Lyve1
|
lymphatic vessel endothelial hyaluronan receptor 1
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of LYVE1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LYVE1 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 1:174,393,387...174,410,977
|
|
| G
|
Lyz2
|
lysozyme 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of LYZ2 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 7:54,792,715...54,798,060
Ensembl chr 7:54,792,716...54,798,011
|
|
| G
|
Lzic
|
leucine zipper and CTNNBIP1 domain containing
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LZIC mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:165,211,359...165,224,569
Ensembl chr 5:165,211,302...165,224,568
|
|
| G
|
Mab21l3
|
mab-21 like 3
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MAB21L3 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 2:191,937,451...191,960,204
Ensembl chr 2:191,937,451...191,960,204
|
|
| G
|
Macc1
|
MET transcriptional regulator MACC1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MACC1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 6:146,495,544...146,574,254
Ensembl chr 6:146,495,861...146,574,260
|
|
| G
|
Macf1
|
microtubule-actin crosslinking factor 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MACF1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:140,908,829...141,234,127
Ensembl chr 5:140,908,837...141,233,890
|
|
| G
|
Mad2l1
|
mitotic arrest deficient 2 like 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MAD2L1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 4:97,236,419...97,247,603
Ensembl chr 4:97,236,503...97,243,222
|
|
| G
|
Mad2l2
|
mitotic arrest deficient 2 like 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAD2L2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:163,846,678...163,859,851
Ensembl chr 5:163,846,687...163,859,851
|
|
| G
|
Maf1
|
MAF1 homolog, negative regulator of RNA polymerase III
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MAF1 protein
|
CTD |
PMID:31645432 |
|
NCBI chr 7:109,955,876...109,958,909
Ensembl chr 7:109,955,282...109,958,910
|
|
| G
|
Mafb
|
MAF bZIP transcription factor B
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAFB mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:169,417,890...169,419,810
Ensembl chr 3:169,416,945...169,419,975
|
|
| G
|
Maff
|
MAF bZIP transcription factor F
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAFF mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MAFF mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:112,791,416...112,804,147
|
|
| G
|
Mafg
|
MAF bZIP transcription factor G
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of MAFG mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr10:106,401,633...106,410,159
|
|
| G
|
Mafk
|
MAF bZIP transcription factor K
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAFK mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr12:19,948,473...19,970,351
Ensembl chr12:19,948,476...19,959,192
|
|
| G
|
Mag
|
myelin-associated glycoprotein
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of MAG mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 1:95,275,728...95,291,133
Ensembl chr 1:95,275,635...95,291,060
|
|
| G
|
Magi1
|
membrane associated guanylate kinase, WW and PDZ domain containing 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of MAGI1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 4:127,762,590...128,368,228
Ensembl chr 4:127,762,590...128,367,833
|
|
| G
|
Mak16
|
MAK16 homolog
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAK16 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr16:67,675,757...67,684,188
Ensembl chr16:67,675,735...67,684,836
|
|
| G
|
Mal2
|
mal, T-cell differentiation protein 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAL2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:87,790,239...87,823,219
Ensembl chr 7:87,790,239...87,850,403
|
|
| G
|
Mall
|
mal, T-cell differentiation protein-like
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of MALL mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MALL mRNA
|
CTD |
PMID:26516004 PMID:33729688 |
|
NCBI chr 3:135,381,180...135,404,136
Ensembl chr 3:135,377,410...135,404,066
|
|
| G
|
Mamdc2
|
MAM domain containing 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAMDC2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:230,290,482...230,443,014
Ensembl chr 1:230,290,499...230,442,711
|
|
| G
|
Man1a2
|
mannosidase, alpha, class 1A, member 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MAN1A2 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 2:190,636,134...190,784,975
Ensembl chr 2:190,615,094...190,784,975
|
|
| G
|
Manf
|
mesencephalic astrocyte-derived neurotrophic factor
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of MANF mRNA Oxygen inhibits the reaction [Oxygen deficiency results in decreased expression of MANF mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 8:116,427,053...116,430,259
Ensembl chr 8:116,427,048...116,429,910
|
|
| G
|
Maoa
|
monoamine oxidase A
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MAOA mRNA
|
CTD |
PMID:19695866 |
|
NCBI chr X:8,615,239...8,681,372
Ensembl chr X:8,615,239...8,682,631
|
|
| G
|
Maob
|
monoamine oxidase B
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAOB mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr X:8,490,405...8,594,065
Ensembl chr X:8,490,344...8,594,375
|
|
| G
|
Map1lc3b
|
microtubule-associated protein 1 light chain 3 beta
|
multiple interactions increases expression decreases expression decreases lipidation
|
ISO
|
[Chloroquine co-treated with Oxygen deficiency] results in increased lipidation of MAP1LC3B protein; [Raloxifene Hydrochloride co-treated with Oxygen deficiency] results in increased lipidation of MAP1LC3B protein; Oxygen deficiency inhibits the reaction [Deoxyglucose results in increased prenylation of MAP1LC3B protein] Oxygen deficiency results in increased expression of MAP1LC3B mRNA [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of MAP1LC3B protein; Octreotide inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of MAP1LC3B protein]; SIRT1 promotes the reaction [SNHG12 mRNA promotes the reaction [Octreotide inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of MAP1LC3B protein]]]; SNHG12 mRNA promotes the reaction [Octreotide inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of MAP1LC3B protein]]; YAP1 promotes the reaction [SNHG12 mRNA promotes the reaction [Octreotide inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of MAP1LC3B protein]]] Oxygen deficiency results in decreased expression of MAP1LC3B mRNA Oxygen deficiency results in decreased lipidation of MAP1LC3B protein
|
CTD |
PMID:20593179 PMID:23624791 PMID:33203845 PMID:35307376 PMID:38909692 |
|
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358 Ensembl chr16:66,574,407...66,584,358
|
|
| G
|
Map2k1
|
mitogen activated protein kinase kinase 1
|
increases response to substance multiple interactions
|
EXP ISO
|
MAP2K1 protein results in increased susceptibility to Oxygen [Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of MAP2K1 mRNA; [Oxygen co-treated with Ozone] inhibits the reaction [Cannabidiol results in decreased expression of MAP2K1 mRNA]; [Oxygen co-treated with Ozone] results in decreased expression of MAP2K1 mRNA; Cannabidiol inhibits the reaction [[Oxygen co-treated with Ozone] results in decreased expression of MAP2K1 mRNA]
|
CTD |
PMID:10780954 PMID:32992648 |
|
NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:73,578,752...73,650,184
|
|
| G
|
Map2k2
|
mitogen activated protein kinase kinase 2
|
multiple interactions
|
ISO
|
[Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of MAP2K2 mRNA; [Oxygen co-treated with Ozone] inhibits the reaction [Cannabidiol results in increased expression of MAP2K2 mRNA]; [Oxygen co-treated with Ozone] results in decreased expression of MAP2K2 mRNA; Cannabidiol inhibits the reaction [[Oxygen co-treated with Ozone] results in decreased expression of MAP2K2 mRNA]
|
CTD |
PMID:32992648 |
|
NCBI chr 7:9,241,449...9,264,216
Ensembl chr 7:9,241,310...9,260,940
|
|
| G
|
Map3k1
|
mitogen-activated protein kinase kinase kinase 1
|
multiple interactions increases expression
|
ISO
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of MAP3K1 mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of MAP3K1 mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of MAP3K1 mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of MAP3K1 mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of MAP3K1 mRNA]
|
CTD |
PMID:23452621 |
|
NCBI chr 2:45,081,889...45,150,555
Ensembl chr 2:45,081,889...45,149,897
|
|
| G
|
Map3k2
|
mitogen activated protein kinase kinase kinase 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAP3K2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr18:24,081,444...24,153,940
Ensembl chr18:24,081,444...24,147,323
|
|
| G
|
Map3k6
|
mitogen-activated protein kinase kinase kinase 6
|
multiple interactions
|
ISO EXP
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of MAP3K6 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MAP3K6 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 5:150,724,029...150,736,113
Ensembl chr 5:150,724,216...150,736,111
|
|
| G
|
Map3k8
|
mitogen-activated protein kinase kinase kinase 8
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of MAP3K8 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr17:58,078,175...58,098,455
Ensembl chr17:58,078,320...58,098,452
|
|
| G
|
Map3k9
|
mitogen-activated protein kinase kinase kinase 9
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MAP3K9 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 6:107,155,008...107,220,304
Ensembl chr 6:107,161,534...107,220,061
|
|
| G
|
Map4k2
|
mitogen activated protein kinase kinase kinase kinase 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAP4K2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:213,074,360...213,090,042
Ensembl chr 1:213,074,377...213,096,987
|
|
| G
|
Map4k5
|
mitogen-activated protein kinase kinase kinase kinase 5
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of MAP4K5 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of MAP4K5 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 6:94,020,079...94,112,943
Ensembl chr 6:94,020,079...94,112,943
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions increases phosphorylation affects phosphorylation decreases phosphorylation
|
ISO EXP
|
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [euscaphic acid promotes the reaction [Oxygen deficiency results in increased phosphorylation of MAPK1 protein]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MAPK1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [tormentic acid promotes the reaction [Oxygen deficiency results in increased phosphorylation of MAPK1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [euscaphic acid promotes the reaction [Oxygen deficiency results in increased phosphorylation of MAPK1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MAPK1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [tormentic acid promotes the reaction [Oxygen deficiency results in increased phosphorylation of MAPK1 protein]]; [betulin co-treated with Oxygen deficiency] results in increased phosphorylation of MAPK1 protein; [Betulinic Acid co-treated with Oxygen deficiency] results in increased phosphorylation of MAPK1 protein; [Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of MAPK1 mRNA; [Oxygen co-treated with Ozone] results in decreased expression of MAPK1 mRNA; [Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in increased phosphorylation of MAPK1 protein; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in increased phosphorylation of MAPK1 protein]; dictamnine inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MAPK1 protein]; euscaphic acid promotes the reaction [Oxygen deficiency results in increased phosphorylation of MAPK1 protein]; Folic Acid inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MAPK1 protein]; genipin inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MAPK1 protein]; tormentic acid promotes the reaction [Oxygen deficiency results in increased phosphorylation of MAPK1 protein]; TXN protein promotes the reaction [Oxygen results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MAPK1 protein] Oxygen deficiency results in increased phosphorylation of MAPK1 protein; Oxygen results in increased phosphorylation of MAPK1 protein Oxygen deficiency affects the phosphorylation of MAPK1 protein [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased susceptibility to SB 239063] which results in increased phosphorylation of MAPK1 protein; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased phosphorylation of MAPK1 protein; [Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of MAPK1 protein; [Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of MAPK1 mRNA; [Oxygen deficiency co-treated with Carbon Dioxide] results in increased phosphorylation of MAPK1 protein; bisphenol A diglycidyl ether inhibits the reaction [Ursolic Acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased phosphorylation of MAPK1 protein]]; epigallocatechin gallate inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MAPK1 protein]; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of MAPK1 protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of MAPK1 protein]; MFN2 protein promotes the reaction [epigallocatechin gallate inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MAPK1 protein]]; notoginsenoside R1 inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of MAPK1 mRNA]; notoginsenoside R1 inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased phosphorylation of MAPK1 protein]; Ursolic Acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased phosphorylation of MAPK1 protein] [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased phosphorylation of MAPK1 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of MAPK1 protein; epigallocatechin gallate inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased phosphorylation of MAPK1 protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of MAPK1 protein]; SOD1 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of MAPK1 protein] Oxygen deficiency results in decreased phosphorylation of MAPK1 protein
|
CTD |
PMID:19228841 PMID:19303870 PMID:19578757 PMID:20812253 PMID:23728938 PMID:24682241 PMID:24718106 PMID:25004876 PMID:25448280 PMID:26116440 PMID:26906511 PMID:27274199 PMID:28478070 PMID:29139225 PMID:29630948 PMID:30266538 PMID:32298737 PMID:32992648 PMID:33181113 PMID:34740634 More...
|
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk10
|
mitogen activated protein kinase 10
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAPK10 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:6,802,247...7,094,103
Ensembl chr14:6,802,295...7,094,100
|
|
| G
|
Mapk11
|
mitogen-activated protein kinase 11
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Oxygen] inhibits the reaction [MAPK11 protein binds to SOD2 protein]; [Oxygen deficiency co-treated with Oxygen] results in decreased activity of MAPK11 protein; Estradiol inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] inhibits the reaction [MAPK11 protein binds to SOD2 protein]]; Estradiol inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased activity of MAPK11 protein]
|
CTD |
PMID:24465521 |
|
NCBI chr 7:122,098,120...122,105,023
Ensembl chr 7:122,098,121...122,105,038
|
|
| G
|
Mapk13
|
mitogen activated protein kinase 13
|
increases expression
|
EXP ISO
|
Oxygen results in increased expression of MAPK13 mRNA Oxygen deficiency results in increased expression of MAPK13 mRNA
|
CTD |
PMID:22911455 PMID:26516004 |
|
NCBI chr20:6,836,979...6,847,197
Ensembl chr20:6,837,013...6,847,191
|
|
| G
|
Mapk14
|
mitogen activated protein kinase 14
|
increases phosphorylation multiple interactions
|
ISO
|
Oxygen deficiency results in increased phosphorylation of MAPK14 protein dictamnine inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MAPK14 protein]
|
CTD |
PMID:30266538 |
|
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions increases phosphorylation affects phosphorylation decreases phosphorylation
|
ISO EXP
|
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [euscaphic acid promotes the reaction [Oxygen deficiency results in increased phosphorylation of MAPK3 protein]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MAPK3 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [tormentic acid promotes the reaction [Oxygen deficiency results in increased phosphorylation of MAPK3 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [euscaphic acid promotes the reaction [Oxygen deficiency results in increased phosphorylation of MAPK3 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MAPK3 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [tormentic acid promotes the reaction [Oxygen deficiency results in increased phosphorylation of MAPK3 protein]]; [betulin co-treated with Oxygen deficiency] results in increased phosphorylation of MAPK3 protein; [Betulinic Acid co-treated with Oxygen deficiency] results in increased phosphorylation of MAPK3 protein; [Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in increased phosphorylation of MAPK3 protein; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in increased phosphorylation of MAPK3 protein]; dictamnine inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MAPK3 protein]; euscaphic acid promotes the reaction [Oxygen deficiency results in increased phosphorylation of MAPK3 protein]; Folic Acid inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MAPK3 protein]; genipin inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MAPK3 protein]; tormentic acid promotes the reaction [Oxygen deficiency results in increased phosphorylation of MAPK3 protein]; TXN protein promotes the reaction [Oxygen results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MAPK3 protein] Oxygen deficiency results in increased phosphorylation of MAPK3 protein; Oxygen results in increased phosphorylation of MAPK3 protein Oxygen deficiency affects the phosphorylation of MAPK3 protein [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased susceptibility to SB 239063] which results in increased phosphorylation of MAPK3 protein; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased phosphorylation of MAPK3 protein; [Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of MAPK3 protein; [Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of MAPK3 mRNA; [Oxygen deficiency co-treated with Carbon Dioxide] results in increased phosphorylation of MAPK3 protein; bisphenol A diglycidyl ether inhibits the reaction [Ursolic Acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased phosphorylation of MAPK3 protein]]; epigallocatechin gallate inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MAPK3 protein]; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of MAPK3 protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of MAPK3 protein]; MFN2 protein promotes the reaction [epigallocatechin gallate inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MAPK3 protein]]; notoginsenoside R1 inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of MAPK3 mRNA]; notoginsenoside R1 inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased phosphorylation of MAPK3 protein]; Ursolic Acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased phosphorylation of MAPK3 protein] [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased phosphorylation of MAPK3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of MAPK3 protein; epigallocatechin gallate inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased phosphorylation of MAPK3 protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of MAPK3 protein]; SOD1 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of MAPK3 protein] Oxygen deficiency results in decreased phosphorylation of MAPK3 protein
|
CTD |
PMID:19228841 PMID:19303870 PMID:19578757 PMID:20812253 PMID:23728938 PMID:24682241 PMID:24718106 PMID:25004876 PMID:25448280 PMID:26116440 PMID:26906511 PMID:27274199 PMID:28478070 PMID:29139225 PMID:29630948 PMID:30266538 PMID:32298737 PMID:33181113 PMID:34740634 More...
|
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Mapk8
|
mitogen-activated protein kinase 8
|
multiple interactions increases phosphorylation increases activity
|
ISO EXP
|
dictamnine inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MAPK8 protein]; MAPK8 protein affects the reaction [Oxygen deficiency results in increased expression of BACE1 protein]; Oxygen deficiency promotes the reaction [HBEGF protein mutant form results in increased phosphorylation of MAPK8 protein]; SB 203580 inhibits the reaction [Oxygen deficiency results in increased activity of MAPK8 protein]; SLC2A1 protein inhibits the reaction [Oxygen deficiency results in increased activity of MAPK8 protein]; TXN protein promotes the reaction [Oxygen results in increased phosphorylation of MAPK8 protein] [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased phosphorylation of MAPK8 protein; bisphenol A diglycidyl ether inhibits the reaction [Ursolic Acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased phosphorylation of MAPK8 protein]]; Tacrolimus inhibits the reaction [Oxygen deficiency results in increased activity of MAPK8 protein]; Ursolic Acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased phosphorylation of MAPK8 protein]
|
CTD |
PMID:10780954 PMID:12892836 PMID:13679210 PMID:19193634 PMID:19196431 PMID:20812253 PMID:27274199 PMID:30266538 More...
|
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
| G
|
Mapk9
|
mitogen-activated protein kinase 9
|
multiple interactions increases phosphorylation
|
ISO EXP
|
MAPK9 protein affects the reaction [Oxygen deficiency results in increased expression of BACE1 protein]; TXN protein promotes the reaction [Oxygen results in increased phosphorylation of MAPK9 protein] Oxygen deficiency results in increased phosphorylation of MAPK9 protein [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased phosphorylation of MAPK9 protein; bisphenol A diglycidyl ether inhibits the reaction [Ursolic Acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased phosphorylation of MAPK9 protein]]; Ursolic Acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased phosphorylation of MAPK9 protein]
|
CTD |
PMID:19196431 PMID:20812253 PMID:27274199 |
|
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228
|
|
| G
|
Mapkapk2
|
MAPK activated protein kinase 2
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of MAPKAPK2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr13:45,066,027...45,112,326
Ensembl chr13:45,066,031...45,112,326
|
|
| G
|
Mapre2
|
microtubule-associated protein, RP/EB family, member 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAPRE2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr18:15,303,502...15,444,306
Ensembl chr18:15,303,533...15,442,796
|
|
| G
|
Mapt
|
microtubule-associated protein tau
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAPT mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108
|
|
| G
|
Marchf5
|
membrane associated ring-CH-type finger 5
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of MARCHF5 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of MARCHF5 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 1:244,343,674...244,365,160
Ensembl chr 1:244,343,630...244,366,462
|
|
| G
|
Marcksl1
|
MARCKS-like 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MARCKSL1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:147,135,827...147,138,150
Ensembl chr 5:147,134,514...147,138,417
|
|
| G
|
Marf1
|
meiosis regulator and mRNA stability factor 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MARF1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:1,395,271...1,439,974
Ensembl chr10:1,395,282...1,439,974
|
|
| G
|
Mars2
|
methionyl-tRNA synthetase 2, mitochondrial
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MARS2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 9:64,214,935...64,228,408
Ensembl chr 9:64,215,128...64,338,443
|
|
| G
|
Masp2
|
MBL associated serine protease 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MASP2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 5:164,319,017...164,332,686
Ensembl chr 5:164,308,991...164,332,705
|
|
| G
|
Matk
|
megakaryocyte-associated tyrosine kinase
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of MATK mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MATK mRNA
|
CTD |
PMID:24205000 PMID:33729688 |
|
NCBI chr 7:9,107,711...9,116,864
Ensembl chr 7:9,107,722...9,112,746
|
|
| G
|
Matn4
|
matrilin 4
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MATN4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:173,539,966...173,554,984
Ensembl chr 3:173,539,966...173,554,984
|
|
| G
|
Mavs
|
mitochondrial antiviral signaling protein
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MAVS mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 3:138,904,673...138,919,129
Ensembl chr 3:138,904,771...138,919,126
|
|
| G
|
Mb
|
myoglobin
|
affects transport multiple interactions
|
ISO
|
MB protein affects the transport of Oxygen [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MB mRNA
|
CTD |
PMID:10468637 PMID:30529165 |
|
NCBI chr 7:110,640,511...110,647,742
Ensembl chr 7:110,640,512...110,647,958
|
|
| G
|
Mbd1
|
methyl-CpG binding domain protein 1
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of MBD1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MBD1 mRNA
|
CTD |
PMID:20880076 PMID:30529165 |
|
NCBI chr18:70,145,093...70,159,744
Ensembl chr18:70,145,114...70,159,703
|
|
| G
|
Mbl2
|
mannose binding lectin 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of MBL2 mRNA
|
CTD |
PMID:35883890 |
|
NCBI chr 1:237,429,873...237,465,567
Ensembl chr 1:237,429,973...237,437,546
|
|
| G
|
Mblac2
|
metallo-beta-lactamase domain containing 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MBLAC2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:13,721,752...13,764,558
Ensembl chr 2:13,721,360...13,766,626
|
|
| G
|
Mbnl2
|
muscleblind-like splicing regulator 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of MBNL2 mRNA
|
CTD |
PMID:20042640 |
|
NCBI chr15:103,792,134...103,949,827
Ensembl chr15:103,792,152...103,949,827
|
|
| G
|
Mboat2
|
membrane bound O-acyltransferase domain containing 2
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of MBOAT2 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MBOAT2 mRNA
|
CTD |
PMID:20880076 PMID:30529165 |
|
NCBI chr 6:47,199,751...47,326,215
Ensembl chr 6:47,199,774...47,326,208
|
|
| G
|
Mbp
|
myelin basic protein
|
increases expression affects methylation decreases expression
|
ISO EXP
|
Oxygen deficiency results in increased expression of MBP mRNA; Oxygen deficiency results in increased expression of MBP protein Oxygen deficiency affects the methylation of MBP promoter Oxygen results in decreased expression of MBP protein
|
CTD |
PMID:24205000 PMID:25937538 PMID:35212449 |
|
NCBI chr18:78,130,652...78,241,174
Ensembl chr18:78,130,325...78,241,174
|
|
| G
|
Mcam
|
melanoma cell adhesion molecule
|
affects expression
|
ISO
|
Oxygen deficiency affects the expression of MCAM mRNA
|
CTD |
PMID:17193925 |
|
NCBI chr 8:53,376,225...53,384,407
Ensembl chr 8:53,376,197...53,384,406
|
|
| G
|
Mcee
|
methylmalonyl CoA epimerase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MCEE mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:127,376,311...127,399,551
Ensembl chr 1:127,376,298...127,400,367
|
|
| G
|
Mcemp1
|
mast cell-expressed membrane protein 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MCEMP1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr12:6,519,709...6,523,880
Ensembl chr12:6,517,854...6,523,880
|
|
| G
|
Mchr1
|
melanin-concentrating hormone receptor 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of MCHR1 mRNA
|
CTD |
PMID:17175027 PMID:26516004 |
|
NCBI chr 7:114,641,721...114,644,913
Ensembl chr 7:114,641,580...114,644,919
|
|
| G
|
Mcm10
|
minichromosome maintenance 10 replication initiation factor
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MCM10 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr17:78,172,049...78,197,644
Ensembl chr17:78,175,398...78,197,636
|
|
| G
|
Mcm2
|
minichromosome maintenance complex component 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MCM2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 4:122,903,679...122,918,205
Ensembl chr 4:122,903,682...122,918,094
|
|
| G
|
Mcm3
|
minichromosome maintenance complex component 3
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MCM3 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 9:30,715,602...30,733,746
Ensembl chr 9:30,715,602...30,733,746
|
|
| G
|
Mcm4
|
minichromosome maintenance complex component 4
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MCM4 mRNA
|
CTD |
PMID:17175027 PMID:26516004 |
|
NCBI chr11:98,762,599...98,776,300
Ensembl chr11:98,762,634...98,776,536
|
|
| G
|
Mcm5
|
minichromosome maintenance complex component 5
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MCM5 mRNA
|
CTD |
PMID:17175027 PMID:26516004 |
|
NCBI chr19:13,488,813...13,510,131
Ensembl chr19:13,488,813...13,517,758
|
|
| G
|
Mcm6
|
minichromosome maintenance complex component 6
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MCM6 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr13:42,379,161...42,404,352
Ensembl chr13:42,379,162...42,465,467
|
|
| G
|
Mcm8
|
minichromosome maintenance 8 homologous recombination repair factor
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MCM8 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 3:140,539,590...140,569,891
Ensembl chr 3:140,539,647...140,569,891
|
|
| G
|
Mcoln2
|
mucolipin TRP cation channel 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MCOLN2 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 2:237,714,100...237,762,979
Ensembl chr 2:237,714,084...237,762,978
|
|
| G
|
Mctp2
|
multiple C2 and transmembrane domain containing 2
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MCTP2 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MCTP2 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 1:135,179,845...135,412,798
Ensembl chr 1:135,179,845...135,412,694
|
|
| G
|
Mcub
|
mitochondrial calcium uniporter dominant negative subunit beta
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MCUB mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:221,153,525...221,223,814
Ensembl chr 2:221,153,525...221,223,814
|
|
| G
|
Mdfi
|
MyoD family inhibitor
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MDFI mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 9:20,654,359...20,672,768
Ensembl chr 9:20,654,417...20,672,767
|
|
| G
|
Mdh1
|
malate dehydrogenase 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MDH1 protein
|
CTD |
PMID:25937538 |
|
NCBI chr14:99,831,934...99,847,227
Ensembl chr14:99,831,615...99,847,232
|
|
| G
|
Mdk
|
midkine
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of MDK mRNA
|
CTD |
PMID:17914565 |
|
NCBI chr 3:98,356,789...98,358,960
Ensembl chr 3:98,356,789...98,358,743
|
|
| G
|
Mdm2
|
MDM2 proto-oncogene
|
multiple interactions increases expression
|
ISO
|
[Cisplatin co-treated with eprenetapopt co-treated with Oxygen deficiency] results in increased expression of MDM2 mRNA; [Oxygen deficiency co-treated with eprenetapopt] results in increased expression of MDM2 mRNA; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [Oxygen deficiency results in increased expression of MDM2 mRNA]]; Tetrachlorodibenzodioxin promotes the reaction [Oxygen deficiency results in increased expression of MDM2 mRNA]; Tetrachlorodibenzodioxin promotes the reaction [Oxygen deficiency results in increased expression of MDM2 protein] Oxygen deficiency results in increased expression of MDM2 mRNA; Oxygen deficiency results in increased expression of MDM2 protein [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MDM2 mRNA
|
CTD |
PMID:19502547 PMID:19578757 PMID:19714248 PMID:25596134 PMID:29690507 PMID:30529165 More...
|
|
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791
|
|
| G
|
Me1
|
malic enzyme 1
|
affects expression
|
ISO
|
Oxygen deficiency affects the expression of ME1 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:96,429,057...96,540,275
|
|
| G
|
Mecr
|
mitochondrial trans-2-enoyl-CoA reductase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MECR mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:149,313,765...149,339,964
Ensembl chr 5:149,313,774...149,342,825
|
|
| G
|
Med1
|
mediator complex subunit 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MED1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr10:83,641,851...83,685,560
Ensembl chr10:83,641,862...83,685,545
|
|
| G
|
Med17
|
mediator complex subunit 17
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MED17 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 8:20,382,995...20,401,993
Ensembl chr 8:20,382,995...20,401,993
|
|
| G
|
Medag
|
mesenteric estrogen-dependent adipogenesis
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MEDAG mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr12:10,649,526...10,670,913
Ensembl chr12:10,649,526...10,692,756
|
|
| G
|
Mef2a
|
myocyte enhancer factor 2a
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of MEF2A mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:130,258,083...130,392,819
Ensembl chr 1:130,260,339...130,392,162
|
|
| G
|
Mef2c
|
myocyte enhancer factor 2C
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MEF2C mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:15,708,732...15,871,639
Ensembl chr 2:15,708,924...15,871,640
|
|
| G
|
Megf9
|
multiple EGF-like-domains 9
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MEGF9 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:89,008,679...89,120,731
Ensembl chr 5:89,008,679...89,120,731
|
|
| G
|
Melk
|
maternal embryonic leucine zipper kinase
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MELK mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 5:63,336,151...63,396,254
Ensembl chr 5:63,336,106...63,396,247
|
|
| G
|
Meox2
|
mesenchyme homeobox 2
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of MEOX2 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MEOX2 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 6:59,584,025...59,644,722
Ensembl chr 6:59,583,785...59,644,700
|
|
| G
|
Met
|
MET proto-oncogene, receptor tyrosine kinase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MET mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:46,756,506...46,870,821
|
|
| G
|
Metap2
|
methionyl aminopeptidase 2
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of METAP2 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of METAP2 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 7:30,299,433...30,327,477
Ensembl chr 7:30,299,433...30,327,521
|
|
| G
|
Metrnl
|
meteorin-like, glial cell differentiation regulator
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of METRNL mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:107,462,148...107,476,143
Ensembl chr10:107,462,109...107,476,135
|
|
| G
|
Mettl1
|
methyltransferase 1, tRNA methylguanosine
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of METTL1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of METTL1 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 7:64,750,189...64,754,531
Ensembl chr 7:64,750,198...64,754,639
|
|
| G
|
Mettl22
|
methyltransferase 22, Kin17 lysine
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of METTL22 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:7,620,279...7,637,334
Ensembl chr10:7,620,279...7,638,222
|
|
| G
|
Mettl24
|
methyltransferase like 24
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of METTL24 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr20:45,724,506...45,847,300
Ensembl chr20:45,724,982...45,843,959
|
|
| G
|
Mettl8
|
methyltransferase 8, tRNA N3-cytidine
|
affects methylation increases expression
|
ISO
|
Oxygen deficiency affects the methylation of METTL8 promoter Oxygen deficiency results in increased expression of METTL8 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 3:76,140,465...76,271,367
Ensembl chr 3:76,144,178...76,271,400
|
|
| G
|
Mex3b
|
mex-3 RNA binding family member B
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MEX3B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:146,264,319...146,268,554
Ensembl chr 1:146,264,318...146,268,543
|
|
| G
|
Mfap3
|
microfibril associated protein 3
|
multiple interactions
|
EXP
|
MFAP3 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
|
CTD |
PMID:21124846 |
|
NCBI chr10:42,197,292...42,213,011
Ensembl chr10:42,197,275...42,210,988
|
|
| G
|
Mfap3l
|
microfibril associated protein 3 like
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MFAP3L mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr16:34,422,490...34,465,544
Ensembl chr16:34,426,696...34,441,709
|
|
| G
|
Mfap4
|
microfibril associated protein 4
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MFAP4 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr10:46,666,552...46,669,613
Ensembl chr10:46,655,722...46,669,740
|
|
| G
|
Mff
|
mitochondrial fission factor
|
multiple interactions
|
ISO EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MFF protein [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased susceptibility to 6-(5-((cyclopropylamino)carbonyl)-3-fluoro-2-methylphenyl)-N-(2,2-dimethylprpyl)-3-pyridinecarboxamide] which results in decreased expression of MFF protein; [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased susceptibility to SB 239063] which results in decreased expression of MFF protein
|
CTD |
PMID:23867156 PMID:26116440 |
|
NCBI chr 9:91,455,931...91,484,171
Ensembl chr 9:91,455,871...91,484,171
|
|
| G
|
Mfn1
|
mitofusin 1
|
decreases expression
|
EXP
|
Oxygen deficiency results in decreased expression of MFN1 protein
|
CTD |
PMID:27684054 |
|
NCBI chr 2:117,240,525...117,288,017
Ensembl chr 2:117,241,759...117,290,190
|
|
| G
|
Mfn2
|
mitofusin 2
|
multiple interactions decreases expression
|
ISO EXP
|
[Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of MFN2 protein; genipin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of MFN2 protein] Oxygen deficiency results in decreased expression of MFN2 mRNA; Oxygen deficiency results in decreased expression of MFN2 protein [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of MFN2 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of MFN2 protein; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MFN2 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MFN2 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of MFN2 protein; [Oxygen deficiency co-treated with Oxygen] results in decreased expression of MFN2 protein; Atorvastatin inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of MFN2 protein]; breviscapine inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MFN2 mRNA]; breviscapine inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MFN2 protein]; dorsomorphin inhibits the reaction [sappanone A inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of MFN2 protein]]; epigallocatechin gallate inhibits the reaction [Oxygen deficiency results in decreased expression of MFN2 mRNA]; epigallocatechin gallate inhibits the reaction [Oxygen deficiency results in decreased expression of MFN2 protein]; ginsenoside Rg1 inhibits the reaction [Oxygen deficiency results in decreased expression of MFN2 mRNA]; ginsenoside Rg1 inhibits the reaction [Oxygen deficiency results in decreased expression of MFN2 protein]; KLF4 protein promotes the reaction [epigallocatechin gallate inhibits the reaction [Oxygen deficiency results in decreased expression of MFN2 mRNA]]; KLF4 protein promotes the reaction [epigallocatechin gallate inhibits the reaction [Oxygen deficiency results in decreased expression of MFN2 protein]]; MFN2 protein inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased chemical synthesis of Adenosine Triphosphate]; MFN2 protein inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased chemical synthesis of Reactive Oxygen Species]; MFN2 protein promotes the reaction [epigallocatechin gallate inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MAPK1 protein]]; MFN2 protein promotes the reaction [epigallocatechin gallate inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MAPK3 protein]]; Oxygen deficiency inhibits the reaction [Glucose results in increased expression of MFN2 protein]; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of MFN2 protein]; Rosiglitazone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of MFN2 mRNA]; Rosiglitazone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of MFN2 protein]; sappanone A inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of MFN2 protein]; Sevoflurane inhibits the reaction [Oxygen deficiency inhibits the reaction [Glucose results in increased expression of MFN2 protein]]; Sevoflurane inhibits the reaction [Oxygen deficiency results in decreased expression of MFN2 protein]
|
CTD |
PMID:24721408 PMID:24898700 PMID:26593335 PMID:27363631 PMID:27684054 PMID:28477916 PMID:28478070 PMID:34358556 PMID:36806343 More...
|
|
NCBI chr 5:163,587,463...163,617,363
Ensembl chr 5:163,587,463...163,618,495
|
|
| G
|
Mfsd10
|
major facilitator superfamily domain containing 10
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MFSD10 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:80,327,961...80,331,984
Ensembl chr14:80,328,410...80,332,063
|
|
| G
|
Mfsd2a
|
MFSD2 lysolipid transporter A, lysophospholipid
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of MFSD2A mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MFSD2A mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 5:140,510,933...140,525,828
Ensembl chr 5:140,510,953...140,525,916
|
|
| G
|
Mgam
|
maltase-glucoamylase
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MGAM mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 4:70,408,263...70,568,752
Ensembl chr 4:70,408,263...70,568,752
|
|
| G
|
Mgarp
|
mitochondria-localized glutamic acid-rich protein
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of MGARP mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr 2:137,582,152...137,590,294
Ensembl chr 2:137,582,152...137,590,481
|
|
| G
|
Mgst1
|
microsomal glutathione S-transferase 1
|
increases expression multiple interactions
|
ISO
|
Oxygen results in increased expression of MGST1 mRNA; Oxygen results in increased expression of MGST1 protein AHR protein affects the reaction [Oxygen results in increased expression of MGST1 protein]
|
CTD |
PMID:23337360 |
|
NCBI chr 4:172,760,930...172,776,157
Ensembl chr 4:172,760,886...172,776,875
|
|
| G
|
Mgst2
|
microsomal glutathione S-transferase 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MGST2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:137,821,787...137,866,664
Ensembl chr 2:137,836,140...137,866,661
|
|
| G
|
Mia
|
MIA SH3 domain containing
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MIA mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:91,601,326...91,603,019
Ensembl chr 1:91,601,327...91,603,019
|
|
| G
|
Mief1
|
mitochondrial elongation factor 1
|
increases expression multiple interactions
|
EXP
|
Oxygen deficiency results in increased expression of MIEF1 protein Ru 360 inhibits the reaction [Oxygen deficiency results in increased expression of MIEF1 protein]
|
CTD |
PMID:25911325 |
|
NCBI chr 7:113,666,918...113,679,550
Ensembl chr 7:113,666,901...113,683,977
|
|
| G
|
Mif
|
macrophage migration inhibitory factor
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of MIF mRNA; Oxygen results in increased expression of MIF mRNA; Oxygen results in increased expression of MIF protein [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MIF mRNA; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of MIF mRNA]
|
CTD |
PMID:10781441 PMID:19502547 PMID:20880076 PMID:23637810 PMID:26516004 PMID:30529165 More...
|
|
NCBI chr20:12,767,138...12,791,222
Ensembl chr 4:134,041,774...134,042,121 Ensembl chr20:134,041,774...134,042,121
|
|
| G
|
Mipep
|
mitochondrial intermediate peptidase
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of MIPEP mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr15:39,102,301...39,227,915
Ensembl chr15:39,102,115...39,227,914
|
|
| G
|
Mipol1
|
mirror-image polydactyly 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MIPOL1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:80,490,330...80,825,413
Ensembl chr 6:80,490,312...80,825,413
|
|
| G
|
Mir126a
|
microRNA 126a
|
decreases expression
|
EXP
|
Oxygen results in decreased expression of MIR126 mRNA
|
CTD |
PMID:22911455 |
|
NCBI chr 3:29,813,150...29,813,267
|
|
| G
|
Mir134
|
microRNA 134
|
increases expression
|
ISO
|
Oxygen results in increased expression of MIR134
|
CTD |
PMID:35848756 |
|
NCBI chr 6:134,570,313...134,570,385
|
|
| G
|
Mir135a2
|
microRNA 135a-2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of MIR135A2 mRNA; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of HMOX1 mRNA]]; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]]; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NQO1 mRNA]]; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of HMOX1 mRNA]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NQO1 mRNA]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSK3B mRNA]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSK3B protein]
|
CTD |
PMID:29719095 |
|
NCBI chr 7:28,499,166...28,499,265
|
|
| G
|
Mir141
|
microRNA 141
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MIR141 mRNA modified form
|
CTD |
PMID:25351418 |
|
NCBI chr 4:159,209,525...159,209,618
|
|
| G
|
Mir142
|
microRNA 142
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of MIR142 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:73,055,104...73,055,190
Ensembl chr10:73,055,097...73,055,207
|
|
| G
|
Mir144
|
microRNA 144
|
multiple interactions
|
ISO
|
[MIR144 mRNA results in decreased expression of SMARCA4 protein] affects the susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of MIR144 mRNA; MIR144 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of HMOX1 mRNA]; MIR144 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NQO1 mRNA]; MIR144 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMARCA4 mRNA]; MIR144 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SMARCA4 protein]; MIR144 mRNA promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]
|
CTD |
PMID:29457851 |
|
NCBI chr10:63,459,397...63,459,479
Ensembl chr10:63,459,397...63,459,479
|
|
| G
|
Mir150
|
microRNA 150
|
decreases expression
|
EXP
|
Oxygen results in decreased expression of MIR150 mRNA
|
CTD |
PMID:22911455 |
|
NCBI chr 1:104,741,487...104,741,571
Ensembl chr 1:104,741,487...104,741,571
|
|
| G
|
Mir151
|
microRNA 151
|
decreases expression
|
EXP
|
Oxygen results in decreased expression of MIR151 mRNA
|
CTD |
PMID:22911455 |
|
NCBI chr 7:107,061,380...107,061,476
|
|
| G
|
Mir186
|
microRNA 186
|
multiple interactions
|
ISO
|
[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of MIR186 mRNA; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]]; MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of HIF1A protein]
|
CTD |
PMID:33759271 |
|
NCBI chr 2:249,241,650...249,241,735
Ensembl chr 2:249,241,650...249,241,735
|
|
| G
|
Mir195
|
microRNA 195
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MIR195 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr10:55,450,495...55,450,581
Ensembl chr10:55,450,495...55,450,581
|
|
| G
|
Mir19a
|
microRNA 19a
|
multiple interactions decreases expression
|
ISO
|
Metformin inhibits the reaction [Oxygen deficiency results in decreased expression of MIR19A mRNA]
|
CTD |
PMID:33476677 |
|
NCBI chr15:98,588,131...98,588,212
Ensembl chr15:98,588,131...98,588,212
|
|
| G
|
Mir200a
|
microRNA 200a
|
multiple interactions decreases cleavage decreases expression
|
ISO
|
DICER1 protein inhibits the reaction [Oxygen deficiency results in decreased cleavage of MIR200A mRNA] Oxygen deficiency results in decreased expression of MIR200A mRNA modified form
|
CTD |
PMID:25351418 |
|
NCBI chr 5:171,930,717...171,930,805
|
|
| G
|
Mir200b
|
microRNA 200b
|
multiple interactions decreases expression decreases cleavage
|
ISO
|
DICER1 protein inhibits the reaction [Oxygen deficiency results in decreased cleavage of MIR200B mRNA] Oxygen deficiency results in decreased expression of MIR200B mRNA modified form
|
CTD |
PMID:25351418 |
|
NCBI chr 5:171,931,495...171,931,589
|
|
| G
|
Mir200c
|
microRNA 200c
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MIR200C mRNA modified form
|
CTD |
PMID:25351418 |
|
NCBI chr 4:159,209,965...159,210,033
|
|
| G
|
Mir205
|
microRNA 205
|
multiple interactions
|
EXP
|
[Antagomirs results in decreased expression of MIR205 mRNA] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PINK1 protein]; [Antagomirs results in decreased expression of MIR205 mRNA] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CASP3 protein modified form]; [Antagomirs results in decreased expression of MIR205 mRNA] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MIR205 mRNA]; [Antagomirs results in decreased expression of MIR205 mRNA] promotes the reaction [Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in increased expression of CASP3 protein modified form]]; [Antagomirs results in decreased expression of MIR205 mRNA] promotes the reaction [Remifentanil inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PINK1 protein]]; [Antagomirs results in decreased expression of MIR205 mRNA] promotes the reaction [Remifentanil inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CASP3 protein modified form]]; [Antagomirs results in decreased expression of MIR205 mRNA] promotes the reaction [Remifentanil inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MIR205 mRNA]]; [Oxygen co-treated with Dithionite] results in increased expression of MIR205 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MIR205 mRNA; MIR205 mRNA inhibits the reaction [Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in increased expression of CASP3 protein modified form]]; Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in increased expression of MIR205 mRNA]; Remifentanil inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MIR205 mRNA]
|
CTD |
PMID:34078833 |
|
NCBI chr13:107,564,535...107,564,642
|
|
| G
|
Mir20a
|
microRNA 20a
|
multiple interactions increases expression
|
ISO
|
MIR20A mRNA affects the reaction [Oxygen deficiency affects the expression of ABCA1 protein] Oxygen deficiency results in increased expression of MIR20A mRNA MIR20A mRNA promotes the reaction [Oxygen deficiency results in decreased expression of ABCA1 mRNA]; MIR20A mRNA promotes the reaction [Oxygen deficiency results in decreased expression of ABCA1 protein]
|
CTD |
PMID:32720422 |
|
NCBI chr15:98,588,303...98,588,387
Ensembl chr15:98,588,303...98,588,387
|
|
| G
|
Mir21
|
microRNA 21
|
increases expression
|
EXP ISO
|
Oxygen results in increased expression of MIR21 mRNA
|
CTD |
PMID:22911455 PMID:35848756 |
|
NCBI chr10:71,902,600...71,902,691
|
|
| G
|
Mir210
|
microRNA 210
|
increases expression decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of MIR210 mRNA Oxygen deficiency results in decreased expression of MIR210 mRNA MIR210 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 mRNA]; MIR210 mRNA results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
|
CTD |
PMID:23108914 PMID:25351418 PMID:25846647 |
|
NCBI chr 1:205,755,923...205,756,032
Ensembl chr 1:205,755,917...205,756,034
|
|
| G
|
Mir214
|
microRNA 214
|
increases expression
|
ISO
|
Oxygen results in increased expression of MIR214
|
CTD |
PMID:35848756 |
|
NCBI chr13:77,121,645...77,121,752
Ensembl chr13:77,121,643...77,121,752
|
|
| G
|
Mir22
|
microRNA 22
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of MIR22 mRNA; Prasugrel Hydrochloride inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of MIR22 mRNA]
|
CTD |
PMID:34174262 |
|
NCBI chr10:60,805,331...60,805,425
Ensembl chr10:60,805,331...60,805,425
|
|
| G
|
Mir30c1
|
microRNA 30c-1
|
multiple interactions
|
EXP
|
[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of MIR30C1 mRNA; [Antagomirs results in decreased expression of MIR30C1 mRNA] inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of BACH1 mRNA]; [Antagomirs results in decreased expression of MIR30C1 mRNA] inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of BACH1 protein]; [Antagomirs results in decreased expression of MIR30C1 mRNA] inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of HMOX1 protein]; [Antagomirs results in decreased expression of MIR30C1 mRNA] inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of MIR30C1 mRNA]; [Antagomirs results in decreased expression of MIR30C1 mRNA] inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of NQO1 protein]; [Antagomirs results in decreased expression of MIR30C1 mRNA] inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] affects the localization of and results in increased activity of NFE2L2 protein]; [Antagomirs results in decreased expression of MIR30C1 mRNA] inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of BACH1 mRNA]; [Antagomirs results in decreased expression of MIR30C1 mRNA] inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of BACH1 protein]; [Antagomirs results in decreased expression of MIR30C1 mRNA] inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of HMOX1 protein]; [Antagomirs results in decreased expression of MIR30C1 mRNA] inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of NQO1 protein]; [Antagomirs results in decreased expression of MIR30C1 mRNA] promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of IL1B protein]; [Antagomirs results in decreased expression of MIR30C1 mRNA] promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of IL6 protein]; [Antagomirs results in decreased expression of MIR30C1 mRNA] promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of TNF protein]; [Antagomirs results in decreased expression of MIR30C1 mRNA] promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased activity of CASP3 protein]; [Oxygen deficiency co-treated with Oxygen] results in increased expression of MIR30C1 mRNA; BACH1 protein inhibits the reaction [MIR30C1 mRNA promotes the reaction [[Oxygen deficiency co-treated with Oxygen] affects the localization of and results in increased activity of NFE2L2 protein]]; MIR30C1 mRNA inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of IL1B protein]; MIR30C1 mRNA inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of IL6 protein]; MIR30C1 mRNA inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of TNF protein]; MIR30C1 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased activity of CASP3 protein]; MIR30C1 mRNA promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of BACH1 mRNA]; MIR30C1 mRNA promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of BACH1 protein]; MIR30C1 mRNA promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of HMOX1 protein]; MIR30C1 mRNA promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of NQO1 protein]; MIR30C1 mRNA promotes the reaction [[Oxygen deficiency co-treated with Oxygen] affects the localization of and results in increased activity of NFE2L2 protein]; MIR30C1 mRNA promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of BACH1 mRNA]; MIR30C1 mRNA promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of BACH1 protein]; MIR30C1 mRNA promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of HMOX1 protein]; MIR30C1 mRNA promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of NQO1 protein]
|
CTD |
PMID:34217758 |
|
NCBI chr 5:139,634,455...139,634,543
|
|
| G
|
Mir335
|
microRNA mir-335
|
decreases expression
|
EXP
|
Oxygen results in decreased expression of MIR335 mRNA
|
CTD |
PMID:22911455 |
|
|
|
| G
|
Mir342
|
microRNA 342
|
decreases expression
|
EXP
|
Oxygen results in decreased expression of MIR342 mRNA
|
CTD |
PMID:22911455 |
|
NCBI chr 6:133,329,655...133,329,753
Ensembl chr 6:133,329,655...133,329,753
|
|
| G
|
Mir34a
|
microRNA 34a
|
increases expression
|
EXP
|
Oxygen results in increased expression of MIR34A mRNA
|
CTD |
PMID:22911455 |
|
NCBI chr 5:165,815,952...165,816,053
Ensembl chr 5:165,815,952...165,816,053
|
|
| G
|
Mir34c
|
microRNA 34c
|
multiple interactions increases expression
|
ISO
|
MIR34C promotes the reaction [Oxygen results in decreased expression of GPX1 protein]; MIR34C promotes the reaction [Oxygen results in decreased expression of SIRT1 mRNA]; MIR34C promotes the reaction [Oxygen results in decreased expression of SIRT1 protein]; MIR34C promotes the reaction [Oxygen results in decreased expression of SOD1 protein]; MIR34C promotes the reaction [Oxygen results in decreased expression of SOD2 mRNA]; MIR34C promotes the reaction [Oxygen results in decreased expression of SOD2 protein]; MIR34C promotes the reaction [Oxygen results in increased expression of CYBA mRNA]; MIR34C promotes the reaction [Oxygen results in increased expression of CYBB mRNA]; MIR34C promotes the reaction [Oxygen results in increased expression of CYBB protein]; MIR34C promotes the reaction [Oxygen results in increased expression of NOX4 mRNA]; MIR34C promotes the reaction [Oxygen results in increased expression of NOX4 protein]; MIR34C promotes the reaction [Oxygen results in increased expression of NPPA mRNA]; MIR34C promotes the reaction [Oxygen results in increased expression of NPPB mRNA] Oxygen results in increased expression of MIR34C
|
CTD |
PMID:35848756 |
|
NCBI chr 8:60,306,091...60,306,167
|
|
| G
|
Mir429
|
microRNA 429
|
decreases cleavage decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased cleavage of MIR429 mRNA Oxygen deficiency results in decreased expression of MIR429 mRNA modified form DICER1 protein inhibits the reaction [Oxygen deficiency results in decreased cleavage of MIR429 mRNA]
|
CTD |
PMID:25351418 |
|
NCBI chr 5:171,929,682...171,929,766
|
|
| G
|
Mir503
|
microRNA 503
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of MIR503 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr X:137,725,856...137,725,926
|
|
| G
|
Mir761
|
microRNA 761
|
multiple interactions
|
ISO
|
[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of MIR761 protein
|
CTD |
PMID:23867156 |
|
NCBI chr 5:129,005,205...129,005,280
Ensembl chr 5:129,005,205...129,005,280
|
|
| G
|
Mis18a
|
MIS18 kinetochore protein A
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MIS18A mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr11:43,454,129...43,467,157
Ensembl chr11:43,454,161...43,476,264
|
|
| G
|
Mitd1
|
microtubule interacting and trafficking domain containing 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MITD1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 9:47,609,743...47,621,033
Ensembl chr 9:47,609,744...47,621,033
|
|
| G
|
Mki67
|
marker of proliferation Ki-67
|
multiple interactions increases expression
|
ISO EXP
|
Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of MKI67 mRNA] [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MKI67 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MKI67 mRNA
|
CTD |
PMID:22629407 PMID:24205000 PMID:33729688 |
|
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593
|
|
| G
|
Mknk2
|
MAPK interacting serine/threonine kinase 2
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of MKNK2 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MKNK2 mRNA
|
CTD |
PMID:20042640 PMID:30529165 |
|
NCBI chr 7:9,690,385...9,701,527
Ensembl chr 7:9,690,421...9,701,529
|
|
| G
|
Mlana
|
melan-A
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MLANA mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:236,883,075...236,897,693
Ensembl chr 1:236,883,075...236,896,880
|
|
| G
|
Mlh1
|
mutL homolog 1
|
multiple interactions decreases expression increases methylation
|
ISO
|
[KDM1A protein binds to RCOR1 protein] promotes the reaction [Oxygen deficiency results in decreased expression of MLH1 mRNA]; [KDM1A protein binds to RCOR1 protein] promotes the reaction [Oxygen deficiency results in decreased expression of MLH1 protein]; [KDM1A protein binds to RCOR1 protein] promotes the reaction [Oxygen deficiency results in increased methylation of MLH1 promoter]; decitabine inhibits the reaction [Oxygen deficiency results in decreased expression of MLH1 mRNA]; decitabine inhibits the reaction [Oxygen deficiency results in increased methylation of MLH1 promoter]; KDM1A protein promotes the reaction [Oxygen deficiency results in decreased expression of MLH1 mRNA]; KDM1A protein promotes the reaction [Oxygen deficiency results in increased methylation of MLH1 promoter]; KDM5B protein promotes the reaction [Oxygen deficiency results in decreased expression of MLH1 mRNA]; Oxygen deficiency promotes the reaction [KDM1A protein binds to MLH1 promoter]; RCOR1 protein promotes the reaction [Oxygen deficiency results in increased methylation of MLH1 promoter] Oxygen deficiency results in decreased expression of MLH1 mRNA; Oxygen deficiency results in decreased expression of MLH1 protein
|
CTD |
PMID:25043185 PMID:28472268 PMID:38909692 |
|
NCBI chr 8:120,074,871...120,112,109
Ensembl chr 8:120,065,900...120,112,011
|
|
| G
|
Mlkl
|
mixed lineage kinase domain like pseudokinase
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MLKL mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MLKL mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr19:56,186,860...56,213,886
Ensembl chr19:56,186,860...56,213,858
|
|
| G
|
Mllt11
|
MLLT11, transcription factor 7 cofactor
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MLLT11 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 2:185,484,791...185,493,961
Ensembl chr 2:185,484,793...185,493,961
|
|
| G
|
Mllt3
|
MLLT3, super elongation complex subunit
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MLLT3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:107,305,008...107,561,352
Ensembl chr 5:107,284,766...107,561,352
|
|
| G
|
Mlph
|
melanophilin
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MLPH mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:98,955,036...98,990,566
Ensembl chr 9:98,955,141...98,990,556
|
|
| G
|
Mlxipl
|
MLX interacting protein-like
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MLXIPL mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr12:27,178,158...27,213,675
Ensembl chr12:27,178,158...27,213,660
|
|
| G
|
Mlycd
|
malonyl-CoA decarboxylase
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MLYCD mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr19:64,356,582...64,372,447
Ensembl chr19:64,356,223...64,372,446
|
|
| G
|
Mmd
|
monocyte to macrophage differentiation-associated
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MMD mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:75,570,366...75,598,610
Ensembl chr10:75,570,397...75,598,609
|
|
| G
|
Mme
|
membrane metallo-endopeptidase
|
increases expression decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of MME mRNA Oxygen deficiency results in decreased expression of MME mRNA; Oxygen deficiency results in decreased expression of MME protein [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MME mRNA
|
CTD |
PMID:23138928 PMID:24236059 PMID:33729688 |
|
NCBI chr 2:149,806,826...149,957,381
Ensembl chr 2:149,872,291...149,953,463
|
|
| G
|
Mmp1
|
matrix metallopeptidase 1
|
multiple interactions decreases expression
|
ISO
|
Cadmium Chloride inhibits the reaction [Oxygen deficiency results in decreased expression of MMP1 mRNA] Oxygen deficiency results in decreased expression of MMP1 mRNA; Oxygen deficiency results in decreased expression of MMP1 protein
|
CTD |
PMID:20193091 |
|
NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:12,943,453...12,963,964
|
|
| G
|
Mmp12
|
matrix metallopeptidase 12
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MMP12 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MMP12 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 8:12,866,652...12,876,554
Ensembl chr 8:12,866,641...12,884,478
|
|
| G
|
Mmp13
|
matrix metallopeptidase 13
|
multiple interactions decreases expression increases expression
|
EXP ISO
|
[Paraquat co-treated with Oxygen] results in decreased expression of MMP13 mRNA; sarpogrelate inhibits the reaction [Oxygen deficiency results in increased expression of MMP13 mRNA] Oxygen deficiency results in decreased expression of MMP13 mRNA; Oxygen deficiency results in decreased expression of MMP13 protein Oxygen deficiency promotes the reaction [Chloroquine results in increased expression of MMP13 mRNA]; TLR9 protein promotes the reaction [Oxygen deficiency promotes the reaction [Chloroquine results in increased expression of MMP13 mRNA]]
|
CTD |
PMID:12882763 PMID:20193091 PMID:24273604 PMID:25931318 |
|
NCBI chr 8:12,782,829...12,793,108
Ensembl chr 8:12,782,813...12,793,105
|
|
| G
|
Mmp14
|
matrix metallopeptidase 14
|
increases expression multiple interactions
|
EXP ISO
|
Oxygen deficiency results in increased expression of MMP14 mRNA; Oxygen deficiency results in increased expression of MMP14 protein [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MMP14 mRNA
|
CTD |
PMID:16980344 PMID:24205000 PMID:30529165 |
|
NCBI chr15:31,857,824...31,867,049
Ensembl chr15:31,857,546...31,869,893
|
|
| G
|
Mmp15
|
matrix metallopeptidase 15
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MMP15 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:9,669,506...9,691,000
Ensembl chr19:9,669,506...9,691,000
|
|
| G
|
Mmp19
|
matrix metallopeptidase 19
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MMP19 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:1,805,732...1,814,054
Ensembl chr 7:1,805,860...1,814,863
|
|
| G
|
Mmp2
|
matrix metallopeptidase 2
|
multiple interactions increases activity increases expression
|
ISO EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP2 protein; MMP2 protein affects the susceptibility to [EDN1 protein co-treated with Oxygen deficiency]; MMP2 protein affects the susceptibility to [Phenylephrine co-treated with Oxygen deficiency] [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP2 protein; bisphenol A diglycidyl ether inhibits the reaction [Ursolic Acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP2 protein]]; Mifepristone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP2 protein]; MMP2 protein affects the susceptibility to [EDN1 protein co-treated with Oxygen deficiency]; MMP2 protein affects the susceptibility to [Phenylephrine co-treated with Oxygen deficiency]; Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of MMP2 mRNA]; Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of MMP2 protein]; saxagliptin inhibits the reaction [Oxygen deficiency results in increased expression of MMP2 mRNA]; saxagliptin inhibits the reaction [Oxygen deficiency results in increased expression of MMP2 protein]; Ursolic Acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP2 protein] Oxygen deficiency results in increased activity of MMP2 protein [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP2 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP2 protein; [TNFRSF8 protein co-treated with Oxygen deficiency] results in decreased secretion of MMP2 protein; AKT1 protein modified form inhibits the reaction [trichostatin A inhibits the reaction [Oxygen deficiency results in increased expression of MMP2 mRNA]]; cyanidin-3-O-beta-glucopyranoside inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased activity of MMP2 protein]; genipin inhibits the reaction [Oxygen deficiency results in increased expression of MMP2 protein]; HIF1A protein promotes the reaction [Oxygen deficiency results in decreased expression of MMP2 mRNA]; marimastat inhibits the reaction [Oxygen deficiency results in increased expression of MMP2 protein]; Minocycline inhibits the reaction [Oxygen deficiency results in increased expression of MMP2 mRNA]; Mustard Gas inhibits the reaction [Oxygen deficiency results in increased expression of MMP2 mRNA]; Mustard Gas inhibits the reaction [Oxygen deficiency results in increased expression of MMP2 protein]; Oxygen deficiency results in increased expression of and results in increased activity of MMP2 protein; trichostatin A inhibits the reaction [Oxygen deficiency results in increased expression of MMP2 mRNA]; trichostatin A inhibits the reaction [Oxygen deficiency results in increased expression of MMP2 protein]; zafirlukast inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP2 mRNA]; zafirlukast inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP2 protein] Oxygen deficiency results in increased expression of MMP2 mRNA; Oxygen deficiency results in increased expression of MMP2 protein
|
CTD |
PMID:16980344 PMID:22340517 PMID:22436003 PMID:22534113 PMID:24292262 PMID:24518827 PMID:26082309 PMID:26476374 PMID:26509796 PMID:27274199 PMID:29630948 PMID:29984229 PMID:30229846 PMID:31629700 PMID:31816286 More...
|
|
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
|
|
| G
|
Mmp3
|
matrix metallopeptidase 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MMP3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:12,925,280...12,938,826
|
|
| G
|
Mmp7
|
matrix metallopeptidase 7
|
multiple interactions increases expression
|
ISO
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of MMP7 mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of MMP7 mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of MMP7 mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of MMP7 mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of MMP7 mRNA]
|
CTD |
PMID:23452621 |
|
NCBI chr 8:13,133,043...13,140,761
Ensembl chr 8:13,133,043...13,140,755
|
|
| G
|
Mmp8
|
matrix metallopeptidase 8
|
multiple interactions
|
EXP ISO
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MMP8 mRNA; [Paraquat co-treated with Oxygen] results in decreased expression of MMP8 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MMP8 mRNA
|
CTD |
PMID:12882763 PMID:30529165 PMID:33729688 |
|
NCBI chr 8:13,008,873...13,018,729
Ensembl chr 8:13,008,890...13,018,729
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
multiple interactions increases activity increases expression
|
ISO EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 protein; AKT1 protein modified form inhibits the reaction [trichostatin A inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA]]; genipin inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 protein]; Mustard Gas inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA]; Mustard Gas inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 protein]; Oxygen deficiency inhibits the reaction [Chloroquine results in decreased expression of MMP9 mRNA]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA]; trichostatin A inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA]; trichostatin A inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 protein]; zafirlukast inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 mRNA]; zafirlukast inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 protein] Oxygen deficiency results in increased activity of MMP9 protein Oxygen deficiency results in increased expression of MMP9 mRNA; Oxygen deficiency results in increased expression of MMP9 protein [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased activity of MMP9 protein; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 protein; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 protein]; Quercetin inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased activity of MMP9 protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 mRNA]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 protein]; U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 mRNA]; U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 protein] 4-chlorobenzyltetrahydroberberine inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA]; 4-chlorobenzyltetrahydroberberine inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 protein]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MMP9 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 protein; acetovanillone inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA]; acetovanillone inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 protein]; bisphenol A diglycidyl ether inhibits the reaction [Ursolic Acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 protein]]; Mifepristone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 protein]; Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA]; Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 protein]; saxagliptin inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA]; saxagliptin inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 protein]; Ursolic Acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 protein]
|
CTD |
PMID:16806698 PMID:18468597 PMID:18674879 PMID:22436003 PMID:23270704 PMID:24273604 PMID:24682241 PMID:26082309 PMID:26476374 PMID:26509796 PMID:27274199 PMID:29630948 PMID:30229846 PMID:31629700 PMID:31816286 PMID:33729688 More...
|
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Mn1
|
MN1 proto-oncogene, transcriptional regulator
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of MN1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr12:50,841,632...50,880,795
Ensembl chr12:50,841,632...50,880,795
|
|
| G
|
Mnat1
|
MNAT1 component of CDK activating kinase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MNAT1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:97,550,566...97,706,598
Ensembl chr 6:97,550,543...97,706,595
|
|
| G
|
Mnda
|
myeloid cell nuclear differentiation antigen
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PYHIN1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr13:88,550,224...88,567,892
Ensembl chr13:88,550,228...88,566,537
|
|
| G
|
Mns1
|
meiosis-specific nuclear structural 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MNS1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 8:82,029,587...82,050,276
Ensembl chr 8:82,029,587...82,050,274
|
|
| G
|
Mob3b
|
MOB kinase activator 3B
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MOB3B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:54,342,509...54,534,164
Ensembl chr 5:54,338,056...54,454,678
|
|
| G
|
Mob4
|
MOB family member 4, phocein
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of MOB4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:64,111,170...64,135,740
Ensembl chr 9:64,111,718...64,135,779
|
|
| G
|
Mon1a
|
MON1 homolog A, secretory trafficking associated
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MON1A mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 8:117,452,868...117,471,780
Ensembl chr 8:117,452,936...117,471,768
|
|
| G
|
Morc4
|
MORC family CW-type zinc finger 4
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MORC4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr X:108,269,197...108,317,611
Ensembl chr X:108,269,383...108,317,553
|
|
| G
|
Morf4l2
|
mortality factor 4 like 2
|
multiple interactions
|
EXP
|
MORF4L2 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
|
CTD |
PMID:21124846 |
|
NCBI chr X:104,874,850...104,885,946
Ensembl chr X:104,852,693...104,892,855
|
|
| G
|
Morn4
|
MORN repeat containing 4
|
multiple interactions
|
EXP
|
MORN4 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
|
CTD |
PMID:21124846 |
|
NCBI chr 1:250,837,639...250,847,943
Ensembl chr 1:250,837,643...250,848,026
|
|
| G
|
Mos
|
MOS proto-oncogene, serine/threonine kinase
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of MOS mRNA
|
CTD |
PMID:17914565 |
|
NCBI chr 5:21,657,549...21,658,856
Ensembl chr 5:21,657,431...21,658,987
|
|
| G
|
Mosmo
|
modulator of smoothened
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of MOSMO mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:184,648,985...184,719,820
Ensembl chr 1:184,648,985...184,719,820
|
|
| G
|
Mpeg1
|
macrophage expressed 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MPEG1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 1:218,876,848...218,881,364
Ensembl chr 1:218,876,069...218,908,715
|
|
| G
|
Mpg
|
N-methylpurine-DNA glycosylase
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of MPG mRNA
|
CTD |
PMID:17914565 |
|
NCBI chr10:15,900,697...15,906,981
Ensembl chr10:15,899,635...15,907,052
|
|
| G
|
Mpo
|
myeloperoxidase
|
multiple interactions increases activity
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MPO protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of MPO protein; bisphenol A diglycidyl ether inhibits the reaction [estradiol 3-benzoate inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MPO protein]]; carnosol inhibits the reaction [Oxygen deficiency results in increased activity of MPO protein]; estradiol 3-benzoate inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MPO protein]; geraniol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MPO protein]; Lansoprazole inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MPO protein]; Quercetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of MPO protein]
|
CTD |
PMID:20740350 PMID:23758074 PMID:24337826 PMID:27363640 |
|
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
|
|
| G
|
Mpp2
|
MAGUK p55 scaffold protein 2
|
multiple interactions increases expression
|
ISO
|
Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of MPP2 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr10:87,511,638...87,544,710
Ensembl chr10:87,511,638...87,544,029
|
|
| G
|
Mpp3
|
MAGUK p55 scaffold protein 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MPP3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:87,445,905...87,475,461
Ensembl chr10:87,445,905...87,474,811
|
|
| G
|
Mpp4
|
MAGUK p55 scaffold protein 4
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of MPP4 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 9:68,063,867...68,103,050
Ensembl chr 9:68,063,867...68,106,128
|
|
| G
|
Mppe1
|
metallophosphoesterase 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MPPE1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr18:63,033,329...63,051,461
Ensembl chr18:63,027,281...63,051,461
|
|
| G
|
Mpst
|
mercaptopyruvate sulfurtransferase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MPST mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:111,836,079...111,843,651
Ensembl chr 7:111,835,587...111,843,650
|
|
| G
|
Mpzl2
|
myelin protein zero-like 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MPZL2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 8:54,244,920...54,256,064
Ensembl chr 8:54,243,556...54,256,074
|
|
| G
|
Mpzl3
|
myelin protein zero-like 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MPZL3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:54,257,235...54,277,422
Ensembl chr 8:54,257,226...54,279,665
|
|
| G
|
Mrc1
|
mannose receptor, C type 1
|
increases expression multiple interactions
|
EXP ISO
|
Oxygen deficiency results in increased expression of MRC1 mRNA deguelin promotes the reaction [Oxygen deficiency results in increased expression of MRC1 mRNA]; HU 308 promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of MRC1 protein]; iodopravadoline inhibits the reaction [peoniflorin promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of MRC1 protein]]; peoniflorin promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of MRC1 protein]
|
CTD |
PMID:22745725 PMID:29560022 PMID:35179300 |
|
NCBI chr17:82,157,725...82,239,411
Ensembl chr17:82,157,705...82,239,410
|
|
| G
|
Mrc2
|
mannose receptor, C type 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of MRC2 mRNA
|
CTD |
PMID:35179300 |
|
NCBI chr10:90,761,751...90,823,055
Ensembl chr10:90,761,878...90,823,055
|
|
| G
|
Mre11
|
MRE11 homolog, double strand break repair nuclease
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRE11A mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:19,900,211...19,961,906
Ensembl chr 8:19,913,772...19,961,904
|
|
| G
|
Mroh7
|
maestro heat-like repeat family member 7
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of MROH7 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 5:126,692,649...126,740,180
Ensembl chr 5:126,692,649...126,731,161
|
|
| G
|
Mrpl12
|
mitochondrial ribosomal protein L12
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPL12 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:106,256,746...106,261,249
Ensembl chr10:106,256,547...106,263,088
|
|
| G
|
Mrpl13
|
mitochondrial ribosomal protein L13
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of MRPL13 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:88,841,265...88,862,821
Ensembl chr 7:88,841,266...88,862,848
|
|
| G
|
Mrpl17
|
mitochondrial ribosomal protein L17
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPL17 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:169,574,010...169,575,699
Ensembl chr 1:169,574,010...169,575,818
|
|
| G
|
Mrpl28
|
mitochondrial ribosomal protein L28
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of MRPL28 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:15,653,006...15,656,062
Ensembl chr10:15,653,179...15,666,971
|
|
| G
|
Mrpl37
|
mitochondrial ribosomal protein L37
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPL37 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:127,056,679...127,075,000
Ensembl chr 5:127,058,716...127,074,980
|
|
| G
|
Mrpl45
|
mitochondrial ribosomal protein L45
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPL45 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:82,805,039...82,816,862
Ensembl chr10:82,804,874...82,816,139
|
|
| G
|
Mrpl52
|
mitochondrial ribosomal protein L52
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPL52 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr15:31,852,927...31,856,160
Ensembl chr15:31,852,760...31,856,162
|
|
| G
|
Mrpl54
|
mitochondrial ribosomal protein L54
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPL54 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:9,103,525...9,106,045
Ensembl chr 7:9,103,525...9,106,045
|
|
| G
|
Mrpl9
|
mitochondrial ribosomal protein L9
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPL9 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:184,768,837...184,775,787
Ensembl chr 2:184,763,529...184,775,777
|
|
| G
|
Mrps10
|
mitochondrial ribosomal protein S10
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPS10 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:21,112,549...21,122,461
Ensembl chr 9:21,112,549...21,122,453
|
|
| G
|
Mrps18b
|
mitochondrial ribosomal protein S18B
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPS18B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr20:2,842,978...2,849,065
Ensembl chr20:2,842,528...2,849,065
|
|
| G
|
Mrps22
|
mitochondrial ribosomal protein S22
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPS22 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:108,063,468...108,076,638
Ensembl chr 8:108,063,471...108,076,638
|
|
| G
|
Mrps26
|
mitochondrial ribosomal protein S26
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MRPS26 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 3:138,222,324...138,223,987
Ensembl chr 3:138,222,165...138,223,987
|
|
| G
|
Mrps27
|
mitochondrial ribosomal protein S27
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPS27 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:32,474,178...32,542,741
Ensembl chr 2:32,473,965...32,542,738
|
|
| G
|
Mrs2
|
magnesium transporter MRS2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRS2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr17:40,491,963...40,515,116
Ensembl chr17:40,491,963...40,511,232
|
|
| G
|
Mrtfa
|
myocardin related transcription factor A
|
multiple interactions increases expression
|
ISO
|
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Oxygen affects the localization of MRTFA protein]; Cytochalasin D inhibits the reaction [Oxygen affects the localization of MRTFA protein]; exoenzyme C3, Clostridium botulinum inhibits the reaction [Oxygen affects the localization of MRTFA protein]; MRTFA protein affects the reaction [Oxygen results in increased expression of ACTA2 mRNA]; MRTFA protein affects the reaction [Oxygen results in increased expression of ACTA2 protein]; Oxygen promotes the reaction [MRTFA protein binds to ACTA2 promoter]; Oxygen results in increased expression of and affects the localization of MRTFA protein Oxygen results in increased expression of MRTFA mRNA
|
CTD |
PMID:23517783 |
|
NCBI chr 7:114,424,481...114,594,594
Ensembl chr 7:114,424,481...114,594,594
|
|
| G
|
Mrto4
|
MRT4 homolog, ribosome maturation factor
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of MRTO4 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MRTO4 mRNA
|
CTD |
PMID:26516004 PMID:33729688 |
|
NCBI chr 5:156,884,985...156,891,738
Ensembl chr 5:156,884,985...156,891,738
|
|
| G
|
Ms4a1
|
membrane spanning 4-domains A1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MS4A1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:217,331,274...217,351,934
Ensembl chr 1:217,331,274...217,343,447
|
|
| G
|
Ms4a6a
|
membrane spanning 4-domains A6A
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MS4A6C mRNA [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MS4A6E mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MS4A6E mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 1:217,826,261...217,839,606
Ensembl chr 1:217,826,261...217,850,013
|
|
| G
|
Ms4a7
|
membrane spanning 4-domains A7
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of MS4A7 mRNA [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MS4A7 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MS4A7 mRNA
|
CTD |
PMID:24205000 PMID:33729688 |
|
NCBI chr 1:217,394,019...217,409,643
Ensembl chr 1:217,394,019...217,409,643
|
|
| G
|
Msh2
|
mutS homolog 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MSH2 mRNA; Oxygen deficiency results in decreased expression of MSH2 protein
|
CTD |
PMID:25030372 PMID:38909692 |
|
NCBI chr 6:12,567,368...12,626,534
Ensembl chr 6:12,567,368...12,626,503
|
|
| G
|
Msmo1
|
methylsterol monooxygenase 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MSMO1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr16:29,747,113...29,764,360
Ensembl chr16:29,747,137...29,764,445
|
|
| G
|
Msmp
|
microseminoprotein, prostate associated
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MSMP mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 5:62,634,721...62,635,771
Ensembl chr 5:62,634,721...62,635,970
|
|
| G
|
Msn
|
moesin
|
affects localization multiple interactions
|
ISO EXP
|
Oxygen deficiency affects the localization of MSN protein [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MSN mRNA
|
CTD |
PMID:20164382 PMID:33729688 |
|
NCBI chr X:65,005,546...65,073,512
Ensembl chr X:65,005,458...65,075,129
|
|
| G
|
Msr1
|
macrophage scavenger receptor 1
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of MSR1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MSR1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MSR1 mRNA
|
CTD |
PMID:26516004 PMID:30529165 PMID:33729688 |
|
NCBI chr16:59,421,250...59,507,070
Ensembl chr16:59,421,057...59,507,070
|
|
| G
|
Msra
|
methionine sulfoxide reductase A
|
increases expression
|
EXP
|
Oxygen deficiency results in increased expression of MSRA mRNA
|
CTD |
PMID:22230185 |
|
NCBI chr15:42,514,818...42,853,278
Ensembl chr15:42,527,045...42,853,279
|
|
| G
|
Msrb2
|
methionine sulfoxide reductase B2
|
increases expression multiple interactions
|
EXP ISO
|
Oxygen deficiency results in increased expression of MSRB2 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MSRB2 mRNA
|
CTD |
PMID:22230185 PMID:30529165 |
|
NCBI chr17:86,882,750...86,908,392
Ensembl chr17:86,882,394...86,908,391
|
|
| G
|
Msrb3
|
methionine sulfoxide reductase B3
|
increases expression
|
EXP
|
Oxygen deficiency results in increased expression of MSRB3 mRNA; Oxygen results in increased expression of MSRB3 mRNA
|
CTD |
PMID:22230185 |
|
NCBI chr 7:58,188,827...58,311,459
Ensembl chr 7:57,968,124...58,311,116
|
|
| G
|
Mst1
|
macrophage stimulating 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of MST1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 8:117,646,485...117,652,016
Ensembl chr 8:117,647,438...117,652,015
|
|
| G
|
Msx2
|
msh homeobox 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MSX2 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr17:11,102,284...11,107,949
Ensembl chr17:11,102,247...11,107,945
|
|
| G
|
Mt-co1
|
mitochondrially encoded cytochrome c oxidase I
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of COX1 protein [Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of COX1 mRNA; [Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of COX1 protein [sulforaphane co-treated with Oxygen] results in increased expression of COX1 protein; NFE2L2 protein affects the reaction [[sulforaphane co-treated with Oxygen] results in increased expression of COX1 protein]
|
CTD |
PMID:19351718 PMID:27693381 PMID:30529165 |
|
NCBI chr MT:5,323...6,867
Ensembl chr MT:5,309...6,853
|
|
| G
|
Mt-nd1
|
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1
|
multiple interactions
|
EXP
|
[Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of ND1 mRNA; [Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of ND1 protein
|
CTD |
PMID:27693381 |
|
NCBI chr MT:2,740...3,694
Ensembl chr MT:2,729...3,685
|
|
| G
|
Mt-nd6
|
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6
|
affects response to substance
|
ISO
|
ND6 gene mutant form affects the susceptibility to Oxygen deficiency
|
CTD |
PMID:15248896 |
|
NCBI chr MT:13,543...14,061
Ensembl chr MT:13,531...14,049
|
|
| G
|
Mt1-ps3
|
metallothionein 1, pseudogene 3
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of MT1E mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr17:79,695,812...79,696,200
Ensembl chr17:79,695,809...79,696,200
|
|
| G
|
Mt1a
|
metallothionein 1A
|
multiple interactions increases expression
|
EXP ISO
|
[Oxygen deficiency co-treated with cobaltous chloride] results in increased expression of MT1A mRNA Oxygen deficiency results in increased expression of MT1A mRNA; Oxygen results in increased expression of MT1A mRNA [N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride co-treated with [Oxygen deficiency co-treated with Blood Glucose deficiency]] results in increased expression of MT1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MT1 mRNA
|
CTD |
PMID:15680347 PMID:19278353 PMID:19640911 PMID:30529165 |
|
NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200 Ensembl chr X:79,695,809...79,696,200 Ensembl chr19:79,695,809...79,696,200
|
|
| G
|
Mt2
|
metallothionein 2
|
multiple interactions increases expression
|
EXP ISO
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MT2A mRNA; [Oxygen deficiency co-treated with cobaltous chloride] results in increased expression of MT2A mRNA Oxygen deficiency results in increased expression of MT2A mRNA; Oxygen results in increased expression of MT2A mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MT2 mRNA
|
CTD |
PMID:15680347 PMID:17706837 PMID:17914565 PMID:19278353 PMID:24236059 PMID:25596134 PMID:28472268 PMID:30529165 PMID:33729688 More...
|
|
NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709
|
|
| G
|
Mt3
|
metallothionein 3
|
affects response to substance decreases response to substance increases expression multiple interactions
|
ISO EXP
|
MT3 protein affects the susceptibility to Oxygen MT3 protein results in decreased susceptibility to Oxygen Oxygen deficiency results in increased expression of MT3 mRNA [Oxygen deficiency co-treated with cobaltous chloride] results in increased expression of MT3 mRNA; cobaltous chloride promotes the reaction [Oxygen deficiency results in increased expression of MT3 mRNA] Oxygen deficiency results in increased expression of MT3 mRNA; Oxygen results in increased expression of MT3 mRNA
|
CTD |
PMID:12058024 PMID:12763630 PMID:15680347 PMID:17706837 PMID:19278353 PMID:22911455 More...
|
|
NCBI chr19:10,854,676...10,856,080
Ensembl chr19:10,854,677...10,856,080
|
|
| G
|
Mtbp
|
MDM2 binding protein
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MTBP mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:88,862,939...88,945,491
Ensembl chr 7:88,862,927...88,945,493
|
|
| G
|
Mtcl1
|
microtubule crosslinking factor 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SOGA2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:113,722,138...113,888,413
Ensembl chr 9:113,753,000...113,888,098
|
|
| G
|
Mtdh
|
metadherin
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of MTDH mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 7:67,192,592...67,250,819
Ensembl chr 7:67,192,393...67,249,584
|
|
| G
|
Mtf1
|
metal-regulatory transcription factor 1
|
multiple interactions increases expression
|
ISO
|
Oxygen deficiency promotes the reaction [HIF1A protein binds to MTF1 promoter] Oxygen deficiency results in increased expression of MTF1 mRNA
|
CTD |
PMID:22087877 |
|
NCBI chr 5:142,347,024...142,391,810
Ensembl chr 5:142,347,054...142,391,810
|
|
| G
|
Mtfp1
|
mitochondrial fission process 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of MTFP1 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr14:83,192,013...83,195,853
Ensembl chr14:83,192,021...83,195,927
|
|
| G
|
Mtfr2
|
mitochondrial fission regulator 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MTFR2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:16,942,814...16,958,218
|
|
| G
|
Mthfd1
|
methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of MTHFD1 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in decreased expression of MTHFD1 mRNA]
|
CTD |
PMID:22629407 PMID:26516004 |
|
NCBI chr 6:100,713,510...100,781,013
Ensembl chr 6:100,713,681...100,781,957
|
|
| G
|
Mthfd1l
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of MTHFD1L mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MTHFD1L mRNA
|
CTD |
PMID:20880076 PMID:30529165 |
|
NCBI chr 1:42,849,424...43,038,313
Ensembl chr 1:42,849,374...43,038,309
|
|
| G
|
Mthfd2
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of MTHFD2 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MTHFD2 mRNA; Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of MTHFD2 mRNA]
|
CTD |
PMID:22629407 PMID:30529165 |
|
NCBI chr 4:117,368,833...117,380,350
Ensembl chr 4:117,368,835...117,380,350
|
|
| G
|
Mtmr10
|
myotubularin related protein 10
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of MTMR10 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:127,271,139...127,322,621
Ensembl chr 1:127,270,870...127,322,621
|
|
| G
|
Mtmr3
|
myotubularin related protein 3
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of MTMR3 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of MTMR3 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr14:83,564,065...83,684,573
Ensembl chr14:83,564,065...83,684,473
|
|
| G
|
Mtmr6
|
myotubularin related protein 6
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of MTMR6 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr15:38,596,091...38,634,023
Ensembl chr15:38,596,032...38,636,672
|
|
| G
|
Mtnap1
|
mitochondrial nucleoid associated protein 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MTNAP1 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr10:99,227,522...99,237,838
Ensembl chr10:99,226,698...99,237,836
|
|
| G
|
Mtor
|
mechanistic target of rapamycin kinase
|
multiple interactions increases expression increases phosphorylation affects phosphorylation
|
ISO EXP
|
[dictamnine co-treated with Oxygen deficiency] results in decreased phosphorylation of MTOR protein; [Oxygen deficiency co-treated with Sirolimus] results in decreased expression of MTOR protein; Curcumin analog inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MTOR protein]; shikonin inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MTOR protein]; Sirolimus inhibits the reaction [Oxygen deficiency results in increased expression of MTOR mRNA] Oxygen deficiency results in increased phosphorylation of MTOR protein; Oxygen results in increased phosphorylation of MTOR protein [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of MTOR protein; HU 308 inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of MTOR protein]; iodopravadoline inhibits the reaction [peoniflorin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of MTOR protein]]; iodopravadoline promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of MTOR protein]; peoniflorin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of MTOR protein] [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of MTOR protein; HU 308 inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of MTOR protein]; iodopravadoline inhibits the reaction [peoniflorin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of MTOR protein]]; iodopravadoline promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of MTOR protein]; peoniflorin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of MTOR protein]; sanggenone C inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MTOR protein] Oxygen deficiency affects the phosphorylation of MTOR protein
|
CTD |
PMID:17968710 PMID:19587783 PMID:20554536 PMID:26087400 PMID:28684144 PMID:28983604 PMID:29560022 PMID:30266538 More...
|
|
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435
|
|
| G
|
Mtrex
|
Mtr4 exosome RNA helicase
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of SKIV2L2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:46,233,528...46,293,827
Ensembl chr 2:46,194,647...46,293,827
|
|
| G
|
Mtrr
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MTRR mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:36,695,376...36,727,341
Ensembl chr 1:36,695,460...36,727,807
|
|
| G
|
Mtss1
|
MTSS I-BAR domain containing 1
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of MTSS1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MTSS1 mRNA
|
CTD |
PMID:26516004 PMID:33729688 |
|
NCBI chr 7:92,378,228...92,517,444
Ensembl chr 7:92,378,238...92,517,303
|
|
| G
|
Mtus1
|
microtubule associated scaffold protein 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MTUS1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr16:57,905,991...58,051,466
Ensembl chr16:57,906,128...58,051,474
|
|
| G
|
Mtx2
|
metaxin 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of MTX2 protein
|
CTD |
PMID:25937538 |
|
NCBI chr 3:80,137,556...80,199,547
Ensembl chr 3:80,137,581...80,271,684
|
|
| G
|
Muc1
|
mucin 1, cell surface associated
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MUC1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:176,933,312...176,938,497
Ensembl chr 2:176,933,047...176,938,491
|
|
| G
|
Muc13
|
mucin 13, cell surface associated
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MUC13 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr11:80,462,350...80,489,773
Ensembl chr11:80,465,737...80,485,474
|
|
| G
|
Muc19
|
mucin 19, oligomeric
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MUC19 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 7:124,897,424...125,018,582
Ensembl chr 7:124,897,424...125,018,582
|
|
| G
|
Muc4
|
mucin 4, cell surface associated
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MUC4 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr11:81,513,321...81,575,200
|
|
| G
|
Muc5ac
|
mucin 5AC, oligomeric mucus/gel-forming
|
multiple interactions increases secretion
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the secretion of MUC5AC protein; NFE2L2 protein affects the reaction [Oxygen results in increased secretion of MUC5AC protein]; NFE2L2 protein affects the reaction [sulforaphane inhibits the reaction [Oxygen results in increased secretion of MUC5AC protein]]; sulforaphane inhibits the reaction [Oxygen results in increased secretion of MUC5AC protein]
|
CTD |
PMID:30529165 |
|
NCBI chr 1:206,293,717...206,326,006
Ensembl chr 1:206,293,869...206,326,006
|
|
| G
|
Muc6
|
mucin 6, oligomeric mucus/gel-forming
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MUC6 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 1:206,155,826...206,194,384
Ensembl chr 1:206,155,593...206,191,864
|
|
| G
|
Mug1
|
murinoglobulin 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MUG1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 4:156,748,351...156,802,132
|
|
| G
|
Mug6
|
murinoglobulin 6
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of CPAMD8 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 4:157,004,905...157,085,187
Ensembl chr 4:157,004,905...157,085,250
|
|
| G
|
Mustn1
|
musculoskeletal, embryonic nuclear protein 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MUSTN1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr16:6,079,355...6,081,608
Ensembl chr16:6,079,277...6,081,586
|
|
| G
|
Mutyh
|
mutY DNA glycosylase
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MUTYH protein
|
CTD |
PMID:25030372 |
|
NCBI chr 5:135,510,666...135,522,777
Ensembl chr 5:135,517,695...135,522,776
|
|
| G
|
Mx1
|
MX dynamin like GTPase 1
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MX1 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MX1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr11:50,269,056...50,294,699
Ensembl chr11:50,269,057...50,292,904
|
|
| G
|
Mx2
|
MX dynamin like GTPase 2
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MX2 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MX2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr11:50,375,101...50,399,373
Ensembl chr11:50,375,191...50,402,478
|
|
| G
|
Mxd1
|
max dimerization protein 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MXD1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 4:120,654,731...120,678,972
Ensembl chr 4:120,654,731...120,675,129
|
|
| G
|
Mxd4
|
Max dimerization protein 4
|
multiple interactions
|
ISO EXP
|
Oxygen affects the reaction [AHR protein results in decreased expression of MXD4 mRNA] [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MXD4 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MXD4 mRNA
|
CTD |
PMID:27103661 PMID:33729688 |
|
NCBI chr14:80,786,768...80,800,790
Ensembl chr14:80,786,342...80,800,788
|
|
| G
|
Mxi1
|
MAX interactor 1, dimerization protein
|
affects expression increases expression
|
ISO
|
Oxygen deficiency affects the expression of MXI1 mRNA Oxygen deficiency results in increased expression of MXI1 mRNA
|
CTD |
PMID:17193925 PMID:20880076 PMID:25596134 PMID:26516004 |
|
NCBI chr 1:262,329,274...262,389,037
Ensembl chr 1:262,328,875...262,389,036
|
|
| G
|
Mxra8
|
matrix remodeling associated 8
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MXRA8 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:171,731,153...171,735,879
Ensembl chr 5:171,731,353...171,735,879
|
|
| G
|
Myb
|
MYB proto-oncogene, transcription factor
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of MYB mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYB mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 1:17,759,309...17,793,306
Ensembl chr 1:17,759,309...17,792,547
|
|
| G
|
Mybbp1a
|
MYB binding protein 1a
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of MYBBP1A mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYBBP1A mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr10:57,555,458...57,565,819
Ensembl chr10:57,555,452...57,566,041
|
|
| G
|
Mybl1
|
MYB proto-oncogene like 1
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of MYBL1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYBL1 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 5:14,365,768...14,401,012
Ensembl chr 5:14,365,768...14,399,588
|
|
| G
|
Mybl2
|
MYB proto-oncogene like 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MYBL2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 3:172,124,765...172,153,221
Ensembl chr 3:172,116,550...172,153,221
|
|
| G
|
Mybphl
|
myosin binding protein H-like
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYBPHL mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:198,692,857...198,706,953
Ensembl chr 2:198,693,101...198,705,738
|
|
| G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
multiple interactions increases degradation increases phosphorylation decreases acetylation decreases expression increases expression
|
ISO EXP
|
[(+)-JQ1 compound co-treated with Oxygen deficiency] results in decreased expression of MYC mRNA; [amurensin G results in decreased activity of SIRT1 protein] inhibits the reaction [Oxygen deficiency results in decreased expression of MYC protein]; [betulin co-treated with Oxygen deficiency] results in decreased expression of MYC protein; [Betulinic Acid co-treated with Oxygen deficiency] results in decreased expression of MYC protein; [HIF1A mRNA co-treated with EPAS1 mRNA] affects the reaction [Oxygen deficiency results in increased degradation of MYC protein]; [Oxygen deficiency co-treated with GSK1210151A] results in decreased expression of MYC mRNA; EPAS1 affects the reaction [Oxygen deficiency results in increased expression of MYC protein]; FBXW7 mRNA affects the reaction [Oxygen deficiency results in increased degradation of MYC protein]; FBXW7 protein affects the reaction [Oxygen deficiency results in increased degradation of MYC protein]; GSK1210151A inhibits the reaction [Oxygen deficiency results in increased expression of MYC mRNA]; molibresib inhibits the reaction [Oxygen deficiency results in increased expression of MYC mRNA]; Oxygen deficiency promotes the reaction [SIRT1 protein binds to MYC protein]; Oxygen deficiency results in increased phosphorylation of and results in increased stability of and results in increased expression of MYC protein; SIRT1 protein affects the reaction [Oxygen deficiency results in decreased expression of MYC protein]; USP28 protein inhibits the reaction [Oxygen deficiency results in increased degradation of MYC protein] Oxygen deficiency results in increased phosphorylation of MYC protein Oxygen deficiency results in decreased acetylation of MYC protein Oxygen deficiency results in increased expression of MYC mRNA; Oxygen deficiency results in increased expression of MYC protein [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYC mRNA; Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased expression of MYC protein]; CDX2 protein inhibits the reaction [Oxygen deficiency results in increased expression of MYC protein]; CTNNB1 protein promotes the reaction [Oxygen deficiency results in increased expression of MYC protein] [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MYC mRNA
|
CTD |
PMID:20046830 PMID:22245592 PMID:23568779 PMID:24236059 PMID:27292261 PMID:30529165 PMID:33181113 PMID:33729688 PMID:38295844 More...
|
|
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
|
|
| G
|
Mycl
|
MYCL proto-oncogene, bHLH transcription factor
|
multiple interactions increases expression
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYCL mRNA Oxygen deficiency results in increased expression of MYCL mRNA
|
CTD |
PMID:30381462 PMID:30529165 |
|
NCBI chr 5:140,559,843...140,566,704
Ensembl chr 5:140,560,152...140,566,699
|
|
| G
|
Mycn
|
MYCN proto-oncogene, bHLH transcription factor
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of MYCN mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 6:41,446,683...41,452,584
Ensembl chr 6:41,446,684...41,452,508
|
|
| G
|
Myct1
|
myc target 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYCT1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:44,423,478...44,434,751
Ensembl chr 1:44,423,544...44,436,992
|
|
| G
|
Myd88
|
MYD88, innate immune signal transduction adaptor
|
multiple interactions increases expression
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYD88 mRNA; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of MYD88 protein] N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of MYD88 mRNA]; saxagliptin inhibits the reaction [Oxygen deficiency results in increased expression of MYD88 mRNA] Oxygen deficiency results in increased expression of MYD88 mRNA; Oxygen deficiency results in increased expression of MYD88 protein 3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of MYD88 mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of MYD88 mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of MYD88 mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of MYD88 mRNA]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of MYD88 mRNA]
|
CTD |
PMID:23452621 PMID:24223152 PMID:30529165 PMID:31629700 |
|
NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:127,952,161...127,956,230
|
|
| G
|
Myh10
|
myosin heavy chain 10
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYH10 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:53,891,955...54,024,032
Ensembl chr10:53,893,166...54,024,036
|
|
| G
|
Myh3
|
myosin heavy chain 3
|
increases expression multiple interactions
|
EXP
|
Oxygen deficiency results in increased expression of MYH3 mRNA Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of MYH3 mRNA]
|
CTD |
PMID:26476374 |
|
NCBI chr10:52,269,185...52,293,000
Ensembl chr10:52,269,185...52,293,000
|
|
| G
|
Myh4
|
myosin heavy chain 4
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MYH4 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr10:52,422,148...52,445,296
Ensembl chr10:52,421,951...52,445,294
|
|
| G
|
Myh7
|
myosin heavy chain 7
|
increases expression multiple interactions
|
EXP ISO
|
Oxygen deficiency results in increased expression of MYH7 mRNA Trimetazidine inhibits the reaction [Oxygen deficiency results in increased expression of MYH7 mRNA] [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MYH7 mRNA; NFE2L2 gene mutant form promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MYH7 mRNA]
|
CTD |
PMID:25937560 PMID:28373008 |
|
NCBI chr15:32,416,525...32,439,851
Ensembl chr15:32,416,527...32,438,194
|
|
| G
|
Myl3
|
myosin light chain 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYL3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:119,617,077...119,623,215
Ensembl chr 8:119,616,868...119,623,216
|
|
| G
|
Myl4
|
myosin, light chain 4
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYL4 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MYL4 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr10:89,949,733...89,985,308
Ensembl chr10:89,949,404...89,985,308
|
|
| G
|
Myl7
|
myosin light chain 7
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYL7 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MYL7 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr14:84,994,644...84,997,173
Ensembl chr14:84,993,736...84,997,372
|
|
| G
|
Myl9
|
myosin light chain 9
|
multiple interactions increases phosphorylation increases expression
|
ISO
|
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MYL9 protein] Oxygen deficiency results in increased expression of MYL9 mRNA
|
CTD |
PMID:20164382 PMID:26516004 |
|
NCBI chr 3:165,742,020...165,748,409
Ensembl chr 3:165,742,046...165,748,410
|
|
| G
|
Mylk
|
myosin light chain kinase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYLK mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr11:79,288,243...79,535,450
Ensembl chr11:79,288,243...79,535,659
|
|
| G
|
Mylk3
|
myosin light chain kinase 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYLK3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:37,858,298...37,916,805
Ensembl chr19:37,865,141...37,915,827
|
|
| G
|
Myo1d
|
myosin ID
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of MYO1D mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:65,986,900...66,263,538
Ensembl chr10:65,975,122...66,263,958
|
|
| G
|
Myo1g
|
myosin IG
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MYO1G mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr14:85,600,619...85,615,760
Ensembl chr14:85,600,619...85,615,760
|
|
| G
|
Myo5a
|
myosin VA
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYO5A mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:84,692,524...84,860,564
Ensembl chr 8:84,692,910...84,856,265
|
|
| G
|
Myo6
|
myosin VI
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYO6 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:89,967,351...90,122,219
Ensembl chr 8:89,967,377...90,122,215
|
|
| G
|
Myom1
|
myomesin 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of MYOM1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 9:118,362,547...118,485,954
Ensembl chr 9:118,362,621...118,485,952
|
|
| G
|
Myom2
|
myomesin 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYOM2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr16:81,222,467...81,295,025
Ensembl chr16:81,221,938...81,295,162
|
|
| G
|
Myom3
|
myomesin 3
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MYOM3 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 5:153,276,306...153,326,847
Ensembl chr 5:153,276,261...153,326,839
|
|
| G
|
Myoz2
|
myozenin 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYOZ2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:213,826,052...213,852,778
Ensembl chr 2:213,826,052...213,852,914
|
|
| G
|
Mzb1
|
marginal zone B and B1 cell-specific protein
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MZB1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr18:27,513,087...27,515,148
Ensembl chr18:27,513,089...27,515,182
|
|
| G
|
Naa30
|
N(alpha)-acetyltransferase 30, NatC catalytic subunit
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of NAA30 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr15:24,935,060...24,954,435
Ensembl chr15:24,935,260...24,954,437
|
|
| G
|
Naa35
|
N(alpha)-acetyltransferase 35, NatC auxiliary subunit
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of NAA35 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr17:5,039,897...5,091,916
Ensembl chr17:5,039,911...5,092,418
|
|
| G
|
Naa50
|
N(alpha)-acetyltransferase 50, NatE catalytic subunit
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NAA50 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr11:70,044,281...70,066,754
Ensembl chr11:70,044,281...70,066,754
|
|
| G
|
Nab2
|
Ngfi-A binding protein 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NAB2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 7:65,382,863...65,389,527
Ensembl chr 7:65,382,863...65,389,255
|
|
| G
|
Naf1
|
nuclear assembly factor 1 ribonucleoprotein
|
increases expression affects methylation
|
ISO
|
Oxygen deficiency results in increased expression of NAF1 mRNA Oxygen deficiency affects the methylation of NAF1 promoter
|
CTD |
PMID:24205000 |
|
NCBI chr16:27,604,228...27,634,963
Ensembl chr16:27,603,918...27,634,963
|
|
| G
|
Naip6
|
NLR family, apoptosis inhibitory protein 6
|
multiple interactions
|
ISO
|
[3,5-bis(2-fluorobenzylidene)piperidin-4-one co-treated with Oxygen deficiency] results in decreased expression of NAIP protein; [Curcumin co-treated with Oxygen deficiency] results in decreased expression of NAIP protein; [Genistein co-treated with Oxygen deficiency] results in decreased expression of NAIP protein; [Plant Extracts co-treated with Oxygen deficiency] results in decreased expression of NAIP protein; [resveratrol co-treated with Oxygen deficiency] results in decreased expression of NAIP protein
|
CTD |
PMID:23452621 |
|
NCBI chr 2:33,241,520...33,293,184
Ensembl chr 2:33,241,521...33,276,859
|
|
| G
|
Nampt
|
nicotinamide phosphoribosyltransferase
|
increases expression decreases expression
|
ISO
|
Oxygen results in increased expression of NAMPT mRNA Oxygen deficiency results in decreased expression of NAMPT mRNA Oxygen deficiency results in increased expression of NAMPT mRNA
|
CTD |
PMID:25447406 PMID:25596134 |
|
NCBI chr 6:55,152,756...55,189,547
Ensembl chr 6:55,151,926...55,189,544
|
|
| G
|
Nanog
|
Nanog homeobox
|
multiple interactions decreases expression
|
ISO
|
Oxygen deficiency promotes the reaction [LIF protein affects the reaction NANOG mRNA] Oxygen deficiency results in decreased expression of NANOG protein
|
CTD |
PMID:26723917 PMID:38909692 |
|
NCBI chr 4:157,615,687...157,623,061
Ensembl chr 4:157,615,687...157,623,061
|
|
| G
|
Nap1l3
|
nucleosome assembly protein 1-like 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NAP1L3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr X:92,607,628...92,610,426
Ensembl chr X:92,604,626...92,610,687
|
|
| G
|
Napsa
|
napsin A aspartic peptidase
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NAPSA mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:104,200,967...104,213,603
Ensembl chr 1:104,200,960...104,213,608
|
|
| G
|
Nars1
|
asparaginyl-tRNA synthetase 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NARS1 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr18:60,259,506...60,275,782
Ensembl chr18:60,259,516...60,275,782
|
|
| G
|
Nat10
|
N-acetyltransferase 10
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NAT10 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:110,566,582...110,604,829
Ensembl chr 3:110,566,582...110,604,836
|
|
| G
|
Ncam1
|
neural cell adhesion molecule 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of NCAM1 mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr 8:58,762,088...59,062,131
Ensembl chr 8:58,762,116...59,061,971
|
|
| G
|
Ncapd2
|
non-SMC condensin I complex, subunit D2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NCAPD2 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 4:159,655,051...159,677,938
Ensembl chr 4:159,655,051...159,677,938
|
|
| G
|
Ncapd3
|
non-SMC condensin II complex, subunit D3
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NCAPD3 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 8:33,696,214...33,765,520
Ensembl chr 8:33,696,270...33,765,518
|
|
| G
|
Ncapg
|
non-SMC condensin I complex, subunit G
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NCAPG mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr14:69,616,473...69,645,445
Ensembl chr14:69,616,473...69,645,445
|
|
| G
|
Ncapg2
|
non-SMC condensin II complex, subunit G2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NCAPG2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 6:143,484,651...143,561,850
Ensembl chr 6:143,485,944...143,560,249
|
|
| G
|
Ncaph
|
non-SMC condensin I complex, subunit H
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of NCAPH mRNA [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of NCAPH mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of NCAPH mRNA
|
CTD |
PMID:26516004 PMID:33729688 |
|
NCBI chr 3:134,825,271...134,852,502
Ensembl chr 3:134,825,271...134,852,502
|
|
| G
|
Ncf1
|
neutrophil cytosolic factor 1
|
affects localization decreases response to substance multiple interactions
|
ISO EXP
|
Oxygen deficiency affects the localization of NCF1 protein NCF1 gene mutant form results in decreased susceptibility to Oxygen deficiency [Semaxinib co-treated with Oxygen deficiency] results in decreased expression of NCF1 mRNA [Oxygen deficiency co-treated with Catechin] results in increased expression of NCF1 mRNA
|
CTD |
PMID:18638544 PMID:24947524 PMID:35883890 |
|
NCBI chr12:28,121,816...28,131,080
Ensembl chr12:28,121,366...28,131,079
|
|
| G
|
Ncf2
|
neutrophil cytosolic factor 2
|
multiple interactions increases expression
|
EXP ISO
|
[Semaxinib co-treated with Oxygen deficiency] results in decreased expression of NCF2 mRNA [Oxygen deficiency co-treated with Catechin] results in decreased expression of NCF2 mRNA Oxygen deficiency results in increased expression of NCF2 mRNA
|
CTD |
PMID:24947524 PMID:35883890 |
|
NCBI chr13:67,505,492...67,536,015
Ensembl chr13:67,505,375...67,536,149
|
|
| G
|
Ncf4
|
neutrophil cytosolic factor 4
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NCF4 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 7:111,705,926...111,723,893
Ensembl chr 7:111,706,520...111,723,898
|
|
| G
|
Nckap5
|
NCK-associated protein 5
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NCKAP5 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr13:39,922,576...40,835,849
Ensembl chr13:39,922,737...40,835,521
|
|
| G
|
Ncl
|
nucleolin
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NCL mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:94,447,559...94,456,083
Ensembl chr 9:94,446,682...94,456,083
|
|
| G
|
Ncln
|
nicalin
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NCLN mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 7:8,862,324...8,872,699
Ensembl chr 7:8,862,751...8,872,698
|
|
| G
|
Ncoa2
|
nuclear receptor coactivator 2
|
multiple interactions increases expression affects methylation decreases expression
|
ISO
|
Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of NCOA2 mRNA] Oxygen deficiency affects the methylation of NCOA2 promoter Oxygen deficiency results in decreased expression of NCOA2 protein
|
CTD |
PMID:22629407 PMID:24205000 PMID:26350169 |
|
NCBI chr 5:10,618,712...10,852,776
Ensembl chr 5:10,618,722...10,852,776
|
|
| G
|
Ncoa5
|
nuclear receptor coactivator 5
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NCOA5 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 3:174,155,731...174,188,862
Ensembl chr 3:174,155,741...174,188,862
|
|
| G
|
Ncor1
|
nuclear receptor co-repressor 1
|
multiple interactions increases expression
|
ISO
|
Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of NCOR1 mRNA]
|
CTD |
PMID:22629407 PMID:24205000 |
|
NCBI chr10:47,498,852...47,641,612
Ensembl chr10:47,498,852...47,640,350
|
|
| G
|
Ncr1
|
natural cytotoxicity triggering receptor 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NCR1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:78,657,409...78,665,255
Ensembl chr 1:78,659,262...78,703,273
|
|
| G
|
Ncr3
|
natural cytotoxicity triggering receptor 3
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NCR3 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr20:3,642,912...3,648,425
Ensembl chr20:3,642,912...3,644,188
|
|
| G
|
Ncr3lg1
|
natural killer cell cytotoxicity receptor 3 ligand 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NCR3LG1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:105,701,953...105,718,251
Ensembl chr 1:105,710,883...105,716,732
|
|
| G
|
Ncstn
|
nicastrin
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of NCSTN mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr13:87,062,827...87,078,839
Ensembl chr13:87,062,831...87,078,839
|
|
| G
|
Ndc1
|
NDC1 transmembrane nucleoporin
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of NDC1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NDC1 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 5:127,384,172...127,431,093
Ensembl chr 5:127,384,665...127,431,090
|
|
| G
|
Ndc80
|
NDC80 kinetochore complex component
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of NDC80 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of NDC80 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 9:118,853,806...118,887,582
Ensembl chr 9:118,853,806...118,887,568
|
|
| G
|
Ndnf
|
neuron-derived neurotrophic factor
|
multiple interactions increases expression
|
ISO
|
1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of NDNF mRNA]
|
CTD |
PMID:24403227 PMID:26516004 |
|
NCBI chr 4:96,274,147...96,311,624
Ensembl chr 4:96,274,147...96,311,624
|
|
| G
|
Ndrg1
|
N-myc downstream regulated 1
|
multiple interactions increases expression
|
ISO EXP
|
(+)-JQ1 compound inhibits the reaction [Oxygen deficiency results in increased expression of NDRG1 mRNA]; 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Oxygen deficiency results in increased expression of NDRG1 mRNA]; [Oxygen deficiency co-treated with VHL protein] results in increased expression of NDRG1 mRNA; Carbon Monoxide inhibits the reaction [Oxygen deficiency results in increased expression of NDRG1 mRNA]; Carbon Monoxide inhibits the reaction [Oxygen deficiency results in increased expression of NDRG1 protein]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of NDRG1 mRNA]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of NDRG1 protein]; Oxygen affects the reaction [Oxygen deficiency results in increased expression of NDRG1 protein]; Oxygen deficiency results in increased expression of and affects the localization of NDRG1 protein; Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of NDRG1 mRNA] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NDRG1 mRNA; [Oxygen deficiency co-treated with Dactinomycin] results in increased stability of NDRG1 mRNA; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of NDRG1 mRNA] Oxygen deficiency results in increased expression of NDRG1 mRNA; Oxygen deficiency results in increased expression of NDRG1 protein [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NDRG1 mRNA
|
CTD |
PMID:10646848 PMID:10910041 PMID:11006124 PMID:12767066 PMID:15341671 PMID:20042640 PMID:20880076 PMID:24066183 PMID:24236059 PMID:26516004 PMID:27292261 PMID:30529165 PMID:33729688 More...
|
|
NCBI chr 7:100,573,526...100,614,902
Ensembl chr 7:100,573,523...100,614,913
|
|
| G
|
Ndrg2
|
NDRG family member 2
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of NDRG2 mRNA NDRG2 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein] [Oxygen deficiency co-treated with Glucose deficiency] affects the localization of NDRG2 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NDRG2 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NDRG2 protein; NDRG2 protein affects the susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]; TP53 protein affects the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NDRG2] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NDRG2 mRNA
|
CTD |
PMID:20880076 PMID:23451161 PMID:30529165 |
|
NCBI chr15:27,074,481...27,087,376
Ensembl chr15:27,074,481...27,083,125
|
|
| G
|
Ndst1
|
N-deacetylase and N-sulfotransferase 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NDST1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr18:56,407,308...56,470,007
Ensembl chr18:56,411,200...56,448,612
|
|
| G
|
Ndufa1
|
NADH:ubiquinone oxidoreductase subunit A1
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of NDUFA1 mRNA [sulforaphane affects the susceptibility to Oxygen] which affects the expression of NDUFA1 mRNA
|
CTD |
PMID:24205000 PMID:30529165 |
|
NCBI chr X:121,289,904...121,293,555
Ensembl chr X:121,289,925...121,293,555
|
|
| G
|
Ndufa4
|
Ndufa4, mitochondrial complex associated
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NDUFA4 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 4:40,968,391...40,975,559
Ensembl chr 4:40,968,391...40,975,559
|
|
| G
|
Ndufa4l2
|
NDUFA4, mitochondrial complex associated like 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of COXFA4L2 mRNA
|
CTD |
PMID:20042640 PMID:26516004 |
|
NCBI chr 7:65,242,169...65,244,296
Ensembl chr 7:65,242,135...65,244,277
|
|
| G
|
Ndufab1
|
NADH:ubiquinone oxidoreductase subunit AB1
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of NDUFAB1 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in decreased expression of NDUFAB1 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 1:186,075,933...186,091,843
Ensembl chr 1:186,057,113...186,089,373
|
|
| G
|
Ndufaf1
|
NADH:ubiquinone oxidoreductase complex assembly factor 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NDUFAF1 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 3:127,089,893...127,104,357
Ensembl chr 3:127,093,659...127,104,020
|
|
| G
|
Ndufaf4
|
NADH:ubiquinone oxidoreductase complex assembly factor 4
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of NDUFAF4 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NDUFAF4 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 5:43,401,795...43,406,967
|
|
| G
|
Ndufaf8
|
NADH:ubiquinone oxidoreductase complex assembly factor 8
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NDUFAF8 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:105,879,908...105,882,059
Ensembl chr10:105,879,908...105,882,904
|
|
| G
|
Ndufb4
|
NADH:ubiquinone oxidoreductase subunit B4
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of NDUFB4 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr11:76,569,178...76,575,879
Ensembl chr11:76,569,178...76,575,879
|
|
| G
|
Ndufb8
|
NADH:ubiquinone oxidoreductase subunit B8
|
multiple interactions increases expression
|
ISO
|
NFE2L2 protein affects the reaction [sulforaphane promotes the reaction [Oxygen results in increased expression of NDUFB8 protein]]; sulforaphane promotes the reaction [Oxygen results in increased expression of NDUFB8 protein]
|
CTD |
PMID:30529165 |
|
NCBI chr 1:253,357,878...253,362,936
Ensembl chr 1:253,357,841...253,362,936
|
|
| G
|
Ndufs1
|
NADH:ubiquinone oxidoreductase core subunit S1
|
multiple interactions
|
EXP
|
[Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NDUFS1 mRNA
|
CTD |
PMID:27693381 |
|
NCBI chr 9:72,040,286...72,073,605
Ensembl chr 9:72,040,090...72,073,605
|
|
| G
|
Neat1
|
nuclear paraspeckle assembly transcript 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NEAT1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:212,507,512...212,568,055
|
|
| G
|
Nebl
|
nebulette
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of NEBL mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr17:85,022,953...85,374,848
Ensembl chr17:85,022,963...85,374,172
|
|
| G
|
Nectin1
|
nectin cell adhesion molecule 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NECTIN1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 8:52,998,662...53,061,745
Ensembl chr 8:52,998,662...53,086,664
|
|
| G
|
Nedd4
|
NEDD4 E3 ubiquitin protein ligase
|
increases expression multiple interactions affects response to substance
|
ISO
|
Oxygen deficiency results in increased expression of NEDD4 protein Melatonin inhibits the reaction [Oxygen deficiency results in increased expression of NEDD4 protein] [NEDD4 protein affects the susceptibility to Oxygen deficiency] which affects the susceptibility to Melatonin; NEDD4 protein affects the susceptibility to Oxygen deficiency
|
CTD |
PMID:31325559 |
|
NCBI chr 8:82,264,751...82,349,642
Ensembl chr 8:82,264,649...82,349,633
|
|
| G
|
Nedd9
|
neural precursor cell expressed, developmentally down-regulated 9
|
decreases expression increases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NEDD9 mRNA Oxygen deficiency results in increased expression of NEDD9 mRNA
|
CTD |
PMID:25596134 PMID:26516004 |
|
NCBI chr17:23,495,531...23,673,780
Ensembl chr17:23,495,492...23,675,668
|
|
| G
|
Nefm
|
neurofilament medium chain
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NEFM protein
|
CTD |
PMID:25937538 |
|
NCBI chr15:46,535,857...46,541,161
Ensembl chr15:46,535,517...46,541,163
|
|
| G
|
Neil1
|
nei-like DNA glycosylase 1
|
affects metabolic processing
|
ISO
|
NEIL1 affects the metabolism of Oxygen
|
CTD |
PMID:21285402 |
|
NCBI chr 8:66,446,106...66,452,844
Ensembl chr 8:66,445,953...66,452,378
|
|
| G
|
Neil3
|
nei-like DNA glycosylase 3
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NEIL3 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr16:45,091,401...45,151,419
Ensembl chr16:45,092,200...45,151,205
|
|
| G
|
Nek6
|
NIMA-related kinase 6
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NEK6 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:42,693,994...42,766,026
Ensembl chr 3:42,693,971...42,767,773
|
|
| G
|
Nek8
|
NIMA-related kinase 8
|
multiple interactions increases expression
|
ISO
|
EPAS1 mutant form inhibits the reaction [Oxygen deficiency results in increased expression of NEK8 protein]; HIF1A mutant form inhibits the reaction [Oxygen deficiency results in increased expression of NEK8 protein] Oxygen deficiency results in increased expression of NEK8 mRNA; Oxygen deficiency results in increased expression of NEK8 protein
|
CTD |
PMID:25451921 |
|
NCBI chr10:63,558,940...63,570,954
Ensembl chr10:63,558,788...63,570,488
|
|
| G
|
Nelfe
|
negative elongation factor complex member E
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of NELFE mRNA Oxygen inhibits the reaction [Oxygen deficiency results in decreased expression of NELFE mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr20:3,981,259...3,987,016
Ensembl chr20:3,981,261...3,986,922
|
|
| G
|
Neo1
|
neogenin 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NEO1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:68,169,711...68,322,158
Ensembl chr 8:68,169,716...68,322,152
|
|
| G
|
Nes
|
nestin
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NES mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:175,736,551...175,746,228
|
|
| G
|
Net1
|
neuroepithelial cell transforming 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of NET1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr17:71,251,145...71,280,345
Ensembl chr17:71,251,149...71,289,270
|
|
| G
|
Neto2
|
neuropilin and tolloid like 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NETO2 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr19:37,517,518...37,588,961
Ensembl chr19:37,517,587...37,591,413
|
|
| G
|
Nf1
|
neurofibromin 1
|
increases response to substance
|
ISO
|
NF1 gene mutant form results in increased susceptibility to Oxygen
|
CTD |
PMID:29847659 |
|
NCBI chr10:64,803,986...65,037,086
Ensembl chr10:64,804,266...65,034,946
|
|
| G
|
Nfatc1
|
nuclear factor of activated T-cells 1
|
affects localization multiple interactions
|
ISO
|
Oxygen deficiency affects the localization of NFATC1 protein Cyclosporine inhibits the reaction [Oxygen deficiency affects the localization of NFATC1 protein]
|
CTD |
PMID:19028555 |
|
NCBI chr18:76,321,386...76,430,997
Ensembl chr18:76,321,386...76,430,990
|
|
| G
|
Nfatc2
|
nuclear factor of activated T-cells 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of NFATC2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 3:177,615,189...177,747,493
Ensembl chr 3:177,618,314...177,747,380
|
|
| G
|
Nfe2l1
|
NFE2 like bZIP transcription factor 1
|
multiple interactions increases expression
|
EXP
|
[cobaltous chloride co-treated with Oxygen deficiency] results in increased expression of NFE2L1 protein Oxygen deficiency results in increased expression of NFE2L1 protein
|
CTD |
PMID:19278353 |
|
NCBI chr10:82,296,824...82,309,472
Ensembl chr10:82,292,508...82,309,375
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
multiple interactions affects activity decreases expression affects expression affects response to substance affects localization increases response to substance increases expression
|
EXP ISO
|
[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Hemin] affects the localization of NFE2L2 protein; [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] affects the localization of NFE2L2 protein; [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of and affects the localization of NFE2L2 protein; [Antagomirs results in decreased expression of MIR30C1 mRNA] inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] affects the localization of and results in increased activity of NFE2L2 protein]; [Nitrites co-treated with Oxygen deficiency] results in increased expression of NFE2L2 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NFE2L2 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and affects the localization of NFE2L2 protein; [Oxygen deficiency co-treated with Oxygen] affects the localization of and results in increased activity of NFE2L2 protein; [Oxygen deficiency co-treated with Oxygen] affects the localization of NFE2L2 protein; [Oxygen deficiency co-treated with Oxygen] results in increased expression of and affects the localization of and results in increased activity of NFE2L2 protein; [Thiazoles analog binds to indoline analog] promotes the reaction [PHLDA3 protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of and affects the localization of and results in increased activity of NFE2L2 protein]]; BACH1 protein inhibits the reaction [MIR30C1 mRNA promotes the reaction [[Oxygen deficiency co-treated with Oxygen] affects the localization of and results in increased activity of NFE2L2 protein]]; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NFE2L2 protein]; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and affects the localization of NFE2L2 protein]; Ethanol inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] affects the localization of NFE2L2 protein]; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]]; KEAP1 protein inhibits the reaction [diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and affects the localization of NFE2L2 protein]]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]; MIR30C1 mRNA promotes the reaction [[Oxygen deficiency co-treated with Oxygen] affects the localization of and results in increased activity of NFE2L2 protein]; MK 2206 inhibits the reaction [PHLDA3 protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of and affects the localization of and results in increased activity of NFE2L2 protein]]; naringin promotes the reaction [[Oxygen deficiency co-treated with Oxygen] affects the localization of NFE2L2 protein]; NFE2L2 mutant form inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of GCLC protein]; NFE2L2 mutant form inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of HMOX1 protein]; NFE2L2 mutant form promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased cleavage of and results in increased activity of CASP3 protein]; NFE2L2 protein mutant form affects the reaction [plumbagin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; NFE2L2 protein promotes the reaction [diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; NFE2L2 protein promotes the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; NFE2L2 protein promotes the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PARP1 protein modified form]]; NFE2L2 protein promotes the reaction [diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of KEAP1 protein]]; NFE2L2 protein promotes the reaction [diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and affects the localization of NFE2L2 protein]]; NFE2L2 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Oxygen]; PHLDA3 protein inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of and affects the localization of NFE2L2 protein]; PHLDA3 protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of and affects the localization of and results in increased activity of NFE2L2 protein]; saxagliptin promotes the reaction [Oxygen deficiency results in increased expression of NFE2L2 mRNA]; saxagliptin promotes the reaction [Oxygen deficiency results in increased expression of NFE2L2 protein] Oxygen deficiency affects the activity of NFE2L2 protein Oxygen deficiency results in decreased expression of NFE2L2 mRNA; Oxygen deficiency results in decreased expression of NFE2L2 protein 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide affects the reaction [SGMS2 protein affects the reaction [Oxygen deficiency affects the localization of NFE2L2 protein]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NFE2L2 mRNA]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NFE2L2 protein]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Oxygen deficiency affects the localization of NFE2L2 protein]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NFE2L2 mRNA]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NFE2L2 protein]; [Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NFE2L2 mRNA; [Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NFE2L2 protein; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of A4GALT mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AAAS mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AAMDC mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AASS mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ABCA3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ABCA8A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ABCB1B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ABCC9 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ABI3BP mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ABTB2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACAD11 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACADM mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACE2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACLY mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACOXL mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACSL1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACSS1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACSS2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACTA1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACTC1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACTN1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACTN2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACYP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADA mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADAM22 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADAM8 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADAMTS2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADAMTS20 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADAMTS4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADAMTS9 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADAT2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADCK3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADCY7 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADCY8 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADGRG2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADGRG3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADGRG6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADM mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADORA2B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADRB1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADRB3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AEN mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AFG2A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AGMO mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AGO1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AGPAT5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AHI1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AHSP mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AIF1L mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AIMP2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AK3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AKAP12 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AKR1B8 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ALAS1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ALAS2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ALDH1A3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ALDH1A7 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ALDH1L2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ALDH6A1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ALG13 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ALG3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ALKBH2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ALPL mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AMPD3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANAPC13 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANAPC15 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANGPT1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANGPT2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANGPTL2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANGPTL4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANGPTL6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANGPTL8 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANKRD1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANKRD28 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANKRD37 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANKRD44 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANKRD49 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANKRD50 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANTXR1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANTXR2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANXA3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANXA8 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AOX1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AOX3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of APBB1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of APEX1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of APLNR mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of APOC1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of APOLD1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of APPL2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of APRT mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of APTX mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AR mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARAP2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AREG mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARG2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARHGAP42 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARHGAP8 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARHGEF15 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARID1A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARID2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARID5A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARL4A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARL6IP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARRB1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARSB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ART3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARTN mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARV1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ASB4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ASNS mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ASPN mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ATAD3A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ATF3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ATF4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ATIC mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ATOSA mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ATP1A2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ATP2A3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ATP6V1C2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ATP7B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ATP8A1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AVPI1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AVPR1A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AZGP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BACH2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BANK1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BATF mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BAX mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BCL11A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BCL11B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BCL2L1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BCL3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BDKRB1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BDKRB2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BEAN1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BEX2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BEX4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BHLHE22 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BHLHE40 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BID mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BLK mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BLOC1S2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BMF mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BMP2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BMP4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BMP6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BPGM mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BPHL mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BRINP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BRIX1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BTBD19 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BTLA mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BYSL mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BZW1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of C1QBP mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of C1QTNF2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of C1QTNF3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of C1QTNF7 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of C3AR1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of C6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CADM1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CADPS2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CALCOCO1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CALD1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CALHM2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CAMP mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CAPG mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CAR13 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CAR8 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CARS1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CASP4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CASTOR2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CAT mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CAV3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CAVIN2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CAVIN3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CBLC mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CBR1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CBR2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CBX6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCDC141 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCDC68 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCDC86 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCKAR mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCL17 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCL2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCL3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCL5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCL7 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCL9 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCN1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCN2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCN4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCNG1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCNI mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCP110 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCPG1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCR1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCR5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCR6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCR7 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCT3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD14 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD177 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD19 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD1D1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD22 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD28 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD300A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD3G mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD59A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD68 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD69 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD74 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD79A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD79B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD80 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD83 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDC34 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDC42EP3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDC42EP4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDCP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDH16 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDH2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDK14 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDK19 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDKN1A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDKN2C mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CEBPA mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CEBPB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CEBPD mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CEP70 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CERS3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CES1D mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CES1E mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CES2B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CES2G mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CFI mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CGREF1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CH25H mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHAC1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHD6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHI3L1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHIA mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHL1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHPT1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHRDL1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHRNA7 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHST7 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHSY3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHTF8 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CKAP2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CKM mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CKMT1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CKMT2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CLDN10 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CLDN4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CLDN8 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CLEC1A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CLEC3B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CLEC5A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CLSTN1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CLTB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CMAH mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CMTM8 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CMTR2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CMYA5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CNKSR1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of COA7 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of COL4A2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of COL4A3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of COL4A4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of COL4A5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of COL5A2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of COLGALT2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of COQ10B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CORIN mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of COX7A1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of COX8B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CPAP mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CPM mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CPNE2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CPT1C mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CPXM1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CR2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CRCT1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CREBL2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CREBRF mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CRIP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CRLF2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CRLF3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CRY1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CSAD mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CSF1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CSF3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CSRNP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CSRP3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CSTB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CSTF1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CTDP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CTNND2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CTPS1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CTTNBP2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CWC27 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CXCL1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CXCL10 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CXCL14 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CXCL16 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CXCL2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CXCL3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CXCL5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CXCR4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CXCR5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CXCR7 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CYBRD1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CYP1A1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CYP1B1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CYP27A1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CYP4V3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CYP51 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CYP7B1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CYRIA mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DAG1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DAPK2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DAPK3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DARC mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DBF4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DBN1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DCLK1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DCTD mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DCTPP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DDAH1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DDIT4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DDX21 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DDX27 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DDX39A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DDX56 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DDX59 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DDX6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DENND4C mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DENR mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DGKZ mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DHRS3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DHRS7C mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DHX35 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DHX37 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DIAPH3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DIO2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DIS3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DISP2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DIXDC1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DLEU2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DMD mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DNAH8 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DNAJA4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DNAJC11 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DNAJC28 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DNASE1L1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DNASE2A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DOCK10 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DOP1B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DPH2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DPH5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DPP4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DPT mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DPYD mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DPYSL2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DRAM1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DTNBP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DUSP4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DUSP6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DYRK3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of E2F2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EAR11 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EBNA1BP2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ECE2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ECM2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EDA2R mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EDN1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EDNRB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EEF1E1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EFEMP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EFHD1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EFR3B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EGFLAM mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EGR1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EGR2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EGR3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EHD4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EHF mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EIF2B3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EIF2S1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EIF4A1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EIF4EBP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EIF6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ELF5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ELFN1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ELP4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EMCN mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EMID1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ENC1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ENO3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ENPEP mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ENPP5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ENTPD1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ENTREP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ENTREP3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EPB41L4B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EPHA1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EPHA2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EPS8L1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ERBB3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ERCC8 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EREG mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ERRFI1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ESYT3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ETF1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ETFBKMT mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ETL4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ETV5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ETV6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EVA1B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EVL mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EXOSC1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EXOSC2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EXPH5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of F13A1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of F3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FABP3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FAM110B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FAM117A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FAM13A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FAM162B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FAM174B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FAM193B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FAM221A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FAM46A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FAM46B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FAM83H mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FAS mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FASN mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FAT3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FBP2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FBXO15 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FBXO17 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FBXO32 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FBXO9 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FCER2A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FCGR1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FCGR2B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FCGR3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FCMR mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FCRL1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FCRLA mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FDFT1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FECH mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FGD2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FGF1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FGF2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FGFR2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FGFR4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FGL2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FHDC1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FHL2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FHOD1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FIGN mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FKBP10 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FKBP5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FMO1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FMO2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FMO5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FMOD mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FNDC1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FOSL1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FOSL2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FOXA1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FOXF2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FRAT2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FRRS1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FRYL mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FSCN1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FST mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FSTL3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FTSJ3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FXN mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FXYD1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FYCO1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FZD7 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of G0S2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GAB1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GABRP mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GADD45A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GADD45B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GADD45G mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GADD45GIP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GAR1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GARS1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GAS1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GAS7 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GBP2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GBP3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GBP6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GBP7 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GCH1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GCHFR mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GDF15 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GEM mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GFER mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GFPT2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GFRA1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GGCT mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GIMAP4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GIMAP8 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GINS1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GJA1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GJB3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GLA mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GLB1L2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GLB1L3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GLCCI1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GLIPR2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GLRX mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GMDS mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GMNN mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GNB1L mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GNG11 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GNL3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GNPNAT1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GOT1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPAM mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPATCH4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPNMB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPR155 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPR160 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPR174 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPR176 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPR35 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPR65 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPR84 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPRASP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPRIN3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPSM2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPT mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GREM2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GRWD1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GSAP mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GSTK1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GSTM1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GSTT3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GSTZ1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GTF2F2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GTF2H1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GTF3C3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GTPBP4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GUCY1A1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GUCY1A2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GULP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GZMA mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of H2-AA mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of H2-OA mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of H2-OB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of H2-T24 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of H2AZ2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of H2BC21 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HACD1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HACD3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HACD4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HACL1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HADH mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HAL mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HAMP mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HAUS2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HAUS6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HBEGF mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HC mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HCAR2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HDAC5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HEATR1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HEPACAM2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HHIP mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HIF1A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HIGD1B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HILPDA mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HKDC1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HLTF mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HMCN1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HMGA2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HMGA2-PS1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HMGCR mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HNMT mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HOGA1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HPGD mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HRC mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HS2ST1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HSD17B11 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HSPA12B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HSPA9 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HSPB7 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HSPB8 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HTR2B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HVCN1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HYCC1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HYKK mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IAH1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IDH1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IER3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IER5L mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IFFO2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IFI203 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IFI47 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IFRD1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IFT20 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IFT70B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IGF2BP2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IGFBP6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IGK-V28 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IGLC2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IKZF2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IL11 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IL13RA1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IL17RA mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IL17RD mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IL18R1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IL1R2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IL4RA mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IL6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of INHBA mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of INHBB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of INMT mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of INPP5B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of INPP5K mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IPO5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IRAK2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IRAK3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IRGM2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IRS1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IRS2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IRX3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IRX5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ISG20 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ISLR mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ITGA1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ITGA8 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ITGAM mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ITGB1BP2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ITIH5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ITM2A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ITPKC mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IVD mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IYD mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of JCHAIN mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of JMJD6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of JPT2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of JUNB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KANK3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KANK4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KAZALD1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCMF1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCNA2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCND2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCNE2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCNE4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCNH1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCNJ13 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCNJ15 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCNK13 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCNK2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCNMB4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCNQ1OT1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCTD11 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCTD12B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCTD21 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KDR mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KHDRBS3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KIF26A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KIF26B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KIT mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KLF10 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KLF12 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KLF15 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KLHDC8A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KLHL24 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KLHL41 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KLRA16 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KLRD1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KLRE1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KPNA3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KRT18 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KRT19 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KRT23 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KRT7 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KRT8 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KRTAP17-1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LAMA3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LBH mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LCN2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LDB3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LDHB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LEPR mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LGALS12 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LGALS3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LGI3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LGMN mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LIF mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LIFR mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LIMCH1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LITAF mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LMO2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LOX mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LPAR3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LPCAT1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LPCAT2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LRAT mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LRG1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LRP12 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LRP4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LRRC17 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LRRC59 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LRRN3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LSG1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LSM4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LTB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LTB4R1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LTBP3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LTBP4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LTV1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LXN mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LY86 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LYAR mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LYPD2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LYVE1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LZIC mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MACF1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAD2L2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAFB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAFF mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAFK mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAK16 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAL2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAMDC2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAOB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAP3K2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAP4K2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAPK10 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAPRE2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAPT mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MARCKSL1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MARF1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MATN4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MBD1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MBLAC2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MBOAT2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MCEE mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MCTP2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MCUB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MDM2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MECR mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MEDAG mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MEF2C mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MEGF9 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MEOX2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MET mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of METTL1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of METTL22 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of METTL24 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MEX3B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MFAP3L mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MFSD10 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MFSD2A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MGST2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MIA mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MIF mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MIPOL1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MIR22HG mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MKI67IP mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MKNK2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MLANA mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MLKL mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MLLT3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MLPH mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MLXIPL mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MMD mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MMP12 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MMP14 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MMP15 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MMP19 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MMP3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MMP8 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MNAT1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MNDAL mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MOB3B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MORC4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MPP3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MPPE1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MPST mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MPZL3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRE11A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPL12 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPL17 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPL37 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPL45 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPL52 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPL54 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPL9 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPS10 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPS18B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPS22 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPS27 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRS2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MS4A1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MS4A4B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MS4A6C mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MS4A6D mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MSMO1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MSR1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MSRB2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MT1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MT2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MTBP mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MTHFD1L mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MTHFD2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MTRR mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MTUS1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MUC1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MUP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MXRA8 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYBBP1A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYBL1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYBPHL mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYC mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYCL mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYCT1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYD88 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYH10 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYL3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYL4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYL7 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYLK mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYLK3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYO5A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYO6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYOM2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYOZ2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MZB1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NAA50 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NAP1L3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NAT10 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NCKAP5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NCL mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NCR1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NDC1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NDRG1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NDRG2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NDST1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NDUFAF4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NEAT1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NEK6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NEO1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NFE2L2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NFIA mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NFIL3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NFKBIA mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NFKBIE mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NFKBIZ mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NHERF2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NHP2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NIBAN3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NID2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NIP7 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NIPA1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NIPAL3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NKAIN4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NKG7 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NKRF mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NLE1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NMD3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NME6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NNAT mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOB1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOC2L mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOC3L mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOC4L mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOL10 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOL11 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOL12 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOLC1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOP14 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOP16 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOP2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOP56 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOP58 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOX4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NPL mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NPNT mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NPPB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NPR2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NR2F1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NR3C2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NRBP2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NREP mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NRG1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NRIP3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NRN1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NRP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NSUN2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NTMT1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NTN4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NUAK1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NUBP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NUDT6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NUDT7 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NUFIP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NUP210 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NUP43 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NUP62 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NUPR1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NUS1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NXPE3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OAZ2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OBSCN mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OCIAD2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ODC1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OGN mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OGT mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OLA1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OLFML1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OMD mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OPTN mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ORC2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OSBPL6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OSM mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OSMR mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OTUD3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of P2RY10 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of P2RY2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of P2RY6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PA2G4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PABPC4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PAIP2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PALMD mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PALS2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PAM mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PAMR1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PANK1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PAPPA mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PARL mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PARM1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PARP14 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PAWR mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PCDH12 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PCDHAC1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PCMTD1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PCMTD2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PCOLCE2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PDE12 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PDE4D mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PDE5A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PDE8B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PDGFD mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PDK4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PDLIM7 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PDSS1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PDZD2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PDZK1IP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PER3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PERP mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PES1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PGAM2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PGF mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PGM2L1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PGM5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PGR mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PGS1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PHACTR2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PHEX mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PHKB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PHLDA1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PHLDA3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PHLPP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PHXR4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PI15 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PI4K2B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PIM1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PINX1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PIRA1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PKD1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PKM mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PKP3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLA1A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLA2G12A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLA2G7 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLAAT3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLAT mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLAU mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLAUR mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLCB1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLCE1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLCXD3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLEKHD1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLIN2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLK2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLK3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLLP mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLN mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLPP2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLSCR2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLSCR4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLTP mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLXDC1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLXDC2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PMM1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PNKD mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PNLIPRP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PNO1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of POGLUT3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of POLE2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of POLK mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of POLR1B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of POLR1E mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of POLR1G mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of POLR2H mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of POLR3C mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of POU2AF1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPA1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPAN mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPAP2B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPBP mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPFIA4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPFIBP2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPL mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPM1K mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPME1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPP1R13L mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPP1R14B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPP1R15A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPP1R3C mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPP1R9A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPRC1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRDM1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRDM16 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRELID3B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRELP mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRICKLE1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRKAR2B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRKCI mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRKD2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRKDC mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRMT1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRMT3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRMT5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRMT6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRMT7 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRR16 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRR5L mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRRG1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRRX1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRSS22 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRSS23 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRXL2C mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PSCA mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PSD3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PSMD8 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PSME3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PSRC1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PSTPIP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PTCH1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PTGER4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PTGES mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PTGFR mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PTGIR mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PTGS1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PTGS2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PTPN13 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PTPN2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PTPRD mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PTRH1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PTX3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PURG mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PUS1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PUS7 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PUS7L mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PVR mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PVT1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PWP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PWP2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PYGB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PYHIN1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of QSOX1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of QTRT1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of R3HCC1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RAB19 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RAB20 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RAB3D mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RABGAP1L mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RABGGTB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RAD23B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RAE1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RALGPS2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RAMP3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RANBP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RANGRF mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RASD1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RASGEF1A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RASGRF2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RASGRP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RASGRP3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RASSF1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RASSF3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RAVER1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RBL2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RBM19 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RBM33 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RBMX2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RCC1L mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RDH11 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RDM1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RECK mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of REL mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RELB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of REPS2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RFC4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RFTN2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RGS16 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RHOC mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RIDA mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RIN1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RIPK3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RIPPLY3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RMDN1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RMDN2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RMND5A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RNASE4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RND3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RNF144A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RNF145 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RNF167 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RNF186 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RNF4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RNF43 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ROR1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RPF2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RPP30 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RPS27L mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RRAS2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RRP12 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RRP15 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RRP8 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RRS1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RSL1D1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RSPH14 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RSPO3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RSRP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RTKN2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RTL8C mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RTN1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RTN2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RTN4RL2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RTP3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RUNDC3B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RYR2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of S100A14 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of S100A4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of S100G mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of S1PR4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SAA1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SAA2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SAA3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SARS1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SAT1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SCD2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SCN3A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SCN7A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SCUBE2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SDAD1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SDCBP2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SEC14L3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SEC14L4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SEC16B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SELE mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SELENBP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SELENOI mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SELP mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SEMA3C mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SEMA4F mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SEMA6B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SEPTIN4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SERGEF mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SERINC5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SERPINA3M mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SERPINA3N mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SERPINB8 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SERPINB9B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SERPINE1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SERTAD1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SERTAD4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SESN1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SESN2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SETD1B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SETD7 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SFN mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SFTPA1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SGMS2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SGPL1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SH3D19 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SH3PXD2B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SH3TC2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SHB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SHH mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SHISA2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SHISA4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SHMT2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SHQ1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SIGLECG mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SIPA1L1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SIX5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC15A3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC16A6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC16A9 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC18B1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC19A1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC19A2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC20A1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC22A23 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC22A3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC23A1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC24A3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC25A23 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC25A25 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC25A33 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC25A34 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC2A1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC2A12 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC2A13 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC2A4RG-PS mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC34A2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC35G1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC36A2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC38A5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC39A14 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC39A4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC3A2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC41A2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC44A3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC4A1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC4A5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC6A14 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC7A1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC7A10 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC7A5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC7A6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLCO4A1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLN mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLPI mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SMARCA2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SMIM3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SMN1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SMPX mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SMYD2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SMYD5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SNAI2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SNCA mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SNED1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SNHG1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SNHG11 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SNHG12 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SNHG14 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SNHG5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SNHG6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SNN mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SNRPA1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SOCS3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SOD2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SOGA2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SORD mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SORL1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SORT1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SOWAHB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SOX18 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SOX4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SOX9 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SPA17 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SPECC1L mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SPHK1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SPIB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SPICE1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SPRY4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SPRYD4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SPTA1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SPTSSA mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SRF mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SRFBP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SRL mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SRM mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SRPK3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SRPX2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SSPN mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SSTR2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SSTR4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ST6GALNAC3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ST8SIA4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of STARD8 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of STARD9 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of STAT3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of STBD1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of STEAP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of STEAP2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of STING1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of STK33 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of STRADB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of STRAP mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of STXBP6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SULT1A1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SURF2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SURF6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SYBU mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SYNE1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SYNE2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SYNM mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SYTL2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TACSTD2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TAF4B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TAMM41 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TARS1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TASOR mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TBC1D2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TBC1D24 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TBC1D2B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TBC1D30 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TBC1D4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TBC1D8B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TBRG4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TBX2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TBX20 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TBXA2R mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TC2N mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TCAP mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TCEA3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TCEAL1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TCF21 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TCF23 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TCP11L2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TDG mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TDRKH mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TEAD4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TECRL mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TENT5C mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TET1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TEX11 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TFPI2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TGFBI mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TGIF1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TGM1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TGM2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of THBD mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of THBS3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of THNSL1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of THSD1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of THUMPD1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TIMM10 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TIMM17A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TIMM8A1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TIMP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TINAG mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TINAGL1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TLCD5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TLE2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TLR13 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TLR4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TLR6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TMA16 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TMCC2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TMEFF2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TMEM119 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TMEM120A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TMEM132C mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TMEM14A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TMEM178 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TMEM182 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TMEM204 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TMEM205 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TMEM252 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TMEM255A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TMEM37 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TMEM43 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TMEM50B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TMEM82 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TMOD4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TMPRSS2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TMTC1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TMTC2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TNC mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TNFAIP2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TNFAIP3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TNFRSF10B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TNFRSF12A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TNFRSF13C mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TNFRSF19 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TNFSF10 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TNFSF9 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TNN mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TNNC1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TNNI3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TNNT1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TNNT2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TNRC6B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TNS2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TOMM40 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TOMM70A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TOP1MT mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TOR4A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TOX3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TPM2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TPPP mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TPPP3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TRAF1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TRAF4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TRAV9D-3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TRDN mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TREM1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TRIB1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TRIB3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TRIL mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TRIM14 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TRIM16 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TRIP6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TRMT10C mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TRMT6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TRMT61A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TRP53BP2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TRP53INP2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TRUB1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TSHB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TSKU mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TSPAN13 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TSPAN17 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TSPAN4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TSPYL4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TSR1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TST mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TTC27 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TTC28 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TTC39B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TTC39C mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TTC6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TTN mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TUBA1C mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TUBB6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TUFT1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TWSG1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TXLNB mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TXNRD1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of UBE2J2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of UCK2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ULK2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of USHBP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of USP46 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of UTP14A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of UTP14B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of UTP15 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of UTP18 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of UTP20 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of UTP4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of VCAN mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of VGLL3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of VKORC1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of VSNL1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of VTN mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of WBP1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of WDR12 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of WDR4 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of WDR43 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of WDR5 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of WDR55 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of WDR6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of WDR74 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of WDR75 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of WFDC6A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of WNT2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of YARS2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of YPEL2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of YPEL3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of YRDC mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZBTB26 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZC3H12A mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZC3H12C mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZC3HAV1L mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZFP202 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZFP266 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZFP329 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZFP37 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZFP455 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZFP467 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZFP563 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZFP593 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZFP612 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZFP704 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZFP760 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZFP866 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZFP874B mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZFP948 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZMAT1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZMAT3 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZMYND8 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZNHIT6 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZRSR2 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZRSR2-PS1 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZSCAN26 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZSWIM7 mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZWINT mRNA; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the secretion of MUC5AC protein; [NFE2L2 protein affects the susceptibility to sulforaphane] affects the reaction [Oxygen deficiency results in increased expression of CCN2 protein]; [NFE2L2 protein affects the susceptibility to sulforaphane] affects the reaction [Oxygen deficiency results in increased expression of SERPINE1 protein]; [NFE2L2 protein affects the susceptibility to sulforaphane] affects the reaction [Oxygen deficiency results in increased expression of VCAM1 protein]; [Oxygen deficiency co-treated with Oxygen] results in increased activity of NFE2L2 protein; [Oxygen deficiency co-treated with Oxygen] results in increased expression of NFE2L2 protein; HIPK2 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased activity of NFE2L2 protein]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NFE2L2 mRNA]]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NFE2L2 protein]]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NFE2L2 mRNA]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NFE2L2 protein]; NFE2L2 gene mutant form promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MYH7 mRNA]; NFE2L2 gene mutant form promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NPPA mRNA]; NFE2L2 gene mutant form promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NPPB mRNA]; NFE2L2 gene mutant form results in increased susceptibility to [Oxygen deficiency co-treated with Blood Glucose deficiency]; NFE2L2 protein affects the reaction [[sulforaphane co-treated with Oxygen] results in increased expression of COX1 protein]; NFE2L2 protein affects the reaction [Oxygen deficiency results in increased expression of CCN2 protein]; NFE2L2 protein affects the reaction [Oxygen deficiency results in increased expression of SERPINE1 protein]; NFE2L2 protein affects the reaction [Oxygen deficiency results in increased expression of VCAM1 protein]; NFE2L2 protein affects the reaction [Oxygen inhibits the reaction [sulforaphane results in increased expression of SDHB protein]]; NFE2L2 protein affects the reaction [Oxygen results in increased activity of RELA protein]; NFE2L2 protein affects the reaction [Oxygen results in increased expression of PLN protein]; NFE2L2 protein affects the reaction [Oxygen results in increased expression of VDAC1 protein]; NFE2L2 protein affects the reaction [Oxygen results in increased secretion of MUC5AC protein]; NFE2L2 protein affects the reaction [PHLPP2 protein affects the reaction [Oxygen deficiency results in increased activity of CASP3 protein]]; NFE2L2 protein affects the reaction [PHLPP2 protein affects the reaction [Oxygen deficiency results in increased expression of NFE2L2 protein]]; NFE2L2 protein affects the reaction [sulforaphane inhibits the reaction [Oxygen results in increased activity of RELA protein]]; NFE2L2 protein affects the reaction [sulforaphane inhibits the reaction [Oxygen results in increased secretion of MUC5AC protein]]; NFE2L2 protein affects the reaction [sulforaphane promotes the reaction [Oxygen results in increased expression of NDUFB8 protein]]; NFE2L2 protein affects the reaction [sulforaphane promotes the reaction [Oxygen results in increased expression of PLN protein]]; NFE2L2 protein affects the reaction [sulforaphane promotes the reaction [Oxygen results in increased expression of VDAC1 protein]]; NFE2L2 protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of SULT1E1 mRNA]; NFE2L2 protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of SULT1E1 protein]; Oxygen deficiency affects the reaction [NFE2L2 protein affects the expression of CASP1 mRNA]; Oxygen deficiency affects the reaction [NFE2L2 protein affects the expression of IL18 mRNA]; Oxygen deficiency results in increased expression of and affects the localization of NFE2L2 protein; PHLPP2 protein affects the reaction [Oxygen deficiency results in increased expression of NFE2L2 protein]; PHLPP2 protein inhibits the reaction [Oxygen deficiency results in increased expression of NFE2L2 mRNA]; SB 216763 inhibits the reaction [SGMS2 protein inhibits the reaction [Oxygen deficiency results in increased expression of and affects the localization of NFE2L2 protein]]; SB 216763 promotes the reaction [Oxygen deficiency affects the localization of NFE2L2 protein]; SGMS2 protein affects the reaction [Oxygen deficiency affects the localization of NFE2L2 protein]; SGMS2 protein inhibits the reaction [Oxygen deficiency results in increased expression of and affects the localization of NFE2L2 protein]; sulforaphane inhibits the reaction [Oxygen affects the localization of NFE2L2 protein]; sulforaphane inhibits the reaction [Oxygen deficiency results in decreased expression of NFE2L2 protein]; TWS 119 inhibits the reaction [PHLPP2 protein inhibits the reaction [Oxygen deficiency results in increased expression of NFE2L2 mRNA]]; wedelolactone inhibits the reaction [Oxygen results in decreased expression of NFE2L2 protein] Oxygen deficiency affects the expression of NFE2L2 mRNA; Oxygen deficiency affects the expression of NFE2L2 protein 2-tert-butylhydroquinone promotes the reaction [Oxygen deficiency results in increased expression of NFE2L2 protein]; [Ascorbic Acid co-treated with alpha-Tocopherol co-treated with ferulic acid] promotes the reaction [[Ozone co-treated with Oxygen] results in increased localization of NFE2L2 protein]; [Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein; [Ozone co-treated with Oxygen] inhibits the reaction [KEAP1 protein results in increased degradation of NFE2L2 protein]; [Ozone co-treated with Oxygen] results in increased expression of and results in increased localization of NFE2L2 protein; GSK3235025 inhibits the reaction [Oxygen deficiency results in decreased expression of NFE2L2 protein]; NFE2L2 protein inhibits the reaction [sodium arsenite inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]]; NFE2L2 protein promotes the reaction [sodium arsenite inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]]; Oxygen deficiency results in increased expression of and affects the localization of NFE2L2 protein; Particulate Matter inhibits the reaction [[Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]]; Vehicle Emissions inhibits the reaction [[Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NFE2L2 protein]] NFE2L2 protein affects the susceptibility to Oxygen deficiency [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the susceptibility to Oxygen deficiency; NFE2L2 protein affects the susceptibility to Oxygen Oxygen deficiency results in decreased expression of NFE2L2 protein; Oxygen results in decreased expression of NFE2L2 protein NFE2L2 gene mutant form results in increased susceptibility to Oxygen deficiency Oxygen deficiency results in increased expression of NFE2L2 mRNA; Oxygen deficiency results in increased expression of NFE2L2 protein
|
CTD |
PMID:20028456 PMID:22892143 PMID:25448280 PMID:25596134 PMID:25773745 PMID:25896937 PMID:25922074 PMID:26270818 PMID:26747958 PMID:27286880 PMID:28373008 PMID:28400208 PMID:29255069 PMID:29719095 PMID:29864481 PMID:29966676 PMID:30096613 PMID:30529165 PMID:31610156 PMID:31629700 PMID:31837296 PMID:31885778 PMID:33111559 PMID:33508982 PMID:34023435 PMID:34217758 PMID:34351043 PMID:35191607 PMID:39038764 PMID:39110510 More...
|
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Nfia
|
nuclear factor I/A
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of NFIA mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NFIA mRNA
|
CTD |
PMID:24205000 PMID:30529165 |
|
NCBI chr 5:117,359,006...117,897,391
Ensembl chr 5:117,359,077...117,891,395
|
|
| G
|
Nfil3
|
nuclear factor, interleukin 3 regulated
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NFIL3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr17:12,432,376...12,447,605
Ensembl chr17:12,432,198...12,450,826
|
|
| G
|
Nfkb1
|
nuclear factor kappa B subunit 1
|
multiple interactions affects localization
|
ISO EXP
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency affects the localization of NFKB1 protein]; AG 1879 inhibits the reaction [Oxygen deficiency promotes the reaction [NFKB1 protein binds to NFKB1 protein]]; AG 1879 inhibits the reaction [Oxygen deficiency promotes the reaction [NFKB1 protein binds to RELA protein]]; Curcumin inhibits the reaction [Oxygen deficiency affects the localization of NFKB1 protein]; diphenyleneiodonium inhibits the reaction [Oxygen deficiency promotes the reaction [RELA protein binds to NFKB1 protein]]; Genistein inhibits the reaction [Oxygen deficiency affects the localization of NFKB1 protein]; Oxygen deficiency promotes the reaction [NFKB1 protein binds to NFKB1 protein]; Oxygen deficiency promotes the reaction [NFKB1 protein binds to RELA protein]; Oxygen deficiency promotes the reaction [RELA protein binds to NFKB1 protein]; Plant Extracts inhibits the reaction [Oxygen deficiency affects the localization of NFKB1 protein]; Resveratrol inhibits the reaction [Oxygen deficiency affects the localization of NFKB1 protein]; Rotenone inhibits the reaction [Oxygen deficiency promotes the reaction [RELA protein binds to NFKB1 protein]] [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NFKB1 protein; NFKB1 protein inhibits the reaction [SOD1 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PTGS2 protein]]; SOD1 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of and results in increased activity of NFKB1 protein] [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NFKB1 protein; cardamonin inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NFKB1 protein]
|
CTD |
PMID:11950692 PMID:16395278 PMID:17671207 PMID:23452621 PMID:28966130 |
|
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
|
|
| G
|
Nfkb2
|
nuclear factor kappa B subunit 2
|
multiple interactions
|
ISO
|
[Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of NFKB2 mRNA; [Oxygen co-treated with Ozone] results in decreased expression of NFKB2 mRNA
|
CTD |
PMID:32992648 |
|
NCBI chr 1:255,106,010...255,114,649
Ensembl chr 1:255,107,374...255,114,637
|
|
| G
|
Nfkbia
|
NFKB inhibitor alpha
|
multiple interactions decreases expression increases degradation increases expression increases phosphorylation
|
ISO EXP
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of NFKBIA mRNA]; 3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased phosphorylation of NFKBIA protein]; [IL1B protein co-treated with Oxygen deficiency] results in increased degradation of NFKBIA protein; AG 1879 inhibits the reaction [Oxygen deficiency results in increased phosphorylation of NFKBIA protein]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of NFKBIA mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased phosphorylation of NFKBIA protein]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of NFKBIA mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased phosphorylation of NFKBIA protein]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of NFKBIA mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased phosphorylation of NFKBIA protein]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of NFKBIA mRNA]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased phosphorylation of NFKBIA protein] Oxygen results in decreased expression of NFKBIA protein Oxygen results in increased degradation of NFKBIA protein [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of NFKBIA protein; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NFKBIA mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased degradation of NFKBIA protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of and results in increased degradation of NFKBIA protein; HU 308 inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of NFKBIA protein]; iodopravadoline inhibits the reaction [peoniflorin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of NFKBIA protein]]; iodopravadoline promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of NFKBIA protein]; peoniflorin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of NFKBIA protein]; Prodigiosin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased degradation of NFKBIA protein]; prolinedithiocarbamate inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased degradation of NFKBIA protein] [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of NFKBIA protein; [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of NFKBIA protein; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased sumoylation of NFKBIA protein; [Oxygen deficiency co-treated with Oxygen] results in decreased expression of NFKBIA mRNA; [Oxygen deficiency co-treated with Oxygen] results in decreased expression of NFKBIA protein; HU 308 inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of NFKBIA protein]; iodopravadoline inhibits the reaction [peoniflorin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of NFKBIA protein]]; iodopravadoline promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of NFKBIA protein]; NUCB2 protein inhibits the reaction [Oxygen results in increased phosphorylation of NFKBIA protein]; peoniflorin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of NFKBIA protein]; Prasugrel Hydrochloride inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased sumoylation of NFKBIA protein]; Resveratrol inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of NFKBIA protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of NFKBIA mRNA]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of NFKBIA protein]
|
CTD |
PMID:11034997 PMID:14652683 PMID:16395278 PMID:17671207 PMID:21925195 PMID:23452621 PMID:24205000 PMID:27064547 PMID:29560022 PMID:30529165 PMID:34174262 PMID:38511245 More...
|
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
| G
|
Nfkbie
|
NFKB inhibitor epsilon
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NFKBIE mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:22,941,037...22,947,872
Ensembl chr 9:22,941,040...22,947,872
|
|
| G
|
Nfkbiz
|
NFKB inhibitor zeta
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NFKBIZ mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr11:58,251,720...58,279,767
Ensembl chr11:58,251,721...58,279,767
|
|
| G
|
Ngf
|
nerve growth factor
|
affects expression increases expression multiple interactions
|
ISO EXP
|
Oxygen affects the expression of NGF mRNA Oxygen deficiency results in increased expression of NGF mRNA NGF protein inhibits the reaction [Quercetin inhibits the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein]]; NGF protein inhibits the reaction [Quercetin inhibits the reaction [Oxygen deficiency results in increased phosphorylation of NTRK1 protein]]; panaxydol promotes the reaction [Oxygen deficiency results in increased expression of NGF mRNA]
|
CTD |
PMID:18541227 PMID:19954754 PMID:26476374 |
|
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834
|
|
| G
|
Ngfr
|
nerve growth factor receptor
|
increases response to substance multiple interactions
|
ISO
|
NGFR protein results in increased susceptibility to Oxygen [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TNFRSF10B mRNA
|
CTD |
PMID:11463606 PMID:30529165 |
|
NCBI chr10:81,012,077...81,030,305
Ensembl chr10:81,012,089...81,030,305
|
|
| G
|
Nherf1
|
NHERF family PDZ scaffold protein 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NHERF1 mRNA
|
CTD |
PMID:25536518 |
|
NCBI chr10:100,902,165...100,919,265
Ensembl chr10:100,901,227...100,919,579
|
|
| G
|
Nherf2
|
NHERF family PDZ scaffold protein 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NHERF2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:14,167,005...14,177,519
Ensembl chr10:14,167,005...14,177,593
|
|
| G
|
Nhp2
|
NHP2 ribonucleoprotein
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NHP2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:36,378,020...36,381,362
Ensembl chr10:36,377,997...36,381,354
|
|
| G
|
Nhs
|
NHS actin remodeling regulator
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of NHS mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr X:36,185,067...36,524,711
Ensembl chr X:36,438,178...36,524,708
|
|
| G
|
Nhsl1
|
NHS-like 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of NHSL1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 1:14,775,874...15,008,327
Ensembl chr 1:14,705,839...15,008,327
|
|
| G
|
Niban2
|
niban apoptosis regulator 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FAM129B mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 3:36,572,356...36,621,968
Ensembl chr 3:36,572,377...36,621,967
|
|
| G
|
Niban3
|
niban apoptosis regulator 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NIBAN3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr16:18,341,108...18,352,571
Ensembl chr16:18,341,141...18,352,575
|
|
| G
|
Nid1
|
nidogen 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of NID1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr17:93,069,013...93,142,416
Ensembl chr17:93,069,278...93,142,386
|
|
| G
|
Nid2
|
nidogen 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NID2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr15:4,507,224...4,562,949
Ensembl chr15:4,506,756...4,562,949
|
|
| G
|
Nifk
|
nucleolar protein interacting with the FHA domain of MKI67
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MKI67IP mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr13:31,946,119...31,955,950
Ensembl chr13:31,946,108...31,959,561
|
|
| G
|
Nim1k
|
NIM1 serine/threonine protein kinase
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of NIM1K mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 2:53,403,467...53,451,248
Ensembl chr 2:53,403,473...53,419,656
|
|
| G
|
Nin
|
ninein
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NIN mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 6:94,261,382...94,363,679
Ensembl chr 6:94,263,206...94,363,610
|
|
| G
|
Ninj1
|
ninjurin 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NINJ1 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr17:15,659,208...15,668,115
Ensembl chr17:15,659,200...15,668,063
|
|
| G
|
Nip7
|
nucleolar pre-rRNA processing protein NIP7
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of NIP7 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NIP7 mRNA
|
CTD |
PMID:24236059 PMID:30529165 |
|
NCBI chr19:51,872,306...51,874,448
Ensembl chr19:51,872,364...51,876,120
|
|
| G
|
Nipa1
|
NIPA magnesium transporter 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of NIPA1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NIPA1 mRNA; Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of NIPA1 mRNA]
|
CTD |
PMID:22629407 PMID:30529165 |
|
NCBI chr 1:115,608,221...116,010,503
Ensembl chr 1:115,974,481...116,010,812
|
|
| G
|
Nipal3
|
NIPA-like domain containing 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NIPAL3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:152,970,934...153,010,006
Ensembl chr 5:152,968,910...153,008,845
|
|
| G
|
Nisch
|
nischarin
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of NISCH mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr16:6,370,809...6,407,104
Ensembl chr16:6,370,809...6,407,387
|
|
| G
|
Nkain4
|
Sodium/potassium transporting ATPase interacting 4
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of NKAIN4 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NKAIN4 mRNA
|
CTD |
PMID:24236059 PMID:30529165 |
|
NCBI chr 3:188,430,862...188,451,561
Ensembl chr 3:188,430,243...188,453,760
|
|
| G
|
Nkap
|
NFKB activating protein
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NKAP mRNA; Streptozocin promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NKAP mRNA]
|
CTD |
PMID:30611788 |
|
NCBI chr X:121,238,714...121,258,360
Ensembl chr X:121,238,404...121,261,238
|
|
| G
|
Nkg7
|
natural killer cell granule protein 7
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NKG7 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:102,981,497...102,982,564
Ensembl chr 1:102,981,450...102,982,562
|
|
| G
|
Nkrf
|
NFKB repressing factor
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NKRF mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr X:120,992,038...121,010,251
Ensembl chr X:120,992,038...121,010,251
|
|
| G
|
Nle1
|
notchless homolog 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NLE1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:68,331,609...68,342,562
Ensembl chr10:68,331,609...68,340,386
|
|
| G
|
Nlgn3
|
neuroligin 3
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of NLGN3 mRNA Simvastatin inhibits the reaction [Oxygen deficiency results in increased expression of NLGN3 mRNA]
|
CTD |
PMID:16373842 |
|
NCBI chr X:70,469,251...70,497,380
Ensembl chr X:70,469,457...70,497,379
|
|
| G
|
Nlrc5
|
NLR family, CARD domain containing 5
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of NLRC5 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of NLRC5 mRNA
|
CTD |
PMID:26516004 PMID:33729688 |
|
NCBI chr19:10,483,601...10,587,223
Ensembl chr19:10,483,755...10,555,786
|
|
| G
|
Nlrp12
|
NLR family, pyrin domain containing 12
|
multiple interactions increases expression
|
ISO EXP
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of NLRP12 mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of NLRP12 mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of NLRP12 mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of NLRP12 mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of NLRP12 mRNA] [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NLRP12 mRNA
|
CTD |
PMID:23452621 PMID:26516004 PMID:33729688 |
|
NCBI chr 1:74,848,020...74,885,945
Ensembl chr 1:74,848,063...74,876,341
|
|
| G
|
Nlrp3
|
NLR family, pyrin domain containing 3
|
multiple interactions increases expression
|
EXP ISO
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NLRP3 mRNA]; [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NLRP3 protein]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NLRP3 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NLRP3 protein; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NLRP3 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NLRP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NLRP3 protein; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NLRP3 protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NLRP3 mRNA]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NLRP3 protein] [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NLRP3 protein; bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NLRP3 protein] Oxygen deficiency results in increased expression of NLRP3 protein
|
CTD |
PMID:26464617 PMID:33729688 PMID:35191607 PMID:37127800 PMID:39038764 |
|
NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,828,014...44,853,394
|
|
| G
|
Nmbr
|
neuromedin B receptor
|
multiple interactions increases expression
|
ISO
|
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Oxygen deficiency results in increased expression of NMBR mRNA]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Oxygen deficiency results in increased expression of NMBR protein]; Oxygen deficiency promotes the reaction [[HIF1A protein binds to NMBR promoter] which results in increased expression of NMBR mRNA]; Oxygen deficiency promotes the reaction [HIF1A protein binds to NMBR promoter] Oxygen deficiency results in increased expression of NMBR mRNA; Oxygen deficiency results in increased expression of NMBR protein
|
CTD |
PMID:24349381 |
|
NCBI chr 1:10,942,476...10,966,174
Ensembl chr 1:10,954,916...10,965,555
|
|
| G
|
Nmd3
|
NMD3 ribosome export adaptor
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NMD3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:156,285,773...156,348,394
Ensembl chr 2:156,322,963...156,350,903
|
|
| G
|
Nme1
|
NME/NM23 nucleoside diphosphate kinase 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NME1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:79,403,939...79,426,620
Ensembl chr10:79,403,940...79,413,310
|
|
| G
|
Nme6
|
NME/NM23 nucleoside diphosphate kinase 6
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NME6 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:118,708,092...118,717,756
Ensembl chr 8:118,711,036...118,718,288
|
|
| G
|
Nmu
|
neuromedin U
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of NMU mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr14:32,198,789...32,226,397
Ensembl chr14:32,198,943...32,226,632
|
|
| G
|
Nnat
|
neuronatin
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of NNAT mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NNAT mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 3:166,646,373...166,648,845
Ensembl chr 3:166,646,384...166,649,086
|
|
| G
|
Nob1
|
NIN1 (RPN12) binding protein 1 homolog
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOB1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:52,232,543...52,245,824
Ensembl chr19:52,232,543...52,256,189
|
|
| G
|
Noc2l
|
NOC2-like nucleolar associated transcriptional repressor
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOC2L mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:172,102,369...172,114,168
Ensembl chr 5:172,101,223...172,114,162
|
|
| G
|
Noc3l
|
NOC3-like DNA replication regulator
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOC3L mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:245,969,179...245,997,761
Ensembl chr 1:245,969,179...245,997,708
|
|
| G
|
Noc4l
|
nucleolar complex associated 4 homolog
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOC4L mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr12:51,675,852...51,680,392
Ensembl chr12:51,675,838...51,680,390
|
|
| G
|
Noct
|
nocturnin
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NOCT mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 2:137,422,074...137,442,282
Ensembl chr 2:137,422,074...137,442,282
|
|
| G
|
Nod1
|
nucleotide-binding oligomerization domain containing 1
|
multiple interactions increases expression
|
ISO
|
3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of NOD1 mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of NOD1 mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of NOD1 mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of NOD1 mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of NOD1 mRNA]
|
CTD |
PMID:23452621 |
|
NCBI chr 4:85,391,142...85,442,281
Ensembl chr 4:85,391,151...85,441,674
|
|
| G
|
Nod2
|
nucleotide-binding oligomerization domain containing 2
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of NOD2 mRNA HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of NOD2 mRNA]; Oxygen deficiency promotes the reaction [HIF1A protein binds to NOD2 promoter]
|
CTD |
PMID:23880069 |
|
NCBI chr19:34,555,832...34,596,281
Ensembl chr19:34,555,832...34,722,846
|
|
| G
|
Nog
|
noggin
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of NOG mRNA
|
CTD |
PMID:24236059 PMID:26516004 |
|
NCBI chr10:74,625,874...74,627,501
Ensembl chr10:74,625,875...74,628,103
|
|
| G
|
Nol10
|
nucleolar protein 10
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOL10 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:45,861,773...45,954,067
Ensembl chr 6:45,872,960...45,954,066
|
|
| G
|
Nol11
|
nucleolar protein 11
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOL11 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:92,621,482...92,641,394
Ensembl chr10:92,621,498...92,641,394
|
|
| G
|
Nol12
|
nucleolar protein 12
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOL12 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:112,373,749...112,379,362
Ensembl chr 7:112,373,845...112,380,357
|
|
| G
|
Nol3
|
nucleolar protein 3
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of NOL3 mRNA
|
CTD |
PMID:17914565 |
|
NCBI chr19:50,066,493...50,068,175
Ensembl chr19:50,063,986...50,068,722
|
|
| G
|
Nol6
|
nucleolar protein 6
|
multiple interactions
|
EXP
|
NOL6 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]
|
CTD |
PMID:21124846 |
|
NCBI chr 5:61,055,863...61,083,249
Ensembl chr 5:61,055,863...61,083,264
|
|
| G
|
Nolc1
|
nucleolar and coiled-body phosphoprotein 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOLC1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:254,870,195...254,881,070
Ensembl chr 1:254,870,319...254,881,069
|
|
| G
|
Nop14
|
NOP14 nucleolar protein
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOP14 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:80,305,912...80,327,053
Ensembl chr14:80,305,338...80,328,655
|
|
| G
|
Nop16
|
NOP16 nucleolar protein
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of NOP16 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOP16 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr17:10,028,058...10,032,975
Ensembl chr17:10,028,034...10,033,038
|
|
| G
|
Nop2
|
NOP2 nucleolar protein
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of NOP2 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOP2 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NOP2 mRNA
|
CTD |
PMID:26516004 PMID:30529165 PMID:33729688 |
|
NCBI chr 4:159,618,894...159,630,697
Ensembl chr 4:159,618,966...159,630,697
|
|
| G
|
Nop56
|
NOP56 ribonucleoprotein
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOP56 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:137,926,187...137,934,971
Ensembl chr 3:137,929,646...137,934,959
|
|
| G
|
Nop58
|
NOP58 ribonucleoprotein
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOP58 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:68,614,992...68,638,911
Ensembl chr 9:68,615,010...68,638,909
|
|
| G
|
Nos1
|
nitric oxide synthase 1
|
decreases expression increases expression
|
EXP
|
Oxygen deficiency results in decreased expression of NOS1 protein Oxygen deficiency results in increased expression of NOS1 mRNA; Oxygen deficiency results in increased expression of NOS1 protein
|
CTD |
PMID:10956627 PMID:18331222 |
|
NCBI chr12:44,276,011...44,456,371
Ensembl chr12:44,287,614...44,371,837
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
multiple interactions increases expression
|
ISO EXP
|
[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of NOS2 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOS2 protein; HU 308 inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of NOS2 protein]; iodopravadoline inhibits the reaction [peoniflorin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of NOS2 protein]]; iodopravadoline promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of NOS2 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of NOS2 protein]; peoniflorin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of NOS2 protein]; Prodigiosin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOS2 protein]; prolinedithiocarbamate inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOS2 protein] [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with zinc protoporphyrin] results in increased expression of NOS2 mRNA; [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with zinc protoporphyrin] results in increased expression of NOS2 protein; [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in increased expression of NOS2 mRNA; [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in increased expression of NOS2 protein; [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of NOS2 mRNA; [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of NOS2 protein; [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of NOS2 protein; [Oxygen co-treated with Glucose] promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOS2 protein]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NOS2 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NOS2 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NOS2 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOS2 protein; cardamonin inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NOS2 mRNA]; Ethanol promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of NOS2 mRNA]; Ethanol promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of NOS2 protein]; Hemin inhibits the reaction [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in increased expression of NOS2 mRNA]; Hemin inhibits the reaction [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in increased expression of NOS2 protein]; Hemin inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of NOS2 mRNA]; Hemin inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of NOS2 protein]; HU 308 inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of NOS2 protein]; iodopravadoline inhibits the reaction [peoniflorin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of NOS2 protein]]; iodopravadoline promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of NOS2 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of NOS2 mRNA]; Oxygen inhibits the reaction [Paraquat results in increased expression of NOS2 protein]; peoniflorin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of NOS2 protein]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of NOS2 mRNA]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of NOS2 protein]; RSVA314 inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NOS2 protein]; RSVA405 inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NOS2 protein]; zinc protoporphyrin promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of NOS2 mRNA]; zinc protoporphyrin promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of NOS2 protein] Oxygen deficiency results in increased expression of NOS2 mRNA; Oxygen deficiency results in increased expression of NOS2 protein
|
CTD |
PMID:18331222 PMID:21914476 PMID:21925195 PMID:23061969 PMID:24223152 PMID:25214260 PMID:25268557 PMID:26722498 PMID:26747958 PMID:28966130 PMID:29560022 PMID:33729688 More...
|
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Nos3
|
nitric oxide synthase 3
|
decreases activity increases phosphorylation decreases expression multiple interactions increases expression
|
ISO EXP
|
Oxygen deficiency results in decreased activity of NOS3 protein Oxygen deficiency results in increased phosphorylation of NOS3 protein Oxygen deficiency results in decreased expression of NOS3 mRNA; Oxygen deficiency results in decreased expression of NOS3 protein [Diethylhexyl Phthalate co-treated with Oxygen] results in decreased expression of NOS3 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of NOS3 mRNA; cardamonin inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of NOS3 mRNA]; Oxygen deficiency promotes the reaction [AGT protein results in increased expression of NOS3 protein]; Oxygen deficiency results in increased expression of and results in increased phosphorylation of NOS3 protein; sarpogrelate promotes the reaction [Oxygen deficiency results in increased expression of NOS3 protein]; tanshinone inhibits the reaction [Oxygen deficiency results in decreased expression of NOS3 protein]; Valsartan inhibits the reaction [Oxygen deficiency promotes the reaction [AGT protein results in increased expression of NOS3 protein]] valsartan inhibits the reaction [Oxygen deficiency results in increased phosphorylation of NOS3 protein] Oxygen deficiency results in increased expression of NOS3 mRNA; Oxygen deficiency results in increased expression of NOS3 protein Oxygen deficiency results in decreased expression of NOS3 mRNA; Oxygen deficiency results in decreased expression of NOS3 protein; Oxygen results in decreased expression of NOS3 mRNA Oxygen deficiency results in increased expression of NOS3 mRNA; Oxygen deficiency results in increased expression of NOS3 protein; Oxygen deficiency results in increased expression of NOS3 protein modified form 3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of NOS3 protein modified form]; 3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of NOS3 protein]; Acetylcysteine inhibits the reaction [Oxygen deficiency results in decreased expression of NOS3 protein]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of NOS3 protein modified form]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of NOS3 protein]; diphenyleneiodonium inhibits the reaction [Oxygen deficiency results in decreased expression of NOS3 protein]; Folic Acid inhibits the reaction [Oxygen deficiency results in decreased expression of NOS3 protein]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of NOS3 protein modified form]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of NOS3 protein]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of NOS3 protein modified form]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of NOS3 protein]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of NOS3 protein modified form]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of NOS3 protein]; U 0126 inhibits the reaction [Oxygen deficiency results in decreased expression of NOS3 protein]
|
CTD |
PMID:10747003 PMID:10956627 PMID:11897773 PMID:12829860 PMID:18001528 PMID:18436887 PMID:23424623 PMID:23452621 PMID:25931318 PMID:26906511 PMID:27313889 PMID:28576411 PMID:28966130 PMID:28985491 More...
|
|
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
| G
|
Notch1
|
notch receptor 1
|
multiple interactions increases expression affects localization
|
ISO EXP
|
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency affects the localization of NOTCH1 protein modified form]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [Oxygen deficiency results in increased expression of NOTCH1 protein] Oxygen deficiency results in increased expression of NOTCH1 mRNA; Oxygen deficiency results in increased expression of NOTCH1 protein
|
CTD |
PMID:24223152 |
|
NCBI chr 3:29,676,040...29,721,613
Ensembl chr 3:29,676,171...29,721,613
|
|
| G
|
Notch2
|
notch receptor 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NOTCH2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 2:188,299,336...188,432,823
Ensembl chr 2:188,299,336...188,432,823
|
|
| G
|
Notch3
|
notch receptor 3
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of NOTCH3 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 7:11,783,550...11,834,585
Ensembl chr 7:11,784,272...11,834,778
|
|
| G
|
Notch4
|
notch receptor 4
|
multiple interactions increases expression
|
EXP
|
Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of NOTCH4 mRNA]
|
CTD |
PMID:26476374 |
|
NCBI chr20:4,164,969...4,189,072
Ensembl chr20:4,161,730...4,189,072
|
|
| G
|
Nova2
|
NOVA alternative splicing regulator 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of NOVA2 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 1:87,700,328...87,741,755
Ensembl chr 1:87,700,328...87,778,669
|
|
| G
|
Nox1
|
NADPH oxidase 1
|
multiple interactions increases expression
|
EXP
|
BQ 788 inhibits the reaction [Oxygen deficiency results in increased expression of NOX1 mRNA]; BQ 788 inhibits the reaction [Oxygen deficiency results in increased expression of NOX1 protein]; cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [Oxygen deficiency results in increased expression of NOX1 protein] Oxygen deficiency results in increased expression of NOX1 mRNA; Oxygen deficiency results in increased expression of NOX1 protein
|
CTD |
PMID:34478853 |
|
NCBI chr X:101,572,338...101,625,571
Ensembl chr X:101,572,340...101,595,520
|
|
| G
|
Nox4
|
NADPH oxidase 4
|
multiple interactions increases expression
|
ISO EXP
|
diphenyleneiodonium inhibits the reaction [Oxygen deficiency results in increased expression of NOX4 protein]; Folic Acid inhibits the reaction [Oxygen deficiency results in increased expression of NOX4 protein]; NOX4 protein promotes the reaction [Oxygen deficiency results in increased expression of and results in increased activity of HIF1A protein]; NOX4 protein promotes the reaction [sodium arsenite inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased activity of HIF1A protein]]; Rosiglitazone inhibits the reaction [Oxygen deficiency results in increased expression of NOX4 mRNA]; U 0126 inhibits the reaction [Oxygen deficiency results in increased expression of NOX4 protein] Oxygen deficiency results in increased expression of NOX4 mRNA; Oxygen results in increased expression of NOX4 mRNA; Oxygen results in increased expression of NOX4 protein [CAV1 gene mutant form results in increased susceptibility to Oxygen deficiency] which results in increased expression of NOX4 mRNA; [CAV1 gene mutant form results in increased susceptibility to Oxygen deficiency] which results in increased expression of NOX4 protein; [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOX4 mRNA; MIR34C promotes the reaction [Oxygen results in increased expression of NOX4 mRNA]; MIR34C promotes the reaction [Oxygen results in increased expression of NOX4 protein]; Rosiglitazone inhibits the reaction [Oxygen deficiency results in increased expression of NOX4 mRNA]; SRT1720 inhibits the reaction [Oxygen results in decreased expression of NOX4 mRNA]; SRT1720 inhibits the reaction [Oxygen results in decreased expression of NOX4 protein] Oxygen deficiency results in increased expression of NOX4 mRNA; Oxygen deficiency results in increased expression of NOX4 protein [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOX4 mRNA; [Semaxinib co-treated with Oxygen deficiency] results in increased expression of NOX4 mRNA; Antigen-Antibody Complex inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOX4 mRNA]; BQ 788 inhibits the reaction [Oxygen deficiency results in increased expression of NOX4 mRNA]; BQ 788 inhibits the reaction [Oxygen deficiency results in increased expression of NOX4 protein]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of NOX4 mRNA]; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of NOX4 protein]; saxagliptin inhibits the reaction [Oxygen deficiency results in increased expression of NOX4 mRNA]; saxagliptin inhibits the reaction [Oxygen deficiency results in increased expression of NOX4 protein]
|
CTD |
PMID:19520921 PMID:24492474 PMID:24835767 PMID:24947524 PMID:26516004 PMID:26906511 PMID:27286880 PMID:27313889 PMID:29702141 PMID:30529165 PMID:31629700 PMID:34478853 PMID:35848756 PMID:35883890 More...
|
|
NCBI chr 1:150,313,736...150,491,480
Ensembl chr 1:150,313,728...150,491,483
|
|
| G
|
Noxa1
|
NADPH oxidase activator 1
|
multiple interactions
|
EXP
|
[Semaxinib co-treated with Oxygen deficiency] results in decreased expression of NOXA1 mRNA
|
CTD |
PMID:24947524 |
|
NCBI chr 3:28,293,643...28,309,828
Ensembl chr 3:28,293,658...28,304,022
|
|
| G
|
Noxo1
|
NADPH oxidase organizer 1
|
multiple interactions
|
EXP
|
[Semaxinib co-treated with Oxygen deficiency] results in decreased expression of NOXO1 mRNA
|
CTD |
PMID:24947524 |
|
NCBI chr10:14,226,473...14,230,541
Ensembl chr10:14,228,205...14,230,541
|
|
| G
|
Npas2
|
neuronal PAS domain protein 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NPAS2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 9:48,959,225...49,138,036
Ensembl chr 9:48,959,148...49,138,037
|
|
| G
|
Npl
|
N-acetylneuraminate pyruvate lyase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NPL mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr13:68,205,602...68,247,940
Ensembl chr13:68,205,603...68,247,999
|
|
| G
|
Npnt
|
nephronectin
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NPNT mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:224,065,191...224,133,567
Ensembl chr 2:224,065,191...224,133,435
|
|
| G
|
Nppa
|
natriuretic peptide A
|
multiple interactions increases expression
|
EXP ISO
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NPPA mRNA; [Phenylephrine co-treated with Oxygen deficiency] results in increased expression of NPPA mRNA; Tea inhibits the reaction [Oxygen deficiency results in increased expression of NPPA protein] [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NPPA mRNA; MIR34C promotes the reaction [Oxygen results in increased expression of NPPA mRNA]; NFE2L2 gene mutant form promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NPPA mRNA]; SRT1720 inhibits the reaction [Oxygen results in increased expression of NPPA mRNA]
|
CTD |
PMID:11042672 PMID:28373008 PMID:29139225 PMID:33729688 PMID:35848756 |
|
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:163,712,184...163,713,493
|
|
| G
|
Nppb
|
natriuretic peptide B
|
increases secretion multiple interactions increases expression
|
ISO EXP
|
Oxygen deficiency results in increased secretion of NPPB protein Rotenone inhibits the reaction [Oxygen deficiency results in increased secretion of NPPB protein] Oxygen deficiency results in increased expression of NPPB mRNA Oxygen deficiency results in increased expression of NPPB mRNA; Oxygen results in increased expression of NPPB mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NPPB mRNA; Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of NPPB mRNA] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NPPB mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NPPB mRNA; MIR34C promotes the reaction [Oxygen results in increased expression of NPPB mRNA]; NFE2L2 gene mutant form promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NPPB mRNA]; SRT1720 inhibits the reaction [Oxygen results in increased expression of NPPB mRNA]
|
CTD |
PMID:17193925 PMID:19502547 PMID:19542490 PMID:24492474 PMID:28373008 PMID:30529165 PMID:33729688 PMID:35848756 More...
|
|
NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:163,699,839...163,701,310
|
|
| G
|
Npr2
|
natriuretic peptide receptor 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NPR2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:62,678,197...62,697,360
Ensembl chr 5:62,678,367...62,697,343
|
|
| G
|
Npr3
|
natriuretic peptide receptor 3
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of NPR3 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 2:62,592,557...62,660,497
Ensembl chr 2:62,597,668...62,660,066
|
|
| G
|
Nptx1
|
neuronal pentraxin 1
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of NPTX1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NPTX1 mRNA
|
CTD |
PMID:24236059 PMID:26516004 PMID:33729688 |
|
NCBI chr10:105,309,578...105,318,829
Ensembl chr10:105,309,578...105,318,863
|
|
| G
|
Npy1r
|
neuropeptide Y receptor Y1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of NPY1R mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr16:27,804,416...27,814,070
Ensembl chr16:27,804,416...27,813,387
|
|
| G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
multiple interactions increases expression affects expression decreases expression
|
ISO EXP
|
[CYP1A2 gene mutant form results in increased susceptibility to Oxygen] which results in increased expression of NQO1 mRNA; [Oxygen deficiency co-treated with Mitomycin] results in decreased activity of NQO1 protein; [Tetrachlorodibenzodioxin co-treated with Mitomycin co-treated with Oxygen deficiency] affects the activity of NQO1 protein; AHR mutant form inhibits the reaction [Oxygen results in increased expression of NQO1 mRNA]; AHR mutant form inhibits the reaction [Oxygen results in increased expression of NQO1 protein]; CYP1A2 gene mutant form inhibits the reaction [Oxygen promotes the reaction [beta-Naphthoflavone results in increased expression of NQO1 protein]] [beta-Naphthoflavone results in increased expression of NQO1 protein] inhibits the reaction [CYP1A1 gene mutant form results in increased susceptibility to Oxygen]; [beta-Naphthoflavone results in increased expression of NQO1 protein] which results in decreased susceptibility to Oxygen; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NQO1 mRNA; [Oxygen deficiency co-treated with Oxygen] results in increased expression of NQO1 mRNA; [Quercetin co-treated with Oxygen] results in increased expression of NQO1 mRNA; [Quercetin co-treated with Oxygen] results in increased expression of NQO1 protein; AHR protein affects the reaction [Oxygen results in increased expression of NQO1 protein]; beta-Naphthoflavone affects the reaction [Oxygen results in increased expression of NQO1 mRNA]; beta-Naphthoflavone promotes the reaction [Oxygen results in increased expression of NQO1 mRNA]; beta-Naphthoflavone promotes the reaction [Oxygen results in increased expression of NQO1 protein]; HIPK2 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of NQO1 mRNA]; MIR144 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NQO1 mRNA]; Omeprazole inhibits the reaction [Oxygen results in increased expression of NQO1 mRNA]; Omeprazole inhibits the reaction [Oxygen results in increased expression of NQO1 protein]; Oxygen inhibits the reaction [beta-Naphthoflavone results in increased expression of NQO1 protein]; Oxygen promotes the reaction [beta-Naphthoflavone results in increased expression of NQO1 mRNA]; PHLPP2 protein inhibits the reaction [Oxygen deficiency results in increased expression of NQO1 mRNA]; sulforaphane inhibits the reaction [Oxygen deficiency results in decreased expression of NQO1 mRNA]; sulforaphane inhibits the reaction [Oxygen deficiency results in decreased expression of NQO1 protein] Oxygen deficiency results in increased expression of NQO1 mRNA; Oxygen results in increased expression of NQO1 mRNA; Oxygen results in increased expression of NQO1 protein Oxygen deficiency affects the expression of NQO1 mRNA [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of NQO1 protein; [Antagomirs results in decreased expression of MIR30C1 mRNA] inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of NQO1 protein]; [Antagomirs results in decreased expression of MIR30C1 mRNA] inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of NQO1 protein]; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NQO1 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NQO1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NQO1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NQO1 protein; [Oxygen deficiency co-treated with Oxygen] results in increased expression of NQO1 protein; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NQO1 protein]; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NQO1 mRNA]; diosmetin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NQO1 protein]; GSK3B protein inhibits the reaction [MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NQO1 mRNA]]; MIR135A2 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NQO1 mRNA]; MIR30C1 mRNA promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of NQO1 protein]; MIR30C1 mRNA promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of NQO1 protein]; PHLDA3 protein inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of NQO1 protein]; PHLDA3 protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of NQO1 protein] Oxygen deficiency results in decreased expression of NQO1 mRNA; Oxygen deficiency results in decreased expression of NQO1 protein
|
CTD |
PMID:16226770 PMID:21745492 PMID:23337360 PMID:25448280 PMID:25596134 PMID:25831079 PMID:25922074 PMID:26272953 PMID:26516004 PMID:28201809 PMID:29180065 PMID:29432836 PMID:29457851 PMID:29719095 PMID:29939353 PMID:29966676 PMID:30096613 PMID:31610156 PMID:31837296 PMID:34217758 PMID:34351043 PMID:35191607 More...
|
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
|
|
| G
|
Nr1d1
|
nuclear receptor subfamily 1, group D, member 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of NR1D1 mRNA Simvastatin inhibits the reaction [Oxygen deficiency results in increased expression of NR1D1 mRNA]
|
CTD |
PMID:16373842 |
|
NCBI chr10:84,224,599...84,231,812
Ensembl chr10:84,224,540...84,231,812
|
|
| G
|
Nr1d2
|
nuclear receptor subfamily 1, group D, member 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of NR1D2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr15:9,955,034...9,981,329
Ensembl chr15:9,954,906...9,981,330
|
|
| G
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NR1I2 mRNA
|
CTD |
PMID:19695866 |
|
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
|
|
| G
|
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3
|
decreases expression increases metabolic processing
|
ISO
|
Oxygen deficiency results in decreased expression of NR1I3 mRNA NR1I3 mRNA results in increased metabolism of Oxygen
|
CTD |
PMID:19695866 PMID:32428594 |
|
NCBI chr13:86,165,327...86,170,362
Ensembl chr13:86,165,349...86,170,370
|
|
| G
|
Nr2f1
|
nuclear receptor subfamily 2, group F, member 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NR2F1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:9,776,179...9,785,924
Ensembl chr 2:9,776,179...9,785,924
|
|
| G
|
Nr3c1
|
nuclear receptor subfamily 3, group C, member 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of NR3C1 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843
|
|
| G
|
Nr3c2
|
nuclear receptor subfamily 3, group C, member 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NR3C2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:47,619,853...47,964,089
Ensembl chr19:47,619,853...47,964,078
|
|
| G
|
Nr4a3
|
nuclear receptor subfamily 4, group A, member 3
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NR4A3 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 5:67,157,141...67,198,287
Ensembl chr 5:67,157,375...67,198,285
|
|
| G
|
Nr5a2
|
nuclear receptor subfamily 5, group A, member 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NR5A2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr13:50,865,253...50,985,107
Ensembl chr13:50,867,920...50,984,938
|
|
| G
|
Nrbp2
|
nuclear receptor binding protein 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NRBP2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:109,679,330...109,685,656
Ensembl chr 7:109,679,330...109,685,588
|
|
| G
|
Nrep
|
neuronal regeneration related protein
|
affects expression multiple interactions
|
ISO
|
Oxygen deficiency affects the expression of NREP mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NREP mRNA
|
CTD |
PMID:25596134 PMID:30529165 |
|
NCBI chr18:25,291,219...25,320,742
Ensembl chr18:25,291,219...25,320,742
|
|
| G
|
Nrf1
|
nuclear respiratory factor 1
|
multiple interactions
|
ISO EXP
|
[Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NRF1 protein; genipin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NRF1 protein] [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NRF1 protein; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NRF1 protein]
|
CTD |
PMID:28477916 PMID:36806343 |
|
NCBI chr 4:59,632,366...59,738,166
Ensembl chr 4:59,632,372...59,738,353
|
|
| G
|
Nrg1
|
neuregulin 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NRG1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr16:65,954,084...67,007,484
Ensembl chr16:65,953,865...66,999,849
|
|
| G
|
Nrip1
|
nuclear receptor interacting protein 1
|
increases expression
|
ISO
|
Oxygen results in increased expression of NRIP1 mRNA
|
CTD |
PMID:27103661 |
|
NCBI chr11:28,382,835...28,466,483
Ensembl chr11:28,378,878...28,467,353
|
|
| G
|
Nrip3
|
nuclear receptor interacting protein 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NRIP3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:173,224,532...173,249,829
Ensembl chr 1:173,224,532...173,251,769
|
|
| G
|
Nrk
|
Nik related kinase
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of NRK mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr X:107,159,154...107,256,417
Ensembl chr X:107,159,233...107,256,417
|
|
| G
|
Nrn1
|
neuritin 1
|
multiple interactions increases expression
|
ISO
|
1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of NRN1 mRNA] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NRN1 mRNA
|
CTD |
PMID:24236059 PMID:24403227 PMID:30529165 |
|
NCBI chr17:28,335,426...28,344,354
Ensembl chr17:28,334,616...28,344,354
|
|
| G
|
Nrp1
|
neuropilin 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NRP1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:73,256,557...73,411,705
Ensembl chr19:73,256,557...73,411,702
|
|
| G
|
Nrros
|
negative regulator of reactive oxygen species
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NRROS mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr11:82,133,608...82,151,160
Ensembl chr11:82,133,144...82,151,308
|
|
| G
|
Nsd3
|
nuclear receptor binding SET domain protein 3
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of NSD3 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of NSD3 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr16:73,056,748...73,170,082
Ensembl chr16:73,061,694...73,168,130
|
|
| G
|
Nsun2
|
NOP2/Sun RNA methyltransferase 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NSUN2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:35,490,583...35,514,839
Ensembl chr 1:35,490,583...35,514,306
|
|
| G
|
Nsun5
|
NOP2/Sun RNA methyltransferase 5
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NSUN5 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr12:26,930,204...26,935,887
Ensembl chr12:26,930,863...26,936,130
|
|
| G
|
Nt5c3a
|
5'-nucleotidase, cytosolic IIIA
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of NT5C3 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of NT5C3 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 4:87,491,828...87,534,838
Ensembl chr 4:87,491,828...87,534,838
|
|
| G
|
Nt5e
|
5' nucleotidase, ecto
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of NT5E mRNA; Oxygen deficiency results in increased expression of NT5E protein [alpha,beta-methyleneadenosine 5'-diphosphate results in decreased activity of NT5E protein] inhibits the reaction [Oxygen deficiency results in increased abundance of Adenosine] 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin inhibits the reaction [Oxygen deficiency results in increased expression of NT5E protein]; deguelin inhibits the reaction [Oxygen deficiency results in increased expression of NT5E protein]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of NT5E protein]
|
CTD |
PMID:20880076 PMID:23437309 PMID:27899277 |
|
NCBI chr 8:98,150,925...98,195,646
Ensembl chr 8:98,150,900...98,195,645
|
|
| G
|
Ntmt1
|
N-terminal Xaa-Pro-Lys N-methyltransferase 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NTMT1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:34,490,972...34,508,316
Ensembl chr 3:34,484,388...34,508,417
|
|
| G
|
Ntn4
|
netrin 4
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of NTN4 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NTN4 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 7:30,073,637...30,187,407
Ensembl chr 7:30,073,333...30,188,309
|
|
| G
|
Ntpcr
|
nucleoside-triphosphatase, cancer-related
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of NTPCR mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr19:70,598,816...70,612,580
Ensembl chr19:70,593,274...70,613,197
|
|
| G
|
Ntrk1
|
neurotrophic receptor tyrosine kinase 1
|
multiple interactions increases expression increases phosphorylation
|
EXP
|
GW 441756 inhibits the reaction [Oxygen deficiency results in increased phosphorylation of NTRK1 protein]; NGF protein inhibits the reaction [Quercetin inhibits the reaction [Oxygen deficiency results in increased phosphorylation of NTRK1 protein]]; Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of NTRK1 mRNA]; Quercetin inhibits the reaction [Oxygen deficiency results in increased phosphorylation of NTRK1 protein]
|
CTD |
PMID:26476374 |
|
NCBI chr 2:175,534,844...175,551,664
Ensembl chr 2:175,534,844...175,551,787
|
|
| G
|
Ntrk2
|
neurotrophic receptor tyrosine kinase 2
|
multiple interactions increases expression
|
EXP
|
EPAS1 mutant form inhibits the reaction [Oxygen deficiency results in increased expression of NTRK2 mRNA] Oxygen deficiency results in increased expression of NTRK2 mRNA; Oxygen deficiency results in increased expression of NTRK2 protein
|
CTD |
PMID:26095976 |
|
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,564,570...5,874,628
|
|
| G
|
Nts
|
neurotensin
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NTS mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 7:39,451,484...39,460,888
Ensembl chr 7:39,451,073...39,460,961
|
|
| G
|
Nuak1
|
NUAK family kinase 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of NUAK1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NUAK1 mRNA
|
CTD |
PMID:25596134 PMID:30529165 |
|
NCBI chr 7:21,217,729...21,289,608
Ensembl chr 7:21,217,681...21,289,354
|
|
| G
|
Nubp1
|
NUBP iron-sulfur cluster assembly factor 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NUBP1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:5,766,157...5,777,648
Ensembl chr10:5,766,157...5,786,422
|
|
| G
|
Nucb2
|
nucleobindin 2
|
decreases expression multiple interactions
|
EXP
|
Oxygen deficiency results in decreased expression of NUCB2 mRNA NUCB2 protein inhibits the reaction [Oxygen results in increased expression of IL1B mRNA]; NUCB2 protein inhibits the reaction [Oxygen results in increased expression of IL1B protein]; NUCB2 protein inhibits the reaction [Oxygen results in increased expression of TNF mRNA]; NUCB2 protein inhibits the reaction [Oxygen results in increased expression of TNF protein]; NUCB2 protein inhibits the reaction [Oxygen results in increased phosphorylation of NFKBIA protein]; NUCB2 protein inhibits the reaction [Oxygen results in increased phosphorylation of RELA protein]; Quercetin inhibits the reaction [Oxygen deficiency results in decreased expression of NUCB2 mRNA]
|
CTD |
PMID:26476374 PMID:38511245 |
|
NCBI chr 1:180,185,121...180,221,644
Ensembl chr 1:180,199,551...180,230,116
|
|
| G
|
Nucks1
|
nuclear casein kinase and cyclin-dependent kinase substrate 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NUCKS1 mRNA
|
CTD |
PMID:17175027 |
|
NCBI chr13:45,897,275...45,926,491
Ensembl chr13:45,897,248...45,923,101
|
|
| G
|
Nudt1
|
nudix hydrolase 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NUDT1 mRNA; Oxygen deficiency results in decreased expression of NUDT1 protein
|
CTD |
PMID:25030372 PMID:35883890 |
|
NCBI chr12:19,416,411...19,423,448
Ensembl chr12:19,416,411...19,424,158
|
|
| G
|
Nudt12
|
nudix hydrolase 12
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of NUDT12 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 9:106,188,930...106,202,340
Ensembl chr 9:106,189,661...106,202,340
|
|
| G
|
Nudt15
|
nudix hydrolase 15
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NUDT15 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr15:55,117,312...55,123,983
|
|
| G
|
Nudt4
|
nudix hydrolase 4
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of NUDT4 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of NUDT4 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 7:32,074,978...32,091,491
Ensembl chr 7:32,075,002...32,091,491
|
|
| G
|
Nudt6
|
nudix hydrolase 6
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NUDT6 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NUDT6 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 2:122,218,031...122,234,488
Ensembl chr 2:122,217,861...122,234,344
|
|
| G
|
Nudt7
|
nudix hydrolase 7
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NUDT7 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:59,034,808...59,049,148
Ensembl chr19:59,034,839...59,063,994
|
|
| G
|
Nuf2
|
NUF2 component of NDC80 kinetochore complex
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NUF2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr13:84,226,448...84,290,957
Ensembl chr13:84,226,509...84,255,598
|
|
| G
|
Nufip1
|
nuclear FMR1 interacting protein 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NUFIP1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr15:57,838,864...57,869,597
Ensembl chr15:57,837,608...57,869,594
|
|
| G
|
Numbl
|
NUMB-like, endocytic adaptor protein
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of NUMBL mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:91,677,437...91,701,415
Ensembl chr 1:91,677,242...91,701,424
|
|
| G
|
Nup160
|
nucleoporin 160
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of NUP160 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:97,120,723...97,183,227
Ensembl chr 3:97,121,628...97,180,720
|
|
| G
|
Nup210
|
nucleoporin 210
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NUP210 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:125,068,736...125,167,238
Ensembl chr 4:125,068,736...125,167,047
|
|
| G
|
Nup35
|
nucleoporin 35
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of NUP35 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 3:85,965,907...85,991,659
Ensembl chr 3:85,945,080...85,992,027
|
|
| G
|
Nup43
|
nucleoporin 43
|
multiple interactions decreases expression
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NUP43 mRNA; Oxygen inhibits the reaction [Oxygen deficiency results in decreased expression of NUP43 mRNA]
|
CTD |
PMID:22629407 PMID:30529165 |
|
NCBI chr 1:3,964,814...3,978,277
Ensembl chr 1:3,938,825...3,978,277
|
|
| G
|
Nup62
|
nucleoporin 62
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NUP62 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:104,435,532...104,451,392
Ensembl chr 1:104,432,093...104,452,710
|
|
| G
|
Nupr1
|
nuclear protein 1, transcriptional regulator
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NUPR1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:190,643,866...190,645,901
Ensembl chr 1:190,643,867...190,645,901
|
|
| G
|
Nus1
|
NUS1 dehydrodolichyl diphosphate synthase subunit
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NUS1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr20:32,354,519...32,381,265
Ensembl chr20:32,354,439...32,381,264
|
|
| G
|
Nxpe2
|
neurexophilin and PC-esterase domain family, member 2
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of NXPE2 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of NXPE2 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 8:57,558,250...57,596,039
Ensembl chr 8:57,558,645...57,592,171
|
|
| G
|
Nxpe3
|
neurexophilin and PC-esterase domain family, member 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NXPE3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr11:58,195,951...58,246,739
Ensembl chr11:58,195,976...58,248,644
|
|
| G
|
Nxph4
|
neurexophilin 4
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of NXPH4 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 7:65,253,043...65,261,864
Ensembl chr 7:65,252,904...65,261,864
|
|
| G
|
Oaf
|
out at first homolog
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of OAF mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 8:52,491,314...52,509,285
Ensembl chr 8:52,491,315...52,509,285
|
|
| G
|
Oas1a
|
2'-5' oligoadenylate synthetase 1A
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of OAS1A mRNA]; [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of OAS1G mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of OAS1A mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of OAS1G mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr12:41,330,423...41,341,130
Ensembl chr12:41,285,211...41,341,128
|
|
| G
|
Oas1i
|
2 ' -5 ' oligoadenylate synthetase 1I
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of OAS1I mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of OAS1I mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr12:41,285,201...41,297,242
|
|
| G
|
Oas2
|
2'-5' oligoadenylate synthetase 2
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of OAS2 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of OAS2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr12:41,464,568...41,492,036
Ensembl chr12:41,467,315...41,495,881
|
|
| G
|
Oas3
|
2'-5'-oligoadenylate synthetase 3
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of OAS3 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr12:41,439,645...41,463,392
Ensembl chr12:41,439,643...41,464,420
|
|
| G
|
Oasl
|
2'-5'-oligoadenylate synthetase-like
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of OASL mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of OASL mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr12:47,343,551...47,356,509
Ensembl chr12:47,343,551...47,356,483
|
|
| G
|
Oasl2
|
2'-5' oligoadenylate synthetase-like 2
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of OASL2 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of OASL2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr12:47,369,829...47,383,337
Ensembl chr12:47,370,028...47,383,185
|
|
| G
|
Oaz2
|
ornithine decarboxylase antizyme 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OAZ2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:75,094,817...75,108,634
Ensembl chr 8:75,094,798...75,108,630
|
|
| G
|
Obscn
|
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OBSCN mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:44,273,686...44,419,275
Ensembl chr10:44,288,866...44,419,297
|
|
| G
|
Ociad2
|
OCIA domain containing 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OCIAD2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:35,225,291...35,243,306
Ensembl chr14:35,225,255...35,243,311
|
|
| G
|
Ocln
|
occludin
|
multiple interactions decreases expression
|
EXP ISO
|
Lipopolysaccharides promotes the reaction [Oxygen deficiency results in decreased expression of OCLN protein]; prolinedithiocarbamate inhibits the reaction [Lipopolysaccharides promotes the reaction [Oxygen deficiency results in decreased expression of OCLN protein]]; prolinedithiocarbamate inhibits the reaction [Oxygen deficiency results in decreased expression of OCLN protein] [dictamnine co-treated with Oxygen deficiency] results in increased expression of OCLN protein; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of OCLN mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of OCLN protein; zafirlukast inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of OCLN mRNA]; zafirlukast inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of OCLN protein]
|
CTD |
PMID:23082119 PMID:30266538 PMID:31816286 |
|
NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:33,391,303...33,430,411
|
|
| G
|
Odc1
|
ornithine decarboxylase 1
|
increases activity increases expression decreases expression multiple interactions
|
EXP ISO
|
Oxygen deficiency results in increased activity of ODC1 protein Oxygen deficiency results in increased expression of ODC1 mRNA Oxygen deficiency results in decreased expression of ODC1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ODC1 mRNA
|
CTD |
PMID:8421708 PMID:26516004 PMID:30529165 |
|
NCBI chr 6:46,058,439...46,065,148
Ensembl chr 6:46,058,463...46,065,146
|
|
| G
|
Ogg1
|
8-oxoguanine DNA glycosylase
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of OGG1 protein
|
CTD |
PMID:25030372 |
|
NCBI chr 4:148,030,237...148,037,599
Ensembl chr 4:148,030,349...148,037,604
|
|
| G
|
Ogn
|
osteoglycin
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OGN mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of OGN mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr17:15,238,500...15,259,167
Ensembl chr17:15,238,500...15,259,252
|
|
| G
|
Ogt
|
O-linked N-acetylglucosamine (GlcNAc) transferase
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OGT mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr X:70,811,317...70,856,123
Ensembl chr X:70,811,319...70,856,123
|
|
| G
|
Oip5
|
Opa interacting protein 5
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of OIP5 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 3:127,047,559...127,057,043
Ensembl chr 3:127,047,559...127,057,043
|
|
| G
|
Ola1
|
Obg-like ATPase 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OLA1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:78,374,440...78,493,401
Ensembl chr 3:78,374,441...78,492,012
|
|
| G
|
Olfml1
|
olfactomedin-like 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OLFML1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:170,889,912...170,914,300
Ensembl chr 1:170,889,980...170,915,762
|
|
| G
|
Olfml2a
|
olfactomedin-like 2A
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of OLFML2A mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 3:43,098,299...43,127,621
Ensembl chr 3:43,098,299...43,127,621
|
|
| G
|
Olr1
|
oxidized low density lipoprotein receptor 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of OLR1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 4:164,612,460...164,635,082
Ensembl chr 4:164,612,463...164,634,598
|
|
| G
|
Omd
|
osteomodulin
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OMD mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr17:15,266,646...15,274,870
Ensembl chr17:15,266,646...15,274,870
|
|
| G
|
Opa1
|
OPA1, mitochondrial dynamin like GTPase
|
multiple interactions decreases expression
|
EXP
|
[Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of OPA1 protein; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of OPA1 protein]; Sevoflurane inhibits the reaction [Oxygen deficiency results in decreased expression of OPA1 protein]
|
CTD |
PMID:27684054 PMID:36806343 |
|
NCBI chr11:84,612,943...84,690,025
Ensembl chr11:84,615,340...84,689,955
|
|
| G
|
Optc
|
opticin
|
multiple interactions increases degradation
|
ISO
|
Edetic Acid inhibits the reaction [Oxygen deficiency results in increased degradation of OPTC protein]
|
CTD |
PMID:22534113 |
|
NCBI chr13:47,906,145...47,920,334
Ensembl chr13:47,906,197...47,917,416
|
|
| G
|
Optn
|
optineurin
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OPTN mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr17:78,118,847...78,169,543
Ensembl chr17:78,118,866...78,169,543
|
|
| G
|
Or1l8
|
olfactory receptor family 1 subfamily L member 8
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of OR1L8 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 3:40,863,247...40,864,179
Ensembl chr 3:40,863,247...40,864,179
|
|
| G
|
Or51i1
|
olfactory receptor family 51 subfamily I member 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of OR51I1 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 1:167,914,467...167,915,411
Ensembl chr 1:167,914,467...167,915,411
|
|
| G
|
Or5p52
|
olfactory receptor family 5 subfamily P member 52
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of OR5P3 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:171,193,967...171,197,104
Ensembl chr 1:171,195,780...171,197,096
|
|
| G
|
Or8i2
|
olfactory receptor family 8 subfamily I member 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of OR8I2 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 3:92,576,324...92,577,256
Ensembl chr 3:92,575,223...92,582,253
|
|
| G
|
Orai3
|
ORAI calcium release-activated calcium modulator 3
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of ORAI3 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 1:191,811,671...191,816,530
Ensembl chr 1:191,811,424...191,816,530
|
|
| G
|
Orc1
|
origin recognition complex, subunit 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ORC1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 5:128,552,975...128,581,943
Ensembl chr 5:128,552,991...128,577,071
|
|
| G
|
Orc2
|
origin recognition complex, subunit 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ORC2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:67,496,097...67,532,548
Ensembl chr 9:67,496,825...67,526,649
|
|
| G
|
Orc6
|
origin recognition complex, subunit 6
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of ORC6 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr19:37,931,085...37,938,856
Ensembl chr19:37,931,090...37,938,856
|
|
| G
|
Osbpl1a
|
oxysterol binding protein-like 1A
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of OSBPL1A mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of OSBPL1A mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr18:4,178,734...4,383,511
Ensembl chr18:4,179,631...4,369,421
|
|
| G
|
Osbpl6
|
oxysterol binding protein-like 6
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OSBPL6 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:81,751,020...81,948,186
Ensembl chr 3:81,750,982...81,946,615
|
|
| G
|
Oscar
|
osteoclast associated Ig-like receptor
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of OSCAR mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:74,521,626...74,529,119
Ensembl chr 1:74,515,001...74,529,119
|
|
| G
|
Osgin1
|
oxidative stress induced growth inhibitor 1
|
affects expression
|
ISO
|
Oxygen deficiency affects the expression of OSGIN1 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr19:64,380,336...64,409,165
Ensembl chr19:64,401,173...64,409,162
|
|
| G
|
Osm
|
oncostatin M
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OSM mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of OSM mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr14:83,327,202...83,332,073
Ensembl chr14:83,327,554...83,331,827
|
|
| G
|
Osmr
|
oncostatin M receptor
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OSMR mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:57,634,517...57,688,802
Ensembl chr 2:57,634,517...57,688,561
|
|
| G
|
Otc
|
ornithine transcarbamylase
|
decreases metabolic processing multiple interactions
|
ISO
|
Oxygen results in decreased metabolism of OTC protein lactacystin inhibits the reaction [Oxygen results in decreased metabolism of OTC protein]
|
CTD |
PMID:11161710 |
|
NCBI chr X:15,126,358...15,202,473
Ensembl chr X:15,126,358...15,239,555
|
|
| G
|
Otud3
|
OTU deubiquitinase 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OTUD3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:156,419,099...156,445,341
Ensembl chr 5:156,423,332...156,445,540
|
|
| G
|
Otud5
|
OTU deubiquitinase 5
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of OTUD5 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of OTUD5 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr X:17,296,750...17,331,257
Ensembl chr X:17,298,029...17,331,054
|
|
| G
|
Otulinl
|
OTU deubiquitinase with linear linkage specificity like
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FAM105A mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 2:80,136,411...80,164,290
Ensembl chr 2:80,139,262...80,166,962
|
|
| G
|
Oxsm
|
3-oxoacyl-ACP synthase, mitochondrial
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of OXSM mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr15:11,641,177...11,645,370
Ensembl chr15:11,634,473...11,683,429
|
|
| G
|
P2ry10
|
P2Y receptor family member 10
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of P2RY10 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr X:76,184,064...76,279,996
Ensembl chr X:76,184,001...76,280,953
|
|
| G
|
P2ry2
|
purinergic receptor P2Y2
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of P2RY2 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of P2RY2 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 1:164,764,119...164,779,578
Ensembl chr 1:164,759,213...164,781,852
|
|
| G
|
P2ry6
|
pyrimidinergic receptor P2Y6
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of P2RY6 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:164,707,188...164,742,689
Ensembl chr 1:164,706,116...164,743,588
|
|
| G
|
P3h2
|
prolyl 3-hydroxylase 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of P3H2 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr11:88,139,086...88,280,221
Ensembl chr11:88,139,078...88,281,203
|
|
| G
|
P4ha1
|
prolyl 4-hydroxylase subunit alpha 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of P4HA1 mRNA Oxygen deficiency promotes the reaction [HIF1A protein binds to P4HA1 promoter]
|
CTD |
PMID:20042640 PMID:20880076 PMID:23880069 PMID:24236059 PMID:25596134 PMID:26516004 PMID:30381462 More...
|
|
NCBI chr20:27,784,696...27,895,785
Ensembl chr20:27,845,141...27,895,404
|
|
| G
|
P4ha2
|
prolyl 4-hydroxylase subunit alpha 2
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of P4HA2 mRNA HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of P4HA2 mRNA]
|
CTD |
PMID:19502547 PMID:20880076 PMID:26516004 |
|
NCBI chr10:38,743,894...38,772,741
Ensembl chr10:38,743,894...38,772,993
|
|
| G
|
Pa2g4
|
proliferation-associated 2G4
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PA2G4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:1,569,326...1,576,794
Ensembl chr 7:1,569,327...1,576,802
|
|
| G
|
Pabpc4
|
poly(A) binding protein, cytoplasmic 4
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PABPC4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:140,847,835...140,864,089
Ensembl chr 5:140,848,225...140,864,087
|
|
| G
|
Padi2
|
peptidyl arginine deiminase 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PADI2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 5:158,492,087...158,534,662
Ensembl chr 5:158,492,066...158,534,662
|
|
| G
|
Padi4
|
peptidyl arginine deiminase 4
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of PADI4 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 5:158,324,417...158,357,466
Ensembl chr 5:158,324,417...158,360,422
|
|
| G
|
Pafah1b2
|
platelet-activating factor acetylhydrolase 1b, catalytic subunit 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PAFAH1B2 protein
|
CTD |
PMID:25937538 |
|
NCBI chr 8:55,156,778...55,208,800
Ensembl chr 8:55,156,779...55,176,836
|
|
| G
|
Pafah1b3
|
platelet-activating factor acetylhydrolase 1b, catalytic subunit 3
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PAFAH1B3 mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr 1:90,009,085...90,011,611
Ensembl chr 1:90,009,085...90,011,611
|
|
| G
|
Paip2
|
poly(A) binding protein interacting protein 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PAIP2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr18:27,475,278...27,492,452
Ensembl chr 1:188,508,623...188,508,997 Ensembl chr18:188,508,623...188,508,997
|
|
| G
|
Pak1ip1
|
PAK1 interacting protein 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of PAK1IP1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr17:23,947,978...23,959,055
Ensembl chr17:23,939,509...23,959,055
|
|
| G
|
Palm
|
paralemmin
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PALM mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 7:10,537,252...10,563,346
Ensembl chr 7:10,537,277...10,563,007
|
|
| G
|
Palmd
|
palmdelphin
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PALMD mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:207,574,413...207,626,239
Ensembl chr 2:207,574,249...207,626,239
|
|
| G
|
Pals2
|
protein associated with LIN7 2, MAGUK p55 family member
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PALS2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:80,504,298...80,584,951
Ensembl chr 4:80,455,657...80,584,950
|
|
| G
|
Pam
|
peptidylglycine alpha-amidating monooxygenase
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of PAM mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PAM mRNA
|
CTD |
PMID:20042640 PMID:26516004 PMID:30529165 |
|
NCBI chr 9:105,445,812...105,719,287
Ensembl chr 9:105,445,929...105,719,285
|
|
| G
|
Pamr1
|
peptidase domain containing associated with muscle regeneration 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PAMR1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:109,340,411...109,443,595
Ensembl chr 3:109,341,476...109,443,585
|
|
| G
|
Pank1
|
pantothenate kinase 1
|
affects expression multiple interactions
|
ISO
|
Oxygen deficiency affects the expression of PANK1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PANK1 mRNA
|
CTD |
PMID:25596134 PMID:30529165 |
|
NCBI chr 1:241,737,371...241,808,126
Ensembl chr 1:241,741,083...241,807,824
|
|
| G
|
Pank3
|
pantothenate kinase 3
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PANK3 mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr10:20,733,191...20,757,017
Ensembl chr10:20,733,127...20,757,015
|
|
| G
|
Pank4
|
pantothenate kinase 4
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of PANK4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:170,807,744...170,824,478
Ensembl chr 5:170,807,745...170,824,477
|
|
| G
|
Pappa
|
pappalysin 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of PAPPA mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PAPPA mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 5:83,513,358...83,751,364
Ensembl chr 5:83,513,358...83,751,361
|
|
| G
|
Paqr4
|
progestin and adipoQ receptor family member 4
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PAQR4 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:13,263,559...13,267,237
Ensembl chr10:13,263,559...13,267,173
|
|
| G
|
Parl
|
presenilin associated, rhomboid-like
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PARL mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr11:94,097,559...94,124,915
Ensembl chr11:94,097,934...94,148,287
|
|
| G
|
Parm1
|
prostate androgen-regulated mucin-like protein 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PARM1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:16,752,541...16,861,570
Ensembl chr14:16,752,541...16,881,138
|
|
| G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
increases cleavage multiple interactions increases expression increases activity decreases expression
|
EXP ISO
|
Oxygen deficiency results in increased cleavage of PARP1 protein [N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride affects the susceptibility to Oxygen deficiency] which results in increased expression of PARP1 protein; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of PARP1 protein; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of PARP1 protein modified form; [Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of PARP1 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PARP1 protein modified form; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PARP1 protein modified form]; KEAP1 protein inhibits the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PARP1 protein modified form]]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of PARP1 protein modified form]; NFE2L2 protein promotes the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PARP1 protein modified form]]; Phenylephrine inhibits the reaction [Oxygen deficiency results in increased cleavage of PARP1 protein]; protosappanin A inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of PARP1 protein] [betulin co-treated with Oxygen] results in increased cleavage of PARP1 protein; [Betulinic Acid co-treated with Oxygen] results in increased cleavage of PARP1 protein; [Glucose co-treated with Oxygen deficiency] results in increased activity of PARP1 protein; AHR mutant form promotes the reaction [Oxygen results in increased cleavage of PARP1 protein]; betulin analog promotes the reaction [Oxygen deficiency results in increased expression of PARP1 protein modified form]; N-ethoxymethyl-3-amino-1,2,4-benzotriazine-1,4-dioxide promotes the reaction [Oxygen deficiency results in increased cleavage of PARP1 protein]; Oxygen deficiency inhibits the reaction [nickel monoxide analog results in increased cleavage of PARP1 protein] Oxygen deficiency results in increased cleavage of PARP1 protein; Oxygen results in increased cleavage of PARP1 protein Oxygen deficiency results in increased activity of PARP1 protein PARP1 gene mutant form inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CXCL1 protein] Oxygen deficiency results in decreased expression of PARP1 mRNA
|
CTD |
PMID:11042672 PMID:15696051 PMID:17131054 PMID:20530905 PMID:22639866 PMID:25221900 PMID:25831079 PMID:26540049 PMID:27270449 PMID:27288104 PMID:29605020 PMID:33181113 PMID:33225685 PMID:35191607 PMID:38909692 More...
|
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
| G
|
Parp10
|
poly (ADP-ribose) polymerase family, member 10
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PARP10 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 7:109,829,721...109,839,054
Ensembl chr 7:109,829,722...109,843,566
|
|
| G
|
Parp12
|
poly (ADP-ribose) polymerase family, member 12
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PARP12 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 4:68,793,411...68,851,214
Ensembl chr 4:68,806,100...68,850,541
|
|
| G
|
Parp14
|
poly (ADP-ribose) polymerase family, member 14
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PARP14 mRNA [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PARP14 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PARP14 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr11:78,408,134...78,440,201
Ensembl chr11:78,408,058...78,440,195
|
|
| G
|
Parp2
|
poly (ADP-ribose) polymerase 2
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of PARP2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr15:26,494,722...26,517,893
Ensembl chr15:26,494,731...26,517,891
|
|
| G
|
Parp9
|
poly (ADP-ribose) polymerase family, member 9
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PARP9 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr11:78,286,282...78,320,409
Ensembl chr11:78,286,287...78,320,608
|
|
| G
|
Parpbp
|
PARP1 binding protein
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of PARPBP mRNA [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PARPBP mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PARPBP mRNA
|
CTD |
PMID:26516004 PMID:33729688 |
|
NCBI chr 7:24,398,897...24,468,330
Ensembl chr 7:24,398,897...24,464,744
|
|
| G
|
Pask
|
PAS domain containing serine/threonine kinase
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PASK mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 9:101,291,673...101,333,288
Ensembl chr 9:101,291,676...101,332,504
|
|
| G
|
Pawr
|
pro-apoptotic WT1 regulator
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PAWR mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:45,531,480...45,611,492
Ensembl chr 7:45,531,637...45,611,492
|
|
| G
|
Pax6
|
paired box 6
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PAX6 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 3:112,590,034...112,611,771
Ensembl chr 3:112,590,391...112,611,763
|
|
| G
|
Pbk
|
PDZ binding kinase
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of PBK mRNA [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PBK mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PBK mRNA
|
CTD |
PMID:26516004 PMID:33729688 |
|
NCBI chr15:44,198,506...44,209,572
Ensembl chr15:44,198,544...44,209,570
|
|
| G
|
Pbrm1
|
polybromo 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of PBRM1 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of PBRM1 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr16:6,219,933...6,319,336
Ensembl chr16:6,219,917...6,319,336
|
|
| G
|
Pcdh10
|
protocadherin 10
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PCDH10 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 2:130,553,432...130,619,591
Ensembl chr 2:130,553,425...130,613,407
|
|
| G
|
Pcdh11x
|
protocadherin 11 X-linked
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PCDH11X mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr X:90,279,191...90,974,671
Ensembl chr X:90,279,235...90,971,393
|
|
| G
|
Pcdh12
|
protocadherin 12
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PCDH12 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr18:30,354,910...30,370,485
Ensembl chr18:30,354,910...30,370,485
|
|
| G
|
Pcdh9
|
protocadherin 9
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PCDH9 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr15:75,748,472...76,646,644 NCBI chr15:76,078,024...76,127,778
Ensembl chr15:75,749,278...76,645,302
|
|
| G
|
Pcdhac1
|
protocadherin alpha subfamily C, 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PCDHAC1 mRNA
|
CTD |
PMID:30529165 |
|
|
|
| G
|
Pcdhac2
|
protocadherin alpha subfamily C, 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PCDHAC2 mRNA
|
CTD |
PMID:26516004 |
|
Ensembl chr18:28,855,256...29,120,227
|
|
| G
|
Pcdhga8
|
protocadherin gamma subfamily A, 8
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PCDHGA8 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr18:29,805,113...29,919,095
|
|
| G
|
Pcf11
|
PCF11 cleavage and polyadenylation factor subunit
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PCF11 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 1:156,109,724...156,136,950
Ensembl chr 1:156,109,724...156,136,435
|
|
| G
|
Pck1
|
phosphoenolpyruvate carboxykinase 1
|
multiple interactions increases expression
|
ISO
|
Oxygen deficiency inhibits the reaction [darinaparsin results in increased expression of PCK1 mRNA] Oxygen deficiency results in increased expression of PCK1 mRNA
|
CTD |
PMID:22535156 PMID:23539316 |
|
NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:182,348,572...182,354,561
|
|
| G
|
Pclaf
|
PCNA clamp associated factor
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PCLAF mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PCLAF mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 8:75,311,028...75,328,108
Ensembl chr 8:75,315,707...75,328,106
|
|
| G
|
Pcm1
|
pericentriolar material 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PCM1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr16:57,711,833...57,808,842
Ensembl chr16:57,711,833...57,808,599
|
|
| G
|
Pcmtd1
|
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PCMTD1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:17,071,629...17,143,803
Ensembl chr 5:17,071,629...17,142,010
|
|
| G
|
Pcmtd2
|
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PCMTD2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:189,337,758...189,360,525
Ensembl chr 3:189,337,816...189,357,001
|
|
| G
|
Pcna
|
proliferating cell nuclear antigen
|
decreases expression increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of PCNA mRNA; Oxygen deficiency results in decreased expression of PCNA protein Oxygen deficiency results in increased expression of PCNA mRNA; Oxygen deficiency results in increased expression of PCNA protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of PCNA protein]; [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with kaempferol] inhibits the reaction [Oxygen deficiency results in increased expression of PCNA protein]; kaempferol inhibits the reaction [Oxygen deficiency results in increased expression of PCNA mRNA]; kaempferol inhibits the reaction [Oxygen deficiency results in increased expression of PCNA protein]; Sildenafil Citrate inhibits the reaction [Oxygen deficiency results in increased expression of PCNA mRNA]; Sildenafil Citrate inhibits the reaction [Oxygen deficiency results in increased expression of PCNA protein]
|
CTD |
PMID:25030372 PMID:26516004 PMID:36940862 |
|
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
|
|
| G
|
Pcnp
|
PEST proteolytic signal containing nuclear protein
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of PCNP mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr11:58,061,885...58,076,436
Ensembl chr11:58,061,570...58,076,436
|
|
| G
|
Pcolce2
|
procollagen C-endopeptidase enhancer 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PCOLCE2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:105,073,086...105,130,725
Ensembl chr 8:105,073,086...105,145,160
|
|
| G
|
Pcsk1
|
proprotein convertase subtilisin/kexin type 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of PCSK1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 2:6,130,045...6,176,974
Ensembl chr 2:6,129,592...6,176,974
|
|
| G
|
Pdcd6ip
|
programmed cell death 6 interacting protein
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PDCD6IP mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 8:122,469,223...122,524,993
Ensembl chr 8:122,469,223...122,524,993
|
|
| G
|
Pde12
|
phosphodiesterase 12
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PDE12 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr16:1,926,807...1,932,383
Ensembl chr16:1,922,131...1,932,611
|
|
| G
|
Pde1a
|
phosphodiesterase 1A
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PDE1A mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 3:85,152,053...85,432,289
Ensembl chr 3:85,154,184...85,519,212
|
|
| G
|
Pde2a
|
phosphodiesterase 2A
|
decreases expression
|
EXP
|
Oxygen deficiency results in decreased expression of PDE2A mRNA; Oxygen deficiency results in decreased expression of PDE2A protein
|
CTD |
PMID:24899690 |
|
NCBI chr 1:165,235,623...165,327,466
Ensembl chr 1:165,235,623...165,327,466
|
|
| G
|
Pde4a
|
phosphodiesterase 4A
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PDE4A mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 8:27,966,978...28,029,721
Ensembl chr 8:27,966,996...28,046,924
|
|
| G
|
Pde4b
|
phosphodiesterase 4B
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of PDE4B mRNA Simvastatin inhibits the reaction [Oxygen deficiency results in increased expression of PDE4B mRNA] Oxygen results in increased expression of PDE4B protein
|
CTD |
PMID:16373842 PMID:18941502 |
|
NCBI chr 5:122,028,956...122,598,267
Ensembl chr 5:122,135,174...122,598,267
|
|
| G
|
Pde4c
|
phosphodiesterase 4C
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PDE4C mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr16:18,724,703...18,745,528
Ensembl chr16:18,725,674...18,744,037
|
|
| G
|
Pde4d
|
phosphodiesterase 4D
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PDE4D mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:41,748,337...43,262,567
Ensembl chr 2:42,110,838...43,262,569
|
|
| G
|
Pde5a
|
phosphodiesterase 5A
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PDE5A mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:213,542,822...213,687,638
Ensembl chr 2:213,542,923...213,684,298
|
|
| G
|
Pde8a
|
phosphodiesterase 8A
|
affects expression
|
ISO
|
Oxygen deficiency affects the expression of PDE8A mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 1:144,575,203...144,698,216
Ensembl chr 1:144,575,428...144,698,215
|
|
| G
|
Pde8b
|
phosphodiesterase 8B
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PDE8B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:28,009,841...28,244,050
Ensembl chr 2:28,011,359...28,244,327
|
|
| G
|
Pde9a
|
phosphodiesterase 9A
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PDE9A mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr20:9,471,136...9,564,286
Ensembl chr20:9,471,167...9,564,286
|
|
| G
|
Pdf
|
peptide deformylase (mitochondrial)
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PDF mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr19:51,859,159...51,861,281
Ensembl chr19:51,859,159...51,861,281
|
|
| G
|
Pdgfa
|
platelet derived growth factor subunit A
|
multiple interactions increases expression
|
ISO
|
1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of PDGFA mRNA]
|
CTD |
PMID:24403227 |
|
NCBI chr12:20,759,366...20,780,337
Ensembl chr12:20,754,208...20,780,322
|
|
| G
|
Pdgfb
|
platelet derived growth factor subunit B
|
multiple interactions increases expression
|
ISO
|
ARNT gene mutant form inhibits the reaction [Oxygen deficiency results in increased expression of PDGFB mRNA]; Simvastatin inhibits the reaction [Oxygen deficiency results in increased expression of PDGFB mRNA]
|
CTD |
PMID:16373842 PMID:20412331 PMID:24236059 |
|
NCBI chr 7:113,419,882...113,438,343
Ensembl chr 7:113,420,710...113,438,343
|
|
| G
|
Pdgfd
|
platelet derived growth factor D
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PDGFD mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:11,773,335...12,007,277
Ensembl chr 8:11,773,475...12,007,271
|
|
| G
|
Pdgfra
|
platelet derived growth factor receptor alpha
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of PDGFRA mRNA Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of PDGFRA mRNA]
|
CTD |
PMID:24205000 PMID:26476374 |
|
NCBI chr14:33,360,027...33,408,604
Ensembl chr14:33,360,028...33,408,516
|
|
| G
|
Pdgfrb
|
platelet derived growth factor receptor beta
|
multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of and results in increased activity of PDGFRB protein; rosiglitazone inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased activity of PDGFRB protein] [Apigenin co-treated with Oxygen deficiency] affects the phosphorylation of PDGFRB protein
|
CTD |
PMID:19520921 PMID:35513012 |
|
NCBI chr18:56,770,348...56,809,228
Ensembl chr18:56,770,348...56,809,233
|
|
| G
|
Pdgfrl
|
platelet-derived growth factor receptor-like
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PDGFRL mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr16:58,051,421...58,111,327
Ensembl chr16:58,051,440...58,111,327
|
|
| G
|
Pdia5
|
protein disulfide isomerase family A, member 5
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PDIA5 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr11:78,777,436...78,892,370
Ensembl chr11:78,777,419...78,864,329
|
|
| G
|
Pdk1
|
pyruvate dehydrogenase kinase 1
|
multiple interactions increases expression
|
ISO
|
[Rotenone co-treated with Thenoyltrifluoroacetone] inhibits the reaction [Oxygen deficiency results in increased expression of PDK1 mRNA]; IL15 protein promotes the reaction [Oxygen deficiency results in increased expression of PDK1 mRNA]; Niclosamide inhibits the reaction [Oxygen deficiency results in increased expression of PDK1 mRNA]; ST6GAL1 protein promotes the reaction [Oxygen deficiency results in increased expression of PDK1 mRNA]; Vorinostat inhibits the reaction [Oxygen deficiency results in increased expression of PDK1 protein]
|
CTD |
PMID:17175027 PMID:17671207 PMID:19502547 PMID:19695866 PMID:20042640 PMID:20880076 PMID:24236059 PMID:25596134 PMID:26305601 PMID:27129235 PMID:29475939 PMID:36318118 More...
|
|
NCBI chr 3:77,113,464...77,144,145
Ensembl chr 3:77,113,473...77,144,145
|
|
| G
|
Pdk3
|
pyruvate dehydrogenase kinase 3
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of PDK3 mRNA Niclosamide inhibits the reaction [Oxygen deficiency results in increased expression of PDK3 mRNA]
|
CTD |
PMID:19502547 PMID:36318118 |
|
NCBI chr X:62,480,535...62,547,371
Ensembl chr X:62,480,535...62,547,371
|
|
| G
|
Pdk4
|
pyruvate dehydrogenase kinase 4
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of PDK4 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PDK4 mRNA
|
CTD |
PMID:25596134 PMID:30529165 |
|
NCBI chr 4:34,558,327...34,568,329
Ensembl chr 4:34,556,330...34,568,381
|
|
| G
|
Pdlim1
|
PDZ and LIM domain 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PDLIM1 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 1:248,991,818...249,040,409
Ensembl chr 1:248,991,818...249,047,379
|
|
| G
|
Pdlim7
|
PDZ and LIM domain 7
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PDLIM7 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr17:9,129,603...9,144,956
Ensembl chr17:9,129,525...9,144,956
|
|
| G
|
Pdpn
|
podoplanin
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of PDPN mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 5:160,884,995...160,919,112
Ensembl chr 5:160,884,993...160,925,637
|
|
| G
|
Pdpr
|
pyruvate dehydrogenase phosphatase regulatory subunit
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PDPR mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr19:55,974,611...56,019,045
Ensembl chr19:55,974,550...56,019,044
|
|
| G
|
Pdss1
|
decaprenyl diphosphate synthase subunit 1
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of PDSS1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PDSS1 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr17:89,964,768...90,006,819
Ensembl chr17:89,968,034...90,006,817
|
|
| G
|
Pdxp
|
pyridoxal phosphatase
|
increases expression decreases expression
|
ISO
|
Oxygen deficiency results in increased expression of PDXP mRNA Oxygen deficiency results in decreased expression of PDXP mRNA
|
CTD |
PMID:20880076 PMID:26516004 |
|
NCBI chr 7:112,352,971...112,358,419
Ensembl chr 7:112,352,726...112,358,419
|
|
| G
|
Pdzd2
|
PDZ domain containing 2
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of PDZD2 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PDZD2 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 2:63,111,650...63,497,520
Ensembl chr 2:63,111,650...63,497,478
|
|
| G
|
Pdzd8
|
PDZ domain containing 8
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PDZD8 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 1:268,435,304...268,492,923
Ensembl chr 1:268,435,304...268,492,913
|
|
| G
|
Pdzk1
|
PDZ domain containing 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PDZK1 mRNA
|
CTD |
PMID:25536518 |
|
NCBI chr 2:187,064,995...187,096,348
Ensembl chr 2:187,065,013...187,096,806
|
|
| G
|
Pdzk1ip1
|
PDZK1 interacting protein 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PDZK1IP1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:133,841,586...133,859,894
Ensembl chr 5:133,841,313...133,859,893
|
|
| G
|
Pecam1
|
platelet and endothelial cell adhesion molecule 1
|
decreases expression increases expression multiple interactions
|
ISO
|
Oxygen results in decreased expression of PECAM1 mRNA Oxygen deficiency results in increased expression of PECAM1 protein HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of PECAM1 protein]; SENP1 protein affects the reaction [Oxygen deficiency results in increased expression of PECAM1 protein]
|
CTD |
PMID:22363622 PMID:31953908 |
|
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:92,090,235...92,151,839
|
|
| G
|
Per2
|
period circadian regulator 2
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PER2 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:99,454,830...99,496,993
|
|
| G
|
Per3
|
period circadian regulator 3
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PER3 mRNA [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PER3 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PER3 mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 5:166,740,914...166,778,243
Ensembl chr 5:166,743,050...166,777,999
|
|
| G
|
Perm1
|
PPARGC1 and ESRR induced regulator, muscle 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PERM1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 5:172,082,249...172,087,542
Ensembl chr 5:172,082,249...172,087,542
|
|
| G
|
Perp
|
p53 apoptosis effector related to PMP22
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PERP mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:15,361,784...15,374,230
Ensembl chr 1:15,361,778...15,374,687
|
|
| G
|
Pes1
|
pescadillo ribosomal biogenesis factor 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PES1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:83,074,346...83,090,726
Ensembl chr14:83,074,319...83,091,718
|
|
| G
|
Pex11a
|
peroxisomal biogenesis factor 11 alpha
|
decreases metabolic processing
|
ISO
|
PEX11A gene mutant form results in decreased metabolism of Oxygen
|
CTD |
PMID:30585412 |
|
NCBI chr 1:143,089,410...143,096,491
Ensembl chr 1:143,089,410...143,096,645
|
|
| G
|
Pfas
|
phosphoribosylformylglycinamidine synthase
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PFAS mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:54,189,157...54,210,685
Ensembl chr10:54,189,157...54,207,272
|
|
| G
|
Pfkfb3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of PFKFB3 mRNA GSK1210151A promotes the reaction [Oxygen deficiency results in increased expression of PFKFB3 mRNA]; IL15 protein promotes the reaction [Oxygen deficiency results in increased expression of PFKFB3 mRNA]; molibresib promotes the reaction [Oxygen deficiency results in increased expression of PFKFB3 mRNA]
|
CTD |
PMID:16025159 PMID:20042640 PMID:20880076 PMID:23539316 PMID:24236059 PMID:27129235 PMID:27292261 More...
|
|
NCBI chr17:71,893,320...71,974,526
Ensembl chr17:71,893,416...71,975,052
|
|
| G
|
Pfkfb4
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4
|
multiple interactions increases expression
|
ISO
|
1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of PFKFB4 mRNA]; Oxygen deficiency promotes the reaction [HIF1A protein results in increased expression of PFKFB4 mRNA] Oxygen deficiency results in increased expression of PFKFB4 mRNA; Oxygen deficiency results in increased expression of PFKFB4 protein
|
CTD |
PMID:16025159 PMID:24236059 PMID:24403227 PMID:25596134 PMID:26516004 PMID:27292261 More...
|
|
NCBI chr 8:118,522,371...118,565,478
Ensembl chr 8:118,522,365...118,565,468
|
|
| G
|
Pfkl
|
phosphofructokinase, liver type
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PFKL mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr20:10,663,907...10,685,967
Ensembl chr20:10,663,955...10,685,966
|
|
| G
|
Pfkp
|
phosphofructokinase, platelet
|
increases expression affects expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of PFKP mRNA Oxygen deficiency affects the expression of PFKP mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of PFKP mRNA
|
CTD |
PMID:17193925 PMID:20042640 PMID:20880076 PMID:33729688 |
|
NCBI chr17:68,639,749...68,704,055
Ensembl chr17:68,639,481...68,705,752
|
|
| G
|
Pgam1
|
phosphoglycerate mutase 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PGAM1 mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr 1:250,673,152...250,680,762
Ensembl chr 1:250,673,049...250,690,203
|
|
| G
|
Pgam2
|
phosphoglycerate mutase 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PGAM2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:84,895,763...84,897,874
Ensembl chr14:84,895,744...84,897,894
|
|
| G
|
Pgam5
|
PGAM family member 5, mitochondrial serine/threonine protein phosphatase
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PGAM5 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr12:52,069,023...52,076,131
Ensembl chr12:52,069,103...52,076,131
|
|
| G
|
Pgf
|
placental growth factor
|
multiple interactions increases expression
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PGF mRNA; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of PGF mRNA] [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of PGF mRNA
|
CTD |
PMID:20880076 PMID:30529165 PMID:33729688 |
|
NCBI chr 6:110,547,165...110,557,747
Ensembl chr 6:110,547,153...110,557,747
|
|
| G
|
Pgk1
|
phosphoglycerate kinase 1
|
multiple interactions increases expression
|
ISO EXP
|
[IL15 protein co-treated with Oxygen deficiency] results in increased expression of PGK1 mRNA; Amphotericin B inhibits the reaction [Oxygen deficiency results in increased expression of PGK1 mRNA]; Cadmium inhibits the reaction [Oxygen deficiency results in increased expression of PGK1 mRNA]; cobaltous chloride promotes the reaction [Oxygen deficiency results in increased expression of PGK1 mRNA]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of PGK1 mRNA]; Niclosamide inhibits the reaction [Oxygen deficiency results in increased expression of PGK1 mRNA] Oxygen deficiency results in increased expression of PGK1 mRNA; Oxygen results in increased expression of PGK1 mRNA [Oxygen deficiency co-treated with AQP3 protein] results in increased expression of PGK1 mRNA
|
CTD |
PMID:10866824 PMID:15225644 PMID:16189267 PMID:19502547 PMID:19695866 PMID:20042640 PMID:20880076 PMID:22911455 PMID:23545307 PMID:23958427 PMID:24236059 PMID:27129235 PMID:34998824 PMID:36318118 More...
|
|
NCBI chr X:75,336,988...75,352,962
Ensembl chr X:75,336,687...75,352,959
|
|
| G
|
Pgls
|
6-phosphogluconolactonase
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PGLS mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr16:18,334,299...18,339,785
Ensembl chr16:18,334,299...18,339,785
|
|
| G
|
Pglyrp1
|
peptidoglycan recognition protein 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of PGLYRP1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:87,659,863...87,665,048
Ensembl chr 1:87,651,271...87,665,048
|
|
| G
|
Pgm1
|
phosphoglucomutase 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PGM1 mRNA
|
CTD |
PMID:24236059 PMID:26516004 |
|
NCBI chr 5:119,710,734...119,770,159
Ensembl chr 5:119,710,737...119,770,159
|
|
| G
|
Pgm2l1
|
phosphoglucomutase 2-like 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PGM2L1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:163,983,917...164,033,027
Ensembl chr 1:163,983,917...164,033,027
|
|
| G
|
Pgm5
|
phosphoglucomutase 5
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PGM5 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:231,752,052...231,939,812
Ensembl chr 1:231,752,052...231,939,812
|
|
| G
|
Pgp
|
phosphoglycolate phosphatase
|
affects methylation increases expression decreases expression multiple interactions
|
ISO
|
Oxygen deficiency affects the methylation of PGP promoter Oxygen deficiency results in increased expression of PGP mRNA Oxygen deficiency results in decreased expression of PGP mRNA [sulforaphane affects the susceptibility to Oxygen] which affects the expression of PGP mRNA
|
CTD |
PMID:20880076 PMID:24205000 PMID:26516004 PMID:30529165 |
|
NCBI chr10:13,999,782...14,002,408
Ensembl chr10:13,999,331...14,002,408
|
|
| G
|
Pgr
|
progesterone receptor
|
affects expression multiple interactions
|
EXP ISO
|
Oxygen deficiency affects the expression of PGR mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PGR mRNA
|
CTD |
PMID:18457817 PMID:30529165 |
|
NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:14,354,398...14,413,271
|
|
| G
|
Pgrmc1
|
progesterone receptor membrane component 1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PGRMC1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr X:120,698,610...120,706,805
Ensembl chr X:120,698,610...120,706,805
|
|
| G
|
Pgs1
|
phosphatidylglycerophosphate synthase 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PGS1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:103,713,306...103,748,924
Ensembl chr10:103,713,316...103,749,233
|
|
| G
|
Phactr2
|
phosphatase and actin regulator 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PHACTR2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:9,411,412...9,680,648
Ensembl chr 1:9,418,085...9,680,583
|
|
| G
|
Phex
|
phosphate regulating endopeptidase X-linked
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PHEX mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr X:41,422,561...41,671,226
Ensembl chr X:41,426,101...41,671,226
|
|
| G
|
Phf24
|
PHD finger protein 24
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of PHF24 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 5:61,939,261...61,966,879
Ensembl chr 5:61,939,900...61,966,875
|
|
| G
|
Phf8
|
PHD finger protein 8
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of PHF8 mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of PHF8 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr X:23,967,126...24,066,473
Ensembl chr X:23,967,556...24,066,471
|
|
| G
|
Phgdh
|
phosphoglycerate dehydrogenase
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PHGDH mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 2:188,595,700...188,624,789
Ensembl chr 2:188,595,700...188,624,789
|
|
| G
|
Phkb
|
phosphorylase kinase regulatory subunit beta
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PHKB mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:37,179,937...37,383,979
Ensembl chr19:37,186,042...37,383,877
|
|
| G
|
Phlda1
|
pleckstrin homology-like domain, family A, member 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of PHLDA1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PHLDA1 mRNA
|
CTD |
PMID:24236059 PMID:30529165 |
|
NCBI chr 7:48,853,690...48,855,894
Ensembl chr 7:48,853,260...48,857,542
|
|
| G
|
Phlda3
|
pleckstrin homology-like domain, family A, member 3
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of PHLDA3 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PHLDA3 mRNA [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of PHLDA3 mRNA; [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of PHLDA3 protein; [Oxygen deficiency co-treated with Oxygen] results in increased expression of PHLDA3 mRNA; [Oxygen deficiency co-treated with Oxygen] results in increased expression of PHLDA3 protein; [Thiazoles analog binds to indoline analog] promotes the reaction [PHLDA3 protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of and affects the localization of and results in increased activity of NFE2L2 protein]]; [Thiazoles analog binds to indoline analog] promotes the reaction [PHLDA3 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of IL1B protein]]; [Thiazoles analog binds to indoline analog] promotes the reaction [PHLDA3 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of IL6 protein]]; [Thiazoles analog binds to indoline analog] promotes the reaction [PHLDA3 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of TNF protein]]; MK 2206 inhibits the reaction [PHLDA3 protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of and affects the localization of and results in increased activity of NFE2L2 protein]]; MK 2206 promotes the reaction [PHLDA3 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased phosphorylation of GSK3B protein]]; MK 2206 promotes the reaction [PHLDA3 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of IL1B protein]]; MK 2206 promotes the reaction [PHLDA3 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of IL6 protein]]; MK 2206 promotes the reaction [PHLDA3 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of TNF protein]]; PHLDA3 protein inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of and affects the localization of NFE2L2 protein]; PHLDA3 protein inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of HMOX1 protein]; PHLDA3 protein inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of NQO1 protein]; PHLDA3 protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of and affects the localization of and results in increased activity of NFE2L2 protein]; PHLDA3 protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of HMOX1 protein]; PHLDA3 protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of NQO1 protein]; PHLDA3 protein promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of IL1B protein]; PHLDA3 protein promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of IL6 protein]; PHLDA3 protein promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of TNF protein]; PHLDA3 protein promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased secretion of [CKM protein binds to CKB protein]]; PHLDA3 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased phosphorylation of GSK3B protein]; PHLDA3 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of IL1B protein]; PHLDA3 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of IL6 protein]; PHLDA3 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of TNF protein]
|
CTD |
PMID:25596134 PMID:30529165 PMID:34351043 |
|
NCBI chr13:49,745,003...49,748,088
Ensembl chr13:49,742,591...49,749,621
|
|
| G
|
Phlpp1
|
PH domain and leucine rich repeat protein phosphatase 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PHLPP1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr13:22,823,132...23,045,619
Ensembl chr13:22,823,132...23,045,619
|
|
| G
|
Phlpp2
|
PH domain and leucine rich repeat protein phosphatase 2
|
multiple interactions increases expression
|
ISO
|
NFE2L2 protein affects the reaction [PHLPP2 protein affects the reaction [Oxygen deficiency results in increased activity of CASP3 protein]]; NFE2L2 protein affects the reaction [PHLPP2 protein affects the reaction [Oxygen deficiency results in increased expression of NFE2L2 protein]]; PHLPP2 protein affects the reaction [Oxygen deficiency results in increased activity of CASP3 protein]; PHLPP2 protein affects the reaction [Oxygen deficiency results in increased expression of NFE2L2 protein]; PHLPP2 protein inhibits the reaction [Oxygen deficiency results in decreased phosphorylation of GSK3B protein]; PHLPP2 protein inhibits the reaction [Oxygen deficiency results in increased expression of HMOX1 mRNA]; PHLPP2 protein inhibits the reaction [Oxygen deficiency results in increased expression of NFE2L2 mRNA]; PHLPP2 protein inhibits the reaction [Oxygen deficiency results in increased expression of NQO1 mRNA]; PHLPP2 protein promotes the reaction [Oxygen deficiency results in increased activity of CASP3 protein]; TWS 119 inhibits the reaction [PHLPP2 protein inhibits the reaction [Oxygen deficiency results in increased expression of NFE2L2 mRNA]]; TWS 119 inhibits the reaction [PHLPP2 protein promotes the reaction [Oxygen deficiency results in increased activity of CASP3 protein]] Oxygen deficiency results in increased expression of PHLPP2 mRNA; Oxygen deficiency results in increased expression of PHLPP2 protein
|
CTD |
PMID:31610156 |
|
NCBI chr19:54,744,581...54,811,258
Ensembl chr19:54,744,581...54,812,259
|
|
| G
|
Pi15
|
peptidase inhibitor 15
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PI15 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:6,178,427...6,206,548
Ensembl chr 5:6,174,963...6,247,841
|
|
| G
|
Pi16
|
peptidase inhibitor 16
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PI16 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr20:7,377,739...7,387,003
Ensembl chr20:7,377,729...7,387,691
|
|
| G
|
Pi4k2a
|
phosphatidylinositol 4-kinase type 2 alpha
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PI4K2A mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:250,850,440...250,878,399
Ensembl chr 1:250,852,154...250,881,811
|
|
| G
|
Pi4k2b
|
phosphatidylinositol 4-kinase type 2 beta
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PI4K2B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:62,434,589...62,461,507
Ensembl chr14:62,424,511...62,461,446
|
|
| G
|
Pi4kb
|
phosphatidylinositol 4-kinase beta
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of PI4KB mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:185,229,392...185,261,697
Ensembl chr 2:185,228,799...185,261,693
|
|
| G
|
Pidd1
|
p53-induced death domain protein 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PIDD1 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 1:205,966,392...205,972,359
Ensembl chr 1:205,966,392...205,971,600
|
|
| G
|
Pigw
|
phosphatidylinositol glycan anchor biosynthesis, class W
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PIGW mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:70,246,904...70,248,412
Ensembl chr10:70,243,810...70,250,329
|
|
| G
|
Pik3c2a
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of PIK3C2A mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:180,012,248...180,117,786
Ensembl chr 1:180,012,248...180,117,773
|
|
| G
|
Pik3ca
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PIK3CA mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 2:117,103,643...117,177,411
Ensembl chr 2:117,143,468...117,177,411
|
|
| G
|
Pik3cb
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
multiple interactions
|
ISO
|
[Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of PIK3CB mRNA; [Oxygen co-treated with Ozone] results in decreased expression of PIK3CB mRNA
|
CTD |
PMID:32992648 |
|
NCBI chr 8:108,474,017...108,579,140
Ensembl chr 8:108,474,019...108,579,331
|
|
| G
|
Pik3cd
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
multiple interactions
|
ISO
|
[Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of PIK3CD mRNA; [Oxygen co-treated with Ozone] results in decreased expression of PIK3CD mRNA
|
CTD |
PMID:32992648 |
|
NCBI chr 5:165,377,994...165,426,620
Ensembl chr 5:165,377,994...165,403,968
|
|
| G
|
Pik3cg
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
decreases expression multiple interactions increases expression
|
ISO EXP
|
Oxygen deficiency results in decreased expression of PIK3CG mRNA kaempferol inhibits the reaction [Oxygen deficiency results in increased expression of PIK3CG mRNA]; kaempferol inhibits the reaction [Oxygen deficiency results in increased expression of PIK3CG protein] Oxygen deficiency results in increased expression of PIK3CG mRNA; Oxygen deficiency results in increased expression of PIK3CG protein
|
CTD |
PMID:24205000 PMID:37923178 |
|
NCBI chr 6:54,494,247...54,529,563
Ensembl chr 6:54,478,603...54,529,509
|
|
| G
|
Pik3ip1
|
phosphoinositide-3-kinase interacting protein 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PIK3IP1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr14:82,428,315...82,440,261
Ensembl chr14:82,428,248...82,440,260
|
|
| G
|
Pik3r1
|
phosphoinositide-3-kinase regulatory subunit 1
|
multiple interactions increases expression decreases phosphorylation
|
ISO EXP
|
[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of PIK3R1 protein; [Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of PIK3R1 mRNA; [Oxygen co-treated with Ozone] results in decreased expression of PIK3R1 mRNA; nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of PIK3R1 protein]; PIK3R1 protein promotes the reaction [Oxygen deficiency results in increased expression of CD36 mRNA]; PIK3R1 protein promotes the reaction [Oxygen deficiency results in increased expression of CD36 protein]; PIK3R1 protein promotes the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; PIK3R1 protein promotes the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Wortmannin inhibits the reaction [nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of PIK3R1 protein]] Oxygen deficiency results in increased expression of PIK3R1 mRNA Oxygen deficiency results in decreased phosphorylation of PIK3R1 protein [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of PIK3R1 protein; HU 308 promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of PIK3R1 protein]; iodopravadoline inhibits the reaction [peoniflorin promotes the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased phosphorylation of PIK3R1 protein]]; Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of PIK3R1 mRNA]; Resveratrol inhibits the reaction [Oxygen deficiency results in decreased phosphorylation of PIK3R1 protein]
|
CTD |
PMID:19640849 PMID:25352008 PMID:26476374 PMID:29560022 PMID:32992648 PMID:38528077 More...
|
|
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:34,612,946...34,626,347
|
|
| G
|
Pik3r2
|
phosphoinositide-3-kinase regulatory subunit 2
|
multiple interactions
|
ISO
|
[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of PIK3R2 protein; [Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of PIK3R2 mRNA; [Oxygen co-treated with Ozone] results in decreased expression of PIK3R2 mRNA; nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of PIK3R2 protein]; Wortmannin inhibits the reaction [nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of PIK3R2 protein]]
|
CTD |
PMID:32992648 PMID:38528077 |
|
NCBI chr16:18,699,389...18,708,045
Ensembl chr16:18,699,448...18,709,665
|
|
| G
|
Pik3r3
|
phosphoinositide-3-kinase regulatory subunit 3
|
multiple interactions
|
ISO
|
[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of PIK3R3 protein; nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of PIK3R3 protein]; Wortmannin inhibits the reaction [nuciferine inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased phosphorylation of PIK3R3 protein]]
|
CTD |
PMID:38528077 |
|
NCBI chr 5:134,936,790...135,009,303
Ensembl chr 5:134,934,857...135,007,762
|
|
| G
|
Pik3r5
|
phosphoinositide-3-kinase, regulatory subunit 5
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of PIK3R5 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr10:53,631,469...53,699,550
Ensembl chr10:53,631,476...53,699,539
|
|
| G
|
Pik3r6
|
phosphoinositide-3-kinase, regulatory subunit 6
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PIK3R6 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:53,702,821...53,754,113
Ensembl chr10:53,704,682...53,754,497
|
|
| G
|
Pim1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
multiple interactions increases expression
|
ISO
|
[2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine co-treated with sorafenib co-treated with Oxygen deficiency] results in decreased expression of PIM1 protein; [sorafenib co-treated with 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] inhibits the reaction [Oxygen deficiency results in increased expression of PIM1 protein]; [sorafenib co-treated with Oxygen deficiency] results in decreased expression of PIM1 protein; sorafenib inhibits the reaction [Oxygen deficiency results in increased expression of PIM1 protein] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PIM1 mRNA
|
CTD |
PMID:23036488 PMID:30529165 |
|
NCBI chr20:7,556,496...7,560,747
Ensembl chr20:7,556,113...7,561,764
|
|
| G
|
Pimreg
|
PICALM interacting mitotic regulator
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of PIMREG mRNA [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PIMREG mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PIMREG mRNA
|
CTD |
PMID:26516004 PMID:33729688 |
|
NCBI chr10:57,168,136...57,173,713
Ensembl chr10:57,167,797...57,173,063
|
|
| G
|
Pink1
|
PTEN induced kinase 1
|
multiple interactions
|
EXP ISO
|
[Antagomirs results in decreased expression of MIR205 mRNA] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PINK1 protein]; [Antagomirs results in decreased expression of MIR205 mRNA] promotes the reaction [Remifentanil inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PINK1 protein]]; [Oxygen co-treated with Dithionite] results in decreased expression of PINK1 protein; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PINK1 protein; [Oxygen deficiency co-treated with Oxygen] results in increased expression of PINK1 protein; dorsomorphin inhibits the reaction [sappanone A inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of PINK1 protein]]; Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in decreased expression of PINK1 protein]; Remifentanil inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PINK1 protein]; sappanone A inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of PINK1 protein] [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of PINK1 protein; genipin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of PINK1 protein]
|
CTD |
PMID:21159781 PMID:28477916 PMID:34078833 PMID:34358556 |
|
NCBI chr 5:155,813,838...155,825,950
Ensembl chr 5:155,813,838...155,825,950
|
|
| G
|
Pinx1
|
PIN2/TERF1 interacting, telomerase inhibitor 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PINX1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr15:42,273,805...42,333,047
Ensembl chr15:42,273,799...42,333,047
|
|
| G
|
Pip5k1c
|
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PIP5K1C mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 7:9,048,135...9,076,751
Ensembl chr 7:9,048,146...9,076,716
|
|
| G
|
Pir
|
pirin
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PIR mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr X:33,740,428...33,851,049
Ensembl chr X:33,740,429...33,851,049
|
|
| G
|
Pira2
|
paired-Ig-like receptor A2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of LILRA6 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 1:74,283,713...74,338,208
|
|
| G
|
Pirb
|
paired Ig-like receptor B
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of PIRB mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 1:74,414,556...74,433,015
Ensembl chr 1:74,331,291...74,422,116
|
|
| G
|
Pirt
|
phosphoinositide-interacting regulator of transient receptor potential channels
|
multiple interactions
|
EXP
|
[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PIRT mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PIRT mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr10:52,112,235...52,127,140
Ensembl chr10:52,111,959...52,131,422
|
|
| G
|
Pitpnm3
|
PITPNM family member 3
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PITPNM3 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:57,173,230...57,265,186
Ensembl chr10:57,175,721...57,265,291
|
|
| G
|
Pjvk
|
pejvakin
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PJVK mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 3:82,002,106...82,012,273
Ensembl chr 3:82,002,368...82,012,451
|
|
| G
|
Pkd1
|
polycystin 1, transient receptor potential channel interacting
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PKD1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:14,077,733...14,125,682
Ensembl chr10:14,078,679...14,125,681
|
|
| G
|
Pkdcc
|
protein kinase domain containing, cytoplasmic
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PKDCC mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 6:17,208,171...17,217,488
Ensembl chr 6:17,208,171...17,218,042
|
|
| G
|
Pkm
|
pyruvate kinase M1/2
|
increases expression multiple interactions affects expression
|
ISO
|
Oxygen deficiency results in increased expression of PKM mRNA [IL15 protein co-treated with Oxygen deficiency] results in increased expression of PKM mRNA; bruceine D affects the reaction [Oxygen deficiency affects the expression of PKM protein]; CTNNBIP1 protein affects the reaction [bruceine D affects the reaction [Oxygen deficiency affects the expression of PKM protein]] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PKM mRNA Oxygen deficiency results in increased expression of PKM protein
|
CTD |
PMID:20880076 PMID:26087400 PMID:27129235 PMID:30529165 PMID:34900531 |
|
NCBI chr 8:68,949,731...68,975,394
Ensembl chr 8:68,948,815...68,975,396
|
|
| G
|
Pkmyt1
|
protein kinase, membrane associated tyrosine/threonine 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PKMYT1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr10:13,252,805...13,263,584
Ensembl chr10:13,252,816...13,264,263
|
|
| G
|
Pkp2
|
plakophilin 2
|
affects expression
|
ISO
|
Oxygen deficiency affects the expression of PKP2 mRNA
|
CTD |
PMID:17193925 |
|
NCBI chr11:98,165,974...98,231,916
Ensembl chr11:98,165,974...98,231,916
|
|
| G
|
Pkp3
|
plakophilin 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PKP3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:205,617,511...205,628,441
Ensembl chr 1:205,617,511...205,628,440
|
|
| G
|
Pla1a
|
phospholipase A1 member A
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLA1A mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr11:75,825,626...75,863,296
Ensembl chr11:75,825,585...75,878,165
|
|
| G
|
Pla2g12a
|
phospholipase A2, group XIIA
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLA2G12A mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:221,110,722...221,126,966
Ensembl chr 2:221,110,685...221,126,964
|
|
| G
|
Pla2g4a
|
phospholipase A2 group 4A
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PLA2G4A mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr13:64,427,921...64,572,352
Ensembl chr13:64,427,916...64,589,641
|
|
| G
|
Pla2g7
|
phospholipase A2 group VII
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLA2G7 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:24,859,491...24,901,747
Ensembl chr 9:24,859,502...24,901,747
|
|
| G
|
Plaat3
|
phospholipase A and acyltransferase 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLAAT3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:214,211,755...214,245,551
Ensembl chr 1:214,211,791...214,246,763
|
|
| G
|
Plac8
|
placenta associated 8
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PLAC8 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr14:9,356,950...9,378,586
Ensembl chr14:9,356,972...9,378,572
|
|
| G
|
Plat
|
plasminogen activator, tissue type
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLAT mRNA [N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride co-treated with PLAT protein] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of VCAM1 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [PLAT protein promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased degradation of CDH5 protein]]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [PLAT protein promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased degradation of TJP1 protein]]; PLAT protein promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased degradation of CDH5 protein]; PLAT protein promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased degradation of TJP1 protein]
|
CTD |
PMID:23876515 PMID:29651748 PMID:30529165 |
|
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696
|
|
| G
|
Plau
|
plasminogen activator, urokinase
|
multiple interactions increases activity increases expression
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLAU mRNA; Oxygen deficiency promotes the reaction [PLAU protein results in increased activity of PLG protein] Oxygen deficiency results in increased activity of PLAU protein Oxygen deficiency results in increased expression of PLAU mRNA Oxygen deficiency results in increased expression of PLAU protein genipin inhibits the reaction [Oxygen deficiency results in increased expression of PLAU protein] [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of PLAU mRNA
|
CTD |
PMID:12485432 PMID:29630948 PMID:30529165 PMID:33729688 |
|
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
|
|
| G
|
Plaur
|
plasminogen activator, urokinase receptor
|
multiple interactions
|
ISO EXP
|
Oxygen deficiency promotes the reaction [SORL1 protein binds to PLAUR protein] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLAUR mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of PLAUR mRNA
|
CTD |
PMID:23486467 PMID:30529165 PMID:33729688 |
|
NCBI chr 1:89,181,363...89,196,308
Ensembl chr 1:89,178,453...89,198,130
|
|
| G
|
Plcb1
|
phospholipase C beta 1
|
increases expression affects methylation multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of PLCB1 mRNA Oxygen deficiency affects the methylation of PLCB1 promoter [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLCB1 mRNA
|
CTD |
PMID:24205000 PMID:30529165 |
|
NCBI chr 3:142,512,765...143,224,042
Ensembl chr 3:142,513,033...143,225,646
|
|
| G
|
Plcd1
|
phospholipase C, delta 1
|
affects localization
|
EXP
|
Oxygen affects the localization of PLCD1 protein
|
CTD |
PMID:12850505 |
|
NCBI chr 8:127,672,955...127,695,939
Ensembl chr 8:127,672,980...127,695,939
|
|
| G
|
Plcd3
|
phospholipase C, delta 3
|
increases expression affects methylation
|
ISO
|
Oxygen deficiency results in increased expression of PLCD3 mRNA Oxygen deficiency affects the methylation of PLCD3 promoter
|
CTD |
PMID:24205000 |
|
NCBI chr10:88,526,802...88,548,116
Ensembl chr10:88,526,802...88,548,069
|
|
| G
|
Plce1
|
phospholipase C, epsilon 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLCE1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:245,655,855...245,964,966
Ensembl chr 1:245,657,080...245,963,828
|
|
| G
|
Plcg1
|
phospholipase C, gamma 1
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of PLCG1 mRNA Oxygen results in decreased expression of and affects the localization of PLCG1 protein
|
CTD |
PMID:12850505 PMID:17914565 |
|
NCBI chr 3:169,805,299...169,836,040
Ensembl chr 3:169,804,846...169,836,050
|
|
| G
|
Plcxd3
|
phosphatidylinositol-specific phospholipase C, X domain containing 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLCXD3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:55,294,597...55,473,968
Ensembl chr 2:55,294,613...55,474,220
|
|
| G
|
Plec
|
plectin
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PLEC mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 7:109,768,447...109,829,798
Ensembl chr 7:109,768,447...109,828,089
|
|
| G
|
Plekha2
|
pleckstrin homology domain containing A2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PLEKHA2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr16:73,641,338...73,704,068
Ensembl chr16:73,641,344...73,703,087
|
|
| G
|
Plekhd1
|
pleckstrin homology and coiled-coil domain containing D1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLEKHD1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 6:106,071,966...106,103,250
Ensembl chr 6:106,071,901...106,117,826
|
|
| G
|
Plg
|
plasminogen
|
multiple interactions
|
ISO
|
Oxygen deficiency promotes the reaction [PLAU protein results in increased activity of PLG protein]
|
CTD |
PMID:12485432 |
|
NCBI chr 1:50,872,927...50,915,406
Ensembl chr 1:50,872,926...50,917,320
|
|
| G
|
Plin2
|
perilipin 2
|
decreases expression multiple interactions increases expression
|
ISO EXP
|
Oxygen deficiency results in decreased expression of PLIN2 mRNA 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PLIN2 mRNA]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PLIN2 protein]]; rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PLIN2 mRNA]; rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PLIN2 protein] Oxygen results in decreased expression of PLIN2 mRNA; Oxygen results in decreased expression of PLIN2 protein 1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of PLIN2 mRNA]; [FV-429 compound co-treated with Oxygen deficiency] affects the expression of PLIN2 protein; [FV-429 compound co-treated with Paclitaxel] inhibits the reaction [Oxygen deficiency results in increased expression of PLIN2 protein]; [Paclitaxel co-treated with FV-429 compound co-treated with Deferoxamine] promotes the reaction [Oxygen deficiency results in increased expression of PLIN2 protein]; [Paclitaxel co-treated with FV-429 compound] inhibits the reaction [Oxygen deficiency results in increased expression of PLIN2 mRNA]; [Paclitaxel co-treated with FV-429 compound] inhibits the reaction [Oxygen deficiency results in increased expression of PLIN2 protein]; Deferoxamine promotes the reaction [Oxygen deficiency results in increased expression of PLIN2 protein]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of PLIN2 protein] Oxygen deficiency results in increased expression of PLIN2 mRNA; Oxygen deficiency results in increased expression of PLIN2 protein [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLIN2 mRNA
|
CTD |
PMID:16617452 PMID:21531777 PMID:24403227 PMID:30529165 PMID:34648812 |
|
NCBI chr 5:106,202,634...106,258,748
Ensembl chr 5:106,202,634...106,258,878
|
|
| G
|
Plk1
|
polo-like kinase 1
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of PLK1 mRNA; Oxygen results in decreased expression of PLK1 mRNA [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PLK1 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PLK1 mRNA
|
CTD |
PMID:26516004 PMID:27103661 PMID:33729688 |
|
NCBI chr 1:186,147,658...186,157,637
Ensembl chr 1:186,147,658...186,157,637
|
|
| G
|
Plk2
|
polo-like kinase 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLK2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:43,702,536...43,708,305
Ensembl chr 2:43,701,865...43,708,296
|
|
| G
|
Plk3
|
polo-like kinase 3
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of PLK3 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLK3 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of PLK3 mRNA
|
CTD |
PMID:25596134 PMID:30529165 PMID:33729688 |
|
NCBI chr 5:135,843,725...135,848,900
Ensembl chr 5:135,843,725...135,848,900
|
|
| G
|
Plk4
|
polo-like kinase 4
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PLK4 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 2:125,730,480...125,748,894
Ensembl chr 2:125,730,460...125,748,892
|
|
| G
|
Pllp
|
plasmolipin
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLLP mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr19:10,321,080...10,341,869
Ensembl chr19:10,321,080...10,342,226
|
|
| G
|
Pln
|
phospholamban
|
increases expression multiple interactions
|
ISO
|
Oxygen results in increased expression of PLN protein [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLN mRNA; NFE2L2 protein affects the reaction [Oxygen results in increased expression of PLN protein]; NFE2L2 protein affects the reaction [sulforaphane promotes the reaction [Oxygen results in increased expression of PLN protein]]; sulforaphane promotes the reaction [Oxygen results in increased expression of PLN protein]
|
CTD |
PMID:30529165 |
|
NCBI chr20:33,166,512...33,182,241
Ensembl chr20:33,172,494...33,182,241
|
|
| G
|
Plod2
|
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PLOD2 mRNA
|
CTD |
PMID:20042640 PMID:24236059 PMID:26516004 |
|
NCBI chr 8:101,964,318...102,047,022
Ensembl chr 8:101,964,318...102,047,022
|
|
| G
|
Plp1
|
proteolipid protein 1
|
decreases expression increases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PLP1 mRNA Oxygen deficiency results in increased expression of PLP1 mRNA
|
CTD |
PMID:24205000 PMID:24236059 |
|
NCBI chr X:104,933,921...104,993,317
Ensembl chr X:104,975,780...104,993,314
|
|
| G
|
Plpp2
|
phospholipid phosphatase 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLPP2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:10,826,534...10,834,628
Ensembl chr 7:10,826,549...10,834,627
|
|
| G
|
Plpp3
|
phospholipid phosphatase 3
|
multiple interactions decreases metabolic processing
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPAP2B mRNA PLPP3 gene mutant form results in decreased metabolism of Oxygen
|
CTD |
PMID:28982073 PMID:30529165 |
|
NCBI chr 5:125,156,000...125,231,119
Ensembl chr 5:125,155,945...125,235,667
|
|
| G
|
Pls1
|
plastin 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PLS1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 8:105,196,312...105,306,252
Ensembl chr 8:105,197,455...105,292,447
|
|
| G
|
Plscr4
|
phospholipid scramblase 4
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLSCR4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:101,867,057...101,905,827
Ensembl chr 8:101,866,888...101,905,831
|
|
| G
|
Pltp
|
phospholipid transfer protein
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLTP mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:173,994,162...174,011,982
Ensembl chr 3:173,994,162...174,012,505
|
|
| G
|
Plvap
|
plasmalemma vesicle associated protein
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of PLVAP mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr16:18,218,966...18,231,279
Ensembl chr16:18,218,967...18,231,454
|
|
| G
|
Plxdc1
|
plexin domain containing 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLXDC1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr10:83,418,837...83,478,451
Ensembl chr10:83,418,837...83,478,755
|
|
| G
|
Plxdc2
|
plexin domain containing 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLXDC2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr17:84,077,793...84,502,831
Ensembl chr17:84,104,864...84,497,999
|
|
| G
|
Plxnb2
|
plexin B2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PLXNB2 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 7:122,111,917...122,138,201
Ensembl chr 7:122,111,917...122,127,746
|
|
| G
|
Pmaip1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
affects expression multiple interactions
|
ISO EXP
|
Oxygen deficiency affects the expression of PMAIP1 mRNA [eprenetapopt co-treated with Oxygen deficiency] promotes the reaction [Cisplatin results in increased expression of PMAIP1 mRNA]; Oxygen deficiency promotes the reaction [Cisplatin results in increased expression of PMAIP1 mRNA] [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of PMAIP1 mRNA
|
CTD |
PMID:25596134 PMID:29690507 PMID:33729688 |
|
NCBI chr18:62,255,970...62,262,384
Ensembl chr18:62,255,598...62,262,382
|
|
| G
|
Pmepa1
|
prostate transmembrane protein, androgen induced 1
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of PMEPA1 mRNA [sulforaphane affects the susceptibility to Oxygen] which affects the expression of PMEPA1 mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of PMEPA1 mRNA
|
CTD |
PMID:25596134 PMID:30529165 PMID:33729688 |
|
NCBI chr 3:182,430,193...182,478,649
Ensembl chr 3:182,430,193...182,478,649
|
|
| G
|
Pml
|
PML nuclear body scaffold
|
affects methylation increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency affects the methylation of PML promoter Oxygen deficiency results in increased expression of PML mRNA [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PML mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PML mRNA
|
CTD |
PMID:24205000 PMID:33729688 |
|
NCBI chr 8:67,523,164...67,557,801
Ensembl chr 8:67,523,164...67,576,083
|
|
| G
|
Pmm1
|
phosphomannomutase 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PMM1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:115,346,767...115,357,137
Ensembl chr 7:115,346,771...115,357,024
|
|
| G
|
Pnck
|
pregnancy up-regulated nonubiquitous CaM kinase
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PNCK mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr X:156,520,751...156,524,828
Ensembl chr X:156,520,753...156,525,352
|
|
| G
|
Pnkd
|
PNKD metallo-beta-lactamase domain containing
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PNKD mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 9:83,317,757...83,386,263
Ensembl chr 9:83,317,738...83,386,262
|
|
| G
|
Pnliprp1
|
pancreatic lipase-related protein 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PNLIPRP1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:267,854,027...267,869,654
Ensembl chr 1:267,854,027...267,869,654
|
|
| G
|
Pno1
|
partner of NOB1 homolog
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of PNO1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PNO1 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr14:95,811,335...95,819,903
Ensembl chr14:95,688,125...95,905,881
|
|
| G
|
Pnpla2
|
patatin-like phospholipase domain containing 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PNPLA2 mRNA
|
CTD |
PMID:23539316 |
|
NCBI chr 1:205,982,279...205,987,361
Ensembl chr 1:205,982,258...205,987,359
|
|
| G
|
Pnpla6
|
patatin-like phospholipase domain containing 6
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PNPLA6 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr12:6,372,284...6,401,632
Ensembl chr12:6,372,293...6,401,631
|
|
| G
|
Podn
|
podocan
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PODN mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 5:128,003,907...128,025,518
Ensembl chr 5:128,008,125...128,110,043
|
|
| G
|
Podxl
|
podocalyxin-like
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PODXL mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 4:61,102,434...61,149,131
Ensembl chr 4:61,102,419...61,149,789
|
|
| G
|
Poglut1
|
protein O-glucosyltransferase 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of POGLUT1 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr11:75,704,119...75,731,964
Ensembl chr11:75,703,833...75,733,519
|
|
| G
|
Poglut3
|
protein O-glucosyltransferase 3
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of POGLUT3 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:62,673,811...62,691,606
Ensembl chr 8:62,673,805...62,691,601
|
|
| G
|
Pola1
|
DNA polymerase alpha 1, catalytic subunit
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of POLA1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr X:62,028,475...62,342,455
Ensembl chr X:62,028,476...62,342,355
|
|
| G
|
Pola2
|
DNA polymerase alpha 2, accessory subunit
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of POLA2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:212,656,500...212,680,667
Ensembl chr 1:212,656,501...212,680,542
|
|
| G
|
Polb
|
DNA polymerase beta
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of POLB protein
|
CTD |
PMID:25030372 |
|
NCBI chr16:76,081,903...76,105,174
Ensembl chr16:76,081,864...76,108,180
|
|
| G
|
Pold1
|
DNA polymerase delta 1, catalytic subunit
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of POLD1 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 1:104,161,984...104,178,074
Ensembl chr 1:104,162,016...104,172,982
|
|
| G
|
Pold2
|
DNA polymerase delta 2, accessory subunit
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of POLD2 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr14:84,962,933...84,969,148
Ensembl chr14:84,962,022...84,967,874
|
|
| G
|
Pold3
|
DNA polymerase delta 3, accessory subunit
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of POLD3 mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 1:163,830,217...163,870,015
Ensembl chr 1:163,830,437...163,869,202
|
|
| G
|
Pole2
|
DNA polymerase epsilon 2, accessory subunit
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of POLE2 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of POLE2 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 6:93,410,713...93,448,782
Ensembl chr 6:93,410,758...93,435,361
|
|
| G
|
Polk
|
DNA polymerase kappa
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of POLK mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:29,556,831...29,616,960
Ensembl chr 2:29,557,336...29,616,960
|
|
| G
|
Polq
|
DNA polymerase theta
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of POLQ mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr11:77,179,190...77,281,270
Ensembl chr11:77,179,209...77,281,268
|
|
| G
|
Polr1a
|
RNA polymerase I subunit A
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of POLR1A mRNA; Oxygen deficiency results in decreased expression of POLR1A protein
|
CTD |
PMID:26516004 PMID:38909692 |
|
NCBI chr 4:105,508,305...105,572,272
Ensembl chr 4:105,508,248...105,574,036
|
|
| G
|
Polr1b
|
RNA polymerase I subunit B
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of POLR1B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 3:136,787,130...136,811,608
Ensembl chr 3:136,787,107...136,811,607
|
|
| G
|
Polr1e
|
RNA polymerase I subunit E
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of POLR1E mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:64,075,123...64,090,900
Ensembl chr 5:64,075,122...64,091,039
|
|
| G
|
Polr1g
|
RNA polymerase I subunit G
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of POLR1G mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of POLR1G mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of POLR1G mRNA
|
CTD |
PMID:26516004 PMID:30529165 PMID:33729688 |
|
NCBI chr 1:88,135,493...88,138,769
Ensembl chr 1:88,135,493...88,138,769
|
|
| G
|
Polr2e
|
RNA polymerase II, I and III subunit E
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of POLR2E mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 7:10,317,332...10,321,280
Ensembl chr 7:10,317,389...10,321,276
|
|
| G
|
Polr2h
|
RNA polymerase II, I and III subunit H
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of POLR2H mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr11:93,696,423...93,701,902
Ensembl chr10:105,353,444...105,354,241 Ensembl chr11:105,353,444...105,354,241
|
|
| G
|
Polr3b
|
RNA polymerase III subunit B
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of POLR3B mRNA
|
CTD |
PMID:24236059 |
|
NCBI chr 7:20,926,866...21,030,133
Ensembl chr 7:20,926,866...21,033,654
|
|
| G
|
Polr3c
|
RNA polymerase III subunit C
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of POLR3C mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:186,935,038...186,950,962
Ensembl chr 2:186,935,038...186,950,962
|
|
| G
|
Polr3f
|
RNA polymerase III subunit F
|
affects expression
|
ISO
|
Oxygen deficiency affects the expression of POLR3F mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 3:152,361,798...152,378,169
Ensembl chr 3:152,361,798...152,378,168
|
|
| G
|
Polr3g
|
RNA polymerase III subunit G
|
decreases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in decreased expression of POLR3G mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of POLR3G mRNA
|
CTD |
PMID:26516004 PMID:33729688 |
|
NCBI chr 2:13,680,893...13,721,802
Ensembl chr 2:13,680,895...13,721,802
|
|
| G
|
Polr3k
|
RNA polymerase III subunit K
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of POLR3K mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 3:189,360,349...189,364,546
Ensembl chr 3:189,360,171...189,366,697
|
|
| G
|
Pomc
|
proopiomelanocortin
|
increases secretion
|
EXP
|
Oxygen results in increased secretion of POMC protein
|
CTD |
PMID:2846107 |
|
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:32,659,346...32,665,173
|
|
| G
|
Pon1
|
paraoxonase 1
|
multiple interactions increases activity
|
ISO
|
Oxygen promotes the reaction [PON1 protein affects the metabolism of Paraoxon] Oxygen results in increased activity of PON1 protein
|
CTD |
PMID:16391483 |
|
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:34,261,289...34,287,924
|
|
| G
|
Pon3
|
paraoxonase 3
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PON3 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr 4:34,323,546...34,350,244
Ensembl chr 4:34,315,889...34,350,244
|
|
| G
|
Pop5
|
POP5 homolog, ribonuclease P/MRP subunit
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of POP5 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr12:47,037,451...47,045,778
Ensembl chr12:47,029,403...47,042,032
|
|
| G
|
Pop7
|
POP7 homolog, ribonuclease P/MRP subunit
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of POP7 mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr12:24,826,161...24,827,202
Ensembl chr12:24,809,994...24,827,522
|
|
| G
|
Por
|
cytochrome p450 oxidoreductase
|
multiple interactions increases metabolic processing
|
ISO
|
diphenyleneiodonium inhibits the reaction [[POR protein results in increased metabolism of Diquat] which results in increased metabolism of Oxygen]; diphenyleneiodonium inhibits the reaction [[POR protein results in increased metabolism of Paraquat] which results in increased metabolism of Oxygen]; NADP promotes the reaction [[POR protein results in increased metabolism of Diquat] which results in increased metabolism of Oxygen]; NADP promotes the reaction [[POR protein results in increased metabolism of Paraquat] which results in increased metabolism of Oxygen]; POR protein inhibits the reaction [Oxygen deficiency affects the localization of HMOX1 protein] [POR protein results in increased metabolism of Diquat] which results in increased metabolism of Oxygen; [POR protein results in increased metabolism of Paraquat] which results in increased metabolism of Oxygen
|
CTD |
PMID:21215309 PMID:22545110 |
|
NCBI chr12:26,587,674...26,655,612
Ensembl chr12:26,587,674...26,635,809
|
|
| G
|
Postn
|
periostin
|
increases expression multiple interactions decreases response to substance
|
ISO
|
Oxygen results in increased expression of POSTN mRNA; Oxygen results in increased expression of POSTN protein [POSTN gene mutant form results in decreased susceptibility to Oxygen] which results in decreased expression of ACTA2 mRNA; [POSTN gene mutant form results in decreased susceptibility to Oxygen] which results in decreased expression of CCL4 mRNA; [POSTN gene mutant form results in decreased susceptibility to Oxygen] which results in decreased expression of CXCL1 mRNA; [POSTN gene mutant form results in decreased susceptibility to Oxygen] which results in decreased expression of CXCL2 mRNA; [POSTN gene mutant form results in decreased susceptibility to Oxygen] which results in decreased expression of ELN mRNA; POSTN gene mutant form inhibits the reaction [Oxygen results in increased expression of CCL4 mRNA]; POSTN gene mutant form inhibits the reaction [Oxygen results in increased expression of CXCL1 mRNA]; POSTN gene mutant form inhibits the reaction [Oxygen results in increased expression of CXCL2 mRNA]; POSTN gene mutant form inhibits the reaction [Oxygen results in increased expression of ELN mRNA]; POSTN gene mutant form inhibits the reaction [Oxygen results in increased expression of POSTN mRNA] 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of POSTN protein]; POSTN protein affects the reaction [Oxygen deficiency results in increased expression of VEGFA mRNA]; POSTN protein affects the reaction [Oxygen deficiency results in increased secretion of VEGFA protein]
|
CTD |
PMID:22363622 PMID:23728938 |
|
NCBI chr 2:140,677,774...140,709,304
Ensembl chr 2:140,677,754...140,709,300
|
|
| G
|
Pou2af1
|
POU class 2 homeobox associating factor 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of POU2AF1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 8:60,418,173...60,445,176
Ensembl chr 8:60,436,844...60,445,176
|
|
| G
|
Pou5f1
|
POU class 5 homeobox 1
|
decreases expression increases expression
|
ISO
|
Oxygen deficiency results in decreased expression of POU5F1 mRNA Oxygen deficiency results in increased expression of POU5F1 protein Oxygen deficiency results in decreased expression of POU5F1 protein
|
CTD |
PMID:16814746 PMID:23725749 PMID:38909692 |
|
NCBI chr20:3,227,836...3,232,598
Ensembl chr20:3,227,837...3,232,598
|
|
| G
|
Ppa1
|
inorganic pyrophosphatase 1
|
affects methylation increases expression multiple interactions
|
ISO
|
Oxygen deficiency affects the methylation of PPA1 promoter Oxygen deficiency results in increased expression of PPA1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPA1 mRNA
|
CTD |
PMID:24205000 PMID:30529165 |
|
NCBI chr20:30,132,088...30,160,492
Ensembl chr20:30,133,504...30,160,489
|
|
| G
|
Ppan
|
peter pan homolog
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPAN mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of PPAN mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 8:27,700,147...27,704,127
Ensembl chr 8:27,700,152...27,704,128
|
|
| G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of PPARA mRNA [resveratrol co-treated with Oxygen deficiency] results in increased expression of PPARA mRNA; rosiglitazone inhibits the reaction [Oxygen deficiency results in decreased expression of PPARA mRNA]
|
CTD |
PMID:21113404 |
|
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
|
|
| G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
decreases expression multiple interactions increases expression affects activity affects expression
|
ISO EXP
|
Oxygen deficiency results in decreased expression of PPARG protein Oxygen deficiency results in decreased expression of PPARG mRNA; Oxygen deficiency results in decreased expression of PPARG protein [Dexamethasone co-treated with Oxygen deficiency] results in increased expression of PPARG mRNA alternative form; [Resveratrol co-treated with Oxygen deficiency] results in increased expression of PPARG protein; bazedoxifene affects the reaction [Oxygen deficiency affects the expression of PPARG protein]; Rosiglitazone inhibits the reaction [Oxygen deficiency results in decreased expression of PPARG mRNA]; Rosiglitazone inhibits the reaction [Oxygen deficiency results in decreased expression of PPARG protein] 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PPARG mRNA]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PPARG protein]]; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARG protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PPARG mRNA; bisphenol A diglycidyl ether inhibits the reaction [Ursolic Acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARG protein]]; Mifepristone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARG protein]; Rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PPARG mRNA]; Rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PPARG protein]; tetrahydropalmatine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PPARG mRNA]; Ursolic Acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARG protein] Oxygen results in decreased expression of PPARG mRNA; Oxygen results in decreased expression of PPARG protein Oxygen deficiency results in increased expression of PPARG protein; Oxygen results in increased expression of PPARG mRNA Oxygen deficiency affects the activity of PPARG protein Oxygen deficiency results in increased expression of PPARG mRNA [Oxygen deficiency co-treated with Oxygen] results in decreased expression of PPARG mRNA; [Oxygen deficiency co-treated with Oxygen] results in decreased expression of PPARG protein; ALKBH5 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of PPARG protein]; PPARG protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of ALCAM protein]; PPARG protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of VIM protein]; PPARG protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of CDH1 protein]; PPARG protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of ENG protein]
|
CTD |
PMID:16617452 PMID:16814746 PMID:19520921 PMID:21113404 PMID:21531777 PMID:22535284 PMID:25596134 PMID:26516004 PMID:27274199 PMID:28859903 PMID:30229846 PMID:34995009 PMID:37606869 More...
|
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
| G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
decreases expression multiple interactions increases expression
|
ISO EXP
|
Oxygen deficiency results in decreased expression of PPARGC1A mRNA; Oxygen deficiency results in decreased expression of PPARGC1A protein [Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of PPARGC1A protein; genipin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of PPARGC1A protein]; rosiglitazone inhibits the reaction [Oxygen deficiency results in decreased expression of PPARGC1A mRNA]; sirtinol inhibits the reaction [genipin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of PPARGC1A protein]] EPAS1 gene mutant form inhibits the reaction [Oxygen deficiency results in decreased expression of PPARGC1A protein]; HIF1A gene mutant form inhibits the reaction [Oxygen deficiency results in decreased expression of PPARGC1A protein] Oxygen deficiency results in increased expression of PPARGC1A mRNA [Nitrites co-treated with Oxygen deficiency] results in increased expression of and results in decreased acetylation of PPARGC1A protein; [Nitrites co-treated with Oxygen deficiency] results in increased expression of PPARGC1A mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARGC1A mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARGC1A protein; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of PPARGC1A protein; [Oxygen deficiency co-treated with Oxygen] results in decreased expression of PPARGC1A protein; dorsomorphin inhibits the reaction [sappanone A inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of PPARGC1A protein]]; PRKAA2 mutant form inhibits the reaction [[Nitrites co-treated with Oxygen deficiency] results in increased expression of PPARGC1A mRNA]; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of PPARGC1A protein]; Rosiglitazone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARGC1A mRNA]; Rosiglitazone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARGC1A protein]; sappanone A inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of PPARGC1A protein]; splitomicin inhibits the reaction [[Nitrites co-treated with Oxygen deficiency] results in increased expression of PPARGC1A mRNA]
|
CTD |
PMID:21113404 PMID:22892143 PMID:23539316 PMID:24503013 PMID:24898700 PMID:28477916 PMID:34358556 PMID:36806343 More...
|
|
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213
|
|
| G
|
Ppargc1b
|
PPARG coactivator 1 beta
|
increases expression decreases expression
|
ISO
|
Oxygen deficiency results in increased expression of PPARGC1B mRNA Oxygen deficiency results in decreased expression of PPARGC1B mRNA
|
CTD |
PMID:23539316 PMID:26516004 |
|
NCBI chr18:57,029,264...57,131,466
Ensembl chr18:57,029,275...57,131,466
|
|
| G
|
Ppat
|
phosphoribosyl pyrophosphate amidotransferase
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PPAT mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr14:31,570,010...31,604,410
Ensembl chr14:31,551,388...31,604,405
|
|
| G
|
Ppbp
|
pro-platelet basic protein
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPBP mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr14:17,586,495...17,587,299
Ensembl chr14:17,586,495...17,587,299
|
|
| G
|
Ppfia4
|
PTPRF interacting protein alpha 4
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of PPFIA4 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPFIA4 mRNA
|
CTD |
PMID:24236059 PMID:26516004 PMID:30529165 |
|
NCBI chr13:48,305,844...48,354,329
Ensembl chr13:48,305,848...48,354,279
|
|
| G
|
Ppfibp1
|
PPFIA binding protein 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PPFIBP1 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 4:181,538,249...181,682,079
Ensembl chr 4:181,539,450...181,682,076
|
|
| G
|
Ppfibp2
|
PPFIA binding protein 2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPFIBP2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:170,916,649...171,062,096
Ensembl chr 1:170,916,649...171,065,618
|
|
| G
|
Ppig
|
peptidylprolyl isomerase G
|
affects expression
|
ISO
|
Oxygen deficiency affects the expression of PPIG mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 3:74,891,846...74,923,010
Ensembl chr 3:74,891,846...74,920,750
|
|
| G
|
Ppl
|
periplakin
|
multiple interactions increases expression
|
ISO EXP
|
1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of PPL mRNA] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPL mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PPL mRNA
|
CTD |
PMID:24403227 PMID:26516004 PMID:30529165 PMID:33729688 |
|
NCBI chr10:10,957,388...11,003,035
Ensembl chr10:10,957,341...11,003,658
|
|
| G
|
Ppm1a
|
protein phosphatase, Mg2+/Mn2+ dependent, 1A
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of PPM1A mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of PPM1A mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 6:97,174,955...97,216,585
Ensembl chr 6:97,174,916...97,216,574
|
|
| G
|
Ppm1b
|
protein phosphatase, Mg2+/Mn2+ dependent, 1B
|
multiple interactions increases expression
|
ISO
|
Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of PPM1B mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 6:15,399,559...15,460,301
Ensembl chr 6:15,399,562...15,460,756
|
|
| G
|
Ppm1d
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PPM1D mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr10:70,670,026...70,706,030
Ensembl chr10:70,670,020...70,706,256
|
|
| G
|
Ppm1k
|
protein phosphatase, Mg2+/Mn2+ dependent, 1K
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPM1K mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:88,942,226...88,969,139
Ensembl chr 4:88,942,386...88,969,136
|
|
| G
|
Ppme1
|
protein phosphatase methylesterase 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPME1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:164,080,242...164,127,261
Ensembl chr 1:164,080,242...164,127,220
|
|
| G
|
Ppp1ca
|
protein phosphatase 1 catalytic subunit alpha
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PPP1CA protein
|
CTD |
PMID:25937538 |
|
NCBI chr 1:210,914,576...210,918,193
Ensembl chr 1:210,914,567...210,918,193
|
|
| G
|
Ppp1cb
|
protein phosphatase 1 catalytic subunit beta
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of PPP1CB mRNA Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of PPP1CB mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr 6:29,681,099...29,712,835
Ensembl chr 6:29,681,100...29,712,924
|
|
| G
|
Ppp1r12a
|
protein phosphatase 1, regulatory subunit 12A
|
affects methylation increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency affects the methylation of PPP1R12A promoter Oxygen deficiency results in increased expression of PPP1R12A mRNA 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid inhibits the reaction [notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased phosphorylation of PPP1R12A protein]]; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased phosphorylation of PPP1R12A protein; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased phosphorylation of PPP1R12A protein]; Y 27632 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased phosphorylation of PPP1R12A protein]
|
CTD |
PMID:24205000 PMID:25305180 |
|
NCBI chr 7:45,368,922...45,480,158
Ensembl chr 7:45,369,315...45,480,157
|
|
| G
|
Ppp1r13l
|
protein phosphatase 1, regulatory subunit 13 like
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of PPP1R13L mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPP1R13L mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 1:88,139,000...88,158,714
Ensembl chr 1:88,140,532...88,158,714
|
|
| G
|
Ppp1r14b
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPP1R14B mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:213,594,416...213,596,527
Ensembl chr12:21,088,517...21,101,431 Ensembl chr 1:21,088,517...21,101,431
|
|
| G
|
Ppp1r15a
|
protein phosphatase 1, regulatory subunit 15A
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of PPP1R15A mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPP1R15A mRNA
|
CTD |
PMID:17914565 PMID:25596134 PMID:30529165 |
|
NCBI chr 1:105,136,521...105,139,596
Ensembl chr 1:105,136,525...105,139,774
|
|
| G
|
Ppp1r3a
|
protein phosphatase 1, regulatory subunit 3A
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PPP1R3A mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 4:43,905,648...43,946,236
Ensembl chr 4:43,905,648...43,946,236
|
|
| G
|
Ppp1r3b
|
protein phosphatase 1, regulatory subunit 3B
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PPP1R3B mRNA
|
CTD |
PMID:20880076 |
|
NCBI chr16:63,533,318...63,545,683
Ensembl chr16:63,532,842...63,549,997
|
|
| G
|
Ppp1r3c
|
protein phosphatase 1, regulatory subunit 3C
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of PPP1R3C mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPP1R3C mRNA
|
CTD |
PMID:20042640 PMID:20880076 PMID:26516004 PMID:30529165 |
|
NCBI chr 1:243,873,524...243,878,527
Ensembl chr 1:243,871,704...243,878,835
|
|
| G
|
Ppp1r3g
|
protein phosphatase 1, regulatory subunit 3G
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PPP1R3G mRNA
|
CTD |
PMID:26516004 |
|
NCBI chr17:29,080,407...29,083,739
Ensembl chr17:29,070,658...29,085,135
|
|
| G
|
Ppp1r9a
|
protein phosphatase 1, regulatory subunit 9A
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPP1R9A mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 4:33,936,949...34,258,927
Ensembl chr 4:33,988,827...34,258,927
|
|
| G
|
Ppp2r3a
|
protein phosphatase 2, regulatory subunit B'', alpha
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PPP2R3A mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 8:110,582,479...110,720,516
Ensembl chr 8:110,583,743...110,677,482
|
|
| G
|
Ppp2r5b
|
protein phosphatase 2, regulatory subunit B', beta
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of PPP2R5B mRNA 1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of PPP2R5B mRNA]
|
CTD |
PMID:24403227 |
|
NCBI chr 1:212,956,533...212,964,706
Ensembl chr 1:212,956,533...212,964,662
|
|
| G
|
Ppp4r2
|
protein phosphatase 4, regulatory subunit 2
|
affects expression
|
ISO
|
Oxygen deficiency affects the expression of PPP4R2 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 4:135,010,919...135,051,844
Ensembl chr 4:135,010,919...135,051,844
|
|
| G
|
Ppp4r3a
|
protein phosphatase 4, regulatory subunit 3A
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PPP4R3A mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr 6:126,032,068...126,098,329
Ensembl chr 6:126,032,068...126,095,543
|
|
| G
|
Pprc1
|
PPARG related coactivator 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPRC1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:254,851,136...254,867,570
Ensembl chr 1:254,851,164...254,867,570
|
|
| G
|
Pram1
|
PML-RARA regulated adaptor molecule 1
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of PRAM1 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr 7:15,125,813...15,142,494
|
|
| G
|
Prdm1
|
PR/SET domain 1
|
increases expression multiple interactions
|
ISO
|
Oxygen deficiency results in increased expression of PRDM1 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRDM1 mRNA
|
CTD |
PMID:25596134 PMID:26516004 PMID:30529165 |
|
NCBI chr20:49,542,465...49,564,088
Ensembl chr20:49,542,465...49,564,088
|
|
| G
|
Prdm16
|
PR/SET domain 16
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRDM16 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 5:170,162,275...170,486,371
Ensembl chr 5:170,162,275...170,485,804
|
|
| G
|
Prdm4
|
PR/SET domain 4
|
multiple interactions
|
ISO
|
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of PRDM4 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:19,841,560...19,868,224
Ensembl chr 7:19,841,743...19,869,313
|
|
| G
|
Prdx1
|
peroxiredoxin 1
|
increases expression
|
EXP
|
Oxygen results in increased expression of PRDX1 mRNA
|
CTD |
PMID:22911455 |
|
NCBI chr 5:135,383,906...135,399,504
Ensembl chr 5:135,383,906...135,399,504
|
|
| G
|
Prdx2
|
peroxiredoxin 2
|
multiple interactions increases expression
|
ISO
|
Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of PRDX2 mRNA]
|
CTD |
PMID:22629407 |
|
NCBI chr19:40,085,788...40,091,083
Ensembl chr19:40,084,430...40,091,006
|
|
| G
|
Prdx3
|
peroxiredoxin 3
|
multiple interactions
|
ISO
|
[Oxygen deficiency co-treated with Catechin] results in increased expression of PRDX3 mRNA
|
CTD |
PMID:35883890 |
|
NCBI chr 1:269,987,691...270,000,111
Ensembl chr 1:269,987,685...270,000,300
|
|
| G
|
Prdx4
|
peroxiredoxin 4
|
multiple interactions
|
ISO
|
[Oxygen deficiency co-treated with Catechin] results in increased expression of PRDX4 mRNA
|
CTD |
PMID:35883890 |
|
NCBI chr X:43,876,374...43,893,815
Ensembl chr X:43,876,417...43,893,812
|
|
| G
|
Prdx6
|
peroxiredoxin 6
|
increases expression decreases expression affects response to substance
|
ISO EXP
|
Oxygen results in increased expression of PRDX6 mRNA; Oxygen results in increased expression of PRDX6 protein Oxygen deficiency results in decreased expression of PRDX6 mRNA; Oxygen deficiency results in decreased expression of PRDX6 protein PRDX6 protein affects the susceptibility to Oxygen
|
CTD |
PMID:12851211 PMID:20627125 PMID:20923568 |
|
NCBI chr13:76,062,082...76,072,631
Ensembl chr13:76,061,554...76,072,657
|
|
| G
|
Prelid1
|
PRELI domain containing 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PRELID1 mRNA
|
CTD |
PMID:24205000 |
|
NCBI chr17:9,310,471...9,313,511
Ensembl chr17:9,310,472...9,313,531
|
|
| G
|
Prelid2
|
PRELI domain containing 2
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PRELID2 mRNA
|
CTD |
PMID:20880076 PMID:24236059 |
|
NCBI chr18:34,120,989...34,212,699
Ensembl chr18:34,125,373...34,212,167
|
|
| G
|
Prelid3b
|
PRELI domain containing 3B
|
multiple interactions
|
ISO EXP
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRELID3B mRNA [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of PRELID3B mRNA
|
CTD |
PMID:30529165 PMID:33729688 |
|
NCBI chr 3:183,681,257...183,689,253
Ensembl chr 3:183,681,255...183,689,289
|
|
| G
|
Prelp
|
proline and arginine rich end leucine rich repeat protein
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRELP mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr13:47,920,480...47,943,547
Ensembl chr13:47,922,590...47,932,324
|
|
| G
|
Prg4
|
proteoglycan 4
|
multiple interactions
|
EXP
|
[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of PRG4 mRNA
|
CTD |
PMID:33729688 |
|
NCBI chr13:65,037,363...65,054,764
Ensembl chr13:65,037,363...65,054,508
|
|
| G
|
Prickle1
|
prickle planar cell polarity protein 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRICKLE1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 7:126,518,587...126,614,581
Ensembl chr 7:126,518,587...126,614,581
|
|
| G
|
Prim1
|
DNA primase subunit 1
|
multiple interactions
|
ISO
|
Oxygen affects the reaction [AHR protein results in increased expression of PRIM1 mRNA]
|
CTD |
PMID:27103661 |
|
NCBI chr 7:1,031,436...1,047,134
|
|
| G
|
Prkaa1
|
protein kinase AMP-activated catalytic subunit alpha 1
|
multiple interactions
|
EXP
|
Oxygen deficiency results in decreased expression of [PRKAA1 protein binds to PRKAA2 protein]; sanggenone C inhibits the reaction [Oxygen deficiency results in decreased expression of [PRKAA1 protein binds to PRKAA2 protein]]
|
CTD |
PMID:28983604 |
|
NCBI chr 2:55,967,766...56,003,450
Ensembl chr 2:55,967,351...56,003,450
|
|
| G
|
Prkaa2
|
protein kinase AMP-activated catalytic subunit alpha 2
|
increases expression multiple interactions
|
ISO EXP
|
Oxygen deficiency results in increased expression of PRKAA2 mRNA Oxygen results in increased expression of PRKAA2 mRNA Oxygen deficiency results in decreased expression of [PRKAA1 protein binds to PRKAA2 protein]; PRKAA2 mutant form inhibits the reaction [[Nitrites co-treated with Oxygen deficiency] results in increased expression of PPARGC1A mRNA]; sanggenone C inhibits the reaction [Oxygen deficiency results in decreased expression of [PRKAA1 protein binds to PRKAA2 protein]]
|
CTD |
PMID:22892143 PMID:22911455 PMID:24236059 PMID:28983604 |
|
NCBI chr 5:125,036,945...125,109,010
Ensembl chr 5:125,042,179...125,108,324
|
|
| G
|
Prkab1
|
protein kinase AMP-activated non-catalytic subunit beta 1
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PRKAB1 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr12:46,248,971...46,259,487
Ensembl chr12:46,249,010...46,259,482
|
|
| G
|
Prkab2
|
protein kinase AMP-activated non-catalytic subunit beta 2
|
decreases expression
|
ISO
|
Oxygen deficiency results in decreased expression of PRKAB2 mRNA
|
CTD |
PMID:25596134 |
|
NCBI chr 2:187,946,008...187,961,615
Ensembl chr 2:187,945,982...187,961,608
|
|
| G
|
Prkar2b
|
protein kinase cAMP-dependent type II regulatory subunit beta
|
multiple interactions
|
EXP ISO
|
2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside inhibits the reaction [[Oxygen co-treated with Glucose deficiency] results in decreased expression of PRKAR2B protein]; [Oxygen co-treated with Glucose deficiency] results in decreased expression of PRKAR2B protein; rhodioloside inhibits the reaction [[Oxygen co-treated with Glucose deficiency] results in decreased expression of PRKAR2B protein] [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRKAR2B mRNA
|
CTD |
PMID:24726522 PMID:30529165 |
|
NCBI chr 6:54,291,143...54,381,639
Ensembl chr 6:54,291,151...54,381,411
|
|
| G
|
Prkcd
|
protein kinase C, delta
|
multiple interactions
|
ISO
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased activity of and results in increased localization of PRKCD protein]; bisindolylmaleimide II inhibits the reaction [Oxygen deficiency results in increased activity of and results in increased localization of PRKCD protein]; Oxygen deficiency results in increased activity of and results in increased localization of PRKCD protein; PRKCD protein promotes the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]; PRKCD protein promotes the reaction [Oxygen deficiency results in increased expression of HSF1 mRNA]; Quercetin inhibits the reaction [Oxygen deficiency results in increased activity of and results in increased localization of PRKCD protein]; Tetradecanoylphorbol Acetate inhibits the reaction [Oxygen deficiency results in increased activity of and results in increased localization of PRKCD protein]; Wortmannin inhibits the reaction [Oxygen deficiency results in increased activity of and results in increased localization of PRKCD protein]
|
CTD |
PMID:11424089 |
|
NCBI chr16:5,775,681...5,806,122
Ensembl chr16:5,775,681...5,805,839
|
|
| G
|
Prkce
|
protein kinase C, epsilon
|
multiple interactions increases activity decreases response to substance
|
ISO EXP
|
GPX1 protein inhibits the reaction [Oxygen deficiency results in increased activity of PRKCE protein]; Hydrogen Peroxide inhibits the reaction [Rotenone inhibits the reaction [Oxygen deficiency results in increased activity of PRKCE protein]]; myxothiazol inhibits the reaction [Oxygen deficiency results in increased activity of PRKCE protein]; PRKCE protein affects the reaction [Oxygen deficiency results in increased abundance of Calcium]; Rotenone inhibits the reaction [Oxygen deficiency results in increased activity of PRKCE protein] PRKCE gene mutant form results in decreased susceptibility to Oxygen deficiency [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PRKCE mRNA
|
CTD |
PMID:17087917 PMID:18638544 PMID:33729688 |
|
NCBI chr 6:13,718,050...14,204,931
Ensembl chr 6:13,718,050...14,204,288
|
|
| G
|
Prkci
|
protein kinase C, iota
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRKCI mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 2:114,250,398...114,310,784
Ensembl chr 2:114,250,398...114,310,784
|
|
| G
|
Prkd1
|
protein kinase D1
|
increases expression
|
ISO
|
Oxygen deficiency results in increased expression of PRKD1 mRNA
|
CTD |
PMID:17175027 |
|
NCBI chr 6:73,460,640...73,774,433
Ensembl chr 6:73,460,640...73,836,509
|
|
| G
|
Prkd2
|
protein kinase D2
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRKD2 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:86,640,095...86,670,476
Ensembl chr 1:86,642,629...86,670,675
|
|
| G
|
Prkdc
|
protein kinase, DNA-activated, catalytic subunit
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRKDC mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr11:98,544,952...98,762,499
Ensembl chr11:98,544,954...98,762,108
|
|
| G
|
Prkn
|
parkin RBR E3 ubiquitin protein ligase
|
multiple interactions
|
ISO EXP
|
[Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of PRKN protein; genipin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of PRKN protein]; sirtinol inhibits the reaction [genipin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of PRKN protein]] [Oxygen deficiency co-treated with Oxygen] results in decreased expression of PRKN protein; dorsomorphin inhibits the reaction [sappanone A inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of PRKN protein]]; sappanone A inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of PRKN protein]
|
CTD |
PMID:28477916 PMID:34358556 |
|
NCBI chr 1:51,236,410...52,430,242
Ensembl chr 1:51,210,330...52,430,304
|
|
| G
|
Prmt1
|
protein arginine methyltransferase 1
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRMT1 mRNA
|
CTD |
PMID:30529165 |
|
NCBI chr 1:104,595,339...104,605,552
Ensembl chr 1:104,595,335...104,604,827
|
|
| G
|
Prmt3
|
protein arginine methyltransferase 3
|
decreases expression multiple interactions
|
ISO
|
Oxygen deficiency results in decreased expression of PRMT3 mRNA [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRMT3 mRNA
|
CTD |
PMID:26516004 PMID:30529165 |
|
NCBI chr 1:108,628,899...108,718,803
Ensembl chr 1:108,626,749...108,718,803
|
|
| G
|
Prmt5
|
protein arginine methyltransferase 5
|
multiple interactions
|
ISO
|
[NFE2L2 protein affects the susceptibility to |